
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/18/2022</td><td class="leftalignment">Zeus Capital</td><td class="leftalignment">Guild Esports (GILD LN) - Large sponsorship deal</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GB00BMWVF760</td><td class="leftalignment">Guild Esports PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bob H. Liao</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Coverage Report : A summary of credit analyst recommendations in the Healthcare sector</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.O / BSX.N / BAX.N / BDX.N / BMY.N / CAH.N / CI.N / CVS.N / JNJ.N / LLY.N / MCK.N / MRK.N / TMO.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / ABC.N / BIIB.O / ABBV.N / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amgen Inc / Boston Scientific Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Amerisourcebergen Corp / Biogen Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / AN=US / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / MCD=US / WEN=US / AGL=US / BLDP=US / AMZN=US / BLD=US / INCY=US / RUN=US / GILD=US / PLUG=US / NOVA=US / LOW=US / THC=US / TTWO=US / LEG=US / VMC=US / HUM=US / CVS=US / CI=US / MLM=US / UNH=US / KFY=US / AMED=US / AMN=US / SWIM=US / ARRY=US / BMRN=US / CBRL=US / KIDS=US / DRI=US / EXEL=US / FCN=US / GFF=US / ABG=US / IBP=US / MAS=US / MHK=US / ASGN=US / REGI=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / CCRN=US / CNC=US / R=US / CNM=US / JAZZ=US / BE=US / DIN=US / ACVA=US / BCO=US / MOH=US / BIIB=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / SPWR=US / CMG=US / REX=US / PGTI=US / GPRE=US / ICFI=US / AWI=US / OC=US / CPRX=US / TAST=US / QSR=US / PRPL=US / LULU=US / IAA=US / ATSG=US / JACK=US / RCUS=US / TREX=US / GNRC=US / FBHS=US / ZNGA=US / ENPH=US / TILE=US / NDLS=US / PTCT=US / FATE=US / CNCE=US / 00770K202 / LOCO=US / OSH=US / UPLD=US / ANTM=US / SHAK=US / GDDY=US / SEDG=US / WING=US / SPNE=US / NVCR=US / 82982L103 / GXO=US / IRTC=US / CRSP=US / ANAB=US / JELD=US / DCPH=US / ALLO=US / FERG=US / AHCO=US / AZEK=US / SHLS=US / PRVA=US / SNPO=US / ROIV=US</td><td class="leftalignment">Cars.com Inc / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / Ballard Power Systems Inc / Amazon.com Inc / TopBuild Corp / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Plug Power Inc / Sunnova Energy International Inc / Lowe's Companies Inc / Tenet Healthcare Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / Humana Inc / CVS Health Corp / Cigna Corp / Martin Marietta Materials Inc / UnitedHealth Group Inc / Korn Ferry / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Array Technologies Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / OrthoPediatrics Corp / Darden Restaurants Inc / Exelixis Inc / FTI Consulting Inc / Griffon Corp / Asbury Automotive Group Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Cross Country Healthcare Inc / Centene Corp / Ryder System Inc / Core & Main Inc / Jazz Pharmaceuticals PLC / Bloom Energy Corp / Dine Brands Global Inc / ACV Auctions Inc / Brinks Co / Molina Healthcare Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / SunPower Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / ICF International Inc / Armstrong World Industries Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / IAA Inc / Air Transport Services Group Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / Zynga Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Upland Software Inc / Anthem Inc / Shake Shack Inc / GoDaddy Inc / Solaredge Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Novocure Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / JELD-WEN Holding Inc / Deciphera Pharmaceuticals Inc / Allogene Therapeutics Inc / Ferguson PLC / Adapthealth Corp / Azek Company Inc / Shoals Technologies Group Inc / Privia Health Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">2022 HC Conf Day 1 Recap : Credit Takeaways from the 40th Annual J.P. Morgan Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BAX.N / BMY.N / CAH.N / HUM.N / GILD.O / ABC.N / BIIB.O / ZTS.N</td><td class="leftalignment">Baxter International Inc / Bristol-Myers Squibb Co / Cardinal Health Inc / Humana Inc / Gilead Sciences Inc / Amerisourcebergen Corp / Biogen Inc / Zoetis Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : JPM22 Investor Event Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Nightcap: Partnerships are good for Pharma/LC biotech but investors looking for M&A</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / INCY=US / GILD=US / BMRN=US / VRTX=US / BIIB=US / RCUS=US / PTCT=US / FATE=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Arcus Biosciences Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : Live from The J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ABT / AME / BAC / BSX / CP / IEX / IOT / MDT / NOC.N / NSC / PEN / PFE.N / PNC / ROP / TFC / USB / GILD.O / GD.N / EPC / REGN.O / VRTX.O / NDSN.O / BIIB.O / DXCM.O / TNDM.OQ / FIVE.O / MEIP.O / NVRO.K / SMAR.K / SWAV.O / LHX.N / BEAM.O</td><td class="leftalignment">Abbott Laboratories / AMETEK Inc / Bank of America Corp / Boston Scientific Corp / Canadian Pacific Railway Ltd / IDEX Corp / Samsara Inc / Medtronic PLC / Northrop Grumman Corp / Norfolk Southern Corp / Penumbra Inc / Pfizer Inc / PNC Financial Services Group Inc / Roper Technologies Inc / Truist Financial Corp / US Bancorp / Gilead Sciences Inc / General Dynamics Corp / Edgewell Personal Care Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nordson Corp / Biogen Inc / Dexcom Inc / Tandem Diabetes Care Inc / Five Below Inc / MEI Pharma Inc / Nevro Corp / Smartsheet Inc / Shockwave Medical Inc / L3harris Technologies Inc / Beam Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">GILD: Takeaways From JPM; HIV Mkt Bounces Back & Oral Remdesivir in the Works</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">GILD: Key Takeaways from GILD Call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAPL / ACI / ADS / AGCO / ASML.AS / ATRC / AXP / BEAM / BOLT / CHD / COF / COST / DE / DFS / DG / DOV / DYN / EL / FDX / GE / GS / INCY / INSP / INTC.O / JPM.N / KR / LOW / LRCX.O / MS / MSFT / NET / NKE / O / PRGO / QCOM.O / ROK / SAP / T / TRMB / URI / ONCR / AMZN.O / GNSS / GILD.O / CNSP.O / EW / PRAX / NVDA.O / RMD / AKAM / SBAC.O / XRAY.O / FMTX / ISRG / VZ / AQUA / NFLX / SYF / PLUG.O / ADSK.O / PCSA.O / ARRY.O / FCEL.O / AMSC.O / AVGO.O / TEAM.O / SIVB.O / ITRI.O / EXAS.O / ANGN.O / 478160104 / 459200101 / CYTK.O / GOOG.O / QSR / ALNY.O / DXCM.O / SPWR.O / CSIQ.O / FSLR.O / IPGP.O / LULU / 02043Q107 / STTK / STX.OQ / WPRT.O / TWIN.O / GPRE.O / TSLA.O / SWAV / PCYO.O / NXPI.O / AMRS.O / ANVS / ENPH.O / FB.O / CNHI / RXDX.O / SEDG.O / RUN.O / IONS.O / WKHS.O / AQMS.O / WINT.O / AQB / OKTA.O / MTEM.O / TMDX / KERN.O / CRWD.O / TCOM.O / ZNTL.O / ORIC.O / PLRX.O / 02081G201 / AMTI.O / LTRN.O / PCVX.O / ANNX.O / PYPD.O / CMPS.OQ / HRMY.O / SPRB.OQ / PMVP / PRLD / KDNY.O / TSHA.O / VLDR.O / AYLA / CYTH.O / BIVI / SHLS.O / APPH / TARS.O / LABP.O / SNSE.O / IMCR.O / PHVS.O / INBX.O / NEXI.O / NKTX.O / LVTX.O / GANX.O / TSP.O / BMEA.O / US00449L1026 / EVAX.O / IKT / 744285206 / CGTX.OQ / CRBU.O / ENVX.O / LILM.O / JSPR.O / BHIL.K / LOCL.k / 871156105 / VERA.O / VRPX.O</td><td class="leftalignment">Apple Inc / Albertsons Companies Inc / Alliance Data Systems Corp / AGCO Corp / ASML Holding NV / AtriCure Inc / American Express Co / Beam Therapeutics Inc / Bolt Biotherapeutics Inc / Church & Dwight Co Inc / Capital One Financial Corp / Costco Wholesale Corp / Deere & Co / Discover Financial Services / Dollar General Corp / Dover Corp / Dyne Therapeutics Inc / Estee Lauder Companies Inc / FedEx Corp / General Electric Co / Goldman Sachs Group Inc / Incyte Corp / Inspire Medical Systems Inc / Intel Corp / JPMorgan Chase & Co / Kroger Co / Lowe's Companies Inc / Lam Research Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Realty Income Corp / Perrigo Company PLC / Qualcomm Inc / Rockwell Automation Inc / SAP SE / AT&T Inc / Trimble Inc / United Rentals Inc / Oncorus Inc / Amazon.com Inc / Genasys Inc / Gilead Sciences Inc / CNS Pharmaceuticals Inc / Edwards Lifesciences Corp / Praxis Precision Medicines Inc / NVIDIA Corp / Resmed Inc / Akamai Technologies Inc / SBA Communications Corp / DENTSPLY SIRONA Inc / Forma Therapeutics Holdings Inc / Intuitive Surgical Inc / Verizon Communications Inc / Evoqua Water Technologies Corp / Netflix Inc / Synchrony Financial / Plug Power Inc / Autodesk Inc / Processa Pharmaceuticals Inc / Array Technologies Inc / Fuelcell Energy Inc / American Superconductor Corp / Broadcom Inc / Atlassian Corporation PLC / SVB Financial Group / Itron Inc / Exact Sciences Corp / Angion Biomedica Corp / Johnson & Johnson / International Business Machines Corp / Cytokinetics Inc / Alphabet Inc / Restaurant Brands International Inc / Alnylam Pharmaceuticals Inc / Dexcom Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / IPG Photonics Corp / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Shattuck Labs Inc / Seagate Technology Holdings PLC / Westport Fuel Systems Inc / Twin Disc Inc / Green Plains Inc / Tesla Inc / Shockwave Medical Inc / Pure Cycle Corp / NXP Semiconductors NV / Amyris Inc / Annovis Bio Inc / Enphase Energy Inc / Meta Platforms Inc / CNH Industrial NV / Prometheus Biosciences Inc / Solaredge Technologies Inc / Sunrun Inc / Ionis Pharmaceuticals Inc / Workhorse Group Inc / Aqua Metals Inc / Windtree Therapeutics Inc / AquaBounty Technologies Inc / Okta Inc / Molecular Templates Inc / Transmedics Group Inc / Akerna Corp / CrowdStrike Holdings Inc / Trip.com Group Ltd / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Pliant Therapeutics Inc / Alphatec Holdings Inc / Applied Molecular Transport Inc. / Lantern Pharma Inc. / Vaxcyte Inc / Annexon Inc / PolyPid Ltd / Compass Pathways PLC / Harmony Biosciences Holdings Inc / Spruce Biosciences Inc / PMV Pharmaceuticals Inc / Prelude Therapeutics Inc / Chinook Therapeutics Inc / Taysha Gene Therapies Inc / Velodyne Lidar Inc / Ayala Pharmaceuticals Inc / Cyclo Therapeutics Inc / BioVie Inc / Shoals Technologies Group Inc / AppHarvest Inc / Tarsus Pharmaceuticals Inc / Landos Biopharma Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Pharvaris NV / Inhibrx Inc / Neximmune Inc / Nkarta Inc / LAVA Therapeutics NV / Gain Therapeutics Inc / TuSimple Holdings Inc / Biomea Fusion Inc / Achilles Therapeutics PLC / Evaxion Biotech A/S / Inhibikase Therapeutics Inc / Proxim Wireless Corp / Cognition Therapeutics Inc / Caribou Biosciences Inc / Enovix Corp / Lilium NV / Jasper Therapeutics Inc / Benson Hill Inc / Local Bounti Corp / Sycamore Entertainment Group Inc / Vera Therapeutics Inc / Virpax Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Trodelvy TROPiCs-02 Preview – Deep Dive into the Clinical Risk</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Ike Oji / Jameson Kao</td></tr>
<tr class="even"><td class="leftalignment">01/08/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">January Effect, Rate Rise, and Rotation</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AAPL / CHD / COST / DG / DOV / EL / GE / GS / INCY / INTC.O / JPM.N / KR / LOW / LRCX.O / MS / MSFT / NET / NKE / O / PRGO / QCOM.O / ROK / SAP / T / URI / AMZN.O / GILD.O / EW / NVDA.O / AKAM / SBAC.O / XRAY.O / ISRG / VZ / NFLX / ADSK.O / AVGO.O / SIVB.O / 459200101 / GOOG.O / QSR / DXCM.O / IPGP.O / LULU / 02043Q107 / STX.OQ / TSLA.O / NXPI.O / ENPH.O / FB.O / OKTA.O / CRWD.O / TCOM.O / 744285206</td><td class="leftalignment">Apple Inc / Church & Dwight Co Inc / Costco Wholesale Corp / Dollar General Corp / Dover Corp / Estee Lauder Companies Inc / General Electric Co / Goldman Sachs Group Inc / Incyte Corp / Intel Corp / JPMorgan Chase & Co / Kroger Co / Lowe's Companies Inc / Lam Research Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Realty Income Corp / Perrigo Company PLC / Qualcomm Inc / Rockwell Automation Inc / SAP SE / AT&T Inc / United Rentals Inc / Amazon.com Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / NVIDIA Corp / Akamai Technologies Inc / SBA Communications Corp / DENTSPLY SIRONA Inc / Intuitive Surgical Inc / Verizon Communications Inc / Netflix Inc / Autodesk Inc / Broadcom Inc / SVB Financial Group / International Business Machines Corp / Alphabet Inc / Restaurant Brands International Inc / Dexcom Inc / IPG Photonics Corp / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Seagate Technology Holdings PLC / Tesla Inc / NXP Semiconductors NV / Enphase Energy Inc / Meta Platforms Inc / Okta Inc / CrowdStrike Holdings Inc / Trip.com Group Ltd / Proxim Wireless Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NNVC-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NNVC.K / BMY / MRK / GILD.O / NBY / GSK / BCRX.O / NVAX.O / CMRX.O</td><td class="leftalignment">NanoViricides Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Gilead Sciences Inc / NovaBay Pharmaceuticals Inc / GlaxoSmithKline PLC / BioCryst Pharmaceuticals Inc / Novavax Inc / Chimerix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BCLI-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BCLI.O / GILD.O / AGEN.O / SGEN.O / BIIB.O / CYTK.O / IDRA.O / BIEI.PK</td><td class="leftalignment">Brainstorm Cell Therapeutics Inc / Gilead Sciences Inc / Agenus Inc / Seagen Inc / Biogen Inc / Cytokinetics Inc / Idera Pharmaceuticals Inc / Premier Biomedical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Suspending Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">00287Y10 / 03116210 / 71708110 / 92532F10 / 37555810 / 75886F10 / 80105N10 / 40637H10 / 31572Q80 / 75046920 / G3910J11 / 61776010 / G8807B10 / 04539610 / 68386J20 / G7627910</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Halozyme Therapeutics Inc / FibroGen Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Theravance Biopharma Inc / Assembly Biosciences Inc / Opthea Ltd / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jim Kelly</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT / AMAT.O / ARW / CCO / DIS / DVN / INTC.O / IPG / KLAC.O / LRCX.O / MCHP.O / OMC / PFE.N / QCOM.O / RKT / RMBS.O / SWN / T / XLNX.O / HUM.N / GILD.O / ASML.O / AUD.N / CMCSA.O / WWE / AAPL.O / CSCO.O / SBGI.O / NVDA.O / MGM.N / GTN / SIRI.O / SGMO.O / AMD.O / ADI.O / VZ / NTAP.O / ARNA.O / SMTC.O / SLAB.O / SNPS.O / CHTR.O / BYD.N / ARGX.O / AYI / MU.O / NEE / MRVL.O / HPQ / CRK.N / HPE / AVGO.O / FCEL.OQ / BLUE.O / BPOP.O / DIOD.O / MKSI.O / NFLX.O / SWKS.O / NXST.O / VIAC.O / DXCM.O / DISCA.O / CDNS.O / STX.O / CVLT.O / CNK.N / PODD.O / JNPR.K / IMAX.N / NXPI.O / CCXI.O / CZR.O / AMCX.O / WDC.O / AMBA.O / RGLS.O / PFSI.K / FOXA.O / RNA.O / HMTV.O / QURE.O / AGTC.O / ANET.K / AFMD.O / QRVO.O / ON.O / CABO.N / TGNA.K / GBT.O / PSTG.K / TMUS.O / VYGR.O / IONS.O / EDIT.O / AGLE.O / NTLA.O / NTNX.O / CRSP.O / LGFb.N / ATUS.N / BOMN.O / ROKU.O / XEL.O / AVT.O / SPOT.K / SSP.O / AVRO.O / DELL.K / IHRT.O / RAPT.O / BEAM.O / CTRA.K / ALGM.O / CHK.O / HMPT.O / VZIO.N / WOLF.N / ARBE.O / MXL.O</td><td class="leftalignment">Abbott Laboratories / Applied Materials Inc / Arrow Electronics Inc / Clear Channel Outdoor Holdings Inc / Walt Disney Co / Devon Energy Corp / Intel Corp / Interpublic Group of Companies Inc / KLA Corp / Lam Research Corp / Microchip Technology Inc / Omnicom Group Inc / Pfizer Inc / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / Southwestern Energy Co / AT&T Inc / Xilinx Inc / Humana Inc / Gilead Sciences Inc / ASML Holding NV / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Apple Inc / Cisco Systems Inc / Sinclair Broadcast Group Inc / NVIDIA Corp / MGM Resorts International / Gray Television Inc / Sirius XM Holdings Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / Analog Devices Inc / Verizon Communications Inc / NetApp Inc / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Charter Communications Inc / Boyd Gaming Corp / argenx SE / Acuity Brands Inc / Micron Technology Inc / Nextera Energy Inc / Marvell Technology Inc / HP Inc / Comstock Resources Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Fuelcell Energy Inc / bluebird bio Inc / Popular Inc / Diodes Inc / MKS Instruments Inc / Netflix Inc / Skyworks Solutions Inc / Nexstar Media Group Inc / ViacomCBS Inc / Dexcom Inc / Discovery Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Commvault Systems Inc / Cinemark Holdings Inc / Insulet Corp / Juniper Networks Inc / Imax Corp / NXP Semiconductors NV / ChemoCentryx Inc / Caesars Entertainment Inc / AMC Networks Inc / Western Digital Corp / Ambarella Inc / Regulus Therapeutics Inc / PennyMac Financial Services Inc / Fox Corp / Avidity Biosciences Inc / Hemisphere Media Group Inc / Uniqure NV / Applied Genetic Technologies Corp / Arista Networks Inc / Affimed NV / Qorvo Inc / ON Semiconductor Corp / Cable One Inc / Tegna Inc / Global Blood Therapeutics Inc / Pure Storage Inc / T-Mobile US Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / Nutanix Inc / CRISPR Therapeutics AG / Lions Gate Entertainment Corp / Altice USA Inc / Boston Omaha Corp / Roku Inc / Xcel Energy Inc / Avnet Inc / Spotify Technology SA / E W Scripps Co / AVROBIO Inc / Dell Technologies Inc / iHeartMedia Inc / Rapt Therapeutics Inc / Beam Therapeutics Inc / Coterra Energy Inc / Allegro Microsystems Inc / Chesapeake Energy Corp / Home Point Capital Inc / Vizio Holding Corp / Wolfspeed Inc / Arbe Robotics Ltd / Maxlinear Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Israel / Luxembourg / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AES.N / AIG.N / BATS.L / BB.N / BCE.TO / BMO.TO / BNS.TO / CCO.TO / CM.TO / CP.TO / CWK.L / DANO.PA / DD.N / DGE.L / GE.N / HEIN.AS / HMb.ST / NA.TO / NSC.N / OREP.PA / PD.TO / PERP.PA / RYN.N / SLB.N / STO.AX / T.TO / TD.TO / ULVR.L / SSE.L / AMZN.O / WY.N / CFP.TO / CNQ.TO / GILD.O / LPX.N / HNKG_p.DE / SJRb.TO / TA.TO / RCIb.TO / AAL.L / CLS.N / CNR.TO / QBRb.TO / UNH.N / CCA.TO / WCC.N / ENB.TO / TRP.TO / CSX.N / UNP.N / CAG.N / BEIG.DE / AEM.N / KGC.N / BBVA.MC / GIBa.TO / CARLb.CO / PCOM.O / ALA.TO / DSGX.O / RRC.N / V.N / ARE.N / ARA.TO / MTB.N / OTEX.O / LB.TO / FTS.TO / CWB.TO / VRTX.O / SWIR.O / JHX.AX / EMA.TO / AIF.TO / CEY.L / PSI.TO / CU.TO / ACOx.TO / COP.N / ASC.L / APF.L / CRC.N / LNG.A / PLUG.OQ / RGLD.O / TCLa.TO / MDI.TO / FM.TO / CHE_u.TO / NST.AX / 878742204 / EDV.TO / NESN.S / HCG.TO / NTR.N / RRL.AX / MOS.N / WEF.TO / RDSb.L / BAM.N / BVIC.L / DRX.L / SES.TO / TDG.N / MA.N / CSU.TO / CPX.TO / CS.TO / 443628102 / H.TO / HFG.L / PPL.TO / DAIGn.DE / CPRI.MI / OSK.TO / BIP.N / ARX.TO / ABI.BR / SFR.AX / CVE.TO / AR.TO / ADN.TO / TOU.TO / PCH.O / TRGP.N / CJT.TO / KEY.TO / CTT.N / GLEN.L / ATD.TO / GEI.TO / IFP.TO / WTE.TO / TRL.TO / TVE.TO / EFN.TO / OPS.TO / ISV.TO / EQB.TO / 46579R104 / CFF.TO / PLC.TO / CIA.TO / KXS.TO / FEVR.L / SHOP.N / TDOC.N / ZG.O / TWM.TO / IMB.L / SPGI.N / TWLO.N / AZRE.N / ECN.TO / ENGH.TO / AQN.N / RCM.OQ / FOOD.TO / JWEL.TO / SSRM.O / KL.N / DBX.O / MI_U.TO / HOMU.TO / ZM.O / RTLR.O / CRWD.O / GMAB.O / ADT1.L / ERE_u.TO / AD_u.TO / LSPD.N / WFG.N / TIXT.TO / RKT.L / MAGT.TO / DBM.TO / SFTC.TO / LSPK.TO / LCFS.TO / NVEI.OQ / FLNC.OQ / CVO.TO</td><td class="leftalignment">AES Corp / American International Group Inc / British American Tobacco PLC / BlackBerry Ltd / BCE Inc / Bank of Montreal / Bank of Nova Scotia / Cameco Corp / Canadian Imperial Bank of Commerce / Canadian Pacific Railway Ltd / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / General Electric Co / Heineken NV / H & M Hennes & Mauritz AB / National Bank of Canada / Norfolk Southern Corp / L'Oreal SA / Precision Drilling Corp / Pernod Ricard SA / Rayonier Inc / Schlumberger NV / Santos Ltd / Telus Corp / Toronto-Dominion Bank / Unilever PLC / SSE PLC / Amazon.com Inc / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Henkel AG & Co KGaA / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Anglo American PLC / Celestica Inc / Canadian National Railway Co / Quebecor Inc / UnitedHealth Group Inc / Cogeco Communications Inc / Wesco International Inc / Enbridge Inc / TC Energy Corp / CSX Corp / Union Pacific Corp / Conagra Brands Inc / Beiersdorf AG / Agnico Eagle Mines Ltd / Kinross Gold Corp / Banco Bilbao Vizcaya Argentaria SA / CGI Inc / Carlsberg A/S / Points International Ltd / AltaGas Ltd / Descartes Systems Group Inc / Range Resources Corp / Visa Inc / Alexandria Real Estate Equities Inc / Aclara Resources Inc / M&T Bank Corp / Open Text Corp / Laurentian Bank of Canada / Fortis Inc / Canadian Western Bank / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / James Hardie Industries PLC / Emera Inc / Altus Group Ltd / Centamin PLC / Pason Systems Inc / Canadian Utilities Ltd / Atco Ltd / Conocophillips / ASOS PLC / Anglo Pacific Group PLC / California Resources Corp / Cheniere Energy Inc / Plug Power Inc / Royal Gold Inc / Transcontinental Inc / Major Drilling Group International Inc / First Quantum Minerals Ltd / Chemtrade Logistics Income Fund / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Nestle SA / Home Capital Group Inc / Nutrien Ltd / Regis Resources Ltd / Mosaic Co / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Britvic PLC / Drax Group PLC / Secure Energy Services Inc / TransDigm Group Inc / Mastercard Inc / Constellation Software Inc / Capital Power Corp / Capstone Mining Corp / Hudbay Minerals Inc / Hydro One Ltd / Hilton Food Group PLC / Pembina Pipeline Corp / Daimler AG / Davide Campari Milano NV / Osisko Mining Inc / Brookfield Infrastructure Partners LP / ARC Resources Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Cenovus Energy Inc / Argonaut Gold Inc / Acadian Timber Corp / Tourmaline Oil Corp / Potlatchdeltic Corp / Targa Resources Corp / Cargojet Inc / Keyera Corp / CatchMark Timber Trust Inc / Glencore PLC / Alimentation Couche-Tard Inc / Gibson Energy Inc / Interfor Corp / Westshore Terminals Investment Corp / Trilogy International Partners Inc / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Opsens Inc / Information Services Corp / Equitable Group Inc / Ivanhoe Mines Ltd / Conifex Timber Inc / Park Lawn Corp / Champion Iron Ltd / Kinaxis Inc / Fevertree Drinks PLC / Shopify Inc / Teladoc Health Inc / Zillow Group Inc / Tidewater Midstream and Infrastructure Ltd / Imperial Brands PLC / S&P Global Inc / Twilio Inc / Azure Power Global Ltd / ECN Capital Corp / Enghouse Systems Ltd / Algonquin Power & Utilities Corp / R1 RCM Inc / Goodfood Market Corp / Jamieson Wellness Inc / SSR Mining Inc / Kirkland Lake Gold Ltd / Dropbox Inc / Minto Apartment Real Estate Investment Trust / BSR Real Estate Investment Trust / Zoom Video Communications Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Adriatic Metals PLC / European Residential REIT / Alaris Equity Partners Income Trust / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Reckitt Benckiser Group PLC / Magnet Forensics Inc / Doman Building Materials Group Ltd / Softchoice Corp (CA) / LifeSpeak Inc / Tidewater Renewables Ltd / Nuvei Corp / Fluence Energy Inc / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Mauritius / Netherlands / Sweden / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Andre-Philippe Hardy, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 31, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : Thinking About the TROPiCS; Data Preview and Doc Rounds Ahead of Key Phase 3 Update</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DVN / PFE.N / T / HUM.N / GILD.O / MGM.N / VZ / ARNA.O / BYD.N / BPOP.O / CZR.O / TMUS.O / CTRA.K</td><td class="leftalignment">Devon Energy Corp / Pfizer Inc / AT&T Inc / Humana Inc / Gilead Sciences Inc / MGM Resorts International / Verizon Communications Inc / Arena Pharmaceuticals Inc / Boyd Gaming Corp / Popular Inc / Caesars Entertainment Inc / T-Mobile US Inc / Coterra Energy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / CARS / FISV=US / LLY=US / AMGN=US / BMY=US / TWTR=US / AMZN=US / EBAY=US / GILD=US / PEB=US / H=US / CRM=US / V=US / MTN=US / VRM=US / MAR=US / EXPE=US / TNL=US / HLT=US / HUM=US / CVS=US / W=US / STZ=US / DV=US / AIR=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CCK=US / CW=US / DRH=US / DCO=US / EEFT=US / HEI=US / HXL=US / TREE=US / MRCY=US / NRDS=US / REGN=US / ROLL=US / SHOP=US / SFT=US / SNAP=US / TRIP=US / TGI=US / TRUE=US / VSEC=US / VRTX=US / WIX=US / WEX=US / FOUR=US / GPN=US / PYPL=US / BKNG=US / PRI=US / FB=US / MTCH=US / SPR=US / EVOP=US / MQ / DKS=US / PTON=US / BIIB=US / FLT=US / MOG.A=US / APP=US / SHO=US / BLDR=US / FIS=US / TDG=US / HST=US / MA=US / WU=US / KTOS=US / WH=US / IAC=US / 45665G303 / HGV=US / GDOT=US / WWD=US / PCRX=US / RLJ=US / VAC=US / ANGI=US / RHP=US / SSTK=US / ABBV=US / GOOGL=US / BABA=US / AFMD=US / CMPR=US / BVH=US / WBA=US / GDDY=US / ETSY=US / AJRD=US / BWXT=US / ZG=US / SQ=US / IBEX=US / NTLA=US / TTD=US / CRSP=US / TRVG=US / PK=US / PLYA=US / AYX=US / CVNA=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / MAXR=US / GSKY=US / FTDR=US / EB=US / AXNX=US / LYFT=US / UBER=US / LSPD=US / APLT=US / LHX=US / RPAY=US / ONEW=US / SPCE=US / AZEK=US / TSHA / PAYA=US / ABNB=US / DASH=US / AFRM=US / VMEO=US / MNTV=US / SQSP=US / 00152K101</td><td class="leftalignment">Albany International Corp / Cars.com Inc / Fiserv Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Twitter Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / CVS Health Corp / Wayfair Inc / Constellation Brands Inc / DoubleVerify Holdings Inc / AAR Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Euronet Worldwide Inc / HEICO Corp / Hexcel Corp / Lendingtree Inc / Mercury Systems Inc / Nerdwallet Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Shopify Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / TrueCar Inc / VSE Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / WEX Inc / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / Marqeta Inc / DICK'S Sporting Goods Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Applovin Corp / Sunstone Hotel Investors Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Western Union Co / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Green Dot Corp / Woodward Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Shutterstock Inc / Abbvie Inc / Alphabet Inc / Alibaba Group Holding Ltd / Affimed NV / Cimpress PLC / Bluegreen Vacations Holding Corp / Walgreens Boots Alliance Inc / GoDaddy Inc / ETSY Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Zillow Group Inc / Block Inc / Ibex Ltd / Intellia Therapeutics Inc / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Alteryx Inc / Carvana Co / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Maxar Technologies Inc / GreenSky Inc / Frontdoor Inc / Eventbrite Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Applied Therapeutics Inc / L3harris Technologies Inc / Repay Holdings Corp / OneWater Marine Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Taysha Gene Therapies Inc / Paya Holdings Inc / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AME / AR / AZO / BAC / CB / CLR / CMS / CNX / CPE / DIS / DLR / DOW / DVN / EL / EOG / EQT / F.N / FNB / FRC / GM.N / GPS / JNJ / MA / MDT / MGY / MRO / NSC / NTB / OLN / PFE.N / PXD / RRC / SM / SNV / SO / STZ / SWN / SYK / SYY / T / WAL / WLL / TROW.O / AMZN.O / HUM.N / GILD.O / ASB / AAPL.O / CSCO.O / MGM.N / VZ / PACW.O / SNPS.O / EXPE.O / BYD.N / CBSH.O / PENN.O / LPI / CHDN.O / WBS / FBP.N / OFG.N / WYNN.O / PBCT.O / SIVB.O / UMBF.O / BPOP.O / BOKF.O / ACGL.O / UMPQ.O / EWBC.O / PNFP.O / FHN / SBNY.O / LVS.N / QSR / ISBC.O / NOG.A / NXPI.O / FIBK.O / CZR.O / BKU / STAG.K / ESTE.K / MTDR.K / FB.O / PDCE.O / FANG.O / ABBV.N / MAR.O / GOOGL.O / BANC.K / TBK.O / QRVO.O / CIVI.K / TDOC.N / GKOS.K / ZBH / TMUS.O / RRR.O / NTLA.O / FHB.O / CDEV.O / OZK.O / BRY.O / AXNX.O / UBER.K / FLTRF.L / CRWD.O / AVTR.K / OAS.O / OVV.N / DKNG.O / CTRA.K / BALY.N / RSI.N / CHK.O / RIVN.O</td><td class="leftalignment">AMETEK Inc / Antero Resources Corp / Autozone Inc / Bank of America Corp / Chubb Ltd / Continental Resources Inc / CMS Energy Corp / CNX Resources Corp / Callon Petroleum Co / Walt Disney Co / Digital Realty Trust Inc / Dow Inc / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Ford Motor Co / FNB Corp / First Republic Bank / General Motors Co / Gap Inc / Johnson & Johnson / Mastercard Inc / Medtronic PLC / Magnolia Oil & Gas Corp / Marathon Oil Corp / Norfolk Southern Corp / Bank of N T Butterfield & Son Ltd / Olin Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / SM Energy Co / Synovus Financial Corp / Southern Co / Constellation Brands Inc / Southwestern Energy Co / Stryker Corp / Sysco Corp / AT&T Inc / Western Alliance Bancorp / Whiting Petroleum Corp / T Rowe Price Group Inc / Amazon.com Inc / Humana Inc / Gilead Sciences Inc / Associated Banc-Corp / Apple Inc / Cisco Systems Inc / MGM Resorts International / Verizon Communications Inc / PacWest Bancorp / Synopsys Inc / Expedia Group Inc / Boyd Gaming Corp / Commerce Bancshares Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Churchill Downs Inc / Webster Financial Corp / First Bancorp / OFG Bancorp / Wynn Resorts Ltd / People's United Financial Inc / SVB Financial Group / UMB Financial Corp / Popular Inc / BOK Financial Corp / Arch Capital Group Ltd / Umpqua Holdings Corp / East West Bancorp Inc / Pinnacle Financial Partners Inc / First Horizon Corp / Signature Bank / Las Vegas Sands Corp / Restaurant Brands International Inc / Investors Bancorp Inc / Northern Oil and Gas Inc / NXP Semiconductors NV / First Interstate BancSystem Inc / Caesars Entertainment Inc / BankUnited Inc / STAG Industrial Inc / Earthstone Energy Inc / Matador Resources Co / Meta Platforms Inc / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Marriott International Inc / Alphabet Inc / Banc of California Inc / Triumph Bancorp Inc / Qorvo Inc / Civitas Resources Inc / Teladoc Health Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Red Rock Resorts Inc / Intellia Therapeutics Inc / First Hawaiian Inc / Centennial Resource Development Inc / Bank Ozk / Berry Corporation (Bry) / Axonics Inc / Uber Technologies Inc / Flutter Entertainment PLC / CrowdStrike Holdings Inc / Avantor Inc / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Coterra Energy Inc / Bally's Corp / Rush Street Interactive Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALTR.O / BOX.N / CNA.L / CP.TO / CRM.N / MSFT.O / NSC.N / PD.N / RWEG.DE / HUM.N / GILD.O / CHKP.O / INCY.O / CNR.TO / DRI.N / DT.N / CSX.N / ADBE.O / UNP.N / CTXS.O / NICE.O / EAT.N / MCD.N / CAG.N / YUM.N / DV.N / SYK.N / DVN.N / JAZZ.O / EXEL.O / AKAM.O / SBUX.O / ARNA.O / STZ.N / RRC.N / ADSK.O / ARE.N / NBIX.O / VTR.N / BMRN.O / VRTX.O / NET.N / VRNT.O / BLU.N / LTC.N / PEGA.OQ / NTCT.OQ / IMGN.O / HOOK.O / BCRX.O / ANSS.O / ICPT.O / FFIV.O / BIIB.O / MNKD.OQ / DPZ.N / TXRH.O / ACAD.O / MPW.N / CMG.N / CVLT.O / VMW.N / TDC.N / ABCA.L / INO.OQ / JACK.OQ / SWI.N / FTNT.O / RXDX.OQ / PCRX.O / MSP.N / WEN.O / SPLK.OQ / SRPT.O / PANW.N / QLYS.O / ABBV.N / INFA.N / ENTA.O / TMUS.N / PTCT.O / DOC.N / AGIO.O / 81762P102 / PTC.O / KPTI.O / XNCR.OQ / ITCI.O / COUP.N / VRNS.O / 922475108 / SAGE.OQ / HUBS.N / XENE.O / NEWR.N / CTRE.O / QSR.N / WBA.N / 03835T200 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / RPD.O / ZG.O / SQ.N / SCWX.O / NTLA.O / TWLO.N / TTD.O / NTNX.O / CRSP.OQ / OKTA.OQ / ATNX.O / SAIL.N / WELL.N / ZS.OQ / SMAR.N / DBX.O / VRCA.OQ / PRVB.O / ESTC.N / ALLO.OQ / SG.N / NBSE.OQ / ZM.O / FSLY.N / KRTX.OQ / MORF.OQ / CRWD.O / DOCU.N / PING.N / DDOG.O / APRE.OQ / IGMS.O / PEAK.N / NLOK.O / ETNB.O / DHC.O / PLRX.OQ / FOUR.N / ZI.O / MGNI.OQ / JAMF.O / DCT.O / PLTR.N / ASAN.N / SPRB.OQ / MTCR.O / SUMO.O / BSY.O / MCFE.OQ / LSPD.N / PUBM.O / AFRM.O / OLO.N / COUR.N / PATH.N / WING.N / XMTR.OQ / 9VC.F / TRMR.OQ / EVCM.O / NABL.N / PWSC.N / BASE.OQ / AVTX.OQ / CWAN.N / GTLB.OQ / ZD.OQ</td><td class="leftalignment">Altair Engineering Inc / Box Inc / Centrica PLC / Canadian Pacific Railway Ltd / Salesforce.Com Inc / Microsoft Corp / Norfolk Southern Corp / PagerDuty Inc / Rwe AG / Humana Inc / Gilead Sciences Inc / Check Point Software Technologies Ltd / Incyte Corp / Canadian National Railway Co / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Adobe Inc / Union Pacific Corp / Citrix Systems Inc / Nice Ltd / Brinker International Inc / McDonald's Corp / Conagra Brands Inc / Yum! Brands Inc / DoubleVerify Holdings Inc / Stryker Corp / Devon Energy Corp / Jazz Pharmaceuticals PLC / Exelixis Inc / Akamai Technologies Inc / Starbucks Corp / Arena Pharmaceuticals Inc / Constellation Brands Inc / Range Resources Corp / Autodesk Inc / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Cloudflare Inc / Verint Systems Inc / BELLUS Health Inc / LTC Properties Inc / Pegasystems Inc / Netscout Systems Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / ANSYS Inc / Intercept Pharmaceuticals Inc / F5 Inc / Biogen Inc / MannKind Corp / Domino's Pizza Inc / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / Chipotle Mexican Grill Inc / Commvault Systems Inc / VMware Inc / Teradata Corp / Abcam PLC / Inovio Pharmaceuticals Inc / Jack in the Box Inc / SolarWinds Corp / Fortinet Inc / Prometheus Biosciences Inc / Pacira Biosciences Inc / Datto Holding Corp / Wendys Co / Splunk Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Qualys Inc / Abbvie Inc / Informatica Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Physicians Realty Trust / Agios Pharmaceuticals Inc / ServiceNow Inc / PTC Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Varonis Systems Inc / Veeva Systems Inc / SAGE Therapeutics Inc / HubSpot Inc / Xenon Pharmaceuticals Inc / New Relic Inc / CareTrust REIT Inc / Restaurant Brands International Inc / Walgreens Boots Alliance Inc / Aptose Biosciences Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Rapid7 Inc / Zillow Group Inc / Block Inc / SecureWorks Corp / Intellia Therapeutics Inc / Twilio Inc / Trade Desk Inc / Nutanix Inc / CRISPR Therapeutics AG / Okta Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Welltower Inc / Zscaler Inc / Smartsheet Inc / Dropbox Inc / Verrica Pharmaceuticals Inc / Provention Bio Inc / Elastic NV / Allogene Therapeutics Inc / Sweetgreen Inc / NeuBase Therapeutics Inc / Zoom Video Communications Inc / Fastly Inc / Karuna Therapeutics Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / DocuSign Inc / Ping Identity Holding Corp / Datadog Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / Healthpeak Properties Inc / NortonLifeLock Inc / 89Bio Inc / Diversified Healthcare Trust / Pliant Therapeutics Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Magnite Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Asana Inc / Spruce Biosciences Inc / Metacrine Inc / Sumo Logic Inc / Bentley Systems Inc / Mcafee Corp / Lightspeed Commerce Inc / PubMatic Inc / Affirm Holdings Inc / Olo Inc / Coursera Inc / UiPath Inc / Wingstop Inc / Xometry Inc / ATAI Life Sciences NV / Tremor International Ltd / EverCommerce Inc / N-Able Inc / PowerSchool Holdings Inc / Couchbase Inc / Avalo Therapeutics Inc / Clearwater Analytics Holdings Inc / GitLab Inc / Ziff Davis Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2022 Large-Cap Biotech Preview</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">AMGN=US / BIIB=US / LLY=US / BMY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / ABBV=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Eli Lilly and Co / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Top Catalysts in Our Universe to Watch In 1H2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / EXEL.O / ARNA.O / BMRN.O / VRTX.O / BLU.N / IMGN.O / ICPT.O / BIIB.O / MNKD.OQ / ACAD.O / SRPT.O / AGIO.O / SAGE.OQ / NTLA.O / CRSP.OQ / ATNX.O / VRCA.OQ / PRVB.O / ALLO.OQ</td><td class="leftalignment">Gilead Sciences Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / ImmunoGen Inc / Intercept Pharmaceuticals Inc / Biogen Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / SAGE Therapeutics Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Athenex Inc / Verrica Pharmaceuticals Inc / Provention Bio Inc / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregory J. Renza, MD / Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Luca Issi, PHD / Yinglu Zhang / Leonid Timashev / Stephen Mallon / Jackie Yan / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">GILD: Could Trodelvy Hit the 2-Month PFS Bogey That KOLs Want?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech “Prep Pack” for Company Meetings</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / HOOK.O / BCRX.O / ICPT.O / BIIB.O / SRPT.O / ABBV.N / ENTA.O / PTCT.O / KPTI.O / ITCI.O / SAGE.OQ / XENE.O / CRBP.OQ / GLPG.O / NBSE.OQ / KRTX.OQ / IGMS.O / ETNB.O / PLRX.OQ / MTCR.O / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Pliant Therapeutics Inc / Metacrine Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">743</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 6, 2022</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AES.N / BP.L / CCO.TO / CMS.N / DGE.L / EIX.N / ENI.MI / NA / REP.MC / SRCL.O / AMZN.O / GILD.O / INCY.O / AAL.L / REE.MC / XOM.N / ENEI.MI / JAZZ.O / MDRX.O / XEL.N / EXC.N / IG.MI / EXPE.O / NBIX.O / VRTX.O / CVX.N / SRG.MI / ENAG.MC / BLU.N / DCO.N / MTCH.OQ / HCSG.O / BCRX.O / ICPT.O / BIIB.O / FM.TO / 878742204 / TRN.MI / ACAD.O / RDSb.L / CS.TO / 443628102 / GALP.LS / PHR.N / SFR.AX / ADUS.OQ / RXDX.OQ / NEE.N / PCRX.O / GLEN.L / ANGI.OQ / VCRA.N / FB.O / SRPT.O / ADT.N / ENTA.O / PTCT.O / 46579R104 / WIX.O / KPTI.O / XNCR.OQ / ITCI.O / GOOGL.O / CIA.TO / NESF.L / CTLT.N / HQY.OQ / 03835T200 / GLPG.O / TDOC.N / GBT.OQ / ZG.O / TRHC.OQ / SNAP.N / RCM.OQ / CVNA.N / RDFN.O / CARG.O / CDMO.OQ / BKNG.O / OPRX.OQ / NXGN.O / LYFT.O / PINS.N / UBER.N / FVRR.N / HCAT.OQ / APRE.OQ / IGMS.O / VVNT.N / PLRX.OQ / OTRK.OQ / AEP.OQ / GDRX.O / TLMD.OQ / SHC.OQ / ABNB.OQ / DASH.N / SKLZ.N / BMBL.OQ / SQSP.N / TTEF.PA / 9VC.F / THRN.OQ / ASCU.TO</td><td class="leftalignment">AES Corp / BP PLC / Cameco Corp / CMS Energy Corp / Diageo PLC / Edison International / Eni SpA / National Bank of Canada / Repsol SA / Stericycle Inc / Amazon.com Inc / Gilead Sciences Inc / Incyte Corp / Anglo American PLC / Red Electrica Corporacion SA / Exxon Mobil Corp / Enel SpA / Jazz Pharmaceuticals PLC / Allscripts Healthcare Solutions Inc / Xcel Energy Inc / Exelon Corp / Italgas SpA / Expedia Group Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Snam SpA / Enagas SA / BELLUS Health Inc / Ducommun Inc / Match Group Inc / Healthcare Services Group Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Terna Rete Elettrica Nazionale SpA / ACADIA Pharmaceuticals Inc / Royal Dutch Shell PLC / Capstone Mining Corp / Hudbay Minerals Inc / Galp Energia SGPS SA / Phreesia Inc / Sandfire Resources Ltd / Addus Homecare Corp / Prometheus Biosciences Inc / Nextera Energy Inc / Pacira Biosciences Inc / Glencore PLC / Angi Inc / Vocera Communications Inc / Meta Platforms Inc / Sarepta Therapeutics Inc / ADT Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Ivanhoe Mines Ltd / Wix.Com Ltd / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Alphabet Inc / Champion Iron Ltd / NextEnergy Solar Fund Ltd / Catalent Inc / Healthequity Inc / Aptose Biosciences Inc / Galapagos NV / Teladoc Health Inc / Global Blood Therapeutics Inc / Zillow Group Inc / Tabula Rasa HealthCare Inc / Snap Inc / R1 RCM Inc / Carvana Co / Redfin Corp / CarGurus Inc / Avid Bioservices Inc / Booking Holdings Inc / OPTIMIZERx Corp / NextGen Healthcare Inc / Lyft Inc / Pinterest Inc / Uber Technologies Inc / Fiverr International Ltd / Health Catalyst Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / Vivint Smart Home Inc / Pliant Therapeutics Inc / Ontrak Inc / American Electric Power Company Inc / Goodrx Holdings Inc / Soc Telemed Inc / Sotera Health Co / Airbnb Inc / DoorDash Inc / Skillz Inc / Bumble Inc / Squarespace Inc / TotalEnergies SE / ATAI Life Sciences NV / Thorne Healthtech Inc / Arizona Sonoran Copper Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Spain / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / JAZZ.O / BLU.N / BIIB.O / ACAD.O / RXDX.OQ / SRPT.O / XNCR.OQ / ITCI.O / 03835T200 / GBT.OQ / APRE.OQ / IGMS.O / PLRX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Jazz Pharmaceuticals PLC / BELLUS Health Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Prometheus Biosciences Inc / Sarepta Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / Pliant Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">4Q21/2022 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">90</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / VRTX.O / BLU.N / BCRX.O / ICPT.O / BIIB.O / ACAD.O / PCRX.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / 03835T200 / GLPG.O / GBT.OQ / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / Galapagos NV / Global Blood Therapeutics Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 78 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">HBAN.OQ / KOP.N / AAN.N / BBY.N / CL.N / COF.N / CVS.N / F.N / HLT.N / SLB.N / T.N / TMO.N / BEN.N / THC.N / GBX.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / TGT.N / XL.N / AMP.N / ARW.N / ATO.N / TWTR.N / HAE.N / STL.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / REGN.OQ / BBBY.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / BCO.N / CVGI.OQ / BBW.N / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / SCHW.N / EXPR.N / DDD.N / GRPN.OQ / FB.OQ / TROX.N / COTY.N / CTG.OQ / MGNX.OQ / LADR.N / TWOU.OQ / FGEN.OQ / ANTM.N / PFX.N / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Huntington Bancshares Inc / Koppers Holdings Inc / Aaron's Company Inc / Best Buy Co Inc / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Greenbrier Companies Inc / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Target Corp / XL Fleet Corp / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Haemonetics Corp / Sterling Bancorp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Regeneron Pharmaceuticals Inc / Bed Bath & Beyond Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Brinks Co / Commercial Vehicle Group Inc / Build-A-Bear Workshop Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / Charles Schwab Corp / Express Inc / 3D Systems Corp / Groupon Inc / Meta Platforms Inc / Tronox Holdings PLC / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Ladder Capital Corp / 2U Inc / FibroGen Inc / Anthem Inc / PhenixFIN Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - January 5, 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AES.N / AIG.N / BATS.L / CP.TO / DD.N / GE.N / HMb.ST / SLB.N / STO.AX / T.TO / SSE.L / AMZN.O / CNQ.TO / GILD.O / LPX.N / UNH.N / WCC.N / SBM.AX / BBVA.MC / ALA.TO / RRC.N / V.N / ARE.N / MTB.N / VRTX.O / COP.N / ASC.L / CRC.N / LNG.A / MOS.N / RDSb.L / BAM.N / DRX.L / SES.TO / TDG.N / MA.N / ARX.TO / CVE.TO / TOU.TO / TRGP.N / ATD.TO / TVE.TO / EFN.TO / TDOC.N / ZG.O / SPGI.N / TWLO.N / AZRE.N / AQN.N / RCM.OQ / ZM.O / RTLR.O / CRWD.O / GMAB.O / FLNC.OQ</td><td class="leftalignment">AES Corp / American International Group Inc / British American Tobacco PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / Schlumberger NV / Santos Ltd / Telus Corp / SSE PLC / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / UnitedHealth Group Inc / Wesco International Inc / St Barbara Ltd / Banco Bilbao Vizcaya Argentaria SA / AltaGas Ltd / Range Resources Corp / Visa Inc / Alexandria Real Estate Equities Inc / M&T Bank Corp / Vertex Pharmaceuticals Inc / Conocophillips / ASOS PLC / California Resources Corp / Cheniere Energy Inc / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Drax Group PLC / Secure Energy Services Inc / TransDigm Group Inc / Mastercard Inc / ARC Resources Ltd / Cenovus Energy Inc / Tourmaline Oil Corp / Targa Resources Corp / Alimentation Couche-Tard Inc / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Teladoc Health Inc / Zillow Group Inc / S&P Global Inc / Twilio Inc / Azure Power Global Ltd / Algonquin Power & Utilities Corp / R1 RCM Inc / Zoom Video Communications Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Fluence Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Denmark / Spain / United Kingdom / Mauritius / Sweden / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - January 4, 2022</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CNQ.TO / AES.N / AIG.N / BATS.L / BCE.TO / CP.TO / CWK.L / DANO.PA / DD.N / DGE.L / GE.N / HEIN.AS / HMb.ST / OREP.PA / PERP.PA / SLB.N / STO.AX / T.TO / ULVR.L / SSE.L / AMZN.O / GILD.O / LPX.N / FN.TO / HNKG_p.DE / POW.TO / SJRb.TO / RCIb.TO / QBRb.TO / UNH.N / CCA.TO / WCC.N / CAG.N / BEIG.DE / AEM.N / BBVA.MC / GIBa.TO / CARLb.CO / ALA.TO / RRC.N / V.N / ARE.N / MTB.N / AGFb.TO / VRTX.O / CIX.TO / COP.N / ASC.L / MEOH.O / CRC.N / LNG.A / PLUG.OQ / X.TO / RGLD.O / NESN.S / HCG.TO / MOS.N / IGM.TO / RDSb.L / BAM.N / BVIC.L / DRX.L / SES.TO / TDG.N / MA.N / CSU.TO / HFG.L / DAIGn.DE / CPRI.MI / SII.TO / ARX.TO / ABI.BR / IFC.TO / AAV.TO / CVE.TO / FSZ.TO / TOU.TO / TRGP.N / CHW.TO / ATD.TO / PXT.TO / TVE.TO / EFN.TO / EQB.TO / FEVR.L / TDOC.N / ZG.O / IMB.L / SPGI.N / TWLO.N / AZRE.N / BBU.N / ECN.TO / ONEX.TO / AQN.N / RCM.OQ / DBX.O / ZM.O / RTLR.O / CRWD.O / GMAB.O / AD_u.TO / RKT.L / FLNC.OQ / DFY.TO</td><td class="leftalignment">Canadian Natural Resources Ltd / AES Corp / American International Group Inc / British American Tobacco PLC / BCE Inc / Canadian Pacific Railway Ltd / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / General Electric Co / Heineken NV / H & M Hennes & Mauritz AB / L'Oreal SA / Pernod Ricard SA / Schlumberger NV / Santos Ltd / Telus Corp / Unilever PLC / SSE PLC / Amazon.com Inc / Gilead Sciences Inc / Louisiana-Pacific Corp / First National Financial Corp / Henkel AG & Co KGaA / Power Corporation of Canada / Shaw Communications Inc / Rogers Communications Inc / Quebecor Inc / UnitedHealth Group Inc / Cogeco Communications Inc / Wesco International Inc / Conagra Brands Inc / Beiersdorf AG / Agnico Eagle Mines Ltd / Banco Bilbao Vizcaya Argentaria SA / CGI Inc / Carlsberg A/S / AltaGas Ltd / Range Resources Corp / Visa Inc / Alexandria Real Estate Equities Inc / M&T Bank Corp / AGF Management Ltd / Vertex Pharmaceuticals Inc / CI Financial Corp / Conocophillips / ASOS PLC / Methanex Corp / California Resources Corp / Cheniere Energy Inc / Plug Power Inc / TMX Group Ltd / Royal Gold Inc / Nestle SA / Home Capital Group Inc / Mosaic Co / IGM Financial Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Britvic PLC / Drax Group PLC / Secure Energy Services Inc / TransDigm Group Inc / Mastercard Inc / Constellation Software Inc / Hilton Food Group PLC / Daimler AG / Davide Campari Milano NV / Sprott Inc / ARC Resources Ltd / Anheuser Busch Inbev SA / Intact Financial Corp / Advantage Energy Ltd / Cenovus Energy Inc / Fiera Capital Corp / Tourmaline Oil Corp / Targa Resources Corp / Chesswood Group Ltd / Alimentation Couche-Tard Inc / Parex Resources Inc / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Equitable Group Inc / Fevertree Drinks PLC / Teladoc Health Inc / Zillow Group Inc / Imperial Brands PLC / S&P Global Inc / Twilio Inc / Azure Power Global Ltd / Brookfield Business Partners LP / ECN Capital Corp / Onex Corp / Algonquin Power & Utilities Corp / R1 RCM Inc / Dropbox Inc / Zoom Video Communications Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Alaris Equity Partners Income Trust / Reckitt Benckiser Group PLC / Fluence Energy Inc / Definity Financial Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Mauritius / Netherlands / Sweden / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 4, 2022</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AES.N / AIG.N / BATS.L / CI.N / CP.TO / CVS.N / CWK.L / DANO.PA / DD.N / DGE.L / GE.N / HEIN.AS / HMb.ST / IBE.MC / OREP.PA / PERP.PA / SLB.N / STO.AX / T.TO / ULVR.L / SSE.L / AMZN.O / HUM.N / CNQ.TO / GILD.O / LPX.N / FN.TO / HNKG_p.DE / POW.TO / THC.N / UHS.N / UNH.N / WCC.N / CAG.N / BEIG.DE / ENEI.MI / BBVA.MC / GIBa.TO / CARLb.CO / HCA.N / CYH.N / ALA.TO / EXC.N / RRC.N / V.N / ARE.N / MTB.N / AGFb.TO / VRTX.O / CIX.TO / COP.N / ASC.L / MEOH.O / CHE.N / CRC.N / LNG.A / SEM.N / X.TO / AMED.O / EQIX.O / NESN.S / HCG.TO / MOS.N / DLR.N / IGM.TO / RDSb.L / LHCG.O / BAM.N / BKD.N / BVIC.L / DRX.L / SES.TO / TDG.N / MA.N / EHTH.O / HFG.L / CPRI.MI / ENSG.O / SII.TO / ARX.TO / ABI.BR / IFC.TO / ADUS.OQ / CVE.TO / FSZ.TO / TOU.TO / TRGP.N / CHW.TO / ATD.TO / TVE.TO / ACHC.O / EFN.TO / EQB.TO / FEVR.L / ANTM.N / TDOC.N / ZG.O / SGRY.O / IMB.L / SPGI.N / TWLO.N / AZRE.N / BBU.N / ECN.TO / ONEX.TO / AQN.N / RCM.OQ / EHC.N / ZM.O / RTLR.O / CRWD.O / GMAB.O / PNTG.OQ / SLQT.N / GOCO.O / AD_u.TO / RKT.L / FLNC.OQ / DFY.TO</td><td class="leftalignment">AES Corp / American International Group Inc / British American Tobacco PLC / Cigna Corp / Canadian Pacific Railway Ltd / CVS Health Corp / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / General Electric Co / Heineken NV / H & M Hennes & Mauritz AB / Iberdrola SA / L'Oreal SA / Pernod Ricard SA / Schlumberger NV / Santos Ltd / Telus Corp / Unilever PLC / SSE PLC / Amazon.com Inc / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / First National Financial Corp / Henkel AG & Co KGaA / Power Corporation of Canada / Tenet Healthcare Corp / Universal Health Services Inc / UnitedHealth Group Inc / Wesco International Inc / Conagra Brands Inc / Beiersdorf AG / Enel SpA / Banco Bilbao Vizcaya Argentaria SA / CGI Inc / Carlsberg A/S / HCA Healthcare Inc / Community Health Systems Inc / AltaGas Ltd / Exelon Corp / Range Resources Corp / Visa Inc / Alexandria Real Estate Equities Inc / M&T Bank Corp / AGF Management Ltd / Vertex Pharmaceuticals Inc / CI Financial Corp / Conocophillips / ASOS PLC / Methanex Corp / Chemed Corp / California Resources Corp / Cheniere Energy Inc / Select Medical Holdings Corp / TMX Group Ltd / Amedisys Inc / Equinix Inc / Nestle SA / Home Capital Group Inc / Mosaic Co / Digital Realty Trust Inc / IGM Financial Inc / Royal Dutch Shell PLC / LHC Group Inc / Brookfield Asset Management Inc / Brookdale Senior Living Inc / Britvic PLC / Drax Group PLC / Secure Energy Services Inc / TransDigm Group Inc / Mastercard Inc / eHealth Inc / Hilton Food Group PLC / Davide Campari Milano NV / Ensign Group Inc / Sprott Inc / ARC Resources Ltd / Anheuser Busch Inbev SA / Intact Financial Corp / Addus Homecare Corp / Cenovus Energy Inc / Fiera Capital Corp / Tourmaline Oil Corp / Targa Resources Corp / Chesswood Group Ltd / Alimentation Couche-Tard Inc / Tamarack Valley Energy Ltd / Acadia Healthcare Company Inc / Element Fleet Management Corp / Equitable Group Inc / Fevertree Drinks PLC / Anthem Inc / Teladoc Health Inc / Zillow Group Inc / Surgery Partners Inc / Imperial Brands PLC / S&P Global Inc / Twilio Inc / Azure Power Global Ltd / Brookfield Business Partners LP / ECN Capital Corp / Onex Corp / Algonquin Power & Utilities Corp / R1 RCM Inc / Encompass Health Corp / Zoom Video Communications Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Pennant Group Inc / SelectQuote Inc / Gohealth Inc / Alaris Equity Partners Income Trust / Reckitt Benckiser Group PLC / Fluence Energy Inc / Definity Financial Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Italy / Mauritius / Netherlands / Sweden / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - January 4, 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AES.N / AIG.N / BATS.L / CP.TO / CWK.L / DANO.PA / DD.N / DGE.L / GE.N / HEIN.AS / HMb.ST / OREP.PA / PERP.PA / SLB.N / STO.AX / T.TO / ULVR.L / SSE.L / AMZN.O / CNQ.TO / GILD.O / LPX.N / HNKG_p.DE / UNH.N / WCC.N / BEIG.DE / BBVA.MC / CARLb.CO / ALA.TO / RRC.N / V.N / ARE.N / MTB.N / VRTX.O / COP.N / ASC.L / CRC.N / LNG.A / PLUG.OQ / NESN.S / MOS.N / RDSb.L / BAM.N / BVIC.L / DRX.L / SES.TO / TDG.N / MA.N / HFG.L / DAIGn.DE / CPRI.MI / ARX.TO / ABI.BR / CVE.TO / TOU.TO / TRGP.N / ATD.TO / TVE.TO / EFN.TO / FEVR.L / TDOC.N / ZG.O / IMB.L / SPGI.N / TWLO.N / AZRE.N / AQN.N / RCM.OQ / DBX.O / ZM.O / RTLR.O / CRWD.O / GMAB.O / RKT.L / FLNC.OQ</td><td class="leftalignment">AES Corp / American International Group Inc / British American Tobacco PLC / Canadian Pacific Railway Ltd / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / General Electric Co / Heineken NV / H & M Hennes & Mauritz AB / L'Oreal SA / Pernod Ricard SA / Schlumberger NV / Santos Ltd / Telus Corp / Unilever PLC / SSE PLC / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Henkel AG & Co KGaA / UnitedHealth Group Inc / Wesco International Inc / Beiersdorf AG / Banco Bilbao Vizcaya Argentaria SA / Carlsberg A/S / AltaGas Ltd / Range Resources Corp / Visa Inc / Alexandria Real Estate Equities Inc / M&T Bank Corp / Vertex Pharmaceuticals Inc / Conocophillips / ASOS PLC / California Resources Corp / Cheniere Energy Inc / Plug Power Inc / Nestle SA / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Britvic PLC / Drax Group PLC / Secure Energy Services Inc / TransDigm Group Inc / Mastercard Inc / Hilton Food Group PLC / Daimler AG / Davide Campari Milano NV / ARC Resources Ltd / Anheuser Busch Inbev SA / Cenovus Energy Inc / Tourmaline Oil Corp / Targa Resources Corp / Alimentation Couche-Tard Inc / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Fevertree Drinks PLC / Teladoc Health Inc / Zillow Group Inc / Imperial Brands PLC / S&P Global Inc / Twilio Inc / Azure Power Global Ltd / Algonquin Power & Utilities Corp / R1 RCM Inc / Dropbox Inc / Zoom Video Communications Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Reckitt Benckiser Group PLC / Fluence Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Mauritius / Netherlands / Sweden / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Top 30 Global Ideas for 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">AIG.N / BATS.L / CP.TO / DD.N / GE.N / HMb.ST / T.TO / SSE.L / AMZN.O / CNQ.TO / GILD.O / LPX.N / UNH.N / WCC.N / BBVA.MC / ALA.TO / V.N / ARE.N / MTB.N / VRTX.O / COP.N / ASC.L / MOS.N / RDSb.L / BAM.N / TDG.N / MA.N / ATD.TO / EFN.TO / TDOC.N / ZG.O / SPGI.N / TWLO.N / RCM.OQ / ZM.O / CRWD.O / GMAB.O</td><td class="leftalignment">American International Group Inc / British American Tobacco PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / Telus Corp / SSE PLC / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / UnitedHealth Group Inc / Wesco International Inc / Banco Bilbao Vizcaya Argentaria SA / AltaGas Ltd / Visa Inc / Alexandria Real Estate Equities Inc / M&T Bank Corp / Vertex Pharmaceuticals Inc / Conocophillips / ASOS PLC / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / TransDigm Group Inc / Mastercard Inc / Alimentation Couche-Tard Inc / Element Fleet Management Corp / Teladoc Health Inc / Zillow Group Inc / S&P Global Inc / Twilio Inc / R1 RCM Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / Spain / United Kingdom / Sweden / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Mr. James Edwardes Jones / Mr. Brad D. Erickson / Scott M. Hanold / Mr. Matthew G. Hedberg / Mr. Ben Hendrix / Mr. Ken G. Herbert / Mr. Rishi N. Jaluria / Geoffrey Kwan, CFA / Robert M. Kwan, CFA / Kennen MacKay, PHD / Brian Abrahams, MD / Sherri Malek / Mr. John B. Musk / Drew McReynolds, CFA / Mme. Irene O. Nattel / Greg M. Pardy, CFA / Daniel R. R. Perlin, CFA / Mr. Paul C. Quinn / Mr. Ashish Sabadra / Walter N. Spracklin, CFA / Mr. Benjamin Toms / Mr. Biraj Borkhataria / Mr. Arun S. Viswanathan / Andrew D. Wong / Michael W. Carroll, CFA / Gerard S. Cassidy / Mr. Richard B. Chamberlain / Mr. Sean W. Dodge, CFA / Mr. Deane Dray, CFA / Mark A. Dwelle, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GBT=US / GILD=US / H=US / CRM=US / MTN=US / HSII=US / MAR=US / TNL=US / KFRC=US / HLT=US / KFY=US / AMN=US / PATH=US / CHH=US / COLL=US / MAN=US / ASGN=US / RARE=US / REGN=US / RHI=US / VRTX=US / SAGE=US / CCRN=US / JAZZ=US / COP=US / APPN=US / INST=US / BDSI=US / MRNS=US / BIIB=US / RNG=US / APTX=US / XM=US / NSP=US / HST=US / CPRX=US / WH=US / HGV=US / VAC=US / RHP=US / FATE=US / CNCE=US / FIVN=US / AFMD=US / HUBS=US / BVH=US / WK=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / PK=US / ANAB=US / PLYA=US / VRNA=US / ARVN=US / CYCN=US / TSHA / COUR=US / UDMY=US / USER=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Gilead Sciences Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Heidrick & Struggles International Inc / Marriott International Inc / Travel + Leisure Co / Kforce Inc / Hilton Worldwide Holdings Inc / Korn Ferry / AMN Healthcare Services Inc / UiPath Inc / Choice Hotels International Inc / Collegium Pharmaceutical Inc / ManpowerGroup Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Vertex Pharmaceuticals Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Jazz Pharmaceuticals PLC / Conocophillips / Appian Corp / Instructure Holdings Inc / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Biogen Inc / RingCentral Inc / Aptinyx Inc / Qualtrics International Inc / Insperity Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Five9 Inc / Affimed NV / HubSpot Inc / Bluegreen Vacations Holding Corp / Workiva Inc / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / Arvinas Inc / Cyclerion Therapeutics Inc / Taysha Gene Therapies Inc / Coursera Inc / Udemy Inc / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">The Business Research Company</td><td class="leftalignment">Gilead Sciences, Inc. (Gilead) Company Briefing (COVID 19 Update)</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Department of Research</td></tr>
<tr class="odd"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">1H22 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">375558103 / 031162100 / 766559603 / 09062X103 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G50871105 / 03835T200 / 78667J108 / 03209R103 / 16383L106 / 868459108 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 68404V100 / 98401F105 / 23284F105 / 03168L105 / 80706P103 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 87808K106 / 483347100 / 37890U108 / 29668H708 / 68906L105 / 04016X101 / 87184Q107 / 481116101 / 59935V107 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 05454B105 / 729139105 / 00972D105 / 760273102 / 00973J101 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 80810D103 / 92243A200 / 74366E102 / 00166B105 / 45790W108 / 04335A105 / 23257D103 / 76029N106 / 4525EP101 / 46565G104 / 52490G102 / 75382E109 / 38341P102 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 92556V106 / 03890D108 / 03835L207 / 413197104 / 002120202 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 00288U106 / 38406L103 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 75974E103 / 09077A106 / 75082Q105 / 23954D109 / 15673T100 / 61225M102 / 730541109 / 670703107 / 68217N105 / 87978U108 / 00032Q104</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Jazz Pharmaceuticals PLC / Aptose Biosciences Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Supernus Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Scholar Rock Holding Corp / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / ESSA Pharma Inc / Otonomy Inc / argenx SE / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Milestone Pharmaceuticals Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Axcella Health Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / Akouos Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Schrodinger Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Replimune Group Inc / Immunic Inc / Iteos Therapeutics Inc / Legend Biotech Corp / Rapt Therapeutics Inc / Gossamer Bio Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Viatris Inc / Aravive Inc / Aptevo Therapeutics Inc / Harmony Biosciences Holdings Inc / aTyr Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Abcellera Biologics Inc / Gracell Biotechnologies Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Reneo Pharmaceuticals Inc / Biomea Fusion Inc / Rain Therapeutics Inc / Day One Biopharmaceuticals Inc / Century Therapeutics Inc / Monte Rosa Therapeutics Inc / POINT Biopharma Global Inc / Nuvalent Inc / Omega Therapeutics Inc / Tempest Therapeutics Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Allison M. Bratzel, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Large Cap Biotech: Price Increases as of Jan 1, 2022 for BIIB, GILD, REGN and VRTX products</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.OQ / BIIB.OQ / REGN.OQ / VRTX.OQ / GILD=US / REGN=US / VRTX=US / BIIB=US</td><td class="leftalignment">Gilead Sciences Inc / Biogen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Five-bagger Gilead jumps 30% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead gains 7.0% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Gilead Sciences, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">100</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Gilead Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">470</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">COVID-19 Vaccine/Therapeutics Names: Expect Volatile 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / REGN.O / VRTX.O / MRNA.O / SRPT.O / INO.O</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / Inovio Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT / AM / AMAT.O / APO / ATR / BDX / BX / DCP / DFS / DHI / DOV / H / HE / INTC.O / KBH / KLAC.O / KNX / LEN / LRCX.O / MAS / MCHP.O / MDT / MHK / MSM / OC / PFE.N / PK / QCOM.O / R / RKT / RMBS.O / SRE / HT / GILD.O / ASML.O / ET / JBHT.O / NVDA.O / MGM.N / PEB.N / HUBG.O / PAA.N / AMD.O / ADI.O / CHH.N / SMTC.O / SLAB.O / SNPS.O / BYD.N / PENN.O / CHDN.O / MU.O / MRVL.O / WYNN.O / DIOD.O / EXAS.O / SWKS.O / SHO.N / BECN.O / LVS.N / DXCM.O / CDNS.O / HST.N / XPO / SAIA.O / CQP.A / PODD.O / NXPI.O / CZR.O / SLM.O / RHP.N / AMBA.O / PFSI.K / PAGP.N / CEQP.K / ENLC.K / CAPL.K / QRVO.O / XHR.N / ON.O / APLE.N / OMF / RRR.O / JELD.K / GH.O / AXNX.O / FLTRF.L / FTCH.K / DKNG.O / BALY.N / ALGM.O / RSI.N / HMPT.O / GXO.N / WOLF.N / ARBE.O / ARIS.K / MXL.O</td><td class="leftalignment">Abbott Laboratories / Antero Midstream Corp / Applied Materials Inc / Apollo Global Management Inc / Aptargroup Inc / Becton Dickinson and Co / Blackstone Inc / DCP Midstream LP / Discover Financial Services / D R Horton Inc / Dover Corp / Hyatt Hotels Corp / Hawaiian Electric Industries Inc / Intel Corp / KB Home / KLA Corp / Knight-Swift Transportation Holdings Inc / Lennar Corp / Lam Research Corp / Masco Corp / Microchip Technology Inc / Medtronic PLC / Mohawk Industries Inc / MSC Industrial Direct Co Inc / Owens Corning / Pfizer Inc / Park Hotels & Resorts Inc / Qualcomm Inc / Ryder System Inc / Rocket Companies Inc / Rambus Inc / Sempra Energy / Hersha Hospitality Trust / Gilead Sciences Inc / ASML Holding NV / Energy Transfer LP / J B Hunt Transport Services Inc / NVIDIA Corp / MGM Resorts International / Pebblebrook Hotel Trust / Hub Group Inc / Plains All American Pipeline LP / Advanced Micro Devices Inc / Analog Devices Inc / Choice Hotels International Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Boyd Gaming Corp / Penn National Gaming Inc / Churchill Downs Inc / Micron Technology Inc / Marvell Technology Inc / Wynn Resorts Ltd / Diodes Inc / Exact Sciences Corp / Skyworks Solutions Inc / Sunstone Hotel Investors Inc / Beacon Roofing Supply Inc / Las Vegas Sands Corp / Dexcom Inc / Cadence Design Systems Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Saia Inc / Cheniere Energy Partners LP / Insulet Corp / NXP Semiconductors NV / Caesars Entertainment Inc / SLM Corp / Ryman Hospitality Properties Inc / Ambarella Inc / PennyMac Financial Services Inc / Plains GP Holdings LP / Crestwood Equity Partners LP / EnLink Midstream LLC / Crossamerica Partners LP / Qorvo Inc / Xenia Hotels & Resorts Inc / ON Semiconductor Corp / Apple Hospitality REIT Inc / OneMain Holdings Inc / Red Rock Resorts Inc / JELD-WEN Holding Inc / Guardant Health Inc / Axonics Inc / Flutter Entertainment PLC / Farfetch Ltd / DraftKings Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Home Point Capital Inc / GXO Logistics Inc / Wolfspeed Inc / Arbe Robotics Ltd / Aris Water Solutions Inc / Maxlinear Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Race to the Bottom? Which Biopharma Has Most LOE Risk in 2025-30 Period?</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">There’s No Biopharma Without M&A; Dip in Deals in 2021 Does Not Make a Trend</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / CTAS.O / KMX.N / NBIX.O / COP.N / CRC.N / BCRX.O / ICPT.O / BIIB.O / ACAD.O / ALNY.O / CFR.S / PCH.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / ZALG.DE / GLPG.O / GBT.OQ / CARR.N</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Cintas Corp / Carmax Inc / Neurocrine Biosciences Inc / Conocophillips / California Resources Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Compagnie Financiere Richemont SA / Potlatchdeltic Corp / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Zalando SE / Galapagos NV / Global Blood Therapeutics Inc / Carrier Global Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Germany / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: 4Q21 - Reimbursement Radar</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GLPG.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Galapagos NV / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Stephen Mallon / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Vial Quality Concern Adds Another Delay to Lenacapavir</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ike Oji</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006969603 / US09061G1013 / US0311621009 / US0718131099 / US1101221083 / US1311931042 / US1985161066 / US2435371073 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US6541061031 / US66987V1098 / US75886F1075 / US7782961038 / US8006771062 / US8305661055 / US8725401090 / US87612E1064 / US9021041085 / US9139031002 / US9182041080 / US92532F1003 / US3448491049 / US6402681083 / US21036P1084 / US2533931026 / US09062X1037 / US0042251084 / US02043Q1076 / US9043111072 / BREMBRACNOR4 / US4103451021 / US03152W1099 / US5500211090 / US36315X1019 / US58933Y1055 / US46333X1081 / US13100M5094 / DE000A1EWWW0 / US29082A1079 / US40412C1018 / US6936561009 / US7512121010 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US1220171060 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US74967X1037 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US89610F1012 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US98585X1046 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US0843101017 / US75943R1023 / US02875D1090 / US07373B1098 / US56854Q2003 / US81181C1045 / US74006W1080 / US55406W1036 / US30260D1037 / US38870X1046 / KYG7614L1095 / US98422T1007 / US01675A1097</td><td class="leftalignment">Puma SE / Biomarin Pharmaceutical Inc / Amgen Inc / Baxter International Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Columbia Sportswear Co / Deckers Outdoor Corp / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Nike Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sangamo Therapeutics Inc / Skechers USA Inc / TJX Companies Inc / Target Corp / II-VI Inc / Universal Health Services Inc / VF Corp / Vertex Pharmaceuticals Inc / Foot Locker Inc / Nektar Therapeutics / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Embraer SA / HanesBrands Inc / Amicus Therapeutics Inc / Lululemon Athletica Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Adidas AG / Embraer SA / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / RH / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Tricida Inc / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Berkeley Lights Inc / Relay Therapeutics Inc / American Outdoor Brands Inc / Beam Global / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / MYT Netherlands Parent BV / Figs Inc / Graphite Bio Inc / Rockley Photonics Holdings Ltd / Xilio Therapeutics Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Brazil / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ATR / DHI / KBH / LEN / MAS / MHK / OC / GILD.O / EXAS.O / BECN.O / JELD.K / GH.O / EPAC.K</td><td class="leftalignment">Aptargroup Inc / D R Horton Inc / KB Home / Lennar Corp / Masco Corp / Mohawk Industries Inc / Owens Corning / Gilead Sciences Inc / Exact Sciences Corp / Beacon Roofing Supply Inc / JELD-WEN Holding Inc / Guardant Health Inc / Enerpac Tool Group Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIR.N / ALB.N / BAC.N / BB.N / BK.N / C.N / CC.N / CCK.N / CE.N / DD.N / DOW.N / ED.N / EMN.N / F.N / FITB.O / FMC.N / GM.N / JPM.N / KEY.N / NTRS.O / PNC.N / PPG.N / RIO.L / SEE.N / USB.N / WFC.N / GILD.O / INCY.O / AAL.L / WLK.N / GS.N / GIS.N / OLN.N / SHW.N / OI.N / BLL.N / STT.N / FDS.N / RPM.N / SLGN.O / MTB.N / VRTX.O / GPK.N / RF.N / BLU.N / HOOK.O / BPOP.O / BIIB.O / IGO.AX / TFC.N / HUN.N / WSA.AX / MS.N / CS.TO / 443628102 / 550372106 / INO.OQ / VALE.N / LYB.N / BERY.N / 505440107 / TSLA.N / KPTI.O / CFG.N / AXTA.N / XENE.O / GLPG.O / VNTR.N / EAF.N / CTVA.N / KRTX.OQ / EPAC.N / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O / PTVE.O / CLVT.N / AMBP.N</td><td class="leftalignment">AAR Corp / Albemarle Corp / Bank of America Corp / BlackBerry Ltd / Bank of New York Mellon Corp / Citigroup Inc / Chemours Co / Crown Holdings Inc / Celanese Corp / Dupont De Nemours Inc / Dow Inc / Consolidated Edison Inc / Eastman Chemical Co / Ford Motor Co / Fifth Third Bancorp / FMC Corp / General Motors Co / JPMorgan Chase & Co / KeyCorp / Northern Trust Corp / PNC Financial Services Group Inc / PPG Industries Inc / Rio Tinto PLC / Sealed Air Corp / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / Incyte Corp / Anglo American PLC / Westlake Chemical Corp / Goldman Sachs Group Inc / General Mills Inc / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / State Street Corp / Factset Research Systems Inc / RPM International Inc / Silgan Holdings Inc / M&T Bank Corp / Vertex Pharmaceuticals Inc / Graphic Packaging Holding Co / Regions Financial Corp / BELLUS Health Inc / HOOKIPA Pharma Inc / Popular Inc / Biogen Inc / IGO Ltd / Truist Financial Corp / Huntsman Corp / Western Areas Ltd / Morgan Stanley / Capstone Mining Corp / Hudbay Minerals Inc / Lundin Mining Corp / Inovio Pharmaceuticals Inc / Vale SA / LyondellBasell Industries NV / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / Tesla Inc / Karyopharm Therapeutics Inc / Citizens Financial Group Inc / Axalta Coating Systems Ltd / Xenon Pharmaceuticals Inc / Galapagos NV / Venator Materials PLC / GrafTech International Ltd / Corteva Inc / Karuna Therapeutics Inc / Enerpac Tool Group Corp / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc / Pactiv Evergreen Inc / CLARIVATE PLC / Ardagh Metal Packaging SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / United Kingdom / Luxembourg / Netherlands / Puerto Rico / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">And The Nominees For Our Best 2021 Note Titles Are...</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BLU.N / HOOK.O / BIIB.O / INO.OQ / KPTI.O / XENE.O / GLPG.O / KRTX.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / Biogen Inc / Inovio Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xenon Pharmaceuticals Inc / Galapagos NV / Karuna Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Stephen Mallon / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 12 21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">EPR.N / GOOGL.OQ / NOC.N / V.N / GILD.OQ / LAMR.OQ / AMZN.OQ / MPWR.OQ / BERY.N / PINC.OQ / ICHR.OQ</td><td class="leftalignment">EPR Properties / Alphabet Inc / Northrop Grumman Corp / Visa Inc / Gilead Sciences Inc / Lamar Advertising Co / Amazon.com Inc / Monolithic Power Systems Inc / Berry Global Group Inc / Premier Inc / Ichor Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Aerospace / Biotechnology / Containers & Packing / Defense / Healthcare / Media / Real Estate / Retailing / Semiconductors / Technology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Top 10 Potential Surprises Of 2022</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US09062X1037 / US89610F1012 / US09061G1013 / US0311621009 / US1101221083 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US66987V1098 / US75886F1075 / US8006771062 / US92532F1003 / US6402681083 / US21036P1084 / US0042251084 / US02043Q1076 / US03152W1099 / US36315X1019 / US58933Y1055 / US46333X1081 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US75943R1023 / US56854Q2003 / US81181C1045 / US74006W1080 / US38870X1046 / US98422T1007</td><td class="leftalignment">Biogen Inc / Tricida Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Constellation Brands Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Relay Therapeutics Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / Graphite Bio Inc / Xilio Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">GILD: Lenacapavir Issues Appear Resolvable, but Speed Is Important Given Descovy Patent Expiry</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GILD: Vials and Tribulations: Quality Issue Derails Lenacapavir; Speed Of Resolution Critical For Salvaging Key HIV Pipeline Program Studies</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ADS / ALLO / DE / INTC.O / NKE / ROK / TRMB / WMT / GILD.O / BRZE.O / PLUG.O / REGN.O / VRTX.O / ITRI.O / SPWR.O / CSIQ.O / WPRT.O / GPRE.O / TSLA.O / PCYO.O / AMRS.O / ENPH.O / CNHI / FATE.O / ALDX.O / ETSY.O / SEDG.O / RUN.O / SPXC / AQMS.O / CLLS.O / 05464C101 / ONCT.O / FVRR.K / SHLS.O / VIRX.O / BLDE.OQ / TSP.O / ENVX.O / LILM.O</td><td class="leftalignment">Alliance Data Systems Corp / Allogene Therapeutics Inc / Deere & Co / Intel Corp / Nike Inc / Rockwell Automation Inc / Trimble Inc / Walmart Inc / Gilead Sciences Inc / Braze Inc / Plug Power Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Itron Inc / SunPower Corp / Canadian Solar Inc / Westport Fuel Systems Inc / Green Plains Inc / Tesla Inc / Pure Cycle Corp / Amyris Inc / Enphase Energy Inc / CNH Industrial NV / Fate Therapeutics Inc / Aldeyra Therapeutics Inc / ETSY Inc / Solaredge Technologies Inc / Sunrun Inc / SPX Corp / Aqua Metals Inc / Cellectis SA / Axon Enterprise Inc / Oncternal Therapeutics Inc / Fiverr International Ltd / Shoals Technologies Group Inc / Viracta Therapeutics Inc / Blade Air Mobility Inc / TuSimple Holdings Inc / Enovix Corp / Lilium NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Opinion Leader Feedback--ASH 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALLO / GILD.O / REGN.O / FATE.O / CLLS.O / ONCT.O / VIRX.O</td><td class="leftalignment">Allogene Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Fate Therapeutics Inc / Cellectis SA / Oncternal Therapeutics Inc / Viracta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SKAN.S: SKAN - Global market leader for high-end aseptic process solutions</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">SKAN.S / 4502.T / BAX.N / EKTAB.ST / PFE.N / PHG.AS / AZN.L / SASY.PA / ROG.S / DHR.N / GEBN.S / NOVN.S / LONN.S / SATG.DE / PKI.N / BANB.S / GSK.L / 6869.T / HOLX.OQ / GILD.OQ / NVAX.OQ / TECN.S / LOGN.S / BEAN.S / IFCN.S / STMN.S / LEHN.S / SCHP.S / BCHN.S / SIKA.S / SOON.S / DIAS.MI / MRNA.OQ / BRG.AX / ABBV.N / CLLS.OQ / EDIT.OQ / VACN.S / CRSP.OQ / COTNE.S / SENSI.S / SIGNC.S / AVTR.N</td><td class="leftalignment">SKAN Group AG / Takeda Pharmaceutical Co Ltd / Baxter International Inc / Elekta AB (publ) / Pfizer Inc / Koninklijke Philips NV / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Geberit AG / Novartis AG / Lonza Group AG / Sartorius AG / PerkinElmer Inc / Bachem Holding AG / GlaxoSmithKline PLC / Sysmex Corp / Hologic Inc / Gilead Sciences Inc / Novavax Inc / Tecan Group AG / Logitech International SA / Belimo Holding AG / Inficon Holding AG / Straumann Holding AG / Lem Holding SA / Schindler Holding AG / Burckhardt Compression Holding AG / Sika AG / Sonova Holding AG / DiaSorin SpA / Moderna Inc / Breville Group Ltd / Abbvie Inc / Cellectis SA / Editas Medicine Inc / VAT Group AG / CRISPR Therapeutics AG / Comet Holding AG / Sensirion Holding AG / SIG Combibloc Group AG / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / United Kingdom / Italy / Japan / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Herr Patrick Laager / Herr. Christoph Gretler</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - BeiGene: TIGIT deal continues to support globalisation strategy and strengthens Novartis collaboration. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGNE.OQ / 6160.HK / NOVN.S / BMY.N / ROG.S / GSK.L / GILD.OQ / AGEN.OQ</td><td class="leftalignment">Beigene Ltd / Beigene Ltd / Novartis AG / Bristol-Myers Squibb Co / Roche Holding AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Agenus Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CI.N / CL.N / CVS.N / DD.N / ECL.N / EIX.N / EL.N / F.N / FSR.N / GM.N / KO.N / MDT.N / MO.N / PNC.N / PPG.N / SLB.N / SO.N / T.N / USB.N / VC.N / PG.N / HUM.N / GILD.O / CPB.N / TEN.N / INCY.O / DUK.N / BWA.N / LEA.N / DRI.N / ADBE.O / IMO.TO / MCD.N / VLO.N / DV.N / PCG.N / MGA.N / AMT.N / JAZZ.O / SHW.N / VZ.N / EXEL.O / XEL.N / ARNA.O / AMP.N / LNC.N / APH.N / SRE.N / EXC.N / FISV.O / AXL.N / ACN.N / PLD.N / NBIX.O / AME.N / BC.N / AJG.N / BMRN.O / REGN.O / VRTX.O / PRU.N / NCR.N / TEL.N / COP.N / CPK.N / PII.N / ST.N / DFS.N / PLUG.OQ / SGEN.OQ / GPN.N / MNST.O / IMGN.O / ACGL.O / ICPT.O / EQIX.O / BIIB.O / TFC.N / ACAD.O / 416515104 / ALNY.O / BKD.N / MA.N / HOG.N / AON.N / DAN.N / MSCI.N / CVE.TO / SPB.N / NEE.N / MTOR.N / SRPT.O / FFHu.TO / MDLZ.OQ / TSLA.N / TMUS.N / BEP.N / AGIO.O / PTC.O / QTWO.N / NEP.N / GBT.OQ / MESO.O / SPGI.N / ADNT.N / ATNX.O / CNNE.N / APTV.N / ITRM.O / VNE.N / GMDA.OQ / GMAB.O / CRNC.OQ / WTRG.N / CARR.N / OTIS.N / NKLA.OQ / FOUR.N / NRIX.OQ / LUMN.N / AEP.OQ / RIDE.OQ / LSPD.N / NUVB.N / TSP.OQ / FLYW.O / DBRG.N / BHG.N / RYAN.N / BASE.OQ / FLNC.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / Medtronic PLC / Altria Group Inc / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Procter & Gamble Co / Humana Inc / Gilead Sciences Inc / Campbell Soup Co / Tenneco Inc / Incyte Corp / Duke Energy Corp / Borgwarner Inc / Lear Corp / Darden Restaurants Inc / Adobe Inc / Imperial Oil Ltd / McDonald's Corp / Valero Energy Corp / DoubleVerify Holdings Inc / PG&E Corp / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Sherwin-Williams Co / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Lincoln National Corp / Amphenol Corp / Sempra Energy / Exelon Corp / Fiserv Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Prologis Inc / Neurocrine Biosciences Inc / AMETEK Inc / Brunswick Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Conocophillips / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Discover Financial Services / Plug Power Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / ImmunoGen Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Alnylam Pharmaceuticals Inc / Brookdale Senior Living Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / Dana Inc / MSCI Inc / Cenovus Energy Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Sarepta Therapeutics Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / PTC Inc / Q2 Holdings Inc / Nextera Energy Partners LP / Global Blood Therapeutics Inc / Mesoblast Ltd / S&P Global Inc / Adient PLC / Athenex Inc / Cannae Holdings Inc / Aptiv PLC / Iterum Therapeutics PLC / Veoneer Inc / Gamida Cell Ltd / Genmab A/S / Cerence Inc / Essential Utilities Inc / Carrier Global Corp / Otis Worldwide Corp / Nikola Corp / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / American Electric Power Company Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Nuvation Bio Inc / TuSimple Holdings Inc / Flywire Corp / DigitalBridge Group Inc / Bright Health Group Inc / Ryan Specialty Group Holdings Inc / Couchbase Inc / Fluence Energy Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Imagine™: Game Changers: Disruptive Forces in Biotech</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (20 December-): Trading sluggish and lacking direction, likely to be range-bound during holiday season</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / GILD.OQ / NVAX.OQ / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Gilead Sciences Inc / Novavax Inc / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品・医療機器セクター: 週間レビューと見通し（12月20日～）: 薄商いで方向感欠く、ホリデーシーズン入りでレンジ相場か</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / GILD.OQ / NVAX.OQ / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Gilead Sciences Inc / Novavax Inc / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">814</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 10 to 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US00724F1012 / US0236081024 / US0311621009 / US0351282068 / US0383361039 / US0394831020 / US0536111091 / US0584981064 / US1101221083 / US1264081035 / US1564311082 / US2017231034 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4227041062 / US5324571083 / US5463471053 / US6516391066 / US65473P1057 / US6703461052 / US7170811035 / US7445731067 / US7802871084 / US8581191009 / US92276F1003 / US9746371007 / US98389B1008 / CA13321L1085 / CA6979001089 / CA8787422044 / CA2918434077 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA1349211054 / CA0636711016 / CA0641491075 / CA8765111064 / CA3359341052 / US20825C1045 / US35671D8570 / AU000000FMG4 / US09062X1037 / CA98462Y1007 / US02043Q1076 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / CA39138C1068 / CA4436281022 / CA1360691010 / US3546131018 / US74144T1088 / US09247X1019 / US44107P1049 / CA95083R1001 / US40637H1095 / CA1375761048 / US74460D1090 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / US30225T1025 / CA0966311064 / CA29258Y1034 / CA1999101001 / CA2271071094 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA46071W2058 / BMG491BT1088 / CA3518581051 / GB00B2QPKJ12 / GB0004300496 / US26884L1098 / US91912E1055 / US1921085049 / IE00B4BNMY34 / CA69946Q1046 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US2296631094 / CA54928Q1081 / AU000000EVN4 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09739D1000 / JE00B5TT1872 / US09609G1004 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3874371147 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0158571053 / CA0213611001 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA8661201167 / CA38045Y1025 / US16208T1025 / CA5054401073 / US45845P1084 / CA0266951064 / CA33812R1091 / CA17039A1066 / CA46579R1047 / US45378A1060 / CA65340P1062 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / CA45868C1095 / CA26153P1045 / CA1264621006 / CA7397211086 / US14174T1079 / CA68827L1013 / US78667J1088 / CA30606C1086 / IE00BQPVQZ61 / CA5503711080 / US30040W1080 / CA74273V1067 / US6378701063 / AU000000S320 / US4278255009 / CA0115321089 / CA05329M1041 / US95040Q1040 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / US53223X1072 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / US43300A2033 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US23355L1061 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / US03753U1060 / CA2960061091 / CA7766521099 / CA8585221051 / US92645B1035 / US3843135084 / US03168L1052 / US2997341035 / CA05585D1033 / US03836N1037 / CA0717341071 / US03843E1047 / CA4039254079 / US04335A1051 / CA38119T8077 / CA13000C2058 / US03990B1017 / CA72765Q8829 / US1255231003 / CA2849025093 / CA45075E1043 / US63253R2013 / AU0000018236 / CA7426943006 / CA57776F4050 / US09260D1072 / CA5625684025 / CA48086P1009 / US30205M1018 / CA29446Y5020 / US03768E1055 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / CA31890B1031 / US14316J1088 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA67079A1021 / US12529R1077 / US3773201062 / CA9004352071 / US3680361090 / CA64782A1075 / CA00288U1066 / CA36261G1028 / US15202L1070 / US24343R1068 / CA65401N1078 / US90364P1057 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA50202P1053 / CA65343M2094 / US1374041093 / CA0156581070 / CA24477T1003 / CA22289D1078 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Adobe Inc / Ameren Corp / Amgen Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Ball Corp / Bristol-Myers Squibb Co / CSX Corp / Century Aluminum Co / Commercial Metals Co / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hecla Mining Co / Eli Lilly and Co / Louisiana-Pacific Corp / Newmont Corporation / NiSource Inc / Nucor Corp / Pfizer Inc / Public Service Enterprise Group Inc / Royal Gold Inc / Steel Dynamics Inc / Ventas Inc / Winnebago Industries Inc / Xcel Energy Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Empire Company Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Canadian Apartment Properties Real Estate Investment Trust / Bank of Montreal / Bank of Nova Scotia / Taseko Mines Ltd / First Quantum Minerals Ltd / Conocophillips / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Great-West Lifeco Inc / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Host Hotels & Resorts Inc / Wesdome Gold Mines Ltd / Halozyme Therapeutics Inc / Canfor Corp / Public Storage / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Extra Space Storage Inc / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Cominar Real Estate Investment Trust / Crombie Real Estate Investment Trust / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / InterRent Real Estate Investment Trust / Invesco Ltd / Franco-Nevada Corp / Fresnillo PLC / Pan African Resources PLC / EQT Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Parex Resources Inc / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / CubeSmart / Lucara Diamond Corp / Evolution Mining Ltd / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Boise Cascade Co / Centamin PLC / bluebird bio Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Granite Real Estate Investment Trust / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Algonquin Power & Utilities Corp / AltaGas Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / Summit Industrial Income REIT / GoGold Resources Inc / Chatham Lodging Trust / Labrador Iron Ore Royalty Corp / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Fission Uranium Corp / Choice Properties Real Estate Investment Trust / Ivanhoe Mines Ltd / Independence Realty Trust Inc / Nexgen Energy Ltd / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Prairiesky Royalty Ltd / CareTrust REIT Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Falco Resources Ltd / Horizon Therapeutics PLC / Lundin Gold Inc / Eversource Energy / Probe Metals Inc / National Storage Affiliates Trust / South32 Ltd / Hersha Hospitality Trust / Alamos Gold Inc / Automotive Properties Real Estate Investment Trust / Welltower Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Life Storage Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Hilton Worldwide Holdings Inc / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / DXC Technology Co / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Apellis Pharmaceuticals Inc / Ero Copper Corp / Roots Corp / Stelco Holdings Inc / Victory Capital Holdings Inc / GrafTech International Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Aptinyx Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Golden Star Resources Ltd / Calibre Mining Corp / Ares Management Corp / Platinum Group Metals Ltd / Cigna Corp / Eldorado Gold Corp / iA Financial Corporation Inc / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / Maverix Metals Inc / Blackstone Inc / Mandalay Resources Corp / Josemaria Resources Inc / Exicure Inc / Equinox Gold Corp / Apollo Global Management Inc / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / First Capital Real Estate Investment Trust / Carlyle Group Inc / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Abcellera Biologics Inc / G Mining Ventures Corp / Centerspace / Decibel Therapeutics Inc / Nickel 28 Capital Corp / UiPath Inc / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / Li-Cycle Holdings Corp / NextSource Materials Inc / Candel Therapeutics Inc / Algoma Steel Group Inc / Definity Financial Corp / Coveo Solutions Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ACA / ALLO / ATRC / GBT / INCY / INSP / MBIO / NBIX / RAD / SAGE / WMT / GILD.O / EW / ONEM.O / RMD / FMTX / ISRG / ALPN / SGEN / REGN.O / VRTX.O / SSNC.O / NKTR / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / LHCG.O / INFI.O / TMDI / TNDM.O / ENSG.O / 483548103 / MRNA.O / BLRX / ADUS.O / AGIO / FATE.O / 02005N100 / RXDX.O / VBLT.O / APTO.O / EVH / 100063846 / IONS.O / 04280A100 / EDIT / VRAY / CRSP / SRRA / ATNX.O / APLS.O / 720795103 / ELOX.OQ / ARVN / XFOR.O / TMDX / KRTX / PSNL.O / 50127T109 / 87164F105 / PNTG.O / GMDA / ZNTL.O / ORIC.O / SPRB.OQ / TARS.O / VOR.O / NKTX.O / BMEA.O / CLNN.O / RZLT.O / CRBU.O / MDNA.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / AtriCure Inc / Global Blood Therapeutics Inc / Incyte Corp / Inspire Medical Systems Inc / Mustang Bio Inc / Neurocrine Biosciences Inc / Rite Aid Corp / SAGE Therapeutics Inc / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Resmed Inc / Forma Therapeutics Holdings Inc / Intuitive Surgical Inc / Alpine Immune Sciences Inc / Seagen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Nektar Therapeutics / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Titan Medical Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / BioLine RX Ltd / Addus Homecare Corp / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Ally Financial Inc / Prometheus Biosciences Inc / Vascular Biogenics Ltd / Aptose Biosciences Inc / Evolent Health Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Editas Medicine Inc / ViewRay Inc / CRISPR Therapeutics AG / Sierra Oncology Inc / Athenex Inc / Apellis Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Personalis Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / Pennant Group Inc / Gamida Cell Ltd / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Spruce Biosciences Inc / Tarsus Pharmaceuticals Inc / Vor Biopharma Inc / Nkarta Inc / Biomea Fusion Inc / Clene Inc. / Rezolute Inc / Caribou Biosciences Inc / Medicenna Therapeutics Corp / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Ladenburg Thalmann & Co. Inc.</td><td class="leftalignment">ASH 2021 Highlights</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD / JNJ / REGN / US23254L6039 / IMGO</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Regeneron Pharmaceuticals Inc / Cyclacel Pharmaceuticals Inc / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ahu Demir, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma Growth Crisis? Lower & Slower Growth Ahead as Major LOEs Loom</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">92532F10 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">GILD - Embedded Expectations Analysis - 2021 12 16</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US0341641035 / US0351282068 / US0394831020 / US1101221083 / US1564311082 / US2017231034 / US2372661015 / US3755581036 / US38059T1060 / US4227041062 / US4404521001 / US5324571083 / US6516391066 / US6703461052 / US75886F1075 / US7802871084 / US8000131040 / US8581191009 / US9024941034 / US9746371007 / CA13321L1085 / CA6979001089 / CA8787422044 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / CA8765111064 / CA3359341052 / US35671D8570 / AU000000FMG4 / BMG169621056 / CA98462Y1007 / CA5503721063 / CA8911605092 / CA4436281022 / CA1360691010 / CA95083R1001 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA29258Y1034 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / US3932221043 / GB00B2QPKJ12 / GB0004300496 / US91912E1055 / US1921085049 / CA69946Q1046 / US72147K1088 / CA66510M2040 / JE00B4T3BW64 / CA54928Q1081 / US4571871023 / AU000000EVN4 / JE00B5TT1872 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0213611001 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA5054401073 / CA33812R1091 / CA46579R1047 / CA65340P1062 / CA7397211086 / CA68827L1013 / CA30606C1086 / CA5503711080 / CA74273V1067 / AU000000S320 / CA0115321089 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / CA2960061091 / CA8585221051 / US3843135084 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA57776F4050 / CA5625684025 / CA48086P1009 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA9004352071 / US3680361090 / CA64782A1075 / CA36261G1028 / CA65401N1078 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA65343M2094 / CA0156581070 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Andersons Inc / AngloGold Ashanti Ltd / Archer-Daniels-Midland Co / Bristol-Myers Squibb Co / Century Aluminum Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Hormel Foods Corp / Eli Lilly and Co / Newmont Corporation / Nucor Corp / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Sanderson Farms Inc / Steel Dynamics Inc / Tyson Foods Inc / Winnebago Industries Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Taseko Mines Ltd / First Quantum Minerals Ltd / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Bunge Ltd / Yamana Gold Inc / Lundin Mining Corp / Toronto-Dominion Bank / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Wesdome Gold Mines Ltd / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Endeavour Silver Corp / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Green Plains Inc / Fresnillo PLC / Pan African Resources PLC / Vale SA / Coeur Mining Inc / Parex Resources Inc / Pilgrims Pride Corp / Northern Dynasty Minerals Ltd / Glencore PLC / Lucara Diamond Corp / Ingredion Inc / Evolution Mining Ltd / Centamin PLC / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / AltaGas Ltd / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / Labrador Iron Ore Royalty Corp / Fission Uranium Corp / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Prairiesky Royalty Ltd / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Probe Metals Inc / South32 Ltd / Alamos Gold Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / GrafTech International Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / Maverix Metals Inc / Mandalay Resources Corp / Josemaria Resources Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / NextSource Materials Inc / Algoma Steel Group Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AXP.N / BAC.N / C.N / CCI.N / COF.N / ECL.N / EDP.LS / FLS.N / GE.N / JPM.N / MDT.N / MMC.N / SGEF.PA / SSE.L / DRE.N / FR.N / GILD.O / ETN.N / DHR.N / WCC.N / DOV.N / IEX.N / ROP.N / EPR.N / HON.N / MMM.N / EMR.N / SBAC.O / AMT.N / JAZZ.O / LBRT.N / GWW.N / JCI.N / STZ.N / HXL.N / NNN.N / CTAS.O / FDS.N / EFX.N / ARE.N / EGP.N / EXPE.O / PLD.N / AME.N / KRC.N / VTR.N / PTEN.O / MCO.N / GTY.N / GGG.N / PNR.N / TT.N / DFS.N / ADC.N / TRU.N / O.N / WPC.N / ADS.N / NVT.N / DLR.N / NESTE.HE / SRC.N / MPW.N / IHS.N / MWA.N / 3IN.L / ATL.MI / RENE.LS / SLRS.MC / MSCI.N / INPP.L / VRSK.O / EGO.N / AR.TO / STAG.N / XYL.N / UKWG.L / PTC.O / XNCR.OQ / SYF.N / CFG.N / 03835T200 / GBT.OQ / ZG.O / SPGI.N / FTV.N / ATKR.N / CRSP.OQ / INVH.N / CVNA.N / GRPG.I / RDFN.O / SWCH.N / AQUA.N / CARG.O / COLD.N / GTES.N / BKNG.O / MGTX.O / ALLO.OQ / GMDA.OQ / FVRR.N / APRE.OQ / EPAC.N / IGMS.O / CARR.N / ABNB.OQ / DASH.N / DBRG.N / CYXT.OQ / BASE.OQ</td><td class="leftalignment">American Express Co / Bank of America Corp / Citigroup Inc / Crown Castle International Corp / Capital One Financial Corp / Ecolab Inc / EDP Energias de Portugal SA / Flowserve Corp / General Electric Co / JPMorgan Chase & Co / Medtronic PLC / Marsh & McLennan Companies Inc / Vinci SA / SSE PLC / Duke Realty Corp / First Industrial Realty Trust Inc / Gilead Sciences Inc / Eaton Corporation PLC / Danaher Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / EPR Properties / Honeywell International Inc / 3M Co / Emerson Electric Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / Liberty Oilfield Services Inc / W W Grainger Inc / Johnson Controls International PLC / Constellation Brands Inc / Hexcel Corp / National Retail Properties Inc / Cintas Corp / Factset Research Systems Inc / Equifax Inc / Alexandria Real Estate Equities Inc / Eastgroup Properties Inc / Expedia Group Inc / Prologis Inc / AMETEK Inc / Kilroy Realty Corp / Ventas Inc / Patterson-UTI Energy Inc / Moody's Corp / Getty Realty Corp / Graco Inc / Pentair PLC / Trane Technologies PLC / Discover Financial Services / Agree Realty Corp / TransUnion / Realty Income Corp / WP Carey Inc / Alliance Data Systems Corp / nVent Electric PLC / Digital Realty Trust Inc / Neste Oyj / Spirit Realty Capital Inc / Medical Properties Trust Inc / IHS Holding Ltd / Mueller Water Products Inc / 3I Infrastructure PLC / Atlantia SpA / Ren Redes Energeticas Nacionais SGPS SA / Solaria Energia y Medio Ambiente SA / MSCI Inc / International Public Partnerships Ltd / Verisk Analytics Inc / Eldorado Gold Corp / Argonaut Gold Inc / STAG Industrial Inc / Xylem Inc / Greencoat UK Wind PLC / PTC Inc / Xencor Inc / Synchrony Financial / Citizens Financial Group Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Zillow Group Inc / S&P Global Inc / Fortive Corp / Atkore Inc / CRISPR Therapeutics AG / Invitation Homes Inc / Carvana Co / Greencoat Renewables PLC / Redfin Corp / Switch Inc / Evoqua Water Technologies Corp / CarGurus Inc / Americold Realty Trust / Gates Industrial Corporation PLC / Booking Holdings Inc / MeiraGTx Holdings PLC / Allogene Therapeutics Inc / Gamida Cell Ltd / Fiverr International Ltd / Aprea Therapeutics Inc / Enerpac Tool Group Corp / IGM Biosciences Inc / Carrier Global Corp / Airbnb Inc / DoorDash Inc / DigitalBridge Group Inc / Cyxtera Technologies Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Portugal / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback - Key takeaways from ASH DLBCL & CAR-T expert call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GMAB.CO / ROG.S / BMY.N / JNJ.N / NOVN.S / GILD.OQ</td><td class="leftalignment">Genmab A/S / Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Matt S. Miksic / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">KOL Call On Lymphoma: Takeaways From Our 2nd Annual Healthcare Private Company Conference</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / XNCR.OQ / CRSP.OQ / ALLO.OQ / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Xencor Inc / CRISPR Therapeutics AG / Allogene Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / Stephen Mallon / Jackie Yan / Yinglu Zhang / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Transcript: ASH Doctor Call</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US1101221083 / US3755581036 / US75886F1075</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">US0236081024 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US5463471053 / US75886F1075 / US9621661043 / CA9528451052 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / CA8911605092 / CA1360691010 / US7376301039 / CA1375761048 / US00287Y1091 / US09739D1000 / CA0158571053 / CA04016A1012 / CA45868C1095 / US78667J1088 / US23355L1061 / CA7766521099 / US90364P1057 / CA50202P1053</td><td class="leftalignment">Ameren Corp / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Regeneron Pharmaceuticals Inc / Weyerhaeuser Co / West Fraser Timber Co Ltd / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Potlatchdeltic Corp / Canfor Corp / Abbvie Inc / Boise Cascade Co / Algonquin Power & Utilities Corp / Argonaut Gold Inc / Interfor Corp / SAGE Therapeutics Inc / DXC Technology Co / Roots Corp / UiPath Inc / Li-Cycle Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">They just said what?! Takeaways from the Kite ASH Q&A session</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Andrew Galler / Dr. Tim M. Anderson, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Doc Call Follow-Up: Focus on CAR-T in DLBCL After Practice Changing Data</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US00287Y1091</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Gilead Post-ASH Virtual Call and Q&A Summary: All About ZUMA-7</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ZUMA ASH Presentations Support Significant Cell Therapy Use In Earlier Lines</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACI / ALLO / BJ / CHD / COST / DG / DLTR / EA / EL / ELF / GBT / INTC.O / KR / MSFT / SONY / TTWO / WMT / GILD.O / ATVI.O / NVDA.O / SFM / HEAR / FMTX / NFLX / PRPL / FRPT / UTZ / HELE.OQ / TEAM.O / 36467W109 / ZNGA / FDEV.L / FATE.O / 82655M107 / APTO.O / VRAY / CRSP / BILI.O / ZM.O / ORIC.O / ASO.OQ / ASAN.K / HUYA.K / OTLY / MNDY.O / KLTR.O / BLZE.O</td><td class="leftalignment">Albertsons Companies Inc / Allogene Therapeutics Inc / BJ's Wholesale Club Holdings Inc / Church & Dwight Co Inc / Costco Wholesale Corp / Dollar General Corp / Dollar Tree Inc / Electronic Arts Inc / Estee Lauder Companies Inc / elf Beauty Inc / Global Blood Therapeutics Inc / Intel Corp / Kroger Co / Microsoft Corp / Sony Group Corp / Take-Two Interactive Software Inc / Walmart Inc / Gilead Sciences Inc / Activision Blizzard Inc / NVIDIA Corp / Sprouts Farmers Market Inc / Turtle Beach Corp / Forma Therapeutics Holdings Inc / Netflix Inc / Purple Innovation Inc / Freshpet Inc / UTZ Brands Inc / Helen of Troy Ltd / Atlassian Corporation PLC / GameStop Corp / Zynga Inc / Frontier Developments PLC / Fate Therapeutics Inc / Sify Technologies Ltd / Aptose Biosciences Inc / ViewRay Inc / CRISPR Therapeutics AG / Bilibili Inc / Zoom Video Communications Inc / Oric Pharmaceuticals Inc / Academy Sports and Outdoors Inc / Asana Inc / HUYA Inc / Oatly Group AB / Monday.Com Ltd / Kaltura Inc / Backblaze Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / India / Israel / Japan / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">FT596 Doesn't Disappoint—Still Doubting iPSC?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FATE.O / ALLO / GILD.O / CRSP</td><td class="leftalignment">Fate Therapeutics Inc / Allogene Therapeutics Inc / Gilead Sciences Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Matthew Biegler / Mark Breidenbach, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US1264081035 / US3755581036 / US45337C1027 / US5324571083 / US6745991058 / US7170811035 / US75886F1075 / US20825C1045 / CA56501R1064 / CA8667961053 / CA39138C1068 / US26884L1098 / US58933Y1055 / US69327R1014 / CA21750U1012 / US31189P1021 / US86771W1053 / US03753U1060 / US03843E1047 / CA45075E1043 / US86745K1043 / US30205M1018</td><td class="leftalignment">CSX Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Occidental Petroleum Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Conocophillips / Manulife Financial Corp / Sun Life Financial Inc / Great-West Lifeco Inc / EQT Corp / Merck & Co Inc / PDC Energy Inc / Copper Mountain Mining Corp / Fate Therapeutics Inc / Sunrun Inc / Apellis Pharmaceuticals Inc / Aquestive Therapeutics Inc / iA Financial Corporation Inc / Sunnova Energy International Inc / Exicure Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BA.N / CP.TO / DD.N / DFDS.CO / NSC.N / VIEV.VI / GILD.O / CNR.TO / CSX.N / UNP.N / STT.N / ARNA.O / REGN.O / VRTX.O / SRG.MI / DCO.N / 878742204 / ALNY.O / DRX.L / ARWR.O / CS.TO / HOG.N / SPR.N / GETP.PA / VRSK.O / FHZN.S / RXDX.OQ / BERY.N / MOLN.S / 03835T200 / GBT.OQ / MESO.O / UBSG.S / NTLA.O / ATNX.O / ALLO.OQ / MORF.OQ / GMAB.O / ETNB.O / PLRX.OQ / NRIX.OQ / CHK.OQ / ASCU.TO</td><td class="leftalignment">Boeing Co / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / DFDS AS / Norfolk Southern Corp / Flughafen Wien AG / Gilead Sciences Inc / Canadian National Railway Co / CSX Corp / Union Pacific Corp / State Street Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Snam SpA / Ducommun Inc / Teck Resources Ltd / Alnylam Pharmaceuticals Inc / Drax Group PLC / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Harley-Davidson Inc / Spirit AeroSystems Holdings Inc / Getlink SE / Verisk Analytics Inc / Flughafen Zuerich AG / Prometheus Biosciences Inc / Berry Global Group Inc / Molecular Partners AG / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mesoblast Ltd / UBS Group AG / Intellia Therapeutics Inc / Athenex Inc / Allogene Therapeutics Inc / Morphic Holding Inc / Genmab A/S / 89Bio Inc / Pliant Therapeutics Inc / Nurix Therapeutics Inc / Chesapeake Energy Corp / Arizona Sonoran Copper Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Austria / Canada / Switzerland / Denmark / France / United Kingdom / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2022 RBC Biotech Outlook Report: Opportunities Abound, After A Tough Year</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">GILD.O / ARNA.O / VRTX.O / ALNY.O / ARWR.O / RXDX.OQ / MOLN.S / GBT.OQ / NTLA.O / MORF.OQ / GMAB.O / ETNB.O / PLRX.OQ / NRIX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Arena Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Prometheus Biosciences Inc / Molecular Partners AG / Global Blood Therapeutics Inc / Intellia Therapeutics Inc / Morphic Holding Inc / Genmab A/S / 89Bio Inc / Pliant Therapeutics Inc / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Yinglu Zhang / Lisa Walter / Jackie Yan / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Mr. Charles Weston / Ms. Zoe Karamanoli, PHD / Jack Reynolds-Clark / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Partner Arena's acquisition by Pfizer is another win for Everest team's BD capabilities. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / ARNA.OQ / PFE.N / GILD.OQ / LJPC.OQ / UTHR.OQ</td><td class="leftalignment">Everest Medicines Ltd / Arena Pharmaceuticals Inc / Pfizer Inc / Gilead Sciences Inc / La Jolla Pharmaceutical Co / United Therapeutics Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Islatravir Clinical Hold by FDA Dims Prospects for Long-Acting Lena Combo</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ike Oji</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 3: Wrap Up and Regeneron Investor Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US58933Y1055 / US31189P1021 / US03753U1060</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE=US / BMY=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / PG=US / WEN=US / AMZN=US / DVN=US / EBAY=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / IGT=US / MGY=US / SWN=US / VRM=US / MUR=US / BYD=US / MAR=US / MRO=US / EXPE=US / TNL=US / MGM=US / HLT=US / PENN=US / NWL=US / W=US / FLO=US / STZ=US / BMRN=US / CBRL=US / CTRA=US / CHD=US / COLL=US / CNX=US / DRI=US / DRH=US / EPC=US / EQT=US / GFF=US / GPOR=US / TREE=US / NOW=US / TEAM=US / REGN=US / SGMO=US / SMG=US / SNAP=US / TRIP=US / WIX=US / CVX=US / POST=US / CGEN=US / SGMS=US / BKNG=US / CNC=US / SNV=US / FB=US / MTCH=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / BDSI=US / MNST=US / PTON=US / IGMS=US / NOMD=US / RNG=US / CZR=US / SHO=US / PLAY=US / FRPT=US / DENN=US / XM=US / THS=US / ESMT=US / CMG=US / ELF=US / TAST=US / CENTA=US / QSR=US / CLR=US / WH=US / NOG=US / IAC=US / JACK=US / AGS=US / RCUS=US / UTZ=US / 45665G303 / INSE / AR=US / OAS=US / HGV=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / SSTK=US / NCLH=US / NDLS=US / GLPI=US / GOOGL=US / VNOM=US / LOCO=US / BABA=US / CIVI=US / CMPR=US / BVH=US / SHAK=US / GDDY=US / ETSY=US / WING=US / ZG=US / EVRI=US / TTD=US / EVBG=US / CDEV=US / TRVG=US / PK=US / PLYA=US / CVNA=US / YEXT=US / SBOW=US / RDFN=US / PETQ=US / CARG=US / SFIX=US / KDP=US / FTDR=US / EB=US / ARVN=US / HARP=US / LYFT=US / UBER=US / FERG=US / BRBR=US / OVV=US / REYN=US / NGMS=US / HYFM=US / CELU=US / ROCC=US / REPX=US / 67421J108 / MNTV=US / DNUT=US / GAMB=US / EWCZ=US / USER=US</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Procter & Gamble Co / Wendys Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Vroom Inc / Murphy Oil Corp / Boyd Gaming Corp / Marriott International Inc / Marathon Oil Corp / Expedia Group Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Newell Brands Inc / Wayfair Inc / Flowers Foods Inc / Constellation Brands Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Coterra Energy Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Gulfport Energy Corp / Lendingtree Inc / ServiceNow Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Post Holdings Inc / Compugen Ltd / Scientific Games Corp / Booking Holdings Inc / Centene Corp / Synovus Financial Corp / Meta Platforms Inc / Match Group Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / IGM Biosciences Inc / Nomad Foods Ltd / RingCentral Inc / Caesars Entertainment Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Qualtrics International Inc / TreeHouse Foods Inc / EngageSmart Inc / Chipotle Mexican Grill Inc / elf Beauty Inc / Carrols Restaurant Group Inc / Central Garden & Pet Co / Restaurant Brands International Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / PlayAGS Inc / Arcus Biosciences Inc / UTZ Brands Inc / Infinity Pharmaceuticals Inc / Inspired Entertainment Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Shutterstock Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Gaming and Leisure Properties Inc / Alphabet Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Alibaba Group Holding Ltd / Civitas Resources Inc / Cimpress PLC / Bluegreen Vacations Holding Corp / Shake Shack Inc / GoDaddy Inc / ETSY Inc / Wingstop Inc / Zillow Group Inc / Everi Holdings Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Yext Inc / SilverBow Resources Inc / Redfin Corp / PetIQ Inc / CarGurus Inc / Stitch Fix Inc / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arvinas Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Reynolds Consumer Products Inc / NeoGames SA / Hydrofarm Holdings Group Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc / Oatly Group AB / Momentive Global Inc / Krispy Kreme Inc / Gambling.com Group Ltd / European Wax Center Inc / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AJG / ALL / AM / AMT / AR / AXP / BA.N / BAX / BMY.N / CB / CCI / CLR / CNC.N / CNX / COO / CPE / CPK / CRM.N / CVS.N / D / DG / DGX / DK / DLR / DVN / DY / EOG / EQT / HD / HEP / HIG / IFF / KNX / LOW / MCHP.O / MGY / MMP / MRK.N / MRO / OKE / OLN / OXY / PFE.N / PGR / PNM / PXD / QCOM.O / RKT / RMBS.O / RNG / RRC / SJI / SLG / SM / SWN / T / TFX / TOL / USM / WES / WLK / WLL / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / IRM / MGM.N / ADBE.O / PAA.N / SBAC.O / MXL / ADI.O / VZ / NWN / ARNA.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / BYD.N / ARGX.O / PENN.O / ISRG.O / LPI / CHDN.O / REGN.O / VRTX.O / MRVL.O / SMG.N / WYNN.O / SIVB.O / DIOD.O / ACGL.O / EQIX.O / OMCL.O / SWKS.O / BIIB.O / DKL / LVS.N / CDNS.O / CNSL.O / CLMT.O / CCOI.O / NOG.A / WRB.N / TSLA.O / NXPI.O / CZR.O / HZNP.O / ESTE.K / MTDR.K / TRGP.K / PDCE.O / AMBA.O / FANG.O / MPLX.K / ABBV.N / PFSI.K / PSXP.K / LGIH.O / FIVN.O / RXDX.O / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / CYAD.O / GBT.O / TMUS.O / RRR.O / EVBG.O / UNIT.O / CLLS.O / CDEV.O / WDAY.O / HESM.K / RYTM.O / SWCH.K / APLS.O / EGHT.K / AUTL.O / BRY.O / KZR.O / AXNX.O / SWAV.O / ZM.O / FLTRF.L / RTLR.O / MORF.O / CABA.O / OAS.O / OVV.N / PGEN.O / BEAM.O / DKNG.O / ZI.O / CTRA.K / GRWG.O / 45258J102 / NWE.O / LUMN.K / BALY.N / ALGM.O / RSI.N / HYFM.O / GRCL.O / CHK.O / HMPT.O / DBRG.N / BLND.N / YOU.N / WKME.O / KLTR.O / WOLF.N / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / American Tower Corp / Antero Resources Corp / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Continental Resources Inc / Centene Corp / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Chesapeake Utilities Corp / Salesforce.Com Inc / CVS Health Corp / Dominion Energy Inc / Dollar General Corp / Quest Diagnostics Inc / Delek US Holdings Inc / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Microchip Technology Inc / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Merck & Co Inc / Marathon Oil Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / SM Energy Co / Southwestern Energy Co / AT&T Inc / Teleflex Inc / Toll Brothers Inc / United States Cellular Corp / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / MGM Resorts International / Adobe Inc / Plains All American Pipeline LP / SBA Communications Corp / Maxlinear Inc / Analog Devices Inc / Verizon Communications Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Boyd Gaming Corp / argenx SE / Penn National Gaming Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Churchill Downs Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / SVB Financial Group / Diodes Inc / Arch Capital Group Ltd / Equinix Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / Las Vegas Sands Corp / Cadence Design Systems Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Horizon Therapeutics PLC / Earthstone Energy Inc / Matador Resources Co / Targa Resources Corp / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / PennyMac Financial Services Inc / Phillips 66 Partners LP / LGI Homes Inc / Five9 Inc / Prometheus Biosciences Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Celyad Oncology SA / Global Blood Therapeutics Inc / T-Mobile US Inc / Red Rock Resorts Inc / Everbridge Inc / Uniti Group Inc / Cellectis SA / Centennial Resource Development Inc / Workday Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Switch Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Flutter Entertainment PLC / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Precigen Inc / Beam Therapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / NorthWestern Corp / Lumen Technologies Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / DigitalBridge Group Inc / Blend Labs Inc / Clear Secure Inc / Walkme Ltd / Kaltura Inc / Wolfspeed Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CRM.N / CVS.N / EIX.N / F.N / FSR.N / GM.N / GOG.L / PD.N / SO.N / T.N / VC.N / GILD.O / TEN.N / CMCSA.O / INCY.O / RBA.N / DUK.N / DIS.N / BWA.N / LEA.N / DT.N / DISH.O / PCG.N / AMT.N / KGC.N / JAZZ.O / VZ.N / XEL.N / LNC.N / APH.N / AXL.N / ACN.N / AJG.N / NBR.N / REGN.O / PRU.N / NCR.N / TEL.N / CPK.N / ST.N / PLUG.OQ / SGEN.OQ / IMGN.O / CASY.O / ACGL.O / EQIX.O / BIIB.O / DLR.N / 416515104 / BKD.N / MA.N / AON.N / DAN.N / INPP.L / NEE.N / NXT.AX / PKI.TO / MSP.N / MTOR.N / FFHu.TO / TSLA.N / TMUS.N / BEP.N / AGIO.O / KPTI.O / XNCR.OQ / COUP.N / NEP.N / HUBS.N / 03835T200 / GBT.OQ / MESO.O / ADNT.N / GDS.O / ATUS.N / ATNX.O / APTV.N / VNE.N / FOCS.O / ESTC.N / GMDA.OQ / SG.N / CRWD.O / GMAB.O / APRE.OQ / CRNC.OQ / IGMS.O / WTRG.N / NKLA.OQ / NRIX.OQ / LUMN.N / AEP.OQ / SUMO.O / RIDE.OQ / NUVB.N / COUR.N / PATH.N / TSP.OQ / BHG.N / XMTR.OQ / RYAN.N / BASE.OQ / GTLB.OQ / ZD.OQ / FLNC.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Edison International / Ford Motor Co / Fisker Inc / General Motors Co / Go-Ahead Group PLC / PagerDuty Inc / Southern Co / AT&T Inc / Visteon Corp / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Incyte Corp / Ritchie Bros Auctioneers Inc / Duke Energy Corp / Walt Disney Co / Borgwarner Inc / Lear Corp / Dynatrace Inc / DISH Network Corp / PG&E Corp / American Tower Corp / Kinross Gold Corp / Jazz Pharmaceuticals PLC / Verizon Communications Inc / Xcel Energy Inc / Lincoln National Corp / Amphenol Corp / American Axle & Manufacturing Holdings Inc / Accenture PLC / Arthur J Gallagher & Co / Nabors Industries Ltd / Regeneron Pharmaceuticals Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Plug Power Inc / Seagen Inc / ImmunoGen Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Equinix Inc / Biogen Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Brookdale Senior Living Inc / Mastercard Inc / Aon PLC / Dana Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Parkland Corp / Datto Holding Corp / Meritor Inc / Fairfax Financial Holdings Ltd / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Coupa Software Inc / Nextera Energy Partners LP / HubSpot Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mesoblast Ltd / Adient PLC / GDS Holdings Ltd / Altice USA Inc / Athenex Inc / Aptiv PLC / Veoneer Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Sweetgreen Inc / CrowdStrike Holdings Inc / Genmab A/S / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Essential Utilities Inc / Nikola Corp / Nurix Therapeutics Inc / Lumen Technologies Inc / American Electric Power Company Inc / Sumo Logic Inc / Lordstown Motors Corp / Nuvation Bio Inc / Coursera Inc / UiPath Inc / TuSimple Holdings Inc / Bright Health Group Inc / Xometry Inc / Ryan Specialty Group Holdings Inc / Couchbase Inc / GitLab Inc / Ziff Davis Inc / Fluence Energy Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Gilead Sciences, Inc. (GILD) - Still banking on Remdesivir?</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : Solid ZUMA-7 Results at ASH Support 2L Approval...But Competition Equally Impressive</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ASH Weekend Update: Key Takeaways for GILD, IGMS, KPTI, and INCY</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.OQ / IGMS.OQ / INCY.OQ / KPTI.OQ / GILD.O / INCY.O / KPTI.O / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / IGM Biosciences Inc / Incyte Corp / Karyopharm Therapeutics Inc / Gilead Sciences Inc / Incyte Corp / Karyopharm Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Read-through of Roche's TIGIT OS data: Benefiting BeiGene's global ambition</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BGNE.OQ / BMY.N / PFE.N / AZN.L / ROG.S / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 1801.HK / GMAB.CO / IMAB.OQ</td><td class="leftalignment">Beigene Ltd / Bristol-Myers Squibb Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Innovent Biologics Inc / Genmab A/S / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 2: More Data Updates With GILD's Yescarta/ZUMA-7 in the Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US09609G1004 / US03753U1060 / US4718711033</td><td class="leftalignment">Gilead Sciences Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ZUMA-1 Survival And ZUMA-7 2L Data Support Kite's "Doubling Down" W/ Auto CAR-T</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASH 2021: ZUMA-7 Sets Up Yescarta 2L LBCL Approval but BMS Not Far Behind</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Ike Oji / Jameson Kao</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 1: Some Encouraging Updates, but We Expect Limited Impact to Shares</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US75886F1075 / US58933Y1055 / US09609G1004 / US03753U1060</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Merck & Co Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASH Updates (Part 4): ZUMA-7 updates as potential 2L therapy in R/R LBCL</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY=US / GILD=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CD19 CAR-T Face-Off in 2L LBCL; GILD Data Supports Approval, BMY Approaching</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">37555810 / BMY.N / 11012210</td><td class="leftalignment">Gilead Sciences Inc / Bristol-Myers Squibb Co / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/11/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Gilead Sciences, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036 / US75886F1075 / CA68620P1018 / CA1380351009 / US62818Q1040 / US01671P1003 / US88688T1007 / CA39342L1085 / CA58507M1077 / CA22587M1068 / CA89788C1041 / US12482W1018 / CA16106R1091 / CA23126M1023 / US1266541028 / CA05156X8843 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / OrganiGram Holdings Inc / Canopy Growth Corp / Mustang Bio Inc / Allakos Inc / Tilray Brands Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Cresco Labs Inc / Trulieve Cannabis Corp / cbdMD Inc / Charlotte's Web Holdings Inc / Curaleaf Holdings Inc / CV Sciences Inc / Aurora Cannabis Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Insights from CITYSCAPE and our Recent Discussion with Genentech</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">11012210 / 37555810 / M2572210 / 640268108 / 771195104 / 58933Y10 / 00653A107 / 58949210 / 09075V10 / 07725L10 / G3910J11 / 81181C10 / 46565G10 / 03969F10 / 05370A10</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Compugen Ltd / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Adaptimmune Therapeutics PLC / Mereo Biopharma Group PLC / BioNTech SE / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Iteos Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Andrew Berens, M.D. / Jeffrey La Rosa / Dilip Joseph / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AJG / ALL / AM / AR / BA.N / BAX / BMY.N / CB / CLR / CNX / COO / CPK / CRM.N / D / DG / DK / DVN / EOG / EQT / HD / HEP / HIG / LOW / MMP / MRK.N / OKE / OLN / OXY / PFE.N / PGR / RRC / SJI / SLG / SWN / WES / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / PAA.N / ADI.O / NWN / ARNA.O / ARGX.O / ISRG.O / REGN.O / VRTX.O / SMG.N / SIVB.O / ACGL.O / OMCL.O / BIIB.O / DKL / CLMT.O / WRB.N / TSLA.O / HZNP.O / TRGP.K / FANG.O / MPLX.K / ABBV.N / PSXP.K / LGIH.O / RXDX.O / SHLX.K / NVRO.K / CIVI.K / PBFX.K / CDEV.O / HESM.K / RYTM.O / APLS.O / BRY.O / KZR.O / AXNX.O / SWAV.O / RTLR.O / MORF.O / CABA.O / CTRA.K / GRWG.O / 45258J102 / HYFM.O / CHK.O / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Antero Resources Corp / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Chesapeake Utilities Corp / Salesforce.Com Inc / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / Lowe's Companies Inc / Magellan Midstream Partners LP / Merck & Co Inc / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / Southwestern Energy Co / Western Midstream Partners LP / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Plains All American Pipeline LP / Analog Devices Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / argenx SE / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Scotts Miracle-Gro Co / SVB Financial Group / Arch Capital Group Ltd / Omnicell Inc / Biogen Inc / Delek Logistics Partners LP / Calumet Specialty Products Partners LP / W R Berkley Corp / Tesla Inc / Horizon Therapeutics PLC / Targa Resources Corp / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Phillips 66 Partners LP / LGI Homes Inc / Prometheus Biosciences Inc / Shell Midstream Partners LP / Nevro Corp / Civitas Resources Inc / PBF Logistics LP / Centennial Resource Development Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT / ACI / AIG / AJG / ALC / ALL / AM / AMAT.O / AMT / AON / AR / ARW / BA.N / BAX / BDX / BEP / BK / BMY.N / BP.N / BSX / CB / CLR / CMA / CNX / COO / COP / COST.O / CPK / CRM.N / CVX / D / DG / DK / DVN / EOG / EQT / F.N / FITB.O / GM.N / HD / HEP / HES / HFC / HIG / INTC.O / JNJ / KLAC.O / KR / LNC / LOW / LRCX.O / MCHP.O / MDT / MET / MMC / MMP / MPC / MRK.N / MUR / NTRS.O / OGE / OKE / OLN / OXY / PEN / PFE.N / PGR / PNC / PRU / PSX / QCOM.O / RE / RKT / RMBS.O / RNG / RNR / RRC / SJI / SLB.N / SLG / STT / SWN / SYK / TFC / TFX / TRV / VLO / WES / WMB / WMT / XLNX.O / ASND.O / AMZN.O / CNQ.TO / GILD.O / ET / AMGN.O / EW / BRO / AAPL.O / CSCO.O / HAL.N / NVDA.O / SU.TO / XOM / PAA.N / PBF / MXL / LBRT.N / IART.O / AMD.O / ADI.O / NWN / NTAP.O / ARNA.O / BJ.N / SMTC.O / SLAB.O / SNPS.O / ARGX.O / AXS / ISRG.O / REGN.O / VRTX.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / BE.N / SMG.N / FCEL.OQ / PLUG.OQ / SIVB.O / BLUE.O / DIOD.O / MMSI.O / ACGL.O / MKSI.O / OMCL.O / SWKS.O / BIIB.O / DKL / VIAC.O / NOV.N / BLDP.OQ / RDSb / DXCM.O / CDNS.O / STX.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / WRB.N / JNPR.K / TSLA.O / NXPI.O / LUNG.O / BKR.N / HZNP.O / WDC.O / TRGP.K / AMBA.O / FANG.O / MPLX.K / UIHC.O / ABBV.N / GTLS.N / VOYA.K / PFSI.K / RNA.O / PSXP.K / FATE.O / LGIH.O / RXDX.O / ANET.K / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / GKOS.K / ZBH / CYAD.O / PSTG.K / NVCR.O / IONS.O / WLTW.O / EDIT.O / NTLA.O / NTNX.O / CLLS.O / CDEV.O / BHF.O / IOVA.O / HESM.K / RYTM.O / APLS.O / EQH / AVT.O / INSP.K / AUTL.O / BRY.O / KZR.O / STRO.O / AXNX.O / DELL.K / SWAV.O / RTLR.O / MORF.O / CHWY.K / BRP.O / CABA.O / PGEN.O / NARI.O / AVNT.K / CTRA.K / BEPC.K / GRWG.O / 45258J102 / ASO.O / EAR.O / ROOT.O / ALGM.O / HYFM.O / GRCL.O / CHK.O / HMPT.O / NPCE.O / RYAN.N / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Antero Resources Corp / Arrow Electronics Inc / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / BP PLC / Boston Scientific Corp / Chubb Ltd / Continental Resources Inc / Comerica Inc / CNX Resources Corp / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chesapeake Utilities Corp / Salesforce.Com Inc / Chevron Corp / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Ford Motor Co / Fifth Third Bancorp / General Motors Co / Home Depot Inc / Holly Energy Partners LP / Hess Corp / HollyFrontier Corp / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kroger Co / Lincoln National Corp / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Magellan Midstream Partners LP / Marathon Petroleum Corp / Merck & Co Inc / Murphy Oil Corp / Northern Trust Corp / OGE Energy Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Penumbra Inc / Pfizer Inc / Progressive Corp / PNC Financial Services Group Inc / Prudential Financial Inc / Phillips 66 / Qualcomm Inc / Everest Re Group Ltd / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Renaissancere Holdings Ltd / Range Resources Corp / South Jersey Industries Inc / Schlumberger NV / SL Green Realty Corp / State Street Corp / Southwestern Energy Co / Stryker Corp / Truist Financial Corp / Teleflex Inc / Travelers Companies Inc / Valero Energy Corp / Western Midstream Partners LP / Williams Companies Inc / Walmart Inc / Xilinx Inc / Ascendis Pharma A/S / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Halliburton Co / NVIDIA Corp / Suncor Energy Inc / Exxon Mobil Corp / Plains All American Pipeline LP / PBF Energy Inc / Maxlinear Inc / Liberty Oilfield Services Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Northwest Natural Holding Co / NetApp Inc / Arena Pharmaceuticals Inc / BJ's Wholesale Club Holdings Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / argenx SE / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Bloom Energy Corp / Scotts Miracle-Gro Co / Fuelcell Energy Inc / Plug Power Inc / SVB Financial Group / bluebird bio Inc / Diodes Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / MKS Instruments Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / ViacomCBS Inc / Nov Inc / Ballard Power Systems Inc / Royal Dutch Shell PLC / Dexcom Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Baker Hughes Co / Horizon Therapeutics PLC / Western Digital Corp / Targa Resources Corp / Ambarella Inc / Diamondback Energy Inc / MPLX LP / United Insurance Holdings Corp / Abbvie Inc / Chart Industries Inc / Voya Financial Inc / PennyMac Financial Services Inc / Avidity Biosciences Inc / Phillips 66 Partners LP / Fate Therapeutics Inc / LGI Homes Inc / Prometheus Biosciences Inc / Arista Networks Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Pure Storage Inc / Novocure Ltd / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / Cellectis SA / Centennial Resource Development Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Equitable Holdings Inc / Avnet Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Sutro Biopharma Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Chewy Inc / BRP Group Inc / Cabaletta Bio Inc / Precigen Inc / Inari Medical Inc / Avient Corp / Coterra Energy Inc / Brookfield Renewable Corp / GrowGeneration Corp / Immunovant Inc / Academy Sports and Outdoors Inc / Eargo Inc / Root Inc / Allegro Microsystems Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / Neuropace Inc / Ryan Specialty Group Holdings Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">GILD/RCUS: Additional color from the Roche TIGIT call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD=US / RCUS=US</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 3 to 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AU000000CIA2 / US0079031078 / US0091581068 / US0311621009 / US0383361039 / US1101221083 / US1264081035 / US1266501006 / US1270971039 / US1475281036 / US1844961078 / US2017231034 / US22160K1051 / US2372661015 / US25179M1036 / US26875P1012 / US30231G1022 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4404521001 / US4433201062 / US4456581077 / US45337C1027 / US4581401001 / US4601461035 / US5324571083 / US56418H1005 / US5962781010 / US6267171022 / US64125C1099 / US6558441084 / US6703461052 / US6745991058 / US6819191064 / US68389X1054 / US7170811035 / US7237871071 / US75281A1097 / US8454671095 / US8851601018 / US9024941034 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA29250N1050 / CA0977512007 / CA4530384086 / CA8787422044 / CA1247651088 / CA2918434077 / CA1469001053 / CA0679011084 / CA1363851017 / CA0099051009 / CA7029251088 / CA8959451037 / US1667641005 / CA13645T1003 / US5658491064 / CA13677F1018 / US0017441017 / US20825C1045 / US2274831047 / US09062X1037 / CA8676EP1086 / CA2052491057 / US14040H1059 / BMG169621056 / CA67072Q1046 / CA2265331074 / US6293775085 / CA98462Y1007 / US02043Q1076 / CA4969024047 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US1331311027 / CA8935781044 / CA2935701078 / US12008R1077 / CA6993202069 / US8288061091 / US1252691001 / US12541W2098 / CA1125851040 / CA0906971035 / US42809H1077 / US57636Q1040 / CA30041N1078 / US59522J1034 / BMG383271050 / US9026531049 / CA2945051027 / CA6179141065 / CA14068G1046 / US5500211090 / US3932221043 / US3886891015 / US2120151012 / US38500T1016 / US26884L1098 / CA6252841045 / CA89154B1022 / CA9838911027 / CA22576C1014 / CA8672241079 / CA25675T1075 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / US98986T1088 / CA00829Q1019 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / US00287Y1091 / CA89156V1067 / US1091941005 / JE00B5TT1872 / US09609G1004 / US69327R1014 / CA04364G1063 / CA02215R1073 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA8204391079 / CA0805581091 / CA0213611001 / CA3565001086 / CA69338U1012 / CA74061A1084 / CA96145A2002 / CA09202D2077 / IE00B4Q5ZN47 / CA38045Y1025 / CA81373C1023 / CA04682R1073 / CA29269R1055 / CA3748252069 / US5764852050 / US25278X1090 / CA4882951060 / CA46579R1047 / US31189P1021 / US03674X1063 / US2267181046 / US1630921096 / CA14150G4007 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / US2383371091 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / CA83179X1087 / US95040Q1040 / US4622221004 / CA17040T3001 / US2057683029 / BMG162341090 / US13462K1097 / US15136A1025 / CA87241L1094 / CA46016U1084 / CA85859H1055 / CA6632782083 / CA15713J1049 / US12653C1080 / US8608971078 / CA35905B1076 / US03753U1060 / CA2960061091 / US00191U1025 / US11135F1012 / US87484T1088 / US76029N1063 / US34417P1003 / US08579X1019 / US04335A1051 / VGG1890L1076 / CA7241121077 / CA14179V5036 / US22052L1044 / CA6744822033 / US03768E1055 / US70614W1009 / US91734M1036 / CA31890B1031 / US69047Q1022 / US80810D1037 / MHY0436Q1098 / CA36168Q1046 / CA4220961078 / US03940R1077 / CA84678A1021 / US5168062058 / US05478C1053 / CA2674881040 / US13123X5086 / CA67079A1021 / CA89055A2039 / US23821D1000 / CA74022D4075 / US03750L1098 / US86333M1080 / US15202L1070 / CA83615X4075 / CA1295844056 / US78440X8048 / US1651677353 / US03743Q1085 / US90364P1057 / CA5362211040 / US44891N2080 / US92719V1008 / CA65532M6062 / CA00791P1071 / CA24874B1085 / US60646V1052 / CA03253E1079 / IE0003LFZ4U7 / CA53229C1077 / US98955K1043 / US4718711033 / US1374041093 / CA23344V1085 / CA0156581070</td><td class="leftalignment">Champion Iron Ltd / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / CSX Corp / CVS Health Corp / Coterra Energy Inc / Caseys General Stores Inc / Clean Harbors Inc / Commercial Metals Co / Costco Wholesale Corp / Darling Ingredients Inc / Devon Energy Corp / EOG Resources Inc / Exxon Mobil Corp / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hormel Foods Corp / Hub Group Inc / J B Hunt Transport Services Inc / Incyte Corp / Intel Corp / International Paper Co / Eli Lilly and Co / ManpowerGroup Inc / Middleby Corp / Murphy Oil Corp / Neurocrine Biosciences Inc / Norfolk Southern Corp / Nucor Corp / Occidental Petroleum Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Thor Industries Inc / Tyson Foods Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Enbridge Inc / Bombardier Inc / Imperial Oil Ltd / Teck Resources Ltd / CAE Inc / Empire Company Ltd / Cascades Inc / Barrick Gold Corp / Canadian Natural Resources Ltd / AKITA Drilling Ltd / Pason Systems Inc / Trican Well Service Ltd / Chevron Corp / Canadian Pacific Railway Ltd / Marathon Oil Corp / Canadian Western Bank / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Biogen Inc / Sunopta Inc / Computer Modelling Group Ltd / Capital One Financial Corp / Bunge Ltd / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Kinross Gold Corp / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Camden Property Trust / Transcontinental Inc / Ensign Energy Services Inc / Builders FirstSource Inc / Paramount Resources Ltd / Simon Property Group Inc / CF Industries Holdings Inc / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Birchcliff Energy Ltd / Hess Corp / Mastercard Inc / Evertz Technologies Ltd / Mid-America Apartment Communities Inc / GeoPark Ltd / UDR Inc / Equitable Group Inc / Morguard Real Estate Investment Trust / Capstone Mining Corp / Lululemon Athletica Inc / Green Plains Inc / Graphic Packaging Holding Co / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Mullen Group Ltd / Total Energy Services Inc / Xebec Adsorption Inc / Crescent Point Energy Corp / Suncor Energy Inc / Dollarama Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Zynga Inc / Africa Oil Corp / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Abbvie Inc / Tourmaline Oil Corp / Bright Horizons Family Solutions Inc / Centamin PLC / bluebird bio Inc / PDC Energy Inc / Ascot Resources Ltd / Altus Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Shawcor Ltd / Belo Sun Mining Corp / AltaGas Ltd / Freehold Royalties Ltd / PHX Energy Services Corp / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Black Diamond Group Ltd / Jazz Pharmaceuticals PLC / GoGold Resources Inc / Secure Energy Services Inc / Athabasca Oil Corp / Enerflex Ltd / Gibson Energy Inc / Matador Resources Co / Diamondback Energy Inc / Kelt Exploration Ltd / Ivanhoe Mines Ltd / Fate Therapeutics Inc / Antero Resources Corp / Criteo SA / Chegg Inc / Cardinal Energy Ltd (Alberta) / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Dave & Buster's Entertainment Inc / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / SmartCentres Real Estate Investment Trust / Welltower Inc / Ionis Pharmaceuticals Inc / Chorus Aviation Inc / Comstock Resources Inc / Brookfield Business Partners LP / Camping World Holdings Inc / Centennial Resource Development Inc / TFI International Inc / International Petroleum Corp / Step Energy Services Ltd / North West Company Inc / CES Energy Solutions Corp / CNX Resources Corp / Stitch Fix Inc / Frontera Energy Corp / Apellis Pharmaceuticals Inc / Ero Copper Corp / ASGN Inc / Broadcom Inc / Talos Energy Inc / Replimune Group Inc / Focus Financial Partners Inc / Berry Corporation (Bry) / Arvinas Inc / Capri Holdings Ltd / Pipestone Energy Corp / Cargojet Inc / Corteva Inc / Obsidian Energy Ltd / Apollo Global Management Inc / Peloton Interactive Inc / US Ecology Inc / First Capital Real Estate Investment Trust / Ovintiv Inc / Schrodinger Inc / Atlas Corp / GFL Environmental Inc / Headwater Exploration Inc / Arch Resources Inc / Spartan Delta Corp / Laredo Petroleum Inc / Azek Company Inc / Dye & Durham Ltd / Callon Petroleum Co / Nuvei Corp / Topaz Energy Corp / Datto Holding Corp / Precision Drilling Corp / Apartment Income REIT Corp / Stride Inc / Centerspace / Source Energy Services Ltd / Calfrac Well Services Ltd / SL Green Realty Corp / Chesapeake Energy Corp / APA Corp (US) / UiPath Inc / Lion Electric Co / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Mister Car Wash Inc / Anaergia Inc / Dole PLC / Lightspeed Commerce Inc / Zevia PBC / Jasper Therapeutics Inc / Candel Therapeutics Inc / D2L Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / France / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">ACA / BAX / DNLI / EBS / ICPT / INMD / NBIX / OM / PRGO / RAD / SAGE / SVA / WMT / GILD.O / EW / ONEM.O / ALKS.O / OPNT.O / REGN.O / SSNC.O / MRNS / NKTR / NOVN.O / CCRN.O / BCRX.O / AMED.O / EXAS.O / ANGN.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / CMMB / FREQ / ACAD.O / ALNY.O / DXCM.O / LHCG.O / MBRX.O / CBAY / CYCC.O / INFI.O / HUMA / 02043Q107 / TNDM.O / ENSG.O / 483548103 / MRNA.O / VERO / 771195104 / ADUS.O / GLAXOSM.LG / SPRO.O / 695127100 / SRPT.O / AERI.O / MDWD.O / 02005N100 / RXDX.O / INO.O / VBLT.O / NVRO / AUPH.O / GLPG.O / EVH / NVCR.O / 100063846 / IONS.O / CLRB.O / VRAY / NTLA / FLGT.O / IOVA / MTEM.O / ATNX.O / PTGX.O / 720795103 / ORTX.O / BNGO.O / IMUX.O / ZM.O / TMDX / IDYA.O / PSNL.O / DMTK.O / XAIR / PNTG.O / BCYC / NMTR.O / ORIC.O / PHGE.K / PLRX.O / NNOX / HGEN.O / TSHA.O / FSTX.O / PRTG.O / SNSE.O / IMCR.O / PHVS.O / 03823M100 / 390320109 / EVAX.O / RZLT.O / SERA.OQ / CGTX.OQ / ATXS.O</td><td class="leftalignment">Arcosa Inc / Baxter International Inc / Denali Therapeutics Inc / Emergent BioSolutions Inc / Intercept Pharmaceuticals Inc / Inmode Ltd / Neurocrine Biosciences Inc / Outset Medical Inc / Perrigo Company PLC / Rite Aid Corp / SAGE Therapeutics Inc / Sinovac Biotech Ltd / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Alkermes Plc / Opiant Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Marinus Pharmaceuticals Inc / Nektar Therapeutics / Novan Inc / Cross Country Healthcare Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Exact Sciences Corp / Angion Biomedica Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Cymabay Therapeutics Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Humacyte Inc / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Venus Concept Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Spero Therapeutics Inc / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / Ally Financial Inc / Prometheus Biosciences Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Aurinia Pharmaceuticals Inc / Galapagos NV / Evolent Health Inc / Novocure Ltd / Truist Financial Corp / Ionis Pharmaceuticals Inc / Cellectar Biosciences Inc / ViewRay Inc / Intellia Therapeutics Inc / Fulgent Genetics Inc / Iovance Biotherapeutics Inc / Molecular Templates Inc / Athenex Inc / Protagonist Therapeutics Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Immunic Inc / Zoom Video Communications Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / Personalis Inc / DermTech Inc / Beyond Air Inc / Pennant Group Inc / Bicycle Therapeutics PLC / 9 Meters Biopharma Inc / Oric Pharmaceuticals Inc / Biomx Inc / Pliant Therapeutics Inc / Nano-X Imaging Ltd / Humanigen Inc / Taysha Gene Therapies Inc / F-Star Therapeutics Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Pharvaris NV / Applied Minerals Inc / Great Elm Capital Corp / Evaxion Biotech A/S / Rezolute Inc / Sera Prognostics Inc / Cognition Therapeutics Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Belgium / Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Nigeria / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 71708110 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAPL / ACA / AMT / APP / APPS / BBY / C.N / CCI / CHTR / CME / COST / DISH / DLR / EA / FOCS / GLW / GS / ICE / ICPT / INTC.O / IS / MCD / MCO / MS / MSFT / NET / NKE / ORCL / QCOM.O / QUIK / RAD / RH / RNG / RXT / SAP / SEIC / SONY / SPOT / T / TTWO / U / UPS / V / WMT / AMZN.O / GILD.O / CMCSA.O / NICE / CSCO.O / ATVI.O / ONEM.O / TRIT / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / CSGS.O / SBAC.O / VG / AMD.O / ADI.O / EQIX / VZ / NFLX / CEVA / CRNT.O / LUMN / SMTC.O / FDS.N / TXN.O / DOX.O / REGN.O / MRVL.O / VRNT / SSNC.O / AVGO.O / NDAQ / XLNX.OQ / NOVN.O / CCRN.O / BCRX.O / AMED.O / EXAS.O / SWKS.O / ANGN.O / BIIB / 00846U101 / 868168105 / GOOG.O / CMMB / FREQ / SPGI / DXCM.O / LHCG.O / MBRX.O / 36467W109 / CBAY / CCOI / CYCC.O / INFI.O / COIN / IVZ / 02043Q107 / ENSG.O / 483548103 / 00826A109 / 771195104 / ADUS.O / GLAXOSM.LG / TSLA.O / NXPI.O / SPRO.O / ZNGA / FB.O / WDAY / TMUS / FDEV.L / WIX.O / ARMK / FIVN.O / 82655M107 / MDWD.O / VBLT.O / QRVO.O / CXDO / AUPH.O / GLPG.O / EVH / NVCR.O / 100063846 / IONS.O / CLRB.O / NTLA / TTD.O / FLGT.O / OKTA.O / MTEM.O / ATNX.O / ROKU.O / MDB.O / EGHT.K / PTGX.O / 720795103 / BILI.O / ORTX.O / BNGO.O / IMUX.O / ZM.O / IDYA.O / FSLY / PSNL.O / DMTK.O / CMBM / PNTG.O / BCYC / DKNG / NMTR.O / ORIC.O / PHGE.K / PLRX.O / FUBO / HGEN.O / TSHA.O / TEUM.PK / ONDS.OQ / PRTG.O / SNSE.O / PHVS.O / DOCN / HUYA.K / EVAX.O / RZLT.O / 975657107 / SERA.OQ / MNDY.O / ATXS.O / NN.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / American Tower Corp / Applovin Corp / Digital Turbine Inc / Best Buy Co Inc / Citigroup Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Costco Wholesale Corp / DISH Network Corp / Digital Realty Trust Inc / Electronic Arts Inc / Focus Financial Partners Inc / Corning Inc / Goldman Sachs Group Inc / Intercontinental Exchange Inc / Intercept Pharmaceuticals Inc / Intel Corp / Ironsource Ltd / McDonald's Corp / Moody's Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Oracle Corp / Qualcomm Inc / QuickLogic Corp / Rite Aid Corp / RH / RingCentral Inc / Rackspace Technology Inc / SAP SE / SEI Investments Co / Sony Group Corp / Spotify Technology SA / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / United Parcel Service Inc / Visa Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Nice Ltd / Cisco Systems Inc / Activision Blizzard Inc / 1Life Healthcare Inc / Triterras Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / CSG Systems International Inc / SBA Communications Corp / Vonage Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / CEVA Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Semtech Corp / Factset Research Systems Inc / Texas Instruments Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Marvell Technology Inc / Verint Systems Inc / SS&C Technologies Holdings Inc / Broadcom Inc / Nasdaq Inc / Xilinx Inc / Novan Inc / Cross Country Healthcare Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Exact Sciences Corp / Skyworks Solutions Inc / Angion Biomedica Corp / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / S&P Global Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / GameStop Corp / Cymabay Therapeutics Inc / Cogent Communications Holdings Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Coinbase Global Inc / Invesco Ltd / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Affymax Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / NXP Semiconductors NV / Spero Therapeutics Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Wix.Com Ltd / Aramark / Five9 Inc / Sify Technologies Ltd / Mediwound Ltd / Vascular Biogenics Ltd / Qorvo Inc / Crexendo Inc / Aurinia Pharmaceuticals Inc / Galapagos NV / Evolent Health Inc / Novocure Ltd / Truist Financial Corp / Ionis Pharmaceuticals Inc / Cellectar Biosciences Inc / Intellia Therapeutics Inc / Trade Desk Inc / Fulgent Genetics Inc / Okta Inc / Molecular Templates Inc / Athenex Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Protagonist Therapeutics Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Immunic Inc / Zoom Video Communications Inc / IDEAYA Biosciences Inc / Fastly Inc / Personalis Inc / DermTech Inc / Cambium Networks Corp / Pennant Group Inc / Bicycle Therapeutics PLC / DraftKings Inc / 9 Meters Biopharma Inc / Oric Pharmaceuticals Inc / Biomx Inc / Pliant Therapeutics Inc / Fubotv Inc / Humanigen Inc / Taysha Gene Therapies Inc / Pareteum Corp / Ondas Holdings Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Pharvaris NV / DigitalOcean Holdings Inc / HUYA Inc / Evaxion Biotech A/S / Rezolute Inc / Winston Pharmaceuticals Inc / Sera Prognostics Inc / Monday.Com Ltd / Astria Therapeutics Inc / NextNav Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / India / Israel / Japan / Luxembourg / Nigeria / Netherlands / United States / Virgin Islands, British / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: ESMO IO: Roche's TIGIT survival data impresses</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ROG.S / BMY.N / AZN.L / GSK.L / GILD.OQ</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / AstraZeneca PLC / GlaxoSmithKline PLC / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Institutional ownership of GILD at Sep 30: 356 (24%) exits from Gilead</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / LH / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / AFMD.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Affimed NV / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Chapter 2: A Well-Designed CAR-T Portfolio that Could Further Drive Mustang’s Valuation</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">US62818Q1040 / US3755581036 / US75886F1075</td><td class="leftalignment">Mustang Bio Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Deep Integrin Expertise with Clinical Catalysts to Come; Initiate at Outperform, $40 PT</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">PLRX.O / ICPT / GILD.O / NOVN.O / CMMB / CBAY / 02043Q107 / GLAXOSM.LG / GLPG.O / PTGX.O / IMUX.O / PHGE.K</td><td class="leftalignment">Pliant Therapeutics Inc / Intercept Pharmaceuticals Inc / Gilead Sciences Inc / Novan Inc / Chemomab Therapeutics Ltd / Cymabay Therapeutics Inc / Alnylam Pharmaceuticals Inc / Glaxo Smithkline Consumer Nigeria PLC / Galapagos NV / Protagonist Therapeutics Inc / Immunic Inc / Biomx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Israel / Nigeria / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jeff M. Jones, Ph.D. / Leland Gershell, MD, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : Potential Future Trodelvy Competitor with Promising Data Update at SABCS</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Skies Are Clearing but Stock Selection Still Important</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">GILD: Slowing HIV Growth May Require More than Trodelvy for Multiple Expansion; Initiating at Equal Weight</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AHT.L / CF.N / CP.TO / DD.N / F.N / GM.N / PD.N / WY.N / CFP.TO / GILD.O / WLK.N / ENB.TO / NBIX.O / FTT.TO / GPK.N / FFBC.O / CASY.O / TIH.TO / NTR.N / MOS.N / HUN.N / WEF.TO / AVAV.OQ / GETP.PA / PCH.O / CFX.TO / MTOR.N / IFP.TO / RFP.N / BERY.N / BLDR.N / IONS.O / CDMO.OQ / NTGY.MC / MGTX.O / CTVA.N / WFG.N / BHG.N / TASK.O / CNM.N / BASE.OQ</td><td class="leftalignment">Ashtead Group PLC / CF Industries Holdings Inc / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / Ford Motor Co / General Motors Co / PagerDuty Inc / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Westlake Chemical Corp / Enbridge Inc / Neurocrine Biosciences Inc / Finning International Inc / Graphic Packaging Holding Co / First Financial Bancorp / Caseys General Stores Inc / Toromont Industries Ltd / Nutrien Ltd / Mosaic Co / Huntsman Corp / Western Forest Products Inc / AeroVironment Inc / Getlink SE / Potlatchdeltic Corp / Canfor Pulp Products Inc / Meritor Inc / Interfor Corp / Resolute Forest Products Inc / Berry Global Group Inc / Builders FirstSource Inc / Ionis Pharmaceuticals Inc / Avid Bioservices Inc / Naturgy Energy Group SA / MeiraGTx Holdings PLC / Corteva Inc / West Fraser Timber Co Ltd / Bright Health Group Inc / Taskus Inc / Core & Main Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Spain / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended September 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended December 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">SABCS 2021: Dato-DXd TNBC Phase 1 Data Look Competitive Versus Trodelvy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Ike Oji / Jameson Kao</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">DS/AZN Data Solid But With Responses More In Line, Supports Our View Trodelvy Will Remain mBC Leader</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASH Annual Meeting 2021 Planner and Preview</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">71708110 / 37555810 / 75886F10 / 478160104 / 640268108 / 80105N10 / 771195104 / 00287Y10 / 28106W10 / 98401F10 / 41358P10 / 01981810 / 09609G10 / 45826J10 / 77313F10 / 55609910 / N0104510 / 31189P10 / 07725L10 / 00847X10 / 37890U10 / 04685N10 / 34633R10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 03969F10 / 98887Q10 / 92765F10 / 37230320 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 92731L10 / 07373V10 / H1718210</td><td class="leftalignment">Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Nektar Therapeutics / Sanofi SA / Roche Holding AG / Abbvie Inc / Editas Medicine Inc / Xencor Inc / Harpoon Therapeutics Inc / Allovir Inc / bluebird bio Inc / Intellia Therapeutics Inc / Rocket Pharmaceuticals Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / Agios Pharmaceuticals Inc / Global Blood Therapeutics Inc / Athenex Inc / Forma Therapeutics Holdings Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Arcus Biosciences Inc / Zai Lab Ltd / Viracta Therapeutics Inc / Genmab A/S / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Vincerx Pharma Inc / Beam Therapeutics Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Netherlands / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Daniel Tarjan, Ph.D. / Na Sun / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Greco Song, Ph.D. / Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Mani Foroohar, M.D. / Christopher Liu, Pharm.D. / Mr. Rick Bienkowski, Ph.D. / Ken Shields / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US02553E1064 / US1101221083 / US2017231034 / US3647601083 / US3755581036 / US45337C1027 / US5324571083 / US6541061031 / US6556641008 / US6703461052 / US6819191064 / US68389X1054 / US7170811035 / US75886F1075 / US7782961038 / US8581191009 / US8725401090 / US8851601018 / US9170471026 / US9182041080 / CA8787422044 / CA87971M1032 / US9129091081 / US02043Q1076 / US9043111072 / US5500211090 / US90384S3031 / CA22576C1014 / US58933Y1055 / US6936561009 / US7512121010 / US98986T1088 / US00287Y1091 / US09609G1004 / CA1348082035 / CA96467A2002 / IE00B4Q5ZN47 / CA3748252069 / US31189P1021 / US1220171060 / US14174T1079 / US72703H1014 / US8760301072 / US8608971078 / US03753U1060 / US63845R1077 / CA8585221051 / US76029N1063 / VGG1890L1076 / US76156B1070 / US88339P1012 / US70614W1009 / US80810D1037 / CA2674881040 / US78440X8048 / US44891N2080 / CA00791P1071 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US4718711033 / US53190C1027 / CA0156581070</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Gap Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Nucor Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Steel Dynamics Inc / TJX Companies Inc / Thor Industries Inc / Urban Outfitters Inc / VF Corp / Teck Resources Ltd / Telus Corp / United States Steel Corp / Alnylam Pharmaceuticals Inc / Under Armour Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Crescent Point Energy Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Zynga Inc / Abbvie Inc / bluebird bio Inc / Canacol Energy Ltd / Whitecap Resources Inc / Jazz Pharmaceuticals PLC / Gibson Energy Inc / Fate Therapeutics Inc / Burlington Stores Inc / CareTrust REIT Inc / Planet Fitness Inc / Tapestry Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / National Vision Holdings Inc / Stelco Holdings Inc / Replimune Group Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Peloton Interactive Inc / Schrodinger Inc / Dye & Durham Ltd / SL Green Realty Corp / IAC/Interactivecorp / Advantage Energy Ltd / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Jasper Therapeutics Inc / Life Time Group Holdings Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Partner Merck Pauses More Studies of Islatravir</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ike Oji</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Additional Islatravir Trial Pause Challenging for Merck's HIV Ambition</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US58933Y1055 / US3755581036</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / BLU.N / BIIB.O / SRPT.O / ENTA.O / KPTI.O / XNCR.OQ / 03835T200 / GBT.OQ / KRTX.OQ / IGMS.O / ETNB.O / PLRX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / BELLUS Health Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Karuna Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Pliant Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 ASH Preview and Itinerary Planner</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US31189P1021 / US03753U1060 / US80810D1037 / US4718711033</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc / Schrodinger Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Georgia / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini / Evan Hua</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / ALLO / MBIO / RAD / WMT / GILD.O / EW / ONEM.O / ISRG / BMRN.O / REGN.O / VRTX.O / CYAD / SSNC.O / CCRN.O / CSTL.O / AMED.O / EXAS.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / ALNY.O / LHCG.O / TMDI / ENSG.O / 483548103 / MRNA.O / ADUS.O / GLAXOSM.LG / FATE.O / VBIV.O / INO.O / EVH / 100063846 / NVTA.K / 04280A100 / CRSP / CLLS.O / MTEM.O / VERU.O / 720795103 / MOTS.O / TMDX / DMTK.O / PNTG.O / HRMY.O / HGEN.O / VOR.O / 03823M100 / CRBU.O / ATXS.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / Mustang Bio Inc / Rite Aid Corp / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Intuitive Surgical Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Celyad Oncology SA / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Castle Biosciences Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Alnylam Pharmaceuticals Inc / LHC Group Inc / Titan Medical Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Fate Therapeutics Inc / VBI Vaccines Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Truist Financial Corp / Invitae Corp / Arrowhead Pharmaceuticals Inc / CRISPR Therapeutics AG / Cellectis SA / Molecular Templates Inc / Veru Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Transmedics Group Inc / DermTech Inc / Pennant Group Inc / Harmony Biosciences Holdings Inc / Humanigen Inc / Vor Biopharma Inc / Applied Minerals Inc / Caribou Biosciences Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAPL / ALLO / AMT / APP / APPS / BBY / CCI / CHTR / CME / DG / DISH / DLR / EA / GLW / GS / INTC.O / IS / KR / MCD / MS / MSFT / NET / NKE / ORCL / QCOM.O / QUIK / RNG / RXT / SAP / SONY / T / TTWO / U / UPS / WH / WMT / ALSN / AMZN.O / GILD.O / CMCSA.O / NICE / CSCO.O / ATVI.O / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / CSGS.O / SBAC.O / FIVE / VG / AMD.O / ADI.O / EQIX / VZ / NFLX / CEVA / CRNT.O / LUMN / LSCC.O / SMTC.O / TXN.O / DOX.O / MRVL.O / VRNT / AVGO.O / XLNX.OQ / SWKS.O / GOOG.O / DXCM.O / 36467W109 / CCOI / ULTA / 00826A109 / TSLA.O / NXPI.O / ZNGA / FB.O / WDAY / TMUS / FDEV.L / FATE.O / WIX.O / FIVN.O / 82655M107 / QRVO.O / CXDO / TTD.O / CRSP / OKTA.O / VERU.O / ROKU.O / MDB.O / EGHT.K / BILI.O / ZM.O / FSLY / CMBM / LTHM.K / DKNG / FUBO / HGEN.O / ASAN.K / TEUM.PK / ONDS.OQ / DOCN / HUYA.K / 975657107 / MNDY.O / NN.O</td><td class="leftalignment">Apple Inc / Allogene Therapeutics Inc / American Tower Corp / Applovin Corp / Digital Turbine Inc / Best Buy Co Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Dollar General Corp / DISH Network Corp / Digital Realty Trust Inc / Electronic Arts Inc / Corning Inc / Goldman Sachs Group Inc / Intel Corp / Ironsource Ltd / Kroger Co / McDonald's Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Oracle Corp / Qualcomm Inc / QuickLogic Corp / RingCentral Inc / Rackspace Technology Inc / SAP SE / Sony Group Corp / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / United Parcel Service Inc / Wyndham Hotels & Resorts Inc / Walmart Inc / Allison Transmission Holdings Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Nice Ltd / Cisco Systems Inc / Activision Blizzard Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / CSG Systems International Inc / SBA Communications Corp / Five Below Inc / Vonage Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / CEVA Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Lattice Semiconductor Corp / Semtech Corp / Texas Instruments Inc / Amdocs Ltd / Marvell Technology Inc / Verint Systems Inc / Broadcom Inc / Xilinx Inc / Skyworks Solutions Inc / Alphabet Inc / Dexcom Inc / GameStop Corp / Cogent Communications Holdings Inc / Ulta Beauty Inc / Affymax Inc / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Fate Therapeutics Inc / Wix.Com Ltd / Five9 Inc / Sify Technologies Ltd / Qorvo Inc / Crexendo Inc / Trade Desk Inc / CRISPR Therapeutics AG / Okta Inc / Veru Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Bilibili Inc / Zoom Video Communications Inc / Fastly Inc / Cambium Networks Corp / Livent Corp / DraftKings Inc / Fubotv Inc / Humanigen Inc / Asana Inc / Pareteum Corp / Ondas Holdings Inc / DigitalOcean Holdings Inc / HUYA Inc / Winston Pharmaceuticals Inc / Monday.Com Ltd / NextNav Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Israel / Japan / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">ASH Fortunes Could Rest on the Fates of a Relative Few</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FATE.O / ALLO / GILD.O / CRSP</td><td class="leftalignment">Fate Therapeutics Inc / Allogene Therapeutics Inc / Gilead Sciences Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Matthew Biegler / Mark Breidenbach, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Dec. 02, 2021 / 2:40PM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / BMY=US / IP=US / GILD=US / PEB=US / H=US / CRM=US / MTN=US / MAR=US / TNL=US / HLT=US / AKR=US / APH=US / CHH=US / CSTR=US / DRH=US / REGN=US / ROLL=US / VRTX=US / CVX=US / PSA=US / SPG=US / SNOW=US / SGMS=US / FBK=US / MTCH=US / SRC=US / AUTL=US / BRX=US / PNFP=US / IGMS=US / STRO=US / BIIB=US / EXR=US / BECN=US / SHO=US / PLAY=US / HST=US / WH=US / IAC=US / EPRT=US / HGV=US / RLJ=US / VAC=US / CUBE=US / SPLK=US / RHP=US / ABBV=US / FATE=US / 00770K202 / AFMD=US / BVH=US / NSA=US / EDIT=US / NTLA=US / PK=US / PLYA=US / OKTA=US / ALLO=US / ESTC=US / HARP=US / CRWD=US / GMAB=US / NCNO=US / CELU=US / DHT.UN=CA / REPX=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Bristol-Myers Squibb Co / International Paper Co / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Amphenol Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Public Storage / Simon Property Group Inc / Snowflake Inc. / Scientific Games Corp / FB Financial Corp / Match Group Inc / Spirit Realty Capital Inc / Autolus Therapeutics PLC / Brixmor Property Group Inc / Pinnacle Financial Partners Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Splunk Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Fate Therapeutics Inc / Aemetis Inc / Affimed NV / Bluegreen Vacations Holding Corp / National Storage Affiliates Trust / Editas Medicine Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / nCino Inc / Celularity Inc / Dri Healthcare Trust / Riley Exploration Permian Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: ASH Planner Highlights 200+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GILD=US / REGN=US / AUTL=US / IGMS=US / STRO=US / ABBV=US / FATE=US / AFMD=US / EDIT=US / NTLA=US / ALLO=US / HARP=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / Editas Medicine Inc / Intellia Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 77 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / CVS.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / TGT.N / XL.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / HAE.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / REGN.OQ / BBBY.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / SCHW.N / EXPR.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / MGNX.OQ / BRX.N / LADR.N / TWOU.OQ / FGEN.OQ / ANTM.N / PFX.N / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Target Corp / XL Fleet Corp / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Haemonetics Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / Regeneron Pharmaceuticals Inc / Bed Bath & Beyond Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Charles Schwab Corp / Express Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Brixmor Property Group Inc / Ladder Capital Corp / 2U Inc / FibroGen Inc / Anthem Inc / PhenixFIN Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 - Get Set for M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AZN / 71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead up 3.1% from 8 week low</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AIT / AZO / BA.N / GWW / KRP / MSM / PEN / PM / RKT / TAP.N / GILD.O / ASB / WCC / HWM.N / DLTR.O / FAST.O / SIVB.O / FHN / SBNY.O / RDSb / TDG.N / MEIP.O / PFSI.K / UNVR.K / FHB.O / FLMN.O / HMPT.O</td><td class="leftalignment">Applied Industrial Technologies Inc / Autozone Inc / Boeing Co / W W Grainger Inc / Kimbell Royalty Partners LP / MSC Industrial Direct Co Inc / Penumbra Inc / Philip Morris International Inc / Rocket Companies Inc / Molson Coors Beverage Co / Gilead Sciences Inc / Associated Banc-Corp / Wesco International Inc / Howmet Aerospace Inc / Dollar Tree Inc / Fastenal Co / SVB Financial Group / First Horizon Corp / Signature Bank / Royal Dutch Shell PLC / TransDigm Group Inc / MEI Pharma Inc / PennyMac Financial Services Inc / Univar Solutions Inc / First Hawaiian Inc / Falcon Minerals Corp / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—November 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZO / BA.N / KRP / PEN / PM / TAP.N / GILD.O / ASB / HWM.N / DLTR.O / SIVB.O / FHN / SBNY.O / TDG.N / MEIP.O / FHB.O / FLMN.O</td><td class="leftalignment">Autozone Inc / Boeing Co / Kimbell Royalty Partners LP / Penumbra Inc / Philip Morris International Inc / Molson Coors Beverage Co / Gilead Sciences Inc / Associated Banc-Corp / Howmet Aerospace Inc / Dollar Tree Inc / SVB Financial Group / First Horizon Corp / Signature Bank / TransDigm Group Inc / MEI Pharma Inc / First Hawaiian Inc / Falcon Minerals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EA / INTC.O / MSFT / QCOM.O / SONY / TTWO / GILD.O / ATVI.O / NVDA.O / HEAR / NFLX / REGN.O / AMED.O / SWKS.O / LHCG.O / 36467W109 / ENSG.O / MRNA.O / ZNGA / FDEV.L / 82655M107 / INO.O / QRVO.O / BILI.O / HUYA.K / 03823M100 / MYPS</td><td class="leftalignment">Electronic Arts Inc / Intel Corp / Microsoft Corp / Qualcomm Inc / Sony Group Corp / Take-Two Interactive Software Inc / Gilead Sciences Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Netflix Inc / Regeneron Pharmaceuticals Inc / Amedisys Inc / Skyworks Solutions Inc / LHC Group Inc / GameStop Corp / Ensign Group Inc / Moderna Inc / Zynga Inc / Frontier Developments PLC / Sify Technologies Ltd / Inovio Pharmaceuticals Inc / Qorvo Inc / Bilibili Inc / HUYA Inc / Applied Minerals Inc / Playstudios Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / United Kingdom / India / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Omicron COVID-19 Strain Adds Uncertainty Into Year-end</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / REGN.O / MRNA.O / INO.O / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIR.N / BA.N / CAS.TO / CP.TO / ELE.MC / IBE.MC / IP.N / NSC.N / RWEG.DE / CFP.TO / GILD.O / LPX.N / INCY.O / CNR.TO / HEI.N / UNH.N / CSX.N / UNP.N / EPC.N / CTAS.O / EXPE.O / NBIX.O / CHD.N / JHX.AX / DCO.N / VSEC.OQ / BIIB.O / ACAD.O / WEF.TO / TDG.N / MERC.O / SPR.N / SLRS.MC / IFP.TO / FB.O / RFP.N / CFF.TO / KPTI.O / GLPG.O / GBT.OQ / BKNG.O / NTGY.MC / LYFT.O / UBER.N / ETNB.O / SPRB.OQ / ABNB.OQ / WFG.N / DBM.TO / ANE.MC / NVEI.OQ</td><td class="leftalignment">AAR Corp / Boeing Co / Cascades Inc / Canadian Pacific Railway Ltd / Endesa SA / Iberdrola SA / International Paper Co / Norfolk Southern Corp / Rwe AG / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Incyte Corp / Canadian National Railway Co / HEICO Corp / UnitedHealth Group Inc / CSX Corp / Union Pacific Corp / Edgewell Personal Care Co / Cintas Corp / Expedia Group Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / James Hardie Industries PLC / Ducommun Inc / VSE Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / TransDigm Group Inc / Mercer International Inc / Spirit AeroSystems Holdings Inc / Solaria Energia y Medio Ambiente SA / Interfor Corp / Meta Platforms Inc / Resolute Forest Products Inc / Conifex Timber Inc / Karyopharm Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Booking Holdings Inc / Naturgy Energy Group SA / Lyft Inc / Uber Technologies Inc / 89Bio Inc / Spruce Biosciences Inc / Airbnb Inc / West Fraser Timber Co Ltd / Doman Building Materials Group Ltd / Corporacion Acciona Energias Renovables SA / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Germany / Spain / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / BIIB.O / ACAD.O / KPTI.O / GLPG.O / GBT.OQ / ETNB.O / SPRB.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / 89Bio Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - Key Questions for management ahead of R&D day</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVN.S / BMY.N / LLY.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / REGN.OQ / GILD.OQ / BAYGN.DE / MOLN.S</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Bayer AG / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Key takeaways from GSK's Management HIV call</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GSK.L / 4507.T / PFE.N / GILD.OQ / HALO.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / Shionogi & Co Ltd / Pfizer Inc / Gilead Sciences Inc / Halozyme Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - A focused large-scale biologics specialist</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">207940.KS / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / 1177.HK / TEVA.TA / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / 005930.KS / 000100.KS / 008930.KS / SFZN.S / BIIB.OQ / 006280.KS / TEVA.N / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / 032830.KS / 128940.KS / ABBV.N / CTLT.N / 196170.KQ / 028260.KS / 2269.HK / 091990.KQ / 302440.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Sino Biopharmaceutical Ltd / Teva Pharmaceutical Industries Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Samsung Electronics Co Ltd / Yuhan Corp / Hanmi Science Co Ltd / Siegfried Holding AG / Biogen Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Samsung Life Insurance Co Ltd / Hanmi Pharm Co Ltd / Abbvie Inc / Catalent Inc / Alteogen Inc / Samsung C&T Corp / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Israel / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Chase a Check (Vol. 2) — Biopharma/MedTech Cash Runway Map</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">11012210 / 71708110 / 37555810 / 00422510 / 771195104 / 03152W10 / 58933Y10 / 02311120 / 45766930 / 80360710 / 05463X10 / 31572Q80 / 00653A107 / 04351P101 / XERS / 98401F10 / 04004760 / 21232630 / 05337M104 / 23283X20 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 98420N10 / 58949210 / 90041T10 / 09627Y10 / Y9530810 / 30052C10 / 09075V10 / 00289Y10 / 09609G10 / 75901B10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / 01438T10 / 74374N10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 98978L20 / 04685N10 / 13089P10 / 34633R10 / 38341P10 / 43906K10 / 46565G10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 98887Q10 / 98943L10 / 45845P10 / 4525EP10 / 78667J10 / 46116X10 / 90400D10 / 69014510 / 35961610 / 55886810 / 05454B10 / 04539610 / 45249V10 / 80405P10 / 75955J40 / 56400P70 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 28617K10 / 03824M10 / 36322Q10 / N4444510 / 45258J10 / 56854Q20 / 74623710 / H9060V101 / 89422G10 / 82939910 / 87410C10 / 36870G10 / 64128810 / 28036F10 / N5749R10 / 24343R10 / 52634L10 / 49705R10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 29251M10 / 81064810 / G637AM10 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Gilead Sciences Inc / ACADIA Pharmaceuticals Inc / Roche Holding AG / Amicus Therapeutics Inc / Merck & Co Inc / Amarin Corporation PLC / Insmed Inc / Sarepta Therapeutics Inc / AxoGen Inc / FibroGen Inc / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Xeris Biopharma Holdings Inc / Xencor Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Xenon Pharmaceuticals Inc / Mereo Biopharma Group PLC / Turning Point Therapeutics Inc / Blueprint Medicines Corp / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Abeona Therapeutics Inc / bluebird bio Inc / Regenxbio Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Zogenix Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Iteos Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Ultragenyx Pharmaceutical Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Assembly Biosciences Inc / Imara Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / MannKind Corp / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / Eledon Pharmaceuticals Inc / Applied Molecular Transport Inc. / Galecto Inc / Immatics NV / Immunovant Inc / Marinus Pharmaceuticals Inc / PureTech Health PLC / VectivBio Holding AG / Travere Therapeutics Inc / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Gemini Therapeutics Inc / Neuropace Inc / Edgewise Therapeutics Inc / Merus NV / Decibel Therapeutics Inc / LENSAR Inc / Kinnate Biopharma Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Netherlands / Singapore / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Joseph P. Schwartz / Mr. Thomas J. Smith / Geoffrey Porges, MBBS / Greco Song, Ph.D. / Priya Sachdeva / Rudy Li, Ph.D. / Jeffrey La Rosa / Will Soghikian / Mike Kratky, CFA / Anna Baran, CFA / Ms. Danielle J. Antalffy / Andrew Berens, M.D. / Mr. Rick Bienkowski, Ph.D. / Jonathan Chang, Ph.D., CFA / Mr. Marc Goodman / Daina Graybosch, Ph.D. / Christopher Liu, Pharm.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">COVID/scope Real-Time Update: Emerging Nu Strain Should Remind of Caution, Not Necessarily Cause Panic</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N / GILD.O / INCY.O / ENTA.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Incyte Corp / Enanta Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">Hong Kong / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US / PEB=US / H=US / MTN=US / MAR=US / TNL=US / HLT=US / FLO=US / CHH=US / DRH=US / SGMO=US / SHO=US / HST=US / WH=US / HGV=US / RLJ=US / VAC=US / RHP=US / BERY=US / FATE=US / AFMD=US / BVH=US / IRTC=US / PK=US / PLYA=US</td><td class="leftalignment">Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Flowers Foods Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Sangamo Therapeutics Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Berry Global Group Inc / Fate Therapeutics Inc / Affimed NV / Bluegreen Vacations Holding Corp / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALLO / AMGN / C.N / DE / ICE / INCY / NBIX / NKE / QCOM.O / RARE / SEIC / VCTR / GILD.O / TRIT / ALKS.O / SQ / ARNA.O / FDS.N / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NDAQ / NKTR / LIFE.O / MSTR.O / PHAR.O / BIIB / MNKD.O / SPGI / ACAD.O / ALNY.O / COIN / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / CBOE.K / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Citigroup Inc / Deere & Co / Intercontinental Exchange Inc / Incyte Corp / Neurocrine Biosciences Inc / Nike Inc / Qualcomm Inc / Ultragenyx Pharmaceutical Inc / SEI Investments Co / Victory Capital Holdings Inc / Gilead Sciences Inc / Triterras Inc / Alkermes Plc / Block Inc / Arena Pharmaceuticals Inc / Factset Research Systems Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nasdaq Inc / Nektar Therapeutics / aTyr Pharma Inc / Microstrategy Inc / Pharming Group NV / Biogen Inc / MannKind Corp / S&P Global Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Coinbase Global Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Cboe Global Markets Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Cayman Islands / France / Ireland / Netherlands / El Salvador / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-3Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALLO / AMGN / INCY / NBIX / RARE / GILD.O / ALKS.O / ARNA.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NKTR / LIFE.O / PHAR.O / BIIB / MNKD.O / ACAD.O / ALNY.O / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Alkermes Plc / Arena Pharmaceuticals Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / aTyr Pharma Inc / Pharming Group NV / Biogen Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ANTO.L / AU.N / CNA.L / EDP.LS / F.N / GM.N / HMb.ST / RIO.L / RWEG.DE / CFP.TO / GILD.O / AAL.L / BOL.ST / CONE.O / NG.L / ITX.MC / VRTX.O / CEY.L / GFI.N / ASC.L / APF.L / MFA.N / CASY.O / ATDb.TO / 878742204 / IHS.N / ATL.MI / HOCM.L / FRES.L / EDPR.LS / VALE.N / BHPB.L / PKI.TO / CAML.L / GLEN.L / POLYP.L / RFP.N / BOOH.L / ZALG.DE / ILPT.O / OPI.OQ / DHC.O / ADT1.L / SBSW.N / WFG.N</td><td class="leftalignment">Antofagasta PLC / AngloGold Ashanti Ltd / Centrica PLC / EDP Energias de Portugal SA / Ford Motor Co / General Motors Co / H & M Hennes & Mauritz AB / Rio Tinto PLC / Rwe AG / Canfor Corp / Gilead Sciences Inc / Anglo American PLC / Boliden AB / CyrusOne Inc / National Grid PLC / Industria de Diseno Textil SA / Vertex Pharmaceuticals Inc / Centamin PLC / Gold Fields Ltd / ASOS PLC / Anglo Pacific Group PLC / MFA Financial Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Teck Resources Ltd / IHS Holding Ltd / Atlantia SpA / Hochschild Mining PLC / Fresnillo PLC / EDP Renovaveis SA / Vale SA / BHP Group PLC / Parkland Corp / Central Asia Metals PLC / Glencore PLC / Polymetal International PLC / Resolute Forest Products Inc / boohoo group plc / Zalando SE / Industrial Logistics Properties Trust / Office Properties Income Trust / Diversified Healthcare Trust / Adriatic Metals PLC / Sibanye Stillwater Ltd / West Fraser Timber Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Spain / United Kingdom / Italy / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: How worried should we be about COVID?</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CCL.N / PFE.N / RYA.I / RCL.N / MRCG.DE / EZJ.L / GILD.OQ / NCLH.N</td><td class="leftalignment">Carnival Corp / Pfizer Inc / Ryanair Holdings PLC / Royal Caribbean Cruises Ltd / Merck KGaA / Easyjet PLC / Gilead Sciences Inc / Norwegian Cruise Line Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Germany / United Kingdom / Ireland / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam / Marc el Koussa</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / VRTX.O</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bangladesh / Canada / China / Germany / Egypt / Spain / France / United Kingdom / Georgia / Hong Kong / Indonesia / India / Italy / Japan / Lao People's Democratic Republic / Malaysia / Nigeria / Poland / Russian Federation / Singapore / Sweden / Turkey / United States / Vietnam / Serbia</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AU.N / AXP.N / BAC.N / BB.N / BCE.TO / BK.N / C.N / COF.N / CVS.N / ELE.MC / FITB.O / JPM.N / KEY.N / NEM.N / NTRS.O / PB.N / PNC.N / T.TO / USB.N / WFC.N / ZION.O / CMA.N / GILD.O / FNV.N / INCY.O / CLS.N / AGI.N / DIS.N / HBAN.O / DT.N / GS.N / AEM.N / ENEI.MI / ADCT.N / KGC.N / JAZZ.O / SGMO.O / STT.N / AKAM.O / PACW.O / DSGX.O / EFX.N / FISV.O / ADSK.O / ACN.N / EXPE.O / WSP.TO / MTB.N / OTEX.O / REGN.O / CVX.N / MCO.N / NCR.N / NET.N / GFI.N / RF.N / CFR.N / CDE.N / FRC.N / HL.N / DFS.N / ADS.N / SGEN.OQ / GPN.N / FFBC.O / IMGN.O / RGLD.O / SIVB.O / BLUE.O / BPOP.O / BOKF.O / COLB.O / WTFC.O / PAAS.O / TCBI.O / STN.TO / GOLD.N / SNC.TO / TFC.N / DPM.TO / FHN.N / EDV.TO / CG.TO / IAU.TO / DLR.N / EDR.N / IAG.N / WAL.N / ALNY.O / MS.N / FIS.N / HICL.L / AUY.N / VMW.N / OSK.TO / NGD.A / HOMB.O / EGO.N / SBB.TO / FTNT.O / AR.TO / TXG.TO / SIL.TO / MOZ.TO / ANGI.OQ / SLM.OQ / PANW.N / ALLY.N / TMUS.N / PRTA.O / DOC.N / AGIO.O / ONB.OQ / 81762P102 / WIX.O / KPTI.O / XNCR.OQ / BTG.N / SYF.N / KXS.TO / CFG.N / GWB.N / ASB.N / WBA.N / 03835T200 / GBT.OQ / MESO.O / EDIT.O / SPGI.N / NTLA.O / OR.N / NTNX.O / SAND.N / CVNA.N / WPM.N / SSRM.O / KL.N / ATNX.O / CARG.O / BKNG.O / DBX.O / ALLO.OQ / GMDA.OQ / LYFT.O / UBER.N / FSLY.N / FVRR.N / GMAB.O / DDOG.O / APRE.OQ / CRNC.OQ / IGMS.O / NLOK.O / EGLX.TO / BEAM.O / PLRX.OQ / FOUR.N / NRIX.OQ / JAMF.O / GATO.N / ABNB.OQ / DASH.N / LSPD.N / CLVT.N / BMBL.OQ / AFRM.O / COUR.N / MAGT.TO / SQSP.N / TFPM.TO / FLYW.O / FA.OQ / TRMR.OQ / ZD.OQ / 12740C103</td><td class="leftalignment">AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BlackBerry Ltd / BCE Inc / Bank of New York Mellon Corp / Citigroup Inc / Capital One Financial Corp / CVS Health Corp / Endesa SA / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Newmont Corporation / Northern Trust Corp / Prosperity Bancshares Inc / PNC Financial Services Group Inc / Telus Corp / US Bancorp / Wells Fargo & Co / Zions Bancorporation NA / Comerica Inc / Gilead Sciences Inc / Franco-Nevada Corp / Incyte Corp / Celestica Inc / Alamos Gold Inc / Walt Disney Co / Huntington Bancshares Inc / Dynatrace Inc / Goldman Sachs Group Inc / Agnico Eagle Mines Ltd / Enel SpA / ADC Therapeutics SA / Kinross Gold Corp / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / State Street Corp / Akamai Technologies Inc / PacWest Bancorp / Descartes Systems Group Inc / Equifax Inc / Fiserv Inc / Autodesk Inc / Accenture PLC / Expedia Group Inc / WSP Global Inc / M&T Bank Corp / Open Text Corp / Regeneron Pharmaceuticals Inc / Chevron Corp / Moody's Corp / NCR Corp / Cloudflare Inc / Gold Fields Ltd / Regions Financial Corp / Cullen/Frost Bankers Inc / Coeur Mining Inc / First Republic Bank / Hecla Mining Co / Discover Financial Services / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / First Financial Bancorp / ImmunoGen Inc / Royal Gold Inc / SVB Financial Group / bluebird bio Inc / Popular Inc / BOK Financial Corp / Columbia Banking System Inc / Wintrust Financial Corp / Pan American Silver Corp / Texas Capital Bancshares Inc / Stantec Inc / Barrick Gold Corp / SNC-Lavalin Group Inc / Truist Financial Corp / Dundee Precious Metals Inc / First Horizon Corp / Endeavour Mining PLC / Centerra Gold Inc / I-80 Gold Corp / Digital Realty Trust Inc / Endeavor Group Holdings Inc / IAMGOLD Corp / Western Alliance Bancorp / Alnylam Pharmaceuticals Inc / Morgan Stanley / Fidelity National Information Services Inc / HICL Infrastructure PLC / Yamana Gold Inc / VMware Inc / Osisko Mining Inc / New Gold Inc / Home BancShares Inc / Eldorado Gold Corp / Sabina Gold & Silver Corp / Fortinet Inc / Argonaut Gold Inc / Torex Gold Resources Inc / Silvercrest Metals Inc / Marathon Gold Corp / Angi Inc / SLM Corp / Palo Alto Networks Inc / Ally Financial Inc / T-Mobile US Inc / Prothena Corporation PLC / Physicians Realty Trust / Agios Pharmaceuticals Inc / Old National Bancorp / ServiceNow Inc / Wix.Com Ltd / Karyopharm Therapeutics Inc / Xencor Inc / B2Gold Corp / Synchrony Financial / Kinaxis Inc / Citizens Financial Group Inc / Great Western Bancorp Inc / Associated Banc-Corp / Walgreens Boots Alliance Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mesoblast Ltd / Editas Medicine Inc / S&P Global Inc / Intellia Therapeutics Inc / Osisko Gold Royalties Ltd / Nutanix Inc / Sandstorm Gold Ltd / Carvana Co / Wheaton Precious Metals Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Athenex Inc / CarGurus Inc / Booking Holdings Inc / Dropbox Inc / Allogene Therapeutics Inc / Gamida Cell Ltd / Lyft Inc / Uber Technologies Inc / Fastly Inc / Fiverr International Ltd / Genmab A/S / Datadog Inc / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / NortonLifeLock Inc / Enthusiast Gaming Holdings Inc / Beam Therapeutics Inc / Pliant Therapeutics Inc / Shift4 Payments Inc / Nurix Therapeutics Inc / Jamf Holding Corp / Gatos Silver Inc / Airbnb Inc / DoorDash Inc / Lightspeed Commerce Inc / CLARIVATE PLC / Bumble Inc / Affirm Holdings Inc / Coursera Inc / Magnet Forensics Inc / Squarespace Inc / Triple Flag Precious Metals Corp / Flywire Corp / First Advantage Corp / Tremor International Ltd / Ziff Davis Inc / Cadence Bank</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Puerto Rico / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - ASH Late Breaking abstracts: Kymriah BELINDA study in 2L aNHL, was failure due to study design?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NOVN.S / BMY.N / GILD.OQ</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: ASH 2021 Planner</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GILD.O / INCY.O / ADCT.N / JAZZ.O / SGMO.O / REGN.O / SGEN.OQ / IMGN.O / BLUE.O / ALNY.O / PRTA.O / AGIO.O / KPTI.O / XNCR.OQ / 03835T200 / GBT.OQ / EDIT.O / NTLA.O / ATNX.O / ALLO.OQ / GMDA.OQ / GMAB.O / APRE.OQ / IGMS.O / BEAM.O / NRIX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / ADC Therapeutics SA / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / bluebird bio Inc / Alnylam Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Athenex Inc / Allogene Therapeutics Inc / Gamida Cell Ltd / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / Beam Therapeutics Inc / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Germany / Denmark / Spain / United Kingdom / Georgia / India / Ireland / Israel / Italy / Lao People's Democratic Republic / Malaysia / Nigeria / Poland / Russian Federation / Turkey / United States / Vietnam / Serbia</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Gregory J. Renza, MD / Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Luca Issi, PHD / Yinglu Zhang / Leonid Timashev / Stephen Mallon / Jackie Yan / Lisa Walter</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASH 2021 Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">375558103 / 031162100 / 75886F107 / 02043Q107 / 45253H101 / 00287Y109 / 03835T200 / 31189P102 / 09627Y109 / 462260100 / 98401F105 / 41358P106 / 37890U108 / 04016X101 / 87184Q107 / 869367102 / 44975P103 / 64049K104 / 65343E108 / 492327101 / 359616109 / 80810D103 / 74366E102 / 00166B105 / 04335A105 / 46565G104 / 501575104 / 14147L108 / 67080M103 / 73730P108 / 81181C104 / 019818103 / 50107A104 / M47364100 / 03835L207 / 19240Q201 / 38406L103 / 45256X103 / 75082Q105 / 15673T100</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / ImmunoGen Inc / Abbvie Inc / Aptose Biosciences Inc / Fate Therapeutics Inc / Blueprint Medicines Corp / Iovance Biotherapeutics Inc / Xencor Inc / Harpoon Therapeutics Inc / Global Blood Therapeutics Inc / argenx SE / Syros Pharmaceuticals Inc / Sutro Biopharma Inc / I-Mab / Neoleukin Therapeutics Inc / NextCure Inc / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Schrodinger Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Arvinas Inc / Iteos Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Seagen Inc / Allovir Inc / Kronos Bio Inc / Gamida Cell Ltd / Aptevo Therapeutics Inc / Cogent Biosciences Inc / Gracell Biotechnologies Inc / Immunitybio Inc / Rain Therapeutics Inc / Century Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Gilead Sciences Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">very smart move: pausing HIV trial with MRK nuc</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Temporary Pause for Phase 2 Lenacapavir and Islatravir LAO Combo</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ike Oji</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GILD - Though Islatravir Setback Nudges Lenacapavir Combo Off Course, Should Still Be A Net Benefit To GILD</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAPL / AGCO / AMT / ATRC / CHD / COST / CRY / DE / DLTR / EA / ECL / EL / GE / GS / INCY / INTC.O / JPM.N / KR / LOW / LRCX.O / MS / MSFT / NET / NKE / O / QCOM.O / ROK / SAP / SONY / T / TREE / TRMB / TTWO / UPS / URI / WMT / WSM / AMZN.O / GXO / GILD.O / CMCSA.O / EW / ATVI.O / NVDA.O / ADBE.O / HEAR / SQ / AKAM / SBAC.O / MPWR.O / XRAY.O / ISRG / AMD.O / ADI.O / VZ / NFLX / PLUG.O / SMTC.O / ARRY.O / FCEL.O / TXN.O / AMSC.O / CRUS.O / AVGO.O / SIVB.O / ITRI.O / 459200101 / DPZ / GOOG.O / QSR / ALNY.O / DXCM.O / 36467W109 / SPWR.O / XPO / CSIQ.O / FSLR.O / IPGP.O / LULU / 02043Q107 / 514766104 / WPRT.O / TWIN.O / TSLA.O / PCYO.O / NXPI.O / AMRS.O / ZNGA / ENPH.O / FB.O / CNHI / FDEV.L / 82655M107 / ETSY.O / SEDG.O / RUN.O / WKHS.O / AQMS.O / EDIT / NTLA / CRSP / AQB / BILI.O / CRWD.O / TCOM.O / 02081G201 / 84764T304 / VLDR.O / SHLS.O / APPH / HUYA.K / TSP.O / 744285206 / ENVX.O / LILM.O</td><td class="leftalignment">Apple Inc / AGCO Corp / American Tower Corp / AtriCure Inc / Church & Dwight Co Inc / Costco Wholesale Corp / CryoLife Inc / Deere & Co / Dollar Tree Inc / Electronic Arts Inc / Ecolab Inc / Estee Lauder Companies Inc / General Electric Co / Goldman Sachs Group Inc / Incyte Corp / Intel Corp / JPMorgan Chase & Co / Kroger Co / Lowe's Companies Inc / Lam Research Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Realty Income Corp / Qualcomm Inc / Rockwell Automation Inc / SAP SE / Sony Group Corp / AT&T Inc / Lendingtree Inc / Trimble Inc / Take-Two Interactive Software Inc / United Parcel Service Inc / United Rentals Inc / Walmart Inc / Williams-Sonoma Inc / Amazon.com Inc / GXO Logistics Inc / Gilead Sciences Inc / Comcast Corp / Edwards Lifesciences Corp / Activision Blizzard Inc / NVIDIA Corp / Adobe Inc / Turtle Beach Corp / Block Inc / Akamai Technologies Inc / SBA Communications Corp / Monolithic Power Systems Inc / DENTSPLY SIRONA Inc / Intuitive Surgical Inc / Advanced Micro Devices Inc / Analog Devices Inc / Verizon Communications Inc / Netflix Inc / Plug Power Inc / Semtech Corp / Array Technologies Inc / Fuelcell Energy Inc / Texas Instruments Inc / American Superconductor Corp / Cirrus Logic Inc / Broadcom Inc / SVB Financial Group / Itron Inc / International Business Machines Corp / Domino's Pizza Inc / Alphabet Inc / Restaurant Brands International Inc / Alnylam Pharmaceuticals Inc / Dexcom Inc / GameStop Corp / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / IPG Photonics Corp / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Landec Corp / Westport Fuel Systems Inc / Twin Disc Inc / Tesla Inc / Pure Cycle Corp / NXP Semiconductors NV / Amyris Inc / Zynga Inc / Enphase Energy Inc / Meta Platforms Inc / CNH Industrial NV / Frontier Developments PLC / Sify Technologies Ltd / ETSY Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Aqua Metals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / AquaBounty Technologies Inc / Bilibili Inc / CrowdStrike Holdings Inc / Trip.com Group Ltd / Alphatec Holdings Inc / Speed Commerce Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / AppHarvest Inc / HUYA Inc / TuSimple Holdings Inc / Proxim Wireless Corp / Enovix Corp / Lilium NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Japan / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Nov 12: Focus on Tagrisso</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Adjusting Model with Arcus Opt-in Payments - Expanding Oncology Portfolio</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Do G. Kim / Ike Oji / Jameson Kao</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/20/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">GILEAD SCIENCES reduced its risk exposure resulting in an upgrade to Slightly Positive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Big Tech Breakout and Small-Cap Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AAPL / AMT / CHD / COST / DLTR / ECL / EL / GE / GS / INCY / INTC.O / JPM.N / KR / LOW / LRCX.O / MS / MSFT / NET / NKE / O / ROK / SAP / T / TREE / URI / WMT / AMZN.O / GILD.O / CMCSA.O / EW / NVDA.O / ADBE.O / SQ / AKAM / SBAC.O / XRAY.O / ISRG / VZ / NFLX / AVGO.O / SIVB.O / 459200101 / DPZ / GOOG.O / QSR / DXCM.O / IPGP.O / LULU / 02043Q107 / TSLA.O / NXPI.O / ENPH.O / FB.O / ETSY.O / CRWD.O / TCOM.O / 744285206</td><td class="leftalignment">Apple Inc / American Tower Corp / Church & Dwight Co Inc / Costco Wholesale Corp / Dollar Tree Inc / Ecolab Inc / Estee Lauder Companies Inc / General Electric Co / Goldman Sachs Group Inc / Incyte Corp / Intel Corp / JPMorgan Chase & Co / Kroger Co / Lowe's Companies Inc / Lam Research Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Realty Income Corp / Rockwell Automation Inc / SAP SE / AT&T Inc / Lendingtree Inc / United Rentals Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Edwards Lifesciences Corp / NVIDIA Corp / Adobe Inc / Block Inc / Akamai Technologies Inc / SBA Communications Corp / DENTSPLY SIRONA Inc / Intuitive Surgical Inc / Verizon Communications Inc / Netflix Inc / Broadcom Inc / SVB Financial Group / International Business Machines Corp / Domino's Pizza Inc / Alphabet Inc / Restaurant Brands International Inc / Dexcom Inc / IPG Photonics Corp / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Tesla Inc / NXP Semiconductors NV / Enphase Energy Inc / Meta Platforms Inc / ETSY Inc / CrowdStrike Holdings Inc / Trip.com Group Ltd / Proxim Wireless Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Netherlands / United States / Jersey</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BLDP=US / AMZN=US / RUN=US / GILD=US / PEB=US / PLUG=US / H=US / V=US / NOVA=US / MTN=US / VRM=US / MAR=US / EXPE=US / TNL=US / HLT=US / CMCSA=US / W=US / ARCC=US / APH=US / ARRY=US / CHH=US / CPRT=US / DRH=US / MAIN=US / MPLX=US / OKE=US / ORCC=US / SGMO=US / SFT=US / SNAP=US / TRGP=US / TRIP=US / WIX=US / POST=US / BKNG=US / DCP=US / FB=US / MTCH=US / BE=US / ECPG=US / PRAA=US / PTON=US / MMP=US / APP=US / AINV=US / BECN=US / SHO=US / SPWR=US / HST=US / MA=US / PNNT=US / WH=US / NOG=US / RCUS=US / TREX=US / GNRC=US / HGV=US / WWD=US / RLJ=US / VAC=US / ANGI=US / ENPH=US / PANW=US / RHP=US / BERY=US / CEQP=US / GOOGL=US / TSLX=US / FIVN=US / 70806A106 / BABA=US / CMPR=US / WK=US / GDDY=US / SEDG=US / GSBD=US / SQ=US / VVV=US / PK=US / PLYA=US / CVNA=US / SFIX=US / FTDR=US / FSK=US / LYFT=US / UBER=US / RTLR=US / BRBR=US / ONEW=US / AZEK=US / SHLS=US / VMEO=US / MNTV=US / SQSP=US / GAMB=US / CRXT=US / 00152K101</td><td class="leftalignment">Ballard Power Systems Inc / Amazon.com Inc / Sunrun Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Plug Power Inc / Hyatt Hotels Corp / Visa Inc / Sunnova Energy International Inc / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Comcast Corp / Wayfair Inc / Ares Capital Corp / Amphenol Corp / Array Technologies Inc / Choice Hotels International Inc / Copart Inc / Diamondrock Hospitality Co / Main Street Capital Corp / MPLX LP / ONEOK Inc / Owl Rock Capital Corp / Sangamo Therapeutics Inc / Shift Technologies Inc / Snap Inc / Targa Resources Corp / Tripadvisor Inc / Wix.Com Ltd / Post Holdings Inc / Booking Holdings Inc / DCP Midstream LP / Meta Platforms Inc / Match Group Inc / Bloom Energy Corp / Encore Capital Group Inc / PRA Group Inc / Peloton Interactive Inc / Magellan Midstream Partners LP / Applovin Corp / Apollo Investment Corp / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / SunPower Corp / Host Hotels & Resorts Inc / Mastercard Inc / Pennantpark Investment Corp / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Trex Company Inc / Generac Holdings Inc / Hilton Grand Vacations Inc / Woodward Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Enphase Energy Inc / Palo Alto Networks Inc / Ryman Hospitality Properties Inc / Berry Global Group Inc / Crestwood Equity Partners LP / Alphabet Inc / Sixth Street Specialty Lending Inc / Five9 Inc / PennantPark Floating Rate Capital Ltd / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / GoDaddy Inc / Solaredge Technologies Inc / Goldman Sachs BDC Inc / Block Inc / Valvoline Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Stitch Fix Inc / Frontdoor Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Rattler Midstream LP / Bellring Brands Inc / OneWater Marine Inc / Azek Company Inc / Shoals Technologies Group Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / Gambling.com Group Ltd / Clarus Therapeutics Holdings Inc / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / CB.N / CCO.TO / CVS.N / ECL.N / EL.N / FGP.L / GM.N / GOG.L / IP.N / L.TO / LVMH.PA / MMC.N / NA / NXT.L / OREP.PA / RTO.L / SCHN.PA / T.TO / DRE.N / VOWG_p.DE / PG.N / AMZN.O / CFP.TO / GILD.O / LPX.N / AAL.L / DV.N / ENEI.MI / AMT.N / LONN.S / VZ.N / STZ.N / HP.N / ARE.N / WSM.N / PLD.N / WSP.TO / KRC.N / CTSH.O / ONT.L / NET.N / ALFA.ST / VSEC.OQ / CRC.N / NRZ.N / COA.L / SIVB.O / BLUE.O / CASY.O / ATDb.TO / BIIB.O / CSH_u.TO / EDR.N / DRX.L / CMG.N / MERC.O / SGRO.L / RENE.LS / KTOS.OQ / ABCA.L / NOG.A / NEE.N / OCDO.L / CIO.N / PKI.TO / IFP.TO / BKR.N / MTDR.N / XYL.N / EFN.TO / HTGC.N / FB.O / RFP.N / SRPT.O / PANW.N / NYCB.N / TSLA.N / ENTA.O / 46579R104 / XNCR.OQ / 922475108 / GOOGL.O / SHOP.N / TDOC.N / PYPL.OQ / UBSG.S / SPGI.N / VACN.S / NTLA.O / TWLO.N / ATKR.N / TTD.O / GDS.O / RCM.OQ / DHER.DE / NTGY.MC / ZM.O / CRWD.O / NOVA.N / GMAB.O / DDOG.O / AZEK.N / MGNI.OQ / PUBM.O / WFG.N / AG1G.DE / COUR.N / SQSP.N / FLYW.O / TTEF.PA / TRMR.OQ</td><td class="leftalignment">Albemarle Corp / Chubb Ltd / Cameco Corp / CVS Health Corp / Ecolab Inc / Estee Lauder Companies Inc / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / International Paper Co / Loblaw Companies Ltd / LVMH Moet Hennessy Louis Vuitton SE / Marsh & McLennan Companies Inc / National Bank of Canada / Next PLC / L'Oreal SA / Rentokil Initial PLC / Schneider Electric SE / Telus Corp / Duke Realty Corp / Volkswagen AG / Procter & Gamble Co / Amazon.com Inc / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Anglo American PLC / DoubleVerify Holdings Inc / Enel SpA / American Tower Corp / Lonza Group AG / Verizon Communications Inc / Constellation Brands Inc / Helmerich and Payne Inc / Alexandria Real Estate Equities Inc / Williams-Sonoma Inc / Prologis Inc / WSP Global Inc / Kilroy Realty Corp / Cognizant Technology Solutions Corp / Oxford Nanopore Technologies PLC / Cloudflare Inc / Alfa Laval AB / VSE Corp / California Resources Corp / New Residential Investment Corp / Coats Group PLC / SVB Financial Group / bluebird bio Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Biogen Inc / Chartwell Retirement Residences / Endeavor Group Holdings Inc / Drax Group PLC / Chipotle Mexican Grill Inc / Mercer International Inc / SEGRO PLC / Ren Redes Energeticas Nacionais SGPS SA / Kratos Defense and Security Solutions Inc / Abcam PLC / Northern Oil and Gas Inc / Nextera Energy Inc / Ocado Group PLC / City Office REIT Inc / Parkland Corp / Interfor Corp / Baker Hughes Co / Matador Resources Co / Xylem Inc / Element Fleet Management Corp / Hercules Capital Inc / Meta Platforms Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / New York Community Bancorp Inc / Tesla Inc / Enanta Pharmaceuticals Inc / Ivanhoe Mines Ltd / Xencor Inc / Veeva Systems Inc / Alphabet Inc / Shopify Inc / Teladoc Health Inc / PayPal Holdings Inc / UBS Group AG / S&P Global Inc / VAT Group AG / Intellia Therapeutics Inc / Twilio Inc / Atkore Inc / Trade Desk Inc / GDS Holdings Ltd / R1 RCM Inc / Delivery Hero SE / Naturgy Energy Group SA / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Sunnova Energy International Inc / Genmab A/S / Datadog Inc / Azek Company Inc / Magnite Inc / PubMatic Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Coursera Inc / Squarespace Inc / Flywire Corp / TotalEnergies SE / Tremor International Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Israel / Italy / Portugal / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare Reform: Impact of Build Back Better on global branded pharma</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / 4503.T / BMY.N / JNJ.N / LLY.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / AMGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Tiago Fauth</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">La Isla No Bonita: Implications Of MRK's Islatravir Setback on GILD's HIV Franchise</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Upgrading to OP: Growth on the Horizon as the Oncology Story Unfolds</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Assuming at Neutral: Fairly Valued and Watching Trodelvy from Sidelines</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ike Oji</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">RCUS assets for the win: GILD grabs them all</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US3755581036 / US03969F1093</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">A Very Small Price To Pay For These Potentially Large IO Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">RCUS/GILD: Triplet looks better than doublet data</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">RCUS.N / GILD=US / RCUS=US</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">From Adenosine to Zimberelimab, RCUS Assets Becoming Core to GILD's LT Oncology Strategy with Opt-In</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">GILD opts into 3 RCUS programs, $10/sh to RCUS</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD=US / RCUS=US</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BODY / US3755581036 / LUCD / US98986X1090 / SRRA / US03969F1093</td><td class="leftalignment">Beachbody Company Inc / Gilead Sciences Inc / Lucid Diagnostics Inc / Zynerba Pharmaceuticals Inc / Sierra Oncology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">SEC Investigation Updates: AEP, BGCP, BRX, CVS, FGEN, GILD, HAE, MYGN, TGT, XL and 174 additional companies</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / BGCP.OQ / CVS.N / TGT.N / XL.N / HAE.N / GILD.OQ / MYGN.OQ / BRX.N / FGEN.OQ</td><td class="leftalignment">American Electric Power Company Inc / BGC Partners Inc / CVS Health Corp / Target Corp / XL Fleet Corp / Haemonetics Corp / Gilead Sciences Inc / Myriad Genetics Inc / Brixmor Property Group Inc / FibroGen Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Financial Services / Healthcare / Real Estate / Retailing / Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Gavin</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q model update: we still think GILD is opting into TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.OQ / US03969F1093 / US3755581036 / RCUS.N</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CP.TO / EDP.LS / EOG.N / F.N / FSR.N / GM.N / MSFT.O / NA / NSC.N / PFE.N / T.N / VC.N / PXD.N / GILD.O / TEN.N / WLL.N / AMGN.O / INCY.O / THC.N / FER.MC / CNR.TO / DUK.N / BWA.N / LEA.N / FE.N / DISH.O / CSX.N / UNP.N / NICE.O / DV.N / MRO.N / PCG.N / PAA.N / DVN.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / MTG.N / RDN.N / VZ.N / LNC.N / APH.N / RRC.N / EQT.N / V.N / OKE.N / AXL.N / AWK.N / IG.MI / EPAY.O / AJG.N / REGN.O / VRTX.O / SRG.MI / PRU.N / SM.N / TEL.N / GFI.N / COP.N / CPE.N / ST.N / SWN.N / SR.N / CRC.N / PEGA.OQ / PLUG.OQ / GPN.N / LIFE.O / CASY.O / ACGL.O / PAAS.O / EQIX.O / ATDb.TO / BIIB.O / DPM.TO / EDV.TO / TRN.MI / DLR.N / ACAD.O / 416515104 / FIS.N / CCOI.O / MA.N / EHTH.O / AON.N / CLR.N / DAN.N / NOG.A / EDPR.LS / PHR.N / PKI.TO / MSP.N / MTOR.N / MTDR.N / SRPT.O / PANW.N / FFHu.TO / FANG.O / ABBV.N / KPT.TO / TSLA.N / TMUS.N / PTCT.O / 81762P102 / ESNT.N / XNCR.OQ / ITCI.O / SAGE.OQ / HQY.OQ / NMIH.O / NEWR.N / GLPG.O / TDOC.N / PYPL.OQ / RGNX.O / SPGI.N / TTD.O / ADNT.N / AQN.N / UNIT.O / CDEV.O / ESTE.N / WOW.N / ATNX.O / SAIL.N / APTV.N / SMAR.N / VRCA.OQ / ITRM.O / OPRX.OQ / VNE.N / HCAT.OQ / GMAB.O / CRNC.OQ / PNTG.OQ / IGMS.O / OAS.OQ / NKLA.OQ / APA.OQ / FOUR.N / NRIX.OQ / RXT.OQ / GOCO.O / IBEX.O / PLTR.N / AEP.OQ / SPRB.OQ / BSY.O / GATO.N / GDRX.O / MCFE.OQ / RIDE.OQ / MAX.N / TLMD.OQ / LSPD.N / PUBM.O / TIXT.TO / AFRM.O / NUVB.N / CHK.OQ / OLO.N / PATH.N / PSFE.N / TSP.OQ / TFPM.TO / FLYW.O / BHG.N / XMTR.OQ / TASK.O / TRMR.OQ / EVCM.O / NABL.N / RYAN.N / TWKS.OQ / GTLB.OQ / ROCC.O</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / EOG Resources Inc / Ford Motor Co / Fisker Inc / General Motors Co / Microsoft Corp / National Bank of Canada / Norfolk Southern Corp / Pfizer Inc / AT&T Inc / Visteon Corp / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Whiting Petroleum Corp / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Ferrovial SA / Canadian National Railway Co / Duke Energy Corp / Borgwarner Inc / Lear Corp / FirstEnergy Corp / DISH Network Corp / CSX Corp / Union Pacific Corp / Nice Ltd / DoubleVerify Holdings Inc / Marathon Oil Corp / PG&E Corp / Plains All American Pipeline LP / Devon Energy Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / MGIC Investment Corp / Radian Group Inc / Verizon Communications Inc / Lincoln National Corp / Amphenol Corp / Range Resources Corp / EQT Corp / Visa Inc / ONEOK Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Italgas SpA / Bottomline Technologies Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Snam SpA / Prudential Financial Inc / SM Energy Co / TE Connectivity Ltd / Gold Fields Ltd / Conocophillips / Callon Petroleum Co / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / California Resources Corp / Pegasystems Inc / Plug Power Inc / Global Payments Inc / aTyr Pharma Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Pan American Silver Corp / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Dundee Precious Metals Inc / Endeavour Mining PLC / Terna Rete Elettrica Nazionale SpA / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mastercard Inc / eHealth Inc / Aon PLC / Continental Resources Inc / Dana Inc / Northern Oil and Gas Inc / EDP Renovaveis SA / Phreesia Inc / Parkland Corp / Datto Holding Corp / Meritor Inc / Matador Resources Co / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / T-Mobile US Inc / PTC Therapeutics Inc / ServiceNow Inc / Essent Group Ltd / Xencor Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Healthequity Inc / NMI Holdings Inc / New Relic Inc / Galapagos NV / Teladoc Health Inc / PayPal Holdings Inc / Regenxbio Inc / S&P Global Inc / Trade Desk Inc / Adient PLC / Algonquin Power & Utilities Corp / Uniti Group Inc / Centennial Resource Development Inc / Earthstone Energy Inc / WideOpenWest Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Veoneer Inc / Health Catalyst Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / IGM Biosciences Inc / Oasis Petroleum Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Nurix Therapeutics Inc / Rackspace Technology Inc / Gohealth Inc / Ibex Ltd / Palantir Technologies Inc / American Electric Power Company Inc / Spruce Biosciences Inc / Bentley Systems Inc / Gatos Silver Inc / Goodrx Holdings Inc / Mcafee Corp / Lordstown Motors Corp / Mediaalpha Inc / Soc Telemed Inc / Lightspeed Commerce Inc / PubMatic Inc / Telus International Cda Inc / Affirm Holdings Inc / Nuvation Bio Inc / Chesapeake Energy Corp / Olo Inc / UiPath Inc / Paysafe Ltd / TuSimple Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Bright Health Group Inc / Xometry Inc / Taskus Inc / Tremor International Ltd / EverCommerce Inc / N-Able Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc / GitLab Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Spiking European COVID Cases Could Negatively Impact NT Biotech Earnings and Clinical Trial Conduct</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NA / PFE.N / GILD.O / JAZZ.O / VRTX.O / BIIB.O / ACAD.O / SRPT.O / ABBV.N / PTCT.O / ITCI.O / SAGE.OQ / GLPG.O / IGMS.O / SPRB.OQ</td><td class="leftalignment">National Bank of Canada / Pfizer Inc / Gilead Sciences Inc / Jazz Pharmaceuticals PLC / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Galapagos NV / IGM Biosciences Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Stephen Mallon / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/13/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Gilead Sciences, Inc.: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/13/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">GILD: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AAPL / ACA / AMT / AXP / AZO / BJ / COST / CSII / CSL / DLTR / ECL / EEFT.O / EL / FOCS / GE / GS / INCY / INTC.O / JPM.N / KR / LOW / LRCX.O / MPAA / MS / MSFT / NET / NKE / O / ORLY / PZZA / RAD / ROK / RXN / SAGE / SAP / SFT / T / TH / TREE / TUP / URI / USM / V / WH / WMT / AMZN.O / GILD.O / EW / ONEM.O / ASTE.O / NVDA.O / ADBE.O / SQ / AKAM / CRVL.O / MPWR.O / XRAY.O / VECO.O / ISRG / ADI.O / VZ / NFLX / PLUG.O / FRPT / UTHR.O / EXTR.O / OSUR.O / AYI / MRVL.O / SSNC.O / AVGO.O / NDAQ / VRTS.OQ / POOL.OQ / CALM.OQ / CCRN.O / TEAM.O / SIVB.O / QDEL.O / NATI.O / AMED.O / PHAR.O / BIIB / 459200101 / 00846U101 / 868168105 / PEB.NZ / DPZ / GOOG.O / SPGI / 315616102 / QSR / DXCM.O / LHCG.O / IOSP.OQ / XPO / ATNI.O / EHTH / IPGP.O / LULU / MASI.O / 02043Q107 / ULTA / ENSG.O / 483548103 / DECK.N / ADUS.O / TSLA.O / NXPI.O / AMRS.O / HZNP.OQ / ENPH.O / FB.O / CG.O / WDAY / PANW.O / TBK.O / EVH / BWXT.K / 100063846 / TTD.O / ROKU.O / MDB.O / 720795103 / CBOE.K / ARVN / LOVE / CRWD.O / PNTG.O / TCOM.O / 975657107 / MYPS / 744285206 / ATXS.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / American Tower Corp / American Express Co / Autozone Inc / BJ's Wholesale Club Holdings Inc / Costco Wholesale Corp / Cardiovascular Systems Inc / Carlisle Companies Inc / Dollar Tree Inc / Ecolab Inc / Euronet Worldwide Inc / Estee Lauder Companies Inc / Focus Financial Partners Inc / General Electric Co / Goldman Sachs Group Inc / Incyte Corp / Intel Corp / JPMorgan Chase & Co / Kroger Co / Lowe's Companies Inc / Lam Research Corp / Motorcar Parts of America Inc / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Realty Income Corp / O'Reilly Automotive Inc / Papa John's International Inc / Rite Aid Corp / Rockwell Automation Inc / Zurn Water Solutions Corp / SAGE Therapeutics Inc / SAP SE / Shift Technologies Inc / AT&T Inc / Target Hospitality Corp / Lendingtree Inc / Tupperware Brands Corp / United Rentals Inc / United States Cellular Corp / Visa Inc / Wyndham Hotels & Resorts Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Astec Industries Inc / NVIDIA Corp / Adobe Inc / Block Inc / Akamai Technologies Inc / CorVel Corp / Monolithic Power Systems Inc / DENTSPLY SIRONA Inc / Veeco Instruments Inc / Intuitive Surgical Inc / Analog Devices Inc / Verizon Communications Inc / Netflix Inc / Plug Power Inc / Freshpet Inc / United Therapeutics Corp / Extreme Networks Inc / OraSure Technologies Inc / Acuity Brands Inc / Marvell Technology Inc / SS&C Technologies Holdings Inc / Broadcom Inc / Nasdaq Inc / Virtus Investment Partners Inc / Pool Corp / Cal-Maine Foods Inc / Cross Country Healthcare Inc / Atlassian Corporation PLC / SVB Financial Group / Quidel Corp / National Instruments Corp / Amedisys Inc / Pharming Group NV / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Pacific Edge Ltd / Domino's Pizza Inc / Alphabet Inc / S&P Global Inc / F5 Inc / Restaurant Brands International Inc / Dexcom Inc / LHC Group Inc / Innospec Inc / XPO Logistics Inc / ATN International Inc / eHealth Inc / IPG Photonics Corp / Lululemon Athletica Inc / Masimo Corp / Alnylam Pharmaceuticals Inc / Ulta Beauty Inc / Ensign Group Inc / Kaman Corp / Deckers Outdoor Corp / Addus Homecare Corp / Tesla Inc / NXP Semiconductors NV / Amyris Inc / Horizon Therapeutics PLC / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Workday Inc / Palo Alto Networks Inc / Triumph Bancorp Inc / Evolent Health Inc / BWX Technologies Inc / Truist Financial Corp / Trade Desk Inc / Roku Inc / MongoDB Inc / Pieris Pharmaceuticals Inc / Cboe Global Markets Inc / Arvinas Inc / Lovesac Co / CrowdStrike Holdings Inc / Pennant Group Inc / Trip.com Group Ltd / Winston Pharmaceuticals Inc / Playstudios Inc / Proxim Wireless Corp / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / United Kingdom / Ireland / Netherlands / New Zealand / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for GILD. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: November Rain Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / INCY.O / BIIB.O / ITCI.O / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Biogen Inc / Intra-Cellular Therapies Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / LSI=US / AMGN=US / BMY=US / DIS=US / MCD=US / WEN=US / PLD=US / BLDP=US / AMZN=US / GILD=US / PEB=US / REI=US / PLUG=US / H=US / V=US / MTN=US / ENR=US / VRM=US / MAR=US / TNL=US / HLT=US / AKR=US / HUM=US / EQR=US / AMK=US / SWIM=US / CBRL=US / CHH=US / DRI=US / DRH=US / MAIN=US / NTST=US / PDM=US / SGMO=US / SHOP=US / FORG=US / VRTX=US / WIX=US / FOUR=US / AEL=US / GPN=US / HIW=US / SNV=US / ADC=US / FRT=US / INTA=US / OHI=US / SRC=US / REG=US / ENSG=US / BRX=US / DIN=US / ACVA=US / MQ / CRD.B=US / APP=US / SHO=US / PLAY=US / DENN=US / ESMT=US / SCPL=US / CMG=US / HST=US / MA=US / RPRX=US / GPRE=US / OC=US / CPRX=US / TAST=US / QSR=US / LUMN=US / WH=US / JACK=US / UTZ=US / BLND=US / HGV=US / SBRA=US / APTS=US / RLJ=US / VAC=US / ZNGA=US / SPLK=US / MEIP=US / RHP=US / NDLS=US / VRNS=US / 00770K202 / LOCO=US / AFMD=US / BVH=US / SHAK=US / CHCT=US / WING=US / MCFT=US / SQ=US / WVE=US / PK=US / PLYA=US / OKTA=US / ROOT=US / BTAI=US / AMTB=US / LSPD=US / ARQT=US / TSHA / DASH=US / AFRM=US / SHLS=US / HLLY=US / OLPX=US / GTLB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / McDonald's Corp / Wendys Co / Prologis Inc / Ballard Power Systems Inc / Amazon.com Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Plug Power Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Vroom Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Humana Inc / Equity Residential / AssetMark Financial Holdings Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Netstreit Corp / Piedmont Office Realty Trust Inc / Sangamo Therapeutics Inc / Shopify Inc / ForgeRock Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Shift4 Payments Inc / American Equity Investment Life Holding Co / Global Payments Inc / Highwoods Properties Inc / Synovus Financial Corp / Agree Realty Corp / Federal Realty Investment Trust / Intapp Inc / Omega Healthcare Investors Inc / Spirit Realty Capital Inc / Regency Centers Corp / Ensign Group Inc / Brixmor Property Group Inc / Dine Brands Global Inc / ACV Auctions Inc / Marqeta Inc / Crawford & Co / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / EngageSmart Inc / Sciplay Corp / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / Mastercard Inc / Royalty Pharma PLC / Green Plains Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / UTZ Brands Inc / Blend Labs Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Splunk Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Noodles & Co / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Community Healthcare Trust Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Block Inc / WAVE Life Sciences Ltd / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Root Inc / BioXcel Therapeutics Inc / Amerant Bancorp Inc / Lightspeed Commerce Inc / Arcutis Biotherapeutics Inc / Taysha Gene Therapies Inc / DoorDash Inc / Affirm Holdings Inc / Shoals Technologies Group Inc / Holley Inc / Olaplex Holdings Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Common threads from investor feedback on Treg competitive landscape</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / LLY=US / MRK=US / BMY=US / GILD=US / SGMO=US</td><td class="leftalignment">Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / BMY=US / OXY=US / AMD=US / RRC=US / IP=US / MDT=US / DVN=US / INCY=US / GILD=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / PLUG=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / IGT=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / ESS=US / CLI=US / DV=US / AVGO=US / BLL=US / BNL=US / ENV=US / ELY=US / CTRA=US / CNX=US / CCK=US / EQT=US / GPOR=US / DOC=US / HOOK=US / REGI=US / TRIP=US / TGI=US / CVX=US / CGEN=US / SGMS=US / BDN=US / OFC=US / CUZ=US / PRI=US / DCP=US / EGP=US / FR=US / JAZZ=US / KIM=US / NHI=US / PRA=US / DRE=US / NLS=US / COP=US / MRNS=US / PTON=US / MMP=US / BIIB=US / RNG=US / APTX=US / NUVA=US / EXR=US / WRK=US / CLR=US / PRPL=US / SEAS=US / TIL=US / NOG=US / RCUS=US / HTA=US / OLO=US / AR=US / OAS=US / HGV=US / ESTE=US / CUBE=US / MTDR=US / PDCE=US / FANG=US / MODN=US / CNCE=US / VNOM=US / CIVI=US / OSH=US / VCEL=US / GSBD=US / NSA=US / EVBG=US / CDEV=US / VRNA=US / SBOW=US / IOVA=US / CARG=US / SAIL=US / COLD=US / FSK=US / RPAY=US / GMAB=US / GOCO=US / PNTG=US / OVV=US / CRMD.US / AZYO=US / ABNB=US / DASH=US / SHLS=US / ROCC=US / DHT.UN=CA / REPX=US / MNTV=US / DNUT=US / PYCR=US / PKG=U / 00152K101</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Medtronic PLC / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Essex Property Trust Inc / Veris Residential Inc / DoubleVerify Holdings Inc / Broadcom Inc / Ball Corp / Bunzl plc / Envestnet Inc / Callaway Golf Co / Coterra Energy Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / Physicians Realty Trust / HOOKIPA Pharma Inc / Renewable Energy Group Inc / Tripadvisor Inc / Triumph Group Inc / Chevron Corp / Compugen Ltd / Scientific Games Corp / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Primerica Inc / DCP Midstream LP / Eastgroup Properties Inc / First Industrial Realty Trust Inc / Jazz Pharmaceuticals PLC / Kimco Realty Corp / National Health Investors Inc / ProAssurance Corp / Duke Realty Corp / Nautilus Inc / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Magellan Midstream Partners LP / Biogen Inc / RingCentral Inc / Aptinyx Inc / NuVasive Inc / Extra Space Storage Inc / Westrock Co / Continental Resources Inc / Purple Innovation Inc / SeaWorld Entertainment Inc / Instil Bio Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Healthcare Trust Of America Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Earthstone Energy Inc / CubeSmart / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Model N Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Civitas Resources Inc / Oak Street Health Inc / Vericel Corp / Goldman Sachs BDC Inc / National Storage Affiliates Trust / Everbridge Inc / Centennial Resource Development Inc / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / CarGurus Inc / SailPoint Technologies Holdings Inc / Americold Realty Trust / FS KKR Capital Corp / Repay Holdings Corp / Genmab A/S / Gohealth Inc / Pennant Group Inc / Ovintiv Inc / CorMedix Inc / Aziyo Biologics Inc / Airbnb Inc / DoorDash Inc / Shoals Technologies Group Inc / Ranger Oil Corp / Dri Healthcare Trust / Riley Exploration Permian Inc / Momentive Global Inc / Krispy Kreme Inc / Paycor HCM Inc / Packaging Corp of America / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Incremental Positives In The Pipeline Update; 2022 May Be A Busy Year</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HOOK=US / GILD=US</td><td class="leftalignment">HOOKIPA Pharma Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Come On In, The Water’s Fine!</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">375558103 / 031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 00166B105 / 46565G104 / 49705R105 / 670703107</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / BMY / GILD / JNJ / LLY / MRK / PFE / ACRS / UTHR / ACRX / BIIB / ABBV / AERI / ALDX</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aclaris Therapeutics Inc / United Therapeutics Corp / AcelRx Pharmaceuticals Inc / Biogen Inc / Abbvie Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Spoke with RCUS; mgmt extremely +ve about data, high degree of confidence in opt-in</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">RCUS=US / GILD=US</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Finally GILD Triggers Opt-in Process, More Data Coming; Outpfrm, PT Stays $68</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ / 03969F10 / 37555810 / RCUS.N</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AASLD 2021 Virtual Meeting Preview and Planner</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">04635310 / 37555810 / 478160104 / 02043Q10 / 00287Y10 / 46222210 / 04280A10 / 604749101 / G3910J11 / 45845P10 / 55886810 / 05454B10 / F4373810 / 28255910 / 23257D10 / 29251M10 / 01626L10</td><td class="leftalignment">AstraZeneca PLC / Gilead Sciences Inc / Johnson & Johnson / Alnylam Pharmaceuticals Inc / Abbvie Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Genfit SA / 89Bio Inc / Cymabay Therapeutics Inc / Enanta Pharmaceuticals Inc / Aligos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Thomas J. Smith / Mani Foroohar, M.D. / Ms. Roanna C. Ruiz / Mike Kratky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALB.N / BA.N / C.N / CNA.L / CP.TO / DD.N / GE.N / NSC.N / SAND.ST / SKFb.ST / WEIR.L / VOWG_p.DE / GILD.O / LPX.N / AAL.L / CNR.TO / DHR.N / LEA.N / WCC.N / ROP.N / CSX.N / TV.TO / UNP.N / WM.N / WHR.N / SHW.N / MTG.N / VLY.N / SNV.N / BC.N / STL.N / ALFA.ST / CPE.N / VSEC.OQ / WBS.N / FCF.N / HCC.N / ONC.TO / PFS.N / WSBC.O / BCRX.O / BIIB.O / RUS.TO / DCP.N / AINV.O / BECN.O / MAIN.N / ACAD.O / ISBC.O / CS.TO / 443628102 / MERC.O / EHTH.O / 3IN.L / DAIGn.DE / KTOS.OQ / GETP.PA / CLW.N / ENV.N / BHPB.L / TRGP.N / CFX.TO / NLSN.N / BKU.N / GLEN.L / FBHS.N / 505440107 / FANG.O / NYCB.N / MRON.L / KPT.TO / TPH.N / TSLA.N / PTC.O / KPTI.O / XNCR.OQ / IBP.N / ITCI.O / CIA.TO / AXTA.N / NEWR.N / SUM.N / PYPL.OQ / RACE.MI / EDIT.O / VACN.S / TTD.O / CDEV.O / RHIM.L / STLC.TO / APTV.N / GTES.N / VCTR.N / EPIRa.ST / RTLR.O / APRE.OQ / CRNC.OQ / BEAM.O / SLQT.N / MOCORP.HE / MCFE.OQ / 900435207 / WFG.N / RKT.L / SQSP.N / EVCM.O</td><td class="leftalignment">Albemarle Corp / Boeing Co / Citigroup Inc / Centrica PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / Norfolk Southern Corp / Sandvik AB / AB Skf / Weir Group PLC / Volkswagen AG / Gilead Sciences Inc / Louisiana-Pacific Corp / Anglo American PLC / Canadian National Railway Co / Danaher Corp / Lear Corp / Wesco International Inc / Roper Technologies Inc / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Waste Management Inc / Whirlpool Corp / Sherwin-Williams Co / MGIC Investment Corp / Valley National Bancorp / Synovus Financial Corp / Brunswick Corp / Sterling Bancorp / Alfa Laval AB / Callon Petroleum Co / VSE Corp / Webster Financial Corp / First Commonwealth Financial Corp / Warrior Met Coal Inc / Oncolytics Biotech Inc / Provident Financial Services Inc / WesBanco Inc / BioCryst Pharmaceuticals Inc / Biogen Inc / Russel Metals Inc / DCP Midstream LP / Apollo Investment Corp / Beacon Roofing Supply Inc / Main Street Capital Corp / ACADIA Pharmaceuticals Inc / Investors Bancorp Inc / Capstone Mining Corp / Hudbay Minerals Inc / Mercer International Inc / eHealth Inc / 3I Infrastructure PLC / Daimler AG / Kratos Defense and Security Solutions Inc / Getlink SE / Clearwater Paper Corp / Envestnet Inc / BHP Group PLC / Targa Resources Corp / Canfor Pulp Products Inc / Nielsen Holdings PLC / BankUnited Inc / Glencore PLC / Fortune Brands Home & Security Inc / Labrador Iron Ore Royalty Corp / Diamondback Energy Inc / New York Community Bancorp Inc / Melrose Industries PLC / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / PTC Inc / Karyopharm Therapeutics Inc / Xencor Inc / Installed Building Products Inc / Intra-Cellular Therapies Inc / Champion Iron Ltd / Axalta Coating Systems Ltd / New Relic Inc / Summit Materials Inc / PayPal Holdings Inc / Ferrari NV / Editas Medicine Inc / VAT Group AG / Trade Desk Inc / Centennial Resource Development Inc / RHI Magnesita NV / Stelco Holdings Inc / Aptiv PLC / Gates Industrial Corporation PLC / Victory Capital Holdings Inc / Epiroc AB / Rattler Midstream LP / Aprea Therapeutics Inc / Cerence Inc / Beam Therapeutics Inc / SelectQuote Inc / Metso Outotec Corp / Mcafee Corp / Turquoise Hill Resources Ltd / West Fraser Timber Co Ltd / Reckitt Benckiser Group PLC / Squarespace Inc / EverCommerce Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Finland / France / United Kingdom / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Adverse Events Monitor – 3Q21</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / BCRX.O / BIIB.O / PTC.O / KPTI.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / BioCryst Pharmaceuticals Inc / Biogen Inc / PTC Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2nd TIGIT Interim Shows More Efficacy Hints - Reflecting Underappreciated Oncology Progress</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / GILD.O / JAZZ.O / VRTX.O / BLU.N / BIIB.O / PCRX.O / ABBV.N / ENTA.O / ITCI.O / XENE.O / GMDA.OQ / MTCR.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Jazz Pharmaceuticals PLC / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Biogen Inc / Pacira Biosciences Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Xenon Pharmaceuticals Inc / Gamida Cell Ltd / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">JSPR: Multiple Shots on the HCT Goal; Initiating with an Outperform Rating and a $15 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">JSPR.OQ / AMGN.OQ / GILD.OQ / CLDX.OQ</td><td class="leftalignment">Jasper Therapeutics Inc / Amgen Inc / Gilead Sciences Inc / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / CGC / CHTR / CRY / MSFT / RAD / T / VCTR / WMT / WW / GILD.O / CMCSA.O / ONEM.O / XRAY.O / VZ / DOX.O / REGN.O / VRTX.O / SSNC.O / CCRN.O / AMED.O / BIIB / 459200101 / 00846U101 / 868168105 / GOOG.O / LHCG.O / PODD.O / MASI.O / ENSG.O / 483548103 / MRNA.O / STX.OQ / 771195104 / ADUS.O / TMUS / EVH / 100063846 / 720795103 / PNTG.O / FCRD / KDNY.O / LTH.N</td><td class="leftalignment">Arcosa Inc / Canopy Growth Corp / Charter Communications Inc / CryoLife Inc / Microsoft Corp / Rite Aid Corp / AT&T Inc / Victory Capital Holdings Inc / Walmart Inc / WW International Inc / Gilead Sciences Inc / Comcast Corp / 1Life Healthcare Inc / DENTSPLY SIRONA Inc / Verizon Communications Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Insulet Corp / Masimo Corp / Ensign Group Inc / Kaman Corp / Moderna Inc / Seagate Technology Holdings PLC / Roche Holding AG / Addus Homecare Corp / T-Mobile US Inc / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / First Eagle Alternative Capital BDC Inc / Chinook Therapeutics Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMO.TO / BNS.TO / CM.TO / NA / NA.TO / STO.AX / TD.TO / TRI.N / WY.N / CFP.TO / CNQ.TO / GILD.O / LPX.N / POW.TO / IMO.TO / MFC.TO / GWO.TO / CJRb.TO / IAG.TO / PCOM.O / ALA.TO / RRC.N / EPD.N / LB.TO / CWB.TO / COP.N / SLF.TO / CRC.N / LNG.A / TCLa.TO / MFI.TO / HCG.TO / MOS.N / IGM.TO / NESTE.HE / WEF.TO / RDSb.L / DRX.L / SES.TO / MERC.O / BIP.N / ARX.TO / IFC.TO / CVE.TO / NEE.N / TOU.TO / CGX.TO / CJT.TO / IFP.TO / AIM.TO / TVE.TO / Y.TO / ENTA.O / EQB.TO / CFF.TO / CIGI.O / RAYa.TO / AZRE.N / BBU.N / AQN.N / BHC.N / WILD.TO / EGLX.TO / GFL.N / LSPD.N / WFG.N / BRMI.TO / SFTC.TO / AKRBP.OL / FORA.TO</td><td class="leftalignment">Bank of Montreal / Bank of Nova Scotia / Canadian Imperial Bank of Commerce / National Bank of Canada / National Bank of Canada / Santos Ltd / Toronto-Dominion Bank / Thomson Reuters Corp / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Power Corporation of Canada / Imperial Oil Ltd / Manulife Financial Corp / Great-West Lifeco Inc / Corus Entertainment Inc / iA Financial Corporation Inc / Points International Ltd / AltaGas Ltd / Range Resources Corp / Enterprise Products Partners LP / Laurentian Bank of Canada / Canadian Western Bank / Conocophillips / Sun Life Financial Inc / California Resources Corp / Cheniere Energy Inc / Transcontinental Inc / Maple Leaf Foods Inc / Home Capital Group Inc / Mosaic Co / IGM Financial Inc / Neste Oyj / Western Forest Products Inc / Royal Dutch Shell PLC / Drax Group PLC / Secure Energy Services Inc / Mercer International Inc / Brookfield Infrastructure Partners LP / ARC Resources Ltd / Intact Financial Corp / Cenovus Energy Inc / Nextera Energy Inc / Tourmaline Oil Corp / Cineplex Inc / Cargojet Inc / Interfor Corp / Aimia Inc / Tamarack Valley Energy Ltd / Yellow Pages Ltd / Enanta Pharmaceuticals Inc / Equitable Group Inc / Conifex Timber Inc / Colliers International Group Inc / Stingray Group Inc / Azure Power Global Ltd / Brookfield Business Partners LP / Algonquin Power & Utilities Corp / Bausch Health Companies Inc / WildBrain Ltd / Enthusiast Gaming Holdings Inc / GFL Environmental Inc / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Boat Rocker Media Inc / Softchoice Corp (CA) / Aker BP ASA / VerticalScope Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Finland / United Kingdom / Mauritius / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Andre-Philippe Hardy, CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Nov. 05, 2021</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">AAPL / ALLO / AMGN / ATRC / CRY / CSII / EXEL / GBT / ICPT / INCY / INSP / IRTC / NBIX / OM / RARE / SAGE / ASND.O / GILD.O / EW / IART.O / SGEN / UTHR.O / PCSA.O / BMRN.O / DRRX.O / REGN.O / VRTX.O / NKTR / CCRN.O / STAA.O / AMED.O / EXAS.O / BIIB / 478160104 / MNKD.O / CMMB / ALNY.O / DXCM.O / LHCG.O / INFI.O / PODD.O / TNDM.O / MRNA.O / 771195104 / ADUS.O / SWAV / SRPT.O / AGIO / FATE.O / AERI.O / 02005N100 / AGRX.O / RXDX.O / APTO.O / AUPH.O / CFMS.O / VKTX / IONS.O / 04280A100 / MDGL / VRAY / NTLA / CRSP / IOVA / ATNX.O / 720795103 / PRVB.O / ORTX.O / BNGO.O / ARVN / XFOR.O / TMDX / PSNL.O / BCYC / ORIC.O / HGEN.O / 03823M100 / CLNN.O / CGTX.OQ</td><td class="leftalignment">Apple Inc / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / CryoLife Inc / Cardiovascular Systems Inc / Exelixis Inc / Global Blood Therapeutics Inc / Intercept Pharmaceuticals Inc / Incyte Corp / Inspire Medical Systems Inc / iRhythm Technologies Inc / Neurocrine Biosciences Inc / Outset Medical Inc / Ultragenyx Pharmaceutical Inc / SAGE Therapeutics Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Seagen Inc / United Therapeutics Corp / Processa Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / DURECT Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / STAAR Surgical Co / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / MannKind Corp / Chemomab Therapeutics Ltd / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / Roche Holding AG / Addus Homecare Corp / Shockwave Medical Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Ally Financial Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Aptose Biosciences Inc / Aurinia Pharmaceuticals Inc / Conformis Inc / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / ViewRay Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Personalis Inc / Bicycle Therapeutics PLC / Oric Pharmaceuticals Inc / Humanigen Inc / Applied Minerals Inc / Clene Inc. / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q21 Review: Moving from Strength to Strength</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">REGN.O / GILD.O / 771195104</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">COVID/scope Real-Time Update: This Morning's PFE Data Marks Turning Point In Pandemic</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / ENTA.O</td><td class="leftalignment">Gilead Sciences Inc / Enanta Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Nov 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US0126531013 / US01988P1084 / US0231351067 / US0382221051 / US0758871091 / US1265011056 / US1266501006 / US16411R2085 / US1924221039 / US22284P1057 / US2358511028 / US2480191012 / US3021301094 / US3755581036 / US4234521015 / US4433201062 / US4448591028 / US4456581077 / US4523271090 / US45253H1014 / US45337C1027 / US4581401001 / US4657411066 / US4824801009 / US5128071082 / US5150981018 / US5184151042 / US5370081045 / US55306N1046 / US5763231090 / US58155Q1031 / US5950171042 / US5951121038 / US67066G1040 / US6745991058 / US6795801009 / US6821891057 / US7392761034 / US7475251036 / US75886F1075 / US8006771062 / US8168501018 / US8610121027 / US8835561023 / US9029251066 / US91347P1057 / US9282981086 / US9507551086 / US9581021055 / US9839191015 / US03073E1055 / US87157D1090 / AU000000LYC6 / US83088M1027 / LU0156801721 / US6402681083 / US88031M1099 / US02043Q1076 / US6098391054 / US6866881021 / US19239V3024 / US50187A1079 / US12541W2098 / US82706C1080 / US57636Q1040 / US78709Y1055 / US75025X1000 / US29089Q1058 / US45784P1012 / US53261M1045 / US88076W1036 / US25470M1099 / US34959E1091 / US1920051067 / US39304D1028 / NL0009538784 / US40412C1018 / JE00B783TY65 / US30212P3038 / US9837931008 / US00912X3026 / US55405Y1001 / US74587V1070 / US41068X1000 / US29428V1044 / US00847X1046 / US00771V1089 / US70438V1061 / US03937C1053 / US69888T2078 / US94419L1017 / US0465131078 / US0994061002 / US2681582019 / US0367521038 / US23283X2062 / US74736K1016 / US9283771007 / US8190471016 / US12685J1051 / US6323071042 / US72703H1014 / US37890U1088 / US74624M1027 / US50127T1097 / US8522341036 / US28106W1036 / US87164F1057 / US00773U1088 / US02081G2012 / US98419J2069 / US01345P1066 / US2067871036 / CA87241L1094 / NL0012169213 / US91325V1089 / US23753F1075 / US80689H1023 / US1468691027 / US03782L1017 / US24665A1034 / US02156K1034 / US4990491049 / US74766Q1013 / US4622601007 / US5011471027 / US03753U1060 / US57777K1060 / US05351X1019 / US05455M1009 / US55910K1088 / US0937121079 / US0197701065 / US53814L1089 / US68570P1012 / US1255231003 / US0144421072 / US98420X1037 / US62921N1054 / US90353T1007 / US70202L1026 / US05352A1007 / US18915M1071 / US85205L1070 / US70614W1009 / US92764N1028 / CA74319B5027 / US69242L1061 / US03969K1088 / US92537N1081 / US7027121000 / US39813G1094 / US4432011082 / CH0499880968 / US57667L1070 / US6833731044 / US65487U1088 / US0843101017 / US12769G1004 / US5015751044 / US20451W1018 / US69353Y1038 / US81181C1045 / US05875B1061 / US5533681012 / US0090661010 / US65443P1021 / US01625V1044 / US5738741041 / US92719V1008 / US25401T1088 / US20717M1036 / US45250K1079 / US00109K1051 / US74276L1052 / 50066V107</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Albemarle Corp / Allscripts Healthcare Solutions Inc / Amazon.com Inc / Applied Materials Inc / Becton Dickinson and Co / CTS Corp / CVS Health Corp / Cheniere Energy Inc / Cognex Corp / Covenant Logistics Group Inc / Danaher Corp / Deluxe Corp / Expeditors International of Washington Inc / Gilead Sciences Inc / Helmerich and Payne Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / Illumina Inc / ImmunoGen Inc / Incyte Corp / Intel Corp / Itron Inc / KLA Corp / Lam Research Corp / Landstar System Inc / Lattice Semiconductor Corp / Littelfuse Inc / MKS Instruments Inc / MasTec Inc / Mckesson Corp / Microchip Technology Inc / Micron Technology Inc / NVIDIA Corp / Occidental Petroleum Corp / Old Dominion Freight Line Inc / ON Semiconductor Corp / Power Integrations Inc / Qualcomm Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Semtech Corp / STMicroelectronics NV / Thermo Fisher Scientific Inc / USA Truck Inc / Universal Display Corp / Vishay Intertechnology Inc / Werner Enterprises Inc / Western Digital Corp / Xilinx Inc / Amerisourcebergen Corp / Synaptics Inc / Lynas Rare Earths Ltd / Skyworks Solutions Inc / Tenaris SA / Nektar Therapeutics / Tenaris SA / Alnylam Pharmaceuticals Inc / Monolithic Power Systems Inc / Ormat Technologies Inc / Cogent Communications Holdings Inc / LHC Group Inc / CH Robinson Worldwide Inc / Silicon Motion Technology Corp / Mastercard Inc / Saia Inc / Radiant Logistics Inc / Emergent BioSolutions Inc / Insulet Corp / Limelight Networks Inc / Teradata Corp / DISH Network Corp / Fortinet Inc / Codexis Inc / Green Dot Corp / NXP Semiconductors NV / HCA Healthcare Inc / Aptiv PLC / Expedia Group Inc / XPO Logistics Inc / Air Lease Corp / MACOM Technology Solutions Holdings Inc / Puma Biotechnology Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Epizyme Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Paylocity Holding Corp / ArcBest Corp / Par Pacific Holdings Inc / Wayfair Inc / Atara Biotherapeutics Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / Anthem Inc / Cytosorbents Corp / Qorvo Inc / Vista Outdoor Inc / Shake Shack Inc / Cable One Inc / Natera Inc / Planet Fitness Inc / Global Blood Therapeutics Inc / Pure Storage Inc / Kura Oncology Inc / Block Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Alphatec Holdings Inc / XOMA Corp / Albireo Pharma Inc / Conduent Inc / TFI International Inc / Qiagen NV / Uniti Group Inc / Daseke Inc / Schneider National Inc / Carvana Co / Appian Corp / Delek US Holdings Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Quanterix Corp / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / MaxCyte Inc / Avaya Holdings Corp / AVROBIO Inc / Magenta Therapeutics Inc / Bloom Energy Corp / Allogene Therapeutics Inc / Livent Corp / Orchard Therapeutics PLC / Cigna Corp / Alector Inc / X4 Pharmaceuticals Inc / NGM Biopharmaceuticals Inc / Uber Technologies Inc / Parsons Corp / Avantor Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Peloton Interactive Inc / Vir Biotechnology Inc / Profound Medical Corp / Oyster Point Pharma Inc / Arcutis Biotherapeutics Inc / Vertiv Holdings Co / Passage Bio Inc / Grid Dynamics Holdings Inc / Howmet Aerospace Inc / ADC Therapeutics SA / Match Group Inc / Ontrak Inc / Nkarta Inc / Berkeley Lights Inc / Caesars Entertainment Inc / Kymera Therapeutics Inc / Compass Pathways PLC / PMV Pharmaceuticals Inc / Seagen Inc / Bally's Corp / Mp Materials Corp / Airbnb Inc / 908 Devices Inc. / Alignment Healthcare Inc / Marvell Technology Inc / Vimeo Inc / DigitalBridge Group Inc / Confluent Inc / Imago BioSciences Inc / AFC Gamma Inc / Procept Biorobotics Corp / KORE Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CARS / DNB / FISV=US / OXY=US / TWTR=US / ADI=US / T=US / RUN=US / GILD=US / CPE=US / EOG=US / TRU=US / WLL=US / PXD=US / PAA=US / SWN=US / MUR=US / MRO=US / EXPE=US / VMC=US / PENN=US / BKI=US / CI=US / W=US / MLM=US / DISH=US / AMN=US / ARW=US / AVT=US / BLL=US / BL=US / KIDS=US / CHH=US / COLL=US / CSGP=US / CW=US / DRH=US / IBP=US / MCHP=US / ORCC=US / OI=US / PCTY=US / RARE=US / REGN=US / SGMO=US / STOR=US / STRA=US / TRGP=US / WW=US / GOLF=US / CVX=US / NET=US / GPN=US / CCRN=US / MANT=US / FNF=US / FRT=US / OHI=US / REG=US / APPN=US / DIN=US / MGNI=US / ATRS=US / MNST=US / PTON=US / IGMS=US / NOMD=US / SHO=US / DENN=US / LHCG=US / BLDR=US / SPWR=US / FIS=US / CCOI=US / GPRE=US / CLR=US / LLNW=US / PAGP=US / ATSG=US / IAC=US / PSN=US / AGS=US / GDOT=US / RLJ=US / CUBE=US / ANGI=US / MEIP=US / GMED=US / FOXF=US / LDOS=US / FATE=US / MBUU=US / QTWO=US / LOCO=US / AFMD=US / CIVI=US / SHAK=US / ZBH=US / CABO=US / SQ=US / NTLA=US / VVV=US / IRTC=US / LGF.B=US / CVNA=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / FNKO=US / LAZY=US / EQH=US / FOCS=US / ALLO=US / AXNX=US / UBER=US / LSPD=US / PLMR=US / XAIR=US / DDOG=US / AHCO=US / OPCH=US / REYN=US / BIGC=US / BALY=US / DASH=US / ROCC=US / VMEO=US / DBRG=US / SNPO=US / EWCZ=US / MNDT=US / CRXT=US</td><td class="leftalignment">Cars.com Inc / Dun & Bradstreet Holdings Inc / Fiserv Inc / Occidental Petroleum Corp / Twitter Inc / Analog Devices Inc / AT&T Inc / Sunrun Inc / Gilead Sciences Inc / Callon Petroleum Co / EOG Resources Inc / TransUnion / Whiting Petroleum Corp / Pioneer Natural Resources Co / Plains All American Pipeline LP / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Vulcan Materials Co / Penn National Gaming Inc / Black Knight Inc / Cigna Corp / Wayfair Inc / Martin Marietta Materials Inc / DISH Network Corp / AMN Healthcare Services Inc / Arrow Electronics Inc / Avnet Inc / Ball Corp / Blackline Inc / OrthoPediatrics Corp / Choice Hotels International Inc / Collegium Pharmaceutical Inc / CoStar Group Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Installed Building Products Inc / Microchip Technology Inc / Owl Rock Capital Corp / O-I Glass Inc / Paylocity Holding Corp / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / STORE Capital Corp / Strategic Education Inc / Targa Resources Corp / WW International Inc / Acushnet Holdings Corp / Chevron Corp / Cloudflare Inc / Global Payments Inc / Cross Country Healthcare Inc / ManTech International Corp / Fidelity National Financial Inc / Federal Realty Investment Trust / Omega Healthcare Investors Inc / Regency Centers Corp / Appian Corp / Dine Brands Global Inc / Magnite Inc / Antares Pharma Inc / Monster Beverage Corp / Peloton Interactive Inc / IGM Biosciences Inc / Nomad Foods Ltd / Sunstone Hotel Investors Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / SunPower Corp / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Green Plains Inc / Continental Resources Inc / Limelight Networks Inc / Plains GP Holdings LP / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / PlayAGS Inc / Green Dot Corp / RLJ Lodging Trust / CubeSmart / Angi Inc / MEI Pharma Inc / Globus Medical Inc / Fox Factory Holding Corp / Leidos Holdings Inc / Fate Therapeutics Inc / Malibu Boats Inc / Q2 Holdings Inc / El Pollo Loco Holdings Inc / Affimed NV / Civitas Resources Inc / Shake Shack Inc / Zimmer Biomet Holdings Inc / Cable One Inc / Block Inc / Intellia Therapeutics Inc / Valvoline Inc / iRhythm Technologies Inc / Lions Gate Entertainment Corp / Carvana Co / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Funko Inc / Lazydays Holdings Inc / Equitable Holdings Inc / Focus Financial Partners Inc / Allogene Therapeutics Inc / Axonics Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / Beyond Air Inc / Datadog Inc / Adapthealth Corp / Option Care Health Inc / Reynolds Consumer Products Inc / Bigcommerce Holdings Inc / Bally's Corp / DoorDash Inc / Ranger Oil Corp / Vimeo Inc / DigitalBridge Group Inc / Snap One Holdings Corp / European Wax Center Inc / Mandiant Inc / Clarus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">ALTR.O / ANA.MC / BCE.TO / CF.N / CI.N / CSGN.S / ECL.N / EDP.LS / FMC.N / RYN.N / TMX.N / CNQ.TO / GILD.O / INCY.O / RBA.N / MET.N / WCC.N / K.N / CTXS.O / MFC.TO / MRO.N / VMC.N / JAZZ.O / RKT.N / SGMO.O / MTG.N / MDRX.O / ARNA.O / LNC.N / CTAS.O / FDS.N / EXPE.O / DNB.N / OTEX.O / GIL.N / REGN.O / VRTX.O / MCO.N / NET.N / SLF.TO / HCC.N / TRU.N / NTCT.OQ / SEM.N / MNST.O / ANSS.O / VIAC.O / LHCG.O / BKD.N / FIS.N / 443628102 / CLR.N / PPL.TO / TDC.N / MSCI.N / VRSK.O / FTNT.O / CTT.N / RFP.N / FFHu.TO / ORCC.N / PRMW.N / KPTI.O / XNCR.OQ / IBP.N / QTWO.N / CIA.TO / 03835T200 / SUM.N / EVA.N / GBT.OQ / RUN.O / SQ.N / SPGI.N / ADVM.OQ / NTLA.O / UN01.DE / LGFB.N / SAND.N / CVNA.N / WPM.N / ATUS.N / RDFN.O / ATNX.O / APTV.N / DBX.O / EQH.N / PRVB.O / FOCS.O / GMDA.OQ / PINS.N / UBER.N / CTVA.N / MORF.OQ / GMAB.O / DDOG.O / APRE.OQ / IGMS.O / NLOK.O / REYN.O / SLQT.N / NKLA.OQ / OTRK.OQ / PTVE.O / ABNB.OQ / LSPD.N / ANE.MC / ZD.OQ / 120681711</td><td class="leftalignment">Altair Engineering Inc / Acciona SA / BCE Inc / CF Industries Holdings Inc / Cigna Corp / Credit Suisse Group AG / Ecolab Inc / EDP Energias de Portugal SA / FMC Corp / Rayonier Inc / Terminix Global Holdings Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Incyte Corp / Ritchie Bros Auctioneers Inc / MetLife Inc / Wesco International Inc / Kellogg Co / Citrix Systems Inc / Manulife Financial Corp / Marathon Oil Corp / Vulcan Materials Co / Jazz Pharmaceuticals PLC / Rocket Companies Inc / Sangamo Therapeutics Inc / MGIC Investment Corp / Allscripts Healthcare Solutions Inc / Arena Pharmaceuticals Inc / Lincoln National Corp / Cintas Corp / Factset Research Systems Inc / Expedia Group Inc / Dun & Bradstreet Holdings Inc / Open Text Corp / Gildan Activewear Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moody's Corp / Cloudflare Inc / Sun Life Financial Inc / Warrior Met Coal Inc / TransUnion / Netscout Systems Inc / Select Medical Holdings Corp / Monster Beverage Corp / ANSYS Inc / ViacomCBS Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Hudbay Minerals Inc / Continental Resources Inc / Pembina Pipeline Corp / Teradata Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / CatchMark Timber Trust Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Owl Rock Capital Corp / Primo Water Corp / Karyopharm Therapeutics Inc / Xencor Inc / Installed Building Products Inc / Q2 Holdings Inc / Champion Iron Ltd / Aptose Biosciences Inc / Summit Materials Inc / Enviva Inc / Global Blood Therapeutics Inc / Sunrun Inc / Block Inc / S&P Global Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / Uniper SE / Lions Gate Entertainment Corp / Sandstorm Gold Ltd / Carvana Co / Wheaton Precious Metals Corp / Altice USA Inc / Redfin Corp / Athenex Inc / Aptiv PLC / Dropbox Inc / Equitable Holdings Inc / Provention Bio Inc / Focus Financial Partners Inc / Gamida Cell Ltd / Pinterest Inc / Uber Technologies Inc / Corteva Inc / Morphic Holding Inc / Genmab A/S / Datadog Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / NortonLifeLock Inc / Reynolds Consumer Products Inc / SelectQuote Inc / Nikola Corp / Ontrak Inc / Pactiv Evergreen Inc / Airbnb Inc / Lightspeed Commerce Inc / Corporacion Acciona Energias Renovables SA / Ziff Davis Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / Spain / Ireland / Israel / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GILD Remains “Inoculated” Against HIV Vaccine Threats, Well Positioned for LT Leadership</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Biotechnology Highlights From ASH Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US3755581036 / US45253H1014 / US45337C1027 / US8006771062 / US6402681083 / US02043Q1076 / US29428V1044 / US00847X1046 / US0465131078 / US37890U1088 / US28106W1036 / US87164F1057 / US03753U1060 / US55910K1088 / US0197701065 / US98420X1037 / CH0499880968 / US5015751044 / US81181C1045 / US45250K1079</td><td class="leftalignment">Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Sangamo Therapeutics Inc / Nektar Therapeutics / Alnylam Pharmaceuticals Inc / Epizyme Inc / Agios Pharmaceuticals Inc / Atara Biotherapeutics Inc / Global Blood Therapeutics Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Magenta Therapeutics Inc / Allogene Therapeutics Inc / X4 Pharmaceuticals Inc / ADC Therapeutics SA / Kymera Therapeutics Inc / Seagen Inc / Imago BioSciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASH 2021 spotlight on REGN, GILD, MEIP, ATNX, SGMO and Aruvant</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD=US / ATNX.OQ / MEIP.OQ / REGN=US / SGMO.OQ / SGMO=US / MEIP=US / ATNX=US</td><td class="leftalignment">Gilead Sciences Inc / Athenex Inc / MEI Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Sangamo Therapeutics Inc / MEI Pharma Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead down 2.8% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">We think stock weakness is overdone on MDS abstract; remain focused on SITC update in solid tumor</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALXO / US3755581036</td><td class="leftalignment">ALX Oncology Holdings Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotechnology: Key ASH Abstract Takeaways From Our Coverage Universe</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / INCY.O / KPTI.O / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Karyopharm Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">CACI=US / DVN=US / GILD=US / PEB=US / APA=US / BR=US / CPE=US / H=US / MTN=US / CRK=US / WLL=US / PXD=US / DIOD=US / SWN=US / MAR=US / MRO=US / TTWO=US / TNL=US / MGM=US / HLT=US / CLI=US / HUM=US / CVS=US / RCL=US / MAC=US / AIZ=US / AMED=US / AMN=US / FUN=US / CTRA=US / KIDS=US / CHH=US / DRH=US / EQIX=US / EXEL=US / GPOR=US / MPLX=US / MCHP=US / OKE=US / REGI=US / SGMO=US / SMG=US / CCRN=US / MANT=US / BKNG=US / EPR=US / HR=US / MTCH=US / SPR=US / CRTO=US / EVOP=US / REG=US / AUTL=US / ECPG=US / MGP=US / MGPI=US / BDSI=US / JRVR=US / RPD=US / PRG=US / FLT=US / KAR=US / BDC=US / HURN=US / SHO=US / BAH=US / AAWW=US / SPWR=US / HST=US / XPO=US / ELF=US / AMRX=US / CLR=US / KTOS=US / WH=US / CWH=US / PSN=US / VRSK=US / GNRC=US / OAS=US / HGV=US / SBRA=US / PCRX=US / RLJ=US / ESTE=US / VAC=US / EA=US / PDCE=US / QLYS=US / RHP=US / FANG=US / NCLH=US / TMUS=US / LDOS=US / GOOGL=US / ARCB=US / HRTG=US / HUBS=US / UPLD=US / BVH=US / WK=US / GDDY=US / ETSY=US / SEDG=US / VKTX=US / WING=US / LOB=US / EVRI=US / PEN=US / 82982L103 / VVV=US / CDEV=US / CRSP=US / PK=US / PLYA=US / SBOW=US / PETQ=US / MAXR=US / COLD=US / ARVN=US / RTLR=US / OVV=US / ONEM=US / ROCC=US / KNBE=US / VMEO=US</td><td class="leftalignment">CACI International Inc / Devon Energy Corp / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Broadridge Financial Solutions Inc / Callon Petroleum Co / Hyatt Hotels Corp / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Southwestern Energy Co / Marriott International Inc / Marathon Oil Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Veris Residential Inc / Humana Inc / CVS Health Corp / Royal Caribbean Cruises Ltd / Macerich Co / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Cedar Fair LP / Coterra Energy Inc / OrthoPediatrics Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / Exelixis Inc / Gulfport Energy Corp / MPLX LP / Microchip Technology Inc / ONEOK Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Cross Country Healthcare Inc / ManTech International Corp / Booking Holdings Inc / EPR Properties / Healthcare Realty Trust Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / Criteo SA / EVO Payments Inc / Regency Centers Corp / Autolus Therapeutics PLC / Encore Capital Group Inc / MGM Growth Properties LLC / MGP Ingredients Inc / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / PROG Holdings Inc / Fleetcor Technologies Inc / KAR Auction Services Inc / Belden Inc / Huron Consulting Group Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Atlas Air Worldwide Holdings Inc / SunPower Corp / Host Hotels & Resorts Inc / XPO Logistics Inc / elf Beauty Inc / Amneal Pharmaceuticals Inc / Continental Resources Inc / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / Camping World Holdings Inc / Parsons Corp / Verisk Analytics Inc / Generac Holdings Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Electronic Arts Inc / PDC Energy Inc / Qualys Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Norwegian Cruise Line Holdings Ltd / T-Mobile US Inc / Leidos Holdings Inc / Alphabet Inc / ArcBest Corp / Heritage Insurance Holdings Inc / HubSpot Inc / Upland Software Inc / Bluegreen Vacations Holding Corp / Workiva Inc / GoDaddy Inc / ETSY Inc / Solaredge Technologies Inc / Viking Therapeutics Inc / Wingstop Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Penumbra Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Maxar Technologies Inc / Americold Realty Trust / Arvinas Inc / Rattler Midstream LP / Ovintiv Inc / 1Life Healthcare Inc / Ranger Oil Corp / Knowbe4 Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / United Kingdom / Liberia / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">The Coming SERD Showdown in Texas: SABCS Planner and Preview</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75046920 / 98401F10 / 76029N10 / 55609910 / 04685N10 / 03969F10 / F5548N10 / 98943L10 / 98985W10</td><td class="leftalignment">Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Radius Health Inc / Xencor Inc / Replimune Group Inc / MacroGenics Inc / Athenex Inc / Arcus Biosciences Inc / Sanofi SA / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Andrew Berens, M.D. / Jonathan Chang, Ph.D., CFA / Daniel Tarjan, Ph.D. / Christopher Liu, Pharm.D. / Faisal Khurshid</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: ALXO, FMTX, and KURA: First-Take on ASH 2021 Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALXO.OQ / FMTX.OQ / KURA.OQ / GILD.OQ / AGIO.OQ / SNDX.OQ</td><td class="leftalignment">ALX Oncology Holdings Inc / Forma Therapeutics Holdings Inc / Kura Oncology Inc / Gilead Sciences Inc / Agios Pharmaceuticals Inc / Syndax Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AXP.N / CNA.L / COF.N / DD.N / EL.N / F.N / GM.N / NA / SRCL.O / TMX.N / WMB.N / ZION.O / CMA.N / TRI.N / GILD.O / LPX.N / AMGN.O / ETN.N / HBAN.O / LEA.N / ADCT.N / SHW.N / OI.N / EXEL.O / AKAM.O / PACW.O / NNN.N / MRCY.O / EPD.N / AME.N / REGN.O / VRTX.O / COP.N / DCO.N / MKL.N / DFS.N / HCC.N / ADC.N / O.N / ADS.N / GPN.N / SIVB.O / COLB.O / AMED.O / WTFC.O / NTR.N / MOS.N / HUN.N / WAL.N / WU.N / PRTS.OQ / VMW.N / CLW.N / ADUS.OQ / VRSK.O / LYB.N / XYL.N / SLM.OQ / MDLZ.OQ / ALLY.N / MPLX.N / USAC.N / PRMW.N / BTG.N / RYAM.N / SAGE.OQ / SYF.N / CTLT.N / NMIH.O / CIGI.O / ZG.O / SGRY.O / RGNX.O / AROC.N / MIME.OQ / ORSTED.CO / BHC.N / LYFT.O / REYN.O / VMD.OQ / PLTR.N / 900435207 / CHK.OQ / COUR.N / ACCA.OL / 120681711</td><td class="leftalignment">American Express Co / Centrica PLC / Capital One Financial Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / National Bank of Canada / Stericycle Inc / Terminix Global Holdings Inc / Williams Companies Inc / Zions Bancorporation NA / Comerica Inc / Thomson Reuters Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Amgen Inc / Eaton Corporation PLC / Huntington Bancshares Inc / Lear Corp / ADC Therapeutics SA / Sherwin-Williams Co / O-I Glass Inc / Exelixis Inc / Akamai Technologies Inc / PacWest Bancorp / National Retail Properties Inc / Mercury Systems Inc / Enterprise Products Partners LP / AMETEK Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Conocophillips / Ducommun Inc / Markel Corp / Discover Financial Services / Warrior Met Coal Inc / Agree Realty Corp / Realty Income Corp / Alliance Data Systems Corp / Global Payments Inc / SVB Financial Group / Columbia Banking System Inc / Amedisys Inc / Wintrust Financial Corp / Nutrien Ltd / Mosaic Co / Huntsman Corp / Western Alliance Bancorp / Western Union Co / Carparts.Com Inc / VMware Inc / Clearwater Paper Corp / Addus Homecare Corp / Verisk Analytics Inc / LyondellBasell Industries NV / Xylem Inc / SLM Corp / Mondelez International Inc / Ally Financial Inc / MPLX LP / USA Compression Partners LP / Primo Water Corp / B2Gold Corp / Rayonier Advanced Materials Inc / SAGE Therapeutics Inc / Synchrony Financial / Catalent Inc / NMI Holdings Inc / Colliers International Group Inc / Zillow Group Inc / Surgery Partners Inc / Regenxbio Inc / Archrock Inc / Mimecast Ltd / Orsted A/S / Bausch Health Companies Inc / Lyft Inc / Reynolds Consumer Products Inc / Viemed Healthcare Inc / Palantir Technologies Inc / Turquoise Hill Resources Ltd / Chesapeake Energy Corp / Coursera Inc / Aker Carbon Capture ASA / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Netherlands / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - 3Q21 Initial Diagnosis of full results following pre-announcement</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">NOVOB.CO / GILD.OQ</td><td class="leftalignment">Novo Nordisk A/S / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">1952.HK: Everest Medicines - 2021 CIC Live takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1952.HK / MRCG.DE / GILD.OQ</td><td class="leftalignment">Everest Medicines Ltd / Merck KGaA / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 11 02</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">APD.N / MRK.N / BDX.N / CL.N / CRM.N / GE.N / SO.N / D.N / DE.N / LEN.N / ORCL.N / ADSK.OQ / GILD.OQ / ICE.N / FIS.N / CME.OQ / POST.N / NOW.N / SNOW.N / ZG.OQ / DASH.N</td><td class="leftalignment">Air Products and Chemicals Inc / Merck & Co Inc / Becton Dickinson and Co / Colgate-Palmolive Co / Salesforce.Com Inc / General Electric Co / Southern Co / Dominion Energy Inc / Deere & Co / Lennar Corp / Oracle Corp / Autodesk Inc / Gilead Sciences Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / CME Group Inc / Post Holdings Inc / ServiceNow Inc / Snowflake Inc. / Zillow Group Inc / DoorDash Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Agriculture / Biotechnology / Building & Building Materials / Chemicals / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Machinery / Media / Pharmaceuticals / Technology / Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 73 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / EXPR.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / MGNX.OQ / BRX.N / LADR.N / TWOU.OQ / ANTM.N / PFX.N / MFIN.OQ / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Express Inc / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Brixmor Property Group Inc / Ladder Capital Corp / 2U Inc / Anthem Inc / PhenixFIN Corp / Medallion Financial Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Gilead Sciences, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Anguilla / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / KO=US / MCD=US / OXY=US / ADI=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / TXN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / EXPE=US / LEG=US / SEIC=US / KFRC=US / AMK=US / BNL=US / CBRL=US / ENV=US / CTRA=US / CNX=US / DRI=US / EQT=US / EXEL=US / GPOR=US / HZO=US / MCHP=US / REGI=US / SBAC=US / SSNC=US / TRIP=US / WIX=US / CVX=US / PSA=US / SPG=US / CGEN=US / BKNG=US / ADC=US / CUZ=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / MGNI=US / OGN / JRVR=US / BIIB=US / TXRH=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / TIL=US / NOG=US / EPRT=US / JACK=US / RCUS=US / GNRC=US / AR=US / OAS=US / NXPI=US / LPLA=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / ABBV=US / NDLS=US / ANIP=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / BWXT=US / WING=US / MCFT=US / WLTW=US / GXO=US / CDEV=US / CRSP=US / TRVG=US / JELD=US / SBOW=US / IOVA=US / FOCS=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / PNTG=US / OVV=US / ZI=US / VTRS=US / ABNB=US / CELU=US / ROCC=US / REPX=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / SEI Investments Co / Kforce Inc / AssetMark Financial Holdings Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Envestnet Inc / Coterra Energy Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Gulfport Energy Corp / MarineMax Inc / Microchip Technology Inc / Renewable Energy Group Inc / SBA Communications Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Compugen Ltd / Booking Holdings Inc / Agree Realty Corp / Cousins Properties Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Organon & Co / James River Group Holdings Ltd / Biogen Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / Generac Holdings Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / ANI Pharmaceuticals Inc / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / BWX Technologies Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Willis Towers Watson PLC / GXO Logistics Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Focus Financial Partners Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Pennant Group Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Viatris Inc / Airbnb Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">SEC Investigation Updates:  GILD, MFIN, MGPI, MSI, SEIC, TUP, UTL</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ / MFIN.OQ / MGPI.OQ / SEIC.OQ / TUP.N / UTL.N / MSI.N</td><td class="leftalignment">Gilead Sciences Inc / Medallion Financial Corp / MGP Ingredients Inc / SEI Investments Co / Tupperware Brands Corp / Unitil Corp / Motorola Solutions Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Beverages & Tobacco / Biotechnology / Financial Services / Household Products / Telecommunications / Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Gavin</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Gilead dips 2.9% in past quarter; State Treasurer State of Michigan decreases 29.2%</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for GILD</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: UPDATED SITC Planner Highlights 60+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BMY=US / INCY=US / GILD=US / EXEL=US / CGEN=US / TIL=US / RCUS=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Exelixis Inc / Compugen Ltd / Instil Bio Inc / Arcus Biosciences Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Morning Minutes: LC, SIVB, CFR, ENVA, GILD / Corporate Events: see calendar below</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ / ENVA.N / LC.N / SIVB.OQ / 375558103 / 229899109 / 78486Q101 / 29357K103 / 52603A208</td><td class="leftalignment">Gilead Sciences Inc / Enova International Inc / LendingClub Corp / SVB Financial Group / Gilead Sciences Inc / Cullen/Frost Bankers Inc / SVB Financial Group / Enova International Inc / LendingClub Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Maxim Research</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SCM.N / HD.N / LOW.N / NKE.N / VZ.N / BJ.N / KMX.N / AMGN.OQ / AAPL.OQ / ASTE.OQ / DIOD.OQ / CRVL.OQ / REGN.OQ / TRMB.OQ / QDEL.OQ / MNRO.OQ / AMSC.OQ / ORLY.OQ / GILD.OQ / VRTS.OQ / FCEL.OQ / ITRI.OQ / INCY.OQ / NATI.OQ / POOL.OQ / NBIX.OQ / CALM.OQ / EEFT.OQ / AMZN.OQ / MKTW.OQ / EXTR.OQ / UTHR.OQ / BMRN.OQ / PLUG.OQ / CHTR.OQ / MTCH.OQ / EXEL.OQ / MRVL.OQ / ARRY.OQ / SGEN.OQ / OSUR.OQ / VRTX.OQ / NFLX.OQ / CMCSA.OQ / PEB.NZ / ALNY.OQ / MPWR.OQ / LHCG.OQ / ATRC.OQ / SPWR.OQ / IOSP.OQ / ATNI.OQ / BIG.N / EHTH.OQ / CSIQ.OQ / FSLR.OQ / FRPT.OQ / LULU.OQ / AGCO.N / CODI.N / XPO.N / DOX.OQ / SAGE.OQ / WW.OQ / FND.N / FOCS.OQ / A71.F / ZWS.N</td><td class="leftalignment">Stellus Capital Investment Corp / Home Depot Inc / Lowe's Companies Inc / Nike Inc / Verizon Communications Inc / BJ's Wholesale Club Holdings Inc / Carmax Inc / Amgen Inc / Apple Inc / Astec Industries Inc / Diodes Inc / CorVel Corp / Regeneron Pharmaceuticals Inc / Trimble Inc / Quidel Corp / Monro Inc / American Superconductor Corp / O'Reilly Automotive Inc / Gilead Sciences Inc / Virtus Investment Partners Inc / Fuelcell Energy Inc / Itron Inc / Incyte Corp / National Instruments Corp / Pool Corp / Neurocrine Biosciences Inc / Cal-Maine Foods Inc / Euronet Worldwide Inc / Amazon.com Inc / MarketWise Inc / Extreme Networks Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Plug Power Inc / Charter Communications Inc / Match Group Inc / Exelixis Inc / Marvell Technology Inc / Array Technologies Inc / Seagen Inc / OraSure Technologies Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Comcast Corp / Pacific Edge Ltd / Alnylam Pharmaceuticals Inc / Monolithic Power Systems Inc / LHC Group Inc / AtriCure Inc / SunPower Corp / Innospec Inc / ATN International Inc / Big Lots Inc / eHealth Inc / Canadian Solar Inc / First Solar Inc / Freshpet Inc / Lululemon Athletica Inc / AGCO Corp / Compass Diversified Holdings / XPO Logistics Inc / Amdocs Ltd / SAGE Therapeutics Inc / WW International Inc / Floor & Decor Holdings Inc / Focus Financial Partners Inc / Ascendis Pharma A/S / Zurn Water Solutions Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Luxembourg / Netherlands / New Zealand / United States / Guernsey</td><td class="leftalignment">Automotive / Biotechnology / Broadcasting & Cable / Consumer / Financial Services / Healthcare / Info. Tech./Peripheral / Leisure & Entertainment / Machinery / Retailing</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Upgrading to Outperform, $200 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALNY.O / AMGN / EXEL / INCY / NBIX / ASND.O / GILD.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / BIIB / MRNA.O / SRPT.O / 04280A100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Amgen Inc / Exelixis Inc / Incyte Corp / Neurocrine Biosciences Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / Sarepta Therapeutics Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Trevor Allred</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 22</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/31/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">10/30/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Information Content of Earnings Releases 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/30/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Gilead Sciences Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Gilead (GILD: $64.88) loses $8 billion in MCap in October, biggest drop in Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 3Q21 Earnings (ABBV, BAX, GILD, LH, MRK) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ / ABBV.N / LH.N / MRK.N / BAX.N / GILD.O</td><td class="leftalignment">Gilead Sciences Inc / Abbvie Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Baxter International Inc / Gilead Sciences Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACA / CHD / RAD / SONY / WMT / GILD.O / ONEM.O / AKAM / SSNC.O / AVGO.O / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / LHCG.O / MASI.O / ENSG.O / 483548103 / ADUS.O / EVH / CFMS.O / 100063846 / 720795103 / CBOE.K / HEXO / PNTG.O</td><td class="leftalignment">Arcosa Inc / Church & Dwight Co Inc / Rite Aid Corp / Sony Group Corp / Walmart Inc / Gilead Sciences Inc / 1Life Healthcare Inc / Akamai Technologies Inc / SS&C Technologies Holdings Inc / Broadcom Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Masimo Corp / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Conformis Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Cboe Global Markets Inc / Hexo Corp / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Veklury Drives Strong 3Q, Beating Estimates; Core Business Recovering Slower than Expected but Remains Steady</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jason McCarthy, Ph.D. / Mr. Michael Okunewitch</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q21 Review: Investors Wary of Delayed Oncology Trials</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Primer Ahead Of Today's KOL Call On Discounted Pricing Strategies For Anti-PD-(L)1s; What To Know</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY / MRK / CKPT / US3755581036 / US45337C1027 / US75886F1075 / US88322Q1085 / US03969F1093</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Checkpoint Therapeutics Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / TG Therapeutics Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - October 22 to 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">AU000000CIA2 / IL0006290147 / GB0000456144 / US0010841023 / US0079031078 / US0231351067 / US0255371017 / US02553E1064 / US0351282068 / US0394831020 / US0530151036 / US0536111091 / US0584981064 / US1170431092 / US1258961002 / US1270971039 / US1423391002 / US1475281036 / US1924461023 / US2017231034 / US2333311072 / US25179M1036 / US2546871060 / US26875P1012 / US2786421030 / US2788651006 / US3755581036 / US4128221086 / US4180561072 / US4278661081 / US4433201062 / US4581401001 / US4601461035 / US5719032022 / US5745991068 / US5770811025 / US5801351017 / US5949181045 / US6102361010 / US6153691059 / US6516391066 / US6558441084 / US6951561090 / US7310681025 / US7607591002 / US7802871084 / AN8068571086 / US8243481061 / US8270481091 / US8552441094 / US8825081040 / US89531P1057 / US9113121068 / US9139031002 / US9182041080 / US92276F1003 / US94106L1098 / US98389B1008 / US9839191015 / AU000000NCM7 / CA1363751027 / CA1367178326 / CA1249003098 / CA59151K1084 / CA0467894006 / CA0977512007 / CA8029121057 / CA5649051078 / CA8787422044 / CA1247651088 / CA5592224011 / CA7751092007 / CA1469001053 / CA0084741085 / CA9528451052 / CA1363851017 / CA15101Q1081 / CA2208741017 / CA8959451037 / IL0010824113 / KR7005930003 / US1667641005 / US9129091081 / US9884981013 / CA3359341052 / US20825C1045 / US2283681060 / AU000000FMG4 / US14040H1059 / US0258161092 / US0605051046 / US49446R1095 / BMG169621056 / CA2265331074 / CA98462Y1007 / US02043Q1076 / US0736851090 / US8826811098 / CA5503721063 / US15135B1017 / US7818462092 / US1508701034 / US74144T1088 / CA8935781044 / US12008R1077 / US44107P1049 / US12541W2098 / US7376301039 / CA0906971035 / CA4495861060 / US57636Q1040 / CA1375761048 / US02208R1068 / GB00B1FW5029 / US9814191048 / CA29258Y1034 / CA6179141065 / CA14068G1046 / BMG491BT1088 / US02913V1035 / US89785X1019 / CA3518581051 / US3886891015 / US2120151012 / US92826C8394 / GB00B2QPKJ12 / US38526M1062 / CA1254911003 / US91912E1055 / US1921085049 / CA6252841045 / CA22576C1014 / CA8672241079 / CA15135U1093 / US2566771059 / US1255818015 / CA14042M1023 / US72147K1088 / NL0009434992 / CA07317Q1054 / CA00208D4084 / CA0985461049 / US40412C1018 / CA00829Q1019 / US30303M1027 / US00287Y1091 / CA0194561027 / US81762P1021 / JE00B5TT1872 / CA55903Q1046 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA0213611001 / CA33564P1036 / CA6752221037 / CA04016A1012 / CA11777Q2099 / US70509V1008 / CA04682R1073 / US16208T1025 / US1630861011 / US34964C1062 / US29355A1079 / US23283R1005 / CA05577W2004 / US65540B1052 / US71943U1043 / US1220171060 / US03674X1063 / US90184L1026 / US1630921096 / CA14150G4007 / US02005N1000 / US80283M1018 / US63938C1080 / CA7397211086 / US65341B1061 / IE00BQPVQZ61 / US2383371091 / BMG0750C1082 / CA76131D1033 / US9840171030 / CA1946931070 / US4278255009 / US5007541064 / CA0115321089 / GB00BWFY5505 / US95040Q1040 / US02079K3059 / US0130911037 / CY0106002112 / GB00BYT5JK65 / GB00BZ09BD16 / US78409V1044 / US45688C1071 / CA94106B1013 / US2057683029 / US15136A1025 / US7005171050 / US43300A2033 / US75134P3038 / US7045511000 / CA9628791027 / US00737L1035 / US12653C1080 / US00191U1025 / CA6568111067 / US2997341035 / US03843E1047 / US08579X1019 / IE00BZ12WP82 / CA13000C2058 / US03990B1017 / CA2849025093 / VGG1890L1076 / AU0000018236 / US35137L1052 / GB00BJT16S69 / CA33767E2024 / US86745K1043 / US2681501092 / CA29446Y5020 / US03768E1055 / US92556H2067 / FR0013467479 / US67098H1041 / US14316J1088 / US03940R1077 / US05478C1053 / US13123X5086 / US35953D1046 / CA89055A2039 / US0412421085 / US1651677353 / US03743Q1085 / US4212981009 / CA5362211040 / CA00791P1071 / CA64016L1013 / CA24874B1085 / GB00BL6K5J42 / US0708301041 / US83303Y1055 / US89269P1030 / LU2369833749 / US5626621065 / US9778521024</td><td class="leftalignment">Champion Iron Ltd / Teva Pharmaceutical Industries Ltd / Antofagasta PLC / AGCO Corp / Advanced Micro Devices Inc / Amazon.com Inc / American Electric Power Company Inc / American Eagle Outfitters Inc / AngloGold Ashanti Ltd / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Avery Dennison Corp / Ball Corp / Brunswick Corp / CMS Energy Corp / Coterra Energy Inc / Carlisle Companies Inc / Caseys General Stores Inc / Cognizant Technology Solutions Corp / Commercial Metals Co / DTE Energy Co / Devon Energy Corp / Walt Disney Co / EOG Resources Inc / eBay Inc / Ecolab Inc / Gilead Sciences Inc / Harley-Davidson Inc / Hasbro Inc / Hershey Co / Hub Group Inc / Intel Corp / International Paper Co / Marriott International Inc / Masco Corp / Mattel Inc / McDonald's Corp / Microsoft Corp / Monro Inc / Moody's Corp / Newmont Corporation / Norfolk Southern Corp / Packaging Corp of America / Polaris Inc / Republic Services Inc / Royal Gold Inc / Schlumberger NV / Sherwin-Williams Co / Silgan Holdings Inc / Starbucks Corp / Texas Instruments Inc / Trex Company Inc / United Parcel Service Inc / Universal Health Services Inc / VF Corp / Ventas Inc / Waste Management Inc / Xcel Energy Inc / Xilinx Inc / Newcrest Mining Ltd / Canadian National Railway Co / Canadian Utilities Ltd / CCL Industries Inc / Methanex Corp / Atco Ltd / Bombardier Inc / Saputo Inc / Maple Leaf Foods Inc / Teck Resources Ltd / CAE Inc / Magna International Inc / Rogers Communications Inc / Cascades Inc / Agnico Eagle Mines Ltd / West Fraser Timber Co Ltd / Canadian Natural Resources Ltd / Celestica Inc / Corus Entertainment Inc / Trican Well Service Ltd / Check Point Software Technologies Ltd / Samsung Electronics Co Ltd / Chevron Corp / United States Steel Corp / Yum! Brands Inc / First Quantum Minerals Ltd / Conocophillips / Crown Holdings Inc / Fortescue Metals Group Ltd / Capital One Financial Corp / American Express Co / Bank of America Corp / Kimco Realty Corp / Bunge Ltd / Crew Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Lundin Mining Corp / Centene Corp / Rush Enterprises Inc / Celanese Corp / T Rowe Price Group Inc / Transcontinental Inc / Builders FirstSource Inc / Host Hotels & Resorts Inc / CH Robinson Worldwide Inc / Potlatchdeltic Corp / Birchcliff Energy Ltd / IGM Financial Inc / Mastercard Inc / Canfor Corp / Altra Industrial Motion Corp / Hochschild Mining PLC / World Acceptance Corp / Endeavour Silver Corp / Morguard Real Estate Investment Trust / Capstone Mining Corp / Invesco Ltd / American Public Education Inc / TrueBlue Inc / Franco-Nevada Corp / Graphic Packaging Holding Co / Continental Resources Inc / Visa Inc / Fresnillo PLC / Grand Canyon Education Inc / CI Financial Corp / Vale SA / Coeur Mining Inc / Mullen Group Ltd / Crescent Point Energy Corp / Suncor Energy Inc / Cenovus Energy Inc / Dollar General Corp / First-Citizens Bank & Trust Co / Capital Power Corp / Pilgrims Pride Corp / LyondellBasell Industries NV / Baytex Energy Corp / ARC Resources Ltd / Bonterra Energy Corp / HCA Healthcare Inc / Africa Oil Corp / Meta Platforms Inc / Abbvie Inc / Allied Properties Real Estate Investment Trust / ServiceNow Inc / Centamin PLC / MAG Silver Corp / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / AltaGas Ltd / First National Financial Corp / OceanaGold Corp / Argonaut Gold Inc / B2Gold Corp / Pebblebrook Hotel Trust / Athabasca Oil Corp / Chatham Lodging Trust / Chefs' Warehouse Inc / Fortune Brands Home & Security Inc / Enphase Energy Inc / CyrusOne Inc / BRP Inc / Noodles & Co / Physicians Realty Trust / Burlington Stores Inc / Antero Resources Corp / Twitter Inc / Chegg Inc / Cardinal Energy Ltd (Alberta) / Ally Financial Inc / Santander Consumer USA Holdings Inc / Navient Corp / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Horizon Therapeutics PLC / Dave & Buster's Entertainment Inc / Axalta Coating Systems Ltd / Restaurant Brands International Inc / Xenia Hotels & Resorts Inc / Colliers International Group Inc / Hersha Hospitality Trust / Kraft Heinz Co / Alamos Gold Inc / Nielsen Holdings PLC / Welltower Inc / Alphabet Inc / Albertsons Companies Inc / Atalaya Mining PLC / Mimecast Ltd / Atlassian Corporation PLC / S&P Global Inc / Ingevity Corp / Waste Connections Inc / Comstock Resources Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Ramaco Resources Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Adtalem Global Education Inc / CNX Resources Corp / ASGN Inc / North American Construction Group Ltd / Evelo Biosciences Inc / Aquestive Therapeutics Inc / Berry Corporation (Bry) / Linde PLC / Calibre Mining Corp / Ares Management Corp / Eldorado Gold Corp / Capri Holdings Ltd / Nickel Mines Ltd / Fox Corp / Tronox Holdings PLC / FirstService Corp / Sunnova Energy International Inc / Dynatrace Inc / Equinox Gold Corp / Apollo Global Management Inc / ViacomCBS Inc / Constellium SE / O-I Glass Inc / Carlyle Group Inc / Arch Resources Inc / Azek Company Inc / Callon Petroleum Co / Fubotv Inc / Topaz Energy Corp / Arko Corp. / Chesapeake Energy Corp / APA Corp (US) / Hayward Holdings Inc / Lion Electric Co / Advantage Energy Ltd / Neighbourly Pharmacy Inc / dentalcorp Holdings Ltd / Endeavour Mining PLC / Bath & Body Works Inc / Snap One Holdings Corp / Traeger Inc / Ardagh Metal Packaging SA / Mandiant Inc / Wolfspeed Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Ireland / Israel / Korea, Republic of / Luxembourg / Netherlands / United States / Virgin Islands, British / South Africa / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000120271 / NL0000226223 / FR0000054470 / US00971T1016 / US0231351067 / US0378331005 / US0718131099 / US1442851036 / US1925761066 / US23918K1088 / US2435371073 / US3755581036 / US4433201062 / US5949181045 / US6668071029 / US7274931085 / US7392761034 / US8552441094 / US8610121027 / US8636671013 / US9029251066 / US9507551086 / US9581021055 / NL0000200384 / US89151E1091 / US20030N1019 / US02209S1033 / US02043Q1076 / US6098391054 / GB00B03MLX29 / RDSa.AS / US2090341072 / US82706C1080 / US48242W1062 / US2521311074 / US7181721090 / US78454L1008 / US92839U2069 / US03027X1000 / US30303M1027 / US96208T1043 / US69318G1067 / US00404A1097 / US23283R1005 / US69366J2006 / US8485771021 / US98936J1016 / US04523Y1055 / NL0010832176 / US02079K1079 / GB00BZ09BD16 / CA87241L1094 / US80689H1023 / US04016X1019 / US5011471027 / US53115L1044 / US05351X1019 / US68373M1071 / US05352A1007 / US85205L1070 / US92537N1081 / US15872M1045 / US65487U1088 / US20451W1018 / US69353Y1038 / US00857U1079 / US44891N2080 / US02290A1025 / 50066V107 / US93403J1060 / US44486Q1031</td><td class="leftalignment">TotalEnergies SE / STMicroelectronics NV / Ubisoft Entertainment SA / Akamai Technologies Inc / Amazon.com Inc / Apple Inc / Baxter International Inc / Carpenter Technology Corp / Cohu Inc / DaVita Inc / Deckers Outdoor Corp / Gilead Sciences Inc / Hub Group Inc / Microsoft Corp / Northrop Grumman Corp / Plantronics Inc / Power Integrations Inc / Starbucks Corp / STMicroelectronics NV / Stryker Corp / USA Truck Inc / Werner Enterprises Inc / Western Digital Corp / Core Laboratories NV / TotalEnergies SE / Comcast Corp / Altria Group Inc / Alnylam Pharmaceuticals Inc / Monolithic Power Systems Inc / Royal Dutch Shell PLC / Royal Dutch Shell PLC / Consolidated Communications Holdings Inc / Silicon Motion Technology Corp / KBR Inc / Dexcom Inc / Philip Morris International Inc / SM Energy Co / Visteon Corp / American Tower Corp / Meta Platforms Inc / WEX Inc / PBF Energy Inc / Acadia Healthcare Company Inc / CyrusOne Inc / PTC Therapeutics Inc / Spirit Airlines Inc / Zendesk Inc / Aspen Aerogels Inc / argenx SE / Alphabet Inc / Atlassian Corporation PLC / TFI International Inc / Schneider National Inc / argenx SE / Krystal Biotech Inc / Liberty Oilfield Services Inc / Avaya Holdings Corp / Opera Ltd / Avantor Inc / SpringWorks Therapeutics Inc / Vertiv Holdings Co / ChampionX Corp / Nkarta Inc / Compass Pathways PLC / PMV Pharmaceuticals Inc / agilon health Inc / IAC/Interactivecorp / Ambrx Biopharma Inc / KORE Group Holdings Inc / Warby Parker Inc / Humacyte Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / CACI=US / LLY=US / PFE=US / ADI=US / AMD=US / IP=US / AGL=US / AMZN=US / INCY=US / TXN=US / GILD=US / AMT=US / PEB=US / BC=US / MPWR=US / CONE=US / V=US / NOVA=US / CHKP=US / IART=US / XLNX=US / TRMK=US / TNL=US / CMCSA=US / CI=US / W=US / WTFC=US / APH=US / AVT=US / CNX=US / CPRT=US / DVA=US / EQT=US / EXPO=US / FCN=US / AJG=US / LH=US / TREE=US / MHK=US / TEAM=US / NTST=US / ASGN=US / REGN=US / SLGN=US / VSEC=US / WEX=US / FOUR=US / CFR=US / CPT=US / OFC=US / CUZ=US / MAA=US / WRE=US / AMSF=US / VICI=US / ACVA=US / MD=US / MOH=US / FLT=US / TPX=US / KAR=US / TXRH=US / BAH=US / MPW=US / KBR=US / MA=US / SAIA=US / PAG=US / TEL=US / TAST=US / EIG=US / PRPL=US / EHC=US / IAA=US / WH=US / RCUS=US / KNSL=US / AR=US / NXPI=US / NLSN=US / LKQ=US / PTCT=US / 00770K202 / CMPR=US / GDDY=US / ETSY=US / SPNE=US / ARGX=US / NVCR=US / WLTW=US / KDP=US / FTDR=US / EB=US / ARQT=US / AIRC=US / HYFM=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Advanced Micro Devices Inc / International Paper Co / agilon health Inc / Amazon.com Inc / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / Monolithic Power Systems Inc / CyrusOne Inc / Visa Inc / Sunnova Energy International Inc / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Xilinx Inc / Trustmark Corp / Travel + Leisure Co / Comcast Corp / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Amphenol Corp / Avnet Inc / CNX Resources Corp / Copart Inc / DaVita Inc / EQT Corp / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Laboratory Corporation of America Holdings / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ASGN Inc / Regeneron Pharmaceuticals Inc / Silgan Holdings Inc / VSE Corp / WEX Inc / Shift4 Payments Inc / Cullen/Frost Bankers Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Mid-America Apartment Communities Inc / Washington Real Estate Investment Trust / Amerisafe Inc / VICI Properties Inc / ACV Auctions Inc / MEDNAX Inc / Molina Healthcare Inc / Fleetcor Technologies Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Texas Roadhouse Inc / Booz Allen Hamilton Holding Corp / Medical Properties Trust Inc / KBR Inc / Mastercard Inc / Saia Inc / Penske Automotive Group Inc / TE Connectivity Ltd / Carrols Restaurant Group Inc / Employers Holdings Inc / Purple Innovation Inc / Encompass Health Corp / IAA Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Antero Resources Corp / NXP Semiconductors NV / Nielsen Holdings PLC / LKQ Corp / PTC Therapeutics Inc / Aemetis Inc / Cimpress PLC / GoDaddy Inc / ETSY Inc / SeaSpine Holdings Corp / argenx SE / Novocure Ltd / Willis Towers Watson PLC / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arcutis Biotherapeutics Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">134</td><td class="leftalignment">AU000000CIA2 / US0010841023 / US0231351067 / US0255371017 / US0584981064 / US1258961002 / US2788651006 / US3755581036 / US4278661081 / US4433201062 / US6516391066 / US7802871084 / US8552441094 / US98389B1008 / CA1367178326 / CA1249003098 / CA59151K1084 / CA0467894006 / CA0977512007 / CA8029121057 / CA4609191032 / CA97535P1045 / CA1247651088 / CA0679011084 / CA9528451052 / IL0010824113 / US9129091081 / US9884981013 / US2283681060 / CA2265331074 / CA98462Y1007 / US02043Q1076 / US8826811098 / US74144T1088 / CA8935781044 / CA1375761048 / CA6179141065 / US38526M1062 / US91912E1055 / CA22576C1014 / CA8672241079 / US72147K1088 / JE00B4T3BW64 / CA96467A2002 / CA0213611001 / CA6752221037 / US23283R1005 / US02005N1000 / US80283M1018 / US63938C1080 / CA0115321089 / GB00BWFY5505 / GB00BYT5JK65 / GB00BZ09BD16 / CA94106B1013 / US7045511000 / CA9628791027 / US2997341035 / US48251W1045 / IE00BZ12WP82 / AU0000018236 / GB00BJT16S69 / US86745K1043 / US03768E1055 / US14316J1088 / CA00791P1071 / LU2369833749</td><td class="leftalignment">Champion Iron Ltd / AGCO Corp / Amazon.com Inc / American Electric Power Company Inc / Ball Corp / CMS Energy Corp / Ecolab Inc / Gilead Sciences Inc / Hershey Co / Hub Group Inc / Newmont Corporation / Royal Gold Inc / Starbucks Corp / Xcel Energy Inc / Canadian Utilities Ltd / CCL Industries Inc / Methanex Corp / Atco Ltd / Bombardier Inc / Saputo Inc / Intertape Polymer Group Inc / Winpak Ltd / CAE Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Check Point Software Technologies Ltd / United States Steel Corp / Yum! Brands Inc / Crown Holdings Inc / Crew Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Texas Roadhouse Inc / T Rowe Price Group Inc / Transcontinental Inc / Canfor Corp / Morguard Real Estate Investment Trust / Grand Canyon Education Inc / Vale SA / Crescent Point Energy Corp / Suncor Energy Inc / Pilgrims Pride Corp / Glencore PLC / Whitecap Resources Inc / AltaGas Ltd / OceanaGold Corp / CyrusOne Inc / Ally Financial Inc / Santander Consumer USA Holdings Inc / Navient Corp / Alamos Gold Inc / Nielsen Holdings PLC / Mimecast Ltd / Atlassian Corporation PLC / Waste Connections Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Evelo Biosciences Inc / KKR & Co Inc / Linde PLC / Nickel Mines Ltd / Tronox Holdings PLC / Sunnova Energy International Inc / Apollo Global Management Inc / Carlyle Group Inc / Advantage Energy Ltd / Ardagh Metal Packaging SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / United Kingdom / Ireland / Israel / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US3755581036 / US02043Q1076 / US92857F1075 / CA05156V1022 / US65343C1027 / IMNM</td><td class="leftalignment">Gilead Sciences Inc / Alnylam Pharmaceuticals Inc / Vocera Communications Inc / Aurinia Pharmaceuticals Inc / NextGen Healthcare Inc / Immunome Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Windfall from Veklury Boosts 3Q21; Core Antivirals Soft but Recovering, PT $75</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">37555810</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AFL.N / AIR.N / BA.N / ECL.N / FLS.N / MO.N / VC.N / AVB.N / AMZN.O / GILD.O / CMCSA.O / CHKP.O / RBA.N / HBAN.O / SU.TO / CLX.N / YUM.N / MRO.N / EMR.N / HSY.N / RMD.N / SIRI.O / VLY.N / SBUX.O / CYH.N / AMP.N / CINF.O / DVA.N / RRC.N / RSG.N / BC.N / MAA.N / AJG.N / PTEN.O / FTT.TO / MCO.N / SSNC.O / CPE.N / CFR.N / MEOH.O / WCN.N / CHE.N / VSEC.OQ / ADS.N / SGEN.OQ / SIGI.O / WSBC.O / COLB.O / ACGL.O / BIIB.O / TIH.TO / NVT.N / TXRH.O / ALNY.O / ARWR.O / TDG.N / ISBC.O / MA.N / HOG.N / MERC.O / AUY.N / KTOS.OQ / ENSG.O / SWI.N / AAV.TO / EGO.N / NLSN.N / ACHC.O / VCRA.N / PTCT.O / 922475108 / ARES.N / CFG.N / SHOP.N / FTV.N / KNSL.OQ / INVH.N / GRPG.I / ORSTED.CO / NEXA.TO / KDP.N / OAS.OQ / TFII.N / CARR.N / APA.OQ</td><td class="leftalignment">Aflac Inc / AAR Corp / Boeing Co / Ecolab Inc / Flowserve Corp / Altria Group Inc / Visteon Corp / Avalonbay Communities Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Check Point Software Technologies Ltd / Ritchie Bros Auctioneers Inc / Huntington Bancshares Inc / Suncor Energy Inc / Clorox Co / Yum! Brands Inc / Marathon Oil Corp / Emerson Electric Co / Hershey Co / Resmed Inc / Sirius XM Holdings Inc / Valley National Bancorp / Starbucks Corp / Community Health Systems Inc / Ameriprise Financial Inc / Cincinnati Financial Corp / DaVita Inc / Range Resources Corp / Republic Services Inc / Brunswick Corp / Mid-America Apartment Communities Inc / Arthur J Gallagher & Co / Patterson-UTI Energy Inc / Finning International Inc / Moody's Corp / SS&C Technologies Holdings Inc / Callon Petroleum Co / Cullen/Frost Bankers Inc / Methanex Corp / Waste Connections Inc / Chemed Corp / VSE Corp / Alliance Data Systems Corp / Seagen Inc / Selective Insurance Group Inc / WesBanco Inc / Columbia Banking System Inc / Arch Capital Group Ltd / Biogen Inc / Toromont Industries Ltd / nVent Electric PLC / Texas Roadhouse Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / TransDigm Group Inc / Investors Bancorp Inc / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Kratos Defense and Security Solutions Inc / Ensign Group Inc / SolarWinds Corp / Advantage Energy Ltd / Eldorado Gold Corp / Nielsen Holdings PLC / Acadia Healthcare Company Inc / Vocera Communications Inc / PTC Therapeutics Inc / Veeva Systems Inc / Ares Management Corp / Citizens Financial Group Inc / Shopify Inc / Fortive Corp / Kinsale Capital Group Inc / Invitation Homes Inc / Greencoat Renewables PLC / Orsted A/S / Nexa Resources SA / Keurig Dr Pepper Inc / Oasis Petroleum Inc / TFI International Inc / Carrier Global Corp / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q21 Take: We expect base business recovery in the near term; key pipeline catalysts are now shifted to 1Q22</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : 3Q Snapshot - Slight TROPiCS Delay Overshadows Big Veklury-Driven Beat</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">GILD - GILD 3Q21 Postview: A big Veklury beat (yawn); Biktarvy doing well; pipeline slips a bit; trims base business</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">3Q21: Veklury Crushes It, But Leaves Us Wanting More From Core Business</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">3Q21: Veklury Provides a Beat as Key Pipeline Updates Delayed</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">my take on delay in Trodelvy Ph 3 HR+ breast trial</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt color on TROPiCS-02: well-powered trial, not about events but getting in scans</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Veklury Leads To Sizable Q3 Beat & Raise; Focus Remains On Arcus/TROPiCS/Magro</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : First Look at 3Q Results - Big Veklury Beat Drives Q...TROPiCS-02 Pushed to 1Q22</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">We spoke with GILD mgmt: more color on RCUS opt-in decision this year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.OQ / RCUS=US / GILD=US</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">3Q21 highlights: mgmt color on RCUS opt-in decision this year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NNVC-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NNVC.K / BMY / MRK / GILD.O / NBY / GSK / BCRX.O / NVAX.O / CMRX.O</td><td class="leftalignment">NanoViricides Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Gilead Sciences Inc / NovaBay Pharmaceuticals Inc / GlaxoSmithKline PLC / BioCryst Pharmaceuticals Inc / Novavax Inc / Chimerix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BCLI-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BCLI.O / GILD.O / AGEN.O / SGEN.O / BIIB.O / CYTK.O / IDRA.O / BIEI.PK</td><td class="leftalignment">Brainstorm Cell Therapeutics Inc / Gilead Sciences Inc / Agenus Inc / Seagen Inc / Biogen Inc / Cytokinetics Inc / Idera Pharmaceuticals Inc / Premier Biomedical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">3Q21 First Take: Veklury Dominates, Overshadowing Mixed Base Biz; Key Onc Readouts Slip To 1Q</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Brief of Gilead Sciences Inc conference call, Oct. 28, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Oct. 28, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on October 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">SBUX.OQ / BAX.N / BP.L / CMS.N / EMN.N / HIG.N / IBM.N / MO.N / MRK.N / NEM.N / NOC.N / SLB.N / SWK.N / TAP.N / TXT.N / HAL.N / TFX.N / FE.N / CAT.N / YUM.N / SYK.N / LH.N / ITW.N / XOM.N / HSY.N / AMT.N / RMD.N / LIN.N / WST.N / DVA.N / RSG.N / AJG.N / MCO.N / MHK.N / AOS.N / ABMD.OQ / AAPL.OQ / HBAN.OQ / MSFT.OQ / TROW.OQ / GILD.OQ / AMZN.OQ / VRSN.OQ / CMCSA.OQ / 0700.HK / MPWR.OQ / DXCM.OQ / RDSa.L / ICE.N / MA.N / 9999.HK / BIO.N / NLSN.N / BKR.N / LKQ.OQ / WDC.OQ / FTV.N / XEL.OQ / CBRE.N / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / CARR.N / 9618.HK / AEP.OQ / ABNB.OQ / WTY.F</td><td class="leftalignment">Starbucks Corp / Baxter International Inc / BP PLC / CMS Energy Corp / Eastman Chemical Co / Hartford Financial Services Group Inc / International Business Machines Corp / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Northrop Grumman Corp / Schlumberger NV / Stanley Black & Decker Inc / Molson Coors Beverage Co / Textron Inc / Halliburton Co / Teleflex Inc / FirstEnergy Corp / Caterpillar Inc / Yum! Brands Inc / Stryker Corp / Laboratory Corporation of America Holdings / Illinois Tool Works Inc / Exxon Mobil Corp / Hershey Co / American Tower Corp / Resmed Inc / Linde PLC / West Pharmaceutical Services Inc / DaVita Inc / Republic Services Inc / Arthur J Gallagher & Co / Moody's Corp / Mohawk Industries Inc / A O Smith Corp / ABIOMED Inc / Apple Inc / Huntington Bancshares Inc / Microsoft Corp / T Rowe Price Group Inc / Gilead Sciences Inc / Amazon.com Inc / Verisign Inc / Comcast Corp / Tencent Holdings Ltd / Monolithic Power Systems Inc / Dexcom Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / Mastercard Inc / NetEase Inc / Bio Rad Laboratories Inc / Nielsen Holdings PLC / Baker Hughes Co / LKQ Corp / Western Digital Corp / Fortive Corp / Xcel Energy Inc / CBRE Group Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / Carrier Global Corp / JD.Com Inc / American Electric Power Company Inc / Airbnb Inc / Willis Towers Watson PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAP.N / AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / KO.N / MCK.N / MO.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / AON.N / ES.N / MRNA.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - I-Mab Biopharma: New report: Global innovation with differentiated product portfolio to drive upside. Initiating Coverage with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IMAB.OQ / PFIZ.NS / GILD.OQ / ABBV.N</td><td class="leftalignment">I-Mab / Pfizer Ltd / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / India / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IMAB: I-Mab Biopharma - Global innovation with differentiated product portfolio to drive upside</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">IMAB.OQ / 4502.T / BMY.N / LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / GILD.OQ / 000661.SZ / 095700.KQ / 300009.SZ / ABBV.N / TGTX.OQ / MGNX.OQ / BGNE.OQ / CRVS.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / ALXO.OQ</td><td class="leftalignment">I-Mab / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Changchun High & New Technology Industries Group Inc / Genexine Inc / Anhui Anke Biotechnology Group Co Ltd / Abbvie Inc / TG Therapeutics Inc / MacroGenics Inc / Beigene Ltd / Corvus Pharmaceuticals Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for GILD</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">GILD - Embedded Expectations Analysis - 2021 10 27</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AIN / LLY=US / PFE=US / TWTR=US / AMD=US / RRC=US / EFX=US / BXP=US / TXN=US / GILD=US / GPK=US / APA=US / MPWR=US / TRU=US / V=US / DIOD=US / XLNX=US / BRO=US / BYD=US / MAR=US / SPOT=US / ADS=US / TTWO=US / ATVI=US / ESS=US / MANH=US / AKR=US / EQR=US / AIR=US / ARCC=US / ATRO=US / CSGP=US / DCO=US / ABG=US / HAS=US / HEI=US / HXL=US / MAIN=US / HZO=US / MRCY=US / MCHP=US / ORCC=US / OI=US / PII=US / ST=US / SGMO=US / STRA=US / TGI=US / VSEC=US / BXS=US / HIW=US / PYPL=US / CNC=US / BDN=US / EGP=US / SPR=US / UDR=US / CATY=US / ECPG=US / PRAA=US / JRVR=US / BIIB=US / AINV=US / DLR=US / XM=US / SCPL=US / TDG=US / HST=US / MA=US / AWI=US / CADE=US / CLR=US / PNNT=US / KTOS=US / NMTR=US / APEI=US / RCUS=US / AAN=US / 45665G303 / OAS=US / NXPI=US / RLJ=US / FBHS=US / ZNGA=US / EA=US / MTDR=US / ENPH=US / MEIP=US / SSTK=US / IBTX=US / CEQP=US / GOOGL=US / TSLX=US / 70806A106 / AFMD=US / ON=US / AJRD=US / GSBD=US / BWXT=US / SQ=US / TENB=US / FSK=US / LHX=US / HYFM=US / RBLX=US / SSBK=US / PKG=U / ROIV=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Twitter Inc / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Boston Properties Inc / Texas Instruments Inc / Gilead Sciences Inc / Graphic Packaging Holding Co / APA Corp (US) / Monolithic Power Systems Inc / TransUnion / Visa Inc / Diodes Inc / Xilinx Inc / Brown & Brown Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Activision Blizzard Inc / Essex Property Trust Inc / Manhattan Associates Inc / Acadia Realty Trust / Equity Residential / AAR Corp / Ares Capital Corp / Astronics Corp / CoStar Group Inc / Ducommun Inc / Asbury Automotive Group Inc / Hasbro Inc / HEICO Corp / Hexcel Corp / Main Street Capital Corp / MarineMax Inc / Mercury Systems Inc / Microchip Technology Inc / Owl Rock Capital Corp / O-I Glass Inc / Polaris Inc / Sensata Technologies Holding PLC / Sangamo Therapeutics Inc / Strategic Education Inc / Triumph Group Inc / VSE Corp / Cadence Bank / Highwoods Properties Inc / PayPal Holdings Inc / Centene Corp / Brandywine Realty Trust / Eastgroup Properties Inc / Spirit AeroSystems Holdings Inc / UDR Inc / Cathay General Bancorp / Encore Capital Group Inc / PRA Group Inc / James River Group Holdings Ltd / Biogen Inc / Apollo Investment Corp / Digital Realty Trust Inc / Qualtrics International Inc / Sciplay Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Armstrong World Industries Inc / Cadence Bank / Continental Resources Inc / Pennantpark Investment Corp / Kratos Defense and Security Solutions Inc / 9 Meters Biopharma Inc / American Public Education Inc / Arcus Biosciences Inc / Aaron's Company Inc / Infinity Pharmaceuticals Inc / Oasis Petroleum Inc / NXP Semiconductors NV / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Matador Resources Co / Enphase Energy Inc / MEI Pharma Inc / Shutterstock Inc / Independent Bank Group Inc / Crestwood Equity Partners LP / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Affimed NV / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / BWX Technologies Inc / Block Inc / Tenable Holdings Inc / FS KKR Capital Corp / L3harris Technologies Inc / Hydrofarm Holdings Group Inc / Roblox Corp / Southern States Bancshares Inc / Packaging Corp of America / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BEN.AX / BMY.N / BSX.N / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / F.N / GM.N / KO.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JKHY.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Jack Henry & Associates Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / France / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended October 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended September 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / SHW.N / GWW.N / JCI.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / PYPL.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / W W Grainger Inc / Johnson Controls International PLC / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended October 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Positive Islatravir PIII Results Bode Well For Potential Long-Acting Combos</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036 / US58933Y1055</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">6758.T / A.N / IBM.N / JPM.N / WMT.N / URI.N / LOW.N / NKE.N / VZ.N / INTC.OQ / AAPL.OQ / FISV.OQ / JKHY.OQ / LRCX.OQ / LIFE.OQ / SIVB.OQ / TRMB.OQ / AMSC.OQ / GILD.OQ / XRAY.OQ / FCEL.OQ / ITRI.OQ / INCY.OQ / DLTR.OQ / O.N / ANSS.OQ / AMZN.OQ / CHRW.OQ / CSGP.OQ / NVDA.OQ / PLUG.OQ / EXPE.OQ / ISRG.OQ / MRVL.OQ / ARRY.OQ / ALGN.OQ / NFLX.OQ / TXN.OQ / ALNY.OQ / DPZ.N / DXCM.OQ / SPWR.OQ / CSIQ.OQ / FSLR.OQ / IPGP.OQ / AIMC.OQ / LULU.OQ / AGCO.N / AVGO.OQ / QSR.TO / ADI.OQ / GOOGL.OQ / PYPL.OQ / WPRT.TO / OGI.TO</td><td class="leftalignment">Sony Group Corp / Agilent Technologies Inc / International Business Machines Corp / JPMorgan Chase & Co / Walmart Inc / United Rentals Inc / Lowe's Companies Inc / Nike Inc / Verizon Communications Inc / Intel Corp / Apple Inc / Fiserv Inc / Jack Henry & Associates Inc / Lam Research Corp / aTyr Pharma Inc / SVB Financial Group / Trimble Inc / American Superconductor Corp / Gilead Sciences Inc / DENTSPLY SIRONA Inc / Fuelcell Energy Inc / Itron Inc / Incyte Corp / Dollar Tree Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / CH Robinson Worldwide Inc / CoStar Group Inc / NVIDIA Corp / Plug Power Inc / Expedia Group Inc / Intuitive Surgical Inc / Marvell Technology Inc / Array Technologies Inc / Align Technology Inc / Netflix Inc / Texas Instruments Inc / Alnylam Pharmaceuticals Inc / Domino's Pizza Inc / Dexcom Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / IPG Photonics Corp / Altra Industrial Motion Corp / Lululemon Athletica Inc / AGCO Corp / Broadcom Inc / Restaurant Brands International Inc / Analog Devices Inc / Alphabet Inc / PayPal Holdings Inc / Westport Fuel Systems Inc / OrganiGram Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / Israel / Japan / Nigeria / Netherlands / United States</td><td class="leftalignment">Agriculture / Biotechnology / Healthcare / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Machinery / Pharmaceuticals / Semiconductors / Technology / Transportation / Internet</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Gilead Sciences, Inc. in Global Virology Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Zeus Capital</td><td class="leftalignment">Guild Esports (GILD LN)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GB00BMWVF760</td><td class="leftalignment">Guild Esports PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bob H. Liao</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NEM.N / NSC.N / PFE.N / PNW.N / SO.N / TEL.PS / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / MTD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / APH.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / CHD.N / TWTR.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / ORLY.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / SWKS.O / CMCSA.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / MSCI.N / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / PLDT Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Mettler-Toledo International Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Twitter Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Skyworks Solutions Inc / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">The Tendency to Chase Returns in Q4</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">A.N / IBM.N / JPM.N / WMT.N / URI.N / LOW.N / NKE.N / VZ.N / INTC.OQ / AAPL.OQ / LRCX.OQ / LIFE.OQ / SIVB.OQ / GILD.OQ / XRAY.OQ / INCY.OQ / DLTR.OQ / O.N / ANSS.OQ / AMZN.OQ / CHRW.OQ / CSGP.OQ / NVDA.OQ / EXPE.OQ / ISRG.OQ / ALGN.OQ / NFLX.OQ / ALNY.OQ / DPZ.N / DXCM.OQ / IPGP.OQ / LULU.OQ / PRXM.PK / AVGO.OQ / GLAXOSM.LG / TSLA.OQ / NXPI.OQ / QSR.TO / CG.OQ / FB.OQ / GOOGL.OQ / ETSY.OQ / WKHS.OQ / CRWD.OQ / 9961.HK</td><td class="leftalignment">Agilent Technologies Inc / International Business Machines Corp / JPMorgan Chase & Co / Walmart Inc / United Rentals Inc / Lowe's Companies Inc / Nike Inc / Verizon Communications Inc / Intel Corp / Apple Inc / Lam Research Corp / aTyr Pharma Inc / SVB Financial Group / Gilead Sciences Inc / DENTSPLY SIRONA Inc / Incyte Corp / Dollar Tree Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / CH Robinson Worldwide Inc / CoStar Group Inc / NVIDIA Corp / Expedia Group Inc / Intuitive Surgical Inc / Align Technology Inc / Netflix Inc / Alnylam Pharmaceuticals Inc / Domino's Pizza Inc / Dexcom Inc / IPG Photonics Corp / Lululemon Athletica Inc / Proxim Wireless Corp / Broadcom Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / NXP Semiconductors NV / Restaurant Brands International Inc / Carlyle Group Inc / Meta Platforms Inc / Alphabet Inc / ETSY Inc / Workhorse Group Inc / CrowdStrike Holdings Inc / Trip.com Group Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / Nigeria / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Utilities / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 3Q Earnings Season: What's on Tap for the Week Ahead</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ALKS.O / BMRN.O / GILD.O / SGEN.O / NVCR.O</td><td class="leftalignment">Alkermes Plc / Biomarin Pharmaceutical Inc / Gilead Sciences Inc / Seagen Inc / Novocure Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Oct 22 2021 11:01AM</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / ATRC / BAX / BOLT / CSII / DNLI / OM / RAD / SAGE / WMT / GILD.O / EW / ONEM.O / VSTM / ISRG / UTHR.O / VRTX.O / SSNC.O / CCRN.O / LIFE.O / AMED.O / ANGN.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / MNKD.O / DXCM.O / LHCG.O / MBRX.O / HUMA / PODD.O / 02043Q107 / TNDM.O / ENSG.O / 483548103 / 771195104 / ADUS.O / SWAV / EVH / 100063846 / IONS.O / ADAP.O / WINT.O / EDIT / VRAY / AVDL.O / KALA.O / MTEM.O / 720795103 / ORTX.O / PDSB.O / PNTG.O / ABST.TO / IMCR.O / VIRX.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / AtriCure Inc / Baxter International Inc / Bolt Biotherapeutics Inc / Cardiovascular Systems Inc / Denali Therapeutics Inc / Outset Medical Inc / Rite Aid Corp / SAGE Therapeutics Inc / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Verastem Inc / Intuitive Surgical Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Angion Biomedica Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / MannKind Corp / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Humacyte Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Roche Holding AG / Addus Homecare Corp / Shockwave Medical Inc / Evolent Health Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Windtree Therapeutics Inc / Editas Medicine Inc / ViewRay Inc / Avadel Pharmaceuticals PLC / Kala Pharmaceuticals Inc / Molecular Templates Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / PDS Biotechnology Corp / Pennant Group Inc / Absolute Software Corp / Immunocore Holdings PLC / Viracta Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAPL / ACA / AMT / APP / APPS / ASML.AS / BOLT / CCI / CHTR / CME / CSL / DFS / DISH / DLR / DNLI / EA / GGG / GLW / INTC.O / IS / MCD / MSFT / NET / NKE / NOW / ORCL / QCOM.O / QUIK / RAD / RNG / RXT / SAP / SONY / SPOT / T / TTWO / U / UPS / WMT / AMZN.O / GILD.O / CMCSA.O / NICE / CSCO.O / ATVI.O / ONEM.O / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / CSGS.O / SBAC.O / MPWR.O / VG / AMD.O / ADI.O / EQIX / VZ / NFLX / CEVA / CRNT.O / LUMN / SMTC.O / NUAN.O / TXN.O / DOX.O / CRUS.O / MRVL.O / VRNT / SSNC.O / HPE / AVGO.O / GTT / XLNX.OQ / CCRN.O / TEAM.O / SIVB.O / AMED.O / SWKS.O / ANGN.O / BIIB / 459200101 / 00846U101 / 868168105 / GOOG.O / 315616102 / LHCG.O / 36467W109 / CCOI / LLNW.OQ / ENSG.O / 483548103 / 514766104 / 771195104 / ADUS.O / TSLA.O / NXPI.O / ZNGA / SPLK.O / FB.O / WDAY / TMUS / FDEV.L / WIX.O / FIVN.O / 563771203 / 82655M107 / CXDO / EVH / 100063846 / EDIT / BABA.K / TTD.O / OKTA.O / ATUS.K / KALA.O / ROKU.O / MDB.O / EGHT.K / 83417M104 / 720795103 / BILI.O / AVYA.K / PDSB.O / ZM.O / FSLY / DDOG.O / CMBM / PNTG.O / DKNG / FUBO / 84764T304 / TEUM.PK / ONDS.OQ / PUBM.O / DOCN / HUYA.K / MNDY.O / PRCH.O / JSPR.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / American Tower Corp / Applovin Corp / Digital Turbine Inc / ASML Holding NV / Bolt Biotherapeutics Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Carlisle Companies Inc / Discover Financial Services / DISH Network Corp / Digital Realty Trust Inc / Denali Therapeutics Inc / Electronic Arts Inc / Graco Inc / Corning Inc / Intel Corp / Ironsource Ltd / McDonald's Corp / Microsoft Corp / Cloudflare Inc / Nike Inc / ServiceNow Inc / Oracle Corp / Qualcomm Inc / QuickLogic Corp / Rite Aid Corp / RingCentral Inc / Rackspace Technology Inc / SAP SE / Sony Group Corp / Spotify Technology SA / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / United Parcel Service Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Nice Ltd / Cisco Systems Inc / Activision Blizzard Inc / 1Life Healthcare Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / CSG Systems International Inc / SBA Communications Corp / Monolithic Power Systems Inc / Vonage Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / CEVA Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Semtech Corp / Nuance Communications Inc / Texas Instruments Inc / Amdocs Ltd / Cirrus Logic Inc / Marvell Technology Inc / Verint Systems Inc / SS&C Technologies Holdings Inc / Hewlett Packard Enterprise Co / Broadcom Inc / GTT Communications Inc / Xilinx Inc / Cross Country Healthcare Inc / Atlassian Corporation PLC / SVB Financial Group / Amedisys Inc / Skyworks Solutions Inc / Angion Biomedica Corp / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / F5 Inc / LHC Group Inc / GameStop Corp / Cogent Communications Holdings Inc / Limelight Networks Inc / Ensign Group Inc / Kaman Corp / Landec Corp / Roche Holding AG / Addus Homecare Corp / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Splunk Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Wix.Com Ltd / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Crexendo Inc / Evolent Health Inc / Truist Financial Corp / Editas Medicine Inc / Alibaba Group Holding Ltd / Trade Desk Inc / Okta Inc / Altice USA Inc / Kala Pharmaceuticals Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Solaredge Technologies Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / Avaya Holdings Corp / PDS Biotechnology Corp / Zoom Video Communications Inc / Fastly Inc / Datadog Inc / Cambium Networks Corp / Pennant Group Inc / DraftKings Inc / Fubotv Inc / Speed Commerce Inc / Pareteum Corp / Ondas Holdings Inc / PubMatic Inc / DigitalOcean Holdings Inc / HUYA Inc / Monday.Com Ltd / Porch Group Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / United Kingdom / India / Israel / Japan / Korea, Republic of / Luxembourg / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / SLB.N / SO.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / ROP.N / CAT.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / HCA.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / FIS.N / STX.AX / ADP.PA / AON.N / MRNA.OQ / CME.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Southern Co / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / HCA Healthcare Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Tricky Set of Oncology Readouts Approaching</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Gilead Sciences, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, GILD</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / ECL.N / EL.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / SLB.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / NUE.N / ROK.N / UHS.N / MET.N / ETN.N / DHR.N / GD.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / SYY.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / IQV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / General Dynamics Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Sysco Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">EnVent Capital Markets</td><td class="leftalignment">Gismondi 1754 Equity Research - Update H1 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GIS=IT</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Italy / United States</td><td class="leftalignment">Apparel & Textiles</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Luigi Tardella</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SE0000108656 / US09061G1013 / US00971T1016 / US0311621009 / US1924461023 / US2786421030 / US30161Q1040 / US3755581036 / US4062161017 / US4282911084 / US4433201062 / US45253H1014 / US45337C1027 / US4567881085 / US4781601046 / US64125C1099 / US75886F1075 / US91307C1027 / US92343V1044 / US92532F1003 / CA1363751027 / US64110L1061 / US2948216088 / US20030N1019 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US00206R1023 / US3020811044 / US29089Q1058 / US92932M1018 / NL0000687663 / US87874R1005 / US53261M1045 / US03152W1099 / BMG3922B1072 / US90384S3031 / US25470M1099 / IE00B4BNMY34 / US46333X1081 / US9100471096 / US29414B1044 / NL0010273215 / US8725901040 / US09609G1004 / US8036071004 / US4576693075 / US6951271005 / US00912X3026 / US74587V1070 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / US0994061002 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US12685J1051 / US37890U1088 / US4622221004 / US07725L1026 / US16119P1084 / US36165L1089 / US2067871036 / US23355L1061 / IL0011407140 / US02156K1034 / US87105L1044 / US76243J1051 / US5011471027 / US77313F1066 / US89854H1023 / US09354A1007 / US05455M1009 / US29260V1052 / US0197701065 / US61775R1059 / US85205L1070 / US39813G1094 / US4432011082 / US65487U1088 / US07373B1098 / US20451W1018 / US69353Y1038 / US81181C1045 / US50107A1043 / KYG3902L1095 / US74767V1098 / US7761531083 / US15961R1059 / US25401T1088 / US30052F1003 / US88546E1055</td><td class="leftalignment">Telefonaktiebolaget LM Ericsson / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Amgen Inc / Cognizant Technology Solutions Corp / eBay Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Hexcel Corp / Hub Group Inc / ImmunoGen Inc / Incyte Corp / Infosys Ltd / Johnson & Johnson / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Verizon Communications Inc / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Telefonaktiebolaget LM Ericsson / Comcast Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / AT&T Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / AerCap Holdings NV / TechTarget Inc / Limelight Networks Inc / Amicus Therapeutics Inc / Genpact Ltd / Ulta Beauty Inc / DISH Network Corp / Accenture PLC / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Epam Systems Inc / ASML Holding NV / T-Mobile US Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Air Lease Corp / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Cable One Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Charter Communications Inc / GDS Holdings Ltd / Conduent Inc / DXC Technology Co / Urogen Pharma Ltd / Altice USA Inc / Switch Inc / Rhythm Pharmaceuticals Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / TTEC Holdings Inc / Blink Charging Co / AVROBIO Inc / Endava PLC / Allogene Therapeutics Inc / Morphic Holding Inc / SpringWorks Therapeutics Inc / Grid Dynamics Holdings Inc / Howmet Aerospace Inc / Nkarta Inc / Beam Global / Compass Pathways PLC / PMV Pharmaceuticals Inc / Seagen Inc / Kronos Bio Inc / GDS Holdings Ltd / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc / DigitalBridge Group Inc / EVgo Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">GILD Model Update</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Earnings Preview: Wishing For A Biotech Rally To End 2021</td><td class="leftalignment">English</td><td class="rightalignment">285</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / PPG.N / SLB.N / T.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / ROK.N / UHS.N / ETN.N / DHR.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / CHTR.OQ / MTCH.OQ / ALGN.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / ANTM.N / TMUS.OQ / CSX.OQ / IQV.N / FB.PS / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Match Group Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Anthem Inc / T-Mobile US Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Transferring Coverage</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US3755581036 / US0197701065 / US77313F1066 / US50107A1043</td><td class="leftalignment">Gilead Sciences Inc / Allogene Therapeutics Inc / Rocket Pharmaceuticals Inc / Kronos Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Mr. Marc A. Frahm, Ph.D., PHD / Mr. Phil M. Nadeau, Ph.D., PHD / Yaron Werber, M.D., MD / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BK.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / OMC.N / PM.N / PPG.N / SLB.N / T.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / UHS.N / HAL.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / SYF.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BK.N / BMY.N / BR.N / BSX.N / CB.N / CCI.N / CE.N / CL.N / CNC.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / SLB.N / T.N / TEL.PS / TRV.N / PG.N / DGX.N / WY.N / NUE.N / UHS.N / HAL.N / ADML.L / DHR.N / GD.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / RCL.N / MCD.N / YUM.N / VLO.N / SYK.N / GLW.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / VFC.N / APH.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / GPC.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / ORLY.OQ / GILD.OQ / DFS.N / TSCO.OQ / POOL.OQ / AMZN.OQ / EBAY.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / LYB.N / MSI.N / KEY.TO / BKR.N / PSX.N / NOW.N / ABBV.N / GOOGL.OQ / SYF.N / CFG.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Broadridge Financial Solutions Inc / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / PLDT Inc / Travelers Companies Inc / Procter & Gamble Co / Quest Diagnostics Inc / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Danaher Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Yum! Brands Inc / Valero Energy Corp / Stryker Corp / Corning Inc / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Amphenol Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Genuine Parts Co / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / O'Reilly Automotive Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Pool Corp / Amazon.com Inc / eBay Inc / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Baker Hughes Co / Phillips 66 / ServiceNow Inc / Abbvie Inc / Alphabet Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--October15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">A.N / AXP.N / CRY.N / JNJ.N / WMT.N / SUP.N / ABMD.OQ / AMGN.OQ / REGN.OQ / STAA.OQ / ICUI.OQ / IDXX.OQ / MMSI.OQ / GILD.OQ / ANIK.OQ / XRAY.OQ / INCY.OQ / IART.OQ / INMD.OQ / AMED.OQ / SSNC.OQ / CERS.OQ / SRDX.OQ / UTHR.OQ / BMRN.OQ / ISRG.OQ / ALGN.OQ / SGEN.OQ / OSUR.OQ / CCRN.OQ / VRTX.OQ / NUVA.OQ / ANGO.OQ / MNKD.OQ / DXCM.OQ / LHCG.OQ / ATRC.OQ / LMAT.OQ / ARAY.OQ / BLRX.TA / PODD.OQ / MASI.OQ / KIDS.OQ / ENSG.OQ / ADUS.OQ / PCRX.OQ / KAMN.N / TMD.TO / SRPT.OQ / ALLY.N / AXGN.OQ / FATE.OQ / FLXN.OQ / BLFS.OQ / GOOGL.OQ / XENT.OQ / SIEN.OQ / VCEL.OQ / EVH.N / SPNE.OQ / CYRX.OQ / IRTC.OQ / ALLO.OQ / SWAV.OQ / BEAM.OQ / VERO.OQ / ONEM.OQ / HUMA.OQ</td><td class="leftalignment">Agilent Technologies Inc / American Express Co / CryoLife Inc / Johnson & Johnson / Walmart Inc / Superior Industries International Inc / ABIOMED Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / STAAR Surgical Co / ICU Medical Inc / IDEXX Laboratories Inc / Merit Medical Systems Inc / Gilead Sciences Inc / Anika Therapeutics Inc / DENTSPLY SIRONA Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Inmode Ltd / Amedisys Inc / SS&C Technologies Holdings Inc / Cerus Corp / Surmodics Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Align Technology Inc / Seagen Inc / OraSure Technologies Inc / Cross Country Healthcare Inc / Vertex Pharmaceuticals Inc / NuVasive Inc / AngioDynamics Inc / MannKind Corp / Dexcom Inc / LHC Group Inc / AtriCure Inc / LeMaitre Vascular Inc / Accuray Inc / BioLine RX Ltd / Insulet Corp / Masimo Corp / OrthoPediatrics Corp / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Kaman Corp / Titan Medical Inc / Sarepta Therapeutics Inc / Ally Financial Inc / AxoGen Inc / Fate Therapeutics Inc / Pacira Biosciences Inc / BioLife Solutions Inc / Alphabet Inc / Intersect Ent Inc / Sientra Inc / Vericel Corp / Evolent Health Inc / SeaSpine Holdings Corp / Cryoport Inc / iRhythm Technologies Inc / Allogene Therapeutics Inc / Shockwave Medical Inc / Beam Therapeutics Inc / Venus Concept Inc / 1Life Healthcare Inc / Humacyte Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Israel / United States</td><td class="leftalignment">Biotechnology / Consumer / Engineering & Construction / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0311621009 / US2666051048 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US88322Q1085 / IL0011313900</td><td class="leftalignment">Amgen Inc / DURECT Corp / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / TG Therapeutics Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q Large Cap Preview: New World Order is Navigating Consistent COVID-19 Trends to the Base Business</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US09062X1037 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Amgen Inc / Biogen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAC.N / BK.N / BMY.N / BSX.N / C.N / CB.N / CCI.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / RHI.N / SLB.N / T.N / TRV.N / PG.N / NUE.N / UHS.N / HAL.N / DHR.N / UNH.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / MCD.N / VLO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / STT.N / HCA.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / MCO.N / TDY.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / SIVB.OQ / ZION.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / TFC.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / MS.N / CMG.N / STX.AX / ADP.PA / CME.OQ / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / KEY.TO / NOW.N / SYF.N / ANTM.N / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Robert Half International Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Procter & Gamble Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Valero Energy Corp / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Moody's Corp / Teledyne Technologies Inc / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Truist Financial Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / CME Group Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Keyera Corp / ServiceNow Inc / Synchrony Financial / Anthem Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AAPL / ADS / ALLO / AMGN / AOS / ASML.AS / AXP / BEAM / BLUE / CME / COF / CSL / DCI / DFS / DOV / EA / FLS / FOCS / GGG / ICE / IEX / INTC.O / ITT / KLAC.O / LECO / LRCX.O / MSFT / PNR / QCOM.O / RMR / RXN / SAP / SONY / TTWO / V / VCTR / WTS / MWA / GILD.O / CBOE / ATVI.O / NVDA.O / HEAR / MPWR.O / VECO.O / AMD.O / ADI.O / NFLX / CEVA / SYF / LSCC.O / SMTC.O / TXN.O / BMRN.O / CRUS.O / VRTX.O / MRVL.O / AVGO.O / NDAQ / XLNX.OQ / SWKS.O / 36467W109 / AIMC / 514766104 / NXPI.O / XYL / ZNGA / FDEV.L / 82655M107 / QRVO.O / SPXC / NTLA / CRSP / AKTS.O / MTEM.O / BILI.O / MGTA / FIXX.O / CRWD.O / 84764T304 / HUYA.K / 010196103 / JSPR.O</td><td class="leftalignment">Apple Inc / Alliance Data Systems Corp / Allogene Therapeutics Inc / Amgen Inc / A O Smith Corp / ASML Holding NV / American Express Co / Beam Therapeutics Inc / bluebird bio Inc / CME Group Inc / Capital One Financial Corp / Carlisle Companies Inc / Donaldson Company Inc / Discover Financial Services / Dover Corp / Electronic Arts Inc / Flowserve Corp / Focus Financial Partners Inc / Graco Inc / Intercontinental Exchange Inc / IDEX Corp / Intel Corp / ITT Inc / KLA Corp / Lincoln Electric Holdings Inc / Lam Research Corp / Microsoft Corp / Pentair PLC / Qualcomm Inc / RMR Group Inc / Zurn Water Solutions Corp / SAP SE / Sony Group Corp / Take-Two Interactive Software Inc / Visa Inc / Victory Capital Holdings Inc / Watts Water Technologies Inc / Mueller Water Products Inc / Gilead Sciences Inc / Cboe Global Markets Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Monolithic Power Systems Inc / Veeco Instruments Inc / Advanced Micro Devices Inc / Analog Devices Inc / Netflix Inc / CEVA Inc / Synchrony Financial / Lattice Semiconductor Corp / Semtech Corp / Texas Instruments Inc / Biomarin Pharmaceutical Inc / Cirrus Logic Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Broadcom Inc / Nasdaq Inc / Xilinx Inc / Skyworks Solutions Inc / GameStop Corp / Altra Industrial Motion Corp / Landec Corp / NXP Semiconductors NV / Xylem Inc / Zynga Inc / Frontier Developments PLC / Sify Technologies Ltd / Qorvo Inc / SPX Corp / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Akoustis Technologies Inc / Molecular Templates Inc / Bilibili Inc / Magenta Therapeutics Inc / Homology Medicines Inc / CrowdStrike Holdings Inc / Speed Commerce Inc / HUYA Inc / Aksys Ltd / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 01</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Non-GAAP EPS and A Closer Look at Restructuring Charges</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BA.N / BDX.N / IR.N / PM.N / RL.N / CPB.N / BWA.N / K.N / CAG.N / HD.N / NKE.N / KMI.N / AAPL.OQ / MSFT.OQ / TT.N / GILD.OQ / CTXS.OQ / AMZN.OQ / SGEN.OQ / NFLX.OQ / NLSN.N / FB.OQ / NOW.N / GOOGL.OQ / ZBH.N / KHC.OQ / TMUS.OQ / HPE.N / DXC.N / EXC.OQ / KDP.OQ / VTRS.OQ</td><td class="leftalignment">Boeing Co / Becton Dickinson and Co / Ingersoll Rand Inc / Philip Morris International Inc / Ralph Lauren Corp / Campbell Soup Co / Borgwarner Inc / Kellogg Co / Conagra Brands Inc / Home Depot Inc / Nike Inc / Kinder Morgan Inc / Apple Inc / Microsoft Corp / Trane Technologies PLC / Gilead Sciences Inc / Citrix Systems Inc / Amazon.com Inc / Seagen Inc / Netflix Inc / Nielsen Holdings PLC / Meta Platforms Inc / ServiceNow Inc / Alphabet Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Hewlett Packard Enterprise Co / DXC Technology Co / Exelon Corp / Keurig Dr Pepper Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ron Graziano / Mr. Amit Varshney / Adrian Szumilo / HOLT Americas</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Ideal for Those Seeking New Blood; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">JSPR.O / AMGN / BEAM / BLUE / GILD.O / VRTX.O / NTLA / MTEM.O / MGTA</td><td class="leftalignment">Jasper Therapeutics Inc / Amgen Inc / Beam Therapeutics Inc / bluebird bio Inc / Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Intellia Therapeutics Inc / Molecular Templates Inc / Magenta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Hold on Tight! Soft Biopharma Q3 Coming as Pandemic Pressures Persist, FX Fades</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">00287Y10 / 03116210 / 71708110 / 92532F10 / 37555810 / 75886F10 / 75046920 / G3910J11 / 61776010 / F5548N10</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Gilead climbs $12 billion (17%) in MCap in 2021, leads Medical/Biomedical sector gains</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAPL / ACI / AGCO / ALLO / AMGN / ATRC / AXP / AZO / CSL / DE / DG / EA / EL / FDX / FOCS / FTR / ICE / INCY / LOW / NET / NKE / NOW / RSI / SBUX / SONY / TRMB / UPS / V / WH / AMZN.O / GXO / GNSS / GILD.O / EW / MSCI / CBOE / GENI / NVDA.O / ADBE.O / RMD / SQ / MPWR.O / VG / IART.O / ADI.O / NFLX / PLUG.O / ADSK.O / SGEN / UTHR.O / ARRY.O / FCEL.O / TXN.O / EXPD.O / BMRN.O / AMSC.O / REGN.O / VRTX.O / MRVL.O / AVGO.O / NDAQ / TEAM.O / ITRI.O / BIIB / DPZ / MNKD.O / SPGI / DXCM.O / SPWR.O / XPO / CSIQ.O / FSLR.O / LULU / ULTA / WPRT.O / TWIN.O / TSLA.O / PCYO.O / NXPI.O / AMRS.O / ENPH.O / FB.O / CG.O / WDAY / CNHI / FATE.O / XENT / QRVO.O / SEDG.O / RUN.O / WKHS.O / AQMS.O / FLGT.O / CRSP / AQB / ROKU.O / MDB.O / LOVE / TPTX.O / CRWD.O / DKNG / 02081G201 / VLDR.O / SHLS.O / APPH / NKTX.O / TSP.O / ENVX.O / LILM.O / MDNA.O</td><td class="leftalignment">Apple Inc / Albertsons Companies Inc / AGCO Corp / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / American Express Co / Autozone Inc / Carlisle Companies Inc / Deere & Co / Dollar General Corp / Electronic Arts Inc / Estee Lauder Companies Inc / FedEx Corp / Focus Financial Partners Inc / Frontier Communications Parent Inc / Intercontinental Exchange Inc / Incyte Corp / Lowe's Companies Inc / Cloudflare Inc / Nike Inc / ServiceNow Inc / Rush Street Interactive Inc / Starbucks Corp / Sony Group Corp / Trimble Inc / United Parcel Service Inc / Visa Inc / Wyndham Hotels & Resorts Inc / Amazon.com Inc / GXO Logistics Inc / Genasys Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / MSCI Inc / Cboe Global Markets Inc / Genius Sports Ltd / NVIDIA Corp / Adobe Inc / Resmed Inc / Block Inc / Monolithic Power Systems Inc / Vonage Holdings Corp / Integra Lifesciences Holdings Corp / Analog Devices Inc / Netflix Inc / Plug Power Inc / Autodesk Inc / Seagen Inc / United Therapeutics Corp / Array Technologies Inc / Fuelcell Energy Inc / Texas Instruments Inc / Expeditors International of Washington Inc / Biomarin Pharmaceutical Inc / American Superconductor Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Broadcom Inc / Nasdaq Inc / Atlassian Corporation PLC / Itron Inc / Biogen Inc / Domino's Pizza Inc / MannKind Corp / S&P Global Inc / Dexcom Inc / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Westport Fuel Systems Inc / Twin Disc Inc / Tesla Inc / Pure Cycle Corp / NXP Semiconductors NV / Amyris Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Workday Inc / CNH Industrial NV / Fate Therapeutics Inc / Intersect Ent Inc / Qorvo Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Aqua Metals Inc / Fulgent Genetics Inc / CRISPR Therapeutics AG / AquaBounty Technologies Inc / Roku Inc / MongoDB Inc / Lovesac Co / Turning Point Therapeutics Inc / CrowdStrike Holdings Inc / DraftKings Inc / Alphatec Holdings Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / AppHarvest Inc / Nkarta Inc / TuSimple Holdings Inc / Enovix Corp / Lilium NV / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Japan / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Large Cap Medtech</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN / INCY / SYK / GILD.O / EW / RMD / SGEN / BMRN.O / REGN.O / VRTX.O / BIIB / XENT</td><td class="leftalignment">Amgen Inc / Incyte Corp / Stryker Corp / Gilead Sciences Inc / Edwards Lifesciences Corp / Resmed Inc / Seagen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Intersect Ent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven M. Lichtman / David Kuang</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALV.N / CAS.TO / CB.N / EL.N / ELE.MC / F.N / FSR.N / GM.N / IBE.MC / KBH.N / KO.N / MSFT.O / NA / PHM.N / RYN.N / T.N / TOL.N / VC.N / WY.N / CFP.TO / GILD.O / TEN.N / CMCSA.O / AMGN.O / INCY.O / FER.MC / BWA.N / LEA.N / K.N / DISH.O / LEN.N / CLX.N / EPC.N / AMT.N / SIRI.O / CONE.O / VZ.N / EXEL.O / DHI.N / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / BC.N / AJG.N / REGN.O / ENR.N / VRTX.O / JHX.AX / PRU.N / NCR.N / TEL.N / SSNC.O / CHE.N / PII.N / ST.N / SWN.N / PLUG.OQ / GPN.N / AMED.O / BIIB.O / DPM.TO / DLR.N / 416515104 / LHCG.O / BKD.N / FIS.N / HOG.N / MERC.O / AON.N / BGS.N / DAN.N / NOG.A / CLW.N / ADUS.OQ / SPB.N / TXG.TO / PCH.O / CFX.TO / CTT.N / MTOR.N / RFP.N / SRPT.O / PANW.N / FFHu.TO / KPT.TO / TPH.N / TSLA.N / ENTA.O / TMUS.N / TMHC.N / PTCT.O / PRTA.O / 81762P102 / QTWO.N / 922475108 / RYAM.N / RGNX.O / SQ.N / MESO.O / RACE.MI / ADVM.OQ / ADNT.N / ESTE.N / WOW.N / ATUS.N / ORSTED.CO / APTV.N / VNE.N / FOCS.O / ZM.O / FSLY.N / CRWD.O / GMAB.O / DOCU.N / CRNC.OQ / PNTG.OQ / ETNB.O / AHCO.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / RIDE.OQ / LSPD.N / DFH.OQ / AFRM.O / PSFE.N / TSP.OQ / OTLY.O / FLYW.O / TASK.O / RYAN.N / TWKS.OQ</td><td class="leftalignment">Autoliv Inc / Cascades Inc / Chubb Ltd / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fisker Inc / General Motors Co / Iberdrola SA / KB Home / Coca-Cola Co / Microsoft Corp / National Bank of Canada / Pultegroup Inc / Rayonier Inc / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Ferrovial SA / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Lennar Corp / Clorox Co / Edgewell Personal Care Co / American Tower Corp / Sirius XM Holdings Inc / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Chemed Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Plug Power Inc / Global Payments Inc / Amedisys Inc / Biogen Inc / Dundee Precious Metals Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Harley-Davidson Inc / Mercer International Inc / Aon PLC / B&G Foods Inc / Dana Inc / Northern Oil and Gas Inc / Clearwater Paper Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Torex Gold Resources Inc / Potlatchdeltic Corp / Canfor Pulp Products Inc / CatchMark Timber Trust Inc / Meritor Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Taylor Morrison Home Corp / PTC Therapeutics Inc / Prothena Corporation PLC / ServiceNow Inc / Q2 Holdings Inc / Veeva Systems Inc / Rayonier Advanced Materials Inc / Regenxbio Inc / Block Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Adient PLC / Earthstone Energy Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / Veoneer Inc / Focus Financial Partners Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Cerence Inc / Pennant Group Inc / 89Bio Inc / Adapthealth Corp / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / Affirm Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Oatly Group AB / Flywire Corp / Taskus Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Patent Patrol – Biotechnology: 3Q21</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">NA / GILD.O / INCY.O / VRTX.O / BIIB.O / SRPT.O / ENTA.O / PTCT.O / ETNB.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / 89Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Our SITC Planner Highlights 60+ Datapoints Not To Be Missed</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / BMY=US / GILD=US / EXEL=US / CGEN=US / TIL=US / RCUS=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / HARP=US / TCRR=US / NXTC=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / Compugen Ltd / Instil Bio Inc / Arcus Biosciences Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CNA.L / RWEG.DE / SSE.L / PEP.N / AVB.N / EQR.N / PXD.N / GILD.O / WLL.N / INCY.O / MET.N / AAL.L / DRI.N / EAT.N / MCD.N / YUM.N / UNM.N / AEM.N / SBUX.O / CPT.N / NBIX.O / ESS.N / SUI.N / MAA.N / VRTX.O / FCF.N / AMH.N / BCRX.O / ICPT.O / BIIB.O / DPZ.N / ELS.N / TXRH.O / ACAD.O / LHCG.O / DRX.L / CMG.N / GETP.PA / 759351604 / JACK.OQ / VALE.N / BHPB.L / GLEN.L / WEN.O / SRPT.O / ENTA.O / PTCT.O / 46579R104 / KPTI.O / ITCI.O / HQY.OQ / QSR.N / S32.AX / GBT.OQ / INVH.N / KL.N / GSHD.O / CRNC.OQ / CHK.OQ / WING.N</td><td class="leftalignment">Centrica PLC / Rwe AG / SSE PLC / PepsiCo Inc / Avalonbay Communities Inc / Equity Residential / Pioneer Natural Resources Co / Gilead Sciences Inc / Whiting Petroleum Corp / Incyte Corp / MetLife Inc / Anglo American PLC / Darden Restaurants Inc / Brinker International Inc / McDonald's Corp / Yum! Brands Inc / Unum Group / Agnico Eagle Mines Ltd / Starbucks Corp / Camden Property Trust / Neurocrine Biosciences Inc / Essex Property Trust Inc / Sun Communities Inc / Mid-America Apartment Communities Inc / Vertex Pharmaceuticals Inc / First Commonwealth Financial Corp / American Homes 4 Rent / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Domino's Pizza Inc / Equity LifeStyle Properties Inc / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / LHC Group Inc / Drax Group PLC / Chipotle Mexican Grill Inc / Getlink SE / Reinsurance Group of America Inc / Jack in the Box Inc / Vale SA / BHP Group PLC / Glencore PLC / Wendys Co / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Healthequity Inc / Restaurant Brands International Inc / South32 Ltd / Global Blood Therapeutics Inc / Invitation Homes Inc / Kirkland Lake Gold Ltd / Goosehead Insurance Inc / Cerence Inc / Chesapeake Energy Corp / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Germany / France / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">3Q21 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / AXP.N / CAH.N / CCK.N / CE.N / COF.N / EIX.N / GPS.N / HLT.N / MAN.N / MO.N / NOC.N / PFE.N / PHM.N / PM.N / SC.N / TMX.N / U.N / USB.N / VNT.N / ZEN.N / PXD.N / DELL.N / NUE.N / X.N / JBL.N / DIS.N / GD.N / AIZ.N / CR.N / AFG.N / R.N / SPOT.N / RCL.N / PRI.N / LH.N / EMR.N / PCG.N / TGT.N / AVY.N / RKT.N / SNV.N / ACN.N / H.N / DNB.N / GPC.N / HRL.N / SAM.N / CVX.N / MHK.N / L.N / GME.N / GPK.N / OSK.N / INTC.OQ / ORI.N / ADPT.OQ / CSL.N / FAF.N / RJF.N / TTC.N / TYL.N / FL.N / QCOM.OQ / ORLY.OQ / GILD.OQ / BRKS.OQ / STLD.OQ / MRCY.OQ / UMPQ.OQ / PLUG.OQ / HAIN.OQ / PNFP.OQ / WYNN.OQ / PA1436583006 / CRI.N / BIIB.OQ / OPEN.OQ / BRKR.OQ / EXP.N / OSH.N / LVS.N / THG.N / BRKb.N / OC.N / FRPT.OQ / CFX.N / MRNA.OQ / CME.OQ / CLH.N / AI.N / AVGO.OQ / NXPI.OQ / CZR.OQ / TRGP.N / SABR.OQ / Z.OQ / ALSN.N / FB.OQ / WEX.N / RNG.N / ALLE.N / ARMK.N / NCLH.N / SNOW.N / FIVN.OQ / ANET.N / SYF.N / CTLT.N / AXTA.N / LBRDK.O / QRVO.OQ / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / ROKU.OQ / MDB.OQ / PFG.OQ / CDAY.N / PLAN.N / STNE.OQ / CPRI.N / NFE.OQ / BYND.OQ / UBER.N / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / JAMF.OQ / DCT.OQ / PLTR.N / SHC.OQ / DASH.N / CERT.OQ / SKLZ.N / DRVN.OQ / SGFY.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / American Express Co / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / Capital One Financial Corp / Edison International / Gap Inc / Hilton Worldwide Holdings Inc / ManpowerGroup Inc / Altria Group Inc / Northrop Grumman Corp / Pfizer Inc / Pultegroup Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Terminix Global Holdings Inc / Unity Software Inc / US Bancorp / Vontier Corp / Zendesk Inc / Pioneer Natural Resources Co / Dell Technologies Inc / Nucor Corp / United States Steel Corp / Jabil Inc / Walt Disney Co / General Dynamics Corp / Assurant Inc / Crane Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Royal Caribbean Cruises Ltd / Primerica Inc / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Synovus Financial Corp / Accenture PLC / Hyatt Hotels Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / Hormel Foods Corp / Boston Beer Company Inc / Chevron Corp / Mohawk Industries Inc / Loews Corp / GameStop Corp / Graphic Packaging Holding Co / Oshkosh Corp / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Carlisle Companies Inc / First American Financial Corp / Raymond James Financial Inc / Toro Co / Tyler Technologies Inc / Foot Locker Inc / Qualcomm Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Azenta Inc / Steel Dynamics Inc / Mercury Systems Inc / Umpqua Holdings Corp / Plug Power Inc / Hain Celestial Group Inc / Pinnacle Financial Partners Inc / Wynn Resorts Ltd / Carnival Corp / Carter's Inc / Biogen Inc / Opendoor Technologies Inc / Bruker Corp / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Hanover Insurance Group Inc / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Colfax Corp / Moderna Inc / CME Group Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Targa Resources Corp / Sabre Corp / Zillow Group Inc / Allison Transmission Holdings Inc / Meta Platforms Inc / WEX Inc / RingCentral Inc / Allegion PLC / Aramark / Norwegian Cruise Line Holdings Ltd / Snowflake Inc. / Five9 Inc / Arista Networks Inc / Synchrony Financial / Catalent Inc / Axalta Coating Systems Ltd / Liberty Broadband Corp / Qorvo Inc / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Roku Inc / MongoDB Inc / Principal Financial Group Inc / Ceridian HCM Holding Inc / Anaplan Inc / StoneCo Ltd / Capri Holdings Ltd / New Fortress Energy Inc / Beyond Meat Inc / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / DoorDash Inc / Certara Inc / Skillz Inc / Driven Brands Holdings Inc / Signify Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - SP500</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACI.N / AFRM.OQ / ALL.N / CRM.N / ECL.N / EIX.N / HLT.N / IBM.N / PFE.N / SC.N / TXT.N / U.N / USB.N / PXD.N / DELL.N / BKI.N / DIS.N / AFG.N / IPG.N / SPOT.N / GS.N / RCL.N / KR.N / PCG.N / WHR.N / DVA.N / PWR.N / CHD.N / HRL.N / CVX.N / GME.N / INTC.OQ / AMGN.OQ / FISV.OQ / TYL.N / WSO.N / QCOM.OQ / GILD.OQ / DFS.N / PLUG.OQ / MOH.N / OPEN.OQ / OSH.N / MKTX.OQ / LVS.N / MELI.OQ / LBTYK.OQ / CME.OQ / STX.OQ / NEE.N / TSLA.OQ / FB.OQ / RNG.N / SNOW.N / FIVN.OQ / SYF.N / CTLT.N / KEYS.N / LBRDK.O / TDOC.N / TWLO.N / TTD.OQ / COUP.OQ / SNAP.N / CVNA.N / ROKU.OQ / PAGS.N / CDAY.N / FTCH.N / UBER.N / TXG.OQ / PTON.OQ / PLTR.N / DASH.N</td><td class="leftalignment">Albertsons Companies Inc / Affirm Holdings Inc / Allstate Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / Hilton Worldwide Holdings Inc / International Business Machines Corp / Pfizer Inc / Santander Consumer USA Holdings Inc / Textron Inc / Unity Software Inc / US Bancorp / Pioneer Natural Resources Co / Dell Technologies Inc / Black Knight Inc / Walt Disney Co / American Financial Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Royal Caribbean Cruises Ltd / Kroger Co / PG&E Corp / Whirlpool Corp / DaVita Inc / Quanta Services Inc / Church & Dwight Co Inc / Hormel Foods Corp / Chevron Corp / GameStop Corp / Intel Corp / Amgen Inc / Fiserv Inc / Tyler Technologies Inc / Watsco Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Plug Power Inc / Molina Healthcare Inc / Opendoor Technologies Inc / Oak Street Health Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Mercadolibre Inc / Liberty Global PLC / CME Group Inc / Seagate Technology Holdings PLC / Nextera Energy Inc / Tesla Inc / Meta Platforms Inc / RingCentral Inc / Snowflake Inc. / Five9 Inc / Synchrony Financial / Catalent Inc / Keysight Technologies Inc / Liberty Broadband Corp / Teladoc Health Inc / Twilio Inc / Trade Desk Inc / Coupa Software Inc / Snap Inc / Carvana Co / Roku Inc / PagSeguro Digital Ltd / Ceridian HCM Holding Inc / Farfetch Ltd / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Palantir Technologies Inc / DoorDash Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Argentina / Brazil / Cayman Islands / United Kingdom / Ireland / Liberia / Luxembourg / United States</td><td class="leftalignment">Advertising / Aerospace / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Defense / Electrical / Electronics / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Media / Pharmaceuticals / Retailing / Semiconductors / Technology / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - October 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CNR.TO / AIG.N / BATS.L / BCE.TO / CAS.TO / CB.N / CP.TO / DD.N / GE.N / HMb.ST / PERP.PA / T.TO / SSE.L / AMZN.O / HUM.N / CNQ.TO / GILD.O / LPX.N / SJRb.TO / RCIb.TO / RBA.N / QBRb.TO / UNH.N / ITP.TO / SU.TO / HD.N / BEIG.DE / BBVA.MC / GIBa.TO / LNC.N / V.N / EPD.N / ARE.N / GIL.N / AJG.N / PRU.N / COP.N / ASC.L / CCLb.TO / ACGL.O / ATDb.TO / SNC.TO / MOS.N / 416515104 / RDSb.L / BAM.N / CSU.TO / AON.N / CLW.N / CJT.TO / FRU.TO / EFN.TO / RFP.N / FFHu.TO / KPT.TO / PLC.TO / FEVR.L / TDOC.N / ZG.O / SPGI.N / TWLO.N / COLD.N / ZM.O / CRWD.O / GMAB.O / GFL.N / TPZ.TO / WFG.N / RYAN.N</td><td class="leftalignment">Canadian National Railway Co / American International Group Inc / British American Tobacco PLC / BCE Inc / Cascades Inc / Chubb Ltd / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / Pernod Ricard SA / Telus Corp / SSE PLC / Amazon.com Inc / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Shaw Communications Inc / Rogers Communications Inc / Ritchie Bros Auctioneers Inc / Quebecor Inc / UnitedHealth Group Inc / Intertape Polymer Group Inc / Suncor Energy Inc / Home Depot Inc / Beiersdorf AG / Banco Bilbao Vizcaya Argentaria SA / CGI Inc / Lincoln National Corp / Visa Inc / Enterprise Products Partners LP / Alexandria Real Estate Equities Inc / Gildan Activewear Inc / Arthur J Gallagher & Co / Prudential Financial Inc / Conocophillips / ASOS PLC / CCL Industries Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / SNC-Lavalin Group Inc / Mosaic Co / Hartford Financial Services Group Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Constellation Software Inc / Aon PLC / Clearwater Paper Corp / Cargojet Inc / Freehold Royalties Ltd / Element Fleet Management Corp / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / KP Tissue Inc / Park Lawn Corp / Fevertree Drinks PLC / Teladoc Health Inc / Zillow Group Inc / S&P Global Inc / Twilio Inc / Americold Realty Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / GFL Environmental Inc / Topaz Energy Corp / West Fraser Timber Co Ltd / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Sep 24</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 10.3.21</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 01988P10 / 00282410 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 44485910 / 45253H10 / 07181310 / 10113710 / 04635310 / 43644010 / 64125C10 / 37555810 / 15678210 / 03116210 / 75886F10 / 46120E60 / 11679410 / M2572210 / 45232710 / 02343610 / 09062X10 / 01625510 / 30063P10 / 478160104 / 640268108 / 075887109 / 00422510 / 02043Q10 / 67070410 / 40637H10 / 207410101 / 205306103 / 45784P10 / 25213110 / 50187A10 / 58502B10 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 02311120 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 05463X10 / 45780L10 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 40412C10 / G5960L10 / 46222210 / 18946410 / 04004760 / 21232630 / 04280A10 / 05337M104 / 23283X20 / 40131M10 / 604749101 / 63230710 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 67181A10 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 58949210 / 09627Y10 / 68071010 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 04685N10 / 13089P10 / 34633R10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 45332Y10 / 80405P10 / N4482110 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / 16961L10 / 65443P10 / 82939910 / 87410C10 / 19240Q20 / 00288U10 / 36870G10 / 64128810 / 00404A10 / N6960510 / 28036F10 / 51506910 / N5749R10 / 24343R10 / 75629V10 / 26622P10 / 52634L10 / 23003110 / 49705R10 / 38246G10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / N5151710 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 75382E10 / 29251M10 / 81064810 / G637AM10 / 15117B20 / 00038020 / 82489T10 / 00653Q10 / 12552310 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 87427V10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Abbott Laboratories / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / ImmunoGen Inc / Baxter International Inc / Boston Scientific Corp / AstraZeneca PLC / Hologic Inc / Neurocrine Biosciences Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Bruker Corp / Compugen Ltd / Illumina Inc / Amedisys Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Becton Dickinson and Co / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / NuVasive Inc / Halozyme Therapeutics Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / LHC Group Inc / MEDNAX Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Amarin Corporation PLC / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / AxoGen Inc / Inogen Inc / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / HCA Healthcare Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Arrowhead Pharmaceuticals Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Mirum Pharmaceuticals Inc / Natera Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Olink Holding AB (publ) / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Inari Medical Inc / Satsuma Pharmaceuticals Inc / InflaRx NV / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / Chinook Therapeutics Inc / 908 Devices Inc. / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Cogent Biosciences Inc / Abcellera Biologics Inc / Gemini Therapeutics Inc / Neuropace Inc / Acadia Healthcare Company Inc / Pharvaris NV / Edgewise Therapeutics Inc / Landos Biopharma Inc / Merus NV / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Doximity Inc / LENSAR Inc / Cullinan Oncology Inc / Kinnate Biopharma Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Rapt Therapeutics Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Celldex Therapeutics Inc / Abcam PLC / Shockwave Medical Inc / Adapthealth Corp / Cigna Corp / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Talkspace Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - October 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AIG.N / BATS.L / CCO.TO / CP.TO / DD.N / GE.N / HMb.ST / NA / STO.AX / T.TO / SSE.L / AMZN.O / HUM.N / CNQ.TO / GILD.O / LPX.N / AAL.L / UNH.N / HD.N / KGC.N / BBVA.MC / ALA.TO / RRC.N / V.N / EPD.N / ARE.N / CEY.L / COP.N / ASC.L / CRC.N / LNG.A / RGLD.O / ACGL.O / ATDb.TO / FM.TO / NST.AX / 878742204 / EDV.TO / NTR.N / MOS.N / NESTE.HE / RDSb.L / BAM.N / DRX.L / SES.TO / CS.TO / 443628102 / HOCM.L / SLR.AX / OSK.TO / GEM.AX / ARX.TO / VALE.N / CVE.TO / BHPB.L / NEE.N / TOU.TO / GLEN.L / TVE.TO / EFN.TO / 46579R104 / CIA.TO / S32.AX / TDOC.N / ZG.O / SPGI.N / TWLO.N / AZRE.N / AKERBP.OL / AQN.N / SSRM.O / KL.N / COLD.N / ZM.O / CRWD.O / GMAB.O / ADT1.L</td><td class="leftalignment">American International Group Inc / British American Tobacco PLC / Cameco Corp / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / National Bank of Canada / Santos Ltd / Telus Corp / SSE PLC / Amazon.com Inc / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Anglo American PLC / UnitedHealth Group Inc / Home Depot Inc / Kinross Gold Corp / Banco Bilbao Vizcaya Argentaria SA / AltaGas Ltd / Range Resources Corp / Visa Inc / Enterprise Products Partners LP / Alexandria Real Estate Equities Inc / Centamin PLC / Conocophillips / ASOS PLC / California Resources Corp / Cheniere Energy Inc / Royal Gold Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Nutrien Ltd / Mosaic Co / Neste Oyj / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Drax Group PLC / Secure Energy Services Inc / Capstone Mining Corp / Hudbay Minerals Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Osisko Mining Inc / G8 Education Ltd / ARC Resources Ltd / Vale SA / Cenovus Energy Inc / BHP Group PLC / Nextera Energy Inc / Tourmaline Oil Corp / Glencore PLC / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Ivanhoe Mines Ltd / Champion Iron Ltd / South32 Ltd / Teladoc Health Inc / Zillow Group Inc / S&P Global Inc / Twilio Inc / Azure Power Global Ltd / Aker BP ASA / Algonquin Power & Utilities Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Americold Realty Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Adriatic Metals PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Denmark / Spain / Finland / United Kingdom / Mauritius / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 75 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / BRX.N / TWOU.OQ / ANTM.N / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Brixmor Property Group Inc / 2U Inc / Anthem Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AIG.N / ANTO.L / BATS.L / BHP.AX / CAS.TO / CCO.TO / CP.TO / DD.N / GE.N / HMb.ST / NA / NCM.AX / RIO.AX / RIO.L / STO.AX / T.TO / SSE.L / AMZN.O / WY.N / HUM.N / CFP.TO / CNQ.TO / GILD.O / LPX.N / AAL.L / UNH.N / ENB.TO / TV.TO / HD.N / AEM.N / SBM.AX / KGC.N / BBVA.MC / BOL.ST / ALA.TO / RRC.N / V.N / EPD.N / ARE.N / JHX.AX / CEY.L / COP.N / ASC.L / APF.L / MEOH.O / CRC.N / HCC.N / LNG.A / RGLD.O / ACGL.O / ATDb.TO / IGO.AX / FMG.AX / SNC.TO / MTL.TO / FM.TO / RMS.AX / NST.AX / 878742204 / EDV.TO / NTR.N / RRL.AX / MOS.N / NESTE.HE / WSA.AX / RDSb.L / BAM.N / 35671D857 / DRX.L / SES.TO / CS.TO / 443628102 / 550372106 / NCU.TO / HOCM.L / SLR.AX / OSK.TO / OZL.AX / ARX.TO / SFR.AX / OGC.TO / AND.TO / VALE.N / CVE.TO / BHPB.L / NEE.N / SLS.TO / TOU.TO / GOR.AX / PCH.O / CJT.TO / CAML.L / GLEN.L / IFP.TO / WTE.TO / EVN.AX / TVE.TO / EFN.TO / RFP.N / 505440107 / 46579R104 / CIA.TO / S32.AX / TDOC.N / ZG.O / SPGI.N / TWLO.N / AZRE.N / AKERBP.OL / AQN.N / SSRM.O / KL.N / NEXA.TO / COLD.N / ZM.O / CRWD.O / GMAB.O / ADT1.L / EGLX.TO / TFII.N / 900435207 / WFG.N / PET.TO</td><td class="leftalignment">American International Group Inc / Antofagasta PLC / British American Tobacco PLC / BHP Group Ltd / Cascades Inc / Cameco Corp / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / National Bank of Canada / Newcrest Mining Ltd / Rio Tinto Ltd / Rio Tinto PLC / Santos Ltd / Telus Corp / SSE PLC / Amazon.com Inc / Weyerhaeuser Co / Humana Inc / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Anglo American PLC / UnitedHealth Group Inc / Enbridge Inc / Trevali Mining Corp / Home Depot Inc / Agnico Eagle Mines Ltd / St Barbara Ltd / Kinross Gold Corp / Banco Bilbao Vizcaya Argentaria SA / Boliden AB / AltaGas Ltd / Range Resources Corp / Visa Inc / Enterprise Products Partners LP / Alexandria Real Estate Equities Inc / James Hardie Industries PLC / Centamin PLC / Conocophillips / ASOS PLC / Anglo Pacific Group PLC / Methanex Corp / California Resources Corp / Warrior Met Coal Inc / Cheniere Energy Inc / Royal Gold Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / IGO Ltd / Fortescue Metals Group Ltd / SNC-Lavalin Group Inc / Mullen Group Ltd / First Quantum Minerals Ltd / Ramelius Resources Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Nutrien Ltd / Regis Resources Ltd / Mosaic Co / Neste Oyj / Western Areas Ltd / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Freeport-McMoRan Inc / Drax Group PLC / Secure Energy Services Inc / Capstone Mining Corp / Hudbay Minerals Inc / Lundin Mining Corp / Nevada Copper Corp / Hochschild Mining PLC / Silver Lake Resources Ltd / Osisko Mining Inc / OZ Minerals Ltd / ARC Resources Ltd / Sandfire Resources Ltd / OceanaGold Corp / Andlauer Healthcare Group Inc / Vale SA / Cenovus Energy Inc / BHP Group PLC / Nextera Energy Inc / Solaris Resources Inc / Tourmaline Oil Corp / Gold Road Resources Ltd / Potlatchdeltic Corp / Cargojet Inc / Central Asia Metals PLC / Glencore PLC / Interfor Corp / Westshore Terminals Investment Corp / Evolution Mining Ltd / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Resolute Forest Products Inc / Labrador Iron Ore Royalty Corp / Ivanhoe Mines Ltd / Champion Iron Ltd / South32 Ltd / Teladoc Health Inc / Zillow Group Inc / S&P Global Inc / Twilio Inc / Azure Power Global Ltd / Aker BP ASA / Algonquin Power & Utilities Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Nexa Resources SA / Americold Realty Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Adriatic Metals PLC / Enthusiast Gaming Holdings Inc / TFI International Inc / Turquoise Hill Resources Ltd / West Fraser Timber Co Ltd / Pet Valu Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Denmark / Spain / Finland / United Kingdom / Ireland / Luxembourg / Mauritius / Norway / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Andre-Philippe Hardy, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">COVID/scope Realtime Update: MRK Data Brightens Light At End Of COVID Tunnel - Implications For Our Space</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / GILD.O / INCY.O / BIIB.O / ENTA.O / PTCT.O / ITCI.O</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Incyte Corp / Biogen Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Top 30 Global Ideas for 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">AIG.N / BATS.L / CP.TO / DD.N / GE.N / HMb.ST / T.TO / SSE.L / AMZN.O / HUM.N / CNQ.TO / GILD.O / LPX.N / UNH.N / HD.N / BBVA.MC / V.N / EPD.N / ARE.N / COP.N / ASC.L / ACGL.O / ATDb.TO / MOS.N / RDSb.L / BAM.N / EFN.TO / TDOC.N / ZG.O / SPGI.N / TWLO.N / COLD.N / ZM.O / CRWD.O / GMAB.O</td><td class="leftalignment">American International Group Inc / British American Tobacco PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / Telus Corp / SSE PLC / Amazon.com Inc / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / UnitedHealth Group Inc / Home Depot Inc / Banco Bilbao Vizcaya Argentaria SA / Visa Inc / Enterprise Products Partners LP / Alexandria Real Estate Equities Inc / Conocophillips / ASOS PLC / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Element Fleet Management Corp / Teladoc Health Inc / Zillow Group Inc / S&P Global Inc / Twilio Inc / Americold Realty Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / Spain / United Kingdom / Sweden / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Mr. Brad D. Erickson / Scott M. Hanold / Mr. Matthew G. Hedberg / Mr. Rishi N. Jaluria / Geoffrey Kwan, CFA / Kennen MacKay, PHD / Sherri Malek / Drew McReynolds, CFA / Frank G. Morgan / Mr. John B. Musk / Brian Abrahams, MD / Mme. Irene O. Nattel / Greg M. Pardy, CFA / Daniel R. R. Perlin, CFA / Mr. Paul C. Quinn / Mr. Ashish Sabadra / Mr. TJ J. Schultz / Walter N. Spracklin, CFA / Mr. Benjamin Toms / Mr. Arun S. Viswanathan / Andrew D. Wong / Mr. Biraj Borkhataria / Michael W. Carroll, CFA / Mr. Richard B. Chamberlain / Mr. Sean W. Dodge, CFA / Mr. Deane Dray, CFA / Mark A. Dwelle, CFA / Mr. James Edwardes Jones</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CCO.TO / DGE.L / NA / PD.N / SGEF.PA / STO.AX / AMZN.O / CNQ.TO / GILD.O / AMGN.O / AAL.L / ADCT.N / KGC.N / EXEL.O / ALA.TO / ARNA.O / RRC.N / KMX.N / ADSK.O / EPD.N / BMRN.O / REGN.O / VRTX.O / MCO.N / CEY.L / COP.N / SWN.N / CRC.N / LNG.A / SGEN.OQ / IMGN.O / RGLD.O / CASY.O / ATDb.TO / BIIB.O / FM.TO / NST.AX / 878742204 / EDV.TO / NTR.N / MOS.N / NESTE.HE / RDSb.L / DRX.L / SES.TO / CS.TO / 443628102 / HOCM.L / SLR.AX / OSK.TO / INO.OQ / ARX.TO / VALE.N / CVE.TO / BHPB.L / NEE.N / TOU.TO / GLEN.L / XYL.N / TVE.TO / FB.O / PANW.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / GOOGL.O / CIA.TO / S32.AX / MESO.O / SPGI.N / AZRE.N / AKERBP.OL / PBYI.OQ / AQN.N / SNAP.N / SSRM.O / KL.N / ATNX.O / ZS.OQ / VRCA.OQ / PINS.N / ZM.O / CRWD.O / GMAB.O / ADT1.L / MGNI.OQ / NRIX.OQ / MTCR.O / NUVB.N / PATH.N / TSP.OQ / ANE.MC</td><td class="leftalignment">Cameco Corp / Diageo PLC / National Bank of Canada / PagerDuty Inc / Vinci SA / Santos Ltd / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Anglo American PLC / ADC Therapeutics SA / Kinross Gold Corp / Exelixis Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Range Resources Corp / Carmax Inc / Autodesk Inc / Enterprise Products Partners LP / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moody's Corp / Centamin PLC / Conocophillips / Southwestern Energy Co / California Resources Corp / Cheniere Energy Inc / Seagen Inc / ImmunoGen Inc / Royal Gold Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Biogen Inc / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Nutrien Ltd / Mosaic Co / Neste Oyj / Royal Dutch Shell PLC / Drax Group PLC / Secure Energy Services Inc / Capstone Mining Corp / Hudbay Minerals Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Osisko Mining Inc / Inovio Pharmaceuticals Inc / ARC Resources Ltd / Vale SA / Cenovus Energy Inc / BHP Group PLC / Nextera Energy Inc / Tourmaline Oil Corp / Glencore PLC / Xylem Inc / Tamarack Valley Energy Ltd / Meta Platforms Inc / Palo Alto Networks Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Alphabet Inc / Champion Iron Ltd / South32 Ltd / Mesoblast Ltd / S&P Global Inc / Azure Power Global Ltd / Aker BP ASA / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Snap Inc / SSR Mining Inc / Kirkland Lake Gold Ltd / Athenex Inc / Zscaler Inc / Verrica Pharmaceuticals Inc / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Adriatic Metals PLC / Magnite Inc / Nurix Therapeutics Inc / Metacrine Inc / Nuvation Bio Inc / UiPath Inc / TuSimple Holdings Inc / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Denmark / Spain / Finland / France / United Kingdom / Ireland / Mauritius / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / VRTX.O / BIIB.O / INO.OQ / ENTA.O / PTCT.O / VRCA.OQ / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Inovio Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Verrica Pharmaceuticals Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead strengthens 2.5% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker - Wegovy launch insights: For The Week Ended Sep 17</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Gilead Sciences, Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ / AMGN.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / BMRN.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / ALNY.OQ / SRPT.OQ / ABBV.N / MRTX.OQ / FATE.OQ / NVTA.N / NTRA.OQ / NTLA.OQ / 6160.HK / BBIO.OQ / 22UAy.DE</td><td class="leftalignment">Moderna Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Biomarin Pharmaceutical Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Invitae Corp / Natera Inc / Intellia Therapeutics Inc / Beigene Ltd / BridgeBio Pharma Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / DRRX.O / RIGL.O / SSNC.O / ISR / SRDX.O / INCY.OQ / EPIX.OQ / SGMO.OQ / CCRN.O / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / CORT.O / CRTX.O / ATRC.OQ / LHCG.O / CYCC.OQ / INFI.OQ / LMAT.O / 02043Q107 / ENSG.OQ / TNDM.O / SLP.OQ / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / MRTX.OQ / AERI.O / TRVN.O / GOOGL.O / ALDX.OQ / 02005N100 / AGRX.OQ / CASI.OQ / MRNS.O / INO.O / VBLT.O / NVRO.N / EVH.N / TDOC.N / CFMS.O / VYGR.OQ / 100063846 / IONS.OQ / SSKN.OQ / SYRS.OQ / SLNO.OQ / PLXP.O / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / ATNX.O / NCNA.O / SYBX.O / DNLI.OQ / CUE.OQ / 720795103 / PRVB.OQ / ORTX.OQ / SWAV.O / XFOR.OQ / PDSB.OQ / BWAY.TA / ORGO.O / ONCT.OQ / BCYC.O / A71.F / XAIR.OQ / PSNL.O / NBSE.O / DMTK.O / FREQ.OQ / PNTG.OQ / BXRX.OQ / ONEM.OQ / ORIC.OQ / ZNTL.OQ / US97382D3035 / AYLA.O / HGEN.O / US74275C2052 / ABST.TO / PRTG.OQ / REGW.M3 / 03823M100 / RZLT.O / HUMA.OQ / ATXS.OQ / CRXT.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / DURECT Corp / Rigel Pharmaceuticals Inc / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Incyte Corp / ESSA Pharma Inc / Sangamo Therapeutics Inc / Cross Country Healthcare Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Corcept Therapeutics Inc / Cortexyme Inc / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / LeMaitre Vascular Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Simulations Plus Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Alphabet Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Agile Therapeutics Inc / CASI Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Evolent Health Inc / Teladoc Health Inc / Conformis Inc / Voyager Therapeutics Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / Syros Pharmaceuticals Inc / Soleno Therapeutics Inc / PLx Pharma Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Athenex Inc / NuCana PLC / Synlogic Inc / Denali Therapeutics Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / X4 Pharmaceuticals Inc / PDS Biotechnology Corp / Brainsway Ltd / Organogenesis Holdings Inc / Oncternal Therapeutics Inc / Bicycle Therapeutics PLC / Ascendis Pharma A/S / Beyond Air Inc / Personalis Inc / NeuBase Therapeutics Inc / DermTech Inc / Frequency Therapeutics Inc / Pennant Group Inc / Baudax Bio Inc / 1Life Healthcare Inc / Oric Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Windtree Therapeutics Inc / Ayala Pharmaceuticals Inc / Humanigen Inc / Processa Pharmaceuticals Inc / Absolute Software Corp / Portage Biotech Inc / Regency World Consulting Ltd / Applied Minerals Inc / Rezolute Inc / Humacyte Inc / Astria Therapeutics Inc / Clarus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / India / Ireland / Israel / Nigeria / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">A Virus' Worst Enemy</td><td class="leftalignment">English</td><td class="rightalignment">114</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Third BD deal in 2H21: Multi-target collaboration with AbCellera to discover new antibodies. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / LLY.N / SASY.PA / NOVN.S / GSK.L / PFIZ.NS / GILD.OQ / 1877.HK / ABCL.OQ / 2142.HK</td><td class="leftalignment">Everest Medicines Ltd / Eli Lilly and Co / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Pfizer Ltd / Gilead Sciences Inc / Shanghai Junshi Biosciences Co Ltd / Abcellera Biologics Inc / Hbm Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / France / United Kingdom / India / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FDX / KKR / MSFT.O / GILD.O / AMGN.O / AAPL.O / NVDA.O / HEAR.O / UPS.N / EXPD.O / RIGL.O / ATVI.OQ / TTWO.OQ / SGMO.OQ / NFLX.O / BIIB.O / CRTX.O / 36467W109 / XPO / 02043Q107 / MRNA.O / GLAXOSM.LG / TSLA.O / ZNGA.O / EA.O / CG.O / MRTX.OQ / FDEV.L / 82655M107 / G29183103 / 02005N100 / MRNS.O / VYGR.OQ / IONS.OQ / SYRS.OQ / APL.PS / SLNO.OQ / VERU.OQ / MTEM.O / ATNX.O / SYBX.O / DNLI.OQ / BILI.O / ORTX.OQ / ORGO.O / BCYC.O / PRTG.OQ / REGW.M3 / HUYA.K / 03823M100 / TBLA.OQ</td><td class="leftalignment">FedEx Corp / KKR & Co Inc / Microsoft Corp / Gilead Sciences Inc / Amgen Inc / Apple Inc / NVIDIA Corp / Turtle Beach Corp / United Parcel Service Inc / Expeditors International of Washington Inc / Rigel Pharmaceuticals Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / Sangamo Therapeutics Inc / Netflix Inc / Biogen Inc / Cortexyme Inc / GameStop Corp / XPO Logistics Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Zynga Inc / Electronic Arts Inc / Carlyle Group Inc / Mirati Therapeutics Inc / Frontier Developments PLC / Sify Technologies Ltd / Eaton Corporation PLC / Ally Financial Inc / Marinus Pharmaceuticals Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Syros Pharmaceuticals Inc / Apollo Global Capital Inc / Soleno Therapeutics Inc / Veru Inc / Molecular Templates Inc / Athenex Inc / Synlogic Inc / Denali Therapeutics Inc / Bilibili Inc / Orchard Therapeutics PLC / Organogenesis Holdings Inc / Bicycle Therapeutics PLC / Portage Biotech Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc / Taboola.com Ltd</td><td class="leftalignment"></td><td class="leftalignment">Philippines / United States / Virgin Islands, British / Cayman Islands / United Kingdom / India / Ireland / Israel / Nigeria</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / MRK=US / HD=US / MCD=US / ADI=US / WEN=US / BXP=US / BLD=US / TXN=US / GILD=US / PEB=US / SLG=US / H=US / MTN=US / LOW=US / IGT=US / BYD=US / MAR=US / LEG=US / TNL=US / VMC=US / MGM=US / HLT=US / PENN=US / MLM=US / AMN=US / SWIM=US / ARW=US / AVT=US / CBRL=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MCHP=US / MHK=US / MCRI=US / PACW=US / REGN=US / REGI=US / SLGN=US / SGMS=US / CCRN=US / CNM=US / COP=US / DIN=US / MRNS=US / RRR=US / TPX=US / EXP=US / CZR=US / KAR=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / HGV=US / RLJ=US / VAC=US / FBHS=US / RHP=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / SHAK=US / WING=US / EDIT=US / 82982L103 / PK=US / JELD=US / PLYA=US / ROKU=US / DCPH=US / KOD=US / FERG=US / DKNG=US / AZEK=US / BALY=US / SNPO=US</td><td class="leftalignment">Cars.com Inc / Merck & Co Inc / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Boston Properties Inc / TopBuild Corp / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Martin Marietta Materials Inc / AMN Healthcare Services Inc / Latham Group Inc / Arrow Electronics Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Silgan Holdings Inc / Scientific Games Corp / Cross Country Healthcare Inc / Core & Main Inc / Conocophillips / Dine Brands Global Inc / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / KAR Auction Services Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Roku Inc / Deciphera Pharmaceuticals Inc / Kodiak Sciences Inc / Ferguson PLC / DraftKings Inc / Azek Company Inc / Bally's Corp / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">696</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Trodelvy competitor TROP2 looks compelling especially in EGFR mutations in NSCLC</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">iNKT Presents Path to Overcome Checkpoint Resistance; Initiating with Outperform, $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">PRTG.OQ / GILD.O / 02043Q107 / ATNX.O / 03823M100</td><td class="leftalignment">Portage Biotech Inc / Gilead Sciences Inc / Alnylam Pharmaceuticals Inc / Athenex Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Second BD deal in 2H21; further strengthen franchise in renal disease. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / GILD.OQ</td><td class="leftalignment">Everest Medicines Ltd / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0116591092 / US02553E1064 / US0378331005 / US0718131099 / US22284P1057 / US2855121099 / US3755581036 / US37733W1053 / US45253H1014 / US5002551043 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9311421039 / US9507551086 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US0003752047 / US0491642056 / PAP310761054 / US1717793095 / NL0000687663 / US01748X1028 / US2473617023 / US90384S3031 / US00922R1059 / US00507V1098 / CA9609083097 / CA0585861085 / US9100471096 / US98986T1088 / US30303M1027 / US00287Y1091 / US72919P2020 / US00912X3026 / US8485771021 / US21240E1055 / US5560991094 / US90184L1026 / US02376R1023 / IE00BLS09M33 / US0994061002 / CA0089118776 / US72703H1014 / US02079K1079 / US23284F1057 / CA87241L1094 / US83304A1060 / US23753F1075 / US80689H1023 / US4990491049 / US6085501095 / US59045L1061 / US09354A1007 / US5904791358 / US9842411095 / US8693671021 / US1567271093 / CH0499880968 / US57667L1070 / US07373B1098 / US81181C1045 / US33813J1060 / US72815L1070 / US12047B1052 / US15961R1059 / LU2314763264 / US35909R1086 / US90089L1089 / US28489L1044 / US30052F1003 / IL0011786154 / US30322L1017 / CA50202P1053 / US7731221062 / IL0011794802</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / Apple Inc / Baxter International Inc / Covenant Logistics Group Inc / Electronic Arts Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / ImmunoGen Inc / Kohls Corp / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Walmart Inc / Werner Enterprises Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / Abb Ltd / Atlas Air Worldwide Holdings Inc / Copa Holdings SA / Ciena Corp / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Air Transport Services Group Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / United Airlines Holdings Inc / Zynga Inc / Meta Platforms Inc / Abbvie Inc / Plug Power Inc / Air Lease Corp / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / Twitter Inc / American Airlines Group Inc / Pentair PLC / Boot Barn Holdings Inc / Air Canada / Planet Fitness Inc / Alphabet Inc / CytomX Therapeutics Inc / TFI International Inc / Snap Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Molecular Templates Inc / Mersana Therapeutics Inc / Blink Charging Co / Mesa Air Group Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / Cerence Inc / ADC Therapeutics SA / Match Group Inc / Beam Global / Seagen Inc / Fisker Inc / Playtika Holding Corp / Bumble Inc / ChargePoint Holdings Inc / Arrival SA / Frontier Group Holdings Inc / TuSimple Holdings Inc / Electric Last Mile Solutions Inc / EVgo Inc / REE Automotive Ltd / F45 Training Holdings Inc / Li-Cycle Holdings Corp / Rocket Lab USA Inc / Cellebrite DI Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AZN provides CD73 POC in lung; we see read-through to AB680 & ARC-7</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">RCUS=US / GILD=US</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AHT.L / BMY.N / CSL.AX / ELE.MC / HSX.L / IBE.MC / JD.L / JNJ.N / KOMN.S / KSP.I / PRTP.PA / SAN.MC / SAPJ.J / STM.PA / AZN.L / AAL.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / BAMI.MI / NOVN.S / FMEG.DE / ENEI.MI / MRCG.DE / BBVA.MC / BANB.S / GSK.L / ITX.MC / FLS.CO / PFIZ.NS / REGN.OQ / GILD.OQ / MAERSKB.CO / IFCN.S / BIIB.OQ / LXSG.DE / DRX.L / ISP.MI / ALM.MC / FXPO.L / SOON.S / GRLS.MC / SABE.MC / BAYGN.DE / 0486.HK / PHNX.L / OCDO.L / CABK.MC / CDR.WA / ABBV.N / OCI.AS / ELIOR.PA / SKIN.S / G24N.DE / LANDI.S / KAPQ.L / MOVE.S / GMAB.CO / JETJ.L / PPGN.S</td><td class="leftalignment">Ashtead Group PLC / Bristol-Myers Squibb Co / CSL Ltd / Endesa SA / Hiscox Ltd / Iberdrola SA / JD Sports Fashion PLC / Johnson & Johnson / Komax Holding AG / Kingspan Group PLC / Kering SA / Banco Santander SA / Sappi Ltd / STMicroelectronics NV / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Banco BPM SpA / Novartis AG / Fresenius Medical Care AG & Co KGaA / Enel SpA / Merck KGaA / Banco Bilbao Vizcaya Argentaria SA / Bachem Holding AG / GlaxoSmithKline PLC / Industria de Diseno Textil SA / FLSmidth & Co A/S / Pfizer Ltd / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / AP Moeller - Maersk A/S / Inficon Holding AG / Biogen Inc / Lanxess AG / Drax Group PLC / Intesa Sanpaolo SpA / Almirall SA / Ferrexpo PLC / Sonova Holding AG / Grifols SA / Banco de Sabadell SA / Bayer AG / OK Rusal MKPAO / Phoenix Group Holdings PLC / Ocado Group PLC / Caixabank SA / CD Projekt SA / Abbvie Inc / OCI NV / Elior Group SA / Cassiopea SpA / Scout24 SE / Landis+Gyr Group AG / NAK Kazatomprom AO / Medacta Group SA / Genmab A/S / Just Eat Takeaway.com NV / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / India / Ireland / Italy / Kazakhstan / Netherlands / Norway / Poland / Russian Federation / Sweden / Turkey / United States / South Africa</td><td class="leftalignment">Apparel & Textiles / Banks / Biotechnology / Building & Building Materials / Chemicals / Consumer / Electronics / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Retailing / Semiconductors / Shipping & Shipbuilding / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / AMGN=US / BMY=US / HD=US / MDT=US / GILD=US / PEB=US / H=US / MTN=US / LOW=US / IGT=US / MAR=US / ADS=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CLI=US / CHH=US / DRH=US / EXEL=US / MHK=US / HOOK=US / REGN=US / SGMO=US / TRIP=US / SGMS=US / CNM=US / MTCH=US / IGMS=US / STRO=US / APP=US / SHO=US / HST=US / WH=US / TIL=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / RHP=US / TILE=US / AERI=US / BWXT=US / PEN=US / IBEX=US / TTD=US / PK=US / PLYA=US / CVNA=US / NCNA=US / DCPH=US / GSKY=US / BTAI=US / TCRR=US / GMAB=US / RBLX=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Medtronic PLC / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Veris Residential Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Exelixis Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Scientific Games Corp / Core & Main Inc / Match Group Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Aerie Pharmaceuticals Inc / BWX Technologies Inc / Penumbra Inc / Ibex Ltd / Trade Desk Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Deciphera Pharmaceuticals Inc / GreenSky Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S / Roblox Corp / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Termination of Coverage</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2369174 / BYWVTY5 / 5531000 / B0SDJB4</td><td class="leftalignment">Gilead Sciences Inc / CytomX Therapeutics Inc / MorphoSys AG / Zealand Pharma A/S</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Sep. 15, 2021 / 12:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ESMO Planner Highlights 130+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / LLY=US / AMGN=US / BMY=US / GILD=US / EXEL=US / HOOK=US / REGN=US / IGMS=US / STRO=US / TIL=US / NCNA=US / DCPH=US / BTAI=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / NuCana PLC / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Billal Jahangiri / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 15 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0378331005 / US0758871091 / US22284P1057 / US2371941053 / US31428X1063 / US3755581036 / US37733W1053 / US45253H1014 / US7711951043 / US9029251066 / US92343V1044 / US9507551086 / US1667641005 / US80105N1054 / US0003752047 / US00206R1023 / US6247581084 / US00287Y1091 / US8725901040 / US5560991094 / US20717E1010 / US23284F1057 / CA87241L1094 / US74967X1037 / US23753F1075 / US80689H1023 / US4990491049 / US6085501095 / US59045L1061 / US9842411095 / US8693671021 / US68570P1012 / US35952H6018 / CH0499880968 / US81181C1045 / US55406W1036 / US67421J1088</td><td class="leftalignment">Apple Inc / Becton Dickinson and Co / Covenant Logistics Group Inc / Darden Restaurants Inc / FedEx Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / ImmunoGen Inc / Roche Holding AG / USA Truck Inc / Verizon Communications Inc / Werner Enterprises Inc / Chevron Corp / Sanofi SA / Abb Ltd / AT&T Inc / Mueller Water Products Inc / Abbvie Inc / T-Mobile US Inc / MacroGenics Inc / Conformis Inc / CytomX Therapeutics Inc / TFI International Inc / RH / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Molecular Templates Inc / Mersana Therapeutics Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / Orchard Therapeutics PLC / Fuelcell Energy Inc / ADC Therapeutics SA / Seagen Inc / MYT Netherlands Parent BV / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ALB.N / ANA.MC / CCK.N / ECL.N / ELE.MC / FMC.N / NTRS.O / PNC.N / PPG.N / SRCL.O / CNQ.TO / GILD.O / WLK.N / DRI.N / OLN.N / SHW.N / AMP.N / AJG.N / VRTX.O / SRG.MI / GPK.N / JCOM.O / BIIB.O / 878742204 / IVZ.N / FHI.N / MTDR.N / SMSS.L / BERY.N / APAM.N / AXTA.N / TDOC.N / VNTR.N / VCTR.N / EAF.N / FVRR.N / IBEX.O / PTVE.O / ANE.MC / CNM.N</td><td class="leftalignment">Albemarle Corp / Acciona SA / Crown Holdings Inc / Ecolab Inc / Endesa SA / FMC Corp / Northern Trust Corp / PNC Financial Services Group Inc / PPG Industries Inc / Stericycle Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Westlake Chemical Corp / Darden Restaurants Inc / Olin Corp / Sherwin-Williams Co / Ameriprise Financial Inc / Arthur J Gallagher & Co / Vertex Pharmaceuticals Inc / Snam SpA / Graphic Packaging Holding Co / Ziff Davis Inc / Biogen Inc / Teck Resources Ltd / Invesco Ltd / Federated Hermes Inc / Matador Resources Co / Smart Metering Systems PLC / Berry Global Group Inc / Artisan Partners Asset Management Inc / Axalta Coating Systems Ltd / Teladoc Health Inc / Venator Materials PLC / Victory Capital Holdings Inc / GrafTech International Ltd / Fiverr International Ltd / Ibex Ltd / Pactiv Evergreen Inc / Corporacion Acciona Energias Renovables SA / Core & Main Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Spain / United Kingdom / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">An Investor's Guide To Bispecific Antibodies - Ahead Of The Curve</td><td class="leftalignment">English</td><td class="rightalignment">120</td><td class="leftalignment">US3755581036 / US37733W1053 / US45253H1014 / US7711951043 / US80105N1054 / US00287Y1091 / US5560991094 / US23284F1057 / US6085501095 / US59045L1061 / US9842411095 / US8693671021 / CH0499880968 / US81181C1045</td><td class="leftalignment">Gilead Sciences Inc / GlaxoSmithKline PLC / ImmunoGen Inc / Roche Holding AG / Sanofi SA / Abbvie Inc / MacroGenics Inc / CytomX Therapeutics Inc / Molecular Templates Inc / Mersana Therapeutics Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / ADC Therapeutics SA / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Mr. Marc A. Frahm, Ph.D., PHD / Mr. Phil M. Nadeau, Ph.D., PHD / Steve M. Scala, R.Ph., CFA, CFA / Mr. Joseph Thome / Yaron Werber, M.D., MD / Cowen Biotechnology Team / Cowen Pharmaceutical Team</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / BIIB.O</td><td class="leftalignment">Gilead Sciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US healthcare reform back in focus: Build Back Better includes direct negotiation</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / CSL.AX / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: The wait is over: New BD deal for COVID mRNA vaccine and mRNA platform. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / SASY.PA / 2196.HK / GILD.OQ / CVAC.OQ</td><td class="leftalignment">Everest Medicines Ltd / Sanofi SA / Shanghai Fosun Pharmaceutical Group Co Ltd / Gilead Sciences Inc / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / France / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / HUM / IVC / MDT / RAD / UNH / WMT / GILD.O / RMD.N / HCA.N / CYH.N / EW.N / SSNC.O / UTHR.OQ / BMRN.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / MNKD.O / LHCG.O / CYCC.OQ / ENSG.OQ / 483548103 / MRNA.O / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / GBT.OQ / APLS.OQ / 100063846 / EDIT.OQ / TCMD.OQ / IRTC.OQ / SLNO.OQ / FIXX.OQ / 720795103 / SWAV.O / PNTG.OQ / ONEM.OQ / HGEN.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Invacare Corp / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Editas Medicine Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Soleno Therapeutics Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Pennant Group Inc / 1Life Healthcare Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AC.TO / ALV.N / CCK.N / ECM.L / F.N / FLS.N / FMC.N / FSR.N / IP.N / MAS.N / RWEG.DE / TMX.N / TOL.N / WEIR.L / CFP.TO / GILD.O / LPX.N / INCY.O / DHR.N / BWA.N / LEA.N / WLK.N / WCC.N / ITP.TO / VMC.N / XEL.N / RRC.N / EQT.N / AXL.N / RSG.N / GPK.N / VRNT.O / WCN.N / CDE.N / GGG.N / SKY.N / CRC.N / PLUG.OQ / JCOM.O / MTL.TO / NTR.N / NVT.N / MOS.N / BECN.O / GMS.N / BLDR.O / CMG.N / MWA.N / DAIGn.DE / TDC.N / GETP.PA / DAN.N / CJT.TO / MTOR.N / XYL.N / PANW.N / BERY.N / UKWG.L / DOOR.N / IBP.N / AXTA.N / ASB.N / AENA.MC / SQ.N / SITE.N / ATKR.N / ADNT.N / VNTR.N / RHIM.L / ORSTED.CO / AQUA.N / GTES.N / ZS.OQ / MGTX.O / AVTR.N / EPAC.N / TFII.N / MOCORP.HE / SUMO.O / TLMD.OQ / DFH.OQ / WFG.N / AFRM.O / PWSC.N / COOK.N</td><td class="leftalignment">Air Canada / Autoliv Inc / Crown Holdings Inc / Electrocomponents PLC / Ford Motor Co / Flowserve Corp / FMC Corp / Fisker Inc / International Paper Co / Masco Corp / Rwe AG / Terminix Global Holdings Inc / Toll Brothers Inc / Weir Group PLC / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Incyte Corp / Danaher Corp / Borgwarner Inc / Lear Corp / Westlake Chemical Corp / Wesco International Inc / Intertape Polymer Group Inc / Vulcan Materials Co / Xcel Energy Inc / Range Resources Corp / EQT Corp / American Axle & Manufacturing Holdings Inc / Republic Services Inc / Graphic Packaging Holding Co / Verint Systems Inc / Waste Connections Inc / Coeur Mining Inc / Graco Inc / Skyline Champion Corp / California Resources Corp / Plug Power Inc / Ziff Davis Inc / Mullen Group Ltd / Nutrien Ltd / nVent Electric PLC / Mosaic Co / Beacon Roofing Supply Inc / GMS Inc / Builders FirstSource Inc / Chipotle Mexican Grill Inc / Mueller Water Products Inc / Daimler AG / Teradata Corp / Getlink SE / Dana Inc / Cargojet Inc / Meritor Inc / Xylem Inc / Palo Alto Networks Inc / Berry Global Group Inc / Greencoat UK Wind PLC / Masonite International Corp / Installed Building Products Inc / Axalta Coating Systems Ltd / Associated Banc-Corp / Aena SME SA / Block Inc / SiteOne Landscape Supply Inc / Atkore Inc / Adient PLC / Venator Materials PLC / RHI Magnesita NV / Orsted A/S / Evoqua Water Technologies Corp / Gates Industrial Corporation PLC / Zscaler Inc / MeiraGTx Holdings PLC / Avantor Inc / Enerpac Tool Group Corp / TFI International Inc / Metso Outotec Corp / Sumo Logic Inc / Soc Telemed Inc / Dream Finders Homes Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / PowerSchool Holdings Inc / Traeger Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Mexico / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">We See Magro, Leading the CD47 Race, as Important Piece of Puzzle for Emerging Oncology Franchise</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: HHS Holds The Line On Biden's Drug Reform Approaches, But Few New Concepts or Specifics</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - New report: ESMO 2021-China pharma/biotech abstracts to watch for potential catalysts</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0013.HK / 1093.HK / AZN.L / 1177.HK / GILD.OQ / 600276.SS / 4568.T / 002422.SZ / MRTX.OQ / 2186.HK / BGNE.OQ / 300558.SZ / ZYME.N / ZLAB.OQ / 1801.HK / 1877.HK / IMAB.OQ / 1952.HK / 2142.HK</td><td class="leftalignment">HUTCHMED (China) Ltd / CSPC Pharmaceutical Group Ltd / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Gilead Sciences Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Mirati Therapeutics Inc / Luye Pharma Group Ltd / Beigene Ltd / Betta Pharmaceuticals Co Ltd / Zymeworks Inc / Zai Lab Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab / Everest Medicines Ltd / Hbm Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: ESMO 2021: China pharma/biotech abstracts to watch for potential catalysts</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">0013.HK / 1093.HK / AZN.L / 1177.HK / GILD.OQ / 600276.SS / 4568.T / 002422.SZ / MRTX.OQ / 2186.HK / BGNE.OQ / 300558.SZ / ZYME.N / ZLAB.OQ / 1801.HK / 1877.HK / IMAB.OQ / 1952.HK / 2142.HK</td><td class="leftalignment">HUTCHMED (China) Ltd / CSPC Pharmaceutical Group Ltd / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Gilead Sciences Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Mirati Therapeutics Inc / Luye Pharma Group Ltd / Beigene Ltd / Betta Pharmaceuticals Co Ltd / Zymeworks Inc / Zai Lab Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab / Everest Medicines Ltd / Hbm Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">COST.O / HELE.O / KR / MSFT.O / WMT / ACI.N / BYND.O / GILD.O / SQ / HEAR.O / ATVI.OQ / TTWO.OQ / NFLX.O / BJRI.OQ / 36467W109 / TMDX.OQ / FRPT.O / ZNGA.O / EA.O / SFM.O / FDEV.L / 82655M107 / PYPL.O / GBT.OQ / COUP.O / BILI.O / SMAR.K / HUYA.K</td><td class="leftalignment">Costco Wholesale Corp / Helen of Troy Ltd / Kroger Co / Microsoft Corp / Walmart Inc / Albertsons Companies Inc / Beyond Meat Inc / Gilead Sciences Inc / Block Inc / Turtle Beach Corp / Activision Blizzard Inc / Take-Two Interactive Software Inc / Netflix Inc / BJ's Restaurants Inc / GameStop Corp / Transmedics Group Inc / Freshpet Inc / Zynga Inc / Electronic Arts Inc / Sprouts Farmers Market Inc / Frontier Developments PLC / Sify Technologies Ltd / PayPal Holdings Inc / Global Blood Therapeutics Inc / Coupa Software Inc / Bilibili Inc / Smartsheet Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Domino Effect in GILD's Pipeline Potentially Starting</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / FR0000054470 / GB0009252882 / DE0006969603 / US09061G1013 / CH0012032048 / CH0012005267 / US0116591092 / US0311621009 / US0463531089 / US1101221083 / US1311931042 / US14149Y1082 / US1985161066 / US2435371073 / US2855121099 / US3377381088 / US3755581036 / US37733W1053 / US45337C1027 / US5324571083 / US58155Q1031 / US6541061031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US7782961038 / US8305661055 / US8308791024 / US8447411088 / US8725401090 / US8740541094 / US9182041080 / US03073E1055 / US3448491049 / US37940X1028 / US4771431016 / US4198791018 / US80105N1054 / US2533931026 / US09062X1037 / US9043111072 / US31620M1062 / US1314761032 / US4103451021 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US6936561009 / US7512121010 / JE00B783TY65 / US98986T1088 / US00287Y1091 / US85916J4094 / US41068X1000 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / DK0060534915 / CA0089118776 / US83417M1045 / US00653A1079 / VGG312491084 / US5904791358 / US98585X1046 / US89377M1099 / US26142R1041 / US02875D1090 / US04271T1007 / US82489W1071 / US30320C1036 / US1241551027 / US30260D1037 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Ubisoft Entertainment SA / GlaxoSmithKline PLC / Puma SE / Biomarin Pharmaceutical Inc / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cardinal Health Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Electronic Arts Inc / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Eli Lilly and Co / Mckesson Corp / Nike Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Ross Stores Inc / Skechers USA Inc / SkyWest Inc / Southwest Airlines Co / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Amerisourcebergen Corp / Foot Locker Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / DICK'S Sporting Goods Inc / Biogen Inc / Under Armour Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / Stereotaxis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Solaredge Technologies Inc / Adaptimmune Therapeutics PLC / Establishment Labs Holdings Inc / Mesa Air Group Inc / Yeti Holdings Inc / Transmedics Group Inc / DraftKings Inc / American Outdoor Brands Inc / Array Technologies Inc / Shoals Technologies Group Inc / FTC Solar Inc / Butterfly Network Inc / Figs Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Panama / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">2126335 / 2000019 / 2486813 / 2973821 / 2050832 / 2942605 / 2270726 / 2317087 / 2328915 / 2369174 / 2048804 / 2138158 / 2829601 / 2853688 / B1F76F9 / B121557 / 2857817 / B03PGL4 / B7TL820 / BCBVTX1 / B4MG4Z6 / B7JYSG3 / B7577T2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BP4GNK9 / BYW36M8 / BJLFHW7 / BZ8FPH3 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BN2R582 / BD72R64 / BMHR7K6 / BL53KF5 / BP2P6L0 / BMW5LX6</td><td class="leftalignment">Bristol-Myers Squibb Co / Amazon.com Inc / Kellogg Co / Alliant Energy Corp / Ameren Corp / Avista Corp / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Gilead Sciences Inc / Pinnacle West Capital Corp / Sempra Energy / Southern Co / Stryker Corp / Western Union Co / Mastercard Inc / Netflix Inc / NorthWestern Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / AMC Networks Inc / Guidewire Software Inc / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Chewy Inc / Editas Medicine Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Relay Therapeutics Inc / Liberty Media Corp / Impel Neuropharma Inc / F45 Training Holdings Inc / Tango Therapeutics Inc / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AC.TO / AEP.N / AES.N / ALV.N / CCK.N / CF.N / CI.N / CP.TO / DCC.L / DFDS.CO / ECM.L / EIX.N / F.N / FLS.N / FMC.N / FSR.N / GM.N / MAS.N / PD.N / PHM.N / PPG.N / RWEG.DE / SCHN.PA / SO.N / T.N / TOL.N / VC.N / WEIR.L / CONG.DE / CFP.TO / GILD.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / ETR.N / THC.N / CNR.TO / BWA.N / LEA.N / WLK.N / WCC.N / DOV.N / IEX.N / ROP.N / DISH.O / ITP.TO / UNP.N / SIEGn.DE / DV.N / MMM.N / VMC.N / ADCT.N / MGA.N / CONE.O / OLN.N / SHW.N / VZ.N / JCI.N / XEL.N / ARNA.O / APH.N / FISV.O / ADSK.O / V.N / AXL.N / IG.MI / RSG.N / NBIX.O / NWN.N / BC.N / FTS.TO / BMRN.O / REGN.O / VRTX.O / EMA.TO / NCR.N / TEL.N / GPK.N / ALFA.ST / CNP.N / WCN.N / BLU.N / CPK.N / GGG.N / PNR.N / PII.N / ST.N / SKY.N / PLUG.OQ / SGEN.OQ / GPN.N / COA.L / SGSN.S / CCLb.TO / BCRX.O / AMED.O / ICPT.O / EQIX.O / SCHN.S / BIIB.O / NTR.N / NVT.N / MOS.N / BECN.O / DLR.N / ACAD.O / GMS.N / BUCN.S / BLDR.O / LHCG.O / SJW.N / FIS.N / MA.N / MWA.N / HOG.N / H.TO / DAIGn.DE / GETP.PA / DAN.N / TXG.TO / NEE.N / CJT.TO / MTOR.N / XYL.N / EFN.TO / SRPT.O / BERY.N / TPH.N / TSLA.N / ENTA.O / TMUS.N / PTCT.O / DOOR.N / IBP.N / ITCI.O / VRNS.O / 922475108 / SAGE.OQ / AXTA.N / GLPG.O / GBT.OQ / SITE.N / MESO.O / RACE.MI / SCWX.O / ATKR.N / AZRE.N / BBU.N / NTNX.O / ADNT.N / AQN.N / OKTA.OQ / WOW.N / VNTR.N / RHIM.L / ORSTED.CO / AQUA.N / APTV.N / GTES.N / ZS.OQ / SMAR.N / DBX.O / EAF.N / ITRM.O / VNE.N / PRVB.O / ZM.O / MORF.OQ / CRWD.O / DOCU.N / APRE.OQ / CRNC.OQ / EPAC.N / WTRG.N / TFII.N / GFL.N / CARR.N / NKLA.OQ / FOUR.N / MOCORP.HE / ASAN.N / MTCR.O / RIDE.OQ / LSPD.N / DFH.OQ / WFG.N / AFRM.O / PATH.N / TSP.OQ / 9VC.F / PWSC.N / BASE.OQ</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / AES Corp / Autoliv Inc / Crown Holdings Inc / CF Industries Holdings Inc / Cigna Corp / Canadian Pacific Railway Ltd / DCC PLC / DFDS AS / Electrocomponents PLC / Edison International / Ford Motor Co / Flowserve Corp / FMC Corp / Fisker Inc / General Motors Co / Masco Corp / PagerDuty Inc / Pultegroup Inc / PPG Industries Inc / Rwe AG / Schneider Electric SE / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weir Group PLC / Continental AG / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Entergy Corp / Tenet Healthcare Corp / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Westlake Chemical Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / DISH Network Corp / Intertape Polymer Group Inc / Union Pacific Corp / Siemens AG / DoubleVerify Holdings Inc / 3M Co / Vulcan Materials Co / ADC Therapeutics SA / Magna International Inc / CyrusOne Inc / Olin Corp / Sherwin-Williams Co / Verizon Communications Inc / Johnson Controls International PLC / Xcel Energy Inc / Arena Pharmaceuticals Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Italgas SpA / Republic Services Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Brunswick Corp / Fortis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Emera Inc / NCR Corp / TE Connectivity Ltd / Graphic Packaging Holding Co / Alfa Laval AB / CenterPoint Energy Inc / Waste Connections Inc / BELLUS Health Inc / Chesapeake Utilities Corp / Graco Inc / Pentair PLC / Polaris Inc / Sensata Technologies Holding PLC / Skyline Champion Corp / Plug Power Inc / Seagen Inc / Global Payments Inc / Coats Group PLC / SGS SA / CCL Industries Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Schindler Holding AG / Biogen Inc / Nutrien Ltd / nVent Electric PLC / Mosaic Co / Beacon Roofing Supply Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / GMS Inc / Bucher Industries AG / Builders FirstSource Inc / LHC Group Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Hydro One Ltd / Daimler AG / Getlink SE / Dana Inc / Torex Gold Resources Inc / Nextera Energy Inc / Cargojet Inc / Meritor Inc / Xylem Inc / Element Fleet Management Corp / Sarepta Therapeutics Inc / Berry Global Group Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Masonite International Corp / Installed Building Products Inc / Intra-Cellular Therapies Inc / Varonis Systems Inc / Veeva Systems Inc / SAGE Therapeutics Inc / Axalta Coating Systems Ltd / Galapagos NV / Global Blood Therapeutics Inc / SiteOne Landscape Supply Inc / Mesoblast Ltd / Ferrari NV / SecureWorks Corp / Atkore Inc / Azure Power Global Ltd / Brookfield Business Partners LP / Nutanix Inc / Adient PLC / Algonquin Power & Utilities Corp / Okta Inc / WideOpenWest Inc / Venator Materials PLC / RHI Magnesita NV / Orsted A/S / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Zscaler Inc / Smartsheet Inc / Dropbox Inc / GrafTech International Ltd / Iterum Therapeutics PLC / Veoneer Inc / Provention Bio Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / DocuSign Inc / Aprea Therapeutics Inc / Cerence Inc / Enerpac Tool Group Corp / Essential Utilities Inc / TFI International Inc / GFL Environmental Inc / Carrier Global Corp / Nikola Corp / Shift4 Payments Inc / Metso Outotec Corp / Asana Inc / Metacrine Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / UiPath Inc / TuSimple Holdings Inc / ATAI Life Sciences NV / PowerSchool Holdings Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Italy / Mauritius / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BLU.N / BCRX.O / ICPT.O / BIIB.O / SRPT.O / ENTA.O / PTCT.O / SAGE.OQ / GLPG.O / GBT.OQ / ITRM.O / PRVB.O / MORF.OQ / APRE.OQ / MTCR.O / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Metacrine Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TNGX - The Next Innovative Player in "La Cumparsita" of Synthetic Lethality; Initiating Coverage of Tango Therapeutics with a BUY Rating and $16 PT</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BP2P6L0 / 0989529 / 0925288 / 2126335 / 2369174 / 2455965 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0 / BK0VHF6 / BYYWPW6 / BL71K91 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Tango Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / IDEAYA Biosciences Inc / Beigene Ltd / Revolution Medicines Inc / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Gilead Sciences, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Anguilla / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 78 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAN.N / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / BRX.N / TWOU.OQ / ANTM.N / NTRA.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Brixmor Property Group Inc / 2U Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Defending AbbVie Here as Rinvoq Should Still Hit $7-8bn Globally</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.N / 71708110 / 37555810 / 00287Y10</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMO.TO / CAS.TO / CM.TO / CP.TO / IBE.MC / NA / RWEG.DE / STO.AX / T.TO / TD.TO / TRI.N / CNQ.TO / GILD.O / AAL.L / ENB.TO / TRP.TO / SU.TO / DVN.N / MGA.N / NG.L / ALA.TO / SRE.N / RRC.N / EPD.N / WSP.TO / FTS.TO / VRTX.O / FTT.TO / COP.N / APF.L / MEOH.O / WCN.N / DOL.TO / CRC.N / HCC.N / LNG.A / CCLb.TO / ATDb.TO / BIIB.O / FMG.AX / TIH.TO / MFI.TO / 878742204 / NTR.N / ACAD.O / NESTE.HE / WSA.AX / RDSb.L / BAM.N / DRX.L / SES.TO / CSU.TO / PPL.TO / GETP.PA / EDPR.LS / ARX.TO / CLW.N / IFC.TO / AAV.TO / CVE.TO / BHPB.L / MNR.N / NEE.N / MEG.TO / TOU.TO / GLEN.L / TVE.TO / EFN.TO / RFP.N / KPT.TO / ENTA.O / PTCT.O / QSR.N / AZRE.N / AKERBP.OL / AQN.N / WPM.N / ORSTED.CO / GMDA.OQ / CRWD.O / FCR_u.TO / GFL.N / AKES.OL / MTCR.O / WFG.N / GIP.V / EVGN.V</td><td class="leftalignment">Bank of Montreal / Cascades Inc / Canadian Imperial Bank of Commerce / Canadian Pacific Railway Ltd / Iberdrola SA / National Bank of Canada / Rwe AG / Santos Ltd / Telus Corp / Toronto-Dominion Bank / Thomson Reuters Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Anglo American PLC / Enbridge Inc / TC Energy Corp / Suncor Energy Inc / Devon Energy Corp / Magna International Inc / National Grid PLC / AltaGas Ltd / Sempra Energy / Range Resources Corp / Enterprise Products Partners LP / WSP Global Inc / Fortis Inc / Vertex Pharmaceuticals Inc / Finning International Inc / Conocophillips / Anglo Pacific Group PLC / Methanex Corp / Waste Connections Inc / Dollarama Inc / California Resources Corp / Warrior Met Coal Inc / Cheniere Energy Inc / CCL Industries Inc / Alimentation Couche-Tard Inc / Biogen Inc / Fortescue Metals Group Ltd / Toromont Industries Ltd / Maple Leaf Foods Inc / Teck Resources Ltd / Nutrien Ltd / ACADIA Pharmaceuticals Inc / Neste Oyj / Western Areas Ltd / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Drax Group PLC / Secure Energy Services Inc / Constellation Software Inc / Pembina Pipeline Corp / Getlink SE / EDP Renovaveis SA / ARC Resources Ltd / Clearwater Paper Corp / Intact Financial Corp / Advantage Energy Ltd / Cenovus Energy Inc / BHP Group PLC / Monmouth Real Estate Investment Corp / Nextera Energy Inc / MEG Energy Corp / Tourmaline Oil Corp / Glencore PLC / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Resolute Forest Products Inc / KP Tissue Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Restaurant Brands International Inc / Azure Power Global Ltd / Aker BP ASA / Algonquin Power & Utilities Corp / Wheaton Precious Metals Corp / Orsted A/S / Gamida Cell Ltd / CrowdStrike Holdings Inc / First Capital Real Estate Investment Trust / GFL Environmental Inc / Aker Solutions ASA / Metacrine Inc / West Fraser Timber Co Ltd / Green Impact Partners Inc / EverGen Infrastructure Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Mauritius / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / VRTX.O / BIIB.O / ACAD.O / ENTA.O / PTCT.O / GMDA.OQ / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Gamida Cell Ltd / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Gilead (GILD: $72.78) rises 6% on high volatility in August 2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GLPG: Search For New CEO As GLPG Looks To Write Next Chapter</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">GILD.O / GLPG.O / GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - August 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BNS.TO / CF.N / CI.N / CRM.N / FMC.N / KO.N / LGEN.L / MAS.N / MICP.PA / MMC.N / MSFT.O / PNC.N / PRTP.PA / PRU.L / RSG.AX / SCHN.PA / TOTF.PA / GILD.O / DIS.N / IEX.N / ROP.N / ADBE.O / SIEGn.DE / AMT.N / SHW.N / BLL.N / NG.L / SBUX.O / ADSK.O / V.N / AWK.N / ACN.N / PLD.N / MCO.N / EQIX.O / COE.AX / NTR.N / MOS.N / NESTE.HE / MA.N / NEE.N / NXT.AX / XYL.N / SPGI.N / WPM.N / ORSTED.CO / APTV.N / CTVA.N</td><td class="leftalignment">Bank of Nova Scotia / CF Industries Holdings Inc / Cigna Corp / Salesforce.Com Inc / FMC Corp / Coca-Cola Co / Legal & General Group PLC / Masco Corp / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Microsoft Corp / PNC Financial Services Group Inc / Kering SA / Prudential PLC / Resolute Mining Ltd / Schneider Electric SE / TotalEnergies SE / Gilead Sciences Inc / Walt Disney Co / IDEX Corp / Roper Technologies Inc / Adobe Inc / Siemens AG / American Tower Corp / Sherwin-Williams Co / Ball Corp / National Grid PLC / Starbucks Corp / Autodesk Inc / Visa Inc / American Water Works Company Inc / Accenture PLC / Prologis Inc / Moody's Corp / Equinix Inc / Cooper Energy Ltd / Nutrien Ltd / Mosaic Co / Neste Oyj / Mastercard Inc / Nextera Energy Inc / NEXTDC Ltd / Xylem Inc / S&P Global Inc / Wheaton Precious Metals Corp / Orsted A/S / Aptiv PLC / Corteva Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Germany / Denmark / Finland / France / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/28/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Gilead Sciences, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BNS.TO / CAS.TO / CF.N / CI.N / CM.TO / CRM.N / FMC.N / IP.N / KO.N / LGEN.L / MAS.N / MICP.PA / MMC.N / MSFT.O / PD.TO / PNC.N / PRTP.PA / PRU.L / RYN.N / SCHN.PA / TOTF.PA / WY.N / CFP.TO / GILD.O / LPX.N / DIS.N / IEX.N / ROP.N / ADBE.O / SIEGn.DE / AMT.N / SHW.N / BLL.N / NG.L / PCOM.O / SBUX.O / ADSK.O / V.N / AWK.N / ACN.N / PLD.N / WSP.TO / FTS.TO / MRD.TO / EXE.TO / ARE.TO / JHX.AX / EMA.TO / MCO.N / CAR_u.TO / CU.TO / EQIX.O / TCLa.TO / STN.TO / ATDb.TO / SMU_U.TO / SNC.TO / REI_u.TO / MRC.TO / MRT_u.TO / MDI.TO / HR_u.TO / CUF_u.TO / CHE_u.TO / HOT_u.TO / AP_u.TO / CSH_u.TO / D_u.TO / CRT_u.TO / BEI_u.TO / HCG.TO / NTR.N / MOS.N / NESTE.HE / WEF.TO / BAM.N / CRR_u.TO / MA.N / MERC.O / AX_u.TO / H.TO / IIP_u.TO / OSK.TO / CLW.N / AR.TO / ADN.TO / NWH_u.TO / TCN.TO / NEE.N / PCH.O / CJT.TO / CFX.TO / CTT.N / IFP.TO / WTE.TO / XYL.N / TVE.TO / RFP.N / MRG_u.TO / DIR_u.TO / GRT_u.TO / KPT.TO / MR_u.TO / CHP_u.TO / CFF.TO / PLZ_u.TO / PLC.TO / RYAM.N / SIA.TO / CIGI.O / FSV.O / WRK.N / SRU_u.TO / TWM.TO / KMP_u.TO / APR_U.TO / SPGI.N / ECN.TO / WPM.N / JWEL.TO / ORSTED.CO / APTV.N / MI_U.TO / HOMU.TO / CTVA.N / FCR_u.TO / ERE_u.TO / AD_u.TO / WFG.N / EVGN.V</td><td class="leftalignment">Bank of Nova Scotia / Cascades Inc / CF Industries Holdings Inc / Cigna Corp / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / FMC Corp / International Paper Co / Coca-Cola Co / Legal & General Group PLC / Masco Corp / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Microsoft Corp / Precision Drilling Corp / PNC Financial Services Group Inc / Kering SA / Prudential PLC / Rayonier Inc / Schneider Electric SE / TotalEnergies SE / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Walt Disney Co / IDEX Corp / Roper Technologies Inc / Adobe Inc / Siemens AG / American Tower Corp / Sherwin-Williams Co / Ball Corp / National Grid PLC / Points International Ltd / Starbucks Corp / Autodesk Inc / Visa Inc / American Water Works Company Inc / Accenture PLC / Prologis Inc / WSP Global Inc / Fortis Inc / Melcor Developments Ltd / Extendicare Inc / Aecon Group Inc / James Hardie Industries PLC / Emera Inc / Moody's Corp / Canadian Apartment Properties Real Estate Investment Trust / Canadian Utilities Ltd / Equinix Inc / Transcontinental Inc / Stantec Inc / Alimentation Couche-Tard Inc / Summit Industrial Income REIT / SNC-Lavalin Group Inc / RioCan Real Estate Investment Trust / Morguard Corp / Morguard Real Estate Investment Trust / Major Drilling Group International Inc / H&R Real Estate Investment Trust / Cominar Real Estate Investment Trust / Chemtrade Logistics Income Fund / American Hotel Income Properties REIT LP / Allied Properties Real Estate Investment Trust / Chartwell Retirement Residences / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Boardwalk Real Estate Investment Trust / Home Capital Group Inc / Nutrien Ltd / Mosaic Co / Neste Oyj / Western Forest Products Inc / Brookfield Asset Management Inc / Crombie Real Estate Investment Trust / Mastercard Inc / Mercer International Inc / Artis Real Estate Investment Trust / Hydro One Ltd / InterRent Real Estate Investment Trust / Osisko Mining Inc / Clearwater Paper Corp / Argonaut Gold Inc / Acadian Timber Corp / NorthWest Healthcare Properties REIT / Tricon Residential Inc / Nextera Energy Inc / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / CatchMark Timber Trust Inc / Interfor Corp / Westshore Terminals Investment Corp / Xylem Inc / Tamarack Valley Energy Ltd / Resolute Forest Products Inc / Morguard North American Residential Real Estate Investment Trust / Dream Industrial Real Estate Investment Trust / Granite Real Estate Investment Trust / KP Tissue Inc / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Conifex Timber Inc / Plaza Retail REIT / Park Lawn Corp / Rayonier Advanced Materials Inc / Sienna Senior Living Inc / Colliers International Group Inc / FirstService Corp / Westrock Co / SmartCentres Real Estate Investment Trust / Tidewater Midstream and Infrastructure Ltd / Killam Apartment REIT / Automotive Properties Real Estate Investment Trust / S&P Global Inc / ECN Capital Corp / Wheaton Precious Metals Corp / Jamieson Wellness Inc / Orsted A/S / Aptiv PLC / Minto Apartment Real Estate Investment Trust / BSR Real Estate Investment Trust / Corteva Inc / First Capital Real Estate Investment Trust / European Residential REIT / Alaris Equity Partners Income Trust / West Fraser Timber Co Ltd / EverGen Infrastructure Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Denmark / Finland / France / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Andre-Philippe Hardy, CFA</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BNS.TO / CF.N / CI.N / CM.TO / CRM.N / FMC.N / KO.N / LGEN.L / MAS.N / MICP.PA / MMC.N / MSFT.O / PNC.N / PRTP.PA / PRU.L / SCHN.PA / TD.TO / TOTF.PA / GILD.O / DIS.N / IEX.N / ROP.N / ADBE.O / SIEGn.DE / AMT.N / SHW.N / BLL.N / NG.L / SBUX.O / ADSK.O / V.N / AWK.N / ACN.N / PLD.N / WSP.TO / ARE.TO / MCO.N / EQIX.O / STN.TO / SNC.TO / NTR.N / MOS.N / NESTE.HE / MA.N / OSK.TO / NEE.N / XYL.N / SPGI.N / WPM.N / ORSTED.CO / APTV.N / CTVA.N</td><td class="leftalignment">Bank of Nova Scotia / CF Industries Holdings Inc / Cigna Corp / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / FMC Corp / Coca-Cola Co / Legal & General Group PLC / Masco Corp / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Microsoft Corp / PNC Financial Services Group Inc / Kering SA / Prudential PLC / Schneider Electric SE / Toronto-Dominion Bank / TotalEnergies SE / Gilead Sciences Inc / Walt Disney Co / IDEX Corp / Roper Technologies Inc / Adobe Inc / Siemens AG / American Tower Corp / Sherwin-Williams Co / Ball Corp / National Grid PLC / Starbucks Corp / Autodesk Inc / Visa Inc / American Water Works Company Inc / Accenture PLC / Prologis Inc / WSP Global Inc / Aecon Group Inc / Moody's Corp / Equinix Inc / Stantec Inc / SNC-Lavalin Group Inc / Nutrien Ltd / Mosaic Co / Neste Oyj / Mastercard Inc / Osisko Mining Inc / Nextera Energy Inc / Xylem Inc / S&P Global Inc / Wheaton Precious Metals Corp / Orsted A/S / Aptiv PLC / Corteva Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Denmark / Finland / France / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BNS.TO / CF.N / CI.N / CM.TO / CRM.N / FMC.N / KO.N / LGEN.L / MAS.N / MICP.PA / MMC.N / MSFT.O / PNC.N / PRTP.PA / PRU.L / RWEG.DE / SCHN.PA / TD.TO / TOTF.PA / ZION.O / GILD.O / DIS.N / IEX.N / ROP.N / ADBE.O / SIEGn.DE / AMT.N / SHW.N / BLL.N / NG.L / SBUX.O / ARNA.O / ADSK.O / V.N / AWK.N / ACN.N / PLD.N / MCO.N / NRZ.N / EQIX.O / NTR.N / MOS.N / NESTE.HE / MA.N / VMW.N / NEE.N / NXT.AX / PCRX.O / MTDR.N / XYL.N / SRPT.O / ITCI.O / OLLI.OQ / GBT.OQ / RPD.O / TRHC.OQ / SPGI.N / KNSL.OQ / UN01.DE / WPM.N / ORSTED.CO / CARG.O / SAIL.N / APTV.N / GSHD.O / OPRX.OQ / CTVA.N / NOVA.N / PING.N / SLQT.N / RXT.OQ / JAMF.O / PUBM.O / OSO.N / FLYW.O</td><td class="leftalignment">Bank of Nova Scotia / CF Industries Holdings Inc / Cigna Corp / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / FMC Corp / Coca-Cola Co / Legal & General Group PLC / Masco Corp / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Microsoft Corp / PNC Financial Services Group Inc / Kering SA / Prudential PLC / Rwe AG / Schneider Electric SE / Toronto-Dominion Bank / TotalEnergies SE / Zions Bancorporation NA / Gilead Sciences Inc / Walt Disney Co / IDEX Corp / Roper Technologies Inc / Adobe Inc / Siemens AG / American Tower Corp / Sherwin-Williams Co / Ball Corp / National Grid PLC / Starbucks Corp / Arena Pharmaceuticals Inc / Autodesk Inc / Visa Inc / American Water Works Company Inc / Accenture PLC / Prologis Inc / Moody's Corp / New Residential Investment Corp / Equinix Inc / Nutrien Ltd / Mosaic Co / Neste Oyj / Mastercard Inc / VMware Inc / Nextera Energy Inc / NEXTDC Ltd / Pacira Biosciences Inc / Matador Resources Co / Xylem Inc / Sarepta Therapeutics Inc / Intra-Cellular Therapies Inc / Ollie's Bargain Outlet Holdings Inc / Global Blood Therapeutics Inc / Rapid7 Inc / Tabula Rasa HealthCare Inc / S&P Global Inc / Kinsale Capital Group Inc / Uniper SE / Wheaton Precious Metals Corp / Orsted A/S / CarGurus Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Goosehead Insurance Inc / OPTIMIZERx Corp / Corteva Inc / Sunnova Energy International Inc / Ping Identity Holding Corp / SelectQuote Inc / Rackspace Technology Inc / Jamf Holding Corp / PubMatic Inc / Olo Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Germany / Denmark / Finland / France / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BNS.TO / CF.N / CI.N / CRM.N / FMC.N / HTG.L / KO.N / LGEN.L / MAS.N / MICP.PA / MMC.N / MSFT.O / PNC.N / PRTP.PA / PRU.L / SCHN.PA / TOTF.PA / GILD.O / DIS.N / IEX.N / ROP.N / ADBE.O / SIEGn.DE / AMT.N / SHW.N / BLL.N / NG.L / SBUX.O / ADSK.O / V.N / AWK.N / ACN.N / PLD.N / MCO.N / EQIX.O / NTR.N / MOS.N / NESTE.HE / MA.N / NEE.N / XYL.N / SPGI.N / WPM.N / JUSTJ.L / ORSTED.CO / APTV.N / CTVA.N</td><td class="leftalignment">Bank of Nova Scotia / CF Industries Holdings Inc / Cigna Corp / Salesforce.Com Inc / FMC Corp / Hunting PLC / Coca-Cola Co / Legal & General Group PLC / Masco Corp / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Microsoft Corp / PNC Financial Services Group Inc / Kering SA / Prudential PLC / Schneider Electric SE / TotalEnergies SE / Gilead Sciences Inc / Walt Disney Co / IDEX Corp / Roper Technologies Inc / Adobe Inc / Siemens AG / American Tower Corp / Sherwin-Williams Co / Ball Corp / National Grid PLC / Starbucks Corp / Autodesk Inc / Visa Inc / American Water Works Company Inc / Accenture PLC / Prologis Inc / Moody's Corp / Equinix Inc / Nutrien Ltd / Mosaic Co / Neste Oyj / Mastercard Inc / Nextera Energy Inc / Xylem Inc / S&P Global Inc / Wheaton Precious Metals Corp / Just Group PLC / Orsted A/S / Aptiv PLC / Corteva Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Denmark / Finland / France / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC ESG Stratify™: The ESG Scoop</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">BNS.TO / CI.N / CRM.N / KO.N / LGEN.L / MAS.N / MICP.PA / MMC.N / MSFT.O / PNC.N / PRTP.PA / PRU.L / SCHN.PA / TOTF.PA / GILD.O / DIS.N / IEX.N / ROP.N / ADBE.O / SIEGn.DE / AMT.N / SHW.N / BLL.N / NG.L / SBUX.O / ADSK.O / V.N / AWK.N / ACN.N / PLD.N / MCO.N / EQIX.O / NESTE.HE / MA.N / NEE.N / XYL.N / SPGI.N / WPM.N / ORSTED.CO / APTV.N</td><td class="leftalignment">Bank of Nova Scotia / Cigna Corp / Salesforce.Com Inc / Coca-Cola Co / Legal & General Group PLC / Masco Corp / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Microsoft Corp / PNC Financial Services Group Inc / Kering SA / Prudential PLC / Schneider Electric SE / TotalEnergies SE / Gilead Sciences Inc / Walt Disney Co / IDEX Corp / Roper Technologies Inc / Adobe Inc / Siemens AG / American Tower Corp / Sherwin-Williams Co / Ball Corp / National Grid PLC / Starbucks Corp / Autodesk Inc / Visa Inc / American Water Works Company Inc / Accenture PLC / Prologis Inc / Moody's Corp / Equinix Inc / Neste Oyj / Mastercard Inc / Nextera Energy Inc / Xylem Inc / S&P Global Inc / Wheaton Precious Metals Corp / Orsted A/S / Aptiv PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Denmark / Finland / France / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Sara Mahaffy / Ms. Lori Calvasina / Carlos Torres / April Lu</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GILD: A Good Week For Yescarta, Now Poised To Pull Ahead As CAR-T Of Choice As Competitors Hit Legal and Clinical Snags</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US / MDT=US / GILD=US / VRM=US / ESS=US / HEI=US / MAN=US / CPT=US / MAA=US / MGNI=US / PTON=US / LLNW=US / 45665G303 / NXRT=US / YEXT=US</td><td class="leftalignment">Pfizer Inc / Medtronic PLC / Gilead Sciences Inc / Vroom Inc / Essex Property Trust Inc / HEICO Corp / ManpowerGroup Inc / Camden Property Trust / Mid-America Apartment Communities Inc / Magnite Inc / Peloton Interactive Inc / Limelight Networks Inc / Infinity Pharmaceuticals Inc / NexPoint Residential Trust Inc / Yext Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Aug 13</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Gilead Sciences Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Macrophage targeting heating up, in our view - M&A read-through from PFE/TRIL acquisition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">45665G303 / PFE.N / PFE=US / GILD=US / INFI.OQ</td><td class="leftalignment">Infinity Pharmaceuticals Inc / Pfizer Inc / Pfizer Inc / Gilead Sciences Inc / Infinity Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE / INTC.O / QCOM.O / W / GILD.O / WCC / KMX.N / AVGO.O / CRUS.OQ / UTHR.OQ / SWKS.OQ / MRNA.O / 00826A109 / FIVE.OQ / PANW.K / QRVO.O / ETSY.O / AKTS.OQ / CVNA.N / PRPL.O / NBSE.O / PTON.OQ / GRWG.O / HGEN.O / REGW.M3</td><td class="leftalignment">Deere & Co / Intel Corp / Qualcomm Inc / Wayfair Inc / Gilead Sciences Inc / Wesco International Inc / Carmax Inc / Broadcom Inc / Cirrus Logic Inc / United Therapeutics Corp / Skyworks Solutions Inc / Moderna Inc / Affymax Inc / Five Below Inc / Palo Alto Networks Inc / Qorvo Inc / ETSY Inc / Akoustis Technologies Inc / Carvana Co / Purple Innovation Inc / NeuBase Therapeutics Inc / Peloton Interactive Inc / GrowGeneration Corp / Humanigen Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CD47 still remains one of the hot targets in IO combos - reads to GILD and ALX from PFE deal</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US3755581036 / PFE.N / LLY / PFE / ALXO</td><td class="leftalignment">Gilead Sciences Inc / Pfizer Inc / Eli Lilly and Co / Pfizer Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Ms. Emma K. Nealon, III / Emily Bodnar</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The ‘Trill’ Of Victory: Acquisition in CD47 Space Validates Magro Oppty, Though Intensifies Competition</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALXO: TRIL Acquisition Underscores Interest in CD47 Landscape; ALXO Remains Well-Positioned</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALXO.OQ / PFE.N / GILD.OQ</td><td class="leftalignment">ALX Oncology Holdings Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">4502.T / ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / HUM / IVC / MDT / RAD / ROG / SYK / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / EW.N / SSNC.O / ISR / SRDX.O / NOVN.OQ / EPIX.OQ / ICPT.OQ / ISRG.OQ / CCRN.O / ICAD.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ANGO.OQ / MBRX.OQ / ATRC.OQ / LHCG.O / BLRX.TA / ENSG.OQ / 483548103 / MRNA.O / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / MDXG.O / AXGN.O / FATE.OQ / GOOGL.O / CBAY.OQ / MRNS.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / ZBH.N / SPNE.O / 100063846 / SSKN.OQ / VREX.OQ / 45780L104 / IPIX.PK / MBIO.OQ / CUE.OQ / 720795103 / MOTS.O / ORTX.OQ / SWAV.O / BWAY.TA / FREQ.OQ / PNTG.OQ / APRE.O / VERO.O / ETNB.O / AYLA.O / FMTX.O / NNOX.O / 03823M100 / N69603145</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Humana Inc / Invacare Corp / Medtronic PLC / Rite Aid Corp / Rogers Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Novan Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AngioDynamics Inc / Moleculin Biotech Inc / AtriCure Inc / LHC Group Inc / BioLine RX Ltd / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / MiMedx Group Inc / AxoGen Inc / Fate Therapeutics Inc / Alphabet Inc / Cymabay Therapeutics Inc / Marinus Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / SeaSpine Holdings Corp / Truist Financial Corp / STRATA Skin Sciences Inc / Varex Imaging Corp / Inogen Inc / Innovation Pharmaceuticals Inc / Mustang Bio Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / Brainsway Ltd / Frequency Therapeutics Inc / Pennant Group Inc / Aprea Therapeutics Inc / Venus Concept Inc / 89Bio Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMT / BSX / CCI.N / CRM.N / CRY.N / DLR / GLW / GS / INTC.O / MCD / MCO / MDT / MS / MSFT.O / NICE.TA / NOW / QCOM.O / QUIK.O / T.N / WMT / 4716.T / AMZN.O / GILD.O / AAPL.O / DISH.O / ADBE.O / SAPG.DE / HEAR.O / UPS.N / SBAC.O / RDWR.O / CRNT.O / LSCC.O / SMTC.O / ADSK.O / CHTR.O / NUAN.O / DOX.O / NET.N / HPE / AVGO.O / GTT / SRDX.O / CSCO.OQ / ATVI.OQ / CSGS.OQ / TTWO.OQ / ICPT.OQ / AKAM.OQ / MRVL.OQ / VRNT.OQ / TEAM.O / EGAN.O / PCTY.O / EQIX.O / NFLX.O / CEVA.O / 92343V104 / 20030N101 / 459200101 / ANGO.OQ / NDAQ.O / 315616102 / 36467W109 / ICE.N / CCOI.O / CME.O / VMW / LLNW.OQ / 771195104 / CSII.O / TSLA.O / AMD.OQ / ZNGA.O / EA.O / SPLK.O / FB.O / MDXG.O / AXGN.O / RNG.N / FATE.OQ / FDEV.L / GOOGL.O / FIVN.O / 563771203 / 82655M107 / SNOW.K / NEWR.K / APPS.O / SHOP.K / SPNE.O / TMUS.OQ / SPGI.K / BABA.K / TTD.OQ / COUP.O / TWLO.K / VREX.OQ / ATUS.K / WDAY.O / ROKU.O / MDB.O / VICp.V / EGHT.K / 83417M104 / BILI.O / AVYA.K / DOCU.O / CBOE.Z / FTCH.N / ESTC.N / CDAY.K / SWAV.O / ZM.OQ / CMBM.OQ / DDOG.O / FVRR.K / FSLY.K / ETNB.O / VG.O / DKNG.O / CXDO.O / RXT.O / TEUM.PK / ONDS.OQ / HUYA.K</td><td class="leftalignment">American Tower Corp / Boston Scientific Corp / Crown Castle International Corp / Salesforce.Com Inc / CryoLife Inc / Digital Realty Trust Inc / Corning Inc / Goldman Sachs Group Inc / Intel Corp / McDonald's Corp / Moody's Corp / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nice Ltd / ServiceNow Inc / Qualcomm Inc / QuickLogic Corp / AT&T Inc / Walmart Inc / Oracle Corp Japan / Amazon.com Inc / Gilead Sciences Inc / Apple Inc / DISH Network Corp / Adobe Inc / SAP SE / Turtle Beach Corp / United Parcel Service Inc / SBA Communications Corp / Radware Ltd / Ceragon Networks Ltd / Lattice Semiconductor Corp / Semtech Corp / Autodesk Inc / Charter Communications Inc / Nuance Communications Inc / Amdocs Ltd / Cloudflare Inc / Hewlett Packard Enterprise Co / Broadcom Inc / GTT Communications Inc / Surmodics Inc / Cisco Systems Inc / Activision Blizzard Inc / CSG Systems International Inc / Take-Two Interactive Software Inc / Intercept Pharmaceuticals Inc / Akamai Technologies Inc / Marvell Technology Inc / Verint Systems Inc / Atlassian Corporation PLC / eGain Corp / Paylocity Holding Corp / Equinix Inc / Netflix Inc / CEVA Inc / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / AngioDynamics Inc / Nasdaq Inc / F5 Inc / GameStop Corp / Intercontinental Exchange Inc / Cogent Communications Holdings Inc / CME Group Inc / VMware Inc / Limelight Networks Inc / Roche Holding AG / Cardiovascular Systems Inc / Tesla Inc / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Splunk Inc / Meta Platforms Inc / MiMedx Group Inc / AxoGen Inc / RingCentral Inc / Fate Therapeutics Inc / Frontier Developments PLC / Alphabet Inc / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Snowflake Inc. / New Relic Inc / Digital Turbine Inc / Shopify Inc / SeaSpine Holdings Corp / T-Mobile US Inc / S&P Global Inc / Alibaba Group Holding Ltd / Trade Desk Inc / Coupa Software Inc / Twilio Inc / Varex Imaging Corp / Altice USA Inc / Workday Inc / Roku Inc / MongoDB Inc / Victory Capital Corp / 8x8 Inc / Solaredge Technologies Inc / Bilibili Inc / Avaya Holdings Corp / DocuSign Inc / Cboe Global Markets Inc / Farfetch Ltd / Elastic NV / Ceridian HCM Holding Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Cambium Networks Corp / Datadog Inc / Fiverr International Ltd / Fastly Inc / 89Bio Inc / Vonage Holdings Corp / DraftKings Inc / Crexendo Inc / Rackspace Technology Inc / Pareteum Corp / Ondas Holdings Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / Germany / United Kingdom / India / Ireland / Israel / Japan / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2516152 / 2486813 / 2270726 / 2317087 / 2670519 / 2328915 / 2342034 / 2369174 / 2689560 / 2048804 / 2989301 / 2503529 / 2857817 / B0T7YX2 / B4N0JJ6 / B7TL820 / BCZS820 / BVVN4Q8 / BYVYD43 / BYW36M8 / BZ1HM42 / BMYML02 / BKTNTR9 / BYQCZ35 / BD72R64 / BNLYJ60</td><td class="leftalignment">Eli Lilly and Co / Kellogg Co / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / PG&E Corp / Pinnacle West Capital Corp / TJX Companies Inc / World Wrestling Entertainment Inc / Netflix Inc / Live Nation Entertainment Inc / Visteon Corp / Meta Platforms Inc / Fate Therapeutics Inc / Eversource Energy / Performance Food Group Co / PayPal Holdings Inc / Adyen NV / DraftKings Inc / ViacomCBS Inc / Madison Square Garden Sports Corp / Liberty Media Corp / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">EL.N / KMB.N / NCM.AX / SSE.L / PG.N / CFP.TO / GILD.O / DUK.N / EPR.N / SGMO.O / STZ.N / CHD.N / SCHN.S / WEF.TO / KNEBV.HE / ARWR.O / IFP.TO / PANW.N / CFF.TO / QURE.O / GLPG.O / RGNX.O / IONS.O / EDIT.O / NTLA.O / CRSP.OQ / FIXX.O / OTIS.N / WFG.N / CLVT.N / TRMR.OQ</td><td class="leftalignment">Estee Lauder Companies Inc / Kimberly-Clark Corp / Newcrest Mining Ltd / SSE PLC / Procter & Gamble Co / Canfor Corp / Gilead Sciences Inc / Duke Energy Corp / EPR Properties / Sangamo Therapeutics Inc / Constellation Brands Inc / Church & Dwight Co Inc / Schindler Holding AG / Western Forest Products Inc / Kone Oyj / Arrowhead Pharmaceuticals Inc / Interfor Corp / Palo Alto Networks Inc / Conifex Timber Inc / Uniqure NV / Galapagos NV / Regenxbio Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Homology Medicines Inc / Otis Worldwide Corp / West Fraser Timber Co Ltd / CLARIVATE PLC / Tremor International Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Finland / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Assessing Strategic Options Around the GILD Partnership: Can GLPG Still Extract Value?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ / GLPG.O / GILD.O</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Muted Response to Lymphoma Data a Head-Scratcher</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FATE.OQ / GILD.O / 771195104</td><td class="leftalignment">Fate Therapeutics Inc / Gilead Sciences Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Matthew Biegler / Mark Breidenbach, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AXAF.PA / CNA.L / PRU.L / SSE.L / GILD.O / CMCSA.O / DRI.N / EAT.N / MCD.N / YUM.N / SBUX.O / JKHY.O / MFA.N / DPZ.N / TXRH.O / VIAC.O / CMG.N / JACK.OQ / AGES.BR / WEN.O / QSR.N / GDS.O / STLC.TO / WING.N</td><td class="leftalignment">AXA SA / Centrica PLC / Prudential PLC / SSE PLC / Gilead Sciences Inc / Comcast Corp / Darden Restaurants Inc / Brinker International Inc / McDonald's Corp / Yum! Brands Inc / Starbucks Corp / Jack Henry & Associates Inc / MFA Financial Inc / Domino's Pizza Inc / Texas Roadhouse Inc / ViacomCBS Inc / Chipotle Mexican Grill Inc / Jack in the Box Inc / Ageas SA / Wendys Co / Restaurant Brands International Inc / GDS Holdings Ltd / Stelco Holdings Inc / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Trodelvy HR+ Data Should Validate Oncology Strategy and Drive Year-End Value Inflection</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">As We Expected, Q2 Beats and Raises for Biopharma and Stocks Now Repricing</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 00287Y10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Gilead Sciences, Inc. (GILD) - Strategic focus on oncology business</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ME: Sitting on a Genome Mine: Initiate with an Outperform Rating and $13 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">ME.OQ / BMY.N / MRK.N / ROG.S / LH.N / MRCG.DE / GSK.L / GILD.OQ / MYGN.OQ / ILMN.OQ / SGEN.OQ / ALM.MC / NVTA.N / NTRA.OQ / BGNE.OQ / 6160.HK</td><td class="leftalignment">23andMe Holding Co. / Bristol-Myers Squibb Co / Merck & Co Inc / Roche Holding AG / Laboratory Corporation of America Holdings / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Myriad Genetics Inc / Illumina Inc / Seagen Inc / Almirall SA / Invitae Corp / Natera Inc / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Spain / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / HUM / KR / MDT / RAD / UNH / WMT / ACI.N / GILD.O / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / SSNC.O / ICPT.OQ / UTHR.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / MBRX.OQ / MNKD.O / ATRC.OQ / LHCG.O / CYCC.OQ / B8FGn.DE / ALCLS.PA / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / BBI.O / MD.N / 771195104 / ADUS.O / SVA.O / USPH.N / GLAXOSM.LG / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / TRVN.O / GOOGL.O / MDWD.O / 02005N100 / CASI.OQ / XENT.OQ / CLRB.OQ / MRNS.O / INO.O / VCEL.O / EVH.N / TDOC.N / GKOS.K / MMD.WA / APLS.OQ / 100063846 / IONS.OQ / FLGT.OQ / MDGL.O / SRRA.O / PLXP.O / IOVA.OQ / ALPN.O / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / SYBX.O / FIXX.OQ / 720795103 / ALLO.OQ / MRKR.OQ / SWAV.O / PDSB.OQ / 21833P103 / BWAY.TA / TPTX.O / ORGO.O / IDYA.OQ / ONCT.OQ / BCYC.O / XAIR.OQ / PNTG.OQ / RLMD.OQ / ORIC.OQ / HGEN.O / NNOX.O</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Kroger Co / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Albertsons Companies Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Moleculin Biotech Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Biofrontera AG / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / Brickell Biotech Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / Sinovac Biotech Ltd / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / Trevena Inc / Alphabet Inc / Mediwound Ltd / Ally Financial Inc / CASI Pharmaceuticals Inc / Intersect Ent Inc / Cellectar Biosciences Inc / Marinus Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Vericel Corp / Evolent Health Inc / Teladoc Health Inc / Glaukos Corp / Milestone Medical Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Fulgent Genetics Inc / Madrigal Pharmaceuticals Inc / Sierra Oncology Inc / PLx Pharma Inc / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Synlogic Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Shockwave Medical Inc / PDS Biotechnology Corp / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Turning Point Therapeutics Inc / Organogenesis Holdings Inc / IDEAYA Biosciences Inc / Oncternal Therapeutics Inc / Bicycle Therapeutics PLC / Beyond Air Inc / Pennant Group Inc / Relmada Therapeutics Inc / Oric Pharmaceuticals Inc / Humanigen Inc / Nano-X Imaging Ltd</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">4502.T / AMT / CCI.N / CRM.N / DLR / ENS / GLW / GS / INTC.O / KKR / MCD / MS / MSFT.O / NICE.TA / QCOM.O / QUIK.O / T.N / WMT / TME / 4716.T / AMZN.O / GILD.O / AAPL.O / DISH.O / SAPG.DE / HEAR.O / NOVN.S / UPS.N / SBAC.O / MPWR.O / RDWR.O / CRNT.O / SMTC.O / CHTR.O / NUAN.O / ARCC.O / DOX.O / NET.N / HPE / AVGO.O / GTT / CSCO.OQ / CRUS.OQ / CRTO.OQ / ATVI.OQ / XLNX.OQ / CSGS.OQ / TTWO.OQ / AKAM.OQ / MRVL.OQ / VRTX.OQ / VRNT.OQ / SWKS.OQ / TXN.OQ / EGAN.O / MTCH.O / EQIX.O / NFLX.O / CEVA.O / 92343V104 / 20030N101 / 459200101 / 315616102 / BIDU.O / 36467W109 / CCOI.O / B8FGn.DE / CME.O / LLNW.OQ / 02043Q107 / 514766104 / TSLA.O / NXPI.O / AMD.OQ / ZNGA.O / EA.O / ADI.OQ / FB.O / CG.O / PERI.O / RNG.N / FATE.OQ / TWTR.K / FDEV.L / CHGG.N / GOOGL.O / FIVN.O / 563771203 / 82655M107 / 02005N100 / ARES.K / SNOW.K / APPS.O / SHOP.K / QUOT.K / TMUS.OQ / TTD.OQ / APL.PS / TWLO.K / ATUS.K / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / WDAY.O / ROKU.O / SYBX.O / EGHT.K / 83417M104 / FIXX.OQ / BILI.O / IQ.O / AVYA.K / TH.OQ / ZM.OQ / CMBM.OQ / TCOM.O / FSLY.K / VG.O / DKNG.O / CXDO.O / GRWG.O / 84764T304 / RXT.O / HGEN.O / TEUM.PK / ONDS.OQ / HUYA.K</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / American Tower Corp / Crown Castle International Corp / Salesforce.Com Inc / Digital Realty Trust Inc / EnerSys / Corning Inc / Goldman Sachs Group Inc / Intel Corp / KKR & Co Inc / McDonald's Corp / Morgan Stanley / Microsoft Corp / Nice Ltd / Qualcomm Inc / QuickLogic Corp / AT&T Inc / Walmart Inc / Tencent Music Entertainment Group / Oracle Corp Japan / Amazon.com Inc / Gilead Sciences Inc / Apple Inc / DISH Network Corp / SAP SE / Turtle Beach Corp / Novartis AG / United Parcel Service Inc / SBA Communications Corp / Monolithic Power Systems Inc / Radware Ltd / Ceragon Networks Ltd / Semtech Corp / Charter Communications Inc / Nuance Communications Inc / Ares Capital Corp / Amdocs Ltd / Cloudflare Inc / Hewlett Packard Enterprise Co / Broadcom Inc / GTT Communications Inc / Cisco Systems Inc / Cirrus Logic Inc / Criteo SA / Activision Blizzard Inc / Xilinx Inc / CSG Systems International Inc / Take-Two Interactive Software Inc / Akamai Technologies Inc / Marvell Technology Inc / Vertex Pharmaceuticals Inc / Verint Systems Inc / Skyworks Solutions Inc / Texas Instruments Inc / eGain Corp / Match Group Inc / Equinix Inc / Netflix Inc / CEVA Inc / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / F5 Inc / Baidu Inc / GameStop Corp / Cogent Communications Holdings Inc / Biofrontera AG / CME Group Inc / Limelight Networks Inc / Alnylam Pharmaceuticals Inc / Landec Corp / Tesla Inc / NXP Semiconductors NV / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Perion Network Ltd / RingCentral Inc / Fate Therapeutics Inc / Twitter Inc / Frontier Developments PLC / Chegg Inc / Alphabet Inc / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Ally Financial Inc / Ares Management Corp / Snowflake Inc. / Digital Turbine Inc / Shopify Inc / Quotient Technology Inc / T-Mobile US Inc / Trade Desk Inc / Apollo Global Capital Inc / Twilio Inc / Altice USA Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Workday Inc / Roku Inc / Synlogic Inc / 8x8 Inc / Solaredge Technologies Inc / Homology Medicines Inc / Bilibili Inc / iQIYI Inc / Avaya Holdings Corp / Target Hospitality Corp / Zoom Video Communications Inc / Cambium Networks Corp / Trip.com Group Ltd / Fastly Inc / Vonage Holdings Corp / DraftKings Inc / Crexendo Inc / GrowGeneration Corp / Speed Commerce Inc / Rackspace Technology Inc / Humanigen Inc / Pareteum Corp / Ondas Holdings Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / India / Israel / Japan / Netherlands / Philippines / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Summer May Be Ending, but Things Are Heating Up for Innate Immunity Drug Development: Featuring Top 10 Hot Targets in Neuro/Immunology</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">0925288 / 2126335 / 2516152 / 2778844 / 2369174 / 2455965 / 7103065 / BGCYWN8 / BMPRZV5 / BJLV8T9</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Novartis AG / Xencor Inc / Kymera Therapeutics Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yatin Suneja / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Four, Maybe Six, Registration Trials to be Underway by YE</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">VERU.OQ / GILD.O / 02005N100</td><td class="leftalignment">Veru Inc / Gilead Sciences Inc / Ally Financial Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Alexandra Heller</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CACI=US / BMY=US / MCD=US / GBT=US / WEN=US / EBAY=US / GILD=US / PEB=US / H=US / MTN=US / DIOD=US / VRM=US / MAR=US / ADS=US / TNL=US / HLT=US / AVT=US / CBRL=US / CHH=US / DRI=US / DRH=US / MCHP=US / SGMO=US / BKNG=US / SIVB=US / DIN=US / FLT=US / APP=US / SHO=US / PLAY=US / DENN=US / CMG=US / TDG=US / HST=US / RPRX=US / TAST=US / QSR=US / WH=US / JACK=US / HGV=US / NXPI=US / APTS=US / RLJ=US / VAC=US / RHP=US / NDLS=US / LOCO=US / ANTM=US / SHAK=US / ON=US / WING=US / PK=US / PLYA=US / MBIN=US / FSK=US / GOCO=US / AVAH=US</td><td class="leftalignment">CACI International Inc / Bristol-Myers Squibb Co / McDonald's Corp / Global Blood Therapeutics Inc / Wendys Co / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Diodes Inc / Vroom Inc / Marriott International Inc / Alliance Data Systems Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Microchip Technology Inc / Sangamo Therapeutics Inc / Booking Holdings Inc / SVB Financial Group / Dine Brands Global Inc / Fleetcor Technologies Inc / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Noodles & Co / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Merchants Bancorp / FS KKR Capital Corp / Gohealth Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALXO: Q2 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALXO.OQ / GILD.OQ / ZYME.N</td><td class="leftalignment">ALX Oncology Holdings Inc / Gilead Sciences Inc / Zymeworks Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">2Q21 Earnings & Model Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Adverse Events Monitor - 2Q21</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / INCY.O / BCRX.O / ICPT.O / BIIB.O / KPTI.O / ITCI.O / SAGE.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALB.N / CC.N / CCK.N / CE.N / CF.N / DD.N / DOW.N / EMN.N / FMC.N / IP.N / PPG.N / RIO.L / SEE.N / WY.N / CFP.TO / GILD.O / TA.TO / INCY.O / WLK.N / PAA.N / OLN.N / SHW.N / OI.N / BLL.N / EFX.N / OKE.N / RPM.N / SLGN.O / WSP.TO / VRTX.O / GPK.N / BCRX.O / ICPT.O / PAAS.O / STN.TO / BIIB.O / SNC.TO / NTR.N / HUN.N / WEF.TO / MPW.N / 443628102 / EONGn.DE / LYB.N / PCH.O / CFX.TO / NGL.N / IFP.TO / RFP.N / SRPT.O / BERY.N / ORCC.N / ENTA.O / PTCT.O / DOOR.N / RNW.TO / TSLX.N / SAGE.OQ / AXTA.N / CTRE.O / GLPG.O / GBT.OQ / UN01.DE / VNTR.N / EAF.N / VRCA.OQ / ITRM.O / PRVB.O / CTVA.N / MORF.OQ / APRE.OQ / PNTG.OQ / NLOK.O / BEAM.O / APA.OQ / JAMF.O / MTCR.O / PTVE.O / BSY.O / PUBM.O / WFG.N / OSO.N / FLYW.O / TASK.O / 9VC.F</td><td class="leftalignment">Albemarle Corp / Chemours Co / Crown Holdings Inc / Celanese Corp / CF Industries Holdings Inc / Dupont De Nemours Inc / Dow Inc / Eastman Chemical Co / FMC Corp / International Paper Co / PPG Industries Inc / Rio Tinto PLC / Sealed Air Corp / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / TransAlta Corp / Incyte Corp / Westlake Chemical Corp / Plains All American Pipeline LP / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / Equifax Inc / ONEOK Inc / RPM International Inc / Silgan Holdings Inc / WSP Global Inc / Vertex Pharmaceuticals Inc / Graphic Packaging Holding Co / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Pan American Silver Corp / Stantec Inc / Biogen Inc / SNC-Lavalin Group Inc / Nutrien Ltd / Huntsman Corp / Western Forest Products Inc / Medical Properties Trust Inc / Hudbay Minerals Inc / E.ON SE / LyondellBasell Industries NV / Potlatchdeltic Corp / Canfor Pulp Products Inc / NGL Energy Partners LP / Interfor Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Owl Rock Capital Corp / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Masonite International Corp / TransAlta Renewables Inc / Sixth Street Specialty Lending Inc / SAGE Therapeutics Inc / Axalta Coating Systems Ltd / CareTrust REIT Inc / Galapagos NV / Global Blood Therapeutics Inc / Uniper SE / Venator Materials PLC / GrafTech International Ltd / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / Provention Bio Inc / Corteva Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Pennant Group Inc / NortonLifeLock Inc / Beam Therapeutics Inc / APA Corp (US) / Jamf Holding Corp / Metacrine Inc / Pactiv Evergreen Inc / Bentley Systems Inc / PubMatic Inc / West Fraser Timber Co Ltd / Olo Inc / Flywire Corp / Taskus Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Germany / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / SRPT.O / ENTA.O / PTCT.O / SAGE.OQ / GLPG.O / GBT.OQ / ITRM.O / PRVB.O / MORF.OQ / APRE.OQ / MTCR.O / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Metacrine Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - ERASe CAncer with a Deep RAS/MAPK-Focused Pipeline - Initiating Coverage with a BUY Rating and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">BNLYBF3 / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / 2713317 / BBFL7S1 / BBPK0J0 / BD9GVY0 / BDHF4K6 / BZ1LFB2 / BZ8FPH3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BMPRZV5 / BMDJ397 / BN2RM92 / BP7KZP7</td><td class="leftalignment">Erasca Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Mirati Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Editas Medicine Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Gilead reports 12.0% sequential fall in Quarterly Net Profit</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead down 1.3% from 8 week high</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 2516152 / 2496113 / 2486813 / 2640147 / 2973821 / 2050832 / 2113393 / 2216850 / 2270726 / 2542049 / 2328915 / 2342034 / 2100920 / 2369174 / 2471950 / 2630513 / 2657802 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2503529 / B121557 / 2212922 / 2769796 / 2857817 / B0T7YX2 / B570P91 / 2598246 / 2982924 / B4MG4Z6 / B7VD3F2 / B83YYY6 / BBGVT40 / B7577T2 / BCGCR79 / BTN1Y11 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BD8DJ71 / BP7RS48 / BWFKZT2 / BMYML02 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BG31GH0 / BKTNTR9 / BJVR9Y9 / BFWK4R7 / BD6D4Y5 / BMH0MR7 / BMDCDP2 / BMPRZV5 / BD72R64 / BNGJQZ8 / BMHR7K6 / BKPGJQ1 / BMBP1Q0 / BL53KF5</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / Kohls Corp / Kellogg Co / Nike Inc / Alliant Energy Corp / Ameren Corp / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Gilead Sciences Inc / Incyte Corp / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Mastercard Inc / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / Lear Corp / Neogenomics Inc / Spectrum Pharmaceuticals Inc / AMC Networks Inc / Duke Energy Corp / ICAD Inc / News Corp / Renewable Energy Group Inc / Sprouts Farmers Market Inc / Medtronic PLC / PayPal Holdings Inc / Shopify Inc / Block Inc / Snap Inc / Intersect Ent Inc / Cellectis SA / DraftKings Inc / Evergy Inc / Spire Inc / Vistra Corp / Y-mAbs Therapeutics Inc / ViacomCBS Inc / iHeartMedia Inc / PagSeguro Digital Ltd / Altair Engineering Inc / Zendesk Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / Liberty Media Corp / Porch Group Inc / Impel Neuropharma Inc / Squarespace Inc / Flywire Corp / F45 Training Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AEP.N / AES.N / AIG.N / ALB.N / ALV.N / CL.N / EIX.N / EL.N / F.N / FLS.N / FSR.N / GM.N / KMB.N / KO.N / MO.N / PNW.N / RYN.N / SO.N / SRCL.O / T.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / GILD.O / CPB.N / LPX.N / TEN.N / WLL.N / CMCSA.O / AMGN.O / DUK.N / BWA.N / LEA.N / K.N / DISH.O / CLX.N / CAG.N / MRO.N / GIS.N / PCG.N / HSY.N / EPC.N / ADCT.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / RKT.N / SGMO.O / VZ.N / EXEL.O / XEL.N / ARNA.O / STZ.N / APH.N / FDS.N / FISV.O / CHTR.O / AXL.N / CHD.N / EPAY.O / NWN.N / BC.N / SAM.N / OPTN.O / REGN.O / ENR.N / NCR.N / TEL.N / ENDP.O / CPK.N / HL.N / PII.N / ST.N / SR.N / AMH.N / PLUG.OQ / GPN.N / ONC.TO / MNST.O / CASY.O / JCOM.O / EQIX.O / ATDb.TO / EDV.TO / MNKD.OQ / NVT.N / DLR.N / IAG.N / WEF.TO / SJW.N / BKD.N / FIS.N / CCOI.O / 025676206 / TEVA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / SII.TO / SPB.N / TXG.TO / NEE.N / CIO.N / PCH.O / ERF.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / ENTA.O / TMUS.N / UKWG.L / VOYA.N / DOO.TO / COTY.N / PRTA.O / BEP.N / ESNT.N / FLXN.O / BTG.N / GLPG.O / SQ.N / RACE.MI / ADVM.OQ / BBU.N / ADNT.N / LGFB.N / PBYI.OQ / SAND.N / UNIT.O / WPM.N / WOW.N / SSRM.O / BHF.O / ATNX.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / AQST.O / NWL.O / 269796108 / CTVA.N / APRE.OQ / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / MGNI.OQ / RXT.OQ / JAMF.O / LUMN.N / PTVE.O / BSY.O / RIDE.OQ / VTRS.OQ / LSPD.N / PUBM.O / NAPA.N / OSO.N / TSP.OQ / OTLY.O / FLYW.O / TASK.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American International Group Inc / Albemarle Corp / Autoliv Inc / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / Fisker Inc / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Pinnacle West Capital Corp / Rayonier Inc / Southern Co / Stericycle Inc / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Whiting Petroleum Corp / Comcast Corp / Amgen Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / PG&E Corp / Hershey Co / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Rocket Companies Inc / Sangamo Therapeutics Inc / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Factset Research Systems Inc / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Bottomline Technologies Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / TE Connectivity Ltd / Endo International PLC / Chesapeake Utilities Corp / Hecla Mining Co / Polaris Inc / Sensata Technologies Holding PLC / Spire Inc / American Homes 4 Rent / Plug Power Inc / Global Payments Inc / Oncolytics Biotech Inc / Monster Beverage Corp / Caseys General Stores Inc / Ziff Davis Inc / Equinix Inc / Alimentation Couche-Tard Inc / Endeavour Mining PLC / MannKind Corp / nVent Electric PLC / Digital Realty Trust Inc / IAMGOLD Corp / Western Forest Products Inc / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / American Equity Investment Life Holding Co / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Sprott Inc / Spectrum Brands Holdings Inc / Torex Gold Resources Inc / Nextera Energy Inc / City Office REIT Inc / Potlatchdeltic Corp / Enerplus Corp / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Voya Financial Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Pacira Biosciences Inc / B2Gold Corp / Galapagos NV / Block Inc / Ferrari NV / Adverum Biotechnologies Inc / Brookfield Business Partners LP / Adient PLC / Lions Gate Entertainment Corp / Puma Biotechnology Inc / Sandstorm Gold Ltd / Uniti Group Inc / Wheaton Precious Metals Corp / WideOpenWest Inc / SSR Mining Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Newell Brands Inc / Eagle Pharmaceuticals Inc / Corteva Inc / Aprea Therapeutics Inc / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Rackspace Technology Inc / Jamf Holding Corp / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Lordstown Motors Corp / Viatris Inc / Lightspeed Commerce Inc / PubMatic Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Oatly Group AB / Flywire Corp / Taskus Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Ireland / Israel / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 30</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21: Pipeline Reshuffle Progresses as TYK2 Advances and Jyseleca EU Launch Continues</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GLPG.O / GILD.O</td><td class="leftalignment">Galapagos NV / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for GILD. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">DNB / PFE=US / T=US / TXN=US / RUN=US / CMA=US / GILD=US / EOG=US / PLUG=US / WLL=US / PB=US / DIOD=US / MUR=US / EWBC=US / TRMK=US / UMPQ=US / MRO=US / EXPE=US / VMC=US / PENN=US / BKI=US / CI=US / W=US / WTFC=US / ARCC=US / AMED=US / AMN=US / SWIM=US / ARW=US / AVT=US / KIDS=US / CHH=US / CSTR=US / COLL=US / CSGP=US / DRH=US / EXEL=US / IBP=US / MAIN=US / MCHP=US / NTST=US / ORCC=US / PACW=US / PCTY=US / REGN=US / ROLL=US / STOR=US / TRGP=US / TRIP=US / WAL=US / GOLF=US / FOUR=US / HTH=US / BXS=US / NET=US / FNF=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / ADC=US / BOKF=US / BDN=US / FB=US / FBK=US / MKL=US / ASB=US / SSB=US / SRC=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / REG=US / APPN=US / AUTL=US / UCBI=US / DIN=US / MGNI=US / PNFP=US / ATRS=US / SBCF=US / PRAA=US / MNST=US / BCO=US / JRVR=US / NOMD=US / TCBI=US / FNB=US / CRD.B=US / FHN=US / AINV=US / RNST=US / DENN=US / LHCG=US / THS=US / BLDR=US / AAWW=US / CMG=US / FIS=US / CCOI=US / CADE=US / PNNT=US / SEAS=US / NOG=US / ATSG=US / IAC=US / EPRT=US / AGS=US / RCUS=US / RLJ=US / ANGI=US / ZNGA=US / PDCE=US / HCI=US / IBTX=US / FOXF=US / FEYE=US / CNCE=US / QTWO=US / TSLX=US / 70806A106 / LOCO=US / SHAK=US / ON=US / GSBD=US / LOB=US / ZG=US / ACBI=US / SQ=US / NTLA=US / VVV=US / CDEV=US / IRTC=US / PK=US / CVNA=US / VRNA=US / RDFN=US / SWCH=US / MBIN=US / FNKO=US / COLD=US / LAZY=US / HWC=US / OZK=US / FOCS=US / EB=US / AXNX=US / FSK=US / AMTB=US / TCRR=US / LSPD=US / PLMR=US / DDOG=US / AHCO=US / BIGC=US / 96758W101 / VMEO=US / MNTV=US / DBRG=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Pfizer Inc / AT&T Inc / Texas Instruments Inc / Sunrun Inc / Comerica Inc / Gilead Sciences Inc / EOG Resources Inc / Plug Power Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Diodes Inc / Murphy Oil Corp / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / Vulcan Materials Co / Penn National Gaming Inc / Black Knight Inc / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Ares Capital Corp / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Arrow Electronics Inc / Avnet Inc / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / CoStar Group Inc / Diamondrock Hospitality Co / Exelixis Inc / Installed Building Products Inc / Main Street Capital Corp / Microchip Technology Inc / Netstreit Corp / Owl Rock Capital Corp / PacWest Bancorp / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / STORE Capital Corp / Targa Resources Corp / Tripadvisor Inc / Western Alliance Bancorp / Acushnet Holdings Corp / Shift4 Payments Inc / Hilltop Holdings Inc / Cadence Bank / Cloudflare Inc / Fidelity National Financial Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / Brandywine Realty Trust / Meta Platforms Inc / FB Financial Corp / Markel Corp / Associated Banc-Corp / SouthState Corp / Spirit Realty Capital Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Regency Centers Corp / Appian Corp / Autolus Therapeutics PLC / United Community Banks Inc / Dine Brands Global Inc / Magnite Inc / Pinnacle Financial Partners Inc / Antares Pharma Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Monster Beverage Corp / Brinks Co / James River Group Holdings Ltd / Nomad Foods Ltd / Texas Capital Bancshares Inc / FNB Corp / Crawford & Co / First Horizon Corp / Apollo Investment Corp / Renasant Corp / Denny's Corp / LHC Group Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Cadence Bank / Pennantpark Investment Corp / SeaWorld Entertainment Inc / Northern Oil and Gas Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / PlayAGS Inc / Arcus Biosciences Inc / RLJ Lodging Trust / Angi Inc / Zynga Inc / PDC Energy Inc / Hci Group Inc / Independent Bank Group Inc / Fox Factory Holding Corp / Mandiant Inc / Concert Pharmaceuticals Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Zillow Group Inc / Atlantic Capital Bancshares Inc / Block Inc / Intellia Therapeutics Inc / Valvoline Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Carvana Co / Verona Pharma PLC / Redfin Corp / Switch Inc / Merchants Bancorp / Funko Inc / Americold Realty Trust / Lazydays Holdings Inc / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Eventbrite Inc / Axonics Inc / FS KKR Capital Corp / Amerant Bancorp Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / Datadog Inc / Adapthealth Corp / Bigcommerce Holdings Inc / WideOpenWest Inc / Vimeo Inc / Momentive Global Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">GILD TIGIT opt-in trigger YE2021; catalyst-rich year coming up. Maintain Buy, $70/sh PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ / RCUS=US / GILD=US / RCUS.N</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / T=US / DVN=US / CMA=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PB=US / MGY=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / MRO=US / TNL=US / KFRC=US / VMC=US / MGM=US / HLT=US / UNM=US / CVS=US / RCL=US / UNH=US / MAC=US / WTFC=US / AIZ=US / AMED=US / AMN=US / APH=US / FUN=US / CENT=US / KIDS=US / CHH=US / CSTR=US / CW=US / DRH=US / EEFT=US / MPLX=US / DOC=US / ASGN=US / OKE=US / PACW=US / RHI=US / SGMO=US / SMG=US / TGI=US / WAL=US / HTH=US / BXS=US / CCRN=US / FNF=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / DCP=US / FRT=US / FBK=US / JAZZ=US / MTCH=US / ASB=US / SSB=US / SPR=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / UCBI=US / VICI=US / ECPG=US / MGP=US / PNFP=US / SBCF=US / BDSI=US / JRVR=US / RPD=US / BIIB=US / FLT=US / TCBI=US / FNB=US / FHN=US / KAR=US / BDC=US / SHO=US / RNST=US / LHCG=US / CHNG=US / HST=US / MA=US / GPRE=US / ELF=US / WU=US / TEL=US / CADE=US / WH=US / IAC=US / PSN=US / JACK=US / SWI=US / VRSK=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / EA=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / UPLD=US / GDDY=US / ETSY=US / LOB=US / EVRI=US / ACBI=US / EDIT=US / 82982L103 / VVV=US / PK=US / PVAC=US / TVTY=US / 50189K103 / PLYA=US / SBOW=US / PETQ=US / ROKU=US / MBIN=US / MAXR=US / EOLS=US / HWC=US / OZK=US / FTDR=US / ALLO=US / AMTB=US / UBER=US / RTLR=US / IMVT=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / AT&T Inc / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Unum Group / CVS Health Corp / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Macerich Co / Wintrust Financial Corp / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Amphenol Corp / Cedar Fair LP / Central Garden & Pet Co / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Euronet Worldwide Inc / MPLX LP / Physicians Realty Trust / ASGN Inc / ONEOK Inc / PacWest Bancorp / Robert Half International Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Cross Country Healthcare Inc / Fidelity National Financial Inc / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / DCP Midstream LP / Federal Realty Investment Trust / FB Financial Corp / Jazz Pharmaceuticals PLC / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / United Community Banks Inc / VICI Properties Inc / Encore Capital Group Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / Biogen Inc / Fleetcor Technologies Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Renasant Corp / LHC Group Inc / Change Healthcare Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Western Union Co / TE Connectivity Ltd / Cadence Bank / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Parsons Corp / Jack in the Box Inc / SolarWinds Corp / Verisk Analytics Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / Upland Software Inc / GoDaddy Inc / ETSY Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Tivity Health Inc / LCI Industries / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Roku Inc / Merchants Bancorp / Maxar Technologies Inc / Evolus Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Rattler Midstream LP / Immunovant Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / Ireland / Liberia / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: SMID-Cap Oncology Take-Aways From Big-Cap 2Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / GILD=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AIRP.PA / ALB.N / ALK.N / AXP.N / BA.N / BAC.N / BAX.N / BDX.N / C.N / CCL.N / CI.N / COF.N / CRM.N / DAL.N / FCX.N / GM.N / GPS.N / JNJ.N / JPM.N / KMB.N / LLY.N / LSI.N / LUV.N / MDT.N / MO.N / NEM.N / PFE.N / PM.N / SC.N / T.N / TMO.N / U.N / WAT.N / WFC.N / PG.N / NUE.N / CPB.N / W.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / D.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / DVN.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / PKI.N / VZ.N / WST.N / MUR.N / KSS.N / ORCL.N / PWR.N / COG.N / EFX.N / V.N / EW.N / CPT.N / HWM.N / ACN.N / PLD.N / CHD.N / AIV.N / HAE.N / MKC.N / MAA.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / MHK.N / GME.N / INTC.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / ATVI.OQ / MSFT.OQ / PBCT.OQ / TEAM.OQ / REGN.OQ / SIVB.OQ / QDEL.OQ / CACC.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / GILD.OQ / DFS.N / COST.OQ / CPRT.OQ / INCY.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / TPR.N / NBIX.OQ / CTXS.OQ / AMZN.OQ / MANH.OQ / NVDA.OQ / BMRN.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / EXAS.OQ / ALGN.OQ / VRTX.OQ / JBLU.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / TFC.N / ACAD.OQ / CG.TO / DPZ.N / MOS.N / DLR.N / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / STX.AX / MA.N / IVZ.N / TDC.N / MRNA.OQ / MSCI.N / AVGO.OQ / FTNT.OQ / MU.OQ / GNRC.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / EPAM.N / SPLK.OQ / PSX.N / SRPT.OQ / GMED.N / ALLY.N / PRGO.N / COTY.N / COMM.OQ / NCLH.N / GOOGL.OQ / SAGE.OQ / HUBS.N / WBA.OQ / TDOC.N / PYPL.OQ / GBT.OQ / IONS.OQ / RETA.OQ / COUP.OQ / LW.N / AYX.N / DXC.N / CVNA.N / IOVA.OQ / AXON.OQ / WDAY.OQ / ROKU.OQ / BKNG.OQ / CBRE.N / FB.PS / CPRI.N / NFE.OQ / PINS.N / FSLY.N / CRWD.OQ / RTX.N / LMND.N / GOCO.OQ / CVAC.OQ / AMWL.N / PLTR.N / VTRS.OQ / TSP.OQ / HON.OQ</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Citigroup Inc / Carnival Corp / Cigna Corp / Capital One Financial Corp / Salesforce.Com Inc / Delta Air Lines Inc / Freeport-McMoRan Inc / General Motors Co / Gap Inc / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Life Storage Inc / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Wayfair Inc / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Dominion Energy Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / PerkinElmer Inc / Verizon Communications Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Kohls Corp / Oracle Corp / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Camden Property Trust / Howmet Aerospace Inc / Accenture PLC / Prologis Inc / Church & Dwight Co Inc / Apartment Investment and Management Co / Haemonetics Corp / McCormick & Company Inc / Mid-America Apartment Communities Inc / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Mohawk Industries Inc / GameStop Corp / Intel Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Activision Blizzard Inc / Microsoft Corp / People's United Financial Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / SVB Financial Group / Quidel Corp / Credit Acceptance Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Costco Wholesale Corp / Copart Inc / Incyte Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Tapestry Inc / Neurocrine Biosciences Inc / Citrix Systems Inc / Amazon.com Inc / Manhattan Associates Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Exact Sciences Corp / Align Technology Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Mosaic Co / Digital Realty Trust Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Invesco Ltd / Teradata Corp / Moderna Inc / MSCI Inc / Broadcom Inc / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Epam Systems Inc / Splunk Inc / Phillips 66 / Sarepta Therapeutics Inc / Globus Medical Inc / Ally Financial Inc / Perrigo Company PLC / Coty Inc / CommScope Holding Company Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Iovance Biotherapeutics Inc / Axon Enterprise Inc / Workday Inc / Roku Inc / Booking Holdings Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Fastly Inc / CrowdStrike Holdings Inc / Raytheon Technologies Corp / Lemonade Inc / Gohealth Inc / CureVac NV / American Well Corp / Palantir Technologies Inc / Viatris Inc / TuSimple Holdings Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / France / United Kingdom / Ireland / Luxembourg / Netherlands / Panama / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2Q take: Pipeline catalysts are building into year-end</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US3755581036 / US92532F1003 / CA39342L1085 / CA22587M1068 / CA89788C1041 / CA23126M1023</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Green Thumb Industries Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Perception is Reality – Spate of FDA Surprises Eroding Physician Confidence</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">0989529 / 717081103 / 375558103 / 532457108 / 09062X103 / 09061G101 / 45337C102 / 00287Y109 / 039697107 / 00972D105</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Eli Lilly and Co / Biogen Inc / Biomarin Pharmaceutical Inc / Incyte Corp / Abbvie Inc / Ardelyx Inc / Akebia Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Yasmeen Rahimi, Ph.D. / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 79 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMZN.OQ / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / PNC.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Amazon.com Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / PNC Financial Services Group Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/31/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead down 1% from 7 week high</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CRY.N / CVS / HAE / HUM / MDT / RAD / SYK / UNH / WMT / GILD.O / TFX.N / ANIK.O / NOVN.S / RMD.N / XRAY.O / HCA.N / CYH.N / COO.N / INSP.N / CERS.O / EW.N / ALGN.O / OSUR.O / DRRX.O / SSNC.O / ISR / SRDX.O / ABMD.OQ / ICUI.OQ / INCY.OQ / IART.OQ / NBIX.OQ / ICPT.OQ / BMRN.OQ / ISRG.OQ / BLUE.OQ / CCRN.O / STAA.O / IDXX.O / INMD.O / MMSI.O / AMED.O / CGEN.O / EXAS.O / BIIB.O / 025816109 / 478160104 / 00846U101 / 881624209 / 868168105 / ANGO.OQ / NUVA.O / ACAD.O / GLPG.AS / ATRC.OQ / DXCM.O / LHCG.O / B8FGn.DE / INFI.OQ / LMAT.O / ALCLS.PA / ARAY.O / PODD.O / MASI.O / 02043Q107 / ENSG.OQ / KIDS.O / 483548103 / MRNA.O / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / GMED.K / PRTA.OQ / AXGN.O / AGIO.OQ / AERI.O / GOOGL.O / MDWD.O / 02005N100 / AGRX.OQ / XENT.OQ / VKTX.O / NVRO.N / SIEN.O / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / CERC.OQ / GKOS.K / ZBH.N / CFMS.O / SPNE.O / NVCR.OQ / 100063846 / SSKN.OQ / SENS.A / TCMD.OQ / IRTC.OQ / SRTS.O / MDGL.O / VREX.OQ / 45780L104 / SLNO.OQ / PLXP.O / KALA.O / 720795103 / SWAV.O / KRTX.OQ / XAIR.OQ / PNTG.OQ / RLMD.OQ / VERO.O / NNOX.O / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Haemonetics Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Teleflex Inc / Anika Therapeutics Inc / Novartis AG / Resmed Inc / DENTSPLY SIRONA Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Inspire Medical Systems Inc / Cerus Corp / Edwards Lifesciences Corp / Align Technology Inc / OraSure Technologies Inc / DURECT Corp / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / ABIOMED Inc / ICU Medical Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / bluebird bio Inc / Cross Country Healthcare Inc / STAAR Surgical Co / IDEXX Laboratories Inc / Inmode Ltd / Merit Medical Systems Inc / Amedisys Inc / Compugen Ltd / Exact Sciences Corp / Biogen Inc / American Express Co / Johnson & Johnson / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Superior Industries International Inc / AngioDynamics Inc / NuVasive Inc / ACADIA Pharmaceuticals Inc / Galapagos NV / AtriCure Inc / Dexcom Inc / LHC Group Inc / Biofrontera AG / Infinity Pharmaceuticals Inc / LeMaitre Vascular Inc / Cellectis SA / Accuray Inc / Insulet Corp / Masimo Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / OrthoPediatrics Corp / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Globus Medical Inc / Prothena Corporation PLC / AxoGen Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Alphabet Inc / Mediwound Ltd / Ally Financial Inc / Agile Therapeutics Inc / Intersect Ent Inc / Viking Therapeutics Inc / Nevro Corp / Sientra Inc / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Avalo Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / SeaSpine Holdings Corp / Novocure Ltd / Truist Financial Corp / STRATA Skin Sciences Inc / Senseonics Holdings Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Sensus Healthcare Inc / Madrigal Pharmaceuticals Inc / Varex Imaging Corp / Inogen Inc / Soleno Therapeutics Inc / PLx Pharma Inc / Kala Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Karuna Therapeutics Inc / Beyond Air Inc / Pennant Group Inc / Relmada Therapeutics Inc / Venus Concept Inc / Nano-X Imaging Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">IN 2 HOURS: Join Our Healthcare Small/Mid Cap 2Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">2Q21 Review: Business Strengthening; Pipeline Coming Into View</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.O / GLPG.AS / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Morning Minutes: CFR, CUBI, EME, GILD, MITK, PRFT, SHIP, VRTX, WRAP, TFFP, VKTX / Corporate Events: see calendar below</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.OQ / CUBI.N / EME.N / MITK.OQ / PRFT.OQ / VKTX.OQ / VRTX.OQ / 375558103 / 92532F100 / 29084Q100 / 229899109 / 606710200 / 71375U101 / 23204G100 / 92686J106 / 98212N107 / 87241J104 / Y73760194</td><td class="leftalignment">Gilead Sciences Inc / Customers Bancorp Inc / EMCOR Group Inc / Mitek Systems Inc / Perficient Inc / Viking Therapeutics Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Vertex Pharmaceuticals Inc / EMCOR Group Inc / Cullen/Frost Bankers Inc / Mitek Systems Inc / Perficient Inc / Customers Bancorp Inc / Viking Therapeutics Inc / Wrap Technologies Inc / TFF Pharmaceuticals Inc / Seanergy Maritime Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">United States / Marshall Islands</td><td class="leftalignment"></td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Maxim Research</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Veklury Continues to Support Topline as Pandemic Recovery Progresses Slower than Expected</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jason McCarthy, Ph.D. / Mr. Michael Okunewitch</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AN=US / HD=US / AVB=US / AMZN=US / T=US / GILD=US / AMT=US / PEB=US / BC=US / CONE=US / V=US / LOW=US / SWN=US / BYD=US / SPOT=US / EXPE=US / ADS=US / TNL=US / ESS=US / MGM=US / HLT=US / AFL=US / HUM=US / CMCSA=US / BKI=US / EQR=US / MLM=US / DV=US / AIZ=US / CHH=US / CYH=US / CNX=US / EQT=US / EXPO=US / FCN=US / AJG=US / LH=US / TREE=US / MAS=US / MHK=US / MCRI=US / TEAM=US / NTST=US / REGN=US / TRIP=US / VSEC=US / VRTX=US / WEX=US / CGEN=US / PYPL=US / BKNG=US / CFR=US / FMBI=US / AVTR=US / CPT=US / OFC=US / CUZ=US / KIM=US / MAA=US / WRE=US / SBSI=US / NLS=US / ENSG=US / AMSF=US / VICI=US / RRR=US / IGMS=US / MMP=US / PRG=US / MOH=US / TPX=US / CZR=US / TXRH=US / HURN=US / DLR=US / XM=US / MPW=US / KBR=US / MA=US / SAIA=US / PAG=US / EHTH=US / WH=US / NXGN=US / IAC=US / RCUS=US / KNSL=US / AR=US / HGV=US / CUBE=US / ANGI=US / TMUS=US / VCYT=US / CMPR=US / ARGX=US / NVCR=US / WLTW=US / CRSP=US / TRVG=US / PK=US / CVNA=US / CARG=US / KDP=US / FTDR=US / SITC=US / ONEW=US / ABNB=US</td><td class="leftalignment">AutoNation Inc / Home Depot Inc / Avalonbay Communities Inc / Amazon.com Inc / AT&T Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / CyrusOne Inc / Visa Inc / Lowe's Companies Inc / Southwestern Energy Co / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / Alliance Data Systems Corp / Travel + Leisure Co / Essex Property Trust Inc / MGM Resorts International / Hilton Worldwide Holdings Inc / Aflac Inc / Humana Inc / Comcast Corp / Black Knight Inc / Equity Residential / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Assurant Inc / Choice Hotels International Inc / Community Health Systems Inc / CNX Resources Corp / EQT Corp / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Laboratory Corporation of America Holdings / Lendingtree Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Atlassian Corporation PLC / Netstreit Corp / Regeneron Pharmaceuticals Inc / Tripadvisor Inc / VSE Corp / Vertex Pharmaceuticals Inc / WEX Inc / Compugen Ltd / PayPal Holdings Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Avantor Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / Washington Real Estate Investment Trust / Southside Bancshares Inc / Nautilus Inc / Ensign Group Inc / Amerisafe Inc / VICI Properties Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Magellan Midstream Partners LP / PROG Holdings Inc / Molina Healthcare Inc / Tempur Sealy International Inc / Caesars Entertainment Inc / Texas Roadhouse Inc / Huron Consulting Group Inc / Digital Realty Trust Inc / Qualtrics International Inc / Medical Properties Trust Inc / KBR Inc / Mastercard Inc / Saia Inc / Penske Automotive Group Inc / eHealth Inc / Wyndham Hotels & Resorts Inc / NextGen Healthcare Inc / IAC/Interactivecorp / Arcus Biosciences Inc / Kinsale Capital Group Inc / Antero Resources Corp / Hilton Grand Vacations Inc / CubeSmart / Angi Inc / T-Mobile US Inc / Veracyte Inc / Cimpress PLC / argenx SE / Novocure Ltd / Willis Towers Watson PLC / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Carvana Co / CarGurus Inc / Keurig Dr Pepper Inc / Frontdoor Inc / Site Centers Corp / OneWater Marine Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">IGMS' Renowned IO CMO Exits Stage Left. What To Make Of It?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IGMS=US / GILD=US</td><td class="leftalignment">IGM Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Veklury Saves the Day, HIV Disappoints w/ Slower Recovery; Oncology Events Loom</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">37555810</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">172</td><td class="leftalignment">GB0007188757 / US0231351067 / US1844961078 / US3755581036 / US4278661081 / US4433201062 / US4601461035 / US5745991068 / US6951561090 / US7607591002 / US8425871071 / US8589121081 / US89531P1057 / US9295661071 / US94106L1098 / US98389B1008 / CA1367178326 / CA59151K1084 / CA30150P1099 / CA7751092007 / CA8911021050 / CA1469001053 / CA9528451052 / CA87971M1032 / CA3495531079 / CA82028K2002 / CA0099051009 / US9129091081 / CA3039011026 / CA7481932084 / US9884981013 / US83088M1027 / US60855R1005 / CA98462Y1007 / US8826811098 / US15135B1017 / US74144T1088 / US57636Q1040 / CA05534B7604 / US2253101016 / CA2945051027 / CA6179141065 / US91912E1055 / CA22576C1014 / CA8672241079 / DE000BAY0017 / CA15135U1093 / US34959E1091 / US72147K1088 / CA00208D4084 / CA86880Y1097 / CA96467A2002 / CA0213611001 / CA6752221037 / US34964C1062 / US45845P1084 / US90184L1026 / BMG0750C1082 / US1638511089 / US96145D1054 / CA0115321089 / US70450Y1038 / US02079K3059 / US0130911037 / GB00BZ09BD16 / CA19239C1068 / US78409V1044 / CA49741E1007 / US7045511000 / US29261A1007 / US00191U1025 / US2997341035 / US48251W1045 / US03990B1017 / CA45075E1043 / GB00BJT16S69 / CA87807B1076 / CA6744822033 / US04546L1061 / US91734M1036 / US14316J1088 / CA36168Q1046 / US05478C1053 / US47012E4035 / CA89055A2039 / CA9004352071 / CA1295844056 / CA00791P1071</td><td class="leftalignment">Rio Tinto PLC / Amazon.com Inc / Clean Harbors Inc / Gilead Sciences Inc / Hershey Co / Hub Group Inc / International Paper Co / Masco Corp / Packaging Corp of America / Republic Services Inc / Southern Co / Stericycle Inc / Trex Company Inc / Wabash National Corp / Waste Management Inc / Xcel Energy Inc / Canadian Utilities Ltd / Methanex Corp / Exco Technologies Ltd / Rogers Communications Inc / Toromont Industries Ltd / Cascades Inc / West Fraser Timber Co Ltd / Telus Corp / Fortis Inc / Shaw Communications Inc / AKITA Drilling Ltd / United States Steel Corp / Fairfax Financial Holdings Ltd / Quebecor Inc / Yum! Brands Inc / Skyworks Solutions Inc / Molina Healthcare Inc / Yamana Gold Inc / Texas Roadhouse Inc / Centene Corp / T Rowe Price Group Inc / Mastercard Inc / BCE Inc / Credit Acceptance Corp / Equitable Group Inc / Morguard Real Estate Investment Trust / Vale SA / Crescent Point Energy Corp / Suncor Energy Inc / Bayer AG / Cenovus Energy Inc / Fortinet Inc / Pilgrims Pride Corp / ARC Resources Ltd / Surge Energy Inc / Whitecap Resources Inc / AltaGas Ltd / OceanaGold Corp / Fortune Brands Home & Security Inc / Intercept Pharmaceuticals Inc / Twitter Inc / Axalta Coating Systems Ltd / Chemours Co / Westrock Co / Alamos Gold Inc / PayPal Holdings Inc / Alphabet Inc / Albertsons Companies Inc / Atlassian Corporation PLC / Cogeco Communications Inc / S&P Global Inc / Kirkland Lake Gold Ltd / Peabody Energy Corp / Encompass Health Corp / ASGN Inc / Evelo Biosciences Inc / KKR & Co Inc / Ares Management Corp / iA Financial Corporation Inc / Tronox Holdings PLC / TC Energy Corp / Obsidian Energy Ltd / AssetMark Financial Holdings Inc / US Ecology Inc / Carlyle Group Inc / GFL Environmental Inc / Azek Company Inc / JAKKS Pacific Inc / Topaz Energy Corp / Turquoise Hill Resources Ltd / Calfrac Well Services Ltd / Advantage Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Germany / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">V / 5671735 / 0989529 / 2000019 / 2778844 / 2045623 / 2219224 / 2216850 / 2270726 / 2829515 / 2567116 / 2670519 / 2328915 / 2100920 / 2369174 / 2689560 / 2730190 / 2829601 / 2098876 / 2931034 / 2503529 / 5531000 / 7123870 / 2971029 / B121557 / B067BM3 / B1Y9TB3 / 2216991 / B3P93Y7 / B5B2106 / B6197Q2 / B03PGL4 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BCBVTX1 / BFDV8K0 / B95N910 / BFLR866 / BYW36M8 / BD3W133 / BXDZ9Z0 / BJLT387 / BDHF4K6 / BNFWR44 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYYWPW6 / BWY52P3 / BYNQ369 / BMH0MR7 / BDVLM39 / BFY7DC4 / BJ9N563 / BMBP1Q0 / BJLV8T9</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / ANSYS Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Edison International / Edwards Lifesciences Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Regeneron Pharmaceuticals Inc / Southern Co / Yum! Brands Inc / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / MorphoSys AG / Nestle SA / LKQ Corp / Mastercard Inc / Molson Coors Beverage Co / Danone SA / Tempur Sealy International Inc / Anheuser Busch Inbev SA / Fortinet Inc / Generac Holdings Inc / NorthWestern Corp / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / PTC Inc / Twitter Inc / PayPal Holdings Inc / Keurig Dr Pepper Inc / Shopify Inc / Avantor Inc / CRISPR Therapeutics AG / Worldline SA / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Beigene Ltd / Blueprint Medicines Corp / Albertsons Companies Inc / Zendesk Inc / argenx SE / Altimmune Inc / Sunnova Energy International Inc / Flywire Corp / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">CSGN.S / ELE.MC / IP.N / MAS.N / MO.N / MRK.N / TOTF.PA / VC.N / SSE.L / AVB.N / TRI.N / GILD.O / CMCSA.O / AAL.L / HBAN.O / TRP.TO / SU.TO / CTXS.O / YUM.N / VLO.N / DV.N / HSY.N / SGMO.O / CYH.N / CINF.O / RRC.N / EQT.N / RSG.N / WSP.TO / BC.N / MAA.N / ARCC.O / AJG.N / VRTX.O / FTT.TO / MCO.N / GPK.N / CFR.N / MEOH.O / SWN.N / NTCT.OQ / ADS.N / SGEN.OQ / SIGI.O / COLB.O / ACGL.O / ICPT.O / STN.TO / TIH.TO / SNC.TO / DLR.N / TXRH.O / 416515104 / RDSb.L / DRX.L / MA.N / MERC.O / EHTH.O / AUY.N / 550372106 / CLR.N / ENSG.O / INPP.L / AAV.TO / EGO.N / CVE.TO / FTNT.O / NLSN.N / VCRA.N / RFP.N / FFHu.TO / FANG.O / TMUS.N / GWB.N / TRHC.OQ / SPGI.N / FTV.N / TWLO.N / KNSL.OQ / UN01.DE / CRSP.OQ / INVH.N / NEXA.TO / NTGY.MC / KDP.N / NXGN.O / CARR.N / 900435207</td><td class="leftalignment">Credit Suisse Group AG / Endesa SA / International Paper Co / Masco Corp / Altria Group Inc / Merck & Co Inc / TotalEnergies SE / Visteon Corp / SSE PLC / Avalonbay Communities Inc / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Anglo American PLC / Huntington Bancshares Inc / TC Energy Corp / Suncor Energy Inc / Citrix Systems Inc / Yum! Brands Inc / Valero Energy Corp / DoubleVerify Holdings Inc / Hershey Co / Sangamo Therapeutics Inc / Community Health Systems Inc / Cincinnati Financial Corp / Range Resources Corp / EQT Corp / Republic Services Inc / WSP Global Inc / Brunswick Corp / Mid-America Apartment Communities Inc / Ares Capital Corp / Arthur J Gallagher & Co / Vertex Pharmaceuticals Inc / Finning International Inc / Moody's Corp / Graphic Packaging Holding Co / Cullen/Frost Bankers Inc / Methanex Corp / Southwestern Energy Co / Netscout Systems Inc / Alliance Data Systems Corp / Seagen Inc / Selective Insurance Group Inc / Columbia Banking System Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / Stantec Inc / Toromont Industries Ltd / SNC-Lavalin Group Inc / Digital Realty Trust Inc / Texas Roadhouse Inc / Hartford Financial Services Group Inc / Royal Dutch Shell PLC / Drax Group PLC / Mastercard Inc / Mercer International Inc / eHealth Inc / Yamana Gold Inc / Lundin Mining Corp / Continental Resources Inc / Ensign Group Inc / International Public Partnerships Ltd / Advantage Energy Ltd / Eldorado Gold Corp / Cenovus Energy Inc / Fortinet Inc / Nielsen Holdings PLC / Vocera Communications Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / T-Mobile US Inc / Great Western Bancorp Inc / Tabula Rasa HealthCare Inc / S&P Global Inc / Fortive Corp / Twilio Inc / Kinsale Capital Group Inc / Uniper SE / CRISPR Therapeutics AG / Invitation Homes Inc / Nexa Resources SA / Naturgy Energy Group SA / Keurig Dr Pepper Inc / NextGen Healthcare Inc / Carrier Global Corp / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Spain / United Kingdom / Luxembourg / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : 2Q Snapshot - Veklury Drives Beat While HIV Weakness Persists</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">GILD - GILD 2Q21 Postview: HIV recovery sluggish, but Veklury and TDF save the print</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Revenue Beats, 2021 Guidance Narrowed As H2 Oncology Milestones Approach</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Tara Bancroft, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Model Update: 2Q Beat Driven Primarily by Veklury; Pipeline Our Focus for 2H</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21: Well Positioned For Steady Recovery and Attractively Valued Into Oncology Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2Q21: Veklury Drives Beat as COVID-19 Impacts HIV</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">my takeaways on TIGIT and HR+ breast trial</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : First Look at 2Q Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">CMO color on Trodelvy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">GILD opt-in commentary - TIGIT/adenosine</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.OQ / RCUS=US / GILD=US / RCUS.N</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21 First Take: Veklury Drives Strong Quarter, Hedging Against Any COVID-Related Product Headwinds</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Brief of Gilead Sciences Inc conference call, Jul. 29, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Jul. 29, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / BAX.N / BP.L / CMS.N / EIX.N / HLT.N / IBM.N / IP.N / MAS.N / MO.N / MRK.N / NOC.N / SLB.N / SO.N / TAP.N / TXT.N / HAL.N / TFX.N / WAB.N / YUM.N / VLO.N / LH.N / XOM.N / HSY.N / AMT.N / MTD.N / MLM.N / WST.N / EW.N / RSG.N / AJG.N / MHK.N / AOS.N / AAPL.OQ / HBAN.OQ / KLAC.OQ / MSFT.OQ / TROW.OQ / SBUX.OQ / GILD.OQ / CTXS.OQ / AMZN.OQ / VRTX.OQ / SWKS.OQ / CMCSA.OQ / 0700.HK / DXCM.OQ / RDSa.L / ICE.N / MA.N / 9999.HK / ES.N / BIO.N / ABI.BR / FTNT.OQ / NLSN.N / BKR.N / LKQ.OQ / TMUS.OQ / SPGI.N / FTV.N / XEL.OQ / WELL.N / CBRE.N / LYFT.OQ / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / CARR.N / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pinterest Inc / Baxter International Inc / BP PLC / CMS Energy Corp / Edison International / Hilton Worldwide Holdings Inc / International Business Machines Corp / International Paper Co / Masco Corp / Altria Group Inc / Merck & Co Inc / Northrop Grumman Corp / Schlumberger NV / Southern Co / Molson Coors Beverage Co / Textron Inc / Halliburton Co / Teleflex Inc / Westinghouse Air Brake Technologies Corp / Yum! Brands Inc / Valero Energy Corp / Laboratory Corporation of America Holdings / Exxon Mobil Corp / Hershey Co / American Tower Corp / Mettler-Toledo International Inc / Martin Marietta Materials Inc / West Pharmaceutical Services Inc / Edwards Lifesciences Corp / Republic Services Inc / Arthur J Gallagher & Co / Mohawk Industries Inc / A O Smith Corp / Apple Inc / Huntington Bancshares Inc / KLA Corp / Microsoft Corp / T Rowe Price Group Inc / Starbucks Corp / Gilead Sciences Inc / Citrix Systems Inc / Amazon.com Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Comcast Corp / Tencent Holdings Ltd / Dexcom Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / Mastercard Inc / NetEase Inc / Eversource Energy / Bio Rad Laboratories Inc / Anheuser Busch Inbev SA / Fortinet Inc / Nielsen Holdings PLC / Baker Hughes Co / LKQ Corp / T-Mobile US Inc / S&P Global Inc / Fortive Corp / Xcel Energy Inc / Welltower Inc / CBRE Group Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / Carrier Global Corp / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Cayman Islands / United Kingdom / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / V / 0989529 / 2126335 / 2550707 / 2437071 / 2280220 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2369174 / 2600088 / 2689560 / 2684703 / 2730190 / 2829601 / 2943523 / 2931034 / 2769796 / B28TS42 / B5B2106 / B03PGL4 / B65LWX6 / B7TL820 / B95N910 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BNFWR44 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BFXC911 / BYY88Y7 / BKS3RS7 / BMG75B4 / BMDCDP2 / BZ4CHH2 / BMZ9Z11</td><td class="leftalignment">American Express Co / Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / McDonald's Corp / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / Monro Inc / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Ulta Beauty Inc / Fortinet Inc / NorthWestern Corp / O'Reilly Automotive Inc / Meta Platforms Inc / PTC Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / Block Inc / Worldline SA / Spotify Technology SA / Fox Corp / Spire Inc / Guardant Health Inc / Alphabet Inc / 10X Genomics Inc / Inventiva SA / Bigcommerce Holdings Inc / Soleno Therapeutics Inc / Prometheus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Yuhan Corp: 2Q21 review: Core business on track, royalty income on an increase; lazertinib development strategy remains key. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">000100.KS / JNJ.N / GILD.OQ</td><td class="leftalignment">Yuhan Corp / Johnson & Johnson / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / PFE.N / SO.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / KLAC.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Pfizer Inc / Southern Co / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / KLA Corp / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for GILD</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Teneobio acquisition expands AMGN's IO pipeline</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009 / US3755581036</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / DD.N / FMC.N / GE.N / MO.N / MSFT.O / PHM.N / RWEG.DE / GILD.O / INCY.O / UHS.N / AAL.L / CLS.N / WM.N / MMM.N / SIRI.O / SBUX.O / ARNA.O / AMP.N / RRC.N / FISV.O / V.N / RPM.N / NBIX.O / CHD.N / SUI.N / VRTX.O / CHE.N / PNR.N / BRO.N / PII.N / ST.N / TRU.N / ICPT.O / BIIB.O / FM.TO / 878742204 / ACAD.O / DRX.L / CVLT.O / IVZ.N / MSCI.N / AAV.TO / PCH.O / MTDR.N / SMSS.L / SRPT.O / AXTA.N / FSV.O / TDOC.N / GBT.OQ / EHC.N / NWL.O / CTVA.N / NLOK.O / OTIS.N / SKLZ.N / ATC.N / DSEY.O</td><td class="leftalignment">Albemarle Corp / Dupont De Nemours Inc / FMC Corp / General Electric Co / Altria Group Inc / Microsoft Corp / Pultegroup Inc / Rwe AG / Gilead Sciences Inc / Incyte Corp / Universal Health Services Inc / Anglo American PLC / Celestica Inc / Waste Management Inc / 3M Co / Sirius XM Holdings Inc / Starbucks Corp / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Range Resources Corp / Fiserv Inc / Visa Inc / RPM International Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Sun Communities Inc / Vertex Pharmaceuticals Inc / Chemed Corp / Pentair PLC / Brown & Brown Inc / Polaris Inc / Sensata Technologies Holding PLC / TransUnion / Intercept Pharmaceuticals Inc / Biogen Inc / First Quantum Minerals Ltd / Teck Resources Ltd / ACADIA Pharmaceuticals Inc / Drax Group PLC / Commvault Systems Inc / Invesco Ltd / MSCI Inc / Advantage Energy Ltd / Potlatchdeltic Corp / Matador Resources Co / Smart Metering Systems PLC / Sarepta Therapeutics Inc / Axalta Coating Systems Ltd / FirstService Corp / Teladoc Health Inc / Global Blood Therapeutics Inc / Encompass Health Corp / Newell Brands Inc / Corteva Inc / NortonLifeLock Inc / Otis Worldwide Corp / Skillz Inc / Atotech Ltd / Diversey Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Imagine™: Game Changers: Disruptive Forces in Biotech</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / David Szeto / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / STE.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / MCD.N / TSN.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / AON.N / ES.N / CME.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / STERIS plc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / CME Group Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Gilead Sciences Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GE.N / GM.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / MCD.N / TSN.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / BLL.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Ball Corp / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 16: Focus on Almirall's US TRx trends</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ALM.MC / 4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Almirall SA / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / BAC.N / BK.N / BOX.N / C.N / CAS.TO / CCI.N / CL.N / CNA.L / COF.N / DFDS.CO / EIX.N / EL.N / F.N / FITB.O / GM.N / IP.N / JPM.N / KEY.N / KMB.N / KO.N / MO.N / NA / NEM.N / NTRS.O / PEG.N / PNC.N / RYN.N / SO.N / T.N / USB.N / WFC.N / SSE.L / PEP.N / BFb.N / PG.N / CFP.TO / GILD.O / FNV.N / CPB.N / CMCSA.O / CHKP.O / INCY.O / FER.MC / DIS.N / ROP.N / K.N / DT.N / DISH.O / GS.N / CLX.N / MCD.N / CAG.N / YUM.N / HON.N / DV.N / GIS.N / HSY.N / EPC.N / VZ.N / STT.N / SBUX.O / XEL.N / STZ.N / FISV.O / V.N / CHTR.O / NBIX.O / CHD.N / NWN.N / MTB.N / SAM.N / BMRN.O / REGN.O / ENR.N / NCR.N / RF.N / CPK.N / HL.N / TYL.N / NRZ.N / GPN.N / MNST.O / FFBC.O / RGLD.O / PCTY.O / BIIB.O / TFC.N / DPM.TO / DPZ.N / DLR.N / TXRH.O / VIAC.O / IAG.N / WEF.TO / DISCA.O / SJW.N / MS.N / CMG.N / FIS.N / MA.N / MERC.O / BGS.N / GETP.PA / CLW.N / FICO.N / EGO.N / SPB.N / NEE.N / TWO.N / MDLZ.OQ / ALLY.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / FOXA.OQ / PTCT.O / BEP.N / 81762P102 / PTC.O / ITCI.O / 922475108 / PAYC.N / NEP.N / CFG.N / QSR.N / CRBP.OQ / GLPG.O / PYPL.OQ / GDS.O / LGFB.N / VST.N / WPM.N / WOW.N / ATUS.N / ORSTED.CO / COLD.N / VNE.N / KDP.N / NWL.O / KRTX.OQ / GMAB.O / NLOK.O / WTRG.N / REYN.O / FOUR.N / RXT.OQ / LUMN.N / LSPD.N / WFG.N / NAPA.N / WING.N / DBM.TO / OTLY.O / XMTR.OQ / 9VC.F / EVCM.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Box Inc / Citigroup Inc / Cascades Inc / Crown Castle International Corp / Colgate-Palmolive Co / Centrica PLC / Capital One Financial Corp / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / International Paper Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / National Bank of Canada / Newmont Corporation / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Rayonier Inc / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Incyte Corp / Ferrovial SA / Walt Disney Co / Roper Technologies Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Conagra Brands Inc / Yum! Brands Inc / Honeywell International Inc / DoubleVerify Holdings Inc / General Mills Inc / Hershey Co / Edgewell Personal Care Co / Verizon Communications Inc / State Street Corp / Starbucks Corp / Xcel Energy Inc / Constellation Brands Inc / Fiserv Inc / Visa Inc / Charter Communications Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / Regions Financial Corp / Chesapeake Utilities Corp / Hecla Mining Co / Tyler Technologies Inc / New Residential Investment Corp / Global Payments Inc / Monster Beverage Corp / First Financial Bancorp / Royal Gold Inc / Paylocity Holding Corp / Biogen Inc / Truist Financial Corp / Dundee Precious Metals Inc / Domino's Pizza Inc / Digital Realty Trust Inc / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Western Forest Products Inc / Discovery Inc / SJW Group / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Mastercard Inc / Mercer International Inc / B&G Foods Inc / Getlink SE / Clearwater Paper Corp / Fair Isaac Corp / Eldorado Gold Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Two Harbors Investment Corp / Mondelez International Inc / Ally Financial Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Fox Corp / PTC Therapeutics Inc / Brookfield Renewable Partners LP / ServiceNow Inc / PTC Inc / Intra-Cellular Therapies Inc / Veeva Systems Inc / Paycom Software Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / Restaurant Brands International Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / GDS Holdings Ltd / Lions Gate Entertainment Corp / Vistra Corp / Wheaton Precious Metals Corp / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Americold Realty Trust / Veoneer Inc / Keurig Dr Pepper Inc / Newell Brands Inc / Karuna Therapeutics Inc / Genmab A/S / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Duckhorn Portfolio Inc / Wingstop Inc / Doman Building Materials Group Ltd / Oatly Group AB / Xometry Inc / ATAI Life Sciences NV / EverCommerce Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / Spain / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Patent Patrol – Biotechnology: 2Q21</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / BIIB.O / PTCT.O / ITCI.O / CRBP.OQ / GLPG.O / KRTX.OQ / 9VC.F</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Karuna Therapeutics Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AES.N / AIG.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CB.N / CI.N / CL.N / CNC.N / CVS.N / DD.N / ECL.N / ED.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / OXY.N / PEG.N / PFE.N / SO.N / TEL.PS / TMO.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / K.N / CAT.N / MCD.N / IFF.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / CHD.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / CNP.N / HAYS.L / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / ZBRA.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / NOW.N / FANG.OQ / ABBV.N / ZTS.N / CDW.OQ / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / IQV.N / APTV.N / XEL.OQ / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Consolidated Edison Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Pfizer Inc / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Kellogg Co / Caterpillar Inc / McDonald's Corp / International Flavors & Fragrances Inc / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Church & Dwight Co Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / CenterPoint Energy Inc / Hays PLC / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Zebra Technologies Corp / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / IQVIA Holdings Inc / Aptiv PLC / Xcel Energy Inc / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AEE.N / AES.N / AIG.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CVS.N / DD.N / EOG.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / EOG Resources Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">EnVent Capital Markets</td><td class="leftalignment">Gismondi 1754 Equity Research - Flash Note</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GIS=IT</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Italy / United States</td><td class="leftalignment">Apparel & Textiles</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Luigi Tardella</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) - New PFE Deal Positions ARV-471 as Potl. Best-in-Class ER Degrader, Removes Downside Scenario and Further Validates TPD Category</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BDZ30Q0 / PFE.N / 2369174 / 2455965 / 2684703 / BMPRZV5 / BP7KZP7</td><td class="leftalignment">Arvinas Inc / Pfizer Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Kymera Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / EOG.N / FCX.N / GE.N / GM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">FR0000054470 / US09061G1013 / US8816242098 / US00971T1016 / US02553E1064 / US0311621009 / US0366421065 / US09058V1035 / US30161Q1040 / US3755581036 / US4062161017 / US45337C1027 / US64125C1099 / US66987V1098 / US75886F1075 / US8305661055 / US91307C1027 / US92532F1003 / CA1363751027 / US64110L1061 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US1696561059 / US29089Q1058 / US2521311074 / US45784P1012 / US53261M1045 / US03152W1099 / US0231112063 / US7181721090 / US46333X1081 / US9100471096 / US4464131063 / NL0010273215 / US5017971046 / US8036071004 / US4576693075 / US88338N1072 / IE00B4Q5ZN47 / US6951271005 / US74587V1070 / US8684591089 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US00771V1089 / US4277461020 / US5034596040 / US90400D1081 / US7613301099 / IE00BJ3V9050 / KYG8807B1068 / US78667J1088 / IE00BQPVQZ61 / US19249H1032 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / US87184Q1076 / US36165L1089 / NL0012169213 / IL0011407140 / VGG111961055 / US04016X1019 / US87105L1044 / US8753722037 / US76243J1051 / US68404V1008 / US05455M1009 / CA0717341071 / KY30744W1070 / US8740602052 / US61775R1059 / US85205L1070 / US65487U1088 / US69353Y1038 / US81181C1045 / US55406W1036 / US92941V2097 / US25401T1088 / US35909D1090</td><td class="leftalignment">Ubisoft Entertainment SA / Biomarin Pharmaceutical Inc / Teva Pharmaceutical Industries Ltd / Akamai Technologies Inc / American Eagle Outfitters Inc / Amgen Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Skechers USA Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Chipotle Mexican Grill Inc / Emergent BioSolutions Inc / Dexcom Inc / Insulet Corp / Limelight Networks Inc / Amicus Therapeutics Inc / Amarin Corporation PLC / Philip Morris International Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Huntington Ingalls Industries Inc / ASML Holding NV / Bath & Body Works Inc / Sarepta Therapeutics Inc / Insmed Inc / TherapeuticsMD Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Puma Biotechnology Inc / Supernus Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Revance Therapeutics Inc / Endo International PLC / Theravance Biopharma Inc / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Coherus BioSciences Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Syros Pharmaceuticals Inc / GDS Holdings Ltd / Qiagen NV / Urogen Pharma Ltd / Biohaven Pharmaceutical Holding Company Ltd / argenx SE / Switch Inc / Tandem Diabetes Care Inc / Rhythm Pharmaceuticals Inc / OptiNose Inc / AVROBIO Inc / Bausch Health Companies Inc / Farfetch Ltd / Takeda Pharmaceutical Co Ltd / Morphic Holding Inc / SpringWorks Therapeutics Inc / Nkarta Inc / PMV Pharmaceuticals Inc / Seagen Inc / MYT Netherlands Parent BV / Vyne Therapeutics Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Japan / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Earnings Preview: Hoping That Solid Financials Are What The Doctor Ordered</td><td class="leftalignment">English</td><td class="rightalignment">238</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / FCX.N / GE.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / PM.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / MTB.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ANTM.N / ZBH.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Freeport-McMoRan Inc / General Electric Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Anthem Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">EDP.LS / EOG.N / NA / OXB.L / RIO.L / SGEF.PA / ZION.O / GILD.O / AMGN.O / INCY.O / UNH.N / EVTG.DE / SGMO.O / VZ.N / EXEL.O / ARNA.O / AMP.N / DPH.L / NBIX.O / WSP.TO / BMRN.O / REGN.O / ABC.N / VRTX.O / ENAG.MC / BLU.N / HCC.N / AMH.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / STN.TO / BIIB.O / IGO.AX / FMG.AX / SNC.TO / FM.TO / 878742204 / SPI.L / ACAD.O / ALNY.O / 35671D857 / ARWR.O / CS.TO / 443628102 / AUY.N / 550372106 / IVZ.N / CVSG.L / INO.OQ / OZL.AX / TCN.TO / SLS.TO / FHI.N / SRPT.O / CLINC.L / 505440107 / APAM.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / CIA.TO / ARES.N / SAGE.OQ / MOLN.S / 03835T200 / AENA.MC / CRBP.OQ / GLPG.O / GBT.OQ / RPD.O / RGNX.O / WVE.OQ / MESO.O / RMR.OQ / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / INVH.N / OVID.O / ATNX.O / VCTR.N / BSIG.N / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / ZM.O / FIXX.O / KRTX.OQ / MORF.OQ / NOVA.N / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / APA.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GATO.N / GDRX.O / ALOO.O / 900435207 / NUVB.N / BHG.N / 9VC.F</td><td class="leftalignment">EDP Energias de Portugal SA / EOG Resources Inc / National Bank of Canada / Oxford BioMedica PLC / Rio Tinto PLC / Vinci SA / Zions Bancorporation NA / Gilead Sciences Inc / Amgen Inc / Incyte Corp / UnitedHealth Group Inc / Evotec SE / Sangamo Therapeutics Inc / Verizon Communications Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / WSP Global Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / Enagas SA / BELLUS Health Inc / Warrior Met Coal Inc / American Homes 4 Rent / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Stantec Inc / Biogen Inc / IGO Ltd / Fortescue Metals Group Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Hudbay Minerals Inc / Yamana Gold Inc / Lundin Mining Corp / Invesco Ltd / CVS Group PLC / Inovio Pharmaceuticals Inc / OZ Minerals Ltd / Tricon Residential Inc / Solaris Resources Inc / Federated Hermes Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Labrador Iron Ore Royalty Corp / Artisan Partners Asset Management Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Champion Iron Ltd / Ares Management Corp / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Aena SME SA / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Rapid7 Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / RMR Group Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Invitation Homes Inc / Ovid Therapeutics Inc / Athenex Inc / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Zoom Video Communications Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Sunnova Energy International Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / APA Corp (US) / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Gatos Silver Inc / Goodrx Holdings Inc / Allogene Therapeutics Inc / Turquoise Hill Resources Ltd / Nuvation Bio Inc / Bright Health Group Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / Portugal / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Biotech Halftime Report: Negativity May Create Long-Term Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">105</td><td class="leftalignment">NA / OXB.L / GILD.O / AMGN.O / INCY.O / EVTG.DE / SGMO.O / EXEL.O / ARNA.O / DPH.L / NBIX.O / BMRN.O / REGN.O / ABC.N / VRTX.O / BLU.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / BIIB.O / SPI.L / ACAD.O / ALNY.O / ARWR.O / CVSG.L / INO.OQ / SRPT.O / CLINC.L / ENTA.O / PTCT.O / PRTA.O / AGIO.O / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / SAGE.OQ / MOLN.S / 03835T200 / CRBP.OQ / GLPG.O / GBT.OQ / RGNX.O / WVE.OQ / MESO.O / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / OVID.O / ATNX.O / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / NRIX.OQ / SPRB.OQ / MTCR.O / ALOO.O / NUVB.N / 9VC.F</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Evotec SE / Sangamo Therapeutics Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / CVS Group PLC / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Ovid Therapeutics Inc / Athenex Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Allogene Therapeutics Inc / Nuvation Bio Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Jack Reynolds-Clark / Yinglu Zhang / Jackie Yan / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Mr. Charles Weston / Stephen Mallon / Leonid Timashev / David Szeto / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 2Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Future Forecasts: July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DOW.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / HAL.N / ETN.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / UAL.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dow Inc / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Halliburton Co / Eaton Corporation PLC / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">New Lena Data Confirm Likely Path Forward for Key HIV Life Cycle Asset, Though with a Few Questions</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GLUE (BUY) - Molecular Glue - Differentiated Approach to Targeted Protein Degradation - Initiating Coverage with a BUY Rating and $30 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BP7KZP7 / 5671735 / 0989529 / 0925288 / 2126335 / 2023607 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / BBFL7S1 / BDHF4K6 / BZ8FPH3 / BWY52P3 / BDZ30Q0 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397 / BN2RM92</td><td class="leftalignment">Monte Rosa Therapeutics Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / bluebird bio Inc / CRISPR Therapeutics AG / Editas Medicine Inc / Blueprint Medicines Corp / Arvinas Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / CNC.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TEL.PS / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / NUE.N / UHS.N / HAL.N / ADML.L / ETN.N / DHR.N / FE.N / GD.N / DOV.N / ROP.N / CAT.N / IPG.N / UNP.N / MCD.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / WHR.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / POOL.OQ / AMZN.OQ / TTWO.OQ / VRSN.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ISRG.OQ / EQIX.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / LVS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / BKR.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / CSX.OQ / IQV.N / XEL.OQ / WELL.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / FirstEnergy Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Interpublic Group of Companies Inc / Union Pacific Corp / McDonald's Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Pool Corp / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Intuitive Surgical Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / CSX Corp / IQVIA Holdings Inc / Xcel Energy Inc / Welltower Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1266501006 / US1567821046 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Cerner Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">4502.T / ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / KR / MDT / RAD / SGE.L / UNH / WMT / ACI.N / GILD.O / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / NBIX.OQ / ICPT.OQ / EXEL.OQ / VRTX.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / ALNY.OQ / MBRX.OQ / ACAD.O / ATRC.OQ / LHCG.O / 02043Q107 / ENSG.OQ / SLP.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / MGNX.O / GOOGL.O / 02005N100 / CBAY.OQ / VKTX.O / EVH.N / TDOC.N / GKOS.K / 100063846 / IONS.OQ / EDIT.OQ / NTLA.O / IRTC.OQ / MDGL.O / PLXP.O / VERU.OQ / MTEM.O / 720795103 / ARVN.OQ / ALLO.OQ / CRSP.BN / BCYC.O / PNTG.OQ / REGW.M3</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Kroger Co / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Albertsons Companies Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Simulations Plus Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / MacroGenics Inc / Alphabet Inc / Ally Financial Inc / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Glaukos Corp / Truist Financial Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / iRhythm Technologies Inc / Madrigal Pharmaceuticals Inc / PLx Pharma Inc / Veru Inc / Molecular Templates Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Bicycle Therapeutics PLC / Pennant Group Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING IN 1 HOUR (11 AM ET): Cantor Healthcare Large Cap 2Q2021 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma / IQVIA Script Trends for the Week Ended July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US7665596034 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2Q21 Large Cap Earnings Preview: We Expect Fewer Surprises and a Recovery in Earnings from COVID</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US75886F1075 / US3755581036 / US45337C1027 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US0400476075 / US03969F1093 / US75382E1091</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Arcus Biosciences Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: Earnings and COVID Rebounds Edition</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / NBIX.O / VRTX.O / BIIB.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DAN / INTC.O / MSFT.O / GILD.O / AAPL.O / BWA.N / HEAR.O / NOVN.S / ATVI.OQ / FLEX.OQ / TTWO.OQ / NFLX.O / BIIB.O / 36467W109 / 02043Q107 / SLP.OQ / TMDX.OQ / 771195104 / TSLA.O / ZNGA.O / EA.O / ENTA.O / PRTA.OQ / FDEV.L / MGNX.O / 82655M107 / 02005N100 / WKHS.O / WPRT.TO / VERU.OQ / APTV.K / BILI.O / ARVN.OQ / 02081G201 / HUYA.K</td><td class="leftalignment">Dana Inc / Intel Corp / Microsoft Corp / Gilead Sciences Inc / Apple Inc / Borgwarner Inc / Turtle Beach Corp / Novartis AG / Activision Blizzard Inc / Flex Ltd / Take-Two Interactive Software Inc / Netflix Inc / Biogen Inc / GameStop Corp / Alnylam Pharmaceuticals Inc / Simulations Plus Inc / Transmedics Group Inc / Roche Holding AG / Tesla Inc / Zynga Inc / Electronic Arts Inc / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Frontier Developments PLC / MacroGenics Inc / Sify Technologies Ltd / Ally Financial Inc / Workhorse Group Inc / Westport Fuel Systems Inc / Veru Inc / Aptiv PLC / Bilibili Inc / Arvinas Inc / Alphatec Holdings Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / United Kingdom / India / Ireland / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Breast Cancer KOL Call Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / NOVN.S / MGNX.O / 02005N100 / VERU.OQ / ARVN.OQ</td><td class="leftalignment">Gilead Sciences Inc / Novartis AG / MacroGenics Inc / Ally Financial Inc / Veru Inc / Arvinas Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Mark Breidenbach, Ph.D. / Alexandra Heller</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / CCI.N / CI.N / COF.N / CVS.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / NA / PB.N / PFE.N / REP.MC / SO.N / T.N / ZION.O / PEP.N / CMA.N / WY.N / HUM.N / CFP.TO / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / HBAN.O / UNH.N / NICE.O / CAG.N / PCG.N / CONE.O / VZ.N / VLY.N / SNV.N / PACW.O / FISV.O / V.N / AWK.N / NBIX.O / NWN.N / STL.N / VRTX.O / NCR.N / CPE.N / CFR.N / BLU.N / CPK.N / FRC.N / WBS.N / FCF.N / DFS.N / ADS.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / BCRX.O / COLB.O / WTFC.O / ICPT.O / EQIX.O / TCBI.O / ATDb.TO / BIIB.O / SJ.TO / MTL.TO / FHN.N / DPZ.N / DLR.N / ACAD.O / WEF.TO / WAL.N / DISCA.O / SJW.N / BKD.N / CMG.N / FIS.N / ISBC.O / MA.N / GALP.LS / INO.OQ / HOMB.O / AND.TO / INPP.L / NEE.N / NXT.AX / PCH.O / CJT.TO / CFX.TO / BKU.N / PCRX.O / IFP.TO / WTE.TO / SLM.OQ / RFP.N / SRPT.O / ALLY.N / NYCB.N / ENTA.O / TMUS.N / PTCT.O / BEP.N / ONB.OQ / KPTI.O / XNCR.OQ / ITCI.O / FLXN.O / AGRX.O / SYF.N / GWB.N / ANTM.N / ASB.N / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / MP1.AX / PVAC.O / CADE.N / OVID.O / ATNX.O / 05971J102 / ITRM.O / NTGY.MC / PRVB.O / GMDA.OQ / LSPD.TO / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / WTRG.N / TFII.N / FOUR.N / DCT.O / SPRB.OQ / MTCR.O / WFG.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Crown Castle International Corp / Cigna Corp / Capital One Financial Corp / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / National Bank of Canada / Prosperity Bancshares Inc / Pfizer Inc / Repsol SA / Southern Co / AT&T Inc / Zions Bancorporation NA / PepsiCo Inc / Comerica Inc / Weyerhaeuser Co / Humana Inc / Canfor Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Huntington Bancshares Inc / UnitedHealth Group Inc / Nice Ltd / Conagra Brands Inc / PG&E Corp / CyrusOne Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / PacWest Bancorp / Fiserv Inc / Visa Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Sterling Bancorp / Vertex Pharmaceuticals Inc / NCR Corp / Callon Petroleum Co / Cullen/Frost Bankers Inc / BELLUS Health Inc / Chesapeake Utilities Corp / First Republic Bank / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / BioCryst Pharmaceuticals Inc / Columbia Banking System Inc / Wintrust Financial Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / Biogen Inc / Stella-Jones Inc / Mullen Group Ltd / First Horizon Corp / Domino's Pizza Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Western Alliance Bancorp / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Investors Bancorp Inc / Mastercard Inc / Galp Energia SGPS SA / Inovio Pharmaceuticals Inc / Home BancShares Inc / Andlauer Healthcare Group Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / BankUnited Inc / Pacira Biosciences Inc / Interfor Corp / Westshore Terminals Investment Corp / SLM Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Ally Financial Inc / New York Community Bancorp Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Old National Bancorp / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Synchrony Financial / Great Western Bancorp Inc / Anthem Inc / Associated Banc-Corp / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Megaport Ltd / Ranger Oil Corp / Cadence Bank / Ovid Therapeutics Inc / Athenex Inc / Cadence Bank / Iterum Therapeutics PLC / Naturgy Energy Group SA / Provention Bio Inc / Gamida Cell Ltd / Lightspeed Commerce Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Essential Utilities Inc / TFI International Inc / Shift4 Payments Inc / Duck Creek Technologies Inc / Spruce Biosciences Inc / Metacrine Inc / West Fraser Timber Co Ltd / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Spain / Ireland / Israel / Portugal / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 02, 2021: Focus on Shingrix trends</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare policy: new and updated democrat proposals: Biden drug proposals via EO; Pelosi & Wyden seek legislative approach</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">How Good is ARC-7 Really? Highlights from Management Meetings This Week</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03969F10 / 37555810</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / HOOK.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / INO.OQ / SRPT.O / ENTA.O / PTCT.O / KPTI.O / XNCR.OQ / ITCI.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / OVID.O / ITRM.O / PRVB.O / GMDA.OQ / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Ovid Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended June 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAC.N / BK.N / C.N / CCO.TO / CF.N / DFDS.CO / FITB.O / IBE.MC / JPM.N / KBH.N / KEY.N / NTRS.O / PHM.N / PNC.N / SGEF.PA / TOL.N / USB.N / WFC.N / GILD.O / INCY.O / AAL.L / LEN.N / GS.N / KGC.N / VLY.N / STT.N / DHI.N / FDS.N / EFX.N / NBIX.O / MTB.N / DNB.N / VRTX.O / MCO.N / SM.N / RF.N / TRU.N / RGLD.O / BPOP.O / BCRX.O / ICPT.O / BIIB.O / GOLD.N / FM.TO / TFC.N / NST.AX / 878742204 / EDV.TO / TRN.MI / NTR.N / MOS.N / ACAD.O / LHCG.O / MS.N / CS.TO / 443628102 / ATL.MI / GETP.PA / SLR.AX / OSK.TO / EONGn.DE / VALE.N / MSCI.N / FICO.N / VRSK.O / BHPB.L / NLSN.N / GLEN.L / SMSS.L / SRPT.O / TPH.N / ENTA.O / TMHC.N / PTCT.O / 46579R104 / KPTI.O / ITCI.O / CIA.TO / CFG.N / S32.AX / 78667J108 / GLPG.O / GBT.OQ / SPGI.N / OR.N / CDEV.O / WPM.N / SSRM.O / KL.N / ORSTED.CO / NTGY.MC / PRVB.O / GMDA.OQ / ADT1.L / SBSW.N / SPRB.OQ / DFH.OQ</td><td class="leftalignment">Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Cameco Corp / CF Industries Holdings Inc / DFDS AS / Fifth Third Bancorp / Iberdrola SA / JPMorgan Chase & Co / KB Home / KeyCorp / Northern Trust Corp / Pultegroup Inc / PNC Financial Services Group Inc / Vinci SA / Toll Brothers Inc / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / Incyte Corp / Anglo American PLC / Lennar Corp / Goldman Sachs Group Inc / Kinross Gold Corp / Valley National Bancorp / State Street Corp / D R Horton Inc / Factset Research Systems Inc / Equifax Inc / Neurocrine Biosciences Inc / M&T Bank Corp / Dun & Bradstreet Holdings Inc / Vertex Pharmaceuticals Inc / Moody's Corp / SM Energy Co / Regions Financial Corp / TransUnion / Royal Gold Inc / Popular Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Barrick Gold Corp / First Quantum Minerals Ltd / Truist Financial Corp / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Terna Rete Elettrica Nazionale SpA / Nutrien Ltd / Mosaic Co / ACADIA Pharmaceuticals Inc / LHC Group Inc / Morgan Stanley / Capstone Mining Corp / Hudbay Minerals Inc / Atlantia SpA / Getlink SE / Silver Lake Resources Ltd / Osisko Mining Inc / E.ON SE / Vale SA / MSCI Inc / Fair Isaac Corp / Verisk Analytics Inc / BHP Group PLC / Nielsen Holdings PLC / Glencore PLC / Smart Metering Systems PLC / Sarepta Therapeutics Inc / Tri Pointe Homes Inc (Delaware) / Enanta Pharmaceuticals Inc / Taylor Morrison Home Corp / PTC Therapeutics Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Champion Iron Ltd / Citizens Financial Group Inc / South32 Ltd / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / S&P Global Inc / Osisko Gold Royalties Ltd / Centennial Resource Development Inc / Wheaton Precious Metals Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Orsted A/S / Naturgy Energy Group SA / Provention Bio Inc / Gamida Cell Ltd / Adriatic Metals PLC / Sibanye Stillwater Ltd / Spruce Biosciences Inc / Dream Finders Homes Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Brazil / Canada / Germany / Denmark / Spain / France / United Kingdom / Israel / Italy / Puerto Rico / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GBT.OQ / PRVB.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Global Blood Therapeutics Inc / Provention Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / BIIB.O / 78667J108 / GLPG.O / GMDA.OQ / SPRB.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Biogen Inc / SAGE Therapeutics Inc / Galapagos NV / Gamida Cell Ltd / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: GILD - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">GILD</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 2Q 2021 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2369174 / 2455965 / 2623911 / 2730190 / 2931034 / 5531000 / B00FWN1 / B19FQ48 / 2713317 / BCBVTX1 / BBFL7S1 / BFDV8K0 / B8DPDT7 / BZ1LFB2 / B0SDJB4 / BG31GH0 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / MorphoSys AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / MacroGenics Inc / Sarepta Therapeutics Inc / Deciphera Pharmaceuticals Inc / Zealand Pharma A/S / Y-mAbs Therapeutics Inc / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Guggenheim Biot Research / Mr. Eddie Hickman, Ph.D. / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - July 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BATS.L / CP.TO / DD.N / GE.N / HMb.ST / NA / T.TO / SSE.L / TRI.N / HUM.N / CNQ.TO / GILD.O / LPX.N / HD.N / BBVA.MC / NKE.N / EQT.N / V.N / EPD.N / DLTR.O / VRTX.O / COP.N / ASC.L / CNP.N / ACGL.O / ATDb.TO / MOS.N / RDSb.L / BAM.N / VALE.N / EFN.TO / TDOC.N / ZG.O / TWLO.N / AKERBP.OL / GDS.O / COLD.N / ZM.O / CRWD.O / GMAB.O / LUNE.ST</td><td class="leftalignment">British American Tobacco PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / National Bank of Canada / Telus Corp / SSE PLC / Thomson Reuters Corp / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Home Depot Inc / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / EQT Corp / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / Vertex Pharmaceuticals Inc / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Vale SA / Element Fleet Management Corp / Teladoc Health Inc / Zillow Group Inc / Twilio Inc / Aker BP ASA / GDS Holdings Ltd / Americold Realty Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Lundin Energy AB</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Norway / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BATS.L / BCE.TO / CP.TO / DANO.PA / DD.N / GE.N / HMb.ST / L.TO / T.TO / ULVR.L / SSE.L / TRI.N / HUM.N / CNQ.TO / GILD.O / LPX.N / SJRb.TO / RCIb.TO / QBRb.TO / CCA.TO / ENB.TO / TV.TO / HD.N / GIS.N / KGC.N / BBVA.MC / NKE.N / STZ.N / V.N / EPD.N / DLTR.O / AGFb.TO / VRTX.O / FTT.TO / CIX.TO / COP.N / ASC.L / CNP.N / DOL.TO / HCC.N / ACGL.O / ATDb.TO / EMPA.TO / FM.TO / 878742204 / NESN.S / MOS.N / SFC.TO / IGM.TO / RDSb.L / BAM.N / 35671D857 / CS.TO / 443628102 / 550372106 / PPL.TO / SII.TO / CVE.TO / FSZ.TO / SLS.TO / EFN.TO / 505440107 / 46579R104 / CIA.TO / SHOP.N / TDOC.N / ZG.O / TWLO.N / ATZ.TO / GDS.O / SAND.N / NEXA.TO / COLD.N / MI_U.TO / ZM.O / CRWD.O / GMAB.O / NBLY.TO / TFPM.TO / DNTL.TO / OTLY.O</td><td class="leftalignment">British American Tobacco PLC / BCE Inc / Canadian Pacific Railway Ltd / Danone SA / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / Loblaw Companies Ltd / Telus Corp / Unilever PLC / SSE PLC / Thomson Reuters Corp / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Shaw Communications Inc / Rogers Communications Inc / Quebecor Inc / Cogeco Communications Inc / Enbridge Inc / Trevali Mining Corp / Home Depot Inc / General Mills Inc / Kinross Gold Corp / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Constellation Brands Inc / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / AGF Management Ltd / Vertex Pharmaceuticals Inc / Finning International Inc / CI Financial Corp / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Dollarama Inc / Warrior Met Coal Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Empire Company Ltd / First Quantum Minerals Ltd / Teck Resources Ltd / Nestle SA / Mosaic Co / Sagicor Financial Company Ltd / IGM Financial Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Freeport-McMoRan Inc / Capstone Mining Corp / Hudbay Minerals Inc / Lundin Mining Corp / Pembina Pipeline Corp / Sprott Inc / Cenovus Energy Inc / Fiera Capital Corp / Solaris Resources Inc / Element Fleet Management Corp / Labrador Iron Ore Royalty Corp / Ivanhoe Mines Ltd / Champion Iron Ltd / Shopify Inc / Teladoc Health Inc / Zillow Group Inc / Twilio Inc / Aritzia Inc / GDS Holdings Ltd / Sandstorm Gold Ltd / Nexa Resources SA / Americold Realty Trust / Minto Apartment Real Estate Investment Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Neighbourly Pharmacy Inc / Triple Flag Precious Metals Corp / dentalcorp Holdings Ltd / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / France / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Ms. Melissa Oliphant</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 02 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BSX / MDT / SGE.L / GILD.O / EXEL.OQ / ISRG.OQ / VRTX.OQ / LIFE.O / AMED.O / BIIB.O / 478160104 / ALNY.OQ / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / 02043Q107 / SPRO.OQ / MRNA.O / 771195104 / CSII.O / GLAXOSM.LG / FATE.OQ / MDWD.O / 02005N100 / INO.O / NVRO.N / VCEL.O / MCRB.OQ / NVCR.OQ / APLS.OQ / NVTA.K / NTLA.O / IRTC.OQ / IOVA.OQ / ACHV.O / BNGO.OQ / ORTX.OQ / CRSP.BN / SWAV.O / IDYA.OQ / KRTX.OQ / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Boston Scientific Corp / Medtronic PLC / Sage Group PLC / Gilead Sciences Inc / Exelixis Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Alnylam Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Spero Therapeutics Inc / Moderna Inc / Roche Holding AG / Cardiovascular Systems Inc / Glaxo Smithkline Consumer Nigeria PLC / Fate Therapeutics Inc / Mediwound Ltd / Ally Financial Inc / Inovio Pharmaceuticals Inc / Nevro Corp / Vericel Corp / Seres Therapeutics Inc / Novocure Ltd / Apellis Pharmaceuticals Inc / Invitae Corp / Intellia Therapeutics Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Achieve Life Sciences Inc / Bionano Genomics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / IDEAYA Biosciences Inc / Karuna Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / Nigeria / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Jul-2021 Watch List: 82 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AMZN.OQ / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / PNC.N / SLB.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O</td><td class="leftalignment">Amazon.com Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Defense / Electronics / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AXP.N / BAC.N / BATS.L / BK.N / C.N / COF.N / CP.TO / CSGN.S / DD.N / F.N / FITB.O / FMS.N / GE.N / GM.N / HMb.ST / JPM.N / KEY.N / NTRS.O / PD.N / PNC.N / T.TO / USB.N / WFC.N / SSE.L / TRI.N / HUM.N / CNQ.TO / GILD.O / LPX.N / HBAN.O / GS.N / HD.N / BBVA.MC / NKE.N / NG.L / MTG.N / RDN.N / STT.N / DVA.N / ADSK.O / V.N / EPD.N / DLTR.O / MTB.N / KRC.N / VRTX.O / RF.N / COP.N / ASC.L / CNP.N / FRC.N / CRC.N / DFS.N / ACGL.O / ATDb.TO / TFC.N / MOS.N / RDSb.L / BAM.N / DRX.L / MS.N / VMW.N / VALE.N / NGL.N / EFN.TO / ALLY.N / ESNT.N / COUP.N / NMIH.O / CFG.N / TDOC.N / ZG.O / TWLO.N / NTNX.O / GDS.O / OKTA.OQ / ESTE.N / COLD.N / ZS.OQ / SMAR.N / ITRM.O / NTGY.MC / ESTC.N / ZM.O / CRWD.O / GMAB.O / DOCU.N / ASAN.N / SUMO.O / PATH.N</td><td class="leftalignment">American Express Co / Bank of America Corp / British American Tobacco PLC / Bank of New York Mellon Corp / Citigroup Inc / Capital One Financial Corp / Canadian Pacific Railway Ltd / Credit Suisse Group AG / Dupont De Nemours Inc / Ford Motor Co / Fifth Third Bancorp / Fresenius Medical Care AG & Co KGaA / General Electric Co / General Motors Co / H & M Hennes & Mauritz AB / JPMorgan Chase & Co / KeyCorp / Northern Trust Corp / PagerDuty Inc / PNC Financial Services Group Inc / Telus Corp / US Bancorp / Wells Fargo & Co / SSE PLC / Thomson Reuters Corp / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Huntington Bancshares Inc / Goldman Sachs Group Inc / Home Depot Inc / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / National Grid PLC / MGIC Investment Corp / Radian Group Inc / State Street Corp / DaVita Inc / Autodesk Inc / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / M&T Bank Corp / Kilroy Realty Corp / Vertex Pharmaceuticals Inc / Regions Financial Corp / Conocophillips / ASOS PLC / CenterPoint Energy Inc / First Republic Bank / California Resources Corp / Discover Financial Services / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Truist Financial Corp / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Drax Group PLC / Morgan Stanley / VMware Inc / Vale SA / NGL Energy Partners LP / Element Fleet Management Corp / Ally Financial Inc / Essent Group Ltd / Coupa Software Inc / NMI Holdings Inc / Citizens Financial Group Inc / Teladoc Health Inc / Zillow Group Inc / Twilio Inc / Nutanix Inc / GDS Holdings Ltd / Okta Inc / Earthstone Energy Inc / Americold Realty Trust / Zscaler Inc / Smartsheet Inc / Iterum Therapeutics PLC / Naturgy Energy Group SA / Elastic NV / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Asana Inc / Sumo Logic Inc / UiPath Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CP.TO / BATS.L / BCE.TO / CAS.TO / DANO.PA / DD.N / GE.N / HMb.ST / NVA.TO / T.TO / ULVR.L / SSE.L / TRI.N / HUM.N / CNQ.TO / GILD.O / LPX.N / SJRb.TO / RCIb.TO / QBRb.TO / CCA.TO / BTE.TO / HD.N / GIS.N / BBVA.MC / NKE.N / STZ.N / V.N / EPD.N / DLTR.O / POU.TO / AGFb.TO / VRTX.O / COP.N / ASC.L / CNP.N / RGLD.O / ACGL.O / ATDb.TO / MTL.TO / NESN.S / CR.TO / MOS.N / RDSb.L / BAM.N / BIR.TO / ARX.TO / CLW.N / CPG.TO / AAV.TO / ATH.TO / MEG.TO / VET.TO / WCP.TO / TOU.TO / ERF.TO / FRU.TO / PEY.TO / TVE.TO / EFN.TO / RFP.N / KPT.TO / KEL.TO / CJ.TO / PSK.TO / LXE.V / TDOC.N / ZG.O / TWLO.N / GDS.O / COLD.N / PIPE.V / ZM.O / CRWD.O / GMAB.O / OVV.N / OTLY.O</td><td class="leftalignment">Canadian Pacific Railway Ltd / British American Tobacco PLC / BCE Inc / Cascades Inc / Danone SA / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / Nuvista Energy Ltd / Telus Corp / Unilever PLC / SSE PLC / Thomson Reuters Corp / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Shaw Communications Inc / Rogers Communications Inc / Quebecor Inc / Cogeco Communications Inc / Baytex Energy Corp / Home Depot Inc / General Mills Inc / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Constellation Brands Inc / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / Paramount Resources Ltd / AGF Management Ltd / Vertex Pharmaceuticals Inc / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Royal Gold Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Mullen Group Ltd / Nestle SA / Crew Energy Inc / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Birchcliff Energy Ltd / ARC Resources Ltd / Clearwater Paper Corp / Crescent Point Energy Corp / Advantage Energy Ltd / Athabasca Oil Corp / MEG Energy Corp / Vermilion Energy Inc / Whitecap Resources Inc / Tourmaline Oil Corp / Enerplus Corp / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Resolute Forest Products Inc / KP Tissue Inc / Kelt Exploration Ltd / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Leucrotta Exploration Inc / Teladoc Health Inc / Zillow Group Inc / Twilio Inc / GDS Holdings Ltd / Americold Realty Trust / Pipestone Energy Corp / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Ovintiv Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / France / United Kingdom / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BARC.L / BATS.L / CP.TO / CSGN.S / DD.N / EXHO.PA / GE.N / HMb.ST / SAND.ST / SRP.L / T.TO / SSE.L / TRI.N / HUM.N / CNQ.TO / GILD.O / LPX.N / DBKGn.DE / HD.N / BBVA.MC / NKE.N / V.N / EPD.N / DLTR.O / VRTX.O / COP.N / ASC.L / CNP.N / ACGL.O / ATDb.TO / MOS.N / RDSb.L / BAM.N / ABCA.L / WRT1V.HE / VALE.N / EFN.TO / TDOC.N / ZG.O / UBSG.S / TWLO.N / GDS.O / COLD.N / ZM.O / CRWD.O / GMAB.O</td><td class="leftalignment">Barclays PLC / British American Tobacco PLC / Canadian Pacific Railway Ltd / Credit Suisse Group AG / Dupont De Nemours Inc / Sodexo SA / General Electric Co / H & M Hennes & Mauritz AB / Sandvik AB / Serco Group PLC / Telus Corp / SSE PLC / Thomson Reuters Corp / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Deutsche Bank AG / Home Depot Inc / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / Vertex Pharmaceuticals Inc / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Abcam PLC / Wartsila Oyj Abp / Vale SA / Element Fleet Management Corp / Teladoc Health Inc / Zillow Group Inc / UBS Group AG / Twilio Inc / GDS Holdings Ltd / Americold Realty Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Top 30 Global Ideas for 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">BATS.L / CP.TO / DD.N / GE.N / HMb.ST / T.TO / SSE.L / TRI.N / HUM.N / CNQ.TO / GILD.O / LPX.N / HD.N / BBVA.MC / NKE.N / V.N / EPD.N / DLTR.O / VRTX.O / COP.N / ASC.L / CNP.N / ACGL.O / ATDb.TO / MOS.N / RDSb.L / BAM.N / EFN.TO / TDOC.N / ZG.O / TWLO.N / GDS.O / COLD.N / ZM.O / CRWD.O / GMAB.O</td><td class="leftalignment">British American Tobacco PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / H & M Hennes & Mauritz AB / Telus Corp / SSE PLC / Thomson Reuters Corp / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Home Depot Inc / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / Vertex Pharmaceuticals Inc / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Element Fleet Management Corp / Teladoc Health Inc / Zillow Group Inc / Twilio Inc / GDS Holdings Ltd / Americold Realty Trust / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Sweden / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Mark A. Dwelle, CFA / Mr. James Edwardes Jones / Mr. Brad D. Erickson / Scott M. Hanold / Mr. Matthew G. Hedberg / Mr. Rishi N. Jaluria / Geoffrey Kwan, CFA / Kennen MacKay, PHD / Sherri Malek / Drew McReynolds, CFA / Brian Abrahams, MD / Frank G. Morgan / Mr. John B. Musk / Mme. Irene O. Nattel / Greg M. Pardy, CFA / Daniel R. R. Perlin, CFA / Mr. Paul C. Quinn / Beth Reed / Mr. TJ J. Schultz / Walter N. Spracklin, CFA / Mr. Benjamin Toms / Jonathan Atkin / Mr. Shelby Tucker, CFA / Mr. Arun S. Viswanathan / Andrew D. Wong / Mr. Biraj Borkhataria / Michael W. Carroll, CFA / Mr. Richard B. Chamberlain / Scot Ciccarelli, CFA / Mr. Sean W. Dodge, CFA / Mr. Deane Dray, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / BMY=US / OXY=US / RRC=US / GBT=US / DVN=US / TXN=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / H=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / TNL=US / HLT=US / W=US / STZ=US / AMED=US / CHH=US / CNX=US / DRH=US / EQT=US / MHK=US / RARE=US / TRIP=US / VRTX=US / CVX=US / SAGE=US / CGEN=US / VNO=US / COP=US / MRNS=US / PTON=US / BIIB=US / APTX=US / SHO=US / HST=US / CPRX=US / CLR=US / WH=US / NOG=US / RCUS=US / AR=US / OAS=US / HGV=US / NXPI=US / RLJ=US / ESTE=US / VAC=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / CNCE=US / VNOM=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CDEV=US / CRSP=US / PK=US / PVAC=US / ANAB=US / PLYA=US / VRNA=US / SBOW=US / ARVN=US / OVV=US / CRMD.US / TSHA / 96758W101</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Range Resources Corp / Global Blood Therapeutics Inc / Devon Energy Corp / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Choice Hotels International Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / Mohawk Industries Inc / Ultragenyx Pharmaceutical Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Chevron Corp / SAGE Therapeutics Inc / Compugen Ltd / Vornado Realty Trust / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Biogen Inc / Aptinyx Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Ranger Oil Corp / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / SilverBow Resources Inc / Arvinas Inc / Ovintiv Inc / CorMedix Inc / Taysha Gene Therapies Inc / WideOpenWest Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">IO Nuggets: Insight Into The Expression & Function of PVRIG & TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CGEN=US / MRK=US / BMY=US / GILD=US / RCUS=US</td><td class="leftalignment">Compugen Ltd / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Zeus Capital</td><td class="leftalignment">Guild Esports (GILD LN) - Solid operational progress</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GB00BMWVF760</td><td class="leftalignment">Guild Esports PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bob H. Liao</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Gilead gains 6.2% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead gains 6.2% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TODAY @ 11 AM ET: Please Join Our Virtual Call to Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / US3755581036 / HTBX.OQ / US62818Q1040 / MRKR.OQ / IMAB.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Heat Biologics Inc / Mustang Bio Inc / Marker Therapeutics Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2367026 / 2516152 / 2000019 / 2496113 / 2486813 / 2973821 / 2216850 / 2280220 / 2270726 / 2542049 / 2317087 / 2328915 / 2369174 / 2707677 / 2730190 / 2138158 / 2829601 / 7123870 / B121557 / B1Y9TB3 / 2857817 / 2951452 / B7TL820 / B7VD3F2 / B8CKK03 / B3V9F12 / BDZCRX3 / BYRY499 / BYY8XK8 / BYVY8G0 / BYW36M8 / BYQHP96 / BXDZ9Z0 / BYNZGK1 / BK7Y2V9 / BJ1N1M9 / BD8DJ71 / BJJMGL2 / BGSP7M9 / BJDX8Y8 / BJMLSD2 / BMG75B4 / BGT0PL8 / BD8QGD5 / BD72R64 / BFY7DC4 / BMCC9R7 / BMC8SQ7</td><td class="leftalignment">General Mills Inc / Eli Lilly and Co / Amazon.com Inc / Kohls Corp / Kellogg Co / Alliant Energy Corp / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Gilead Sciences Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Nestle SA / Mastercard Inc / Danone SA / Netflix Inc / J M Smucker Co / Meta Platforms Inc / Duke Energy Corp / Mondelez International Inc / PVH Corp / RingCentral Inc / Kraft Heinz Co / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Shopify Inc / Block Inc / Akero Therapeutics Inc / Capri Holdings Ltd / Snap Inc / Fox Corp / Zoom Video Communications Inc / Mirum Pharmaceuticals Inc / Karuna Therapeutics Inc / Inventiva SA / DiaMedica Therapeutics Inc / Liberty Media Corp / Liberty Media Corp / Altimmune Inc / SCYNEXIS Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Gilead Sciences, Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BEAM / US3755581036 / US92532F1003 / US28238P1093 / US98401F1057 / US28106W1036 / US4834971032</td><td class="leftalignment">Beam Therapeutics Inc / Gilead Sciences Inc / Vertex Pharmaceuticals Inc / eHealth Inc / Xencor Inc / Editas Medicine Inc / Kalvista Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Highlights From IVA EASL KOL Event and Presentations; Our EASL Takeaways for AKRO, GILD, and MIRM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2369174 / BK7Y2V9 / BJDX8Y8 / BMG75B4</td><td class="leftalignment">Gilead Sciences Inc / Akero Therapeutics Inc / Mirum Pharmaceuticals Inc / Inventiva SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2113393 / 2280220 / 2270726 / 2576941 / 2670519 / 2100920 / 2369174 / 2455965 / 2471950 / 2689560 / 2672689 / 2684703 / 2707677 / 2138158 / 2825933 / 2829601 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / BCZS820 / BDZCRX3 / BYVY8G0 / BYW36M8 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BHC8X90 / BD8DJ71 / BMQ5T49 / BWFKZT2 / BJJMGL2 / BKTNTR9 / BGSP7M9</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Boston Beer Company Inc / DTE Energy Co / Walt Disney Co / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / Biogen Inc / Incyte Corp / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Fate Therapeutics Inc / RingCentral Inc / Alphabet Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Color us believers in the future of conditioning; Initiating at OW and $20 PT</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">MGTA.OQ / BEAM / US3755581036 / US92532F1003 / US28106W1036 / OT1A.F</td><td class="leftalignment">Magenta Therapeutics Inc / Beam Therapeutics Inc / Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Editas Medicine Inc / Orchard Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emma K. Nealon, III / Ms. Alethia R. Young</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : ZUMA-7 Hits and Opens Potential March of Cell Therapy into Earlier Treatment Settings</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead down 1.9% from 3 week high</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / CSIQ.O / GLAXOSM.LG / PERI.O / APTV.K / IDYA.OQ</td><td class="leftalignment">Gilead Sciences Inc / Canadian Solar Inc / Glaxo Smithkline Consumer Nigeria PLC / Perion Network Ltd / Aptiv PLC / IDEAYA Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Nigeria / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Yescarta Improves Event-Free Survival by 60% in ZUMA-7; Results Consistent With Our Expectations; Also Positive for Cell Therapy Space</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.OQ / 2126335 / 2369174 / BCZS820 / BFZNYB7 / BDHF4K6 / BWFKZT2</td><td class="leftalignment">Gilead Sciences Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Cellectis SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ZUMA-7 Meets Primary And Secondary Endpoints, Likely To Move Yescarta Into 2L</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Strong ZUMA-7 Data A Nice, Albeit Expected, Win In Year Oncology Franchise Comes To Fruition</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / CCI.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / PD.N / PFE.N / PNN.L / RWEG.DE / SO.N / T.N / SSE.L / DRE.N / TRI.N / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / REE.MC / GIS.N / JAZZ.O / CONE.O / NG.L / VZ.N / EXEL.O / KMX.N / AWK.N / NWN.N / BMRN.O / REGN.O / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / SEM.N / CASY.O / EQIX.O / ATDb.TO / BIIB.O / DLR.N / WEF.TO / ALNY.O / DISCA.O / SJW.N / DRX.L / TEVA.N / SLRS.MC / EONGn.DE / BHPB.L / NEE.N / CIO.N / SPLK.OQ / ABBV.N / TMUS.N / PRTA.O / BEP.N / ESNT.N / NEP.N / DEA.N / 78667J108 / EDIT.O / NTLA.O / TWLO.N / UN01.DE / NTNX.O / CRSP.OQ / GREG.MC / VST.N / ORSTED.CO / EHC.N / SMAR.N / DBX.O / CWEN.N / OSMT.O / 269796108 / ZM.O / FSLY.N / GMAB.O / DOCU.N / WTRG.N / BEAM.O / IGIC.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Rwe AG / Southern Co / AT&T Inc / SSE PLC / Duke Realty Corp / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Red Electrica Corporacion SA / General Mills Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Carmax Inc / American Water Works Company Inc / Northwest Natural Holding Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Select Medical Holdings Corp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Digital Realty Trust Inc / Western Forest Products Inc / Alnylam Pharmaceuticals Inc / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Solaria Energia y Medio Ambiente SA / E.ON SE / BHP Group PLC / Nextera Energy Inc / City Office REIT Inc / Splunk Inc / Abbvie Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Nextera Energy Partners LP / Easterly Government Properties Inc / SAGE Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Twilio Inc / Uniper SE / Nutanix Inc / CRISPR Therapeutics AG / Grenergy Renovables SA / Vistra Corp / Orsted A/S / Encompass Health Corp / Smartsheet Inc / Dropbox Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Essential Utilities Inc / Beam Therapeutics Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: Digesting Biotech in June Edition</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / BIIB.O / 78667J108</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jun 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / GE / HUM / JPM / MDT / RAD / SGE.L / UNH / WMT / AMZN.O / GILD.O / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / ISR / IART.OQ / BMRN.OQ / AMRN.OQ / ISRG.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / ATRC.OQ / LHCG.O / B8FGn.DE / ARAY.O / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / PRTA.OQ / GOOGL.O / 02005N100 / XENT.OQ / NVRO.N / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / 100063846 / SSKN.OQ / SYRS.OQ / TCMD.OQ / IRTC.OQ / VREX.OQ / SRRA.O / ALPN.O / ACHV.O / 720795103 / SWAV.O / 21833P103 / XAIR.OQ / PNTG.OQ / VERO.O / NNOX.O / 03823M100 / 29271J109</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / General Electric Co / Humana Inc / JPMorgan Chase & Co / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / IsoRay Inc / Integra Lifesciences Holdings Corp / Biomarin Pharmaceutical Inc / Amarin Corporation PLC / Intuitive Surgical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / LHC Group Inc / Biofrontera AG / Accuray Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Prothena Corporation PLC / Alphabet Inc / Ally Financial Inc / Intersect Ent Inc / Nevro Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Truist Financial Corp / STRATA Skin Sciences Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Varex Imaging Corp / Sierra Oncology Inc / Alpine Immune Sciences Inc / Achieve Life Sciences Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Corbus Pharmaceuticals Holdings Inc / Beyond Air Inc / Pennant Group Inc / Venus Concept Inc / Nano-X Imaging Ltd / Applied Minerals Inc / Thermic Science International Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Israel / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US8336351056 / IL0002810146 / US2371941053 / US2372661015 / US31428X1063 / US3755581036 / US6541061031 / US8168511090 / US9111631035 / CA4609191032 / US20451N1019 / CA4436281022 / IE00B4BNMY34 / US61945C1036 / DE000KSAG888 / US03820J1007 / CA5503711080 / US95040Q1040 / CA67077M1086 / US03843E1047 / US46121Y2019 / CA64016L1013</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Icl Group Ltd / Darden Restaurants Inc / Darling Ingredients Inc / FedEx Corp / Gilead Sciences Inc / Nike Inc / Sempra Energy / United Natural Foods Inc / Intertape Polymer Group Inc / Compass Minerals International Inc / Hudbay Minerals Inc / Accenture PLC / Mosaic Co / K&S AG / Applied Genetic Technologies Corp / Lundin Gold Inc / Welltower Inc / Nutrien Ltd / Aquestive Therapeutics Inc / Intrepid Potash Inc / Neighbourly Pharmacy Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / Germany / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Interim HDV Data Keeps Expected Hepcludex Filing on Track</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">DIS=US / ADI=US / AMZN=US / TXN=US / GILD=US / PEB=US / H=US / MTN=US / MAR=US / EXPE=US / TNL=US / HLT=US / AKR=US / ELY=US / CHH=US / DRH=US / EQIX=US / INFO=US / TRIP=US / WGO=US / GOLF=US / BKNG=US / BIIB=US / SHO=US / GMS=US / HST=US / WH=US / RCUS=US / HGV=US / RLJ=US / VAC=US / EA=US / RHP=US / 00770K202 / TRVG=US / PK=US / PLYA=US / TSHA / ABNB=US</td><td class="leftalignment">Walt Disney Co / Analog Devices Inc / Amazon.com Inc / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Callaway Golf Co / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / IHS Markit Ltd / Tripadvisor Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Booking Holdings Inc / Biogen Inc / Sunstone Hotel Investors Inc / GMS Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Electronic Arts Inc / Ryman Hospitality Properties Inc / Aemetis Inc / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Taysha Gene Therapies Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NL0000226223 / DE0006231004 / DE0006969603 / US0079031078 / US0378331005 / US0382221051 / US1311931042 / US1727551004 / US1985161066 / US2435371073 / US3755581036 / US4581401001 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5261071071 / US5370081045 / US55306N1046 / US5951121038 / US6541061031 / US67066G1040 / US7392761034 / US7475251036 / US7782961038 / US8305661055 / US8610121027 / US8725401090 / US8807701029 / US9182041080 / US9282981086 / US9581021055 / US3448491049 / US83088M1027 / US21036P1084 / US2533931026 / US1572101053 / US6098391054 / US9043111072 / US82706C1080 / US4103451021 / US5500211090 / DE000A1EWWW0 / US6936561009 / US7512121010 / NL0010273215 / US55405Y1001 / KYG037AX1015 / US1220171060 / US74736K1016 / US29444U7000 / US4622221004 / IE00BY7QL619 / KYG4740B1059 / US4811161011 / US11135F1012 / US98585X1046 / US89377M1099 / US50050N1037 / US88339P1012 / IE00BK9ZQ967 / US14448C1045 / US02875D1090 / US73739W1045 / US55406W1036 / US5738741041 / IE00BKVD2N49 / US30260D1037</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Puma SE / Advanced Micro Devices Inc / Apple Inc / Applied Materials Inc / Callaway Golf Co / Cirrus Logic Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Gilead Sciences Inc / Intel Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Littelfuse Inc / MKS Instruments Inc / Micron Technology Inc / Nike Inc / NVIDIA Corp / Power Integrations Inc / Qualcomm Inc / Ross Stores Inc / Skechers USA Inc / STMicroelectronics NV / TJX Companies Inc / Teradyne Inc / VF Corp / Vishay Intertechnology Inc / Western Digital Corp / Foot Locker Inc / Skyworks Solutions Inc / Constellation Brands Inc / DICK'S Sporting Goods Inc / CEVA Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / HanesBrands Inc / Lululemon Athletica Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / ASML Holding NV / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Burlington Stores Inc / Qorvo Inc / Equinix Inc / Ionis Pharmaceuticals Inc / Johnson Controls International PLC / Ichor Holdings Ltd / Jounce Therapeutics Inc / Broadcom Inc / Yeti Holdings Inc / Transmedics Group Inc / Kontoor Brands Inc / RealReal Inc / Trane Technologies PLC / Carrier Global Corp / American Outdoor Brands Inc / Poshmark Inc / MYT Netherlands Parent BV / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GB0007188757 / US0231351067 / US1258961002 / US2546871060 / US3755581036 / US75886F1075 / US9746371007 / CA8029121057 / CA4530384086 / CA2918434077 / CA1363851017 / US1667641005 / US7665596034 / US49446R1095 / US3546131018 / US74144T1088 / US1011211018 / US09247X1019 / BMG491BT1088 / CA8672241079 / CA15135U1093 / CA5527041084 / CA9237251058 / CA00208D4084 / CA2927661025 / US30303M1027 / CA0158571053 / CA04682R1073 / US2921041065 / US03674X1063 / US90184L1026 / US2267181046 / IE00BQPVQZ61 / US29444U7000 / GB00BWFY5505 / US02079K3059 / US4622221004 / BMG475671050 / CA53680Q2071 / US03753U1060 / US92645B1035 / US80706P1030 / US48251W1045 / US03843E1047 / US50015M1099 / US03990B1017 / US35137L1052 / US09260D1072 / US30205M1018 / US03768E1055 / US14316J1088 / US78440X8048 / US24343R1068 / CA00791P1071</td><td class="leftalignment">Rio Tinto PLC / Amazon.com Inc / CMS Energy Corp / Walt Disney Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Winnebago Industries Inc / Saputo Inc / Imperial Oil Ltd / Empire Company Ltd / Canadian Natural Resources Ltd / Chevron Corp / Rigel Pharmaceuticals Inc / Kimco Realty Corp / Franklin Resources Inc / T Rowe Price Group Inc / Boston Properties Inc / BlackRock Inc / Invesco Ltd / Suncor Energy Inc / Cenovus Energy Inc / MEG Energy Corp / Vermilion Energy Inc / ARC Resources Ltd / Enerplus Corp / Meta Platforms Inc / Algonquin Power & Utilities Corp / Athabasca Oil Corp / Empire State Realty Trust Inc / Antero Resources Corp / Twitter Inc / Criteo SA / Horizon Therapeutics PLC / Equinix Inc / Nielsen Holdings PLC / Alphabet Inc / Ionis Pharmaceuticals Inc / IHS Markit Ltd / Lithium Americas Corp / Apellis Pharmaceuticals Inc / Victory Capital Holdings Inc / Scholar Rock Holding Corp / KKR & Co Inc / Aquestive Therapeutics Inc / Kodiak Sciences Inc / Ares Management Corp / Fox Corp / Blackstone Inc / Exicure Inc / Apollo Global Management Inc / Carlyle Group Inc / SL Green Realty Corp / Decibel Therapeutics Inc / Advantage Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">V / 5671735 / 0925288 / 2000019 / 2026242 / 2437071 / 2219224 / 2216850 / 2280220 / 2270726 / 2317087 / 2328915 / 2369174 / 2672689 / 2829601 / 2928683 / 5531000 / B1F76F9 / 2857817 / B7TL820 / B783TY6 / B424494 / BFLR866 / BD8DJ71 / BJ2Z0H2 / BFZ1K46 / BYXJQG9 / BG31GH0 / BZ1LFG7 / BN4RD42 / BNTB3N8 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Sanofi SA / GlaxoSmithKline PLC / Amazon.com Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Gilead Sciences Inc / Patterson Companies Inc / Southern Co / VF Corp / MorphoSys AG / Western Union Co / Netflix Inc / Meta Platforms Inc / Aptiv PLC / Splunk Inc / Twitter Inc / Snap Inc / Pinterest Inc / Spotify Technology SA / Spire Inc / Y-mAbs Therapeutics Inc / Roku Inc / CureVac NV / Vizio Holding Corp / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Encouraging ARC-7 TIGIT Read-through to CGEN, ITOS and MRK</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">37555810 / M2572210 / 771195104 / 58933Y10 / 58949210 / 46565G10 / 03969F10</td><td class="leftalignment">Gilead Sciences Inc / Compugen Ltd / Roche Holding AG / Merck & Co Inc / Mereo Biopharma Group PLC / Iteos Therapeutics Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jeffrey La Rosa / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IBE.MC / KBH.N / PERP.PA / T.N / GILD.O / CMCSA.O / DIS.N / EQIX.O / VIAC.O / DISCA.O / ARWR.O / MA.N / ATL.MI / SMSS.L / FOXA.OQ / LGFB.N / AQN.N / EPAC.N</td><td class="leftalignment">Iberdrola SA / KB Home / Pernod Ricard SA / AT&T Inc / Gilead Sciences Inc / Comcast Corp / Walt Disney Co / Equinix Inc / ViacomCBS Inc / Discovery Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / Atlantia SpA / Smart Metering Systems PLC / Fox Corp / Lions Gate Entertainment Corp / Algonquin Power & Utilities Corp / Enerpac Tool Group Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Spain / France / United Kingdom / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Key takeaways from New GSK</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GSK.L / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / HALO.OQ / BAYGN.DE / CVAC.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Halozyme Therapeutics Inc / Bayer AG / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Positive Tone on RCUS Call, Triplet Anti-TIGIT Combination in Particular; GILD to Make Opt-In Decision Later This Year</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">TIGIT Study Continues On, Though Leaves Us - And GILD - Wanting More</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Not Yet Ready to Option TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">RCUS Provides Update On Anti-TIGIT Dom's Ph. II; GILD's Opt-In Decision By YE</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">CC trumps PR color; triplet could be better vs. other doublets. Reiterate Buy, PT $70/sh</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">RCUS=US / GILD=US</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">TIGIT studies to continue, call at 5PM; $3-$4/sh potential upside if GILD opts in</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.OQ / RCUS=US / GILD=US / RCUS.N</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">2000019 / 2778844 / 2222631 / 2280220 / 2270726 / 2542049 / 2342034 / 2369174 / 2829601 / 2857817 / 2951452 / B3D7K31 / B7TL820 / B7VD3F2 / B424494 / BYVYD43 / BD8DJ71 / BJFSR88 / BKDS4H5 / BNFWR44 / BKTNTR9 / BYY88Y7</td><td class="leftalignment">Amazon.com Inc / Merck & Co Inc / Cooper Companies Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Fiserv Inc / Gilead Sciences Inc / Southern Co / Netflix Inc / J M Smucker Co / Discovery Inc / Meta Platforms Inc / Duke Energy Corp / Splunk Inc / Performance Food Group Co / Snap Inc / Uniqure NV / Bill.com Holdings Inc / Worldline SA / ViacomCBS Inc / Alphabet Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: First CAR-T approval: A small step in commercialisation, a big step in advancing innovative pipeline. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2196.HK / 600196.SS / BMY.N / NOVN.S / GILD.OQ / BLUE.OQ</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Bristol-Myers Squibb Co / Novartis AG / Gilead Sciences Inc / bluebird bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">600276.SS: Jiangsu Hengrui Medicine Co. Ltd - Deep-dive for innovative drug pipeline supporting upside; reiterate OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">600276.SS / 1093.HK / 4503.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / 600267.SS / 0867.HK / 4568.T / 3933.HK / BAYGN.DE / 0460.HK / 601607.SS / 002422.SZ / 300003.SZ / 2607.HK / ABBV.N / 1513.HK / 2186.HK / 1530.HK / 1558.HK / BGNE.OQ / 300558.SZ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / CSPC Pharmaceutical Group Ltd / Astellas Pharma Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / Zhejiang Hisun Pharmaceutical Co Ltd / China Medical System Holdings Ltd / Daiichi Sankyo Co Ltd / United Laboratories International Holdings Ltd / Bayer AG / Sihuan Pharmaceutical Holdings Group Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Lepu Medical Technology Beijing Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Abbvie Inc / Livzon Pharmaceutical Group Inc / Luye Pharma Group Ltd / 3SBio Inc / YiChang HEC ChangJiang Pharmaceutical Co Ltd / Beigene Ltd / Betta Pharmaceuticals Co Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / GILD=US / LOW=US / LEG=US / VMC=US / MLM=US / SWIM=US / CBRL=US / CW=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / CRTO=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / RCUS=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / UPLD=US / SHAK=US / WING=US / EVRI=US / 82982L103 / JELD=US / FOCS=US / UBER=US / FERG=US / ARQT=US / AZEK=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Gilead Sciences Inc / Lowe's Companies Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Criteo SA / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Upland Software Inc / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Focus Financial Partners Inc / Uber Technologies Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AME / EMR / GE / HON / MSFT.O / RBC / ROP / SBH.N / GILD.O / SAPG.DE / HEAR.O / LFUS.O / AYI / ATVI.OQ / TTWO.OQ / LECO.O / NFLX.O / 030506109 / 36467W109 / GNRC.K / ZNGA.O / EA.O / 82655M107 / G29183103 / MCRB.OQ / 40434L105 / HUBB.K / SRRA.O / BILI.O / HUYA.K / 03823M100</td><td class="leftalignment">AMETEK Inc / Emerson Electric Co / General Electric Co / Honeywell International Inc / Microsoft Corp / Regal Rexnord Corp / Roper Technologies Inc / Sally Beauty Holdings Inc / Gilead Sciences Inc / SAP SE / Turtle Beach Corp / Littelfuse Inc / Acuity Brands Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / Lincoln Electric Holdings Inc / Netflix Inc / American Woodmark Corp / GameStop Corp / Generac Holdings Inc / Zynga Inc / Electronic Arts Inc / Sify Technologies Ltd / Eaton Corporation PLC / Seres Therapeutics Inc / HP Inc / Hubbell Inc / Sierra Oncology Inc / Bilibili Inc / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Growth Profile with Catalysts Coming Into View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">TIGIT data due in a week, GILD opt-in could mean $3-$4/sh to RCUS</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.OQ / RCUS=US / GILD=US</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">700</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / BB.N / CAS.TO / CCI.N / CCK.N / CL.N / EIX.N / EL.N / FOUG.PA / GPS.N / IP.N / KMB.N / KO.N / MRK.N / PD.N / PFE.N / PNN.L / SGEF.PA / SO.N / SVT.L / T.N / VIEV.VI / SSE.L / PEP.N / BFb.N / PG.N / CFP.TO / GILD.O / FNV.N / CPB.N / CMCSA.O / THC.N / DUK.N / LEA.N / REE.MC / K.N / DISH.O / ADBE.O / CLX.N / CAG.N / GIS.N / EPC.N / AMT.N / JAZZ.O / CONE.O / NG.L / VZ.N / STZ.N / FISV.O / AWK.N / CHD.N / NWN.N / APT.AX / SAM.N / FRAG.DE / ENR.N / NCR.N / GPK.N / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / GPN.N / MNST.O / EQIX.O / 02209S103 / TRN.MI / MNKD.OQ / 427866108 / SJW.N / FIS.N / ADP.PA / ATL.MI / BGS.N / GETP.PA / SPB.N / FHZN.S / TXG.TO / NEE.N / SLS.TO / PCH.O / XYL.N / MDLZ.OQ / PRMW.N / VOYA.N / COTY.N / BEP.N / 81762P102 / CEQP.N / ESNT.N / BTG.N / NEP.N / HQY.OQ / AENA.MC / WRK.N / GBT.OQ / RUN.O / TRHC.OQ / AZRE.N / NTNX.O / VST.N / AQUA.N / SAIL.N / DBX.O / AMRX.N / NTGY.MC / KDP.N / CWEN.N / NWL.O / LSPD.TO / 269796108 / PEAK.N / AZEK.N / WTRG.N / REYN.O / IGIC.OQ / FOUR.N / ZI.O / IBEX.O / LUMN.N / NVEIu.TO / PUBM.O / WFG.N / AFRM.O / NAPA.N / OTLY.O / FLYW.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / BlackBerry Ltd / Cascades Inc / Crown Castle International Corp / Crown Holdings Inc / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eiffage SA / Gap Inc / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Vinci SA / Southern Co / Severn Trent PLC / AT&T Inc / Flughafen Wien AG / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Comcast Corp / Tenet Healthcare Corp / Duke Energy Corp / Lear Corp / Red Electrica Corporacion SA / Kellogg Co / DISH Network Corp / Adobe Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Constellation Brands Inc / Fiserv Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Afterpay Ltd / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Energizer Holdings Inc / NCR Corp / Graphic Packaging Holding Co / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Global Payments Inc / Monster Beverage Corp / Equinix Inc / Altria Group Inc / Terna Rete Elettrica Nazionale SpA / MannKind Corp / Hershey Co / SJW Group / Fidelity National Information Services Inc / Aeroports de Paris SA / Atlantia SpA / B&G Foods Inc / Getlink SE / Spectrum Brands Holdings Inc / Flughafen Zuerich AG / Torex Gold Resources Inc / Nextera Energy Inc / Solaris Resources Inc / Potlatchdeltic Corp / Xylem Inc / Mondelez International Inc / Primo Water Corp / Voya Financial Inc / Coty Inc / Brookfield Renewable Partners LP / ServiceNow Inc / Crestwood Equity Partners LP / Essent Group Ltd / B2Gold Corp / Nextera Energy Partners LP / Healthequity Inc / Aena SME SA / Westrock Co / Global Blood Therapeutics Inc / Sunrun Inc / Tabula Rasa HealthCare Inc / Azure Power Global Ltd / Nutanix Inc / Vistra Corp / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Dropbox Inc / Amneal Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Clearway Energy Inc / Newell Brands Inc / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / Healthpeak Properties Inc / Azek Company Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / Shift4 Payments Inc / ZoomInfo Technologies Inc / Ibex Ltd / Lumen Technologies Inc / Nuvei Corp / PubMatic Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Oatly Group AB / Flywire Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Austria / Bermuda / Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Italy / Mauritius / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC’s Gilead Oncology Week Day 5 Recap: Partnered Programs May Have An Edge Targeting Adenosine Path</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC’s Gilead Oncology Week Wrap-Up: Winning Portfolio Of I/O Assets Could Transform LT Trajectory</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 6.18.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 00282410 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 58949210 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710 / 00288U10 / 90184D10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Abbott Laboratories / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc / Abcellera Biologics Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / AMZN=US / T=US / DVN=US / GILD=US / PEB=US / H=US / MTN=US / VRM=US / MAR=US / SPOT=US / EXPE=US / LEG=US / TNL=US / MGM=US / HLT=US / W=US / DV=US / AMN=US / CBRL=US / CHH=US / DRH=US / AJG=US / MHK=US / SGMO=US / SNAP=US / TRIP=US / TGI=US / WIX=US / NET=US / CCRN=US / BKNG=US / FAF=US / FB=US / OHI=US / UCBI=US / PTON=US / TPX=US / CZR=US / APP=US / SHO=US / HST=US / MA=US / GPRE=US / CLR=US / PRPL=US / WH=US / OLO=US / HGV=US / RLJ=US / VAC=US / ANGI=US / RHP=US / TILE=US / FATE=US / GOOGL=US / MTNB=US / BABA=US / CMPR=US / GDDY=US / VKTX=US / WLTW=US / PK=US / PLYA=US / CVNA=US / SFIX=US / FOCS=US / FTDR=US / FSK=US / LYFT=US / UBER=US / APLT=US / FSKR=US / VMEO=US</td><td class="leftalignment">Amgen Inc / Amazon.com Inc / AT&T Inc / Devon Energy Corp / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Spotify Technology SA / Expedia Group Inc / Leggett & Platt Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Wayfair Inc / DoubleVerify Holdings Inc / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Arthur J Gallagher & Co / Mohawk Industries Inc / Sangamo Therapeutics Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / Wix.Com Ltd / Cloudflare Inc / Cross Country Healthcare Inc / Booking Holdings Inc / First American Financial Corp / Meta Platforms Inc / Omega Healthcare Investors Inc / United Community Banks Inc / Peloton Interactive Inc / Tempur Sealy International Inc / Caesars Entertainment Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / Continental Resources Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Olo Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Interface Inc / Fate Therapeutics Inc / Alphabet Inc / Matinas BioPharma Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Viking Therapeutics Inc / Willis Towers Watson PLC / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Stitch Fix Inc / Focus Financial Partners Inc / Frontdoor Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Applied Therapeutics Inc / FS KKR Capital Corp / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CCI.N / DFDS.CO / GOG.L / SGC.L / SGEF.PA / AVB.N / GILD.O / FER.MC / ADBE.O / LEN.N / CPT.N / ARE.N / ESS.N / UDR.N / SUI.N / MAA.N / VTR.N / AJG.N / LTC.N / AMH.N / ELS.N / MPW.N / NGD.A / DOC.N / CTRE.O / AENA.MC / INVH.N / FSK.N / PEAK.N / DHC.O / ALOO.O</td><td class="leftalignment">Crown Castle International Corp / DFDS AS / Go-Ahead Group PLC / Stagecoach Group PLC / Vinci SA / Avalonbay Communities Inc / Gilead Sciences Inc / Ferrovial SA / Adobe Inc / Lennar Corp / Camden Property Trust / Alexandria Real Estate Equities Inc / Essex Property Trust Inc / UDR Inc / Sun Communities Inc / Mid-America Apartment Communities Inc / Ventas Inc / Arthur J Gallagher & Co / LTC Properties Inc / American Homes 4 Rent / Equity LifeStyle Properties Inc / Medical Properties Trust Inc / New Gold Inc / Physicians Realty Trust / CareTrust REIT Inc / Aena SME SA / Invitation Homes Inc / FS KKR Capital Corp / Healthpeak Properties Inc / Diversified Healthcare Trust / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / Spain / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC’s Gilead Oncology Week Day 4 Recap: Partners Could Provide High-Science Optionality</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : Highlights from Our Management Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">GILD entry into iPSC in-line w/ recent commentary & +ve for field, in our view; FATE still in lead.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD=US / FATE=US / SGMO=US</td><td class="leftalignment">Gilead Sciences Inc / Fate Therapeutics Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2434209 / 2516152 / 2280220 / 2270726 / 2670519 / 2328915 / 2369174 / 2455965 / 2689560 / 2829601 / B1F76F9 / B02R1L6 / B03PGL4 / 2949758 / B7TL820 / B783TY6 / B7VD3F2 / BFDV8K0 / BFLR866 / BYVY8G0 / BXDZ9Z0 / BF5L3T2 / BD9GVY0 / BJFSR88 / BWY52P3 / BN4RD42 / BFY7DC4 / BN4NJG4 / BMF1LH5</td><td class="leftalignment">American Express Co / Home Depot Inc / Eli Lilly and Co / DTE Energy Co / Walt Disney Co / Exelon Corp / Nextera Energy Inc / Gilead Sciences Inc / Biogen Inc / PG&E Corp / Southern Co / Western Union Co / ALLETE Inc / NorthWestern Corp / Nexstar Media Group Inc / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / MacroGenics Inc / Twitter Inc / Alphabet Inc / Shopify Inc / Elanco Animal Health Inc / Zai Lab Ltd / Uniqure NV / Blueprint Medicines Corp / CureVac NV / Altimmune Inc / Freeline Therapeutics Holdings PLC / Honest Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AAP.N / CCI.N / GOG.L / PFE.N / SGC.L / T.N / WY.N / CFP.TO / GILD.O / CMCSA.O / SBAC.O / AMT.N / CONE.O / VZ.N / CHTR.O / EQIX.O / DLR.N / DRX.L / CCOI.O / ADP.PA / ATL.MI / EDPR.LS / ADUS.OQ / NXT.AX / PCH.O / IFP.TO / RFP.N / NYCB.N / JACK.N / TMUS.N / RYAM.N / AZRE.N / GDS.O / UNIT.O / WOW.N / ATUS.N / APRE.OQ / LUMN.N / PUBM.O / WFG.N / PPM.AX</td><td class="leftalignment">Advance Auto Parts Inc / Crown Castle International Corp / Go-Ahead Group PLC / Pfizer Inc / Stagecoach Group PLC / AT&T Inc / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Comcast Corp / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / Charter Communications Inc / Equinix Inc / Digital Realty Trust Inc / Drax Group PLC / Cogent Communications Holdings Inc / Aeroports de Paris SA / Atlantia SpA / EDP Renovaveis SA / Addus Homecare Corp / NEXTDC Ltd / Potlatchdeltic Corp / Interfor Corp / Resolute Forest Products Inc / New York Community Bancorp Inc / Jack in the Box Inc / T-Mobile US Inc / Rayonier Advanced Materials Inc / Azure Power Global Ltd / GDS Holdings Ltd / Uniti Group Inc / WideOpenWest Inc / Altice USA Inc / Aprea Therapeutics Inc / Lumen Technologies Inc / PubMatic Inc / West Fraser Timber Co Ltd / Pepper Money Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Cayman Islands / Spain / France / United Kingdom / Italy / Mauritius / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC’s Gilead Oncology Week Day 3 Recap: Trodelvy Has Room To Grow In mTNBC and ER+ Indications</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Highlights from Our Guggenheim BioPharma Strategy Series Fireside Chat with CMO Merdad Parsey</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MGNX (BUY) – MGNX Expands Strategic Collaboration With ZLAB For Novel CD3/CD47-Based Bispecifics</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BFDV8K0 / 2369174 / BD9GVY0</td><td class="leftalignment">MacroGenics Inc / Gilead Sciences Inc / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Mr. Seamus Fernandez / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AXP.N / BAC.N / C.N / CAS.TO / CI.N / COF.N / IP.N / JPM.N / NA / RYN.N / SGEF.PA / WY.N / HUM.N / CFP.TO / GILD.O / LPX.N / AAL.L / DUK.N / UNH.N / XOM.N / ARE.N / CVX.N / JHX.AX / FTT.TO / ENAG.MC / DFS.N / ADS.N / TIH.TO / WEF.TO / MERC.O / EHTH.O / CLW.N / ADN.TO / PCH.O / CFX.TO / CTT.N / IFP.TO / RFP.N / KPT.TO / CFF.TO / RYAM.N / SYF.N / ANTM.N / WRK.N / AQUA.N / SLQT.N / GOCO.O / WFG.N / DBM.TO</td><td class="leftalignment">American Express Co / Bank of America Corp / Citigroup Inc / Cascades Inc / Cigna Corp / Capital One Financial Corp / International Paper Co / JPMorgan Chase & Co / National Bank of Canada / Rayonier Inc / Vinci SA / Weyerhaeuser Co / Humana Inc / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Anglo American PLC / Duke Energy Corp / UnitedHealth Group Inc / Exxon Mobil Corp / Alexandria Real Estate Equities Inc / Chevron Corp / James Hardie Industries PLC / Finning International Inc / Enagas SA / Discover Financial Services / Alliance Data Systems Corp / Toromont Industries Ltd / Western Forest Products Inc / Mercer International Inc / eHealth Inc / Clearwater Paper Corp / Acadian Timber Corp / Potlatchdeltic Corp / Canfor Pulp Products Inc / CatchMark Timber Trust Inc / Interfor Corp / Resolute Forest Products Inc / KP Tissue Inc / Conifex Timber Inc / Rayonier Advanced Materials Inc / Synchrony Financial / Anthem Inc / Westrock Co / Evoqua Water Technologies Corp / SelectQuote Inc / Gohealth Inc / West Fraser Timber Co Ltd / Doman Building Materials Group Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Spain / France / United Kingdom / Ireland / Iran, Islamic Republic of / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC’s Gilead Oncology Week Day 2 Recap: TIGIT Assets Could Compete in Emerging Space</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DANO.PA / HUM.N / GILD.O / AAL.L / NG.L / PEGA.OQ / SRPT.O / ESTE.N / ORSTED.CO / ZI.O / PUBM.O / DNTL.TO</td><td class="leftalignment">Danone SA / Humana Inc / Gilead Sciences Inc / Anglo American PLC / National Grid PLC / Pegasystems Inc / Sarepta Therapeutics Inc / Earthstone Energy Inc / Orsted A/S / ZoomInfo Technologies Inc / PubMatic Inc / dentalcorp Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC's Gilead Oncology Week Day 1 Recap: Magrolimab Promise and Optionality</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / AMT / BE / BSX / CAT / CCI.N / CI / CLH / CMG / CMI / COST.O / CRM.N / DAN / DE / DHI / DLR / ECL.N / EL.N / ENS / FDX / GS / INTC.O / JCI / JPM / K / KKR / LRCX.O / MDT / MS / MSFT.O / NEP / NOW / O / ORA / ROP / RSG / T.N / UNH / URI / WM / ZEN / 4716.T / AMZN.O / EBAY.O / GILD.O / AAPL.O / FIS / BWA.N / NVDA.O / ADBE.O / DTE.N / SAPG.DE / SQ / NOVN.S / SBAC.O / HRB.N / ADSK.O / EW.N / ARE.N / DLTR.O / IO.N / CSGP.O / FCEL.O / ALGN.O / BLK.N / CREE.O / NET.N / AVGO.O / JBHT.OQ / ATVI.OQ / XLNX.OQ / AMSC.OQ / BMRN.OQ / AKAM.OQ / PLUG.OQ / ISRG.OQ / VRTX.OQ / SWKS.OQ / TEAM.O / SIVB.O / TRMB.O / EGAN.O / ITRI.O / PCTY.O / ANSS.O / LPSN.O / EQIX.O / NFLX.O / 92343V104 / 459200101 / ALNY.OQ / 0700.HK / DPZ / ATRC.OQ / SPWR.O / CSIQ.O / FSLR.O / IPGP.O / 02043Q107 / MRNA.O / TMDX.OQ / TWIN.O / CSII.O / AGCO.K / GLAXOSM.LG / TSLA.O / AMRC.K / AMRS.OQ / QSR.TO / ENPH.O / FB.O / CG.O / HASI.N / AGIO.OQ / RNG.N / FATE.OQ / WIX.O / GOOGL.O / PAYC.K / SABR.O / ARES.K / APS.TO / HUBS.K / SHOP.K / SEDG.O / RUN.O / TMUS.OQ / WKHS.O / WCN.TO / AQMS.O / BABA.K / 34959J108 / TTD.OQ / APL.PS / COUP.O / WPRT.TO / TWLO.K / UAA / HLNE.OQ / WDAY.O / APTV.K / EGHT.K / DOCU.O / CWENa.K / CRSP.BN / SWAV.O / XFOR.OQ / UBER.K / A71.F / NLOK.O / BILL.K / AVNT.K / 02081G201 / FMTX.O / RWRh.V / STEP.O / 03823M100</td><td class="leftalignment">Albemarle Corp / American Tower Corp / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Crown Castle International Corp / Cigna Corp / Clean Harbors Inc / Chipotle Mexican Grill Inc / Cummins Inc / Costco Wholesale Corp / Salesforce.Com Inc / Dana Inc / Deere & Co / D R Horton Inc / Digital Realty Trust Inc / Ecolab Inc / Estee Lauder Companies Inc / EnerSys / FedEx Corp / Goldman Sachs Group Inc / Intel Corp / Johnson Controls International PLC / JPMorgan Chase & Co / Kellogg Co / KKR & Co Inc / Lam Research Corp / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / ServiceNow Inc / Realty Income Corp / Ormat Technologies Inc / Roper Technologies Inc / Republic Services Inc / AT&T Inc / UnitedHealth Group Inc / United Rentals Inc / Waste Management Inc / Zendesk Inc / Oracle Corp Japan / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Apple Inc / Fidelity National Information Services Inc / Borgwarner Inc / NVIDIA Corp / Adobe Inc / DTE Energy Co / SAP SE / Block Inc / Novartis AG / SBA Communications Corp / H & R Block Inc / Autodesk Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Dollar Tree Inc / ION Geophysical Corp / CoStar Group Inc / Fuelcell Energy Inc / Align Technology Inc / BlackRock Inc / Wolfspeed Inc / Cloudflare Inc / Broadcom Inc / J B Hunt Transport Services Inc / Activision Blizzard Inc / Xilinx Inc / American Superconductor Corp / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Plug Power Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Atlassian Corporation PLC / SVB Financial Group / Trimble Inc / eGain Corp / Itron Inc / Paylocity Holding Corp / ANSYS Inc / LivePerson Inc / Equinix Inc / Netflix Inc / Verizon Communications Inc / International Business Machines Corp / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Domino's Pizza Inc / AtriCure Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / IPG Photonics Corp / Alnylam Pharmaceuticals Inc / Moderna Inc / Transmedics Group Inc / Twin Disc Inc / Cardiovascular Systems Inc / AGCO Corp / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Ameresco Inc / Amyris Inc / Restaurant Brands International Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Agios Pharmaceuticals Inc / RingCentral Inc / Fate Therapeutics Inc / Wix.Com Ltd / Alphabet Inc / Paycom Software Inc / Sabre Corp / Ares Management Corp / Aptose Biosciences Inc / HubSpot Inc / Shopify Inc / Solaredge Technologies Inc / Sunrun Inc / T-Mobile US Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Alibaba Group Holding Ltd / Fortive Corp / Trade Desk Inc / Apollo Global Capital Inc / Coupa Software Inc / Westport Fuel Systems Inc / Twilio Inc / Under Armour Inc / Hamilton Lane Inc / Workday Inc / Aptiv PLC / 8x8 Inc / DocuSign Inc / Clearway Energy Inc / CRISPR Therapeutics AG / Shockwave Medical Inc / X4 Pharmaceuticals Inc / Uber Technologies Inc / Ascendis Pharma A/S / NortonLifeLock Inc / Bill.com Holdings Inc / Avient Corp / Alphatec Holdings Inc / Forma Therapeutics Holdings Inc / Strathmore Plus Energy Corp / StepStone Group Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Japan / Nigeria / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">To RSV or Not to RSV? Prevention Could Generate $10bn in Vaccine Sales 2030</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / 60770K10</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 6.13.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">00282410 / 71708110 / 00846U10 / 10113710 / 92532F10 / 88355610 / 87936910 / 37555810 / M2572210 / 45232710 / 30063P10 / 98956P10 / 67070410 / 45784P10 / 58933Y10 / 00653A107 / 04351P101 / 00287Y10 / 04004760 / 04280A10 / 40131M10 / 604749101 / 98420N10 / 42226A10 / 90041T10 / 74340E10 / 87337910 / 45826J10 / 55609910 / 74374N10 / 31189P10 / G3910J11 / H0026310 / 24344T10 / 92857F10 / 04685N10 / 34633R10 / 46565G10 / 60468T10 / 03969F10 / 78667J10 / 64157F10 / 55886810 / 49232710 / 75955J40 / 87808K10 / 87166L10 / 89422G10</td><td class="leftalignment">Abbott Laboratories / Pfizer Inc / Agilent Technologies Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Teleflex Inc / Gilead Sciences Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Zimmer Biomet Holdings Inc / NuVasive Inc / Insulet Corp / Merck & Co Inc / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Abbvie Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Guardant Health Inc / Mirum Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Healthequity Inc / Turning Point Therapeutics Inc / Progyny Inc / Tabula Rasa HealthCare Inc / Intellia Therapeutics Inc / MacroGenics Inc / Provention Bio Inc / Fate Therapeutics Inc / GlaxoSmithKline PLC / AC Immune SA / Deciphera Pharmaceuticals Inc / Vocera Communications Inc / Athenex Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Mirati Therapeutics Inc / Arcus Biosciences Inc / SAGE Therapeutics Inc / Nevro Corp / Madrigal Pharmaceuticals Inc / Keros Therapeutics Inc / Relmada Therapeutics Inc / TCR2 Therapeutics Inc / Synlogic Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">06/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Growth Outpacing Safety While Yields Fall</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">AMT / CCI.N / CI / CMG / CMI / COST.O / DHI / DLR / ECL.N / EL.N / FDX / GS / INTC.O / JPM / KKR / LRCX.O / MS / MSFT.O / O / ROP / T.N / UNH / URI / AMZN.O / EBAY.O / GILD.O / AAPL.O / FIS / NVDA.O / DTE.N / SAPG.DE / SQ / NOVN.S / SBAC.O / HRB.N / EW.N / ARE.N / DLTR.O / CSGP.O / ALGN.O / NET.N / AVGO.O / ATVI.OQ / XLNX.OQ / BMRN.OQ / AKAM.OQ / ISRG.OQ / SWKS.OQ / SIVB.O / ANSS.O / EQIX.O / NFLX.O / 92343V104 / 459200101 / ALNY.OQ / 0700.HK / DPZ / IPGP.O / MRNA.O / GLAXOSM.LG / TSLA.O / QSR.TO / FB.O / FATE.OQ / GOOGL.O / TMUS.OQ / 34959J108 / UAA / UBER.K / NLOK.O / 03823M100</td><td class="leftalignment">American Tower Corp / Crown Castle International Corp / Cigna Corp / Chipotle Mexican Grill Inc / Cummins Inc / Costco Wholesale Corp / D R Horton Inc / Digital Realty Trust Inc / Ecolab Inc / Estee Lauder Companies Inc / FedEx Corp / Goldman Sachs Group Inc / Intel Corp / JPMorgan Chase & Co / KKR & Co Inc / Lam Research Corp / Morgan Stanley / Microsoft Corp / Realty Income Corp / Roper Technologies Inc / AT&T Inc / UnitedHealth Group Inc / United Rentals Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Apple Inc / Fidelity National Information Services Inc / NVIDIA Corp / DTE Energy Co / SAP SE / Block Inc / Novartis AG / SBA Communications Corp / H & R Block Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Dollar Tree Inc / CoStar Group Inc / Align Technology Inc / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / Xilinx Inc / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Intuitive Surgical Inc / Skyworks Solutions Inc / SVB Financial Group / ANSYS Inc / Equinix Inc / Netflix Inc / Verizon Communications Inc / International Business Machines Corp / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Domino's Pizza Inc / IPG Photonics Corp / Moderna Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Restaurant Brands International Inc / Meta Platforms Inc / Fate Therapeutics Inc / Alphabet Inc / T-Mobile US Inc / Fortive Corp / Under Armour Inc / Uber Technologies Inc / NortonLifeLock Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Nigeria / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HGEN: Bringing Calm to the (Cytokine) Storm; Initiate with an Outperform Rating and $28 TP</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">HGEN.OQ / BMY.N / SASY.PA / ROG.S / NOVN.S / GSK.L / REGN.OQ / GILD.OQ / IMAB.OQ</td><td class="leftalignment">Humanigen Inc / Bristol-Myers Squibb Co / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Tiago Fauth / Matthew Terwelp / Mr. Thomas Deal / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharmaceuticals: Five key takeaways from ASCO breast cancer expert call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GILD.OQ / SGEN.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Gilead Sciences Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Jun. 09, 2021 / 2:10PM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / BMY=US / GBT=US / BLD=US / INCY=US / GL=US / GILD=US / PAA=US / CHRS=US / LEG=US / VMC=US / MLM=US / PATH=US / BNL=US / DRI=US / ENDP=US / IBP=US / MHK=US / NTST=US / REGN=US / THO=US / VRTX=US / HIW=US / BDN=US / PRI=US / EGP=US / KIM=US / MAA=US / UDR=US / DRE=US / AUTL=US / DIN=US / OGN / BCO=US / TPX=US / EXP=US / BECN=US / TXRH=US / BLDR=US / PGTI=US / OC=US / KTOS=US / TREX=US / OLO=US / APTS=US / MEIP=US / ABBV=US / TILE=US / HTRG=US / DEA=US / 82982L103 / CRSP=US / YEXT=US / COLD=US / EOLS=US / UBER=US / GMAB=US / AZEK=US / VTRS=US / DASH=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Globe Life Inc / Gilead Sciences Inc / Plains All American Pipeline LP / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / UiPath Inc / Bunzl plc / Darden Restaurants Inc / Endo International PLC / Installed Building Products Inc / Mohawk Industries Inc / Netstreit Corp / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Vertex Pharmaceuticals Inc / Highwoods Properties Inc / Brandywine Realty Trust / Primerica Inc / Eastgroup Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / UDR Inc / Duke Realty Corp / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Brinks Co / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / PGT Innovations Inc / Owens Corning / Kratos Defense and Security Solutions Inc / Trex Company Inc / Olo Inc / Preferred Apartment Communities Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / Heritage Insurance Holdings Inc / Easterly Government Properties Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Yext Inc / Americold Realty Trust / Evolus Inc / Uber Technologies Inc / Genmab A/S / Azek Company Inc / Viatris Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v2.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GLTO: Myelofibrosis KOL Webinar</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GLTO.OQ / GILD.OQ</td><td class="leftalignment">Galecto Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Roger Xu / Mr. Thomas Deal / Matthew Terwelp / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Gilead Sciences</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GB0009895292 / US0311621009 / US3755581036 / US23282W6057 / US24823R1059</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Gilead Sciences Inc / Cytokinetics Inc / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING SOON @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: KOL Video Call To Discuss ASCO Highlights at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM / JNJ / LLY / MRK / PFE / GILD.O / US75886F1075 / BSLN.S / HTBX.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Basilea Pharmaceutica AG / Heat Biologics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / MRK=US / LLY=US / PEP=US / AMGN=US / CAG=US / KO=US / CL=US / PG=US / T=US / INCY=US / GILD=US / ENR=US / MANH=US / NWL=US / FLO=US / STZ=US / PATH=US / ENV=US / CENT=US / CHD=US / COLL=US / EPC=US / HAIN=US / REGN=US / SMG=US / FOUR=US / POST=US / GPN=US / SNV=US / AUTL=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / BIIB=US / FRPT=US / DENN=US / THS=US / FIS=US / ELF=US / TIL=US / AAN=US / UTZ=US / OLO=US / MEIP=US / ABBV=US / FATE=US / COUP=US / SQ=US / NTLA=US / IOVA=US / PETQ=US / EQH=US / KDP=US / BTAI=US / HARP=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / REYN=US / ZI=US / BIGC=US / HYFM=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Energizer Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / UiPath Inc / Envestnet Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Shift4 Payments Inc / Post Holdings Inc / Global Payments Inc / Synovus Financial Corp / Autolus Therapeutics PLC / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Fidelity National Information Services Inc / elf Beauty Inc / Instil Bio Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / Coupa Software Inc / Block Inc / Intellia Therapeutics Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Equitable Holdings Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Harpoon Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">US0311621009 / US25179M1036 / US3755581036 / US56418H1005 / US5949181045 / US6745991058 / US7703231032 / US92276F1003 / CA4530384086 / CA1247651088 / CA1363851017 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US20825C1045 / US2274831047 / CA67072Q1046 / US79466L3024 / US0534841012 / US2538681030 / CA8911605092 / CA1360691010 / CA6993202069 / US8288061091 / US44107P1049 / CA0906971035 / US42809H1077 / US29472R1086 / US8666741041 / US74460D1090 / US4219461047 / US5021751020 / US63633D1046 / US89785X1019 / CA22576C1014 / CA15135U1093 / CA69946Q1046 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA7170461064 / CA4932711001 / CA89156V1067 / CA96467A2002 / US78573L1061 / CA3748252069 / US5764852050 / US23283R1005 / CA4882951060 / CA05577W2004 / US71943U1043 / US31189P1021 / CA7397211086 / US14174T1079 / US42225P5017 / US29444U7000 / US95040Q1040 / US37954A2042 / US43300A2033 / US05722G1004 / US00191U1025 / US15677J1088 / CA7241121077 / US73757R1023 / US42250P1030 / CA4220961078</td><td class="leftalignment">Amgen Inc / Devon Energy Corp / Gilead Sciences Inc / ManpowerGroup Inc / Microsoft Corp / Occidental Petroleum Corp / Robert Half International Inc / Ventas Inc / Imperial Oil Ltd / CAE Inc / Canadian Natural Resources Ltd / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Nuvista Energy Ltd / Salesforce.Com Inc / Avalonbay Communities Inc / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Paramount Resources Ltd / Simon Property Group Inc / Host Hotels & Resorts Inc / Birchcliff Energy Ltd / Hess Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / TrueBlue Inc / Crescent Point Energy Corp / Cenovus Energy Inc / Parex Resources Inc / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Peyto Exploration & Development Corp / Keyera Corp / Tourmaline Oil Corp / Whitecap Resources Inc / Sabra Health Care REIT Inc / Gibson Energy Inc / Matador Resources Co / CyrusOne Inc / Kelt Exploration Ltd / BRP Inc / Physicians Realty Trust / Fate Therapeutics Inc / Prairiesky Royalty Ltd / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Welltower Inc / Global Medical REIT Inc / Hilton Worldwide Holdings Inc / Baker Hughes Co / ASGN Inc / Ceridian HCM Holding Inc / Pipestone Energy Corp / Postal Realty Trust Inc / Healthpeak Properties Inc / Headwater Exploration Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASCO 2021: Key Takeaways for Diversified Biopharma</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">37555810 / 03116210 / G3910J11 / 61776010 / F5548N10</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / MorphoSys AG / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASCO Takes: Stage Set For AUTO1 / Read-Throughs From ZUMA-3</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AUTL=US / GILD=US</td><td class="leftalignment">Autolus Therapeutics PLC / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Incremental ASCO data looks consistent; GILD is setting up for many updates over 2021 in heme-onco</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASCO 2021: Incrementally Positive Updates; Key Oncology Catalysts Still to Come</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/7 @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / GILD.O / AMGN.O / HCA.N / CYH.N / COO.N / ICPT.OQ / UTHR.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / DXCM.O / LHCG.O / ALCLS.PA / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / MRNA.O / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / PRTA.OQ / TRVN.O / GOOGL.O / INO.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / 100063846 / IRTC.OQ / ATXI.OQ / 720795103 / ALLO.OQ / 21833P103 / BWAY.TA / ONCT.OQ / PSNL.O / NBSE.O / BXRX.OQ / ETNB.O / ORIC.OQ / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Trevena Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / iRhythm Technologies Inc / Avenue Therapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Oncternal Therapeutics Inc / Personalis Inc / NeuBase Therapeutics Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMT / CCI.N / COST.O / DLR / GLW / GS / INTC.O / MS / MSFT.O / NICE.TA / QCOM.O / QUIK.O / RMBS.O / T.N / WMT / 4716.T / AMZN.O / GILD.O / AAPL.O / NVDA.O / DISH.O / HEAR.O / UPS.N / SBAC.O / RDWR.O / CRNT.O / HRB.N / SMTC.O / CHTR.O / NUAN.O / DOX.O / NET.N / HPE / AVGO.O / GTT / ATVI.OQ / XLNX.OQ / AMSC.OQ / CSGS.OQ / TTWO.OQ / AKAM.OQ / MRVL.OQ / VRNT.OQ / SWKS.OQ / TXN.OQ / LIFE.O / EGAN.O / EQIX.O / SYNA.O / NFLX.O / CEVA.O / 478160104 / 92343V104 / 20030N101 / 459200101 / 0700.HK / BIDU.O / 36467W109 / CCOI.O / ALCLS.PA / CME.O / LLNW.OQ / LULU.O / 02043Q107 / 00826A109 / TSLA.O / NXPI.O / AMD.OQ / ZNGA.O / EA.O / ADI.OQ / FB.O / AMBA.O / RNG.N / TWTR.K / GOOGL.O / FIVN.O / 563771203 / 82655M107 / SNOW.K / INO.O / QRVO.O / APPS.O / TMUS.OQ / BABA.K / TTD.OQ / TWLO.K / SNAP.K / ATUS.K / MDB.O / STM.BN / APTV.K / EGHT.K / BILI.O / AVYA.K / DOCU.O / ALLO.OQ / UNFI.K / ZM.OQ / ONCT.OQ / CMBM.OQ / CRWD.O / FSLY.K / VG.O / DKNG.O / RXT.O / TEUM.PK / ONDS.OQ / REGW.M3 / HUYA.K / 03823M100 / 975657107</td><td class="leftalignment">American Tower Corp / Crown Castle International Corp / Costco Wholesale Corp / Digital Realty Trust Inc / Corning Inc / Goldman Sachs Group Inc / Intel Corp / Morgan Stanley / Microsoft Corp / Nice Ltd / Qualcomm Inc / QuickLogic Corp / Rambus Inc / AT&T Inc / Walmart Inc / Oracle Corp Japan / Amazon.com Inc / Gilead Sciences Inc / Apple Inc / NVIDIA Corp / DISH Network Corp / Turtle Beach Corp / United Parcel Service Inc / SBA Communications Corp / Radware Ltd / Ceragon Networks Ltd / H & R Block Inc / Semtech Corp / Charter Communications Inc / Nuance Communications Inc / Amdocs Ltd / Cloudflare Inc / Hewlett Packard Enterprise Co / Broadcom Inc / GTT Communications Inc / Activision Blizzard Inc / Xilinx Inc / American Superconductor Corp / CSG Systems International Inc / Take-Two Interactive Software Inc / Akamai Technologies Inc / Marvell Technology Inc / Verint Systems Inc / Skyworks Solutions Inc / Texas Instruments Inc / aTyr Pharma Inc / eGain Corp / Equinix Inc / Synaptics Inc / Netflix Inc / CEVA Inc / Johnson & Johnson / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / Tencent Holdings Ltd / Baidu Inc / GameStop Corp / Cogent Communications Holdings Inc / Cellectis SA / CME Group Inc / Limelight Networks Inc / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Affymax Inc / Tesla Inc / NXP Semiconductors NV / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Ambarella Inc / RingCentral Inc / Twitter Inc / Alphabet Inc / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Snowflake Inc. / Inovio Pharmaceuticals Inc / Qorvo Inc / Digital Turbine Inc / T-Mobile US Inc / Alibaba Group Holding Ltd / Trade Desk Inc / Twilio Inc / Snap Inc / Altice USA Inc / MongoDB Inc / STMicroelectronics NV / Aptiv PLC / 8x8 Inc / Bilibili Inc / Avaya Holdings Corp / DocuSign Inc / Allogene Therapeutics Inc / United Natural Foods Inc / Zoom Video Communications Inc / Oncternal Therapeutics Inc / Cambium Networks Corp / CrowdStrike Holdings Inc / Fastly Inc / Vonage Holdings Corp / DraftKings Inc / Rackspace Technology Inc / Pareteum Corp / Ondas Holdings Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc / Winston Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / India / Israel / Japan / Netherlands / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009 / US1266501006 / US3755581036 / US4448591028 / US75886F1075 / US15135B1017 / US74587V1070 / US31189P1021 / US0367521038 / US03969F1093 / US1255231003 / US71944F1066</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Gilead Sciences Inc / Humana Inc / Regeneron Pharmaceuticals Inc / Centene Corp / Puma Biotechnology Inc / Fate Therapeutics Inc / Anthem Inc / Arcus Biosciences Inc / Cigna Corp / Phreesia Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / ANA.MC / BP.L / CAS.TO / CMS.N / CNA.L / ED.N / EDP.LS / ENI.MI / HTG.L / IBE.MC / NA / NVA.TO / PD.N / PD.TO / PEG.N / PMO.L / RYN.N / SGEF.PA / SO.N / TOTF.PA / SSE.L / ACI.N / AMZN.O / WY.N / PXD.N / CNQ.TO / GILD.O / WLL.N / TA.TO / INCY.O / ETR.N / CLS.N / FE.N / TRP.TO / IMO.TO / SU.TO / BTE.TO / VLO.N / MRO.N / PCG.N / DVN.N / XEL.N / STZ.N / RRC.N / EQT.N / EXPE.O / DG.N / NBIX.O / NWN.N / POU.TO / PVH.N / ESI.TO / VRTX.O / CVX.N / SRG.MI / SM.N / PSI.TO / COP.N / CNP.N / CPE.N / ENDP.O / BLU.N / BKH.N / CPK.N / PNR.N / SWN.N / SR.N / CRC.N / HOOK.O / ORLY.O / BCRX.O / ICPT.O / BIIB.O / CFW.TO / TXRH.O / ACAD.O / NESTE.HE / SJW.N / DRX.L / SES.TO / BLX.TO / TEVA.N / GALP.LS / BIR.TO / PRTS.OQ / CLR.N / PPL.TO / LULU.O / RENE.LS / INO.OQ / INE.TO / BIP.N / NOG.A / ARX.TO / PHR.N / CLW.N / CPG.TO / AAV.TO / CVE.TO / CEU.TO / ATH.TO / MEG.TO / VET.TO / WCP.TO / B44XTX8 / TOU.TO / PCH.O / ERF.TO / FRU.TO / PEY.TO / PKI.TO / NPI.TO / KEY.TO / CTT.N / GEI.TO / MTDR.N / TVE.TO / RFP.N / SRPT.O / FIVE.OQ / FANG.O / ABBV.N / KPT.TO / KEL.TO / PRMW.N / ENTA.O / PTCT.O / BEP.N / KPTI.O / XNCR.OQ / ITCI.O / PSK.TO / BMEB.L / LXE.V / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / ZG.O / TWM.TO / SCWX.O / PARR.N / AZRE.N / AQN.N / PVAC.O / GREG.MC / CDEV.O / CVNA.N / ESTE.N / VST.N / OVID.O / RDFN.O / CARG.O / AY.O / SDRY.L / BKNG.O / AMRX.N / ITRM.O / PRVB.O / FLMN.OQ / CWEN.N / ESLX.PA / GMDA.OQ / PIPE.V / LYFT.O / NBSE.OQ / UBER.N / MNRL.N / KRTX.OQ / MORF.OQ / CRWD.O / APRE.OQ / IGMS.O / ETNB.O / OAS.OQ / OVV.N / WTRG.N / LUNE.ST / APA.OQ / ASAN.N / SPRB.OQ / MTCR.O / SUMO.O / TPZ.TO / VTRS.OQ / ABNB.OQ / DASH.N / CHK.OQ / TSP.OQ / 120385055 / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Acciona SA / BP PLC / Cascades Inc / CMS Energy Corp / Centrica PLC / Consolidated Edison Inc / EDP Energias de Portugal SA / Eni SpA / Hunting PLC / Iberdrola SA / National Bank of Canada / Nuvista Energy Ltd / PagerDuty Inc / Precision Drilling Corp / Public Service Enterprise Group Inc / Harbour Energy PLC / Rayonier Inc / Vinci SA / Southern Co / TotalEnergies SE / SSE PLC / Albertsons Companies Inc / Amazon.com Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Whiting Petroleum Corp / TransAlta Corp / Incyte Corp / Entergy Corp / Celestica Inc / FirstEnergy Corp / TC Energy Corp / Imperial Oil Ltd / Suncor Energy Inc / Baytex Energy Corp / Valero Energy Corp / Marathon Oil Corp / PG&E Corp / Devon Energy Corp / Xcel Energy Inc / Constellation Brands Inc / Range Resources Corp / EQT Corp / Expedia Group Inc / Dollar General Corp / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Paramount Resources Ltd / PVH Corp / Ensign Energy Services Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Snam SpA / SM Energy Co / Pason Systems Inc / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Endo International PLC / BELLUS Health Inc / Black Hills Corp / Chesapeake Utilities Corp / Pentair PLC / Southwestern Energy Co / Spire Inc / California Resources Corp / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Calfrac Well Services Ltd / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / Neste Oyj / SJW Group / Drax Group PLC / Secure Energy Services Inc / Boralex Inc / Teva Pharmaceutical Industries Ltd / Galp Energia SGPS SA / Birchcliff Energy Ltd / Carparts.Com Inc / Continental Resources Inc / Pembina Pipeline Corp / Lululemon Athletica Inc / Ren Redes Energeticas Nacionais SGPS SA / Inovio Pharmaceuticals Inc / Innergex Renewable Energy Inc / Brookfield Infrastructure Partners LP / Northern Oil and Gas Inc / ARC Resources Ltd / Phreesia Inc / Clearwater Paper Corp / Crescent Point Energy Corp / Advantage Energy Ltd / Cenovus Energy Inc / CES Energy Solutions Corp / Athabasca Oil Corp / MEG Energy Corp / Vermilion Energy Inc / Whitecap Resources Inc / Pandora A/S / Tourmaline Oil Corp / Potlatchdeltic Corp / Enerplus Corp / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Parkland Corp / Northland Power Inc / Keyera Corp / CatchMark Timber Trust Inc / Gibson Energy Inc / Matador Resources Co / Tamarack Valley Energy Ltd / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Five Below Inc / Diamondback Energy Inc / Abbvie Inc / KP Tissue Inc / Kelt Exploration Ltd / Primo Water Corp / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Prairiesky Royalty Ltd / B&M European Value Retail SA / Leucrotta Exploration Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Zillow Group Inc / Tidewater Midstream and Infrastructure Ltd / SecureWorks Corp / Par Pacific Holdings Inc / Azure Power Global Ltd / Algonquin Power & Utilities Corp / Ranger Oil Corp / Grenergy Renovables SA / Centennial Resource Development Inc / Carvana Co / Earthstone Energy Inc / Vistra Corp / Ovid Therapeutics Inc / Redfin Corp / CarGurus Inc / Atlantica Sustainable Infrastructure PLC / Superdry PLC / Booking Holdings Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Provention Bio Inc / Falcon Minerals Corp / Clearway Energy Inc / EssilorLuxottica SA / Gamida Cell Ltd / Pipestone Energy Corp / Lyft Inc / NeuBase Therapeutics Inc / Uber Technologies Inc / Brigham Minerals Inc / Karuna Therapeutics Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Essential Utilities Inc / Lundin Energy AB / APA Corp (US) / Asana Inc / Spruce Biosciences Inc / Metacrine Inc / Sumo Logic Inc / Topaz Energy Corp / Viatris Inc / Airbnb Inc / DoorDash Inc / Chesapeake Energy Corp / TuSimple Holdings Inc / Parkland Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Mauritius / Portugal / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / HOOK.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / INO.OQ / SRPT.O / ENTA.O / PTCT.O / KPTI.O / XNCR.OQ / ITCI.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / OVID.O / ITRM.O / PRVB.O / GMDA.OQ / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Ovid Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">ASCO 2021: Range of Interesting Abstracts, Not Just Large-cap</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / LIFE.O / ALCLS.PA / 02043Q107 / INO.O / ALLO.OQ / ONCT.OQ / REGW.M3 / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / aTyr Pharma Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Allogene Therapeutics Inc / Oncternal Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Israel / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/7 @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Gilead Sciences, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Anguilla / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Jun. 02, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AXP / COF / DFS / INTC.O / MS / MSFT.O / NPO / QCOM.O / T.N / 4716.T / GILD.O / AMGN.O / FIS / NVDA.O / SPOT.N / SQ / HEAR.O / LSCC.O / SMTC.O / FISV.O / GPN / AVGO.O / JKHY.OQ / ATVI.OQ / TTWO.OQ / UTHR.OQ / MRVL.OQ / VRTX.OQ / LIFE.O / BIIB.O / 92343V104 / 78442P106 / 36467W109 / 02043Q107 / MRNA.O / ZNGA.O / EA.O / AMBA.O / 82655M107 / G29183103 / INO.O / APPS.O / 63938C108 / CATB.OQ / PYPL.O / TMUS.OQ / TTD.OQ / IRTC.OQ / BILI.O / 21833P103 / ZM.OQ / ONCT.OQ / NBSE.O / SONM.O / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">American Express Co / Capital One Financial Corp / Discover Financial Services / Intel Corp / Morgan Stanley / Microsoft Corp / EnPro Industries Inc / Qualcomm Inc / AT&T Inc / Oracle Corp Japan / Gilead Sciences Inc / Amgen Inc / Fidelity National Information Services Inc / NVIDIA Corp / Spotify Technology SA / Block Inc / Turtle Beach Corp / Lattice Semiconductor Corp / Semtech Corp / Fiserv Inc / Global Payments Inc / Broadcom Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Marvell Technology Inc / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Verizon Communications Inc / SLM Corp / GameStop Corp / Alnylam Pharmaceuticals Inc / Moderna Inc / Zynga Inc / Electronic Arts Inc / Ambarella Inc / Sify Technologies Ltd / Eaton Corporation PLC / Inovio Pharmaceuticals Inc / Digital Turbine Inc / Navient Corp / Astria Therapeutics Inc / PayPal Holdings Inc / T-Mobile US Inc / Trade Desk Inc / iRhythm Technologies Inc / Bilibili Inc / Corbus Pharmaceuticals Holdings Inc / Zoom Video Communications Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Sonim Technologies Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / India / Ireland / Israel / Japan / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CAH.N / CC.N / CL.N / COF.N / CRM.N / ECL.N / EIX.N / EOG.N / F.N / FCX.N / FDX.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KMB.N / LLY.N / LMT.N / MRK.N / SC.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / AAL.L / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / NKE.N / LIN.N / OLN.N / IT.N / TGT.N / AVY.N / RKT.N / BLL.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / VFC.N / NRG.N / PWR.N / NEU.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / HAE.N / PVH.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / INTC.OQ / CTSH.OQ / ABMD.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / JKHY.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / SIVB.OQ / QDEL.OQ / QCOM.OQ / INTU.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / STLD.OQ / AMZN.OQ / LNG.A / MRCY.OQ / NVDA.OQ / SBAC.OQ / BMRN.OQ / PACW.OQ / TREE.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / TXN.OQ / CMCSA.OQ / BIIB.OQ / TPX.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / WAL.N / MS.N / FIS.N / STX.AX / RPRX.OQ / HES.N / MA.N / AWI.N / FSLR.OQ / CNK.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / NEE.N / TSLA.OQ / LPLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / LDOS.N / RNG.N / COMM.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / SQ.N / IONS.OQ / IAC.OQ / TTD.OQ / COUP.OQ / UAA.N / AYX.N / DXC.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / QRTEA.OQ / FB.PS / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / LMND.N / AMWL.N / VTRS.OQ / HON.OQ</td><td class="leftalignment">Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Cardinal Health Inc / Chemours Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Linde PLC / Olin Corp / Gartner Inc / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / VF Corp / NRG Energy Inc / Quanta Services Inc / NewMarket Corp / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Haemonetics Corp / PVH Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Jack Henry & Associates Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Quidel Corp / Qualcomm Inc / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Lendingtree Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Western Alliance Bancorp / Morgan Stanley / Fidelity National Information Services Inc / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Cinemark Holdings Inc / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / LPL Financial Holdings Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / Leidos Holdings Inc / RingCentral Inc / CommScope Holding Company Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Block Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Trade Desk Inc / Coupa Software Inc / Under Armour Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Lemonade Inc / American Well Corp / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-1Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / AMGN.O / UTHR.OQ / VRTX.OQ / LIFE.O / BIIB.O / 02043Q107 / MRNA.O / INO.O / CATB.OQ / ONCT.OQ / NBSE.O / REGW.M3 / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Astria Therapeutics Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US3755581036 / US62818Q1040</td><td class="leftalignment">Gilead Sciences Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Jun. 01, 2021 / 1:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / BMO.TO / CAS.TO / CL.N / CM.TO / CRM.N / EDP.LS / EIX.N / EL.N / ELE.MC / IBE.MC / IP.N / KMB.N / KO.N / MRK.N / NA.TO / PD.N / PEG.N / PFE.N / RYN.N / SO.N / STO.AX / T.N / T.TO / TD.TO / PEP.N / DRE.N / FR.N / TRI.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / GILD.O / CPB.N / LPX.N / CMCSA.O / AMGN.O / INCY.O / AAL.L / DUK.N / TRP.TO / K.N / DT.N / ADBE.O / SU.TO / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / HCA.N / STZ.N / EXC.N / FISV.O / EQT.N / ADSK.O / EPD.N / AWK.N / EGP.N / PLD.N / NBIX.O / CHD.N / NWN.N / WSP.TO / SAM.N / ENR.N / VRTX.O / JHX.AX / CEY.L / NCR.N / VRNT.O / COP.N / CNP.N / WCN.N / CPK.N / DOL.TO / TYL.N / CRC.N / LNG.A / NTCT.OQ / GPN.N / MNST.O / EFX.TO / CCLb.TO / CASY.O / PCTY.O / ICPT.O / EQIX.O / ATDb.TO / BIIB.O / TIH.TO / 02209S103 / NTR.N / DLR.N / SCL.TO / ACAD.O / 427866108 / WEF.TO / RDSb.L / BAM.N / SJW.N / DRX.L / FIS.N / CSU.TO / MERC.O / 3IN.L / BGS.N / PPL.TO / HOCM.L / ARX.TO / UTL.N / CLW.N / VALE.N / IFC.TO / CVE.TO / ADN.TO / SPB.N / NEE.N / TOU.TO / NXT.AX / PCH.O / CFX.TO / FRU.TO / SXY.AX / CTT.N / STAG.N / IFP.TO / PXT.TO / POLYP.L / EFN.TO / SPLK.OQ / RFP.N / SRPT.O / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / 81762P102 / CFF.TO / COUP.N / VRNS.O / QTWO.N / RYAM.N / HUBS.N / QSR.N / CAR.AX / 78667J108 / EVA.N / GLPG.O / WRK.N / IONS.O / NTNX.O / GDS.O / AQN.N / OKTA.OQ / WPM.N / ZS.OQ / SMAR.N / VRCA.OQ / ITRM.O / NTGY.MC / KDP.N / ESTC.N / NWL.O / ZM.O / MORF.OQ / CRWD.O / PING.N / FCR_u.TO / REYN.O / GFL.N / FOUR.N / ZI.O / AKES.OL / PLTR.N / ASAN.N / WFG.N / AFRM.O / TEEC.L / NAPA.N / PATH.N / AVAH.OQ / GIP.V / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Bank of Montreal / Cascades Inc / Colgate-Palmolive Co / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / Iberdrola SA / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Rayonier Inc / Southern Co / Santos Ltd / AT&T Inc / Telus Corp / Toronto-Dominion Bank / PepsiCo Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Comcast Corp / Amgen Inc / Incyte Corp / Anglo American PLC / Duke Energy Corp / TC Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Suncor Energy Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / HCA Healthcare Inc / Constellation Brands Inc / Exelon Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Eastgroup Properties Inc / Prologis Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / Boston Beer Company Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Verint Systems Inc / Conocophillips / CenterPoint Energy Inc / Waste Connections Inc / Chesapeake Utilities Corp / Dollarama Inc / Tyler Technologies Inc / California Resources Corp / Cheniere Energy Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / CCL Industries Inc / Caseys General Stores Inc / Paylocity Holding Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Toromont Industries Ltd / Altria Group Inc / Nutrien Ltd / Digital Realty Trust Inc / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / SJW Group / Drax Group PLC / Fidelity National Information Services Inc / Constellation Software Inc / Mercer International Inc / 3I Infrastructure PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / ARC Resources Ltd / Unitil Corp / Clearwater Paper Corp / Vale SA / Intact Financial Corp / Cenovus Energy Inc / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Senex Energy Ltd / CatchMark Timber Trust Inc / STAG Industrial Inc / Interfor Corp / Parex Resources Inc / Polymetal International PLC / Element Fleet Management Corp / Splunk Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Conifex Timber Inc / Coupa Software Inc / Varonis Systems Inc / Q2 Holdings Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Restaurant Brands International Inc / Carsales.Com Ltd / SAGE Therapeutics Inc / Enviva Inc / Galapagos NV / Westrock Co / Ionis Pharmaceuticals Inc / Nutanix Inc / GDS Holdings Ltd / Algonquin Power & Utilities Corp / Okta Inc / Wheaton Precious Metals Corp / Zscaler Inc / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / First Capital Real Estate Investment Trust / Reynolds Consumer Products Inc / GFL Environmental Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Aker Solutions ASA / Palantir Technologies Inc / Asana Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Duckhorn Portfolio Inc / UiPath Inc / Aveanna Healthcare Holdings Inc / Green Impact Partners Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Cayman Islands / Spain / United Kingdom / Ireland / Netherlands / Norway / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: The 3 Pushes And 3 Pulls We See Influencing M&A Activity In The Sector; Expect 2H21 Uptick</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BIIB.O / ACAD.O / GLPG.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Galapagos NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Stephen Mallon / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IMAB.O / JNJ / LLY / MRK / PFE / US3755581036 / BSLN / HCM.O / MBIO.O</td><td class="leftalignment">I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/29/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 82 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Defense / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Gilead (GILD: $66.11) rises 3% on high volatility in May 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.28.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Gilead Sciences, Inc. (GILD) - A slower pandemic recovery for FY21</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN=US / DIS=US / MCD=US / AGL=US / AMZN=US / T=US / GILD=US / NVDA=US / PEB=US / H=US / MTN=US / VRM=US / SCOR=US / EWBC=US / BRO=US / MAR=US / UMPQ=US / TNL=US / HLT=US / WTFC=US / CHH=US / CW=US / DRH=US / DCO=US / AJG=US / MCRI=US / PACW=US / HOOK=US / REGN=US / WAL=US / HTH=US / SNOW=US / CGEN=US / BXS=US / FNF=US / CFB=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / WRE=US / CATY=US / GBCI=US / REG=US / NFLX=US / ECPG=US / PNFP=US / SBCF=US / PRAA=US / STRO=US / BIIB=US / FNB=US / FHN=US / SHO=US / RNST=US / REX=US / HST=US / ELF=US / CADE=US / TAST=US / QSR=US / NMTR=US / WH=US / RCUS=US / HGV=US / NLSN=US / PCRX=US / RLJ=US / VAC=US / MEIP=US / RHP=US / ABBV=US / IBTX=US / FATE=US / NMIH=US / EVH=US / ACBI=US / PK=US / LGF.B=US / PLYA=US / OKTA=US / CVNA=US / ROKU=US / HWC=US / BTAI=US / OZK=US / ALLO=US / HARP=US / PLMR=US / HCAT=US / AVAH=US</td><td class="leftalignment">Amgen Inc / Walt Disney Co / McDonald's Corp / agilon health Inc / Amazon.com Inc / AT&T Inc / Gilead Sciences Inc / NVIDIA Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Vroom Inc / Comscore Inc / East West Bancorp Inc / Brown & Brown Inc / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / Choice Hotels International Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Snowflake Inc. / Compugen Ltd / Cadence Bank / Fidelity National Financial Inc / Crossfirst Bankshares Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Washington Real Estate Investment Trust / Cathay General Bancorp / Glacier Bancorp Inc / Regency Centers Corp / Netflix Inc / Encore Capital Group Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Sutro Biopharma Inc / Biogen Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / REX American Resources Corp / Host Hotels & Resorts Inc / elf Beauty Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Fate Therapeutics Inc / NMI Holdings Inc / Evolent Health Inc / Atlantic Capital Bancshares Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Okta Inc / Carvana Co / Roku Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Bank Ozk / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Health Catalyst Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Setting A Realistic Bar For HOOK's Landmark Data Presentation</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HOOK=US / GILD=US</td><td class="leftalignment">HOOKIPA Pharma Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / AMZN=US / T=US / INCY=US / GILD=US / VZ=US / CHRS=US / EWBC=US / MANH=US / MLM=US / DV=US / WTFC=US / AIZ=US / CBRL=US / ELY=US / EXEL=US / HEI=US / MAIN=US / OKE=US / HOOK=US / REGN=US / GOLF=US / CGEN=US / CFB=US / SNV=US / SIVB=US / ABCB=US / FB=US / FBK=US / SSB=US / GBCI=US / NLS=US / PNFP=US / SBCF=US / JRVR=US / STRO=US / RNG=US / IAC=US / RCUS=US / CLNY=US / KNSL=US / MEIP=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / ACBI=US / ZS=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / OZK=US / FTDR=US / ALLO=US / HARP=US / UBER=US / GMAB=US / AVAH=US / VMEO=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Amazon.com Inc / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / Coherus BioSciences Inc / East West Bancorp Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Wintrust Financial Corp / Assurant Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Exelixis Inc / HEICO Corp / Main Street Capital Corp / ONEOK Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Acushnet Holdings Corp / Compugen Ltd / Crossfirst Bankshares Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Glacier Bancorp Inc / Nautilus Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Sutro Biopharma Inc / RingCentral Inc / IAC/Interactivecorp / Arcus Biosciences Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / MEI Pharma Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / Genmab A/S / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AAP.N / ANTO.L / DFDS.CO / GOG.L / IBE.MC / VIEV.VI / GILD.O / DV.N / INTU.O / SHW.N / AZO.N / IG.MI / URBN.O / BLU.N / HOOK.O / ORLY.O / GOLD.N / FM.TO / ACAD.O / ARWR.O / NCU.TO / GETP.PA / GLEN.L / SRPT.O / QURE.O / ENLC.N / S32.AX / 03835T200 / GBT.OQ / OR.N / ZS.OQ / PRVB.O / MORF.OQ / AVAH.OQ</td><td class="leftalignment">Advance Auto Parts Inc / Antofagasta PLC / DFDS AS / Go-Ahead Group PLC / Iberdrola SA / Flughafen Wien AG / Gilead Sciences Inc / DoubleVerify Holdings Inc / Intuit Inc / Sherwin-Williams Co / Autozone Inc / Italgas SpA / Urban Outfitters Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Barrick Gold Corp / First Quantum Minerals Ltd / ACADIA Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Nevada Copper Corp / Getlink SE / Glencore PLC / Sarepta Therapeutics Inc / Uniqure NV / EnLink Midstream LLC / South32 Ltd / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Osisko Gold Royalties Ltd / Zscaler Inc / Provention Bio Inc / Morphic Holding Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Austria / Canada / Denmark / Spain / France / United Kingdom / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ASCO Planner v2.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Our Top Biotech Takeaways from the RBC Capital Markets Global Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / BLU.N / HOOK.O / ACAD.O / ARWR.O / SRPT.O / QURE.O / 03835T200 / GBT.OQ / PRVB.O / MORF.OQ</td><td class="leftalignment">Gilead Sciences Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / ACADIA Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Sarepta Therapeutics Inc / Uniqure NV / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Provention Bio Inc / Morphic Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Michael Murray / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Kennen MacKay, PHD / Leonid Timashev / David Szeto / Stephen Mallon / Yinglu Zhang / Lisa Walter</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Gilead adds 6.7% in past quarter; Institutional Ownership up 3%</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights in Breast Cancer from Our ASCO KOL Preview Day</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">04635310 / 37555810 / 75046920 / 81181C10 / F5548N10 / 98943L10</td><td class="leftalignment">AstraZeneca PLC / Gilead Sciences Inc / Radius Health Inc / Seagen Inc / Sanofi SA / Zentalis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Andrew Berens, M.D. / Christopher Liu, Pharm.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2973821 / 2270726 / 2670519 / 2369174 / 2459020 / 2657802 / 2048804 / 2829601 / 2928683 / 2980906 / 7103065 / B125XQ6 / B0T7YX2 / B02R1L6 / B3D7K31 / 2949758 / B7TL820 / BCZS820 / B87ZMX0 / BYVY8G0 / BXDZ9Z0 / BYNZGK1 / BFZNYB7 / BDHF4K6 / BHC8X90 / BD8DJ71 / BWFKZT2 / BFMXGR0 / BKTNTR9 / BMDJ085</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Exelon Corp / Gilead Sciences Inc / Intuit Inc / OGE Energy Corp / Pinnacle West Capital Corp / Southern Co / VF Corp / Foot Locker Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Nexstar Media Group Inc / Meta Platforms Inc / Fate Therapeutics Inc / Palo Alto Networks Inc / Alphabet Inc / Shopify Inc / Block Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Cellectis SA / Evergy Inc / ViacomCBS Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : Updated Credit Views from the "USD HG Coverage and Rating Report"</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABC.N / AMGN.O / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CI.N / JNJ.N / LLY.N / MCK.N / MRK.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / BIIB.O / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amerisourcebergen Corp / Amgen Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Biogen Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, May 21, 2021 / 12:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / EW.N / INCY.OQ / IART.OQ / EXEL.OQ / ISRG.OQ / CCRN.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ATRC.OQ / LHCG.O / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / MRTX.OQ / GOOGL.O / XENT.OQ / CLRB.OQ / MRNS.O / CATB.OQ / EVH.N / TDOC.N / GBT.OQ / MMD.WA / APLS.OQ / 100063846 / IRTC.OQ / SRRA.O / PLXP.O / IOVA.OQ / ALPN.O / MBIO.OQ / NCNA.O / CUE.OQ / 720795103 / SURF.O / VCNX.OQ / MOTS.O / ALLO.OQ / ORTX.OQ / SWAV.O / PDSB.OQ / BWAY.TA / PNTG.OQ / IGMS.O / VERO.O / ORIC.OQ / AYLA.O / FMTX.O / REGW.M3</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Integra Lifesciences Holdings Corp / Exelixis Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Mirati Therapeutics Inc / Alphabet Inc / Intersect Ent Inc / Cellectar Biosciences Inc / Marinus Pharmaceuticals Inc / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / Milestone Medical Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / iRhythm Technologies Inc / Sierra Oncology Inc / PLx Pharma Inc / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Mustang Bio Inc / NuCana PLC / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Surface Oncology Inc / Vaccinex Inc / Motus GI Holdings Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / PDS Biotechnology Corp / Brainsway Ltd / Pennant Group Inc / IGM Biosciences Inc / Venus Concept Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMT / CCI.N / DLR / ENS / GLW / GS / INTC.O / MSFT.O / NICE.TA / QCOM.O / QUIK.O / SGE.L / T.N / WMT / 4716.T / AMZN.O / GILD.O / AAPL.O / NVDA.O / DISH.O / HEAR.O / NOVN.S / UPS.N / SBAC.O / RDWR.O / CRNT.O / CHTR.O / NUAN.O / DOX.O / NET.N / HPE / GTT / ATVI.OQ / IART.OQ / TTWO.OQ / AKAM.OQ / MRVL.OQ / VRTX.OQ / VRNT.OQ / TXN.OQ / MNRO.O / EGAN.O / EQIX.O / NFLX.O / CEVA.O / 92343V104 / 20030N101 / 459200101 / 36467W109 / CCOI.O / CME.O / LLNW.OQ / TSLA.O / AMD.OQ / ZNGA.O / EA.O / FB.O / PANW.K / RNG.N / CHGG.N / GOOGL.O / FIVN.O / 563771203 / 82655M107 / PAYC.K / SNOW.K / APPS.O / TMUS.OQ / TTD.OQ / TWLO.K / SNAP.K / ATUS.K / ROKU.O / EGHT.K / BILI.O / AVYA.K / BWAY.TA / ZM.OQ / CMBM.OQ / IGMS.O / FSLY.K / VG.O / DKNG.O / RXT.O / TEUM.PK / ONDS.OQ / HUYA.K</td><td class="leftalignment">American Tower Corp / Crown Castle International Corp / Digital Realty Trust Inc / EnerSys / Corning Inc / Goldman Sachs Group Inc / Intel Corp / Microsoft Corp / Nice Ltd / Qualcomm Inc / QuickLogic Corp / Sage Group PLC / AT&T Inc / Walmart Inc / Oracle Corp Japan / Amazon.com Inc / Gilead Sciences Inc / Apple Inc / NVIDIA Corp / DISH Network Corp / Turtle Beach Corp / Novartis AG / United Parcel Service Inc / SBA Communications Corp / Radware Ltd / Ceragon Networks Ltd / Charter Communications Inc / Nuance Communications Inc / Amdocs Ltd / Cloudflare Inc / Hewlett Packard Enterprise Co / GTT Communications Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Akamai Technologies Inc / Marvell Technology Inc / Vertex Pharmaceuticals Inc / Verint Systems Inc / Texas Instruments Inc / Monro Inc / eGain Corp / Equinix Inc / Netflix Inc / CEVA Inc / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / GameStop Corp / Cogent Communications Holdings Inc / CME Group Inc / Limelight Networks Inc / Tesla Inc / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Palo Alto Networks Inc / RingCentral Inc / Chegg Inc / Alphabet Inc / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Paycom Software Inc / Snowflake Inc. / Digital Turbine Inc / T-Mobile US Inc / Trade Desk Inc / Twilio Inc / Snap Inc / Altice USA Inc / Roku Inc / 8x8 Inc / Bilibili Inc / Avaya Holdings Corp / Brainsway Ltd / Zoom Video Communications Inc / Cambium Networks Corp / IGM Biosciences Inc / Fastly Inc / Vonage Holdings Corp / DraftKings Inc / Rackspace Technology Inc / Pareteum Corp / Ondas Holdings Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Israel / Japan / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Call Takeaways: Diffuse Large B-cell Lymphoma (DLBCL)</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / NOVN.S / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Novartis AG / IGM Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00846U1016 / US0311621009 / US2666051048 / US3755581036 / US75886F1075 / US02043Q1076 / US74587V1070 / IL0011313900 / CA68620P1018 / CA1380351009 / US03969F1093 / US88688T1007 / US15117B2025 / CA05156X8843 / US56854Q2003 / US40434H2031 / CA4283043079</td><td class="leftalignment">Agilent Technologies Inc / Amgen Inc / DURECT Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Puma Biotechnology Inc / Galmed Pharmaceuticals Ltd / OrganiGram Holdings Inc / Canopy Growth Corp / Arcus Biosciences Inc / Tilray Brands Inc / Celldex Therapeutics Inc / Aurora Cannabis Inc / Marinus Pharmaceuticals Inc / HTG Molecular Diagnostics Inc / Hexo Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">NA / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss ASCO Highlights on 6/7 at 12 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O / FATE.O / GILD.O / REGN.O / PBYI.O / RCUS.K</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / MRKR.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / Marker Therapeutics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000077919 / US0126531013 / US0311621009 / US0530151036 / US1264081035 / US17275R1023 / US22284P1057 / US2310211063 / US30161Q1040 / US3614481030 / US3755581036 / US3936571013 / US4456581077 / US45253H1014 / US45337C1027 / US6558441084 / US66987V1098 / US6795801009 / US6937181088 / US7043261079 / US75886F1075 / US7782961038 / US8447411088 / US8725401090 / US87612E1064 / US8965221091 / US9029251066 / US9078181081 / US9297401088 / US9507551086 / CA1363751027 / CA13645T1003 / US3570231007 / US9043111072 / US78709Y1055 / US29089Q1058 / US9837931008 / US74587V1070 / US16934W1062 / US29428V1044 / US1220171060 / US5560991094 / US70438V1061 / US70432V1026 / US03937C1053 / US09627Y1091 / US00653A1079 / US07725L1026 / CA87241L1094 / US23753F1075 / US80689H1023 / US3621LQ1099 / US4990491049 / US8760301072 / CA53680Q2071 / US02083G1004 / US1010441053 / US67022C1062 / US4622601007 / VGG273581030 / US05351X1019 / SE0009414576 / US15677J1088 / US86877M2098 / US55910K1088 / US29260V1052 / US9842411095 / KY30744W1070 / US8693671021 / US40131M1099 / US0197701065 / US53814L1089 / US18453H1068 / CA16106R1091 / US09203E1055 / US92537N1081 / CH0499880968 / US05370A1088 / US81181C1045 / US74767V1098 / US55406W1036 / US15961R1059 / US49926T1043 / US83089J1088</td><td class="leftalignment">JCDecaux SA / Albemarle Corp / Amgen Inc / Automatic Data Processing Inc / CSX Corp / Cisco Systems Inc / Covenant Logistics Group Inc / Cummins Inc / Exelixis Inc / GATX Corp / Gilead Sciences Inc / Greenbrier Companies Inc / J B Hunt Transport Services Inc / ImmunoGen Inc / Incyte Corp / Norfolk Southern Corp / Novartis AG / Old Dominion Freight Line Inc / Paccar Inc / Paychex Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Southwest Airlines Co / TJX Companies Inc / Target Corp / Trinity Industries Inc / USA Truck Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / FreightCar America Inc / Under Armour Inc / Saia Inc / Emergent BioSolutions Inc / XPO Logistics Inc / Puma Biotechnology Inc / Chimerix Inc / Epizyme Inc / Burlington Stores Inc / MacroGenics Inc / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Blueprint Medicines Corp / Adaptimmune Therapeutics PLC / Beigene Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / G1 Therapeutics Inc / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Boston Omaha Corp / NuCana PLC / Iovance Biotherapeutics Inc / Despegar.com Corp / Avaya Holdings Corp / Oncopeptides AB / Ceridian HCM Holding Inc / Surface Oncology Inc / Magenta Therapeutics Inc / Endava PLC / Y-mAbs Therapeutics Inc / Farfetch Ltd / Sutro Biopharma Inc / Guardant Health Inc / Allogene Therapeutics Inc / Livent Corp / Clear Channel Outdoor Holdings Inc / Charlotte's Web Holdings Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / Avidity Biosciences Inc / Seagen Inc / Quantumscape Corp / MYT Netherlands Parent BV / ChargePoint Holdings Inc / Knowbe4 Inc / Skywater Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / BMY=US / HD=US / ADI=US / T=US / GILD=US / AMT=US / PEB=US / H=US / MTN=US / VZ=US / LOW=US / MAR=US / ADS=US / TTWO=US / TNL=US / HLT=US / BMRN=US / CHH=US / CPRT=US / DRH=US / RARE=US / REGN=US / STRO=US / EXP=US / AWH / SHO=US / NSP=US / HST=US / WH=US / TIL=US / JACK=US / RCUS=US / HGV=US / RLJ=US / VAC=US / MEIP=US / RHP=US / FATE=US / 00770K202 / UPLD=US / VVV=US / PK=US / GDS=US / PLYA=US / IOVA=US / BTAI=US / ALLO=US / FERG=US / SPCE=US / KNBE=US</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Analog Devices Inc / AT&T Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Lowe's Companies Inc / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Copart Inc / Diamondrock Hospitality Co / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sutro Biopharma Inc / Eagle Materials Inc / Aspira Women's Health Inc / Sunstone Hotel Investors Inc / Insperity Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Jack in the Box Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Aemetis Inc / Upland Software Inc / Valvoline Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Ferguson PLC / Virgin Galactic Holdings Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Four Highlights and Insights from ASCO Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">11012210 / 37555810 / 75886F10 / 03969F10 / F5548N10</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Arcus Biosciences Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Biotech Highlights From ASCO Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0311621009 / US30161Q1040 / US3755581036 / US45253H1014 / US45337C1027 / US66987V1098 / US75886F1075 / US74587V1070 / US16934W1062 / US29428V1044 / US5560991094 / US09627Y1091 / US00653A1079 / US3621LQ1099 / US02083G1004 / US4622601007 / SE0009414576 / US86877M2098 / US55910K1088 / US9842411095 / US8693671021 / CH0499880968 / US81181C1045</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Novartis AG / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Chimerix Inc / Epizyme Inc / MacroGenics Inc / Blueprint Medicines Corp / Adaptimmune Therapeutics PLC / G1 Therapeutics Inc / Alpine Immune Sciences Inc / Iovance Biotherapeutics Inc / Oncopeptides AB / Surface Oncology Inc / Magenta Therapeutics Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / ADC Therapeutics SA / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2259101 / 2126335 / 2000019 / 2536763 / 2973821 / 2437071 / 2175672 / 2190750 / 2208073 / 2270726 / 2542049 / 2670519 / 2342034 / 2369174 / 2459202 / 2459020 / 2645409 / 2657802 / 2048804 / 2440637 / 2825933 / 2829601 / 2989301 / 2769796 / B02R1L6 / B3D7K31 / B1HJLW5 / B44C366 / B7TL820 / B7VD3F2 / B9M2WX3 / B87ZMX0 / B95WG16 / BVVN4Q8 / BYY8XK8 / BF4VBS8 / BF5L3T2 / BFZNYB7 / BK7Y2V9 / BFZ1K46 / BFMXGR0 / BFNR303 / BFWK4R7 / BHZSB82 / BP3YM85 / BL95N25 / BZ1LFG7 / BYY88Y7 / BKWD3M9 / BGKG6M3 / BLBLMD5 / BMDJ085 / BMC8SQ7 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Target Corp / Bristol-Myers Squibb Co / Amazon.com Inc / Lowe's Companies Inc / Alliant Energy Corp / Biomarin Pharmaceutical Inc / Cardinal Health Inc / Chesapeake Utilities Corp / Copart Inc / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Fiserv Inc / Gilead Sciences Inc / IDEXX Laboratories Inc / Intuit Inc / NiSource Inc / OGE Energy Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / South Jersey Industries Inc / Southern Co / TJX Companies Inc / Fidelity National Information Services Inc / ALLETE Inc / Discovery Inc / Emergent BioSolutions Inc / Heska Corp / Meta Platforms Inc / Duke Energy Corp / Bath & Body Works Inc / Palo Alto Networks Inc / Zoetis Inc / Eversource Energy / WEC Energy Group Inc / BioXcel Therapeutics Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Akero Therapeutics Inc / Spotify Technology SA / Evergy Inc / Northwest Natural Holding Co / PagSeguro Digital Ltd / Covetrus Inc / Trupanion Inc / Phibro Animal Health Corp / Roku Inc / Alphabet Inc / Progyny Inc / StoneCo Ltd / Array Technologies Inc / Shoals Technologies Group Inc / BTRS Holdings Inc / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ASCO 2021 Abstracts Highlight Key Updates for 25 Stocks in Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 4595739 / 5531000 / 2982924 / BBFL7S1 / BCZS820 / BFDV8K0 / BBPK0J0 / BFZNYB7 / BZBY005 / BZ1LFB2 / BMQ5T49 / BKVDFF7 / BG31GH0 / BJXBP30 / BYYWPW6 / BWY52P3 / BL71K91 / BWY4XV3 / BN2R582 / BMDJ397</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / MorphoSys AG / Spectrum Pharmaceuticals Inc / bluebird bio Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Allogene Therapeutics Inc / Merus NV / Deciphera Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Revolution Medicines Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - May 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NA / WY.N / CFP.TO / GILD.O / LPX.N / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / NBIX.O / WSP.TO / VTR.N / BMRN.O / OPTN.O / REGN.O / ARE.TO / JHX.AX / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / STN.TO / SNC.TO / CWX.TO / MNKD.OQ / ACAD.O / WEF.TO / MPW.N / LHCG.O / BKD.N / ARWR.O / CRR_u.TO / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / TOU.TO / PCH.O / PCRX.O / IFP.TO / ACHC.O / OPS.TO / VCRA.N / RFP.N / SRPT.O / CLINC.L / DLGD.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / CFF.TO / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / SRU_u.TO / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / VTRS.OQ / SHC.OQ / WFG.N / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Neurocrine Biosciences Inc / WSP Global Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Aecon Group Inc / James Hardie Industries PLC / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Stantec Inc / SNC-Lavalin Group Inc / Doman Building Materials Group Ltd / MannKind Corp / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / Crombie Real Estate Investment Trust / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Tourmaline Oil Corp / Potlatchdeltic Corp / Pacira Biosciences Inc / Interfor Corp / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Conifex Timber Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / SmartCentres Real Estate Investment Trust / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Viatris Inc / Sotera Health Co / West Fraser Timber Co Ltd / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NA / SVT.L / TOL.N / GILD.O / DRI.N / EAT.N / MCD.N / YUM.N / HD.N / LOW.N / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / SBUX.O / CYH.N / ARNA.O / TJX.N / FISV.O / V.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / SRG.MI / ENDP.O / BLU.N / CHE.N / SGEN.OQ / GPN.N / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / DPZ.N / TXRH.O / ACAD.O / MPW.N / LHCG.O / BKD.N / CMG.N / FIS.N / ARWR.O / MA.N / EHTH.O / ATL.MI / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / WEN.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / DLGD.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / QSR.N / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / SGRY.O / RGNX.O / SQ.N / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / FTV.N / RCM.OQ / OVID.O / ORSTED.CO / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / NTGY.MC / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / FOUR.N / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / ALOO.O / VTRS.OQ / SHC.OQ / DHT_u.TO / WING.N</td><td class="leftalignment">National Bank of Canada / Severn Trent PLC / Toll Brothers Inc / Gilead Sciences Inc / Darden Restaurants Inc / Brinker International Inc / McDonald's Corp / Yum! Brands Inc / Home Depot Inc / Lowe's Companies Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Starbucks Corp / Community Health Systems Inc / Arena Pharmaceuticals Inc / TJX Companies Inc / Fiserv Inc / Visa Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Snam SpA / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Global Payments Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / Domino's Pizza Inc / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / eHealth Inc / Atlantia SpA / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Wendys Co / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Restaurant Brands International Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / Block Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / Fortive Corp / R1 RCM Inc / Ovid Therapeutics Inc / Orsted A/S / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Naturgy Energy Group SA / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Shift4 Payments Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Allogene Therapeutics Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Capital Markets Global Healthcare Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">81</td><td class="leftalignment">NA / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Financial Services / Healthcare / Insurance / Manufacturing / Pharmaceuticals / Real Estate / Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research / Mr. Gregory J. Renza, MD / Douglas M. Miehm / Mr. Charles Weston / Brian Abrahams, MD / Daniel Busby / Michael W. Carroll, CFA / Mr. Sean W. Dodge, CFA / Mr. Anton Hie / Mr. Luca Issi, PHD / Kennen MacKay, PHD / Frank G. Morgan</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">MEIP/RCUS have stellar data, stock could be up; but given the market condition -?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD=US / MEIP.OQ / RCUS=US / AMGN=US / REGN=US / GILD.OQ / MEIP=US / FATE=US / BTAI=US</td><td class="leftalignment">Gilead Sciences Inc / MEI Pharma Inc / Arcus Biosciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / MEI Pharma Inc / Fate Therapeutics Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ASCO: What's new and what we're paying attention to</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O / PBYI.O / RCUS.K</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Gilead Sciences, Inc. (NASDAQ: GILD) - Highlights from the RBC Global Healthcare Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, May 19, 2021 / 10:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy Treatments, Thursday May 27th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / HCM.O / MRKR.O / MBIO.O / HGEN.O</td><td class="leftalignment">Aravive Inc / I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Marker Therapeutics Inc / Mustang Bio Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">HD=US / OXY=US / RRC=US / BLD=US / DVN=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / H=US / MTN=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / TTWO=US / TNL=US / VMC=US / HLT=US / MLM=US / CHH=US / CNX=US / DRH=US / EQT=US / IBP=US / CVX=US / PRA=US / GBCI=US / COP=US / STRO=US / SHO=US / BAH=US / BLDR=US / HST=US / CLR=US / WH=US / TIL=US / NOG=US / RCUS=US / AR=US / HGV=US / RLJ=US / ESTE=US / VAC=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / VRNS=US / VNOM=US / IBEX=US / CDEV=US / PK=US / PVAC=US / PLYA=US / AYX=US / SBOW=US / IOVA=US / MAXR=US / ALLO=US / RTLR=US / OVV=US / SPCE=US / AIRC=US</td><td class="leftalignment">Home Depot Inc / Occidental Petroleum Corp / Range Resources Corp / TopBuild Corp / Devon Energy Corp / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Choice Hotels International Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / Installed Building Products Inc / Chevron Corp / ProAssurance Corp / Glacier Bancorp Inc / Conocophillips / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Builders FirstSource Inc / Host Hotels & Resorts Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Antero Resources Corp / Hilton Grand Vacations Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Varonis Systems Inc / Viper Energy Partners LP / Ibex Ltd / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Playa Hotels & Resorts NV / Alteryx Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Maxar Technologies Inc / Allogene Therapeutics Inc / Rattler Midstream LP / Ovintiv Inc / Virgin Galactic Holdings Inc / Apartment Income REIT Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Should Investors Steer Clear of the Gilead Sciences Inc?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">There's something about TIGIT - we see continued interest; RCUS TIGIT catalyst coming soon (2Q2021)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD=US / RCUS=US / GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Gilead Sciences, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / TWTR=US / GBT=US / CL=US / AMZN=US / T=US / EBAY=US / INCY=US / GILD=US / VZ=US / IGT=US / VRM=US / BYD=US / SPOT=US / EXPE=US / MGM=US / AKR=US / PENN=US / W=US / DV=US / AMK=US / PATH=US / COLL=US / TREE=US / NOW=US / MCRI=US / REGN=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / PSA=US / SNOW=US / SGMS=US / NET=US / HIW=US / PYPL=US / BKNG=US / EGP=US / FB=US / MTCH=US / AUTL=US / BDSI=US / RRR=US / PTON=US / BIIB=US / RNG=US / CZR=US / EXR=US / GMS=US / PGTI=US / WH=US / TIL=US / IAC=US / 45665G303 / OLO=US / NLSN=US / ANGI=US / MEIP=US / SSTK=US / ABBV=US / VOYA=US / PTCT=US / FATE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / VCEL=US / GDDY=US / ETSY=US / ARGX=US / ZG=US / SQ=US / WVE=US / MIME=US / TTD=US / CRSP=US / TRVG=US / GDS=US / CVNA=US / YEXT=US / IOVA=US / RDFN=US / ROKU=US / CARG=US / SFIX=US / ROOT=US / COLD=US / FTDR=US / SVMK=US / EB=US / SITC=US / AMTB=US / LYFT=US / UBER=US / GMAB=US / DKNG=US / CRMD.US / BALY=US / ABNB=US / DASH=US / NGMS=US / COUR-US / KNBE=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Twitter Inc / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / AT&T Inc / eBay Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Acadia Realty Trust / Penn National Gaming Inc / Wayfair Inc / DoubleVerify Holdings Inc / AssetMark Financial Holdings Inc / UiPath Inc / Collegium Pharmaceutical Inc / Lendingtree Inc / ServiceNow Inc / Monarch Casino & Resort Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Public Storage / Snowflake Inc. / Scientific Games Corp / Cloudflare Inc / Highwoods Properties Inc / PayPal Holdings Inc / Booking Holdings Inc / Eastgroup Properties Inc / Meta Platforms Inc / Match Group Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / Extra Space Storage Inc / GMS Inc / PGT Innovations Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Olo Inc / Nielsen Holdings PLC / Angi Inc / MEI Pharma Inc / Shutterstock Inc / Abbvie Inc / Voya Financial Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / Vericel Corp / GoDaddy Inc / ETSY Inc / argenx SE / Zillow Group Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / GDS Holdings Ltd / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / DraftKings Inc / CorMedix Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / NeoGames SA / Coursera Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / AXAF.PA / CL.N / DFDS.CO / EIX.N / EL.N / KMB.N / KO.N / MRK.N / MUVGn.DE / NA / PEG.N / PFE.N / SCOR.PA / SO.N / T.N / PEP.N / BFb.N / PG.N / GILD.O / CPB.N / CMCSA.O / CHKP.O / INCY.O / DUK.N / K.N / DISH.O / CTXS.O / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / SBAC.O / KGC.N / JAZZ.O / CONE.O / NG.L / VZ.N / STZ.N / AMP.N / EXC.N / FISV.O / AWK.N / CHD.N / NWN.N / JKHY.O / SAM.N / OPTN.O / ENR.N / NCR.N / NET.N / SSNC.O / ENAG.MC / CNP.N / ENDP.O / CPK.N / GPN.N / MNST.O / IMGN.O / HOOK.O / BLUE.O / CASY.O / FFIV.O / EQIX.O / ATDb.TO / 02209S103 / MNKD.OQ / DLR.N / 427866108 / SJW.N / FIS.N / CVLT.O / 3IN.L / IVZ.N / BGS.N / RENE.LS / BEZG.L / GETP.PA / INO.OQ / UTL.N / NGD.A / FTNT.O / SPB.N / NEE.N / FHI.N / TWO.N / PCRX.O / PANW.N / QLYS.O / MDLZ.OQ / APAM.N / ABBV.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / BEP.N / AGIO.O / KPTI.O / FLXN.O / AGRX.O / RPD.O / SQ.N / MIME.OQ / SRENH.S / MP1.AX / OR.N / CRSP.OQ / UNIT.O / GREG.MC / DXC.N / ROOT.TO / VCTR.N / AMRX.N / VRCA.OQ / NTGY.MC / KDP.N / XERS.O / AQST.O / OSMT.O / NWL.O / 269796108 / PING.N / DDOG.O / APRE.OQ / NLOK.O / REYN.O / FOUR.N / RXT.OQ / IBEX.O / LUMN.N / PLTR.N / ALOO.O / VTRS.OQ / TIXT.TO / AFRM.O / NAPA.N / PATH.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / AXA SA / Colgate-Palmolive Co / DFDS AS / Edison International / Estee Lauder Companies Inc / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Public Service Enterprise Group Inc / Pfizer Inc / Scor SE / Southern Co / AT&T Inc / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Incyte Corp / Duke Energy Corp / Kellogg Co / DISH Network Corp / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / SBA Communications Corp / Kinross Gold Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Fiserv Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Jack Henry & Associates Inc / Boston Beer Company Inc / OptiNose Inc / Energizer Holdings Inc / NCR Corp / Cloudflare Inc / SS&C Technologies Holdings Inc / Enagas SA / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Global Payments Inc / Monster Beverage Corp / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / Caseys General Stores Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / MannKind Corp / Digital Realty Trust Inc / Hershey Co / SJW Group / Fidelity National Information Services Inc / Commvault Systems Inc / 3I Infrastructure PLC / Invesco Ltd / B&G Foods Inc / Ren Redes Energeticas Nacionais SGPS SA / Beazley PLC / Getlink SE / Inovio Pharmaceuticals Inc / Unitil Corp / New Gold Inc / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Federated Hermes Inc / Two Harbors Investment Corp / Pacira Biosciences Inc / Palo Alto Networks Inc / Qualys Inc / Mondelez International Inc / Artisan Partners Asset Management Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Rapid7 Inc / Block Inc / Mimecast Ltd / Swiss Re AG / Megaport Ltd / Osisko Gold Royalties Ltd / CRISPR Therapeutics AG / Uniti Group Inc / Grenergy Renovables SA / DXC Technology Co / Roots Corp / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Eagle Pharmaceuticals Inc / Ping Identity Holding Corp / Datadog Inc / Aprea Therapeutics Inc / NortonLifeLock Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Palantir Technologies Inc / Allogene Therapeutics Inc / Viatris Inc / Telus International Cda Inc / Affirm Holdings Inc / Duckhorn Portfolio Inc / UiPath Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALXO: Q1 2021 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALXO.OQ / GILD.OQ</td><td class="leftalignment">ALX Oncology Holdings Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Trodelvy potential China approval expected YE21; Potential first Trop2 ADC in China with high commercial potential. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1952.HK / 1093.HK / PFE.N / AZN.L / MRCG.DE / GILD.OQ / 4568.T / 002422.SZ</td><td class="leftalignment">Everest Medicines Ltd / CSPC Pharmaceutical Group Ltd / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - May 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NA / OXB.L / APH.L / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Alliance Pharma PLC / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.14.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC's ASCO 2021 Planner</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">NA / GILD.O / INCY.O / HOOK.O / BLUE.O / INO.OQ / KPTI.O / CRSP.OQ / APRE.OQ / ALOO.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / HOOKIPA Pharma Inc / bluebird bio Inc / Inovio Pharmaceuticals Inc / Karyopharm Therapeutics Inc / CRISPR Therapeutics AG / Aprea Therapeutics Inc / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregory J. Renza, MD / Michael Murray / Brian Abrahams, MD / Mr. Luca Issi, PHD / Kennen MacKay, PHD / Yinglu Zhang / Leonid Timashev / David Szeto / Stephen Mallon / Lisa Walter</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v1.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DIS=US / AMZN=US / INCY=US / GILD=US / TNL=US / HLT=US / CBRL=US / HOOK=US / CGEN=US / AMSF=US / AUTL=US / UCBI=US / CPSI=US / IGMS=US / CRD.B=US / APTX=US / AWH / KBR=US / PGTI=US / EHTH=US / TAST=US / EIG=US / PSN=US / UTZ=US / CLNY=US / TREX=US / HGV=US / PCRX=US / VAC=US / LKQ=US / ABBV=US / PINC=US / FATE=US / BABA=US / NEWR=US / WVE=US / IOVA=US / FSK=US / OSMT=US / HARP=US / TCRR=US / NXTC=US / XAIR=US / FSKR=US / AZEK=US / ABNB=US / DASH=US / HYFM=US</td><td class="leftalignment">Walt Disney Co / Amazon.com Inc / Incyte Corp / Gilead Sciences Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Cracker Barrel Old Country Store Inc / HOOKIPA Pharma Inc / Compugen Ltd / Amerisafe Inc / Autolus Therapeutics PLC / United Community Banks Inc / Computer Programs and Systems Inc / IGM Biosciences Inc / Crawford & Co / Aptinyx Inc / Aspira Women's Health Inc / KBR Inc / PGT Innovations Inc / eHealth Inc / Carrols Restaurant Group Inc / Employers Holdings Inc / Parsons Corp / UTZ Brands Inc / DigitalBridge Group Inc / Trex Company Inc / Hilton Grand Vacations Inc / Pacira Biosciences Inc / Marriott Vacations Worldwide Corp / LKQ Corp / Abbvie Inc / Premier Inc / Fate Therapeutics Inc / Alibaba Group Holding Ltd / New Relic Inc / WAVE Life Sciences Ltd / Iovance Biotherapeutics Inc / FS KKR Capital Corp / Osmotica Pharmaceuticals PLC / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Beyond Air Inc / FS KKR Capital Corp / Azek Company Inc / Airbnb Inc / DoorDash Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Israel / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">CI.N / EOG.N / NA / OXB.L / PPG.N / PXD.N / APH.L / GILD.O / TA.TO / DIS.N / NICE.O / MRO.N / PAA.N / DVN.N / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / RRC.N / EQT.N / ARE.N / RPM.N / NBIX.O / VTR.N / AJG.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / SWIR.O / SM.N / COP.N / CPE.N / ENDP.O / BLU.N / CHE.N / SWN.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / BIIB.O / TCW.TO / MNKD.OQ / ACAD.O / MPW.N / BLDR.O / LHCG.O / BAM.N / BKD.N / ARWR.O / EHTH.O / 3IN.L / CLR.N / INO.OQ / ENSG.O / NOG.A / AGNC.O / ADUS.OQ / TRGP.N / PCRX.O / MTDR.N / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / FANG.O / ABBV.N / ENTA.O / PTCT.O / PRTA.O / BPY.N / DOC.N / 81762P102 / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / CAPL.N / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / GOOS.TO / CDEV.O / ESTE.N / OVID.O / ORSTED.CO / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / OAS.OQ / AZEK.N / SLQT.N / AHCO.O / VMD.OQ / APA.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / MAX.N / TLMD.OQ / VTRS.OQ / SHC.OQ / PUBM.O / DHT_u.TO / CHK.OQ</td><td class="leftalignment">Cigna Corp / EOG Resources Inc / National Bank of Canada / Oxford BioMedica PLC / PPG Industries Inc / Pioneer Natural Resources Co / Alliance Pharma PLC / Gilead Sciences Inc / TransAlta Corp / Walt Disney Co / Nice Ltd / Marathon Oil Corp / Plains All American Pipeline LP / Devon Energy Corp / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Range Resources Corp / EQT Corp / Alexandria Real Estate Equities Inc / RPM International Inc / Neurocrine Biosciences Inc / Ventas Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / SM Energy Co / Conocophillips / Callon Petroleum Co / Endo International PLC / BELLUS Health Inc / Chemed Corp / Southwestern Energy Co / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Trican Well Service Ltd / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / Builders FirstSource Inc / LHC Group Inc / Brookfield Asset Management Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / 3I Infrastructure PLC / Continental Resources Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Northern Oil and Gas Inc / AGNC Investment Corp / Addus Homecare Corp / Targa Resources Corp / Pacira Biosciences Inc / Matador Resources Co / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Diamondback Energy Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Brookfield Property Partners LP / Physicians Realty Trust / ServiceNow Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Crossamerica Partners LP / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Canada Goose Holdings Inc / Centennial Resource Development Inc / Earthstone Energy Inc / Ovid Therapeutics Inc / Orsted A/S / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / Oasis Petroleum Inc / Azek Company Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / APA Corp (US) / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Mediaalpha Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / PubMatic Inc / Dri Healthcare Trust / Chesapeake Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AC.TO / NA / OXB.L / APH.L / GILD.O / TA.TO / QBRb.TO / TV.TO / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / WSP.TO / VTR.N / BMRN.O / EXE.TO / OPTN.O / REGN.O / VRTX.O / SWIR.O / CIX.TO / CAR_u.TO / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / CCLb.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / TCW.TO / HR_u.TO / CHR.TO / BEI_u.TO / HCG.TO / MNKD.OQ / SCL.TO / ACAD.O / MPW.N / LHCG.O / BAM.N / BKD.N / ARWR.O / CTCa.TO / EHTH.O / IIP_u.TO / INO.OQ / ENSG.O / SPB.TO / ADUS.OQ / EIF.TO / NWH_u.TO / TCN.TO / NPI.TO / PCRX.O / LGO.TO / DR.TO / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / Y.TO / ENTA.O / PTCT.O / PRTA.O / BPY.N / DOC.N / KPTI.O / XNCR.OQ / CJ.TO / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / TWM.TO / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / GOOS.TO / STEP.TO / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">Air Canada / National Bank of Canada / Oxford BioMedica PLC / Alliance Pharma PLC / Gilead Sciences Inc / TransAlta Corp / Quebecor Inc / Trevali Mining Corp / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / WSP Global Inc / Ventas Inc / Biomarin Pharmaceutical Inc / Extendicare Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / CI Financial Corp / Canadian Apartment Properties Real Estate Investment Trust / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / CCL Industries Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Trican Well Service Ltd / H&R Real Estate Investment Trust / Chorus Aviation Inc / Boardwalk Real Estate Investment Trust / Home Capital Group Inc / MannKind Corp / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookfield Asset Management Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / Canadian Tire Corporation Ltd / eHealth Inc / InterRent Real Estate Investment Trust / Inovio Pharmaceuticals Inc / Ensign Group Inc / Superior Plus Corp / Addus Homecare Corp / Exchange Income Corp / NorthWest Healthcare Properties REIT / Tricon Residential Inc / Northland Power Inc / Pacira Biosciences Inc / Largo Inc / Medical Facilities Corp / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Yellow Pages Ltd / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Brookfield Property Partners LP / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Cardinal Energy Ltd (Alberta) / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / Tidewater Midstream and Infrastructure Ltd / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Canada Goose Holdings Inc / Step Energy Services Ltd / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LVMH.PA / NA / OXB.L / PRTP.PA / APH.L / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / WG.L / BRBY.L / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / LEGD.PA / CFR.S / EHTH.O / HRGV.L / BEZG.L / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / URW.AS / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / National Bank of Canada / Oxford BioMedica PLC / Kering SA / Alliance Pharma PLC / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / John Wood Group PLC / Burberry Group PLC / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / Legrand SA / Compagnie Financiere Richemont SA / eHealth Inc / Hargreaves Lansdown PLC / Beazley PLC / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Unibail-Rodamco-Westfield SE / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Capital Markets Global Healthcare Virtual Conference Preview</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">NA / OXB.L / APH.L / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Alliance Pharma PLC / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research / Kennen MacKay, PHD / Frank G. Morgan / Mr. Gregory J. Renza, MD / Douglas M. Miehm / Mr. Charles Weston / Ms. Lori Calvasina / Sara Mahaffy / Brian Abrahams, MD / Daniel Busby / Michael W. Carroll, CFA / Mr. Sean W. Dodge, CFA / Mr. Anton Hie / Mr. Luca Issi, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Earnings Recap and Pipeline Updates for HARP, HOOK, IGMS, & NXTC</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">HARP=US / NXTC=US / GILD=US / HOOK=US / IGMS=US / ABBV=US</td><td class="leftalignment">Harpoon Therapeutics Inc / NextCure Inc / Gilead Sciences Inc / HOOKIPA Pharma Inc / IGM Biosciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, May 13, 2021 / 2:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: Catalysts & COVID Edition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / NBIX.O / VRTX.O / HOOK.O / BCRX.O / BIIB.O / SRPT.O / PTCT.O / KPTI.O / 78667J108 / NBSE.OQ / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / SAGE Therapeutics Inc / NeuBase Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Booster Shots - Charts highlighted: REYN, CAG, THS, EZPW, FCFS, ALKS, CNC, EXEL, GILD, AMPH, CUE, RGLD, USM, and ED</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.OQ / ALKS.OQ / AMPH.OQ / CAG.N / CNC.N / CUE.OQ / ED.N / EXEL.OQ / EZPW.OQ / REYN.OQ / RGLD.OQ / THS.N / USM.N</td><td class="leftalignment">Gilead Sciences Inc / Alkermes Plc / Amphastar Pharmaceuticals Inc / Conagra Brands Inc / Centene Corp / Cue Biopharma Inc / Consolidated Edison Inc / Exelixis Inc / EZCORP Inc / Reynolds Consumer Products Inc / Royal Gold Inc / TreeHouse Foods Inc / United States Cellular Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2000019 / 2050832 / 2732635 / 2219224 / 2542049 / 2342034 / 2369174 / 2471950 / 2515030 / 2657802 / 2689560 / 2684703 / 2048804 / 5531000 / B1F76F9 / B125XQ6 / B7TL820 / BCBVTX1 / B4MG4Z6 / BBFL7S1 / B8DPDT7 / BFLR866 / BFZCHN7 / BJ36RM8 / BYVY8G0 / BYZLV46 / BDHF4K6 / BD8DJ71 / BKS3SM8 / B0SDJB4 / BZ1HM42 / BJ2Z0H2 / BFMXGR0 / BZ05388 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BMG75B4 / BD8Q1B8 / BYNPPC6 / BG0Q4Y1 / BKT6B38 / BK71LV3 / BMDCDP2 / BMPRZV5 / BN0SDK5 / BLBLMD5 / BFY7DC4 / BMDJ085 / BMC8SQ7 / BNTB3N8 / BD5GSZ4</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Ameren Corp / AutoNation Inc / CMS Energy Corp / Dominion Energy Inc / Fiserv Inc / Gilead Sciences Inc / Incyte Corp / Lithia Motors Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / MorphoSys AG / Western Union Co / Portland General Electric Co / Meta Platforms Inc / Agios Pharmaceuticals Inc / AMC Networks Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Pacira Biosciences Inc / Alphabet Inc / InflaRx NV / CRISPR Therapeutics AG / Snap Inc / IGM Biosciences Inc / Zealand Pharma A/S / Adyen NV / Pinterest Inc / Evergy Inc / Global Blood Therapeutics Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Inventiva SA / Tivity Health Inc / DENTSPLY SIRONA Inc / Exicure Inc / SmileDirectClub Inc / Relmada Therapeutics Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / American Well Corp / Array Technologies Inc / Altimmune Inc / Shoals Technologies Group Inc / BTRS Holdings Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ALB.N / CC.N / CCK.N / CE.N / DD.N / EMN.N / F.N / FMC.N / IBE.MC / NA / PPG.N / RWEG.DE / SEE.N / SSE.L / GILD.O / INCY.O / WLK.N / DT.N / EPR.N / OLN.N / SHW.N / OI.N / BLL.N / PCOM.O / NLY.N / RPM.N / SLGN.O / REGN.O / VRTX.O / GPK.N / WES.N / HCC.N / HOOK.O / ICPT.O / BIIB.O / HUN.N / 3IN.L / VMW.N / LYB.N / MSP.N / AMCX.O / WEN.O / SRPT.O / BERY.N / 505440107 / VRNS.O / FLXN.O / AXTA.N / 78667J108 / CRBP.OQ / GLPG.O / RMR.OQ / VNTR.N / ORSTED.CO / STLC.TO / EAF.N / NBSE.OQ / CTVA.N / KRTX.OQ / 260557103 / IGMS.O / ETNB.O / GOCO.O / PTVE.O / 900435207 / ATC.N / CHK.OQ / DSEY.O</td><td class="leftalignment">Albemarle Corp / Chemours Co / Crown Holdings Inc / Celanese Corp / Dupont De Nemours Inc / Eastman Chemical Co / Ford Motor Co / FMC Corp / Iberdrola SA / National Bank of Canada / PPG Industries Inc / Rwe AG / Sealed Air Corp / SSE PLC / Gilead Sciences Inc / Incyte Corp / Westlake Chemical Corp / Dynatrace Inc / EPR Properties / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / Points International Ltd / Annaly Capital Management Inc / RPM International Inc / Silgan Holdings Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Graphic Packaging Holding Co / Western Midstream Partners LP / Warrior Met Coal Inc / HOOKIPA Pharma Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Huntsman Corp / 3I Infrastructure PLC / VMware Inc / LyondellBasell Industries NV / Datto Holding Corp / AMC Networks Inc / Wendys Co / Sarepta Therapeutics Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / Varonis Systems Inc / Pacira Biosciences Inc / Axalta Coating Systems Ltd / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / RMR Group Inc / Venator Materials PLC / Orsted A/S / Stelco Holdings Inc / GrafTech International Ltd / NeuBase Therapeutics Inc / Corteva Inc / Karuna Therapeutics Inc / Dow Inc / IGM Biosciences Inc / 89Bio Inc / Gohealth Inc / Pactiv Evergreen Inc / Turquoise Hill Resources Ltd / Atotech Ltd / Chesapeake Energy Corp / Diversey Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Top Catalysts in Our Universe to Watch Into Mid-Year</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">NA / GILD.O / INCY.O / VRTX.O / HOOK.O / ICPT.O / BIIB.O / SRPT.O / 78667J108 / CRBP.OQ / GLPG.O / NBSE.OQ / KRTX.OQ / IGMS.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / HOOKIPA Pharma Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EHA Abstracts Highlight Largely Incremental Updates in Our Coverage; Potl. Readthru to AGIO, BGNE, BPMC, BLUE, CRSP, GILD, GMAB, IGMS, INCY, MOR, KYMR</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2369174 / 2471950 / 4595739 / 5531000 / BCBVTX1 / BBFL7S1 / BDHF4K6 / BKS3SM8 / BYYWPW6 / BWY52P3 / BMPRZV5</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Genmab A/S / MorphoSys AG / Agios Pharmaceuticals Inc / bluebird bio Inc / CRISPR Therapeutics AG / IGM Biosciences Inc / Beigene Ltd / Blueprint Medicines Corp / Kymera Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, May 12, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAP.N / BBY.N / COST.O / CWK.L / DANO.PA / IBE.MC / KO.N / RWEG.DE / ULVR.L / WMT.N / SSE.L / PXD.N / GILD.O / INCY.O / AAL.L / ENB.TO / K.N / IMO.TO / SU.TO / CAG.N / VLO.N / HD.N / LOW.N / INTU.O / WM.N / KGC.N / AZO.N / KMX.N / EQT.N / DLTR.O / WSM.N / DG.N / RSG.N / WSP.TO / JKHY.O / WCN.N / NRZ.N / DKS.N / BCRX.O / ICPT.O / STN.TO / SNC.TO / SAP.TO / MFI.TO / DCP.N / NESN.S / 443628102 / 3IN.L / BGS.N / HFG.L / PBF.N / VALE.N / CVE.TO / MPC.N / GEI.TO / MTDR.N / PSX.N / FIVE.OQ / ORCC.N / PRGO.N / VOYA.N / COTY.N / LB.N / KPTI.O / ITCI.O / CIA.TO / SUM.N / OLLI.OQ / MIME.OQ / OR.N / BHF.O / ORSTED.CO / MGTX.O / GMDA.OQ / NLOK.O / BEAM.O / GFL.N / SLQT.N / JAMF.O / PLTR.N / BSY.O / OSO.N</td><td class="leftalignment">Advance Auto Parts Inc / Best Buy Co Inc / Costco Wholesale Corp / Cranswick PLC / Danone SA / Iberdrola SA / Coca-Cola Co / Rwe AG / Unilever PLC / Walmart Inc / SSE PLC / Pioneer Natural Resources Co / Gilead Sciences Inc / Incyte Corp / Anglo American PLC / Enbridge Inc / Kellogg Co / Imperial Oil Ltd / Suncor Energy Inc / Conagra Brands Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Intuit Inc / Waste Management Inc / Kinross Gold Corp / Autozone Inc / Carmax Inc / EQT Corp / Dollar Tree Inc / Williams-Sonoma Inc / Dollar General Corp / Republic Services Inc / WSP Global Inc / Jack Henry & Associates Inc / Waste Connections Inc / New Residential Investment Corp / DICK'S Sporting Goods Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Stantec Inc / SNC-Lavalin Group Inc / Saputo Inc / Maple Leaf Foods Inc / DCP Midstream LP / Nestle SA / Hudbay Minerals Inc / 3I Infrastructure PLC / B&G Foods Inc / Hilton Food Group PLC / PBF Energy Inc / Vale SA / Cenovus Energy Inc / Marathon Petroleum Corp / Gibson Energy Inc / Matador Resources Co / Phillips 66 / Five Below Inc / Owl Rock Capital Corp / Perrigo Company PLC / Voya Financial Inc / Coty Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Champion Iron Ltd / Summit Materials Inc / Ollie's Bargain Outlet Holdings Inc / Mimecast Ltd / Osisko Gold Royalties Ltd / Brighthouse Financial Inc / Orsted A/S / MeiraGTx Holdings PLC / Gamida Cell Ltd / NortonLifeLock Inc / Beam Therapeutics Inc / GFL Environmental Inc / SelectQuote Inc / Jamf Holding Corp / Palantir Technologies Inc / Bentley Systems Inc / Olo Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Adverse Events Monitor - 1Q21</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / INCY.O / BCRX.O / ICPT.O / KPTI.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2973821 / 2219224 / 2175672 / 2222631 / 2037170 / 2328915 / 2369174 / 2415204 / 2457864 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 4595739 / 7103065 / B1F76F9 / B121557 / B19FQ48 / B125XQ6 / B7TL820 / B4MG4Z6 / B7VD3F2 / BJ0XLZ3 / BDZCRX3 / BFH3N85 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYVFC94 / BF4VBS8 / BK0VHF6 / BD9GVY0 / BJXPS33 / BD8DJ71 / BJFSR88 / BYZR4X4 / BP7RS48 / BKVDFF7 / BYXJQG9 / BZ1LFG7 / BL71K91 / BD6JX35 / BZ0P3Z5 / BYTJZL1 / BDD1B07 / BKT6B38 / BF3N4P3 / BM8MM05 / BLBLMD5 / BNG3RZ7 / BMDJ085 / BLR6S36</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Cardinal Health Inc / Cooper Companies Inc / 8x8 Inc / Nextera Energy Inc / Gilead Sciences Inc / Hawaiian Electric Industries Inc / ImmunoGen Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Genmab A/S / Novartis AG / Western Union Co / Mastercard Inc / Amicus Therapeutics Inc / Portland General Electric Co / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Heron Therapeutics Inc / RingCentral Inc / Veeva Systems Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / US Foods Holding Corp / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / BELLUS Health Inc / Snap Inc / Uniqure NV / Axsome Therapeutics Inc / Intersect Ent Inc / Oric Pharmaceuticals Inc / Spire Inc / Roku Inc / Revolution Medicines Inc / Krystal Biotech Inc / Tegna Inc / Zogenix Inc / Rubius Therapeutics Inc / SmileDirectClub Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Array Technologies Inc / Leslie's Inc / Shoals Technologies Group Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AXAF.PA / CCK.N / DD.N / DFDS.CO / RENA.PA / SAND.ST / SSE.L / VOWG_p.DE / CONG.DE / WY.N / CFP.TO / GILD.O / FER.MC / REE.MC / TV.TO / UNP.N / SUN.N / WM.N / MMM.N / CONE.O / OI.N / BLL.N / RSG.N / SLGN.O / ENR.N / VRTX.O / WCN.N / BLU.N / HCC.N / BIIB.O / RUS.TO / MAIN.N / ACAD.O / WEF.TO / 443628102 / PRTS.OQ / DAIGn.DE / GETP.PA / INO.OQ / ABI.BR / PCH.O / CFX.TO / MTOR.N / IFP.TO / RFP.N / PANW.N / BERY.N / 505440107 / PTCT.O / 81762P102 / XNCR.OQ / ITCI.O / QURE.O / RYAM.N / AXTA.N / AENA.MC / RACE.MI / VACN.S / PARR.N / UN01.DE / PVAC.O / OKTA.OQ / STLC.TO / SAIL.N / APTV.N / GTES.N / VCTR.N / ZS.OQ / PRVB.O / 269796108 / MORF.OQ / CRWD.O / CRNC.OQ / GFL.N / MOCORP.HE / RXT.OQ / 900435207 / MAX.N / VTRS.OQ / WFG.N / AFRM.O / ATC.N / TSP.OQ</td><td class="leftalignment">AXA SA / Crown Holdings Inc / Dupont De Nemours Inc / DFDS AS / Renault SA / Sandvik AB / SSE PLC / Volkswagen AG / Continental AG / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Ferrovial SA / Red Electrica Corporacion SA / Trevali Mining Corp / Union Pacific Corp / Sunoco LP / Waste Management Inc / 3M Co / CyrusOne Inc / O-I Glass Inc / Ball Corp / Republic Services Inc / Silgan Holdings Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Waste Connections Inc / BELLUS Health Inc / Warrior Met Coal Inc / Biogen Inc / Russel Metals Inc / Main Street Capital Corp / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Hudbay Minerals Inc / Carparts.Com Inc / Daimler AG / Getlink SE / Inovio Pharmaceuticals Inc / Anheuser Busch Inbev SA / Potlatchdeltic Corp / Canfor Pulp Products Inc / Meritor Inc / Interfor Corp / Resolute Forest Products Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / ServiceNow Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Rayonier Advanced Materials Inc / Axalta Coating Systems Ltd / Aena SME SA / Ferrari NV / VAT Group AG / Par Pacific Holdings Inc / Uniper SE / Ranger Oil Corp / Okta Inc / Stelco Holdings Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Gates Industrial Corporation PLC / Victory Capital Holdings Inc / Zscaler Inc / Provention Bio Inc / Eagle Pharmaceuticals Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Cerence Inc / GFL Environmental Inc / Metso Outotec Corp / Rackspace Technology Inc / Turquoise Hill Resources Ltd / Mediaalpha Inc / Viatris Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Atotech Ltd / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / VRTX.O / BLU.N / BIIB.O / ACAD.O / PTCT.O / XNCR.OQ / PRVB.O / MORF.OQ</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / PTC Therapeutics Inc / Xencor Inc / Provention Bio Inc / Morphic Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AEP.N / AES.N / AIG.N / ALV.N / AU.N / BARC.L / CCO.TO / CL.N / DFDS.CO / EIX.N / EL.N / EOG.N / F.N / GM.N / KMB.N / KO.N / PEG.N / PFE.N / PNN.L / SO.N / T.N / T.TO / VC.N / PEP.N / BFb.N / PG.N / GILD.O / CPB.N / TEN.N / CMCSA.O / CHKP.O / FER.MC / DUK.N / BWA.N / LEA.N / ENB.TO / TRP.TO / K.N / CTXS.O / CLX.N / CAG.N / GIS.N / EPC.N / SBAC.O / AMT.N / VZ.N / EXEL.O / STZ.N / APH.N / EXC.N / FISV.O / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ENR.N / NCR.N / NET.N / TEL.N / CNP.N / ENDP.O / CPK.N / CHE.N / PII.N / ST.N / AMH.N / SEM.N / GPN.N / MNST.O / FFIV.O / EQIX.O / 02209S103 / DLR.N / 427866108 / KOS.N / SJW.N / BKD.N / FIS.N / CCOI.O / HOG.N / CVLT.O / BGS.N / PPL.TO / GETP.PA / DAN.N / NOG.A / SII.TO / UTL.N / 759351604 / CVE.TO / FTNT.O / SPB.N / NEE.N / ERF.TO / PCRX.O / MTOR.N / QLYS.O / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / BEP.N / ESNT.N / IBP.N / FLXN.O / AENA.MC / GLPG.O / PYPL.OQ / RPD.O / SQ.N / RACE.MI / TRHC.OQ / ADNT.N / UNIT.O / WOW.N / ATNX.O / APTV.N / AMRX.N / VNE.N / KDP.N / XERS.O / OSMT.O / NWL.O / 269796108 / HCAT.OQ / GMAB.O / PING.N / DDOG.O / CRNC.OQ / PNTG.OQ / REYN.O / NKLA.OQ / APA.OQ / FOUR.N / RXT.OQ / JAMF.O / LUMN.N / PTVE.O / BSY.O / VTRS.OQ / TIXT.TO / AFRM.O / NAPA.N / OSO.N / TSP.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American International Group Inc / Autoliv Inc / AngloGold Ashanti Ltd / Barclays PLC / Cameco Corp / Colgate-Palmolive Co / DFDS AS / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Public Service Enterprise Group Inc / Pfizer Inc / Pennon Group PLC / Southern Co / AT&T Inc / Telus Corp / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Ferrovial SA / Duke Energy Corp / Borgwarner Inc / Lear Corp / Enbridge Inc / TC Energy Corp / Kellogg Co / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Verizon Communications Inc / Exelixis Inc / Constellation Brands Inc / Amphenol Corp / Exelon Corp / Fiserv Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Energizer Holdings Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Chemed Corp / Polaris Inc / Sensata Technologies Holding PLC / American Homes 4 Rent / Select Medical Holdings Corp / Global Payments Inc / Monster Beverage Corp / F5 Inc / Equinix Inc / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Kosmos Energy Ltd / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Harley-Davidson Inc / Commvault Systems Inc / B&G Foods Inc / Pembina Pipeline Corp / Getlink SE / Dana Inc / Northern Oil and Gas Inc / Sprott Inc / Unitil Corp / Reinsurance Group of America Inc / Cenovus Energy Inc / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Enerplus Corp / Pacira Biosciences Inc / Meritor Inc / Qualys Inc / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / Brookfield Renewable Partners LP / Essent Group Ltd / Installed Building Products Inc / Pacira Biosciences Inc / Aena SME SA / Galapagos NV / PayPal Holdings Inc / Rapid7 Inc / Block Inc / Ferrari NV / Tabula Rasa HealthCare Inc / Adient PLC / Uniti Group Inc / WideOpenWest Inc / Athenex Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Eagle Pharmaceuticals Inc / Health Catalyst Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Pennant Group Inc / Reynolds Consumer Products Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rackspace Technology Inc / Jamf Holding Corp / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Viatris Inc / Telus International Cda Inc / Affirm Holdings Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - Early Dato-DXd breast data suggest promising competitive profile</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.L / GILD.OQ / 4568.T</td><td class="leftalignment">AstraZeneca PLC / Gilead Sciences Inc / Daiichi Sankyo Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Solid Competitor Data, But We Remain Confident Doc Experience w/ Trodelvy Will Enable Good Uptake</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.7.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 07, 2021</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / GE / HUM / MDT / RAD / SGE.L / SYK / UNH / WMT / GILD.O / AMGN.O / AAPL.O / NOVN.S / HCA.N / CYH.N / INSP.N / EW.N / DRRX.O / INCY.OQ / NBIX.OQ / EPIX.OQ / ICPT.OQ / UTHR.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / MNKD.O / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / ALCLS.PA / BLRX.TA / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / ENTA.O / FATE.OQ / AUP.TO / AERI.O / TRVN.O / GLMD.OQ / GOOGL.O / ALDX.OQ / MDWD.O / 02005N100 / AGRX.OQ / CBAY.OQ / APS.TO / VKTX.O / NVRO.N / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / GKOS.K / ZBH.N / CFMS.O / GBT.OQ / 100063846 / EDIT.OQ / NVTA.K / ADAP.O / NTLA.O / SYRS.OQ / TCMD.OQ / FLGT.OQ / IRTC.OQ / MDGL.O / VREX.OQ / SLNO.OQ / IOVA.OQ / VERU.OQ / KALA.O / ATNX.O / FIXX.OQ / 720795103 / PRVB.OQ / ARVN.OQ / ALLO.OQ / MRKR.OQ / CRSP.BN / XFOR.OQ / 21833P103 / DTIL.O / IMUX.O / TPTX.O / ONCT.OQ / KRTX.OQ / PSNL.O / PNTG.OQ / BXRX.OQ / ETNB.O / ORIC.OQ / PHGE.K / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / General Electric Co / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / DURECT Corp / Incyte Corp / Neurocrine Biosciences Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / BioLine RX Ltd / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Galmed Pharmaceuticals Ltd / Alphabet Inc / Aldeyra Therapeutics Inc / Mediwound Ltd / Ally Financial Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Aptose Biosciences Inc / Viking Therapeutics Inc / Nevro Corp / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Global Blood Therapeutics Inc / Truist Financial Corp / Editas Medicine Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Madrigal Pharmaceuticals Inc / Varex Imaging Corp / Soleno Therapeutics Inc / Iovance Biotherapeutics Inc / Veru Inc / Kala Pharmaceuticals Inc / Athenex Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Arvinas Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / CRISPR Therapeutics AG / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Precision BioSciences Inc / Immunic Inc / Turning Point Therapeutics Inc / Oncternal Therapeutics Inc / Karuna Therapeutics Inc / Personalis Inc / Pennant Group Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Biomx Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / India / Ireland / Israel / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACA / ALB.N / AMN / AMT / AXP / BKI / CCI.N / CHE / CI / CNC / CVS / DLR / HUM / KKR / MSFT.O / NICE.TA / NKE / ORA / RAD / RBC / RXN / T.N / TPR / UNH / WMT / ZEN / AMZN.O / BYND.O / GILD.O / FIS / WTS.N / KLR / SAPG.DE / SQ / HEAR.O / INTU.O / NOVN.S / RDWR.O / HCA.N / CYH.N / HRB.N / PZZA.O / CHTR.O / IO.N / DRRX.O / DOX.O / NET.N / ATVI.OQ / INCY.OQ / EPIX.OQ / TTWO.OQ / ICPT.OQ / AKAM.OQ / EXPE.OQ / BLUE.OQ / VRNT.OQ / CCRN.O / EGAN.O / AMED.O / PCTY.O / EQIX.O / SYNA.O / NFLX.O / GPRO.O / 478160104 / 92343V104 / 20030N101 / 459200101 / 00846U101 / 868168105 / DPZ / OLED.O / PBH.N / ACAD.O / LHCG.O / 36467W109 / CCOI.O / ALCLS.PA / LULU.O / 02043Q107 / ENSG.OQ / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / BLN.V / ADUS.O / USPH.N / GLAXOSM.LG / SLRC.O / TSLA.O / SUNS.O / ZNGA.O / EA.O / FB.O / ENTA.O / SFM.O / RNG.N / FATE.OQ / AUP.TO / TRVN.O / GLMD.OQ / GOOGL.O / ALDX.OQ / 82655M107 / 02005N100 / CBAY.OQ / VKTX.O / APPS.O / VRAY.OQ / EVH.N / TDOC.N / WING.O / SHOP.K / PYPL.O / SPXC.K / TMUS.OQ / 100063846 / ADAP.O / CDXC.OQ / NTLA.O / SYRS.OQ / FLGT.OQ / IRTC.OQ / TWLO.K / MDGL.O / UAA / CVNA.N / IOVA.OQ / ROKU.O / CARG.O / APTV.K / EGHT.K / FIXX.OQ / 720795103 / BILI.O / PRVB.OQ / FOCS.OQ / ALLO.OQ / MRKR.OQ / CRSP.BN / XFOR.OQ / 21833P103 / DTIL.O / IMUX.O / ZM.OQ / CMBM.OQ / KRTX.OQ / PTON.OQ / DDOG.O / PNTG.OQ / FSLY.K / ETNB.O / VG.O / ORIC.OQ / BILL.K / PHGE.K / RXT.O / HGEN.O / FROG.O / NMFC.O / ONDS.OQ / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / AMN Healthcare Services Inc / American Tower Corp / American Express Co / Black Knight Inc / Crown Castle International Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Digital Realty Trust Inc / Humana Inc / KKR & Co Inc / Microsoft Corp / Nice Ltd / Nike Inc / Ormat Technologies Inc / Rite Aid Corp / Regal Rexnord Corp / Zurn Water Solutions Corp / AT&T Inc / Tapestry Inc / UnitedHealth Group Inc / Walmart Inc / Zendesk Inc / Amazon.com Inc / Beyond Meat Inc / Gilead Sciences Inc / Fidelity National Information Services Inc / Watts Water Technologies Inc / Kaleyra Inc / SAP SE / Block Inc / Turtle Beach Corp / Intuit Inc / Novartis AG / Radware Ltd / HCA Healthcare Inc / Community Health Systems Inc / H & R Block Inc / Papa John's International Inc / Charter Communications Inc / ION Geophysical Corp / DURECT Corp / Amdocs Ltd / Cloudflare Inc / Activision Blizzard Inc / Incyte Corp / ESSA Pharma Inc / Take-Two Interactive Software Inc / Intercept Pharmaceuticals Inc / Akamai Technologies Inc / Expedia Group Inc / bluebird bio Inc / Verint Systems Inc / Cross Country Healthcare Inc / eGain Corp / Amedisys Inc / Paylocity Holding Corp / Equinix Inc / Synaptics Inc / Netflix Inc / GoPro Inc / Johnson & Johnson / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Domino's Pizza Inc / Universal Display Corp / Prestige Consumer Healthcare Inc / ACADIA Pharmaceuticals Inc / LHC Group Inc / GameStop Corp / Cogent Communications Holdings Inc / Cellectis SA / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Blackline Safety Corp / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / SLR Investment Corp / Tesla Inc / SLR Senior Investment Corp / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Enanta Pharmaceuticals Inc / Sprouts Farmers Market Inc / RingCentral Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Trevena Inc / Galmed Pharmaceuticals Ltd / Alphabet Inc / Aldeyra Therapeutics Inc / Sify Technologies Ltd / Ally Financial Inc / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Digital Turbine Inc / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Wingstop Inc / Shopify Inc / PayPal Holdings Inc / SPX Corp / T-Mobile US Inc / Truist Financial Corp / Adaptimmune Therapeutics PLC / Chromadex Corp / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Twilio Inc / Madrigal Pharmaceuticals Inc / Under Armour Inc / Carvana Co / Iovance Biotherapeutics Inc / Roku Inc / CarGurus Inc / Aptiv PLC / 8x8 Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / Provention Bio Inc / Focus Financial Partners Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / CRISPR Therapeutics AG / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Precision BioSciences Inc / Immunic Inc / Zoom Video Communications Inc / Cambium Networks Corp / Karuna Therapeutics Inc / Peloton Interactive Inc / Datadog Inc / Pennant Group Inc / Fastly Inc / 89Bio Inc / Vonage Holdings Corp / Oric Pharmaceuticals Inc / Bill.com Holdings Inc / Biomx Inc / Rackspace Technology Inc / Humanigen Inc / Jfrog Ltd / New Mountain Finance Corp / Ondas Holdings Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / India / Israel / Nigeria / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">DNB / AMGN=US / TWTR=US / BLD=US / DVN=US / RUN=US / GILD=US / EOG=US / WLL=US / PAA=US / DIOD=US / CHRS=US / EXPE=US / CLI=US / PENN=US / BKI=US / W=US / AMED=US / AMN=US / ARW=US / ATRO=US / AVT=US / ENV=US / KIDS=US / CW=US / DRH=US / EPC=US / EQT=US / HAIN=US / DOC=US / MCHP=US / ORCC=US / REGN=US / STOR=US / TRIP=US / GOLF=US / FOUR=US / NET=US / PYPL=US / LCI=US / EVOP=US / REG=US / AUTL=US / BDSI=US / PRAA=US / MNST=US / PTON=US / JRVR=US / NOMD=US / RPD=US / BECN=US / LHCG=US / THS=US / BLDR=US / FIS=US / HST=US / OC=US / PAGP=US / SEAS=US / ATSG=US / IAC=US / PSN=US / AGS=US / CLNY=US / HTA=US / KNSL=US / GDOT=US / NLSN=US / ESTE=US / ANGI=US / PDCE=US / NCLH=US / FOXF=US / FATE=US / QTWO=US / LOCO=US / SHAK=US / CHCT=US / CABO=US / SQ=US / NTLA=US / ADVM=US / CDEV=US / IRTC=US / CRSP=US / PK=US / CVNA=US / ROKU=US / CARG=US / FNKO=US / COLD=US / FOCS=US / SVMK=US / EB=US / AXNX=US / UBER=US / DDOG=US / BRBR=US / AHCO=US / PNTG=US / OPCH=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Amgen Inc / Twitter Inc / TopBuild Corp / Devon Energy Corp / Sunrun Inc / Gilead Sciences Inc / EOG Resources Inc / Whiting Petroleum Corp / Plains All American Pipeline LP / Diodes Inc / Coherus BioSciences Inc / Expedia Group Inc / Veris Residential Inc / Penn National Gaming Inc / Black Knight Inc / Wayfair Inc / Amedisys Inc / AMN Healthcare Services Inc / Arrow Electronics Inc / Astronics Corp / Avnet Inc / Envestnet Inc / OrthoPediatrics Corp / Curtiss-Wright Corp / Diamondrock Hospitality Co / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Physicians Realty Trust / Microchip Technology Inc / Owl Rock Capital Corp / Regeneron Pharmaceuticals Inc / STORE Capital Corp / Tripadvisor Inc / Acushnet Holdings Corp / Shift4 Payments Inc / Cloudflare Inc / PayPal Holdings Inc / Lannett Company Inc / EVO Payments Inc / Regency Centers Corp / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / PRA Group Inc / Monster Beverage Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Nomad Foods Ltd / Rapid7 Inc / Beacon Roofing Supply Inc / LHC Group Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Owens Corning / Plains GP Holdings LP / SeaWorld Entertainment Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / PlayAGS Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Kinsale Capital Group Inc / Green Dot Corp / Nielsen Holdings PLC / Earthstone Energy Inc / Angi Inc / PDC Energy Inc / Norwegian Cruise Line Holdings Ltd / Fox Factory Holding Corp / Fate Therapeutics Inc / Q2 Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Community Healthcare Trust Inc / Cable One Inc / Block Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Carvana Co / Roku Inc / CarGurus Inc / Funko Inc / Americold Realty Trust / Focus Financial Partners Inc / Momentive Global Inc / Eventbrite Inc / Axonics Inc / Uber Technologies Inc / Datadog Inc / Bellring Brands Inc / Adapthealth Corp / Pennant Group Inc / Option Care Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Differentiated Story in Fibrosis; Initiate at Outperform, $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">CMMB / GILD.O / NOVN.S / DRRX.O / INCY.OQ / ICPT.OQ / 02043Q107 / GLAXOSM.LG / ENTA.O / GLMD.OQ / CBAY.OQ / VKTX.O / MDGL.O / 21833P103 / IMUX.O / ETNB.O / PHGE.K / 03823M100</td><td class="leftalignment">Chemomab Therapeutics Ltd / Gilead Sciences Inc / Novartis AG / DURECT Corp / Incyte Corp / Intercept Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Glaxo Smithkline Consumer Nigeria PLC / Enanta Pharmaceuticals Inc / Galmed Pharmaceuticals Ltd / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Madrigal Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Immunic Inc / 89Bio Inc / Biomx Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Israel / Nigeria / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jeff M. Jones, Ph.D. / Leland Gershell, MD, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">OpCo Innovation Series: Get Ready for Cancer Cell Therapy’s Golden Age</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">GILD.O / NOVN.S / BLUE.OQ / ALCLS.PA / 02043Q107 / FATE.OQ / ADAP.O / IOVA.OQ / ALLO.OQ / MRKR.OQ / CRSP.BN / DTIL.O</td><td class="leftalignment">Gilead Sciences Inc / Novartis AG / bluebird bio Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Fate Therapeutics Inc / Adaptimmune Therapeutics PLC / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / CRISPR Therapeutics AG / Precision BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Matthew Biegler / Mr. Mark Breidenbach, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Favorable Upside/Downside on COVID-19 with EUA Filing in 2Q21; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">HGEN.O / GILD.O / NOVN.S / 771195104 / GLAXOSM.LG / 02005N100 / REGW.M3</td><td class="leftalignment">Humanigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Glaxo Smithkline Consumer Nigeria PLC / Ally Financial Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / India / Nigeria / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA / Susan Chor</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">The Rise To A Crescendo Starts With A Single Note</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AUTL=US / GILD=US</td><td class="leftalignment">Autolus Therapeutics PLC / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">2434209 / 2778844 / 2050832 / 2045623 / 2942605 / 2111955 / 2219224 / 2190750 / 2216850 / 2280220 / 2270726 / 2542049 / 2670519 / 2328915 / 2369174 / 2623911 / 2632003 / 2645409 / 2657802 / 2689560 / 2048804 / 2707677 / 2440637 / 2573083 / 2138158 / 2799351 / 2829601 / 4595739 / 5531000 / 2795393 / 2712013 / B1F76F9 / B121557 / 2769796 / 2713317 / 2857817 / B125XQ6 / B2R3PV1 / B4Y1MH7 / 2598246 / 2390817 / B3SWPT2 / B7TL820 / BFRTDG1 / B7254K9 / BBFL7S1 / BCZS820 / B8L2798 / BJ0KXV4 / BDZCRX3 / BQPVQZ6 / BYVY8G0 / BS7K7C9 / BYVYD43 / BYW36M8 / BFZNYB7 / BJXBP41 / BQT3XY6 / BKDS4H5 / BKTHM05 / BZ1HM42 / BJ5FZ74 / BR4T3B3 / BGCYWN8 / BZ8FPH3 / BLGJ610 / BFMXGR0 / BJJMGL2 / BFNR303 / BZ05388 / BJXBP30 / BYWMQJ2 / BYQHPK7 / BYYWPW6 / BDH65C8 / BJ9NFQ3 / BK71LY6 / BF3W461 / BKS3RS7 / BD8Q1B8 / BF3N4P3 / BZ4CHH2 / BLBLMD5 / BNG3RZ7 / BN4NJG4 / BD5GSZ4</td><td class="leftalignment">Home Depot Inc / Merck & Co Inc / Ameren Corp / ANSYS Inc / Avista Corp / Borgwarner Inc / CMS Energy Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Nextera Energy Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / New York Times Co / NiSource Inc / OGE Energy Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / Genmab A/S / MorphoSys AG / Amerisourcebergen Corp / Global Payments Inc / Western Union Co / Mastercard Inc / Fidelity National Information Services Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / KAR Auction Services Inc / Neogenomics Inc / Gray Television Inc / Ameresco Inc / Meta Platforms Inc / Aerie Pharmaceuticals Inc / AxoGen Inc / bluebird bio Inc / Fate Therapeutics Inc / Hemisphere Media Group Inc / ONE Gas Inc / RingCentral Inc / Horizon Therapeutics PLC / Alphabet Inc / Nevro Corp / Performance Food Group Co / PayPal Holdings Inc / Allogene Therapeutics Inc / Alcon AG / Cyberark Software Ltd / Bill.com Holdings Inc / Passage Bio Inc / Adyen NV / Adaptive Biotechnologies Corp / HubSpot Inc / Xencor Inc / Editas Medicine Inc / Warner Music Group Corp / Evergy Inc / Fox Corp / Northwest Natural Holding Co / Global Blood Therapeutics Inc / Turning Point Therapeutics Inc / Alteryx Inc / Zymeworks Inc / Beigene Ltd / PetIQ Inc / Neoleukin Therapeutics Inc / WW International Inc / Tandem Diabetes Care Inc / 10X Genomics Inc / Tivity Health Inc / Arena Pharmaceuticals Inc / Soleno Therapeutics Inc / Array Technologies Inc / Leslie's Inc / Freeline Therapeutics Holdings PLC / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Gilead Sciences Inc: 1 director</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CC.N / CCI.N / CVS.N / DD.N / FLS.N / PFE.N / PNN.L / TRI.N / PXD.N / GILD.O / LPX.N / INCY.O / ETN.N / K.N / SU.TO / UNP.N / VMC.N / PAA.N / DVN.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / SGMO.O / RDN.N / NBIX.O / EPAY.O / AME.N / JKHY.O / PRU.N / COP.N / BKH.N / LNG.A / GPN.N / MNST.O / ICPT.O / EQIX.O / DLR.N / ACAD.O / ARWR.O / MWA.N / WU.N / CVLT.O / CQP.A / ATL.MI / IVZ.N / ADUS.OQ / FHI.N / PCRX.O / STAG.N / MPC.N / XYL.N / SRPT.O / MPLX.N / FANG.O / USAC.N / ENTA.O / TMUS.N / PTCT.O / BEP.N / ITCI.O / CIA.TO / PAYC.N / BTG.N / CTLT.N / NMIH.O / 03835T200 / 78667J108 / CIGI.O / GDS.O / UAA.N / RCM.OQ / CDEV.O / OVID.O / ATNX.O / OMP.N / ORSTED.CO / NEXA.TO / BHC.N / ETRN.N / PEAK.N / ETNB.O / OAS.OQ / VMD.OQ / MTCR.O / MCFE.OQ</td><td class="leftalignment">Chemours Co / Crown Castle International Corp / CVS Health Corp / Dupont De Nemours Inc / Flowserve Corp / Pfizer Inc / Pennon Group PLC / Thomson Reuters Corp / Pioneer Natural Resources Co / Gilead Sciences Inc / Louisiana-Pacific Corp / Incyte Corp / Eaton Corporation PLC / Kellogg Co / Suncor Energy Inc / Union Pacific Corp / Vulcan Materials Co / Plains All American Pipeline LP / Devon Energy Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Sangamo Therapeutics Inc / Radian Group Inc / Neurocrine Biosciences Inc / Bottomline Technologies Inc / AMETEK Inc / Jack Henry & Associates Inc / Prudential Financial Inc / Conocophillips / Black Hills Corp / Cheniere Energy Inc / Global Payments Inc / Monster Beverage Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Mueller Water Products Inc / Western Union Co / Commvault Systems Inc / Cheniere Energy Partners LP / Atlantia SpA / Invesco Ltd / Addus Homecare Corp / Federated Hermes Inc / Pacira Biosciences Inc / STAG Industrial Inc / Marathon Petroleum Corp / Xylem Inc / Sarepta Therapeutics Inc / MPLX LP / Diamondback Energy Inc / USA Compression Partners LP / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Intra-Cellular Therapies Inc / Champion Iron Ltd / Paycom Software Inc / B2Gold Corp / Catalent Inc / NMI Holdings Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Colliers International Group Inc / GDS Holdings Ltd / Under Armour Inc / R1 RCM Inc / Centennial Resource Development Inc / Ovid Therapeutics Inc / Athenex Inc / Oasis Midstream Partners LP / Orsted A/S / Nexa Resources SA / Bausch Health Companies Inc / Equitrans Midstream Corp / Healthpeak Properties Inc / 89Bio Inc / Oasis Petroleum Inc / Viemed Healthcare Inc / Metacrine Inc / Mcafee Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Italy / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / ICPT.O / ACAD.O / SRPT.O / ENTA.O / OVID.O / ETNB.O / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Ovid Therapeutics Inc / 89Bio Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALXN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIOb / JNJ / GILD.O / REGN.O / VRTX.O / RARE.O / BIIB.O / SRPT.O / AGIO.O / QGEN.K</td><td class="leftalignment">Bio Rad Laboratories Inc / Johnson & Johnson / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Qiagen NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Morning Minutes: BWXT, ENVA, MLSS, GILD / Corporate Events: see calendar below</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.OQ / BWXT.N / ENVA.N / MLSS.A / 375558103 / 59935P209 / 29357K103 / 05605H100</td><td class="leftalignment">Gilead Sciences Inc / BWX Technologies Inc / Enova International Inc / Milestone Scientific Inc / Gilead Sciences Inc / Milestone Scientific Inc / Enova International Inc / BWX Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Maxim Research</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / MDT=US / BLD=US / DVN=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / CHRS=US / MRO=US / LEG=US / KFRC=US / VMC=US / MLM=US / CBRL=US / CNX=US / DRI=US / EQT=US / EXEL=US / GFF=US / IBP=US / HZO=US / MAS=US / MHK=US / HOOK=US / REGN=US / REGI=US / RHI=US / WIX=US / CVX=US / SAGE=US / PSA=US / EPD=US / CGEN=US / BXS=US / SNV=US / ADC=US / CUZ=US / OHI=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / STRO=US / TPX=US / EXP=US / FHN=US / CDLX=US / BECN=US / SHO=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / KBR=US / CMG=US / REX=US / CCOI=US / XPO=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / EPRT=US / JACK=US / RCUS=US / CLNY=US / TREX=US / AR=US / NLSN=US / WWD=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / TILE=US / NDLS=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / SEDG=US / BWXT=US / WING=US / SPNE=US / CABO=US / ACBI=US / AXSM=US / 82982L103 / CDEV=US / CRSP=US / PVAC=US / JELD=US / CVNA=US / SBOW=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / DCPH=US / MAXR=US / BTAI=US / FTDR=US / SVMK=US / ALLO=US / KOD=US / HARP=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / ZI=US / AZEK=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Coherus BioSciences Inc / Marathon Oil Corp / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Griffon Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / Wix.Com Ltd / Chevron Corp / SAGE Therapeutics Inc / Public Storage / Enterprise Products Partners LP / Compugen Ltd / Cadence Bank / Synovus Financial Corp / Agree Realty Corp / Cousins Properties Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Sutro Biopharma Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Cardlytics Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / XPO Logistics Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / DigitalBridge Group Inc / Trex Company Inc / Antero Resources Corp / Nielsen Holdings PLC / Woodward Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Carvana Co / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Kodiak Sciences Inc / Harpoon Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - May 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">CA4509131088 / US0234361089 / US0311621009 / US1270971039 / US3755581036 / US6267171022 / US6821891057 / US6937181088 / US7237871071 / US75281A1097 / US8454671095 / US9139031002 / CA0084741085 / US5658491064 / CA7392391016 / US35671D8570 / CA5734591046 / US14040H1059 / US9497461015 / US6174464486 / US38141G1040 / CA98462Y1007 / CA0010921058 / CA4495861060 / US42809H1077 / US74460D1090 / US3932221043 / US2120151012 / CA1254911003 / US78454L1008 / CA5527041084 / NL0009434992 / US98986T1088 / CA3748252069 / US00404A1097 / US5764852050 / CA46579R1047 / US03674X1063 / US1638511089 / CA8485101031 / US45688C1071 / US12653C1080 / US29261A1007 / US87484T1088 / US53814L1089 / US57778K1051 / CA14179V5036 / US69047Q1022 / CA89055A2039</td><td class="leftalignment">IAMGOLD Corp / Amedisys Inc / Amgen Inc / Coterra Energy Inc / Gilead Sciences Inc / Murphy Oil Corp / ON Semiconductor Corp / Paccar Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Universal Health Services Inc / Agnico Eagle Mines Ltd / Marathon Oil Corp / Power Corporation of Canada / Freeport-McMoRan Inc / Martinrea International Inc / Capital One Financial Corp / Wells Fargo & Co / Morgan Stanley / Goldman Sachs Group Inc / Yamana Gold Inc / AGF Management Ltd / IGM Financial Inc / Hess Corp / Public Storage / Green Plains Inc / Continental Resources Inc / CI Financial Corp / SM Energy Co / MEG Energy Corp / LyondellBasell Industries NV / Zynga Inc / Gibson Energy Inc / Acadia Healthcare Company Inc / Matador Resources Co / Ivanhoe Mines Ltd / Antero Resources Corp / Chemours Co / Spin Master Corp / Ingevity Corp / CNX Resources Corp / Encompass Health Corp / Talos Energy Inc / Livent Corp / Maxar Technologies Inc / Cargojet Inc / Ovintiv Inc / Topaz Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / SUN.BO / NOVOB.CO / NOVN.S / 4768.T / GSK.L / UCB.BR / AMGN.OQ / ALKS.OQ / GILD.OQ / UTHR.OQ / BIIB.OQ / 4568.T / TEVA.N / ALM.MC / BAYGN.DE / 4578.T / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Alkermes Plc / Gilead Sciences Inc / United Therapeutics Corp / Biogen Inc / Daiichi Sankyo Co Ltd / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Otsuka Holdings Co Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: April 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ALB.N / AN.N / AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CL.N / CNC.N / COF.N / CRM.N / ED.N / EIX.N / EOG.N / FCX.N / GE.N / GM.N / GPS.N / IBM.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / MRK.N / OXY.N / TXT.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / DHR.N / DIS.N / UNH.N / FE.N / URI.N / DE.N / CAT.N / SPOT.N / AMG.N / GS.N / CLX.N / HON.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / LIN.N / OLN.N / TGT.N / AVY.N / PKI.N / VZ.N / NYT.N / KSS.N / HRB.N / ORCL.N / KMX.N / PWR.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / AIV.N / HAE.N / LB.TO / BLK.N / CVX.N / MHK.N / NWS.AX / IRM.N / NCR.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / COHR.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / PII.N / REGN.OQ / SIVB.OQ / XLNX.OQ / QDEL.OQ / QCOM.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / VSAT.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / NVDA.OQ / BMRN.OQ / PACW.OQ / EXPE.OQ / TREE.OQ / MRVL.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / SGEN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / BIIB.OQ / SNX.N / TPX.N / SBNY.OQ / AGO.N / ACAD.OQ / MOS.N / MKTX.OQ / DXCM.OQ / WAL.N / MS.N / STX.AX / MA.N / AWI.N / FSLR.OQ / IVZ.N / CLR.N / QGEN.N / TDC.N / SATS.OQ / MRNA.OQ / NWSA.OQ / AGCO.N / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / NXPI.OQ / ADSGN.F / LPLA.OQ / AMD.OQ / XYL.N / SLM.OQ / ENPH.OQ / TRIP.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / RNG.N / MAR.OQ / PTC.OQ / GOOGL.OQ / PAYC.N / EQC.N / HUBS.N / ETSY.OQ / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / IONS.OQ / RETA.OQ / TWLO.N / COUP.OQ / CDEV.OQ / AYX.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / PEP.OQ / ZS.OQ / FB.PS / STNE.OQ / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / RTX.N / CARR.N / LMND.N / AMWL.N / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / AutoNation Inc / Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / Consolidated Edison Inc / Edison International / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Occidental Petroleum Corp / Textron Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Affiliated Managers Group Inc / Goldman Sachs Group Inc / Clorox Co / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Linde PLC / Olin Corp / Target Corp / Avery Dennison Corp / PerkinElmer Inc / Verizon Communications Inc / New York Times Co / Kohls Corp / H & R Block Inc / Oracle Corp / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Haemonetics Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Mohawk Industries Inc / News Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Coherent Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / SVB Financial Group / Xilinx Inc / Quidel Corp / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / ViaSat Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Expedia Group Inc / Lendingtree Inc / Marvell Technology Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Seagen Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Biogen Inc / TD Synnex Corp / Tempur Sealy International Inc / Signature Bank / Assured Guaranty Ltd / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Dexcom Inc / Western Alliance Bancorp / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Invesco Ltd / Continental Resources Inc / Qiagen NV / Teradata Corp / EchoStar Corp / Moderna Inc / News Corp / AGCO Corp / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / Adidas AG / LPL Financial Holdings Inc / Advanced Micro Devices Inc / Xylem Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / RingCentral Inc / Marriott International Inc / PTC Inc / Alphabet Inc / Paycom Software Inc / Equity Commonwealth / HubSpot Inc / ETSY Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Centennial Resource Development Inc / Alteryx Inc / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / PepsiCo Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / American Well Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Germany / Ireland / Luxembourg / Netherlands / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0311621009 / US3755581036 / US03152W1099 / US03820J1007 / CA68620P1018 / US00289Y1073 / CA1380351009 / US00773U1088 / US8162121045 / US03969F1093 / US88688T1007 / CA39342L1085 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA05156X8843 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Amicus Therapeutics Inc / Applied Genetic Technologies Corp / OrganiGram Holdings Inc / Abeona Therapeutics Inc / Canopy Growth Corp / Adverum Biotechnologies Inc / Selecta Biosciences Inc / Arcus Biosciences Inc / Tilray Brands Inc / Green Thumb Industries Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Aurora Cannabis Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist ASCO Planner v1.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Pipeline Advancement is The Focus as Pandemic and 1Q Seasonality Impact Core Business</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jason McCarthy, Ph.D. / Mr. Michael Okunewitch</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GBT=US / CL=US / AMZN=US / DVN=US / GILD=US / EOG=US / REI=US / CHTR=US / XOM=US / WLL=US / PXD=US / HSII=US / SWN=US / VRM=US / MRO=US / EXPE=US / KFRC=US / MANH=US / NWL=US / W=US / DISH=US / KFY=US / AMN=US / B=US / BMRN=US / COLL=US / EXPO=US / GFF=US / LH=US / TREE=US / MAN=US / HZO=US / MHK=US / ASGN=US / RARE=US / RHI=US / SGMO=US / STRA=US / SNAP=US / THO=US / TRIP=US / VRTX=US / WIX=US / WGO=US / CVX=US / SAGE=US / CCRN=US / BKNG=US / CFR=US / FB=US / ENSG=US / AMSF=US / VICI=US / MGP=US / BDSI=US / MRNS=US / PTON=US / PRG=US / BIIB=US / MOG.A=US / APTX=US / NUVA=US / WMG=US / AAWW=US / NSP=US / CPRX=US / EIG=US / QSR=US / CLR=US / TIL=US / NOG=US / CWH=US / RCUS=US / KNSL=US / OLO=US / ESTE=US / ANGI=US / FANG=US / ABBV=US / GLPI=US / CNCE=US / GOOGL=US / FIVN=US / HTRG=US / BABA=US / CMPR=US / WK=US / RLMD=US / GDDY=US / ETSY=US / VKTX=US / ARGX=US / NVCR=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / EVBG=US / CRSP=US / PVAC=US / ANAB=US / JELD=US / CVNA=US / VRNA=US / SBOW=US / IOVA=US / SFIX=US / LAZY=US / FTDR=US / SVMK=US / ARVN=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / LHX=US / OVV=US / ONEW=US / CRMD.US / DASH=US / COUR-US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / Devon Energy Corp / Gilead Sciences Inc / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Exxon Mobil Corp / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Southwestern Energy Co / Vroom Inc / Marathon Oil Corp / Expedia Group Inc / Kforce Inc / Manhattan Associates Inc / Newell Brands Inc / Wayfair Inc / DISH Network Corp / Korn Ferry / AMN Healthcare Services Inc / Barnes Group Inc / Biomarin Pharmaceutical Inc / Collegium Pharmaceutical Inc / Exponent Inc / Griffon Corp / Laboratory Corporation of America Holdings / Lendingtree Inc / ManpowerGroup Inc / MarineMax Inc / Mohawk Industries Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Robert Half International Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Snap Inc / Thor Industries Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Winnebago Industries Inc / Chevron Corp / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / Meta Platforms Inc / Ensign Group Inc / Amerisafe Inc / VICI Properties Inc / MGM Growth Properties LLC / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / PROG Holdings Inc / Biogen Inc / Moog Inc / Aptinyx Inc / NuVasive Inc / Warner Music Group Corp / Atlas Air Worldwide Holdings Inc / Insperity Inc / Catalyst Pharmaceuticals Inc / Employers Holdings Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Camping World Holdings Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Olo Inc / Earthstone Energy Inc / Angi Inc / Diamondback Energy Inc / Abbvie Inc / Gaming and Leisure Properties Inc / Concert Pharmaceuticals Inc / Alphabet Inc / Five9 Inc / Heritage Insurance Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / Relmada Therapeutics Inc / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / argenx SE / Novocure Ltd / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Everbridge Inc / CRISPR Therapeutics AG / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Carvana Co / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Stitch Fix Inc / Lazydays Holdings Inc / Frontdoor Inc / Momentive Global Inc / Arvinas Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / L3harris Technologies Inc / Ovintiv Inc / OneWater Marine Inc / CorMedix Inc / DoorDash Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">How we view Iovance (IOVA) & Instil (TIL): TILs ultimately will be valued bigger than they are today</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">IOVA.OQ / GILD=US / TIL=US / IOVA=US</td><td class="leftalignment">Iovance Biotherapeutics Inc / Gilead Sciences Inc / Instil Bio Inc / Iovance Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Mr. Asthika Goonewardene / Ms. Srikripa Devarakonda, PHD / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">1Q Take: We expect pipeline catalysts throughout '21, starting in 2Q</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ / RCUS.N / ALXO.OQ</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 85 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Gilead (GILD:$63.47) drops 3%, trailing 77% of stocks</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for GILD. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">BAX / BSX / CHE / CNC / CRY.N / HUM / MDT / SYK / UNH / GILD.O / AMGN.O / NOVN.S / RMD.N / CYH.N / EW.N / IART.OQ / NBIX.OQ / BMRN.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 881624209 / ALNY.OQ / ACAD.O / ATRC.OQ / DXCM.O / CYCC.OQ / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / MRNA.O / BBI.O / AGIO.OQ / ALDX.OQ / 02005N100 / CLRB.OQ / INO.O / VKTX.O / TDOC.N / CFMS.O / NVCR.OQ / APLS.OQ / MDGL.O / IOVA.OQ / 720795103 / ALLO.OQ / MRKR.OQ / ORTX.OQ / CRSP.BN / SWAV.O / BWAY.TA / KRTX.OQ / NBSE.O / CRDF.OQ / FMTX.O / REGW.M3 / 03823M100</td><td class="leftalignment">Baxter International Inc / Boston Scientific Corp / Chemed Corp / Centene Corp / CryoLife Inc / Humana Inc / Medtronic PLC / Stryker Corp / UnitedHealth Group Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Teva Pharmaceutical Industries Ltd / Alnylam Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / Cyclacel Pharmaceuticals Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Moderna Inc / Brickell Biotech Inc / Agios Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Cellectar Biosciences Inc / Inovio Pharmaceuticals Inc / Viking Therapeutics Inc / Teladoc Health Inc / Conformis Inc / Novocure Ltd / Apellis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / Brainsway Ltd / Karuna Therapeutics Inc / NeuBase Therapeutics Inc / Cardiff Oncology Inc / Forma Therapeutics Holdings Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Tough Q1 But Pipeline Thesis Intact with Many Catalysts in 2021, Outperform</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">37555810</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q21 results; we're starting to see the path to growth story but await execution; maintain HOLD</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD=US / RCUS=US</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">ACA / AMT / CAT / CCI.N / CRY.N / DLR / DRI / GLW / GS / INTC.O / KKR / MA / MCD / MSFT.O / NICE.TA / QCOM.O / QUIK.O / T.N / UNH / WMT / ZEN / 4716.T / AMZN.O / GILD.O / AAPL.O / NVDA.O / DISH.O / HEAR.O / INTU.O / UPS.N / SBAC.O / RMD.N / MPWR.O / RDWR.O / TREE.O / CYH.N / CRNT.O / HRB.N / SMTC.O / FISV.O / CHTR.O / NUAN.O / ARCC.O / DOX.O / NET.N / HPE / AVGO.O / GTT / AOS.N / CRUS.OQ / ATVI.OQ / XLNX.OQ / TTWO.OQ / BMRN.OQ / AKAM.OQ / MRVL.OQ / ADS.N / VRTX.OQ / VRNT.OQ / SWKS.OQ / TXN.OQ / TEAM.O / EGAN.O / MMSI.O / AMED.O / EQIX.O / NFLX.O / CEVA.O / 92343V104 / 20030N101 / 459200101 / ALNY.OQ / DPZ / TXRH.O / NDAQ.O / DXCM.O / 36467W109 / ICE.N / CCOI.O / CYCC.OQ / FSLR.O / AIMC.O / CME.O / PODD.O / LLNW.OQ / ENSG.OQ / 514766104 / AGCO.K / GNRC.K / FTNT.O / TSLA.O / NXPI.O / ZNGA.O / EA.O / ADI.OQ / FB.O / CG.O / AGIO.OQ / RNG.N / TWTR.K / GOOGL.O / FIVN.O / 563771203 / 82655M107 / 02005N100 / ARES.K / SNOW.K / VKTX.O / QRVO.O / APPS.O / NVCR.OQ / TMUS.OQ / WCN.TO / AQMS.O / APL.PS / TWLO.K / MDGL.O / HLNE.OQ / ATUS.K / WSC.OQ / EGHT.K / BILI.O / AVYA.K / CRSP.BN / ZM.OQ / UBER.K / CMBM.OQ / PTON.OQ / FSLY.K / VG.O / DKNG.O / CRDF.OQ / ZI.OQ / FMTX.O / 84764T304 / RXT.O / TEUM.PK / ONDS.OQ / HUYA.K / 03823M100</td><td class="leftalignment">Arcosa Inc / American Tower Corp / Caterpillar Inc / Crown Castle International Corp / CryoLife Inc / Digital Realty Trust Inc / Darden Restaurants Inc / Corning Inc / Goldman Sachs Group Inc / Intel Corp / KKR & Co Inc / Mastercard Inc / McDonald's Corp / Microsoft Corp / Nice Ltd / Qualcomm Inc / QuickLogic Corp / AT&T Inc / UnitedHealth Group Inc / Walmart Inc / Zendesk Inc / Oracle Corp Japan / Amazon.com Inc / Gilead Sciences Inc / Apple Inc / NVIDIA Corp / DISH Network Corp / Turtle Beach Corp / Intuit Inc / United Parcel Service Inc / SBA Communications Corp / Resmed Inc / Monolithic Power Systems Inc / Radware Ltd / Lendingtree Inc / Community Health Systems Inc / Ceragon Networks Ltd / H & R Block Inc / Semtech Corp / Fiserv Inc / Charter Communications Inc / Nuance Communications Inc / Ares Capital Corp / Amdocs Ltd / Cloudflare Inc / Hewlett Packard Enterprise Co / Broadcom Inc / GTT Communications Inc / A O Smith Corp / Cirrus Logic Inc / Activision Blizzard Inc / Xilinx Inc / Take-Two Interactive Software Inc / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Marvell Technology Inc / Alliance Data Systems Corp / Vertex Pharmaceuticals Inc / Verint Systems Inc / Skyworks Solutions Inc / Texas Instruments Inc / Atlassian Corporation PLC / eGain Corp / Merit Medical Systems Inc / Amedisys Inc / Equinix Inc / Netflix Inc / CEVA Inc / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / Alnylam Pharmaceuticals Inc / Domino's Pizza Inc / Texas Roadhouse Inc / Nasdaq Inc / Dexcom Inc / GameStop Corp / Intercontinental Exchange Inc / Cogent Communications Holdings Inc / Cyclacel Pharmaceuticals Inc / First Solar Inc / Altra Industrial Motion Corp / CME Group Inc / Insulet Corp / Limelight Networks Inc / Ensign Group Inc / Landec Corp / AGCO Corp / Generac Holdings Inc / Fortinet Inc / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Agios Pharmaceuticals Inc / RingCentral Inc / Twitter Inc / Alphabet Inc / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Ally Financial Inc / Ares Management Corp / Snowflake Inc. / Viking Therapeutics Inc / Qorvo Inc / Digital Turbine Inc / Novocure Ltd / T-Mobile US Inc / Waste Connections Inc / Aqua Metals Inc / Apollo Global Capital Inc / Twilio Inc / Madrigal Pharmaceuticals Inc / Hamilton Lane Inc / Altice USA Inc / Willscot Mobile Mini Holdings Corp / 8x8 Inc / Bilibili Inc / Avaya Holdings Corp / CRISPR Therapeutics AG / Zoom Video Communications Inc / Uber Technologies Inc / Cambium Networks Corp / Peloton Interactive Inc / Fastly Inc / Vonage Holdings Corp / DraftKings Inc / Cardiff Oncology Inc / ZoomInfo Technologies Inc / Forma Therapeutics Holdings Inc / Speed Commerce Inc / Rackspace Technology Inc / Pareteum Corp / Ondas Holdings Inc / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / India / Israel / Japan / Netherlands / Philippines / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Virtual ASCO Planner</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">45337C10 / 75991610 / 71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75886F10 / M2572210 / 45232710 / 30063P10 / 478160104 / 640268108 / 30161Q104 / 64049M20 / 58933Y10 / G0176710 / 53220K50 / 92337F10 / 46185L10 / 00653A107 / 74587V10 / 00287Y10 / 98401F10 / 18946410 / 40131M10 / 58490H10 / 63230710 / 05358830 / 76029N10 / 41358P10 / 09627Y10 / 09075V10 / 09609G10 / 55609910 / N0104510 / 31189P10 / 07725L10 / G3910J11 / 24344T10 / 29428V10 / 81181C10 / 04685N10 / 13089P10 / 22101510 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 89620X50 / 98887Q10 / 98943L10 / 98985W10</td><td class="leftalignment">Incyte Corp / Repligen Corp / Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Exelixis Inc / Neogenomics Inc / Merck & Co Inc / Alkermes Plc / Ligand Pharmaceuticals Inc / Veracyte Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Puma Biotechnology Inc / Abbvie Inc / Xencor Inc / Clovis Oncology Inc / Guardant Health Inc / Medicenna Therapeutics Corp / Natera Inc / Aveo Pharmaceuticals Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Blueprint Medicines Corp / BioNTech SE / bluebird bio Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Deciphera Pharmaceuticals Inc / Epizyme Inc / Seagen Inc / Athenex Inc / Calithera Biosciences Inc / Corvus Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Pfizer Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Andrew Berens, M.D. / Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Mr. Puneet Souda</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">NL0000226223 / US09061G1013 / US01741R1023 / US01988P1084 / US0231351067 / US0463531089 / US0718131099 / US1005571070 / US1265011056 / US1270971039 / US1727551004 / US1912161007 / US2910111044 / US3695501086 / US3755581036 / US4234521015 / US4824801009 / US5801351017 / US5951121038 / US6549022043 / US6668071029 / US7134481081 / US7392761034 / US8610121027 / US8832031012 / US8835561023 / US92532F1003 / US9581021055 / US83088M1027 / US20030N1019 / US21036P1084 / US02043Q1076 / US60871R2094 / FI0009013296 / US2538681030 / US19239V3024 / US2090341072 / US8936411003 / US48242W1062 / US3020811044 / US3364331070 / US29089Q1058 / US8485741099 / US53261M1045 / US25470M1099 / US64110D1046 / US25470F1049 / US25470F3029 / US78454L1008 / IE00B58JVZ52 / US69404D1081 / US92839U2069 / US03027X1000 / US96208T1043 / US64051T1007 / US23283R1005 / PR30040P1032 / US00847X1046 / US8086251076 / US5560991094 / US90184L1026 / US98936J1016 / US0396971071 / US29444U7000 / US09627Y1091 / US61174X1090 / US74624M1027 / GB00BZ09BD16 / US34959J1088 / US90138F1021 / IE00BY7QL619 / US36165L1089 / US64104Y1064 / CA87241L1094 / US80689H1023 / US8760301072 / US7625441040 / US09354A1007 / US2575541055 / US49271V1008 / KY30744W1070 / US40131M1099 / US55087P1049 / US90353T1007 / US76156B1070 / US61775R1059 / US4432011082 / US8334451098 / US07373B1098 / US81181C1045 / US74767V1098 / US7761531083 / US55406W1036 / US15961R1059</td><td class="leftalignment">STMicroelectronics NV / Biomarin Pharmaceutical Inc / Allegheny Technologies Inc / Allscripts Healthcare Solutions Inc / Amazon.com Inc / AstraZeneca PLC / Baxter International Inc / Boston Beer Company Inc / CTS Corp / Coterra Energy Inc / Cirrus Logic Inc / Coca-Cola Co / Emerson Electric Co / General Dynamics Corp / Gilead Sciences Inc / Helmerich and Payne Inc / KLA Corp / McDonald's Corp / Micron Technology Inc / Nokia Oyj / Northrop Grumman Corp / PepsiCo Inc / Power Integrations Inc / STMicroelectronics NV / Textron Inc / Thermo Fisher Scientific Inc / Vertex Pharmaceuticals Inc / Western Digital Corp / Skyworks Solutions Inc / Comcast Corp / Constellation Brands Inc / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / Neste Oyj / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / TransDigm Group Inc / KBR Inc / Exlservice Holdings Inc / First Solar Inc / Emergent BioSolutions Inc / Spirit AeroSystems Holdings Inc / Limelight Networks Inc / DISH Network Corp / NetApp Inc / Discovery Inc / Discovery Inc / SM Energy Co / Seagate Technology Holdings PLC / Pacific Biosciences of California Inc / Visteon Corp / American Tower Corp / WEX Inc / NeoPhotonics Corp / CyrusOne Inc / Evertec Inc / Agios Pharmaceuticals Inc / Science Applications International Corp / MacroGenics Inc / Twitter Inc / Zendesk Inc / Ardelyx Inc / Equinix Inc / Blueprint Medicines Corp / Monster Beverage Corp / Pure Storage Inc / Atlassian Corporation PLC / Fortive Corp / Twilio Inc / Johnson Controls International PLC / GDS Holdings Ltd / Neste Oyj / TFI International Inc / Schneider National Inc / Tapestry Inc / Ribbon Communications Inc / Blink Charging Co / Domo Inc / Keurig Dr Pepper Inc / Farfetch Ltd / Guardant Health Inc / Lyft Inc / Uber Technologies Inc / Revolve Group Inc / Morphic Holding Inc / Howmet Aerospace Inc / Snowflake Inc. / Beam Global / Seagen Inc / Quantumscape Corp / Romeo Power Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Finland / United Kingdom / Ireland / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / BMY=US / MCD=US / TWTR=US / ICLR=US / AMZN=US / GILD=US / AMT=US / PEB=US / BC=US / CONE=US / V=US / IGT=US / SWN=US / TRMK=US / TNL=US / MDRX=US / AKR=US / AFL=US / HUM=US / CMCSA=US / RCL=US / AMED=US / BMRN=US / CHD=US / CNX=US / DRI=US / DVA=US / EEFT=US / EXPO=US / FCN=US / AJG=US / TREE=US / MHK=US / TEAM=US / NTST=US / OKE=US / SMG=US / VSEC=US / VRTX=US / WEX=US / OPT=US / SGMS=US / ADC=US / AVTR=US / CPT=US / OFC=US / CUZ=US / KIM=US / MKL=US / SSB=US / ENSG=US / AMSF=US / MMP=US / MOH=US / TPX=US / TXRH=US / DLR=US / MPW=US / KBR=US / CCOI=US / MA=US / GPRE=US / WU=US / PAG=US / EHTH=US / CLR=US / LLNW=US / WH=US / AGS=US / SWI=US / KNSL=US / AR=US / HGV=US / CUBE=US / FBHS=US / MTDR=US / SPLK=US / LKQ=US / ABBV=US / NDLS=US / FIVN=US / 00770K202 / CMPR=US / ZG=US / EVRI=US / WLTW=US / ADVM=US / VVV=US / VRNA=US / RDFN=US / MBIN=US / SYNH=US / KDP=US / SITC=US / OVV=US / ONEW=US / AIRC=US / HYFM=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / McDonald's Corp / Twitter Inc / ICON PLC / Amazon.com Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / CyrusOne Inc / Visa Inc / International Game Technology PLC / Southwestern Energy Co / Trustmark Corp / Travel + Leisure Co / Allscripts Healthcare Solutions Inc / Acadia Realty Trust / Aflac Inc / Humana Inc / Comcast Corp / Royal Caribbean Cruises Ltd / Amedisys Inc / Biomarin Pharmaceutical Inc / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / DaVita Inc / Euronet Worldwide Inc / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ONEOK Inc / Scotts Miracle-Gro Co / VSE Corp / Vertex Pharmaceuticals Inc / WEX Inc / Opthea Ltd / Scientific Games Corp / Agree Realty Corp / Avantor Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Kimco Realty Corp / Markel Corp / SouthState Corp / Ensign Group Inc / Amerisafe Inc / Magellan Midstream Partners LP / Molina Healthcare Inc / Tempur Sealy International Inc / Texas Roadhouse Inc / Digital Realty Trust Inc / Medical Properties Trust Inc / KBR Inc / Cogent Communications Holdings Inc / Mastercard Inc / Green Plains Inc / Western Union Co / Penske Automotive Group Inc / eHealth Inc / Continental Resources Inc / Limelight Networks Inc / Wyndham Hotels & Resorts Inc / PlayAGS Inc / SolarWinds Corp / Kinsale Capital Group Inc / Antero Resources Corp / Hilton Grand Vacations Inc / CubeSmart / Fortune Brands Home & Security Inc / Matador Resources Co / Splunk Inc / LKQ Corp / Abbvie Inc / Noodles & Co / Five9 Inc / Aemetis Inc / Cimpress PLC / Zillow Group Inc / Everi Holdings Inc / Willis Towers Watson PLC / Adverum Biotechnologies Inc / Valvoline Inc / Verona Pharma PLC / Redfin Corp / Merchants Bancorp / Syneos Health Inc / Keurig Dr Pepper Inc / Site Centers Corp / Ovintiv Inc / OneWater Marine Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / Ireland / Liberia / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 Revenue Soft, But 2021 Guidance Reiterated; Oncology Pipeline In Focus</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Tara Bancroft, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0231351067 / US0536111091 / US1170431092 / US1258961002 / US1491231015 / US3755581036 / US4278661081 / US4448591028 / US4601461035 / US5745991068 / US5801351017 / US6516391066 / US7010941042 / US7802871084 / US8425871071 / US8589121081 / US89531P1057 / US92532F1003 / US98389B1008 / CA1367178326 / CA59151K1084 / CA0467894006 / CA0977512007 / CA30150P1099 / CA90457D1006 / CA5592224011 / CA5266821092 / CA0084741085 / CA15101Q1081 / CA7029251088 / US9129091081 / CA3039011026 / US83088M1027 / US60855R1005 / US20451N1019 / US25754A2015 / CA98462Y1007 / US02043Q1076 / US0736851090 / US8826811098 / US74144T1088 / US12008R1077 / US57636Q1040 / CA05534B7604 / CA3518581051 / CA00765F1018 / US34959E1091 / US72147K1088 / CA07317Q1054 / CA0194561027 / CA96467A2002 / CA0213611001 / CA6752221037 / CA80013R2063 / US34964C1062 / US0942351083 / CA68827L1013 / US5007541064 / CA0115321089 / CA83125J1049 / US02079K3059 / GB00BZ09BD16 / US78409V1044 / CA94106B1013 / US7045511000 / CA6568111067 / US2997341035 / US03990B1017 / GB00BJT16S69 / US61775R1059 / US71722W1071 / US67098H1041 / CA1033101082 / US14316J1088 / US05478C1053 / CA1295844056</td><td class="leftalignment">Amazon.com Inc / Avery Dennison Corp / Brunswick Corp / CMS Energy Corp / Caterpillar Inc / Gilead Sciences Inc / Hershey Co / Humana Inc / International Paper Co / Masco Corp / McDonald's Corp / Newmont Corporation / Parker-Hannifin Corp / Royal Gold Inc / Southern Co / Stericycle Inc / Trex Company Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Canadian Utilities Ltd / Methanex Corp / Atco Ltd / Bombardier Inc / Exco Technologies Ltd / Uni-Select Inc / Magna International Inc / Leon's Furniture Ltd / Agnico Eagle Mines Ltd / Celestica Inc / Pason Systems Inc / United States Steel Corp / Fairfax Financial Holdings Ltd / Skyworks Solutions Inc / Molina Healthcare Inc / Compass Minerals International Inc / Domino's Pizza Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / T Rowe Price Group Inc / Builders FirstSource Inc / Mastercard Inc / BCE Inc / Franco-Nevada Corp / Advantage Energy Ltd / Fortinet Inc / Pilgrims Pride Corp / Baytex Energy Corp / Allied Properties Real Estate Investment Trust / Whitecap Resources Inc / AltaGas Ltd / OceanaGold Corp / Sandstorm Gold Ltd / Fortune Brands Home & Security Inc / Bloomin' Brands Inc / Osisko Gold Royalties Ltd / Kraft Heinz Co / Alamos Gold Inc / Sleep Country Canada Holdings Inc / Alphabet Inc / Atlassian Corporation PLC / S&P Global Inc / Waste Connections Inc / Peabody Energy Corp / North American Construction Group Ltd / Evelo Biosciences Inc / Ares Management Corp / Tronox Holdings PLC / Morphic Holding Inc / Phathom Pharmaceuticals Inc / O-I Glass Inc / Boyd Group Services Inc / Carlyle Group Inc / Azek Company Inc / Calfrac Well Services Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">V / 2126335 / 2000019 / 2486813 / 2778844 / 2003698 / 2026242 / 2437071 / 2219224 / 2229126 / 2317087 / 2345022 / 2369174 / 2459020 / 2689560 / 2440637 / 2138158 / 2829601 / 2931034 / 2971029 / B00FWN1 / B121557 / B067BM3 / 2769796 / 2216991 / 2857817 / B125XQ6 / B3D7K31 / B1HJLW5 / B5B2106 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BCBVTX1 / BFDV8K0 / B95N910 / BFLR866 / B76LYJ2 / BYRY499 / BVVN4Q8 / BF4VBS8 / BD3W133 / BXDZ9Z0 / BYNZGK1 / BJLKVS6 / BFZ1K46 / BMYML02 / BP3YM85 / BWY52P3 / BMH0MR7 / BM8MM05 / BYXR425 / BLBLMD5 / 021513106</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / ABIOMED Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Columbia Sportswear Co / Entergy Corp / Macy's Inc / Gilead Sciences Inc / Intuit Inc / PG&E Corp / CenterPoint Energy Inc / Sempra Energy / Southern Co / Vertex Pharmaceuticals Inc / LKQ Corp / Alnylam Pharmaceuticals Inc / Mastercard Inc / Molson Coors Beverage Co / Fidelity National Information Services Inc / Tempur Sealy International Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Emergent BioSolutions Inc / Fortinet Inc / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / PTC Inc / Twitter Inc / Vocera Communications Inc / Kraft Heinz Co / Eversource Energy / BioXcel Therapeutics Inc / Keurig Dr Pepper Inc / Shopify Inc / Block Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Trupanion Inc / Blueprint Medicines Corp / Zendesk Inc / Madison Square Garden Entertainment Corp / RH / Array Technologies Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AFL.N / BCE.TO / BP.L / DGE.L / EL.N / ENI.MI / IP.N / MRK.N / NA / REP.MC / SRCL.O / TOTF.PA / ULVR.L / VC.N / GILD.O / SJRb.TO / RCIb.TO / FER.MC / CLS.N / CTXS.O / MCD.N / AEM.N / XOM.N / OLN.N / MDRX.O / CINF.O / FISV.O / V.N / ARE.N / CHD.N / SLGN.O / WSP.TO / BC.N / KRC.N / MAA.N / VTR.N / AJG.N / BMRN.O / VRTX.O / CVX.N / FTT.TO / CFR.N / MEOH.O / WCN.N / MKL.N / ADS.N / SGEN.OQ / GPN.N / SIGI.O / ORLY.O / COLB.O / AMED.O / STN.TO / TIH.TO / SNC.TO / 02209S103 / NVT.N / DPZ.N / TXRH.O / NESTE.HE / 427866108 / RDSb.L / ALNY.O / FIS.N / ISBC.O / MA.N / MERC.O / GALP.LS / 550372106 / ATL.MI / CLR.N / ENSG.O / PBF.N / SWI.N / AAV.TO / EGO.N / FTNT.O / SMSS.L / FBHS.N / ACHC.O / VCRA.N / RFP.N / FFHu.TO / MDLZ.OQ / TMHC.N / AGIO.O / GWB.N / EVA.N / PYPL.OQ / SQ.N / FTV.N / ATKR.N / KNSL.OQ / SAND.N / INVH.N / ORSTED.CO / NEXA.TO / GSHD.O / KDP.N / BHC.N / MORF.OQ / PEAK.N / 2222.SE / DHC.O / OVV.N / CARR.N / FOUR.N / NRIX.OQ</td><td class="leftalignment">Aflac Inc / BCE Inc / BP PLC / Diageo PLC / Estee Lauder Companies Inc / Eni SpA / International Paper Co / Merck & Co Inc / National Bank of Canada / Repsol SA / Stericycle Inc / TotalEnergies SE / Unilever PLC / Visteon Corp / Gilead Sciences Inc / Shaw Communications Inc / Rogers Communications Inc / Ferrovial SA / Celestica Inc / Citrix Systems Inc / McDonald's Corp / Agnico Eagle Mines Ltd / Exxon Mobil Corp / Olin Corp / Allscripts Healthcare Solutions Inc / Cincinnati Financial Corp / Fiserv Inc / Visa Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Silgan Holdings Inc / WSP Global Inc / Brunswick Corp / Kilroy Realty Corp / Mid-America Apartment Communities Inc / Ventas Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Finning International Inc / Cullen/Frost Bankers Inc / Methanex Corp / Waste Connections Inc / Markel Corp / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Selective Insurance Group Inc / O'Reilly Automotive Inc / Columbia Banking System Inc / Amedisys Inc / Stantec Inc / Toromont Industries Ltd / SNC-Lavalin Group Inc / Altria Group Inc / nVent Electric PLC / Domino's Pizza Inc / Texas Roadhouse Inc / Neste Oyj / Hershey Co / Royal Dutch Shell PLC / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Investors Bancorp Inc / Mastercard Inc / Mercer International Inc / Galp Energia SGPS SA / Lundin Mining Corp / Atlantia SpA / Continental Resources Inc / Ensign Group Inc / PBF Energy Inc / SolarWinds Corp / Advantage Energy Ltd / Eldorado Gold Corp / Fortinet Inc / Smart Metering Systems PLC / Fortune Brands Home & Security Inc / Acadia Healthcare Company Inc / Vocera Communications Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Taylor Morrison Home Corp / Agios Pharmaceuticals Inc / Great Western Bancorp Inc / Enviva Inc / PayPal Holdings Inc / Block Inc / Fortive Corp / Atkore Inc / Kinsale Capital Group Inc / Sandstorm Gold Ltd / Invitation Homes Inc / Orsted A/S / Nexa Resources SA / Goosehead Insurance Inc / Keurig Dr Pepper Inc / Bausch Health Companies Inc / Morphic Holding Inc / Healthpeak Properties Inc / Saudi Arabian Oil Co / Diversified Healthcare Trust / Ovintiv Inc / Carrier Global Corp / Shift4 Payments Inc / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Luxembourg / Portugal / Saudi Arabia / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 1Q21 Earnings Highlights — What Mattered for Credit (BAX, BMY, GILD, LH, MRK, TMO)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.OQ / BAX.N / BMY.N / LH.N / MRK.N / TMO.N / GILD.O</td><td class="leftalignment">Gilead Sciences Inc / Baxter International Inc / Bristol-Myers Squibb Co / Laboratory Corporation of America Holdings / Merck & Co Inc / Thermo Fisher Scientific Inc / Gilead Sciences Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">GILD - GILD 1Q21 Postview: COVID overhang continues, but Veklury soothes the pain</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : 1Q Snapshot - Tough Quarter but Recovery and Pipeline Catalysts on the Horizon</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q21 Review: Soft Quarter Portends Gradual Recovery</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GILD.O / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">1Q21: Veklury as the Offset</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Modest Updates Post-1Q; 1Q Rev Miss but 2021 FY Guidance Affirmed; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">1Q21: Pandemic and Seasonal Headwinds Pressure HIV, But Oncology Readouts On Track</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : First Look at 1Q Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q21 cal: GILD interested in TILs & off-the-shelf therapies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">1Q21 First Take: Soft Quarter, But Catalyst-Rich 2021 Should Help Climb From Discounted Multiple</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Brief of Gilead Sciences Inc conference call, Apr. 29, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Apr. 29, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q Earnings Season: Read-Through from MRK's Results</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / GILD.O / AMGN.O / REGN.O / SGEN.O / CLVS.O</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Clovis Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Apr 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMZN.OQ / BAX.N / BMY.N / CMS.N / EMN.N / IP.N / METR.KL / MO.N / MRK.N / NEM.N / NOC.N / SO.N / TAP.N / TMO.N / TXT.N / TFX.N / PH.N / WAB.N / CAT.N / MCD.N / LH.N / HSY.N / AMT.N / WST.N / DVA.N / COG.N / CHD.N / TWTR.N / AJG.N / MHK.N / AOS.N / ABMD.OQ / KLAC.OQ / TROW.OQ / GILD.OQ / DISH.OQ / CTXS.OQ / PTEN.OQ / VRTX.OQ / SWKS.OQ / CMCSA.OQ / DPZ.N / DXCM.OQ / RDSa.L / ICE.N / MA.N / BIO.N / FTNT.OQ / GNRC.N / FBHS.N / LKQ.OQ / WDC.OQ / KHC.OQ / WLTW.OQ / SPGI.N / FTV.N / XEL.OQ / CBRE.N / CARR.N / MCDG.MU</td><td class="leftalignment">Amazon.com Inc / Baxter International Inc / Bristol-Myers Squibb Co / CMS Energy Corp / Eastman Chemical Co / International Paper Co / MKH Bhd / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Northrop Grumman Corp / Southern Co / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Textron Inc / Teleflex Inc / Parker-Hannifin Corp / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / McDonald's Corp / Laboratory Corporation of America Holdings / Hershey Co / American Tower Corp / West Pharmaceutical Services Inc / DaVita Inc / Coterra Energy Inc / Church & Dwight Co Inc / Twitter Inc / Arthur J Gallagher & Co / Mohawk Industries Inc / A O Smith Corp / ABIOMED Inc / KLA Corp / T Rowe Price Group Inc / Gilead Sciences Inc / DISH Network Corp / Citrix Systems Inc / Patterson-UTI Energy Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Comcast Corp / Domino's Pizza Inc / Dexcom Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / Mastercard Inc / Bio Rad Laboratories Inc / Fortinet Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / LKQ Corp / Western Digital Corp / Kraft Heinz Co / Willis Towers Watson PLC / S&P Global Inc / Fortive Corp / Xcel Energy Inc / CBRE Group Inc / Carrier Global Corp / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Malaysia / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, GILD</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg / Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">GSK.L / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / GILD.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Gilead Sciences Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for GILD</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Preview and Planner - Key Updates Across Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 4595739 / 5531000 / 2982924 / BCBVTX1 / BBFL7S1 / BCZS820 / BFDV8K0 / BBPK0J0 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BYWVTY5 / BWY4XV3 / BN2R582 / BMC5RV6 / BMDJ397</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / MorphoSys AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / CytomX Therapeutics Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Adicet Bio Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Kelsey Goodwin / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Peer Group Analytics - Q4 FY2020</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ANTO.L / BP.L / COF.N / GE.N / MMC.N / MSFT.O / PFE.N / PHM.N / RIO.L / HUM.N / GILD.O / AMGN.O / UHS.N / FER.MC / AAL.L / ROP.N / UNP.N / CLX.N / WM.N / MMM.N / BOL.ST / SBUX.O / AMP.N / RRC.N / FISV.O / V.N / SUI.N / BMRN.O / REGN.O / NCR.N / BLU.N / CHE.N / BRO.N / PII.N / ST.N / SGEN.OQ / BCRX.O / ACGL.O / FFIV.O / FM.TO / ACAD.O / ALNY.O / ARWR.O / CLR.N / INO.OQ / VALE.N / BHPB.L / GLEN.L / SMSS.L / MDLZ.OQ / ABBV.N / SYF.N / 03835T200 / FSV.O / GBT.OQ / UBSG.S / ADVM.OQ / CRSP.OQ / ORSTED.CO / EHC.N / ITRM.O / NTGY.MC / PRVB.O / KRTX.OQ / MORF.OQ / APRE.OQ / ETNB.O / SPRB.OQ</td><td class="leftalignment">Antofagasta PLC / BP PLC / Capital One Financial Corp / General Electric Co / Marsh & McLennan Companies Inc / Microsoft Corp / Pfizer Inc / Pultegroup Inc / Rio Tinto PLC / Humana Inc / Gilead Sciences Inc / Amgen Inc / Universal Health Services Inc / Ferrovial SA / Anglo American PLC / Roper Technologies Inc / Union Pacific Corp / Clorox Co / Waste Management Inc / 3M Co / Boliden AB / Starbucks Corp / Ameriprise Financial Inc / Range Resources Corp / Fiserv Inc / Visa Inc / Sun Communities Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / NCR Corp / BELLUS Health Inc / Chemed Corp / Brown & Brown Inc / Polaris Inc / Sensata Technologies Holding PLC / Seagen Inc / BioCryst Pharmaceuticals Inc / Arch Capital Group Ltd / F5 Inc / First Quantum Minerals Ltd / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Continental Resources Inc / Inovio Pharmaceuticals Inc / Vale SA / BHP Group PLC / Glencore PLC / Smart Metering Systems PLC / Mondelez International Inc / Abbvie Inc / Synchrony Financial / Aptose Biosciences Inc / FirstService Corp / Global Blood Therapeutics Inc / UBS Group AG / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Orsted A/S / Encompass Health Corp / Iterum Therapeutics PLC / Naturgy Energy Group SA / Provention Bio Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / 89Bio Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biopharma: Our Top 15 Most Interesting/Surprising Takeaways From RBC's Doctor Days</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / GILD.O / BMRN.O / REGN.O / BLU.N / SGEN.OQ / BCRX.O / ALNY.O / ARWR.O / ABBV.N / ADVM.OQ / PRVB.O / KRTX.OQ / ETNB.O / SPRB.OQ</td><td class="leftalignment">Pfizer Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BELLUS Health Inc / Seagen Inc / BioCryst Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Abbvie Inc / Adverum Biotechnologies Inc / Provention Bio Inc / Karuna Therapeutics Inc / 89Bio Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Steve Daddeo / Michael Murray / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Daniel Busby / Leonid Timashev / David Szeto / Yinglu Zhang / Lisa Walter</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALXO: Trillium R&D Day Update: Monotherapy Promotion, but Combination Intentions</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALXO.OQ / GILD.OQ / ABBV.N / IMAB.OQ</td><td class="leftalignment">ALX Oncology Holdings Inc / Gilead Sciences Inc / Abbvie Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bradley P. Canino / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">GILD - GILD 1Q21 earnings preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Compass: Risk-On Rotations vs. Weaker Seasonality; Russell 2000, Biotech, EM Improving; Charts Highlighted: LVMUY, LULU, VFC, TPR, PVH, COLM, HBI, GIL, RL, UAA, GOOS, GIII, OXM, MOV, DLA, ETN, JCI, MGA, BWA, LEA, ALV, ADNT, WDC, STX, and NTAP</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">NTAP.OQ / LVMH.PA / RL.N / ETN.N / LEA.N / JCI.N / VFC.N / GIII.OQ / OXM.N / GILD.OQ / MOV.N / TPR.N / COLM.OQ / DLA.A / GIL.TO / STX.AX / HBI.N / LULU.OQ / WDC.OQ / ADNT.N / UAA.N / GOOS.TO</td><td class="leftalignment">NetApp Inc / LVMH Moet Hennessy Louis Vuitton SE / Ralph Lauren Corp / Eaton Corporation PLC / Lear Corp / Johnson Controls International PLC / VF Corp / G-III Apparel Group Ltd / Oxford Industries Inc / Gilead Sciences Inc / Movado Group Inc / Tapestry Inc / Columbia Sportswear Co / Delta Apparel Inc / Gildan Activewear Inc / Strike Energy Ltd / HanesBrands Inc / Lululemon Athletica Inc / Western Digital Corp / Adient PLC / Under Armour Inc / Canada Goose Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / France / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALXO: Taking Stock of the CD47 Blocker Buffet Ahead of Competitor R&D Day</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALXO.OQ / GILD.OQ / ABBV.N / TGTX.OQ / IMAB.OQ</td><td class="leftalignment">ALX Oncology Holdings Inc / Gilead Sciences Inc / Abbvie Inc / TG Therapeutics Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bradley P. Canino / Matthew Terwelp / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Gilead climbs 13% in 2021, outperforming Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">EnVent Capital Markets</td><td class="leftalignment">Gismondi 1754 Equity Research - Update FY20</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">GIS=IT</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Italy / United States</td><td class="leftalignment">Apparel & Textiles</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / ESTIMATE CHANGES / OPERATING RESULTS / PRICE / RATINGS CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Luigi Tardella</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / ALB.N / AXP / BAC.N / BAX / BE / BSX / C.N / CAT / CCI.N / CI / CLH / CMI / COF / CSL / DAN / DE / EL.N / ENS / GS / JCI / JEF / JPM / KKR / MDT / MS / MSFT.O / NEP / NOW / ORA / PNC.N / RSG / T.N / TEL / UNH / USB / W / WFC.N / WM / TME / AMZN.O / GILD.O / AAPL.O / BWA.N / NVDA.O / NOVN.S / MPWR.O / SBUX.O / SMTC.O / EW.N / FCEL.O / LSTR.O / CREE.O / NET.N / AVGO.O / AMSC.OQ / IART.OQ / NBIX.OQ / TTWO.OQ / PLUG.OQ / MRVL.OQ / BLUE.OQ / TXN.OQ / MGRC.O / TEAM.O / SIVB.O / TRMB.O / ITRI.O / GNSS.O / NFLX.O / 478160104 / 92343V104 / 459200101 / 316773100 / 0700.HK / OLED.O / NDAQ.O / ATRC.OQ / DXCM.O / G02602103 / 029899101 / SPWR.O / XPO / CSIQ.O / FSLR.O / PODD.O / LULU.O / 02043Q107 / TNDM.O / 514766104 / MRNA.O / BBI.O / TWIN.O / CSII.O / AGCO.K / ADUS.O / TSLA.O / AMRC.K / AMRS.OQ / ENPH.O / FB.O / CG.O / HASI.N / RNG.N / WIX.O / CLRB.OQ / 174610105 / QRVO.O / ETSY.O / SEDG.O / ZG.OQ / RUN.O / TMUS.OQ / WKHS.O / WCN.TO / AQMS.O / SPGI.K / TTD.OQ / APL.PS / COUP.O / WPRT.TO / SNAP.K / OKTA.O / IOVA.OQ / RDFN.O / WDAY.O / ROKU.O / MDB.O / APTV.K / 720795103 / OSS.O / FOCS.OQ / ESTC.N / MRKR.OQ / CWENa.K / CRSP.BN / FTDR.O / UBER.K / CRWD.O / PTON.OQ / VG.O / DKNG.O / AVNT.K / 02081G201 / RWRh.V / 120248964</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / American Express Co / Bank of America Corp / Baxter International Inc / Bloom Energy Corp / Boston Scientific Corp / Citigroup Inc / Caterpillar Inc / Crown Castle International Corp / Cigna Corp / Clean Harbors Inc / Cummins Inc / Capital One Financial Corp / Carlisle Companies Inc / Dana Inc / Deere & Co / Estee Lauder Companies Inc / EnerSys / Goldman Sachs Group Inc / Johnson Controls International PLC / Jefferies Financial Group Inc / JPMorgan Chase & Co / KKR & Co Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / ServiceNow Inc / Ormat Technologies Inc / PNC Financial Services Group Inc / Republic Services Inc / AT&T Inc / TE Connectivity Ltd / UnitedHealth Group Inc / US Bancorp / Wayfair Inc / Wells Fargo & Co / Waste Management Inc / Tencent Music Entertainment Group / Amazon.com Inc / Gilead Sciences Inc / Apple Inc / Borgwarner Inc / NVIDIA Corp / Novartis AG / Monolithic Power Systems Inc / Starbucks Corp / Semtech Corp / Edwards Lifesciences Corp / Fuelcell Energy Inc / Landstar System Inc / Wolfspeed Inc / Cloudflare Inc / Broadcom Inc / American Superconductor Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Plug Power Inc / Marvell Technology Inc / bluebird bio Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / SVB Financial Group / Trimble Inc / Itron Inc / Genasys Inc / Netflix Inc / Johnson & Johnson / Verizon Communications Inc / International Business Machines Corp / Fifth Third Bancorp / Tencent Holdings Ltd / Universal Display Corp / Nasdaq Inc / AtriCure Inc / Dexcom Inc / Amdocs Ltd / American States Water Co / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Insulet Corp / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Landec Corp / Moderna Inc / Brickell Biotech Inc / Twin Disc Inc / Cardiovascular Systems Inc / AGCO Corp / Addus Homecare Corp / Tesla Inc / Ameresco Inc / Amyris Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / RingCentral Inc / Wix.Com Ltd / Cellectar Biosciences Inc / Citizens Financial Group Inc / Qorvo Inc / ETSY Inc / Solaredge Technologies Inc / Zillow Group Inc / Sunrun Inc / T-Mobile US Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / S&P Global Inc / Trade Desk Inc / Apollo Global Capital Inc / Coupa Software Inc / Westport Fuel Systems Inc / Snap Inc / Okta Inc / Iovance Biotherapeutics Inc / Redfin Corp / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Pieris Pharmaceuticals Inc / One Stop Systems Inc / Focus Financial Partners Inc / Elastic NV / Marker Therapeutics Inc / Clearway Energy Inc / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Vonage Holdings Corp / DraftKings Inc / Avient Corp / Alphatec Holdings Inc / Strathmore Plus Energy Corp / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Philippines / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Unleashing Cellular Myrmidons in Battle Against Cancer; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">ACHL / GILD.O / NOVN.S / BLUE.OQ / 02043Q107 / IOVA.OQ / MRKR.OQ</td><td class="leftalignment">Achilles Therapeutics PLC / Gilead Sciences Inc / Novartis AG / bluebird bio Inc / Alnylam Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Marker Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mark Breidenbach, Ph.D. / Mr. Matthew Biegler</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / FDS / HELE.O / HON / HUM / MCO / MDT / RAD / SYK / UNH / WMT / GILD.O / HCA.N / CYH.N / EW.N / INCY.OQ / BMRN.OQ / ISRG.OQ / VRTX.OQ / CCRN.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / LHCG.O / CME.O / ENSG.OQ / 483548103 / MRNA.O / MD.N / ADUS.O / USPH.N / FIVE.OQ / GOOGL.O / INO.O / EVH.N / TDOC.N / ZBH.N / CFMS.O / 100063846 / SPGI.K / 720795103 / PNTG.OQ / REGW.M3</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Factset Research Systems Inc / Helen of Troy Ltd / Honeywell International Inc / Humana Inc / Moody's Corp / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / CME Group Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Five Below Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / Conformis Inc / Truist Financial Corp / S&P Global Inc / Pieris Pharmaceuticals Inc / Pennant Group Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Large Cap Medical Devices</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAX / BSX / CI / HUM / MDT / SYK / UNH / GILD.O / HCA.N / CYH.N / EW.N / INCY.OQ / BMRN.OQ / ISRG.OQ / VRTX.OQ / BIIB.O / ZBH.N / REGW.M3</td><td class="leftalignment">Baxter International Inc / Boston Scientific Corp / Cigna Corp / Humana Inc / Medtronic PLC / Stryker Corp / UnitedHealth Group Inc / Gilead Sciences Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Zimmer Biomet Holdings Inc / Regency World Consulting Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / India / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steven M. Lichtman / David Kuang</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Large-Cap Biotechnology: Termination of Coverage</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ACRX.OQ / BIIB.OQ / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Biogen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">- Credit Suisse U Eq. Res.</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Gilead Sciences Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Short Term Headwind - The FTC's Flawed Assumptions About Biopharma M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / AMGN=US / BMY=US / GILD=US / AZN=US / GSK=US / JNJ=US / ILMN=US / VRTX=US / SNY=US / ABBV=US</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Illumina Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AN=US / AMGN=US / BMY=US / DIS=US / PG=US / T=US / INCY=US / GILD=US / AMT=US / PEB=US / AKAM=US / CHTR=US / H=US / CONE=US / MTN=US / VZ=US / CCI=US / MGY=US / THC=US / MAR=US / SPOT=US / MRO=US / LEG=US / TNL=US / HLT=US / CMCSA=US / UNH=US / DISH=US / WTFC=US / BMRN=US / CHH=US / DRH=US / EQIX=US / HXL=US / MAN=US / PRGO=US / REGN=US / SBAC=US / VRTX=US / SNV=US / JAZZ=US / NFLX=US / PNFP=US / BIIB=US / TPX=US / EXP=US / SHO=US / DLR=US / PLAY=US / GMS=US / CCOI=US / HST=US / RPRX=US / LLNW=US / PRPL=US / LUMN=US / WH=US / CLNY=US / HGV=US / PCRX=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / TMUS=US / SPNE=US / CABO=US / CRSP=US / PK=US / GDS=US / PLYA=US / SBOW=US / ROKU=US / SWCH=US / BHC=US / ARVN=US / AXNX=US / GMAB=US / 96758W101 / HIMS=US</td><td class="leftalignment">AutoNation Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Charter Communications Inc / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Magnolia Oil & Gas Corp / Tenet Healthcare Corp / Marriott International Inc / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Wintrust Financial Corp / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / Hexcel Corp / ManpowerGroup Inc / Perrigo Company PLC / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Synovus Financial Corp / Jazz Pharmaceuticals PLC / Netflix Inc / Pinnacle Financial Partners Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / GMS Inc / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / DigitalBridge Group Inc / Hilton Grand Vacations Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / T-Mobile US Inc / SeaSpine Holdings Corp / Cable One Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / SilverBow Resources Inc / Roku Inc / Switch Inc / Bausch Health Companies Inc / Arvinas Inc / Axonics Inc / Genmab A/S / WideOpenWest Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAP.N / ALVG.DE / AXAF.PA / FITB.O / FOUG.PA / HEIN.AS / HSX.L / KEY.N / MUVGn.DE / NTRS.O / PNN.L / RIO.L / SCOR.PA / TRV.N / ZURN.S / CMA.N / PG.N / GILD.O / INCY.O / THC.N / DOV.N / CSX.N / MRO.N / SNV.N / HNRGn.DE / IG.MI / NBIX.O / SAM.N / SRG.MI / BLUE.O / WTFC.O / ICPT.O / BIIB.O / DCP.N / ELS.N / ACAD.O / DRX.L / LRE.L / HOG.N / BEZG.L / WRB.N / SMSS.L / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GLPG.O / GBT.OQ / SRENH.S</td><td class="leftalignment">Advance Auto Parts Inc / Allianz SE / AXA SA / Fifth Third Bancorp / Eiffage SA / Heineken NV / Hiscox Ltd / KeyCorp / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Northern Trust Corp / Pennon Group PLC / Rio Tinto PLC / Scor SE / Travelers Companies Inc / Zurich Insurance Group AG / Comerica Inc / Procter & Gamble Co / Gilead Sciences Inc / Incyte Corp / Tenet Healthcare Corp / Dover Corp / CSX Corp / Marathon Oil Corp / Synovus Financial Corp / Hannover Rueck SE / Italgas SpA / Neurocrine Biosciences Inc / Boston Beer Company Inc / Snam SpA / bluebird bio Inc / Wintrust Financial Corp / Intercept Pharmaceuticals Inc / Biogen Inc / DCP Midstream LP / Equity LifeStyle Properties Inc / ACADIA Pharmaceuticals Inc / Drax Group PLC / Lancashire Holdings Ltd / Harley-Davidson Inc / Beazley PLC / W R Berkley Corp / Smart Metering Systems PLC / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Galapagos NV / Global Blood Therapeutics Inc / Swiss Re AG</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Germany / France / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC’s RxChecks: Dovato Gaining Steam, But Biktarvy Holds Strong</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: 2Q21 - Reimbursement Radar</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GLPG.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Galapagos NV / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 1Q21 Biotech Earnings Consensus Cheat Sheet: BIIB</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / BAYGN.DE / ABBV.N</td><td class="leftalignment">Biogen Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Bringing investors back to Biotech -- What's on tap for 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN=US / BIIB=US / INCY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / CRSP=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Upcoming Biopharma Regulatory Events to Watch Given Tougher Environment</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / INCY=US / GILD=US / MOR=DE / AZN=US / GSK=US / ALKS=US / BMRN=US / ICPT=US / VRTX=US / SGEN=US / SAGE=US / PRVB=US / SNY=US / BIIB=US / ACAD=US / ALNY=US / MNKD=US / FOLD=US / IFRX=US / ASND=US / CCXI=US / FGEN=US / ABBV=US / MRTX=US / MGNX=US / ITCI=US / QURE=US / AUPH=US / BPMC=US / AXSM=US / RETA=US / BHVN=US / BBIO=US / MIRM=US / GMAB=US / TVTX=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / MorphoSys AG / AstraZeneca PLC / GlaxoSmithKline PLC / Alkermes Plc / Biomarin Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Provention Bio Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Amicus Therapeutics Inc / InflaRx NV / Ascendis Pharma A/S / ChemoCentryx Inc / FibroGen Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Aurinia Pharmaceuticals Inc / Blueprint Medicines Corp / Axsome Therapeutics Inc / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / BridgeBio Pharma Inc / Mirum Pharmaceuticals Inc / Genmab A/S / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / Denmark / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAP.N / IBE.MC / KBH.N / KO.N / PHM.N / PPG.N / TOL.N / ZION.O / WY.N / CFP.TO / GILD.O / SJRb.TO / RCIb.TO / INCY.O / LEN.N / VLO.N / DHI.N / KMI.N / AZO.N / RRC.N / NBIX.O / MTB.N / GPC.N / DK.N / STL.N / VRTX.O / WBS.N / LTC.N / HOOK.O / ORLY.O / BIIB.O / 02209S103 / CWX.TO / ALNY.O / DRX.L / PRTS.OQ / PBF.N / PCH.O / MPC.N / HFC.N / IFP.TO / PSX.N / RFP.N / TPH.N / TMHC.N / ONB.OQ / ITCI.O / RYAM.N / CRBP.OQ / GLPG.O / TRHC.OQ / PARR.N / OVID.O / IGMS.O / WFG.N</td><td class="leftalignment">Advance Auto Parts Inc / Iberdrola SA / KB Home / Coca-Cola Co / Pultegroup Inc / PPG Industries Inc / Toll Brothers Inc / Zions Bancorporation NA / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Shaw Communications Inc / Rogers Communications Inc / Incyte Corp / Lennar Corp / Valero Energy Corp / D R Horton Inc / Kinder Morgan Inc / Autozone Inc / Range Resources Corp / Neurocrine Biosciences Inc / M&T Bank Corp / Genuine Parts Co / Delek US Holdings Inc / Sterling Bancorp / Vertex Pharmaceuticals Inc / Webster Financial Corp / LTC Properties Inc / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Biogen Inc / Altria Group Inc / Doman Building Materials Group Ltd / Alnylam Pharmaceuticals Inc / Drax Group PLC / Carparts.Com Inc / PBF Energy Inc / Potlatchdeltic Corp / Marathon Petroleum Corp / HollyFrontier Corp / Interfor Corp / Phillips 66 / Resolute Forest Products Inc / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / Old National Bancorp / Intra-Cellular Therapies Inc / Rayonier Advanced Materials Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Tabula Rasa HealthCare Inc / Par Pacific Holdings Inc / Ovid Therapeutics Inc / IGM Biosciences Inc / West Fraser Timber Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Spain / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Patent Patrol – Biotechnology: 1Q21</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / HOOK.O / ITCI.O / CRBP.OQ / GLPG.O / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / HOOKIPA Pharma Inc / Intra-Cellular Therapies Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - JNJ 1Q21 Earnings Readthroughs to our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / AMGN.OQ / GILD.OQ / INCY.OQ / BIIB.OQ / SAGE.OQ</td><td class="leftalignment">Johnson & Johnson / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US3755581036 / US88322Q1085 / CA1380351009 / US88688T1007</td><td class="leftalignment">Gilead Sciences Inc / TG Therapeutics Inc / Canopy Growth Corp / Tilray Brands Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">HR+ breast trial in 2H:  following up from podcast</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LBPS=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / DDDD=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">4D Pharma PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / 4D Pharma PLC / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Staying Positive, HGEN Reports Its Third Good Data Readout This Year</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HGEN.O / US3755581036</td><td class="leftalignment">Humanigen Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">What Could Successful PoC's Mean to RCUS and GILD Stocks?</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GILD.OQ / RCUS.N / GILD=US / RCUS=US</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 Earnings Preview: Hoping Solid Financials Will Spark A Rebound</td><td class="leftalignment">English</td><td class="rightalignment">228</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 1Q21 EPS Preview: Biotech Headwinds Led to Underperformance in Q1, but M&A Could Provide Catalysts to Lift Sentiment</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / LLY.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / EXEL.OQ / SGEN.OQ / VRTX.OQ / GLPG.AS / EPZM.OQ / MRTX.OQ / BPMC.OQ / DCPH.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Exelixis Inc / Seagen Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Epizyme Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Deciphera Pharmaceuticals Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park / Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Paying It Forward With Better HIV Treatments</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">MRK / US3755581036</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: TSHA now pivotal-stage; JNJ C19 safety pause</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US1266501006 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US69366J2006 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / PTC Therapeutics Inc / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">1Q21 Large Cap Preview: We see mostly solid prints across the board in spite of COVID</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0311621009 / US09062X1037 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Amgen Inc / Biogen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.16.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Strong Volume Trends in Q1, but Currency and COVID Therapies Both Major Factors</td><td class="leftalignment">English</td><td class="rightalignment">101</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / GSK=US / REGN=US / VRTX=US / SNY=US / RDUS=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended April 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Elliott Advisors takes stake in GSK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GSK.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 02, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Correction: A Guide to TIGIT Tickers and Trades in 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / GILD=US / CGEN=US / MREO=US / RCUS=US / BGNE=US / ITOS=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Compugen Ltd / Mereo Biopharma Group PLC / Arcus Biosciences Inc / Beigene Ltd / Iteos Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges / Joseph P. Schwartz</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2219224 / 2270726 / 2542049 / 2317087 / 2369174 / 2515030 / 2645409 / 2689560 / 2707677 / 2440637 / 2138158 / 2980906 / 2857817 / B125XQ6 / B3D7K31 / B1HJLW5 / B7TL820 / B7VD3F2 / BJ3V905 / BJ0XLZ3 / BFLR866 / BFZCHN7 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BFNF1D6 / BD9GVY0 / BFMXGR0 / BYXJQG9 / BZ1LFG7 / BK71LY6 / BFFVVC1 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Gilead Sciences Inc / Lithia Motors Inc / NiSource Inc / PG&E Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sempra Energy / Foot Locker Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Emergent BioSolutions Inc / Meta Platforms Inc / Duke Energy Corp / Endo International PLC / Heron Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Amneal Pharmaceuticals Inc / Zai Lab Ltd / Evergy Inc / Spire Inc / Roku Inc / WW International Inc / Bausch Health Companies Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Trodelvy Granted Accelerated Approval in mUC; PT to $79 and Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GILD: Gilead Sciences, Inc - Encouraged by GILD's continued progress in oncology, as Trodelvy granted accelerated approval for mUC; data on bigger opportunity in HR+/HER2- expected later this year</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Adenosine Program Provides I/O Optionality, Rux Life Cycle Still Immediate Value Driver</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">INCY.O / GILD.O</td><td class="leftalignment">Incyte Corp / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: 6-mo MRNA C19 data; DRNA sells ALNY royalties</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ALNY.OQ / MRNA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / CACI=US / AMGN=US / CAG=US / DIS=US / DVN=US / INCY=US / GILD=US / BC=US / CRM=US / IGT=US / BYD=US / SPOT=US / MGM=US / PENN=US / BL=US / COLL=US / EXEL=US / HZO=US / MCRI=US / NTST=US / PII=US / HOOK=US / REGN=US / THO=US / WGO=US / CGEN=US / SGMS=US / MANT=US / CRTO=US / NFLX=US / AUTL=US / BDSI=US / RRR=US / IGMS=US / STRO=US / PRG=US / CZR=US / BAH=US / NSP=US / KBR=US / PGTI=US / ICFI=US / SAIC=US / CWH=US / PSN=US / RCUS=US / TREX=US / OLO=US / FBHS=US / ZNGA=US / MEIP=US / LDOS=US / FATE=US / MBUU=US / COUP=US / BABA=US / HUBS=US / MCFT=US / IRTC=US / CRSP=US / LGF.B=US / ROKU=US / NCNA=US / ALLO=US / TCRR=US / NXTC=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / NCNO=US / BALY=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Amgen Inc / Conagra Brands Inc / Walt Disney Co / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / Brunswick Corp / Salesforce.Com Inc / International Game Technology PLC / Boyd Gaming Corp / Spotify Technology SA / MGM Resorts International / Penn National Gaming Inc / Blackline Inc / Collegium Pharmaceutical Inc / Exelixis Inc / MarineMax Inc / Monarch Casino & Resort Inc / Netstreit Corp / Polaris Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Winnebago Industries Inc / Compugen Ltd / Scientific Games Corp / ManTech International Corp / Criteo SA / Netflix Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Sutro Biopharma Inc / PROG Holdings Inc / Caesars Entertainment Inc / Booz Allen Hamilton Holding Corp / Insperity Inc / KBR Inc / PGT Innovations Inc / ICF International Inc / Science Applications International Corp / Camping World Holdings Inc / Parsons Corp / Arcus Biosciences Inc / Trex Company Inc / Olo Inc / Fortune Brands Home & Security Inc / Zynga Inc / MEI Pharma Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Malibu Boats Inc / Coupa Software Inc / Alibaba Group Holding Ltd / HubSpot Inc / Mastercraft Boat Holdings Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Lions Gate Entertainment Corp / Roku Inc / NuCana PLC / Allogene Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / nCino Inc / Bally's Corp / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">AACR Takeaways - ZNTL In Investor's Focus Among Many Early and Mostly Preclinical Data Presentations Among Our Coverage</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ZNTL.OQ / 5671735 / 0989529 / 2023607 / 2778844 / 2369174 / 2457864 / 2471950 / 4595739 / 7103065 / 2982924 / BCBVTX1 / BFDV8K0 / BBPK0J0 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BKVDFF7 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Genmab A/S / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / Mirati Therapeutics Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Oric Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Mr. Etzer Darout / Mr. Seamus Fernandez / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR tidbits and expectations for 2Q2021 TIGIT data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">RCUS=US / GILD=US</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.9.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Apr 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / ONCT=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / ADCT=US / WMT=US / INCY=US / CMS=US / GILD=US / DGX=US / NVS=US / AZN=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / LH=US / LIFE=US / RKT=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / BIIB=US / ACAD=US / GOOG=US / LHCG=US / CHNG=US / BNGO=US / TPTX=US / EHC=US / ATHX=US / TMDI=US / SWAV=US / ADUS=US / SRNE=US / IRWD=US / SLRX=US / ACHC=US / CCXI=US / TGTX=US / ABBV=US / CTRE=US / OTIC=US / VBLT=US / CLRB=US / WBA=US / SNPHY=US / NVTA=US / EVH=US / GKOS=US / BGNE=US / RETA=US / APVO=US / FLGT=US / IRTC=US / PLXP=US / CYCN=US / TMDX=US / KRTX=US / PNTG=US / NNOX=US / KDNY=US / TVTX=US / EVAX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Oncternal Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / ADC Therapeutics SA / Walmart Inc / Incyte Corp / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / General Electric Co / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Rocket Companies Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Bionano Genomics Inc / Turning Point Therapeutics Inc / Encompass Health Corp / Athersys Inc / Titan Medical Inc / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Ironwood Pharmaceuticals Inc / Salarius Pharmaceuticals Inc / Acadia Healthcare Company Inc / ChemoCentryx Inc / TG Therapeutics Inc / Abbvie Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Invitae Corp / Evolent Health Inc / Glaukos Corp / Beigene Ltd / Reata Pharmaceuticals Inc / Aptevo Therapeutics Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / PLx Pharma Inc / Cyclerion Therapeutics Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Pennant Group Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Travere Therapeutics Inc / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / LLY.N / MRK.N / AZN.L / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / CTLT.N / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Catalent Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">0989529 / 2701271 / 2270726 / 2317087 / 2369174 / 2689560 / 2684703 / 2862532 / 2829601 / B1F76F9 / B121557 / 2857817 / B2R3PV1 / B3D7K31 / 2390817 / 2949758 / B7TL820 / B7VD3F2 / BFLR866 / BFH3N85 / BTN1Y44 / BYNZGK1 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BDFZSP1 / BYQHPK7 / BYWVTY5 / BZ0P3Z5 / BMC5RV6</td><td class="leftalignment">AstraZeneca PLC / Costco Wholesale Corp / Walt Disney Co / Entergy Corp / Gilead Sciences Inc / PG&E Corp / Pfizer Inc / E W Scripps Co / Southern Co / Western Union Co / Mastercard Inc / Netflix Inc / American Water Works Company Inc / Discovery Inc / Gray Television Inc / Nexstar Media Group Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Veeva Systems Inc / Walgreens Boots Alliance Inc / Block Inc / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / Spire Inc / Vistra Corp / ViacomCBS Inc / Okta Inc / Zymeworks Inc / CytomX Therapeutics Inc / Tegna Inc / Adicet Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ANTO.L / BAC.N / BARC.L / BNPP.PA / C.N / CAS.TO / CSGN.S / F.N / GM.N / GPS.N / HSBA.L / JPM.N / RIO.L / RL.N / SGEF.PA / SOGN.PA / SSE.L / WY.N / PXD.N / CFP.TO / GILD.O / LPX.N / TEN.N / INCY.O / UHS.N / AAL.L / SU.TO / GS.N / DBKGn.DE / UNM.N / NKE.N / BOL.ST / VFC.N / TJX.N / ROST.O / NBIX.O / ANF.N / PVH.N / OPTN.O / VRTX.O / CAGR.PA / PRU.N / URBN.O / COP.N / SWN.N / SEM.N / SIGI.O / ICPT.O / BIIB.O / CWX.TO / ACAD.O / WEF.TO / MS.N / ISBC.O / CS.TO / 443628102 / AEO.N / LULU.O / DAN.N / CLW.N / VALE.N / BHPB.L / PCH.O / CFX.TO / MTOR.N / GLEN.L / IFP.TO / ACHC.O / RFP.N / SRPT.O / 505440107 / KPT.TO / ENTA.O / PTCT.O / BURL.N / LB.N / KPTI.O / ITCI.O / RYAM.N / GBT.OQ / UBSG.S / UAA.N / OKTA.OQ / GOOS.TO / ORSTED.CO / EHC.N / NTGY.MC / LUMN.N / WFG.N / WING.N</td><td class="leftalignment">Antofagasta PLC / Bank of America Corp / Barclays PLC / BNP Paribas SA / Citigroup Inc / Cascades Inc / Credit Suisse Group AG / Ford Motor Co / General Motors Co / Gap Inc / HSBC Holdings PLC / JPMorgan Chase & Co / Rio Tinto PLC / Ralph Lauren Corp / Vinci SA / Societe Generale SA / SSE PLC / Weyerhaeuser Co / Pioneer Natural Resources Co / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / Incyte Corp / Universal Health Services Inc / Anglo American PLC / Suncor Energy Inc / Goldman Sachs Group Inc / Deutsche Bank AG / Unum Group / Nike Inc / Boliden AB / VF Corp / TJX Companies Inc / Ross Stores Inc / Neurocrine Biosciences Inc / Abercrombie & Fitch Co / PVH Corp / OptiNose Inc / Vertex Pharmaceuticals Inc / Credit Agricole SA / Prudential Financial Inc / Urban Outfitters Inc / Conocophillips / Southwestern Energy Co / Select Medical Holdings Corp / Selective Insurance Group Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Doman Building Materials Group Ltd / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Morgan Stanley / Investors Bancorp Inc / Capstone Mining Corp / Hudbay Minerals Inc / American Eagle Outfitters Inc / Lululemon Athletica Inc / Dana Inc / Clearwater Paper Corp / Vale SA / BHP Group PLC / Potlatchdeltic Corp / Canfor Pulp Products Inc / Meritor Inc / Glencore PLC / Interfor Corp / Acadia Healthcare Company Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / KP Tissue Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Burlington Stores Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Rayonier Advanced Materials Inc / Global Blood Therapeutics Inc / UBS Group AG / Under Armour Inc / Okta Inc / Canada Goose Holdings Inc / Orsted A/S / Encompass Health Corp / Naturgy Energy Group SA / Lumen Technologies Inc / West Fraser Timber Co Ltd / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: Highlights from Our Breast Cancer KOL Discussion with a Focus on HER2 Low Disease</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2516152 / 2369174 / 2684703 / BFDV8K0 / BMQ5T49 / BYQHPK7 / BYWVTY5 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Gilead Sciences Inc / Pfizer Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Zymeworks Inc / CytomX Therapeutics Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">1Q21 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - Revisiting our Outperform and addressing investor pushbacks</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">AZN.L / 1093.HK / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / FGEN.PS / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / First Gen Corp / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Hong Kong / Philippines / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 mins — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: GILD - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">GILD</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th (Today) — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ONCT=US / TMDI=US / MRK=US / NKE=US / BMY=US / INTC=US / AMD=US / MSFT=US / MDT=US / ADCT=US / INCY=US / GILD=US / NVDA=US / NVS=US / AZN=US / JNJ=US / TTWO=US / ATVI=US / PENN=US / HEAR=US / ISRG=US / GME=US / DKS=US / TH=US / BNGO=US / RSI=US / 700-HK=US / UBI-PAR=US / SRNE=US / SLRX=US / 2454-TW=US / ZNGA=US / EA=US / TGTX=US / ABBV=US / OTIC=US / CLRB=US / BGNE=US / APVO=US / FLGT=US / BILI=US / HUYA=US / ESTC=US / TMDX=US / DKNG=US / CRSR=US / PLTK=US / EVAX=US</td><td class="leftalignment">Oncternal Therapeutics Inc / Titan Medical Inc / Merck & Co Inc / Nike Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / ADC Therapeutics SA / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / Novartis AG / AstraZeneca PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / Penn National Gaming Inc / Turtle Beach Corp / Intuitive Surgical Inc / GameStop Corp / DICK'S Sporting Goods Inc / Target Hospitality Corp / Bionano Genomics Inc / Rush Street Interactive Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Sorrento Therapeutics Inc / Salarius Pharmaceuticals Inc / MediaTek Inc / Zynga Inc / Electronic Arts Inc / TG Therapeutics Inc / Abbvie Inc / Otonomy Inc / Cellectar Biosciences Inc / Beigene Ltd / Aptevo Therapeutics Inc / Fulgent Genetics Inc / Bilibili Inc / HUYA Inc / Elastic NV / Transmedics Group Inc / DraftKings Inc / Corsair Gaming Inc / Playtika Holding Corp / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Info. Tech./Computers / Info. Tech./Software / Retailing / Semiconductors / Services</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / NBIX.O / BLU.N / BIIB.O / ACAD.O / SRPT.O / PTCT.O / KPTI.O / 03835T200 / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / BELLUS Health Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Aptose Biosciences Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Portfolio Manager's Guide to ESG - April 2021</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">A.N / AAP.N / ABT.N / AIG.N / ALB.N / ALK.N / APD.N / BA.N / BAC.N / BAX.N / BBY.N / BDX.N / BMY.N / BSX.N / CAH.N / CCL.N / CE.N / CF.N / CI.N / CL.N / CNC.N / CVS.N / DAL.N / DD.N / DOW.N / ECL.N / EL.N / EMN.N / EOG.N / F.N / FCX.N / FDX.N / FLS.N / FMC.N / GE.N / GM.N / GPS.N / HLT.N / IP.N / IR.N / KMB.N / KO.N / LMT.N / LUV.N / MAS.N / MO.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PPG.N / RHI.N / RL.N / SEE.N / SGEF.PA / SLB.N / SWK.N / TAP.N / TXT.N / WMB.N / WMT.N / PG.N / DGX.N / PXD.N / NUE.N / ROK.N / CPB.N / HAL.N / AAL.L / ADML.L / ETN.N / DHR.N / BWA.N / CMI.N / GD.N / URI.N / DE.N / DOV.N / IEX.N / PH.N / ROP.N / K.N / WAB.N / CAT.N / MGM.N / LEN.N / UNP.N / RCL.N / CLX.N / MCD.N / CAG.N / TSN.N / SYY.N / YUM.N / VLO.N / HD.N / LOW.N / MRO.N / UPS.N / WM.N / KR.N / ITW.N / MMM.N / GIS.N / EMR.N / VMC.N / XOM.N / HSY.N / DVN.N / WHR.N / NKE.N / LIN.N / TGT.N / AVY.N / SHW.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / HCA.N / JCI.N / COO.N / DHI.N / STZ.N / VFC.N / DVA.N / TJX.N / KMI.N / AZO.N / KMX.N / PWR.N / COG.N / EFX.N / EW.N / OKE.N / HWM.N / LEG.N / RSG.N / SNA.N / CHD.N / AME.N / GPC.N / MKC.N / HRL.N / PVH.N / LB.TO / ABC.N / CVX.N / MHK.N / TDY.N / COP.N / HAYS.L / AOS.N / ABMD.OQ / AMGN.OQ / CERN.OQ / CTAS.OQ / EXPD.OQ / FAST.OQ / HOLX.OQ / JBHT.OQ / PCAR.OQ / PNR.N / ROL.N / ROST.OQ / SJM.N / TT.N / SBUX.OQ / ODFL.OQ / ORLY.OQ / GILD.OQ / COST.OQ / TSCO.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / HSIC.OQ / POOL.OQ / TPR.N / AMZN.OQ / CHRW.OQ / EBAY.OQ / EXPE.OQ / GRMN.OQ / ALGN.OQ / WYNN.OQ / MNST.OQ / BIIB.OQ / DPZ.N / MOS.N / LVS.N / NDAQ.OQ / NOV.N / DXCM.OQ / CMG.N / TDG.N / HES.N / HBI.N / ULTA.OQ / NVR.N / BIO.N / VRSK.OQ / GNRC.N / TSLA.OQ / LYB.N / CZR.OQ / NLSN.N / HII.N / HFC.N / BKR.N / FBHS.N / XYL.N / PSX.N / LKQ.OQ / MDLZ.OQ / FANG.OQ / ABBV.N / LDOS.N / MAR.OQ / ALLE.N / NCLH.N / CTLT.N / ANTM.N / WBA.OQ / ETSY.OQ / WRK.N / KHC.OQ / CSX.OQ / FTV.N / LW.N / UAA.N / APTV.N / PEP.OQ / BKNG.OQ / UAL.OQ / NWL.OQ / CTVA.N / LHX.N / J.N / RTX.N / CARR.N / OTIS.N / APA.OQ / HON.OQ / 1U1.DE</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Abbott Laboratories / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Air Products and Chemicals Inc / Boeing Co / Bank of America Corp / Baxter International Inc / Best Buy Co Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Carnival Corp / Celanese Corp / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Flowserve Corp / FMC Corp / General Electric Co / General Motors Co / Gap Inc / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Masco Corp / Altria Group Inc / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PPG Industries Inc / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Vinci SA / Schlumberger NV / Stanley Black & Decker Inc / Molson Coors Beverage Co / Textron Inc / Williams Companies Inc / Walmart Inc / Procter & Gamble Co / Quest Diagnostics Inc / Pioneer Natural Resources Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Halliburton Co / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Borgwarner Inc / Cummins Inc / General Dynamics Corp / United Rentals Inc / Deere & Co / Dover Corp / IDEX Corp / Parker-Hannifin Corp / Roper Technologies Inc / Kellogg Co / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / MGM Resorts International / Lennar Corp / Union Pacific Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Conagra Brands Inc / Tyson Foods Inc / Sysco Corp / Yum! Brands Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / Waste Management Inc / Kroger Co / Illinois Tool Works Inc / 3M Co / General Mills Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / Hershey Co / Devon Energy Corp / Whirlpool Corp / Nike Inc / Linde PLC / Target Corp / Avery Dennison Corp / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / HCA Healthcare Inc / Johnson Controls International PLC / Cooper Companies Inc / D R Horton Inc / Constellation Brands Inc / VF Corp / DaVita Inc / TJX Companies Inc / Kinder Morgan Inc / Autozone Inc / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Edwards Lifesciences Corp / ONEOK Inc / Howmet Aerospace Inc / Leggett & Platt Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / AMETEK Inc / Genuine Parts Co / McCormick & Company Inc / Hormel Foods Corp / PVH Corp / Laurentian Bank of Canada / Amerisourcebergen Corp / Chevron Corp / Mohawk Industries Inc / Teledyne Technologies Inc / Conocophillips / Hays PLC / A O Smith Corp / ABIOMED Inc / Amgen Inc / Cerner Corp / Cintas Corp / Expeditors International of Washington Inc / Fastenal Co / Hologic Inc / J B Hunt Transport Services Inc / Paccar Inc / Pentair PLC / Rollins Inc / Ross Stores Inc / J M Smucker Co / Trane Technologies PLC / Starbucks Corp / Old Dominion Freight Line Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Costco Wholesale Corp / Tractor Supply Co / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / Henry Schein Inc / Pool Corp / Tapestry Inc / Amazon.com Inc / CH Robinson Worldwide Inc / eBay Inc / Expedia Group Inc / Garmin Ltd / Align Technology Inc / Wynn Resorts Ltd / Monster Beverage Corp / Biogen Inc / Domino's Pizza Inc / Mosaic Co / Las Vegas Sands Corp / Nasdaq Inc / Nov Inc / Dexcom Inc / Chipotle Mexican Grill Inc / TransDigm Group Inc / Hess Corp / HanesBrands Inc / Ulta Beauty Inc / NVR Inc / Bio Rad Laboratories Inc / Verisk Analytics Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Caesars Entertainment Inc / Nielsen Holdings PLC / Huntington Ingalls Industries Inc / HollyFrontier Corp / Baker Hughes Co / Fortune Brands Home & Security Inc / Xylem Inc / Phillips 66 / LKQ Corp / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Leidos Holdings Inc / Marriott International Inc / Allegion PLC / Norwegian Cruise Line Holdings Ltd / Catalent Inc / Anthem Inc / Walgreens Boots Alliance Inc / ETSY Inc / Westrock Co / Kraft Heinz Co / CSX Corp / Fortive Corp / Lamb Weston Holdings Inc / Under Armour Inc / Aptiv PLC / PepsiCo Inc / Booking Holdings Inc / United Airlines Holdings Inc / Newell Brands Inc / Corteva Inc / L3harris Technologies Inc / Jacobs Engineering Group Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / APA Corp (US) / Honeywell International Inc / 1&1 AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Gilead Sciences Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Pursuing High Value Targets in Oncology; Initiate at Outperform & $14 PT</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">ONCT=US / MRK=US / BMY=US / ADCT=US / INCY=US / GILD=US / NVS=US / AZN=US / JNJ=US / SRNE=US / SLRX=US / TGTX=US / ABBV=US / OTIC=US / CLRB=US / BGNE=US / APVO=US</td><td class="leftalignment">Oncternal Therapeutics Inc / Merck & Co Inc / Bristol-Myers Squibb Co / ADC Therapeutics SA / Incyte Corp / Gilead Sciences Inc / Novartis AG / AstraZeneca PLC / Johnson & Johnson / Sorrento Therapeutics Inc / Salarius Pharmaceuticals Inc / TG Therapeutics Inc / Abbvie Inc / Otonomy Inc / Cellectar Biosciences Inc / Beigene Ltd / Aptevo Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 Mins: Checkup with FTC Expert – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th (Tomorrow) — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Etzer Darout / Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Checkup with FTC Expert on April 6th (Today) – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: March 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / AAL.L / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Anglo American PLC / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: Precision Medicine Comes to IBD; Initiating with an Outperform Rating and a $30 TP</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">RXDX.OQ / 4502.T / BMY.N / JNJ.N / LLY.N / PFE.N / HUM.N / AZN.L / ROG.S / NOVN.S / UCB.BR / GILD.OQ / ARNA.OQ / GLPG.AS / ABBV.N / MCRB.OQ</td><td class="leftalignment">Prometheus Biosciences Inc / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Humana Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Ucb SA / Gilead Sciences Inc / Arena Pharmaceuticals Inc / Galapagos NV / Abbvie Inc / Seres Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mr. Tiago Fauth / Mark Connolly / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Invite: Checkup with FTC Expert on April 6th (Tomorrow) – New Challenges for Healthcare M&A or More of the Same?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. David M. Westenberg / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IMTX=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Immatics NV / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AFL.N / AIG.N / AMAT.O / AMD.N / CB.N / CCO.TO / CRM.N / EIX.N / F.N / GM.N / INTC.O / LRCX.O / MMC.N / QCOM.O / RYN.N / SO.N / T.N / TRV.N / WY.N / PXD.N / GILD.O / ASML.O / CMCSA.O / AMGN.O / AAPL.O / MET.N / AAL.L / DIS.N / D.N / NVDA.O / DT.N / DISH.O / UNM.N / AMT.N / KGC.N / GIBa.TO / CONE.O / ADI.O / VZ.N / HCA.N / EXEL.O / XEL.N / PACW.O / CINF.O / LNC.N / KMX.N / FISV.O / SNPS.O / ADSK.O / CHTR.O / AWK.N / NBIX.O / NWN.N / TXN.O / AJG.N / REGN.O / VRTX.O / PFG.N / MU.O / PRU.N / NCR.N / NET.N / CNP.N / CPK.N / MKL.N / BRO.N / RLI.N / GPN.N / SIGI.O / CASY.O / ACGL.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / FM.TO / NST.AX / 878742204 / NTR.N / MOS.N / DLR.N / ACAD.O / 416515104 / CDNS.O / SJW.N / FIS.N / 025676206 / CS.TO / 443628102 / AON.N / SLR.AX / WRB.N / 759351604 / CLW.N / VALE.N / FTNT.O / SPB.N / NEE.N / PCH.O / CTT.N / GLEN.L / ACHC.O / SPLK.OQ / WDC.O / PANW.N / QLYS.O / FFHu.TO / 505440107 / TSLA.N / ENTA.O / TMUS.N / VOYA.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / PTC.O / ITCI.O / COUP.N / VRNS.O / CIA.TO / BTG.N / NEP.N / S32.AX / PYPL.OQ / RPD.O / MESO.O / TWLO.N / OR.N / KNSL.OQ / GDS.O / ICHR.O / PBYI.OQ / OKTA.OQ / WPM.N / BHF.O / KL.N / SAIL.N / APTV.N / EHC.N / ZS.OQ / EQH.N / GSHD.O / VNE.N / ESTC.N / CRWD.O / GMAB.O / PING.N / DDOG.O / SBSW.N / IGIC.OQ / FOUR.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / American International Group Inc / Applied Materials Inc / Advanced Micro Devices Inc / Chubb Ltd / Cameco Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Intel Corp / Lam Research Corp / Marsh & McLennan Companies Inc / Qualcomm Inc / Rayonier Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Gilead Sciences Inc / ASML Holding NV / Comcast Corp / Amgen Inc / Apple Inc / MetLife Inc / Anglo American PLC / Walt Disney Co / Dominion Energy Inc / NVIDIA Corp / Dynatrace Inc / DISH Network Corp / Unum Group / American Tower Corp / Kinross Gold Corp / CGI Inc / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Xcel Energy Inc / PacWest Bancorp / Cincinnati Financial Corp / Lincoln National Corp / Carmax Inc / Fiserv Inc / Synopsys Inc / Autodesk Inc / Charter Communications Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Texas Instruments Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / Cloudflare Inc / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Rli Corp / Global Payments Inc / Selective Insurance Group Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Nutrien Ltd / Mosaic Co / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Cadence Design Systems Inc / SJW Group / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Capstone Mining Corp / Hudbay Minerals Inc / Aon PLC / Silver Lake Resources Ltd / W R Berkley Corp / Reinsurance Group of America Inc / Clearwater Paper Corp / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / CatchMark Timber Trust Inc / Glencore PLC / Acadia Healthcare Company Inc / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Labrador Iron Ore Royalty Corp / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / PTC Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Varonis Systems Inc / Champion Iron Ltd / B2Gold Corp / Nextera Energy Partners LP / South32 Ltd / PayPal Holdings Inc / Rapid7 Inc / Mesoblast Ltd / Twilio Inc / Osisko Gold Royalties Ltd / Kinsale Capital Group Inc / GDS Holdings Ltd / Ichor Holdings Ltd / Puma Biotechnology Inc / Okta Inc / Wheaton Precious Metals Corp / Brighthouse Financial Inc / Kirkland Lake Gold Ltd / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Zscaler Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Shift4 Payments Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 1Q 2021 Earnings Preview — Who Will Surprise This Q?</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2369174 / 2455965 / 2623911 / 2730190 / 2931034 / 5531000 / B00FWN1 / B19FQ48 / 2713317 / BCBVTX1 / B8DPDT7 / BZ1LFB2 / B0SDJB4 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / MorphoSys AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Sarepta Therapeutics Inc / Deciphera Pharmaceuticals Inc / Zealand Pharma A/S / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Guggenheim Biot Research / Yige Guo, Ph.D. / Mr. Eddie Hickman, Ph.D. / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Mr. Charles Zhu, Ph.D., III / Aaron Welch, Ph.D. / Paul Jeng, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">AI-Powered ETF Works with IBM Watson to Analyze Market Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / WMT.N / GME.N / GILD.OQ / COST.OQ / MRNA.OQ / AMC.N / TDOC.N</td><td class="leftalignment">Johnson & Johnson / Walmart Inc / GameStop Corp / Gilead Sciences Inc / Costco Wholesale Corp / Moderna Inc / AMC Entertainment Holdings Inc / Teladoc Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) update for QURE in hemB; new tech for DRNA</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">UQ1.F / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Uniqure NV / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 86 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / XPO.N / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / XPO Logistics Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Education / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BATS.L / BB.N / BCE.TO / BMO.TO / BNS.TO / CI.N / CM.TO / CP.TO / DD.N / GE.N / IP.N / KGF.L / NA.TO / NSC.N / PD.TO / RYN.N / STO.AX / T.TO / TD.TO / SSE.L / TRI.N / WY.N / HUM.N / CFP.TO / CNQ.TO / GILD.O / LPX.N / SJRb.TO / TA.TO / RCIb.TO / CLS.N / CNR.TO / QBRb.TO / CCA.TO / ENB.TO / TRP.TO / CSX.N / SU.TO / BTE.TO / UNP.N / HD.N / WM.N / BBVA.MC / NKE.N / GIBa.TO / DSGX.O / EQT.N / V.N / EPD.N / DLTR.O / RSG.N / OTEX.O / POU.TO / SWIR.O / JHX.AX / AIF.TO / SM.N / COP.N / ASC.L / CNP.N / WCN.N / DOL.TO / LNG.A / ONC.TO / EFX.TO / ACGL.O / TCLa.TO / ATDb.TO / MRE.TO / RUS.TO / SAP.TO / MDI.TO / TFC.N / HCG.TO / CWX.TO / CMG.TO / MOS.N / SCL.TO / WEF.TO / RDSb.L / BAM.N / CTCa.TO / CSU.TO / CPX.TO / ET.TO / 443628102 / MERC.O / BIR.TO / AX_u.TO / PPL.TO / ARX.TO / CLW.N / CPG.TO / AAV.TO / ADN.TO / ACQ.TO / ATH.TO / VET.TO / WCP.TO / TOU.TO / PCH.O / ERF.TO / CJT.TO / CFX.TO / FRU.TO / PEY.TO / NPI.TO / CTT.N / DR.TO / IFP.TO / PXT.TO / WTE.TO / EFN.TO / OPS.TO / RFP.N / ABBV.N / KPT.TO / ISV.TO / CFF.TO / CJ.TO / PLC.TO / PSK.TO / RYAM.N / KXS.TO / GUD.TO / AUPH.O / EVA.N / SHOP.N / TDOC.N / WRK.N / TWM.TO / TWLO.N / ATZ.TO / ECN.TO / AKERBP.OL / ENGH.TO / ONEX.TO / GDS.O / AQN.N / JWEL.TO / MAXR.N / COLD.N / MI_U.TO / BHC.N / HOMU.TO / PIPE.V / LSPD.TO / CRWD.O / GMAB.O / GFL.N / AKES.OL / ERE_u.TO / TPZ.TO / WFG.N / DHT_u.TO</td><td class="leftalignment">British American Tobacco PLC / BlackBerry Ltd / BCE Inc / Bank of Montreal / Bank of Nova Scotia / Cigna Corp / Canadian Imperial Bank of Commerce / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / International Paper Co / Kingfisher PLC / National Bank of Canada / Norfolk Southern Corp / Precision Drilling Corp / Rayonier Inc / Santos Ltd / Telus Corp / Toronto-Dominion Bank / SSE PLC / Thomson Reuters Corp / Weyerhaeuser Co / Humana Inc / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Celestica Inc / Canadian National Railway Co / Quebecor Inc / Cogeco Communications Inc / Enbridge Inc / TC Energy Corp / CSX Corp / Suncor Energy Inc / Baytex Energy Corp / Union Pacific Corp / Home Depot Inc / Waste Management Inc / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / CGI Inc / Descartes Systems Group Inc / EQT Corp / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / Republic Services Inc / Open Text Corp / Paramount Resources Ltd / Sierra Wireless Inc / James Hardie Industries PLC / Altus Group Ltd / SM Energy Co / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Waste Connections Inc / Dollarama Inc / Cheniere Energy Inc / Oncolytics Biotech Inc / Enerflex Ltd / Arch Capital Group Ltd / Transcontinental Inc / Alimentation Couche-Tard Inc / Martinrea International Inc / Russel Metals Inc / Saputo Inc / Major Drilling Group International Inc / Truist Financial Corp / Home Capital Group Inc / Doman Building Materials Group Ltd / Computer Modelling Group Ltd / Mosaic Co / Shawcor Ltd / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Canadian Tire Corporation Ltd / Constellation Software Inc / Capital Power Corp / Evertz Technologies Ltd / Hudbay Minerals Inc / Mercer International Inc / Birchcliff Energy Ltd / Artis Real Estate Investment Trust / Pembina Pipeline Corp / ARC Resources Ltd / Clearwater Paper Corp / Crescent Point Energy Corp / Advantage Energy Ltd / Acadian Timber Corp / AutoCanada Inc / Athabasca Oil Corp / Vermilion Energy Inc / Whitecap Resources Inc / Tourmaline Oil Corp / Potlatchdeltic Corp / Enerplus Corp / Cargojet Inc / Canfor Pulp Products Inc / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Northland Power Inc / CatchMark Timber Trust Inc / Medical Facilities Corp / Interfor Corp / Parex Resources Inc / Westshore Terminals Investment Corp / Element Fleet Management Corp / Opsens Inc / Resolute Forest Products Inc / Abbvie Inc / KP Tissue Inc / Information Services Corp / Conifex Timber Inc / Cardinal Energy Ltd (Alberta) / Park Lawn Corp / Prairiesky Royalty Ltd / Rayonier Advanced Materials Inc / Kinaxis Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Enviva Inc / Shopify Inc / Teladoc Health Inc / Westrock Co / Tidewater Midstream and Infrastructure Ltd / Twilio Inc / Aritzia Inc / ECN Capital Corp / Aker BP ASA / Enghouse Systems Ltd / Onex Corp / GDS Holdings Ltd / Algonquin Power & Utilities Corp / Jamieson Wellness Inc / Maxar Technologies Inc / Americold Realty Trust / Minto Apartment Real Estate Investment Trust / Bausch Health Companies Inc / BSR Real Estate Investment Trust / Pipestone Energy Corp / Lightspeed Commerce Inc / CrowdStrike Holdings Inc / Genmab A/S / GFL Environmental Inc / Aker Solutions ASA / European Residential REIT / Topaz Energy Corp / West Fraser Timber Co Ltd / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Ireland / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Research Digest / Equity</td><td class="leftalignment">Cindy Graham</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Gilead Expands Collaboration in Multi-Target Deal</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.OQ / CA00288U1066 / US3755581036 / ABCL.OQ</td><td class="leftalignment">Gilead Sciences Inc / Abcellera Biologics Inc / Gilead Sciences Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Jameson Kao / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Expanded Collaboration with GILD Highlights Value of the Technology Stack</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ / ABCL=US / GILD=US / ABCL.OQ</td><td class="leftalignment">Gilead Sciences Inc / Abcellera Biologics Inc / Gilead Sciences Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Puneet Souda</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AIG.N / ALV.N / AXP.N / BAC.N / BATS.L / BK.N / C.N / CI.N / CL.N / COF.N / CP.TO / CWK.L / DANO.PA / DD.N / DGE.L / EL.N / F.N / FITB.O / GE.N / GM.N / IP.N / JPM.N / KEY.N / KGF.L / KMB.N / KO.N / L.TO / NTRS.O / OREP.PA / PB.N / PNC.N / RYN.N / SGEF.PA / STO.AX / TRV.N / ULVR.L / USB.N / VC.N / WFC.N / ZION.O / SSE.L / PEP.N / CMA.N / TRI.N / BFb.N / PG.N / WY.N / HUM.N / CFP.TO / CNQ.TO / GILD.O / LPX.N / TEN.N / MET.N / HBAN.O / BWA.N / LEA.N / K.N / ADBE.O / SU.TO / GS.N / CLX.N / CAG.N / HD.N / GIS.N / EPC.N / BBVA.MC / NKE.N / MRU.TO / NG.L / VLY.N / STT.N / HCA.N / SNV.N / PACW.O / STZ.N / APH.N / EQT.N / V.N / EPD.N / AXL.N / DLTR.O / NBIX.O / MTB.N / GIL.N / PVH.N / STL.N / VRTX.O / JHX.AX / MU.O / SM.N / TEL.N / VRNT.O / RF.N / COP.N / ASC.L / CNP.N / CFR.N / FRC.N / ST.N / WBS.N / FCF.N / DFS.N / LNG.A / PFS.N / EFX.TO / FFBC.O / PBCT.O / SIVB.O / WSBC.O / BPOP.O / CASY.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / TCBI.O / ATDb.TO / EMPA.TO / BIIB.O / MFI.TO / TFC.N / FHN.N / NESN.S / CWX.TO / MOS.N / SCL.TO / 427866108 / WEF.TO / WAL.N / RDSb.L / BAM.N / BVIC.L / MS.N / ISBC.O / CTCa.TO / MERC.O / PPL.TO / CPRI.MI / DAN.N / CLW.N / HOMB.O / AAV.TO / ADN.TO / TOU.TO / PCH.O / CFX.TO / FRU.TO / BKU.N / CTT.N / MTOR.N / IFP.TO / PXT.TO / SMSS.L / SLM.OQ / EFN.TO / SPLK.OQ / RFP.N / WDC.O / SRPT.O / MDLZ.OQ / ALLY.N / NYCB.N / ABBV.N / KPT.TO / COTY.N / PTCT.O / ONB.OQ / CFF.TO / KPTI.O / COUP.N / RYAM.N / SYF.N / CFG.N / GWB.N / FEVR.L / ASB.N / WBA.N / 78667J108 / EVA.N / TDOC.N / WRK.N / RPD.O / TWLO.N / AKERBP.OL / ADNT.N / GDS.O / OKTA.OQ / CADE.N / GRPG.I / ROOT.TO / APTV.N / 05971J102 / COLD.N / SMAR.N / VNE.N / NTGY.MC / ZM.O / KRTX.OQ / CRWD.O / GMAB.O / CRNC.OQ / ETNB.O / REYN.O / NKLA.OQ / AKES.OL / ASAN.N / SUMO.O / MCFE.OQ / WFG.N</td><td class="leftalignment">American International Group Inc / Autoliv Inc / American Express Co / Bank of America Corp / British American Tobacco PLC / Bank of New York Mellon Corp / Citigroup Inc / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Canadian Pacific Railway Ltd / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / General Electric Co / General Motors Co / International Paper Co / JPMorgan Chase & Co / KeyCorp / Kingfisher PLC / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Northern Trust Corp / L'Oreal SA / Prosperity Bancshares Inc / PNC Financial Services Group Inc / Rayonier Inc / Vinci SA / Santos Ltd / Travelers Companies Inc / Unilever PLC / US Bancorp / Visteon Corp / Wells Fargo & Co / Zions Bancorporation NA / SSE PLC / PepsiCo Inc / Comerica Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Humana Inc / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / MetLife Inc / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / Kellogg Co / Adobe Inc / Suncor Energy Inc / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / Home Depot Inc / General Mills Inc / Edgewell Personal Care Co / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Metro Inc / National Grid PLC / Valley National Bancorp / State Street Corp / HCA Healthcare Inc / Synovus Financial Corp / PacWest Bancorp / Constellation Brands Inc / Amphenol Corp / EQT Corp / Visa Inc / Enterprise Products Partners LP / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Neurocrine Biosciences Inc / M&T Bank Corp / Gildan Activewear Inc / PVH Corp / Sterling Bancorp / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Micron Technology Inc / SM Energy Co / TE Connectivity Ltd / Verint Systems Inc / Regions Financial Corp / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Cullen/Frost Bankers Inc / First Republic Bank / Sensata Technologies Holding PLC / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Cheniere Energy Inc / Provident Financial Services Inc / Enerflex Ltd / First Financial Bancorp / People's United Financial Inc / SVB Financial Group / WesBanco Inc / Popular Inc / Caseys General Stores Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / Biogen Inc / Maple Leaf Foods Inc / Truist Financial Corp / First Horizon Corp / Nestle SA / Doman Building Materials Group Ltd / Mosaic Co / Shawcor Ltd / Hershey Co / Western Forest Products Inc / Western Alliance Bancorp / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Britvic PLC / Morgan Stanley / Investors Bancorp Inc / Canadian Tire Corporation Ltd / Mercer International Inc / Pembina Pipeline Corp / Davide Campari Milano NV / Dana Inc / Clearwater Paper Corp / Home BancShares Inc / Advantage Energy Ltd / Acadian Timber Corp / Tourmaline Oil Corp / Potlatchdeltic Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / BankUnited Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Parex Resources Inc / Smart Metering Systems PLC / SLM Corp / Element Fleet Management Corp / Splunk Inc / Resolute Forest Products Inc / Western Digital Corp / Sarepta Therapeutics Inc / Mondelez International Inc / Ally Financial Inc / New York Community Bancorp Inc / Abbvie Inc / KP Tissue Inc / Coty Inc / PTC Therapeutics Inc / Old National Bancorp / Conifex Timber Inc / Karyopharm Therapeutics Inc / Coupa Software Inc / Rayonier Advanced Materials Inc / Synchrony Financial / Citizens Financial Group Inc / Great Western Bancorp Inc / Fevertree Drinks PLC / Associated Banc-Corp / Walgreens Boots Alliance Inc / SAGE Therapeutics Inc / Enviva Inc / Teladoc Health Inc / Westrock Co / Rapid7 Inc / Twilio Inc / Aker BP ASA / Adient PLC / GDS Holdings Ltd / Okta Inc / Cadence Bank / Greencoat Renewables PLC / Roots Corp / Aptiv PLC / Cadence Bank / Americold Realty Trust / Smartsheet Inc / Veoneer Inc / Naturgy Energy Group SA / Zoom Video Communications Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / 89Bio Inc / Reynolds Consumer Products Inc / Nikola Corp / Aker Solutions ASA / Asana Inc / Sumo Logic Inc / Mcafee Corp / West Fraser Timber Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / France / United Kingdom / Ireland / Netherlands / Norway / Puerto Rico / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - April 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CNR.TO / BATS.L / BB.N / BCE.TO / BMO.TO / BNS.TO / CI.N / CL.N / CM.TO / CP.TO / CWK.L / DANO.PA / DD.N / DGE.L / EL.N / GE.N / IP.N / KGF.L / KMB.N / KO.N / L.TO / NA.TO / NSC.N / OREP.PA / RYN.N / STO.AX / T.TO / TD.TO / ULVR.L / SSE.L / PEP.N / TRI.N / BFb.N / PG.N / WY.N / HUM.N / CFP.TO / CNQ.TO / GILD.O / LPX.N / SJRb.TO / TA.TO / RCIb.TO / CLS.N / QBRb.TO / CCA.TO / ENB.TO / TRP.TO / K.N / CSX.N / SU.TO / BTE.TO / UNP.N / CLX.N / CAG.N / HD.N / WM.N / GIS.N / EPC.N / BBVA.MC / NKE.N / GIBa.TO / MRU.TO / STZ.N / DSGX.O / EQT.N / V.N / EPD.N / DLTR.O / RSG.N / OTEX.O / GIL.N / POU.TO / AGFb.TO / SWIR.O / JHX.AX / AIF.TO / SM.N / COP.N / ASC.L / CNP.N / WCN.N / DOL.TO / LNG.A / ONC.TO / EFX.TO / CASY.O / ACGL.O / ATDb.TO / EMPA.TO / RUS.TO / SAP.TO / MFI.TO / TFC.N / NESN.S / CWX.TO / CMG.TO / MOS.N / SCL.TO / 427866108 / WEF.TO / RDSb.L / BAM.N / BVIC.L / SES.TO / CTCa.TO / CSU.TO / CPX.TO / ET.TO / MERC.O / BIR.TO / PPL.TO / CPRI.MI / ARX.TO / CLW.N / CPG.TO / AAV.TO / ADN.TO / ATH.TO / VET.TO / WCP.TO / TOU.TO / PCH.O / ERF.TO / CFX.TO / FRU.TO / PEY.TO / NPI.TO / CTT.N / DR.TO / IFP.TO / PXT.TO / EFN.TO / OPS.TO / RFP.N / MDLZ.OQ / ABBV.N / KPT.TO / COTY.N / ISV.TO / CFF.TO / CJ.TO / PLC.TO / PSK.TO / RYAM.N / KXS.TO / GUD.TO / FEVR.L / AUPH.O / EVA.N / SHOP.N / TDOC.N / WRK.N / TWLO.N / ATZ.TO / AKERBP.OL / ENGH.TO / ONEX.TO / GDS.O / AQN.N / KL.N / ROOT.TO / COLD.N / MAV.TO / BHC.N / HOMU.TO / PIPE.V / LSPD.TO / CRWD.O / GMAB.O / REYN.O / GFL.N / AKES.OL / TPZ.TO / WFG.N / DHT_u.TO</td><td class="leftalignment">Canadian National Railway Co / British American Tobacco PLC / BlackBerry Ltd / BCE Inc / Bank of Montreal / Bank of Nova Scotia / Cigna Corp / Colgate-Palmolive Co / Canadian Imperial Bank of Commerce / Canadian Pacific Railway Ltd / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / Estee Lauder Companies Inc / General Electric Co / International Paper Co / Kingfisher PLC / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / National Bank of Canada / Norfolk Southern Corp / L'Oreal SA / Rayonier Inc / Santos Ltd / Telus Corp / Toronto-Dominion Bank / Unilever PLC / SSE PLC / PepsiCo Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Humana Inc / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Celestica Inc / Quebecor Inc / Cogeco Communications Inc / Enbridge Inc / TC Energy Corp / Kellogg Co / CSX Corp / Suncor Energy Inc / Baytex Energy Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Home Depot Inc / Waste Management Inc / General Mills Inc / Edgewell Personal Care Co / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / CGI Inc / Metro Inc / Constellation Brands Inc / Descartes Systems Group Inc / EQT Corp / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / Republic Services Inc / Open Text Corp / Gildan Activewear Inc / Paramount Resources Ltd / AGF Management Ltd / Sierra Wireless Inc / James Hardie Industries PLC / Altus Group Ltd / SM Energy Co / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Waste Connections Inc / Dollarama Inc / Cheniere Energy Inc / Oncolytics Biotech Inc / Enerflex Ltd / Caseys General Stores Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Empire Company Ltd / Russel Metals Inc / Saputo Inc / Maple Leaf Foods Inc / Truist Financial Corp / Nestle SA / Doman Building Materials Group Ltd / Computer Modelling Group Ltd / Mosaic Co / Shawcor Ltd / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Britvic PLC / Secure Energy Services Inc / Canadian Tire Corporation Ltd / Constellation Software Inc / Capital Power Corp / Evertz Technologies Ltd / Mercer International Inc / Birchcliff Energy Ltd / Pembina Pipeline Corp / Davide Campari Milano NV / ARC Resources Ltd / Clearwater Paper Corp / Crescent Point Energy Corp / Advantage Energy Ltd / Acadian Timber Corp / Athabasca Oil Corp / Vermilion Energy Inc / Whitecap Resources Inc / Tourmaline Oil Corp / Potlatchdeltic Corp / Enerplus Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Northland Power Inc / CatchMark Timber Trust Inc / Medical Facilities Corp / Interfor Corp / Parex Resources Inc / Element Fleet Management Corp / Opsens Inc / Resolute Forest Products Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Coty Inc / Information Services Corp / Conifex Timber Inc / Cardinal Energy Ltd (Alberta) / Park Lawn Corp / Prairiesky Royalty Ltd / Rayonier Advanced Materials Inc / Kinaxis Inc / Knight Therapeutics Inc / Fevertree Drinks PLC / Aurinia Pharmaceuticals Inc / Enviva Inc / Shopify Inc / Teladoc Health Inc / Westrock Co / Twilio Inc / Aritzia Inc / Aker BP ASA / Enghouse Systems Ltd / Onex Corp / GDS Holdings Ltd / Algonquin Power & Utilities Corp / Kirkland Lake Gold Ltd / Roots Corp / Americold Realty Trust / Mav Beauty Brands Inc / Bausch Health Companies Inc / BSR Real Estate Investment Trust / Pipestone Energy Corp / Lightspeed Commerce Inc / CrowdStrike Holdings Inc / Genmab A/S / Reynolds Consumer Products Inc / GFL Environmental Inc / Aker Solutions ASA / Topaz Energy Corp / West Fraser Timber Co Ltd / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / France / United Kingdom / Ireland / Netherlands / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: Macro March Edition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / NBIX.O / VRTX.O / BIIB.O / SRPT.O / PTCT.O / KPTI.O / 78667J108 / KRTX.OQ / ETNB.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / SAGE Therapeutics Inc / Karuna Therapeutics Inc / 89Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">2Q21 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">375558103 / 031162100 / 09062X103 / 92532F100 / 45337C102 / 695127100 / 803607100 / 023111206 / 868459108 / 60468T105 / 01345P106 / G11196105 / 07725L102 / 81750R102 / 462260100 / 558868105 / 67022C106 / 039697107 / H17182108 / 67576A100 / 14147L108 / 01626L105</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Incyte Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Amarin Corporation PLC / Supernus Pharmaceuticals Inc / Mirati Therapeutics Inc / Albireo Pharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Beigene Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / NuCana PLC / Ardelyx Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Cardiff Oncology Inc / Aligos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Eleanor Maughan, Ph.D. / David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Tyler M. Van Buren, M.SC</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - April 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BATS.L / CI.N / CL.N / CP.TO / CWK.L / DANO.PA / DD.N / DGE.L / EL.N / GE.N / HMb.ST / KGF.L / KMB.N / KO.N / L.TO / OREP.PA / STO.AX / ULVR.L / SSE.L / PEP.N / TRI.N / BFb.N / PG.N / HUM.N / CNQ.TO / GILD.O / K.N / SU.TO / CLX.N / CAG.N / HD.N / GIS.N / EPC.N / BBVA.MC / NKE.N / MRU.TO / STZ.N / EQT.N / V.N / EPD.N / DLTR.O / GIL.N / SM.N / COP.N / ASC.L / CNP.N / LNG.A / EFX.TO / CASY.O / ACGL.O / ATDb.TO / EMPA.TO / MFI.TO / TFC.N / NESN.S / MOS.N / SCL.TO / 427866108 / RDSb.L / BAM.N / BVIC.L / CTCa.TO / PPL.TO / CPRI.MI / TOU.TO / FRU.TO / PXT.TO / EFN.TO / MDLZ.OQ / ABBV.N / COTY.N / FEVR.L / EVA.N / TDOC.N / TWLO.N / AKERBP.OL / GDS.O / ROOT.TO / COLD.N / CRWD.O / GMAB.O / REYN.O / AKES.OL</td><td class="leftalignment">British American Tobacco PLC / Cigna Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / Estee Lauder Companies Inc / General Electric Co / H & M Hennes & Mauritz AB / Kingfisher PLC / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / L'Oreal SA / Santos Ltd / Unilever PLC / SSE PLC / PepsiCo Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Kellogg Co / Suncor Energy Inc / Clorox Co / Conagra Brands Inc / Home Depot Inc / General Mills Inc / Edgewell Personal Care Co / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Metro Inc / Constellation Brands Inc / EQT Corp / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / Gildan Activewear Inc / SM Energy Co / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Cheniere Energy Inc / Enerflex Ltd / Caseys General Stores Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Empire Company Ltd / Maple Leaf Foods Inc / Truist Financial Corp / Nestle SA / Mosaic Co / Shawcor Ltd / Hershey Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Britvic PLC / Canadian Tire Corporation Ltd / Pembina Pipeline Corp / Davide Campari Milano NV / Tourmaline Oil Corp / Freehold Royalties Ltd / Parex Resources Inc / Element Fleet Management Corp / Mondelez International Inc / Abbvie Inc / Coty Inc / Fevertree Drinks PLC / Enviva Inc / Teladoc Health Inc / Twilio Inc / Aker BP ASA / GDS Holdings Ltd / Roots Corp / Americold Realty Trust / CrowdStrike Holdings Inc / Genmab A/S / Reynolds Consumer Products Inc / Aker Solutions ASA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / France / United Kingdom / Netherlands / Norway / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Top 30 Global Ideas for 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">BATS.L / CI.N / CP.TO / DD.N / GE.N / KGF.L / SSE.L / TRI.N / HUM.N / CNQ.TO / GILD.O / HD.N / BBVA.MC / NKE.N / V.N / EPD.N / DLTR.O / ASC.L / CNP.N / ACGL.O / ATDb.TO / TFC.N / MOS.N / RDSb.L / BAM.N / EFN.TO / ABBV.N / TDOC.N / TWLO.N / GDS.O / COLD.N / CRWD.O / GMAB.O</td><td class="leftalignment">British American Tobacco PLC / Cigna Corp / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / Kingfisher PLC / SSE PLC / Thomson Reuters Corp / Humana Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Home Depot Inc / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Visa Inc / Enterprise Products Partners LP / Dollar Tree Inc / ASOS PLC / CenterPoint Energy Inc / Arch Capital Group Ltd / Alimentation Couche-Tard Inc / Truist Financial Corp / Mosaic Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Element Fleet Management Corp / Abbvie Inc / Teladoc Health Inc / Twilio Inc / GDS Holdings Ltd / Americold Realty Trust / CrowdStrike Holdings Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / Spain / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Mr. Deane Dray, CFA / Mark A. Dwelle, CFA / Mr. James Edwardes Jones / Kate Fitzsimons / Mr. Matthew G. Hedberg / Geoffrey Kwan, CFA / Kennen MacKay, PHD / Sherri Malek / Drew McReynolds, CFA / Frank G. Morgan / Brian Abrahams, MD / Mr. John B. Musk / Mme. Irene O. Nattel / Greg M. Pardy, CFA / Daniel R. R. Perlin, CFA / Mr. TJ J. Schultz / Walter N. Spracklin, CFA / Randall S. Stanicky, CFA / Mr. Benjamin Toms / Mr. Shelby Tucker, CFA / Mr. Arun S. Viswanathan / Jonathan Atkin / Andrew D. Wong / Mr. Biraj Borkhataria / Michael W. Carroll, CFA / Gerard S. Cassidy / Mr. Richard B. Chamberlain / Scot Ciccarelli, CFA / Mr. Sean W. Dodge, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CBPO-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BAX / GILD.O / GSK / NVAX.O / CPHI.K / SVA.O</td><td class="leftalignment">Baxter International Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Novavax Inc / China Pharma Holdings Inc / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead adds 12% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / PTCT.O / GLPG.O / PRVB.O / GMDA.OQ / APRE.OQ / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / PTC Therapeutics Inc / Galapagos NV / Provention Bio Inc / Gamida Cell Ltd / Aprea Therapeutics Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / China / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Gilead Sciences, Inc. MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on April 7th — The Emerging Breast Cancer Landscape — Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EPZM: Margin of Safety (for Drug and Stock); Initiate with an Outperform Rating, $13 TP</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">EPZM.OQ / BMY.N / ROG.S / NOVN.S / REGN.OQ / GILD.OQ / INCY.OQ / EXEL.OQ / SGEN.OQ / BAYGN.DE / ABBV.N / TGTX.OQ / MGNX.OQ / BPMC.OQ / PBYI.OQ / ZLAB.OQ / DCPH.OQ / GMAB.CO</td><td class="leftalignment">Epizyme Inc / Bristol-Myers Squibb Co / Roche Holding AG / Novartis AG / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Exelixis Inc / Seagen Inc / Bayer AG / Abbvie Inc / TG Therapeutics Inc / MacroGenics Inc / Blueprint Medicines Corp / Puma Biotechnology Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: What's an Oncology Drug Worth? Data from a Decade of Oncology M&A</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">4502.T / 4503.T / BMY.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVN.S / MRCG.DE / 4768.T / GSK.L / AMGN.OQ / GILD.OQ / SGEN.OQ / 4568.T / JAZZ.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Jazz Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNS.OQ / US3755581036 / US56854Q2003</td><td class="leftalignment">Marinus Pharmaceuticals Inc / Gilead Sciences Inc / Marinus Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">BLUE Blood, Ide-Cel Approval Is Positive For Heme Malignancy Drug Development</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HGEN.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / US3755581036</td><td class="leftalignment">Humanigen Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) results from PRQR & KRYS; ide-cel approved</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/27/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Gilead Sciences, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.26.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAER.S / BARC.L / BB.N / BNPP.PA / CBKG.DE / CSGN.S / HSBA.L / JNJ.N / LLOY.L / MRK.N / PFE.N / SAN.MC / SOGN.PA / GILD.O / TA.TO / AMGN.O / DBKGn.DE / BBVA.MC / 0989529 / CVX.N / CAGR.PA / NWG.L / INGA.AS / TEVA.N / CS.TO / 443628102 / CBRO.L / GTE.TO / PXT.TO / ABBV.N / PRGO.N / GUD.TO / ABNd.AS / UBSG.S / MTRO.L / APR_U.TO / VMUK.L / PAGPA.L</td><td class="leftalignment">Julius Baer Gruppe AG / Barclays PLC / BlackBerry Ltd / BNP Paribas SA / Commerzbank AG / Credit Suisse Group AG / HSBC Holdings PLC / Johnson & Johnson / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Banco Santander SA / Societe Generale SA / Gilead Sciences Inc / TransAlta Corp / Amgen Inc / Deutsche Bank AG / Banco Bilbao Vizcaya Argentaria SA / AstraZeneca PLC / Chevron Corp / Credit Agricole SA / Natwest Group PLC / ING Groep NV / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Hudbay Minerals Inc / Close Brothers Group PLC / Gran Tierra Energy Inc / Parex Resources Inc / Abbvie Inc / Perrigo Company PLC / Knight Therapeutics Inc / ABN Amro Bank NV / UBS Group AG / Metro Bank PLC / Automotive Properties Real Estate Investment Trust / Virgin Money UK PLC / Paragon Banking Group PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / BMY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">AACR Annual Meeting 2021 Congress Planner</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">375558103 / 031162100 / 75886F107 / 45337C102 / 45253H101 / 29667D104 / 00287Y109 / 189464100 / 31189P102 / 60468T105 / 09627Y109 / 52187K101 / 07725L102 / 462260100 / 67022C106 / 98401F105 / 23284F105 / 019770106 / H17182108 / 41358P106 / 87808K106 / 481116101 / 44975P103 / 02083G100 / 24344T101 / 04335A105 / 46565G104 / 14147L108 / 81181C104 / 03835L108 / 38406L103</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / ImmunoGen Inc / ESSA Bancorp Inc / Abbvie Inc / Clovis Oncology Inc / Fate Therapeutics Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Beigene Ltd / Iovance Biotherapeutics Inc / NuCana PLC / Xencor Inc / CytomX Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Jounce Therapeutics Inc / I-Mab / Alpine Immune Sciences Inc / Deciphera Pharmaceuticals Inc / Arvinas Inc / Iteos Therapeutics Inc / Cardiff Oncology Inc / Seagen Inc / Aptevo Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Eleanor Maughan, Ph.D. / Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Tyler M. Van Buren, M.SC</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABF.L / AEGN.AS / AHT.L / ALVG.DE / AXAF.PA / BAER.S / BARC.L / BNPP.PA / BNZL.L / BOY.L / BRW.L / CBKG.DE / CNA.L / CNE.L / CPI.L / CSGN.S / CWK.L / DANO.PA / DCC.L / DFDS.CO / DPLM.L / ECM.L / FGP.L / FOUG.PA / GOG.L / HMSO.L / HSBA.L / HSX.L / HTG.L / IMI.L / JD.L / JNJ.N / JSG.L / LAND.L / LLOY.L / MKS.L / MRK.N / MUVGn.DE / NA / NEX.L / NXT.L / OREP.PA / OXB.L / PFE.N / PFG.L / PNN.L / PRU.L / ROR.L / RPS.L / RTO.L / SAN.MC / SGC.L / SGEF.PA / SLA.L / SMWH.L / SOGN.PA / SRP.L / TLW.L / TPK.L / TTG.L / ULVR.L / VIEV.VI / WKP.L / ZURN.S / RAT.L / GILD.O / AMGN.O / DBKGn.DE / ESP.L / BBVA.MC / ENT.L / JTC.L / BYG.L / MORG.DE / DPH.L / IG.MI / 0989529 / IGG.L / FRAG.DE / CVX.N / CAGR.PA / CEY.L / ENAG.MC / AV.L / WG.L / FLS.CO / ASC.L / HAYS.L / APF.L / COA.L / NWG.L / SGSN.S / RTN.L / INGA.AS / HSV.L / NESN.S / SPI.L / BRK.L / NESTE.HE / BUCN.S / KOS.N / PFC.L / BVIC.L / DUFN.S / LRE.L / HICL.L / TEVA.N / DNLM.L / OERL.S / MARS.L / DLN.L / DWNG.DE / 3IN.L / ATL.MI / HFG.L / MONY.L / RENE.LS / CBRO.L / SLRS.MC / HOCM.L / XPS.L / BEZG.L / ABCA.L / CVSG.L / VGP1.BR / GTE.TO / INPP.L / FHZN.S / PHNX.L / SUBC.OL / CAML.L / PXT.TO / SMSS.L / BOSSn.DE / CLINC.L / DLGD.L / ABBV.N / LMPL.L / PRGO.N / MGAMM.L / UKWG.L / BOOH.L / BBOXT.L / NN.AS / DC.L / MOLN.S / FEVR.L / SNNS.L / G24N.DE / AMUN.PA / GYM.L / ABNd.AS / CMCX.L / UBSG.S / SRENH.S / MTRO.L / PAGE.L / BFIT.AS / CTEC.L / IWG.L / TCAPI.L / TKOO.PA / GREG.MC / JUSTJ.L / IHR.L / DHER.DE / GRPG.I / FERG.L / SUPR.L / WHRW.L / AFM.L / RHIM.L / SDRY.L / ENOG.L / QLT.L / HNSA.ST / TMV.DE / VMUK.L / UPR.IR / PAGPA.L / FRAS.L / JETJ.L / 001306785 / DOCS.L / TEEC.L</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / Ashtead Group PLC / Allianz SE / AXA SA / Julius Baer Gruppe AG / Barclays PLC / BNP Paribas SA / Bunzl plc / Bodycote PLC / Brewin Dolphin Holdings PLC / Commerzbank AG / Centrica PLC / Capricorn Energy PLC / Capita PLC / Credit Suisse Group AG / Cranswick PLC / Danone SA / DCC PLC / DFDS AS / Diploma PLC / Electrocomponents PLC / FirstGroup PLC / Eiffage SA / Go-Ahead Group PLC / Hammerson PLC / HSBC Holdings PLC / Hiscox Ltd / Hunting PLC / IMI PLC / JD Sports Fashion PLC / Johnson & Johnson / Johnson Service Group PLC / Land Securities Group PLC / Lloyds Banking Group PLC / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / National Express Group PLC / Next PLC / L'Oreal SA / Oxford BioMedica PLC / Pfizer Inc / Provident Financial PLC / Pennon Group PLC / Prudential PLC / Rotork PLC / RPS Group PLC / Rentokil Initial PLC / Banco Santander SA / Stagecoach Group PLC / Vinci SA / Abrdn PLC / WH Smith PLC / Societe Generale SA / Serco Group PLC / Tullow Oil PLC / Travis Perkins PLC / TT electronics PLC / Unilever PLC / Flughafen Wien AG / Workspace Group PLC / Zurich Insurance Group AG / Rathbones Group PLC / Gilead Sciences Inc / Amgen Inc / Deutsche Bank AG / Empiric Student Property PLC / Banco Bilbao Vizcaya Argentaria SA / Entain PLC / Jtc PLC / Big Yellow Group PLC / MorphoSys AG / Dechra Pharmaceuticals PLC / Italgas SpA / AstraZeneca PLC / IG Group Holdings PLC / Fraport AG Frankfurt Airport Services Worldwide / Chevron Corp / Credit Agricole SA / Centamin PLC / Enagas SA / Aviva PLC / John Wood Group PLC / FLSmidth & Co A/S / ASOS PLC / Hays PLC / Anglo Pacific Group PLC / Coats Group PLC / Natwest Group PLC / SGS SA / Restaurant Group PLC / ING Groep NV / HomeServe PLC / Nestle SA / Spire Healthcare Group PLC / Brooks Macdonald Group PLC / Neste Oyj / Bucher Industries AG / Kosmos Energy Ltd / Petrofac Ltd / Britvic PLC / Dufry AG / Lancashire Holdings Ltd / HICL Infrastructure PLC / Teva Pharmaceutical Industries Ltd / Dunelm Group PLC / OC Oerlikon Corporation AG Pfaeffikon / Marston's PLC / Derwent London PLC / Deutsche Wohnen SE / 3I Infrastructure PLC / Atlantia SpA / Hilton Food Group PLC / Moneysupermarket.Com Group PLC / Ren Redes Energeticas Nacionais SGPS SA / Close Brothers Group PLC / Solaria Energia y Medio Ambiente SA / Hochschild Mining PLC / XPS Pensions Group PLC / Beazley PLC / Abcam PLC / CVS Group PLC / VGP NV / Gran Tierra Energy Inc / International Public Partnerships Ltd / Flughafen Zuerich AG / Phoenix Group Holdings PLC / Subsea 7 SA / Central Asia Metals PLC / Parex Resources Inc / Smart Metering Systems PLC / Hugo Boss AG / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Londonmetric Property PLC / Perrigo Company PLC / Morgan Advanced Materials PLC / Greencoat UK Wind PLC / boohoo group plc / Tritax Big Box Reit PLC / NN Group NV / Currys PLC / Molecular Partners AG / Fevertree Drinks PLC / Sanne Group PLC / Scout24 SE / Amundi SA / GYM Group PLC / ABN Amro Bank NV / CMC Markets PLC / UBS Group AG / Swiss Re AG / Metro Bank PLC / Pagegroup PLC / Basic Fit NV / ConvaTec Group PLC / IWG Plc / TP ICAP Group PLC / Tikehau Capital SCA / Grenergy Renovables SA / Just Group PLC / Impact Healthcare REIT PLC / Delivery Hero SE / Greencoat Renewables PLC / Ferguson PLC / Supermarket Income REIT PLC / Warehouse REIT PLC / Alpha Financial Markets Consulting PLC / RHI Magnesita NV / Superdry PLC / Energean PLC / Quilter PLC / Hansa Biopharma AB / TeamViewer AG / Virgin Money UK PLC / Uniphar PLC / Paragon Banking Group PLC / Frasers Group PLC / Just Eat Takeaway.com NV / Bureau Veritas SA / Dr Martens PLC / Triple Point Energy Efficiency Infrastructure Company Plc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / Sweden / United States / Isle of Man / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Zeus Capital</td><td class="leftalignment">Guild Esports (GILD LN) - Fresh sponsorship</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GB00BMWVF760</td><td class="leftalignment">Guild Esports PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bob H. Liao</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: Is Pharma at a positive ESG inflection point?</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / GILD.O / AMGN.O / 0989529 / TEVA.N / ABBV.N / PRGO.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / AstraZeneca PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Sara Mahaffy / Mr. Daniel J. Busby / Steve Daddeo / James Hong</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FMS.N / KBH.N / RWEG.DE / SSE.L / GILD.O / GIS.N / NBIX.O / VRTX.O / BLU.N / NRZ.N / PRTS.OQ / LULU.O / GETP.PA / HTGC.N / SRPT.O / KPTI.O / ITCI.O / ORSTED.CO / APTV.N / NBSE.OQ / KRTX.OQ / EPAC.N / ETNB.O / AKES.OL / ACC-ME.OL / TE.PA</td><td class="leftalignment">Fresenius Medical Care AG & Co KGaA / KB Home / Rwe AG / SSE PLC / Gilead Sciences Inc / General Mills Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / New Residential Investment Corp / Carparts.Com Inc / Lululemon Athletica Inc / Getlink SE / Hercules Capital Inc / Sarepta Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Orsted A/S / Aptiv PLC / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Enerpac Tool Group Corp / 89Bio Inc / Aker Solutions ASA / Aker Carbon Capture ASA / Technip Energies NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / China / Germany / Denmark / France / United Kingdom / Netherlands / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Healthcare Policy Update: Drug Pricing Reform Battle Lines to Be Drawn in Coming Months</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / NBIX.O / VRTX.O / SRPT.O / KPTI.O / ITCI.O / NBSE.OQ / KRTX.OQ / ETNB.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Sarepta Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / 89Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Large Cap Modestly Higher / STSA With Greatest Sequential Change Among SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Focus on in Trodelvy, Nefecon and etrasimod catalysts in 2021/2022. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1952.HK / GILD.OQ / ARNA.OQ</td><td class="leftalignment">Everest Medicines Ltd / Gilead Sciences Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Mar 12, 2021: Focus on 1Q21 trends for EU Majors</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Gilead Revenue up 10.0%</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call on April 7th: The Emerging Breast Cancer Landscape – Upcoming Enhertu HER2-Low Trial & Other Key Breast Cancer Trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2516152 / 2778844 / 2369174 / BFDV8K0 / BYQHPK7 / BYWVTY5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / MacroGenics Inc / Zymeworks Inc / CytomX Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / PEP=US / BMY=US / CAG=US / DIS=US / KO=US / CL=US / PG=US / MDT=US / INCY=US / RUN=US / GILD=US / PEB=US / H=US / V=US / MTN=US / ENR=US / MAR=US / EXPE=US / TTWO=US / TNL=US / HLT=US / AKR=US / NWL=US / EQR=US / W=US / FLO=US / MAC=US / STZ=US / AIR=US / CENT=US / CHH=US / CHD=US / COLL=US / DRH=US / EPC=US / HAIN=US / NTST=US / SMG=US / TRIP=US / POST=US / BKNG=US / OFC=US / FRT=US / SRC=US / REG=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / STRO=US / SHO=US / FRPT=US / THS=US / SPWR=US / SCPL=US / HST=US / MA=US / ELF=US / WH=US / RCUS=US / AAN=US / 45665G303 / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / ENPH=US / MEIP=US / RHP=US / PINC=US / GOOGL=US / COUP=US / ETSY=US / SEDG=US / NSA=US / TRVG=US / PK=US / PLYA=US / PETQ=US / ROKU=US / SMAR=US / KDP=US / BTAI=US / APLT=US / BRBR=US / REYN=US / ABNB=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / PepsiCo Inc / Bristol-Myers Squibb Co / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / Medtronic PLC / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Marriott International Inc / Expedia Group Inc / Take-Two Interactive Software Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Newell Brands Inc / Equity Residential / Wayfair Inc / Flowers Foods Inc / Macerich Co / Constellation Brands Inc / AAR Corp / Central Garden & Pet Co / Choice Hotels International Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Hain Celestial Group Inc / Netstreit Corp / Scotts Miracle-Gro Co / Tripadvisor Inc / Post Holdings Inc / Booking Holdings Inc / Corporate Office Properties Trust / Federal Realty Investment Trust / Spirit Realty Capital Inc / Regency Centers Corp / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Freshpet Inc / TreeHouse Foods Inc / SunPower Corp / Sciplay Corp / Host Hotels & Resorts Inc / Mastercard Inc / elf Beauty Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Aaron's Company Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Premier Inc / Alphabet Inc / Coupa Software Inc / ETSY Inc / Solaredge Technologies Inc / National Storage Affiliates Trust / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Roku Inc / Smartsheet Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Applied Therapeutics Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALV.N / ANTO.L / BAC.N / BHP.AX / BK.N / C.N / CL.N / CP.TO / EDP.LS / EL.N / F.N / GM.N / JPM.N / KMB.N / KO.N / MRK.N / NCM.AX / NEM.N / NSC.N / PFE.N / RIO.AX / RIO.L / RSG.AX / T.N / VC.N / WFC.N / PEP.N / BFb.N / PG.N / GILD.O / FNV.N / CPB.N / TEN.N / AAL.L / CNR.TO / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / TV.TO / UNP.N / GS.N / CLX.N / CAG.N / GIS.N / EPC.N / SBM.AX / AMT.N / BOL.ST / NG.L / VZ.N / STT.N / EXEL.O / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / ACN.N / NBIX.O / CHD.N / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / VRTX.O / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / HCC.N / GPN.N / MNST.O / BLUE.O / CASY.O / BCRX.O / EQIX.O / ATDb.TO / IGO.AX / FMG.AX / GOLD.N / FM.TO / RMS.AX / NST.AX / 02209S103 / 878742204 / RRL.AX / DLR.N / WSA.AX / 427866108 / ALNY.O / 35671D857 / MS.N / FIS.N / ARWR.O / MA.N / CS.TO / HOG.N / 443628102 / 550372106 / BGS.N / NCU.TO / SLR.AX / DAN.N / EDPR.LS / OZL.AX / SFR.AX / NGD.A / OGC.TO / VALE.N / SPB.N / BHPB.L / GOR.AX / CAML.L / PCRX.O / MTOR.N / GLEN.L / EVN.AX / SPLK.OQ / PANW.N / MDLZ.OQ / 505440107 / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / VRNS.O / CIA.TO / S32.AX / PYPL.OQ / GBT.OQ / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / ADNT.N / CRSP.OQ / PBYI.OQ / OKTA.OQ / SAIL.N / APTV.N / NEXA.TO / ZS.OQ / VNE.N / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / OSMT.O / NWL.O / CRWD.O / PING.N / CRNC.OQ / REYN.O / SBSW.N / NKLA.OQ / FOUR.N / SPRB.OQ / 900435207 / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">Autoliv Inc / Antofagasta PLC / Bank of America Corp / BHP Group Ltd / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Rio Tinto Ltd / Rio Tinto PLC / Resolute Mining Ltd / AT&T Inc / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Anglo American PLC / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Boliden AB / National Grid PLC / Verizon Communications Inc / State Street Corp / Exelixis Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / Global Payments Inc / Monster Beverage Corp / bluebird bio Inc / Caseys General Stores Inc / BioCryst Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / IGO Ltd / Fortescue Metals Group Ltd / Barrick Gold Corp / First Quantum Minerals Ltd / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Teck Resources Ltd / Regis Resources Ltd / Digital Realty Trust Inc / Western Areas Ltd / Hershey Co / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Morgan Stanley / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / B&G Foods Inc / Nevada Copper Corp / Silver Lake Resources Ltd / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Sandfire Resources Ltd / New Gold Inc / OceanaGold Corp / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Gold Road Resources Ltd / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Evolution Mining Ltd / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / South32 Ltd / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Adient PLC / CRISPR Therapeutics AG / Puma Biotechnology Inc / Okta Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Nexa Resources SA / Zscaler Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Osmotica Pharmaceuticals PLC / Newell Brands Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / Nikola Corp / Shift4 Payments Inc / Spruce Biosciences Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Cayman Islands / Spain / United Kingdom / Ireland / Luxembourg / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Rare & Specialty Disease Day – Hereditary Angioedema</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.O / BCRX.O / IONS.O</td><td class="leftalignment">Gilead Sciences Inc / BioCryst Pharmaceuticals Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / David Szeto / Leonid Timashev / Edwin Delfin / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">All eyes on TIGIT triplet interim in 1H2021; we highlight catalyst-rich year ahead</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">RCUS=US / GILD=US</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SLDB makes progress in DMD</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">SLDB.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Solid Biosciences Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 3.21.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRK=US / ABT=US / AMGN=US / INSP=US / GILD=US / SAN=FR / ATRC=US / BLUE=US / CSTL=US / ILMN=US / TFX=US / PRVB=US / CGEN=US / BIIB=US / ACRS=US / ACAD=US / QTRX=US / FOLD=US / PODD=US / RCUS=US / SRPT=US / MRTX=US / MGNX=US / QURE=US / AFMD=US / NVRO=US / ZBH=US / LNTH=US / WVE=US / MRUS=US / RETA=US / BHVN=US / REPL=US / HARP=US / ETNB=US / KROS=US / FMTX=US / ITOS=US / CGEM=US</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Amgen Inc / Inspire Medical Systems Inc / Gilead Sciences Inc / Sanofi SA / AtriCure Inc / bluebird bio Inc / Castle Biosciences Inc / Illumina Inc / Teleflex Inc / Provention Bio Inc / Compugen Ltd / Biogen Inc / Aclaris Therapeutics Inc / ACADIA Pharmaceuticals Inc / Quanterix Corp / Amicus Therapeutics Inc / Insulet Corp / Arcus Biosciences Inc / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / MacroGenics Inc / Uniqure NV / Affimed NV / Nevro Corp / Zimmer Biomet Holdings Inc / Lantheus Holdings Inc / WAVE Life Sciences Ltd / Merus NV / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / Replimune Group Inc / Harpoon Therapeutics Inc / 89Bio Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / FLS.N / FOUG.PA / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / TRI.N / RAT.L / CONG.DE / WY.N / PXD.N / CFP.TO / CNQ.TO / GILD.O / CMCSA.O / SJRb.TO / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / XOM.N / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / EXC.N / AZO.N / V.N / CHTR.O / DLTR.O / DG.N / PLD.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / ATDb.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / WEF.TO / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / PCH.O / CJT.TO / IFP.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / ENOG.L / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / WILD.TO / GFL.N / MOCORP.HE / 77311W101 / WFG.N / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Flowserve Corp / Eiffage SA / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Thomson Reuters Corp / Rathbones Group PLC / Continental AG / Weyerhaeuser Co / Pioneer Natural Resources Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Comcast Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Exxon Mobil Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Western Forest Products Inc / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Potlatchdeltic Corp / Cargojet Inc / Interfor Corp / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Energean PLC / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / WildBrain Ltd / GFL Environmental Inc / Metso Outotec Corp / Rocket Companies Inc / West Fraser Timber Co Ltd / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Andre-Philippe Hardy, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / AVB=US / AMZN=US / GILD=US / MTN=US / VRM=US / EXPE=US / ESS=US / EQR=US / AIR=US / AMN=US / HOOK=US / SNAP=US / TRIP=US / WIX=US / CCRN=US / BKNG=US / CPT=US / FB=US / MAA=US / UDR=US / NLS=US / PTON=US / BIIB=US / APTS=US / ANGI=US / IBTX=US / GOOGL=US / 00770K202 / BABA=US / CMPR=US / GDDY=US / NXRT=US / CVNA=US / SFIX=US / SYNH=US / BTAI=US / FTDR=US / SVMK=US / LYFT=US / UBER=US / AIRC=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Avalonbay Communities Inc / Amazon.com Inc / Gilead Sciences Inc / Vail Resorts Inc / Vroom Inc / Expedia Group Inc / Essex Property Trust Inc / Equity Residential / AAR Corp / AMN Healthcare Services Inc / HOOKIPA Pharma Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cross Country Healthcare Inc / Booking Holdings Inc / Camden Property Trust / Meta Platforms Inc / Mid-America Apartment Communities Inc / UDR Inc / Nautilus Inc / Peloton Interactive Inc / Biogen Inc / Preferred Apartment Communities Inc / Angi Inc / Independent Bank Group Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / NexPoint Residential Trust Inc / Carvana Co / Stitch Fix Inc / Syneos Health Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Lyft Inc / Uber Technologies Inc / Apartment Income REIT Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 0925288 / 2008154 / 2640147 / 2778844 / 2026242 / 2270726 / 2317087 / 2328915 / 2100920 / 2369174 / 2459020 / 2689560 / 2680905 / 2048804 / 2799351 / 2967589 / B1F76F9 / B121557 / B067BM3 / 2212922 / 2769796 / 2857817 / B5B1S13 / BBGVT40 / B87ZMX0 / B8DPDT7 / BFZCHN7 / BYNZGK1 / BFZ1K46 / BZ8VJQ8 / BKTNTR9</td><td class="leftalignment">American Express Co / GlaxoSmithKline PLC / Adobe Inc / Nike Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / Intuit Inc / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / Williams-Sonoma Inc / Western Union Co / Mastercard Inc / Molson Coors Beverage Co / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Dollar General Corp / News Corp / Palo Alto Networks Inc / Sarepta Therapeutics Inc / Wix.Com Ltd / Block Inc / Spotify Technology SA / Vistra Corp / ViacomCBS Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Highlights from HIV KOL Discussion; Enthusiasm for Long Acting Category Broadly Positive for MRK/GILD Collaboration</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ / MRK.N / 0925288 / 2778844 / 2369174</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc / GlaxoSmithKline PLC / Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">702</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / INCY.OQ / LLY.N / MRK.N / AZN.L / SASY.PA / AMGN.OQ / REGN.OQ / ALKS.OQ / STSA.OQ / GILD.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / TEVA.N / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / SAGE.OQ / ZBH.N / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Incyte Corp / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / SAGE Therapeutics Inc / Zimmer Biomet Holdings Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / FLS.N / FOUG.PA / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / WY.N / PXD.N / CNQ.TO / GILD.O / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / XOM.N / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / EXC.N / AZO.N / V.N / CHTR.O / DLTR.O / DG.N / PLD.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / WEB.AX / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / ENOG.L / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / WILD.TO / MOCORP.HE / 77311W101 / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Flowserve Corp / Eiffage SA / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Weyerhaeuser Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Exxon Mobil Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / Webjet Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Energean PLC / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / WildBrain Ltd / Metso Outotec Corp / Rocket Companies Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call Starting in 15 mins: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Catalyst-Rich Year to Build On Encouraging Prior Efficacy Signals</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HOOK=US / GILD=US</td><td class="leftalignment">HOOKIPA Pharma Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Doc Call on March 18th (Today): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Mr. Seamus Fernandez / Paul Jeng, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Today): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - March 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CNR.TO / ABF.L / AEGN.AS / AES.N / AGL.AX / ALV.N / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / F.N / FLS.N / FOUG.PA / GM.N / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VC.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / PXD.N / CNQ.TO / GILD.O / TEN.N / CMCSA.O / POW.TO / TA.TO / RCIb.TO / AAPL.O / AGI.N / QBRb.TO / DIS.N / BWA.N / LEA.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / GWO.TO / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / APH.N / EXC.N / AZO.N / V.N / CHTR.O / AXL.N / DLTR.O / DG.N / PLD.N / BC.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / TEL.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / PII.N / ST.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / ATDb.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IGM.TO / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / HOG.N / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / DAN.N / PBF.N / SII.TO / OZL.AX / ARX.TO / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / MTOR.N / WTE.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TSLA.N / TMUS.N / UKWG.L / ISV.TO / BEP.N / 81762P102 / IBP.N / PLC.TO / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / ADNT.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / APTV.N / ENOG.L / VNE.N / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / CRNC.OQ / WILD.TO / NKLA.OQ / MOCORP.HE / 77311W101 / TPZ.TO / DHT_u.TO</td><td class="leftalignment">Canadian National Railway Co / Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Autoliv Inc / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Ford Motor Co / Flowserve Corp / Eiffage SA / General Motors Co / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Visteon Corp / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Power Corporation of Canada / TransAlta Corp / Rogers Communications Inc / Apple Inc / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Great-West Lifeco Inc / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Amphenol Corp / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Brunswick Corp / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / TE Connectivity Ltd / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IGM Financial Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Harley-Davidson Inc / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / Dana Inc / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / ARC Resources Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Meritor Inc / Westshore Terminals Investment Corp / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Information Services Corp / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / Park Lawn Corp / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / Adient PLC / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Aptiv PLC / Energean PLC / Veoneer Inc / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / Cerence Inc / WildBrain Ltd / Nikola Corp / Metso Outotec Corp / Rocket Companies Inc / Topaz Energy Corp / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALV.N / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / F.N / FLS.N / FOUG.PA / GM.N / GPS.N / HSBA.L / KBH.N / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PD.N / PHM.N / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VC.N / VOLVb.ST / WEIR.L / SSE.L / CMA.N / RAT.L / CONG.DE / PXD.N / CNQ.TO / GILD.O / TEN.N / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / BWA.N / LEA.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / LEN.N / EAT.N / VLO.N / MFC.TO / CJRb.TO / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / DHI.N / STZ.N / AMP.N / APH.N / EXC.N / AZO.N / V.N / CHTR.O / AXL.N / DLTR.O / WSM.N / DG.N / PLD.N / BC.N / DK.N / IGG.L / AJG.N / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / TEL.N / GPK.N / AVGO.O / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / PII.N / ST.N / SMTC.OQ / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / HOG.N / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / DAN.N / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / MTOR.N / EVN.AX / PSX.N / SRPT.O / FIVE.OQ / BERY.N / DIR_u.TO / ABBV.N / TPH.N / TSLA.N / TMUS.N / UKWG.L / TMHC.N / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / AGRX.O / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / TDOC.N / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / ADNT.N / CTEC.L / CDEV.O / VST.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / APTV.N / ENOG.L / VNE.N / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / CRNC.OQ / NKLA.OQ / MOCORP.HE / 77311W101 / DFH.OQ / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Autoliv Inc / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Ford Motor Co / Flowserve Corp / Eiffage SA / General Motors Co / Gap Inc / HSBC Holdings PLC / KB Home / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PagerDuty Inc / Pultegroup Inc / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Visteon Corp / Volvo AB / Weir Group PLC / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Lennar Corp / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Corus Entertainment Inc / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / D R Horton Inc / Constellation Brands Inc / Ameriprise Financial Inc / Amphenol Corp / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Williams-Sonoma Inc / Dollar General Corp / Prologis Inc / Brunswick Corp / Delek US Holdings Inc / IG Group Holdings PLC / Arthur J Gallagher & Co / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / TE Connectivity Ltd / Graphic Packaging Holding Co / Broadcom Inc / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Semtech Corp / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Harley-Davidson Inc / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / Dana Inc / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Meritor Inc / Evolution Mining Ltd / Phillips 66 / Sarepta Therapeutics Inc / Five Below Inc / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Taylor Morrison Home Corp / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / Agile Therapeutics Inc / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Teladoc Health Inc / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / Adient PLC / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Aptiv PLC / Energean PLC / Veoneer Inc / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / Cerence Inc / Nikola Corp / Metso Outotec Corp / Rocket Companies Inc / Dream Finders Homes Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - March 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALV.N / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CPI.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / F.N / FLS.N / FOUG.PA / GM.N / GPS.N / HMb.ST / HSBA.L / JD.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / SRP.L / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VC.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / PXD.N / CNQ.TO / GILD.O / TEN.N / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / BWA.N / LEA.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / APH.N / EXC.N / AZO.N / V.N / CHTR.O / AXL.N / DLTR.O / DG.N / PLD.N / BC.N / DK.N / IGG.L / ITX.MC / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / TEL.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / PII.N / ST.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / HOG.N / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / DAN.N / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / PHNX.L / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / MTOR.N / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TSLA.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / ZALG.DE / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / ADNT.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / APTV.N / ENOG.L / VNE.N / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / CRNC.OQ / MNG.L / WILD.TO / NKLA.OQ / MOCORP.HE / 77311W101 / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Autoliv Inc / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Capita PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Ford Motor Co / Flowserve Corp / Eiffage SA / General Motors Co / Gap Inc / H & M Hennes & Mauritz AB / HSBC Holdings PLC / JD Sports Fashion PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / Serco Group PLC / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Visteon Corp / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Amphenol Corp / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Brunswick Corp / Delek US Holdings Inc / IG Group Holdings PLC / Industria de Diseno Textil SA / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / TE Connectivity Ltd / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Harley-Davidson Inc / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / Dana Inc / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / Phoenix Group Holdings PLC / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Meritor Inc / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Zalando SE / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / Adient PLC / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Aptiv PLC / Energean PLC / Veoneer Inc / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / Cerence Inc / M&G PLC / WildBrain Ltd / Nikola Corp / Metso Outotec Corp / Rocket Companies Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Global Views on Recovery & Inflation</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ABF.L / AEGN.AS / AES.N / AGL.AX / ALVG.DE / AMAT.O / AU.N / AXP.N / BAC.N / BCE.TO / BHP.AX / CBKG.DE / CCK.N / CI.N / CNE.L / CP.TO / CPG.L / CSGN.S / DANO.PA / DD.N / DFDS.CO / ED.N / EIX.N / ENI.MI / FLS.N / FOUG.PA / GPS.N / HSBA.L / L.TO / MICP.PA / MKS.L / MRK.N / MUVGn.DE / NA / NCM.AX / NSC.N / NXT.L / PPG.N / RAND.AS / RIO.AX / SCOR.PA / SECUb.ST / T.N / TD.TO / TLW.L / TOL.N / TRV.N / VOLVb.ST / WEIR.L / WFC.N / WMB.N / SSE.L / CMA.N / RAT.L / CONG.DE / WY.N / PXD.N / CNQ.TO / GILD.O / CMCSA.O / TA.TO / RCIb.TO / AAPL.O / CNR.TO / AGI.N / QBRb.TO / DIS.N / WCC.N / DRI.N / DT.N / CSX.N / ABBN.S / IMO.TO / SU.TO / EAT.N / VLO.N / MFC.TO / XOM.N / CJRb.TO / WHR.N / NKE.N / MRU.TO / SHW.N / GWW.N / VZ.N / HCA.N / ADEN.S / STZ.N / AMP.N / EXC.N / AZO.N / V.N / CHTR.O / DLTR.O / DG.N / PLD.N / DK.N / IGG.L / ARE.TO / CVX.N / MU.O / MHK.N / CEY.L / CAR_u.TO / PSI.TO / NET.N / GPK.N / FLS.CO / COP.N / CPE.N / MEOH.O / DOL.TO / FRC.N / HCC.N / CCLb.TO / RGLD.O / SIVB.O / HOOK.O / ORLY.O / ACGL.O / TCBI.O / TCLa.TO / EMPA.TO / IGO.AX / SNC.TO / RUS.TO / CHE_u.TO / RTN.L / 02209S103 / NTR.N / DPZ.N / SPI.L / MOS.N / TXRH.O / VIAC.O / IAG.N / 416515104 / WSA.AX / BUCN.S / MPW.N / BLDR.O / STX.O / 35671D857 / ALD.AX / TEVA.N / MA.N / MWA.N / CPX.TO / MARS.L / DWNG.DE / H.TO / IVZ.N / DAIGn.DE / CBRO.L / BEZG.L / ABCA.L / GETP.PA / PBF.N / SII.TO / OZL.AX / ABI.BR / SFR.AX / CLW.N / AND.TO / VALE.N / IFC.TO / CPG.TO / ADUS.OQ / BHPB.L / MEG.TO / WCP.TO / LYB.N / CJT.TO / EVN.AX / PSX.N / BERY.N / DIR_u.TO / ABBV.N / TMUS.N / UKWG.L / BEP.N / 81762P102 / IBP.N / ENLC.N / ARES.N / BMEB.L / NEP.N / HQY.OQ / AXTA.N / S32.AX / CIGI.O / FSV.O / RAYa.TO / VNAn.DE / AMUN.PA / GYM.L / CMCX.L / BFIT.AS / TWLO.N / CTEC.L / CDEV.O / VST.N / WPM.N / JUSTJ.L / IHR.L / SUPR.L / ORSTED.CO / ENOG.L / MI_U.TO / CWEN.N / ESTC.N / NBSE.OQ / CRWD.O / 260557103 / WILD.TO / MOCORP.HE / 77311W101 / DHT_u.TO</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / AES Corp / AGL Energy Ltd / Allianz SE / Applied Materials Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BCE Inc / BHP Group Ltd / Commerzbank AG / Crown Holdings Inc / Cigna Corp / Capricorn Energy PLC / Canadian Pacific Railway Ltd / Compass Group PLC / Credit Suisse Group AG / Danone SA / Dupont De Nemours Inc / DFDS AS / Consolidated Edison Inc / Edison International / Eni SpA / Flowserve Corp / Eiffage SA / Gap Inc / HSBC Holdings PLC / Loblaw Companies Ltd / Compagnie Generale des Etablissements Michelin SCA / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newcrest Mining Ltd / Norfolk Southern Corp / Next PLC / PPG Industries Inc / Randstad NV / Rio Tinto Ltd / Scor SE / Securitas AB / AT&T Inc / Toronto-Dominion Bank / Tullow Oil PLC / Toll Brothers Inc / Travelers Companies Inc / Volvo AB / Weir Group PLC / Wells Fargo & Co / Williams Companies Inc / SSE PLC / Comerica Inc / Rathbones Group PLC / Continental AG / Weyerhaeuser Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Comcast Corp / TransAlta Corp / Rogers Communications Inc / Apple Inc / Canadian National Railway Co / Alamos Gold Inc / Quebecor Inc / Walt Disney Co / Wesco International Inc / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Abb Ltd / Imperial Oil Ltd / Suncor Energy Inc / Brinker International Inc / Valero Energy Corp / Manulife Financial Corp / Exxon Mobil Corp / Corus Entertainment Inc / Whirlpool Corp / Nike Inc / Metro Inc / Sherwin-Williams Co / W W Grainger Inc / Verizon Communications Inc / HCA Healthcare Inc / Adecco Group AG / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Autozone Inc / Visa Inc / Charter Communications Inc / Dollar Tree Inc / Dollar General Corp / Prologis Inc / Delek US Holdings Inc / IG Group Holdings PLC / Aecon Group Inc / Chevron Corp / Micron Technology Inc / Mohawk Industries Inc / Centamin PLC / Canadian Apartment Properties Real Estate Investment Trust / Pason Systems Inc / Cloudflare Inc / Graphic Packaging Holding Co / FLSmidth & Co A/S / Conocophillips / Callon Petroleum Co / Methanex Corp / Dollarama Inc / First Republic Bank / Warrior Met Coal Inc / CCL Industries Inc / Royal Gold Inc / SVB Financial Group / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Texas Capital Bancshares Inc / Transcontinental Inc / Empire Company Ltd / IGO Ltd / SNC-Lavalin Group Inc / Russel Metals Inc / Chemtrade Logistics Income Fund / Restaurant Group PLC / Altria Group Inc / Nutrien Ltd / Domino's Pizza Inc / Spire Healthcare Group PLC / Mosaic Co / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / Western Areas Ltd / Bucher Industries AG / Medical Properties Trust Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Freeport-McMoRan Inc / Ampol Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Mueller Water Products Inc / Capital Power Corp / Marston's PLC / Deutsche Wohnen SE / Hydro One Ltd / Invesco Ltd / Daimler AG / Close Brothers Group PLC / Beazley PLC / Abcam PLC / Getlink SE / PBF Energy Inc / Sprott Inc / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Vale SA / Intact Financial Corp / Crescent Point Energy Corp / Addus Homecare Corp / BHP Group PLC / MEG Energy Corp / Whitecap Resources Inc / LyondellBasell Industries NV / Cargojet Inc / Evolution Mining Ltd / Phillips 66 / Berry Global Group Inc / Dream Industrial Real Estate Investment Trust / Abbvie Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Installed Building Products Inc / EnLink Midstream LLC / Ares Management Corp / B&M European Value Retail SA / Nextera Energy Partners LP / Healthequity Inc / Axalta Coating Systems Ltd / South32 Ltd / Colliers International Group Inc / FirstService Corp / Stingray Group Inc / Vonovia SE / Amundi SA / GYM Group PLC / CMC Markets PLC / Basic Fit NV / Twilio Inc / ConvaTec Group PLC / Centennial Resource Development Inc / Vistra Corp / Wheaton Precious Metals Corp / Just Group PLC / Impact Healthcare REIT PLC / Supermarket Income REIT PLC / Orsted A/S / Energean PLC / Minto Apartment Real Estate Investment Trust / Clearway Energy Inc / Elastic NV / NeuBase Therapeutics Inc / CrowdStrike Holdings Inc / Dow Inc / WildBrain Ltd / Metso Outotec Corp / Rocket Companies Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Papua New Guinea / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Electrical / Energy / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Andrew E. Brooke / Mr. Christopher E. Carril / Michael W. Carroll, CFA / Gerard S. Cassidy / Mr. Richard B. Chamberlain / Mr. Maurice Choy / Scot Ciccarelli, CFA / Sam Crittenden, CFA / Ruairi Cullinane / Mike Dahl / Brian Abrahams, MD / Mr. Luke Davis / Mr. Sean W. Dodge, CFA / Mr. Deane Dray, CFA / Mark A. Dwelle, CFA / Mr. James Edwardes Jones / Mr. Mark L. Fielding / Kate Fitzsimons / Mr. Karl Green / Scott M. Hanold / Mr. Michael Harvey / Mr. Gordon Aitken / Mr. Matthew G. Hedberg / Mr. Kamran Hossain / Herr. Nick Housden / Alexander Jackson / Mr. Mandeep Jagpal / Mr. Paul Kaner / Mr. Sabahat Khan / Sebastian Kuenne, CFA / Geoffrey Kwan, CFA / Robert M. Kwan, CFA / Jon G. Arfstrom, CPA / Mr. Kenneth S. Lee / Mr. Julian Livingston-Booth / Mr. Matt Logan / Mr. Keith Mackey / Mr. Kutgun Maral / Drew McReynolds, CFA / Douglas M. Miehm / Darko Mihelic, CFA / Mr. Nik Modi / Frank G. Morgan / Jonathan Atkin / Mr. John B. Musk / Mr. Tom Narayan / Mme. Irene O. Nattel / Mr. Nelson Ng, CFA / Greg M. Pardy, CFA / Mr. Kaan Peker / Daniel R. R. Perlin, CFA / Mr. Paul C. Quinn / Mr. Gordon Ramsay / Anke Reingen / Mr. Ben E. Bathurst / Mr. TJ J. Schultz / Ms. Elvira Scotto, CFA / Walter N. Spracklin, CFA / Randall S. Stanicky, CFA / Mr. Al J. Stanton / Mr. Mitch T. Steves / Mr. Benjamin Toms / Mr. Shelby Tucker, CFA / Mr. Arun S. Viswanathan / Mr. Charles Weston / Mr. Pammi Bir, CPA / Mr. Josh M. Wolfson / Andrew D. Wong / Ms. Christine Zhou / Mr. Biraj Borkhataria / Mr. Tyler Broda, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Tomorrow): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on 18th March: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">DMAC (BUY): Keeping Up with the Kallikreins - Raising Stroke PoS Ahead of Phase 2/3 IND; Previewing DKD Data in 2Q; PT to $25 (from $16)</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">BGT0PL8 / 0989529 / 2516152 / 2369174</td><td class="leftalignment">DiaMedica Therapeutics Inc / AstraZeneca PLC / Eli Lilly and Co / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">HIV KOL Call Takeaways: A Strong Combo Likely To Help Extend GILD's Leadership</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren, M.SC / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D. / James Delorme, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US09062X1037 / US0042251084 / US42226A1079 / US05464T1043 / US0327973006 / US24823R1059</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Healthequity Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call on 18th March:  The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2778844 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">LIFE: COVID Patients' Biomarker Data Validate ATYR1923's MOA-Raising PT to $20</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LIFE.OQ / GILD</td><td class="leftalignment">aTyr Pharma Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">MRK Gilead Collaboration Solidifies Strength In HIV</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.OQ / US58933Y1055 / US3755581036</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AACR 2021 Virtual Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">PFE=US / AMGN=US / INCY=US / GILD=US / SAN=FR / AZN=US / GSK=US / JNJ=US / IMGN=US / EXAS=US / ILMN=US / HOOK=US / REGN=US / NTRA=US / TPTX=US / BOLT=US / NEO=US / RCUS=US / VSTM=US / ABBV=US / MRTX=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AFMD=US / BPMC=US / BGNE=US / MRUS=US / MRSN=US / GH=US / BHC=US / REPL=US / RUBY=US / SBTX=US / TWST=US / HARP=US / TCRR=US / BNTX=US / GMAB=US / RVMD=US / ZNTL=US / ITOS=US / MOLN=DE</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / ImmunoGen Inc / Exact Sciences Corp / Illumina Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Natera Inc / Turning Point Therapeutics Inc / Bolt Biotherapeutics Inc / Neogenomics Inc / Arcus Biosciences Inc / Verastem Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Affimed NV / Blueprint Medicines Corp / Beigene Ltd / Merus NV / Mersana Therapeutics Inc / Guardant Health Inc / Bausch Health Companies Inc / Replimune Group Inc / Rubius Therapeutics Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / BioNTech SE / Genmab A/S / Revolution Medicines Inc / Zentalis Pharmaceuticals Inc / Iteos Therapeutics Inc / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges / Dr. Andrew S. Berens, MD / Mr. Jonathan W. Chang, PHD / Mr. Puneet Souda</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2026242 / 2942605 / 2317087 / 2328915 / 2342034 / 2369174 / 2630513 / 2684703 / 2048804 / 2980906 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B2R3PV1 / B28TS42 / B7TL820 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BF4VBS8 / BP7RS48 / BFZ1K46 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BDD1B07 / BP8XZL1 / BFY7DC4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Entergy Corp / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / New Jersey Resources Corp / Pfizer Inc / Pinnacle West Capital Corp / Foot Locker Inc / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / American Water Works Company Inc / Ulta Beauty Inc / Meta Platforms Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / BioXcel Therapeutics Inc / Intersect Ent Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Vistra Corp / ViacomCBS Inc / Rubius Therapeutics Inc / Healthequity Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / GILD=US / AMT=US / VZ=US / LOW=US / PB=US / CHRS=US / LEG=US / DISH=US / BNL=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / SBAC=US / STOR=US / ABCB=US / ADC=US / BOKF=US / FFIN=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / EPRT=US / JACK=US / TREX=US / CUBE=US / FBHS=US / TILE=US / TMUS=US / NDLS=US / CNCE=US / LOCO=US / HQY=US / SHAK=US / RLMD=US / WING=US / ZG=US / 82982L103 / ANAB=US / JELD=US / RDFN=US / BTAI=US / OPCH=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / American Tower Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / DISH Network Corp / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / STORE Capital Corp / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / First Financial Bankshares Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / AnaptysBio Inc / JELD-WEN Holding Inc / Redfin Corp / BioXcel Therapeutics Inc / Option Care Health Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FR0000121014 / US0079031078 / US1156372096 / US22284P1057 / US31428X1063 / US3377381088 / US3755581036 / US5150981018 / US6795801009 / US7392761034 / US9029251066 / US9507551086 / US0003752047 / US31620M1062 / US57636Q1040 / US78709Y1055 / US87874R1005 / US1940141062 / US9837931008 / US03937C1053 / CA76131D1033 / CA87241L1094 / US23753F1075 / US80689H1023 / US6904691010 / US4990491049 / US7172241090 / US05370A1088 / CA67079A1021 / US82024L1035 / US00810F1066 / US82489W1071</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Advanced Micro Devices Inc / Brown-Forman Corp / Covenant Logistics Group Inc / FedEx Corp / Fiserv Inc / Gilead Sciences Inc / Landstar System Inc / Old Dominion Freight Line Inc / Power Integrations Inc / USA Truck Inc / Werner Enterprises Inc / Abb Ltd / Fidelity National Information Services Inc / Mastercard Inc / Saia Inc / TechTarget Inc / Colfax Corp / XPO Logistics Inc / ArcBest Corp / Restaurant Brands International Inc / TFI International Inc / Daseke Inc / Schneider National Inc / Ovid Therapeutics Inc / Knight-Swift Transportation Holdings Inc / PhaseBio Pharmaceuticals Inc / Avidity Biosciences Inc / Nuvei Corp / Shattuck Labs Inc / AerSale Corp / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - March 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">US2017231034 / US3755581036 / US5463471053 / US6703461052 / US7549071030 / US75886F1075 / US8581191009 / US9621661043 / CA8787422044 / CA1247651088 / CA7751092007 / CA9528451052 / CA82028K2002 / CA0099051009 / US9129091081 / AU000000FMG4 / US7376301039 / CA32076V1031 / US5021751020 / US63633D1046 / CA3518581051 / US91912E1055 / CA8672241079 / IE00B4BNMY34 / DE000BAY0017 / US09739D1000 / US03209R1032 / US9840171030 / US1638511089 / US00856G1094 / GB00BF3ZNS54 / CA8585221051 / GB00BJT16S69 / CA59124U6051 / US90278Q1085 / CA67079A1021</td><td class="leftalignment">Commercial Metals Co / Gilead Sciences Inc / Louisiana-Pacific Corp / Nucor Corp / Rayonier Inc / Regeneron Pharmaceuticals Inc / Steel Dynamics Inc / Weyerhaeuser Co / Teck Resources Ltd / CAE Inc / Rogers Communications Inc / West Fraser Timber Co Ltd / Shaw Communications Inc / AKITA Drilling Ltd / United States Steel Corp / Fortescue Metals Group Ltd / Potlatchdeltic Corp / First Majestic Silver Corp / LTC Properties Inc / National Health Investors Inc / Franco-Nevada Corp / Vale SA / Suncor Energy Inc / Accenture PLC / Bayer AG / Boise Cascade Co / Amphastar Pharmaceuticals Inc / Xenia Hotels & Resorts Inc / Chemours Co / AgroFresh Solutions Inc / Venator Materials PLC / Stelco Holdings Inc / Tronox Holdings PLC / Metalla Royalty & Streaming Ltd / Ufp Industries Inc / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMD.N / AU.N / AXP.N / BAC.N / C.N / COF.N / CP.TO / JPM.N / NCM.AX / NEM.N / NSC.N / PNN.L / RSG.AX / RWEG.DE / GILD.O / FNV.N / SJRb.TO / RCIb.TO / FER.MC / AAL.L / CNR.TO / AGI.N / DRI.N / CSX.N / UNP.N / EAT.N / AEM.N / SBM.AX / KGC.N / BOL.ST / SNPS.O / V.N / FRAG.DE / CEY.L / GFI.N / DFS.N / ADS.N / RGLD.O / GOLD.N / RMS.AX / NST.AX / RRL.AX / TXRH.O / IAG.N / CDNS.O / MA.N / AUY.N / HOCM.L / SLR.AX / FRES.L / NGD.A / OGC.TO / EGO.N / GOR.AX / SMSS.L / POLYP.L / EVN.AX / PRTA.O / BTG.N / SYF.N / HQY.OQ / CRBP.OQ / OR.N / SAND.N / WPM.N / OVID.O / KL.N / NEXA.TO / SBSW.N</td><td class="leftalignment">Advanced Micro Devices Inc / AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / Citigroup Inc / Capital One Financial Corp / Canadian Pacific Railway Ltd / JPMorgan Chase & Co / Newcrest Mining Ltd / Newmont Corporation / Norfolk Southern Corp / Pennon Group PLC / Resolute Mining Ltd / Rwe AG / Gilead Sciences Inc / Franco-Nevada Corp / Shaw Communications Inc / Rogers Communications Inc / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Alamos Gold Inc / Darden Restaurants Inc / CSX Corp / Union Pacific Corp / Brinker International Inc / Agnico Eagle Mines Ltd / St Barbara Ltd / Kinross Gold Corp / Boliden AB / Synopsys Inc / Visa Inc / Fraport AG Frankfurt Airport Services Worldwide / Centamin PLC / Gold Fields Ltd / Discover Financial Services / Alliance Data Systems Corp / Royal Gold Inc / Barrick Gold Corp / Ramelius Resources Ltd / Northern Star Resources Ltd / Regis Resources Ltd / Texas Roadhouse Inc / IAMGOLD Corp / Cadence Design Systems Inc / Mastercard Inc / Yamana Gold Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Fresnillo PLC / New Gold Inc / OceanaGold Corp / Eldorado Gold Corp / Gold Road Resources Ltd / Smart Metering Systems PLC / Polymetal International PLC / Evolution Mining Ltd / Prothena Corporation PLC / B2Gold Corp / Synchrony Financial / Healthequity Inc / Corbus Pharmaceuticals Holdings Inc / Osisko Gold Royalties Ltd / Sandstorm Gold Ltd / Wheaton Precious Metals Corp / Ovid Therapeutics Inc / Kirkland Lake Gold Ltd / Nexa Resources SA / Sibanye Stillwater Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / China / Cayman Islands / Germany / Spain / United Kingdom / Ireland / Luxembourg / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Lenacapavir combo deal preserves flexibility in the long-term while accelerating timelines by two years</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036 / MRK</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4507.T: Shionogi - Virtual pharma tour; Shionogi is a Japanese leader in COVID-19 therapies and HIV franchise</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4507.T / MRK.N / GILD.OQ / 2318.HK</td><td class="leftalignment">Shionogi & Co Ltd / Merck & Co Inc / Gilead Sciences Inc / Ping An Insurance Group Co of China Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4507.T: 塩野義製薬 - ヴァ―チャルファーマツアー開催、COVID-19治療とHIVフランチャイズで日本をリードする</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4507.T / MRK.N / GILD.OQ / 2318.HK</td><td class="leftalignment">Shionogi & Co Ltd / Merck & Co Inc / Gilead Sciences Inc / Ping An Insurance Group Co of China Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">GILD+MRK To Collaborate On Long Acting Lenacapavir And Islatravir HIV Regimens</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Deep-Dive Slide Deck Shows Lena + Isla Are Better Together, Suggesting MRK Deal Is Right Move</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Merck Collaboration Accelerates Long-Acting HIV Treatment Timelines</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lenacapavir and Islatravir Finally Hooking Up but Not Exclusive</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / GILD=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD & MRK Combine on First In Class Long Acting HIV Molecules; We're Positive on Deal Given HIV Competitive Dynamics</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2778844 / 2369174</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Etzer Darout / Mr. Seamus Fernandez / Paul Jeng, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Intriguing collaboration with GILD on long-acting HIV treatments</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.OQ / MRK=US / MRK.N / GILD=US</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc / Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">GILD/MRK Collab Thoughts: Keeps Your Friends Close, And Your Enemies Closer</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren, M.SC / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D. / James Delorme, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MRK And GILD HIV Collaboration Helps Improve Earnings Visibility in 2028+</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / US3755581036</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Love at First Dose: Lena-Isla Partnership a Long Time Coming, Positive for GILD's HIV Franchise</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SVRA=US / TRVN=US / MRK=US / BSX=US / CSII=US / FDX=US / ABT=US / AMGN=US / BMY=US / CAT=US / WM=US / BWA=US / MDT=US / QCOM=US / T=US / DT=US / INCY=US / RUN=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / FCEL=US / PLUG=US / NVS=US / TROW=US / CRY=US / JCI=US / JNJ=US / DE=US / RSG=US / ALB=US / AMSC=US / ARNA=US / ARRY=US / ATRC=US / AVNT=US / CMI=US / CREE=US / DRI=US / DRRX=US / EW=US / INSM=US / ITRI=US / MS=US / ROK=US / TER=US / TRMB=US / RHHBY=US / SIVB=US / NEP=US / SWKS=US / ICAD=US / BE=US / CLH=US / WCN=US / BIIB=US / ISR=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / PDD=US / SPWR=US / CSIQ=US / FSLR=US / ARAY=US / BX=US / DAN=US / WPRT=US / SWAV=US / AGCO=US / CPIX=US / TSLA=US / DANA=US / AMRC=US / PCRX=US / ENPH=US / SPLK=US / HASI=US / CNHI=US / HRTX=US / BABA=US / EKTAY=US / NEWR=US / SEDG=US / LIVN=US / AQMS=US / CERC=US / VRAY=US / WKHS=US / IRTC=US / VERU=US / ATXI=US / APTV=US / VOW3-DE=US / CWEN=US / ESTC=US / DDOG=US / BXRX=US / TARA=US / SUMO=US / VLDR=US / SHLS=US / CHPT=US / GOEV=US</td><td class="leftalignment">Savara Inc / Trevena Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / FedEx Corp / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Caterpillar Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Qualcomm Inc / AT&T Inc / Dynatrace Inc / Incyte Corp / Sunrun Inc / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Novartis AG / T Rowe Price Group Inc / CryoLife Inc / Johnson Controls International PLC / Johnson & Johnson / Deere & Co / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Arena Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Cummins Inc / Wolfspeed Inc / Darden Restaurants Inc / DURECT Corp / Edwards Lifesciences Corp / Insmed Inc / Itron Inc / Morgan Stanley / Rockwell Automation Inc / Teradyne Inc / Trimble Inc / Roche Holding AG / SVB Financial Group / Nextera Energy Partners LP / Skyworks Solutions Inc / ICAD Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Biogen Inc / IsoRay Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Accuray Inc / Blackstone Inc / Dana Inc / Westport Fuel Systems Inc / Shockwave Medical Inc / AGCO Corp / Cumberland Pharmaceuticals Inc / Tesla Inc / Dana Gas PJSC / Ameresco Inc / Pacira Biosciences Inc / Enphase Energy Inc / Splunk Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Heron Therapeutics Inc / Alibaba Group Holding Ltd / Elekta AB (publ) / New Relic Inc / Solaredge Technologies Inc / LivaNova PLC / Aqua Metals Inc / Avalo Therapeutics Inc / ViewRay Inc / Workhorse Group Inc / iRhythm Technologies Inc / Veru Inc / Avenue Therapeutics Inc / Aptiv PLC / Volkswagen AG / Clearway Energy Inc / Elastic NV / Datadog Inc / Baudax Bio Inc / Protara Therapeutics Inc / Sumo Logic Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Canoo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Arab Emirates / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABF.L / AEP.N / ALV.N / AU.N / CAS.TO / CI.N / CL.N / CMS.N / EDP.LS / EIX.N / EL.N / F.N / FGP.L / GM.N / GOG.L / HMb.ST / IBE.MC / IP.N / JD.L / KBH.N / KMB.N / KO.N / MKS.L / MRK.N / NCM.AX / NEM.N / NXT.L / PD.N / PFE.N / PHM.N / RSG.AX / RYN.N / SO.N / T.N / TOL.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / GILD.O / FNV.N / CPB.N / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / DUK.N / AGI.N / BWA.N / LEA.N / PNM.N / K.N / DT.N / DISH.O / LEN.N / CLX.N / CAG.N / GIS.N / AEM.N / EPC.N / SBM.AX / AMT.N / KGC.N / NKE.N / JAZZ.O / CONE.O / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ITX.MC / BMRN.O / OPTN.O / REGN.O / ENR.N / JHX.AX / CEY.L / NCR.N / NET.N / TEL.N / GFI.N / ASC.L / CNP.N / ENDP.O / CPK.N / PII.N / ST.N / SEM.N / SGEN.OQ / GPN.N / MNST.O / RGLD.O / BLUE.O / CASY.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / RMS.AX / NST.AX / 02209S103 / CWX.TO / RRL.AX / DLR.N / IAG.N / 427866108 / WEF.TO / FIS.N / ARWR.O / TEVA.N / MA.N / HOG.N / MERC.O / AUY.N / ATL.MI / BGS.N / HOCM.L / SLR.AX / ENSG.O / DAN.N / NOG.A / FRES.L / NGD.A / CLW.N / OGC.TO / ADUS.OQ / EGO.N / ADN.TO / SPB.N / NEE.N / GOR.AX / PCH.O / CFX.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / POLYP.L / EVN.AX / SPLK.OQ / RFP.N / BOSSn.DE / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / COTY.N / PRTA.O / 81762P102 / CFF.TO / LB.N / KPTI.O / XNCR.OQ / VRNS.O / BOOH.L / BTG.N / AGRX.O / RYAM.N / ZALG.DE / 03835T200 / SHOP.N / WRK.N / SGRY.O / RACE.MI / TWLO.N / OR.N / ADNT.N / CRSP.OQ / GDS.O / SAND.N / AQN.N / OKTA.OQ / VST.N / WPM.N / KL.N / ATNX.O / SAIL.N / APTV.N / EHC.N / SDRY.L / ZS.OQ / AMRX.N / ITRM.O / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / FOCS.O / ESTC.N / GMDA.OQ / OSMT.O / NWL.O / OPI.OQ / CRWD.O / GMAB.O / PING.N / APRE.OQ / CRNC.OQ / IGMS.O / FRAS.L / REYN.O / SBSW.N / IGIC.OQ / NKLA.OQ / FOUR.N / GOCO.O / ALOO.O / MAX.N / WFG.N / AG1G.DE / 120291281 / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / Autoliv Inc / AngloGold Ashanti Ltd / Cascades Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / H & M Hennes & Mauritz AB / Iberdrola SA / International Paper Co / JD Sports Fashion PLC / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Marks and Spencer Group PLC / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Next PLC / PagerDuty Inc / Pfizer Inc / Pultegroup Inc / Resolute Mining Ltd / Rayonier Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Alamos Gold Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Lennar Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Kinross Gold Corp / Nike Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Industria de Diseno Textil SA / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Gold Fields Ltd / ASOS PLC / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Royal Gold Inc / bluebird bio Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Doman Building Materials Group Ltd / Regis Resources Ltd / Digital Realty Trust Inc / IAMGOLD Corp / Hershey Co / Western Forest Products Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Atlantia SpA / B&G Foods Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Ensign Group Inc / Dana Inc / Northern Oil and Gas Inc / Fresnillo PLC / New Gold Inc / Clearwater Paper Corp / OceanaGold Corp / Addus Homecare Corp / Eldorado Gold Corp / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Gold Road Resources Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Polymetal International PLC / Evolution Mining Ltd / Splunk Inc / Resolute Forest Products Inc / Hugo Boss AG / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / Coty Inc / Prothena Corporation PLC / ServiceNow Inc / Conifex Timber Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Xencor Inc / Varonis Systems Inc / boohoo group plc / B2Gold Corp / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Zalando SE / Aptose Biosciences Inc / Shopify Inc / Westrock Co / Surgery Partners Inc / Ferrari NV / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / CRISPR Therapeutics AG / GDS Holdings Ltd / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Vistra Corp / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Superdry PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Office Properties Income Trust / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Frasers Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Gohealth Inc / Allogene Therapeutics Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GILD: Gilead Sciences, Inc - Merck HIV Partnership: Follow-up from our call with Gilead management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.OQ / MRK.N</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: GSK: Readacross from Merck/Gilead collaboration in HIV</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ / GSK.L / MRK.N / 4507.T / PFE.N</td><td class="leftalignment">Gilead Sciences Inc / GlaxoSmithKline PLC / Merck & Co Inc / Shionogi & Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GILD: Gilead Sciences, Inc - Gilead to partner with Merck on long-acting HIV combo therapy providing a logical path forward for the franchise</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.OQ / MRK.N</td><td class="leftalignment">Gilead Sciences Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Calliditas submitted Nefecon NDA to US FDA, suggesting China filing might accelerate. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1952.HK / GILD.OQ / ARNA.OQ</td><td class="leftalignment">Everest Medicines Ltd / Gilead Sciences Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Oncology Doctor Day Takeaways – Breast Cancer</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / SGEN.OQ / ATNX.O</td><td class="leftalignment">Gilead Sciences Inc / Seagen Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / David Szeto / Yinglu Zhang / Lisa Walter / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Oncology Doctor Day Takeaways – Non-Hodgkin Lymphoma (Antibodies and Small Molecules)</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / INCY.O / KPTI.O / XNCR.OQ / 03835T200 / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Karyopharm Therapeutics Inc / Xencor Inc / Aptose Biosciences Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregory J. Renza, MD / Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Luca Issi, PHD / Yinglu Zhang / Leonid Timashev / David Szeto / Edwin Delfin / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Oncology Doctor Day Takeaways – NHL (Cell Therapy)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Luca Issi, PHD / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Lisa Walter / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Oncology Doctor Day Takeaways – MDS/MPN/AML</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / INCY.O / KPTI.O / XNCR.OQ / 03835T200 / APRE.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Karyopharm Therapeutics Inc / Xencor Inc / Aptose Biosciences Inc / Aprea Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / David Szeto / Yinglu Zhang / Lisa Walter / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Oncology Doctor Day Takeaways – Genitourinary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.O / EXEL.O / SGEN.OQ / ARWR.O</td><td class="leftalignment">Gilead Sciences Inc / Exelixis Inc / Seagen Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Edwin Delfin / David Szeto / Leonid Timashev / Lisa Walter / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BNTX/PFE efficacy in C19; (+) LentiGlobin news</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE.N / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Pfizer Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Momentum Soon Set for Major Rebalance</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AMGN=US / QCOM=US / INCY=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / TROW=US / MS=US / TER=US / SIVB=US / SWKS=US / BIIB=US / BX=US</td><td class="leftalignment">Amgen Inc / Qualcomm Inc / Incyte Corp / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / T Rowe Price Group Inc / Morgan Stanley / Teradyne Inc / SVB Financial Group / Skyworks Solutions Inc / Biogen Inc / Blackstone Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Global Gene Therapy Market: Current Analysis and Forecast (2020-2027)</td><td class="leftalignment">English</td><td class="rightalignment">302</td><td class="leftalignment">BGT=AU / BMY=US / GILD=US / NOVN=CH / BMRN=US / BLUE=US / null / BIIB=US / ORTX=US / RGNX=US / QURE=US</td><td class="leftalignment">Bio-Gene Technology Ltd / Bristol-Myers Squibb Co / Gilead Sciences Inc / Novartis AG / Biomarin Pharmaceutical Inc / bluebird bio Inc / One 97 Communications Ltd / Biogen Inc / Orchard Therapeutics PLC / Regenxbio Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Germany / Spain / France / United Kingdom / India / Italy / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">OPT=US / VBIV=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / BMY=US / MDT=US / AMZN=US / WMT=US / INSP=US / CMS=US / GILD=US / DGX=US / BBI=US / RMD=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ISRG=US / LH=US / PHAR=US / REGN=US / USPH=US / UHS=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MRNS=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / EHC=US / NMTR=US / TMDI=US / SPRO=US / ASND=US / ADUS=US / ACHC=US / PRTA=US / OM=US / FLXN=US / CTRE=US / ALDX=US / XENT=US / WBA=US / EVH=US / ZBH=US / CATB=US / LIVN=US / CERC=US / AVDL=US / SRRA=US / SLNO=US / SYNH=US / FIXX=US / MRKR=US / GMDA=US / PDSB=US / TMDX=US / BCYC=US / KRTX=US / BNTX=US / PNTG=US</td><td class="leftalignment">Opthea Ltd / VBI Vaccines Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Amazon.com Inc / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Brickell Biotech Inc / Resmed Inc / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / Pharming Group NV / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Titan Medical Inc / Spero Therapeutics Inc / Ascendis Pharma A/S / Addus Homecare Corp / Acadia Healthcare Company Inc / Prothena Corporation PLC / Outset Medical Inc / Pacira Biosciences Inc / CareTrust REIT Inc / Aldeyra Therapeutics Inc / Intersect Ent Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Zimmer Biomet Holdings Inc / Astria Therapeutics Inc / LivaNova PLC / Avalo Therapeutics Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Soleno Therapeutics Inc / Syneos Health Inc / Homology Medicines Inc / Marker Therapeutics Inc / Gamida Cell Ltd / PDS Biotechnology Corp / Transmedics Group Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / BioNTech SE / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.12.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / ALDX=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000121014 / US0028241000 / US00738A1060 / US00846U1016 / US0126531013 / US02553E1064 / US0311621009 / US0463531089 / US1101221083 / US17275R1023 / US22160K1051 / US2358511028 / US30226D1063 / US3156161024 / US3377381088 / US3647601083 / US3755581036 / US37733W1053 / US4364401012 / US4523271090 / US4781601046 / US48203R1041 / US5002551043 / US5324571083 / US6245801062 / US62855J1043 / US6549022043 / US6556641008 / US66987V1098 / US6701002056 / US7140461093 / US7170811035 / US75886F1075 / US87612E1064 / US8835561023 / US9021041085 / US91307C1027 / US9311421039 / US9418481035 / US30063P1057 / US37940X1028 / AU000000LYC6 / US2948216088 / US1167941087 / US31620M1062 / US57636Q1040 / US1717793095 / US79546E1047 / US55616P1049 / US90384S3031 / US92826C8394 / US58933Y1055 / US13100M5094 / US1920051067 / US9100471096 / US69404D1081 / US92335C1062 / US98978V1035 / US5017971046 / US64051T1007 / US45845P1084 / US69366J2006 / US63009R1095 / US03823U1025 / CH0210483332 / US09062W2044 / US0404131064 / US78667J1088 / US0994061002 / IE00BTN1Y115 / US46185L1035 / US6323071042 / US70450Y1038 / US72703H1014 / US8522341036 / US26856L1035 / US74967X1037 / NL0012169213 / CA1350861060 / US03236M2008 / US8760301072 / CA53680Q2071 / US74766Q1013 / US7625441040 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / KY30744W1070 / US40131M1099 / US53814L1089 / US90184D1000 / VGG1890L1076 / US05352A1007 / US76156B1070 / US71535D1063 / US39874R1014 / US00650F1093 / US88339P1012 / US24984K1051 / US88025U1097 / US30068X1037 / US92766K1060 / US14448C1045 / US12233L1070 / US57667L1070 / US0843101017 / US07373B1098 / CA67079A1021 / US5533681012 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US73739W1045 / US55406W1036 / US12047B1052 / US15961R1059</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abbott Laboratories / ADTRAN Inc / Agilent Technologies Inc / Albemarle Corp / American Eagle Outfitters Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cisco Systems Inc / Costco Wholesale Corp / Danaher Corp / Extreme Networks Inc / F5 Inc / Fiserv Inc / Gap Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Hologic Inc / Illumina Inc / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Eli Lilly and Co / Movado Group Inc / Myriad Genetics Inc / Nokia Oyj / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PerkinElmer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / Thermo Fisher Scientific Inc / II-VI Inc / United Therapeutics Corp / Walmart Inc / Waters Corp / Exact Sciences Corp / Global Payments Inc / Lynas Rare Earths Ltd / Telefonaktiebolaget LM Ericsson / Bruker Corp / Fidelity National Information Services Inc / Mastercard Inc / Ciena Corp / Sally Beauty Holdings Inc / Macy's Inc / Ulta Beauty Inc / Visa Inc / Merck & Co Inc / Calix Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Vera Bradley Inc / Zoetis Inc / Bath & Body Works Inc / NeoPhotonics Corp / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / Compagnie Financiere Richemont SA / BioLife Solutions Inc / Arista Networks Inc / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Medtronic PLC / Invitae Corp / Natera Inc / PayPal Holdings Inc / Planet Fitness Inc / Block Inc / elf Beauty Inc / RH / Qiagen NV / Canada Goose Holdings Inc / Amyris Inc / Tapestry Inc / Lithium Americas Corp / Quanterix Corp / Ribbon Communications Inc / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Farfetch Ltd / Guardant Health Inc / Livent Corp / Twist Bioscience Corp / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Personalis Inc / Grocery Outlet Holding Corp / Adaptive Biotechnologies Corp / RealReal Inc / DermTech Inc / 10X Genomics Inc / Exagen Inc / Virgin Galactic Holdings Inc / Carrier Global Corp / Burning Rock Biotech Ltd / Match Group Inc / Berkeley Lights Inc / Beam Global / Nuvei Corp / Mp Materials Corp / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / Poshmark Inc / MYT Netherlands Parent BV / Bumble Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / JNJ.N / LLY.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Johnson & Johnson / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Synthetic Lethality Primer - A Prelude to Innovative IDEAYAs in DNA Damage Repare and Next-Generation Targeted Oncology</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 2730190 / 5531000 / 7103065 / 2982924 / BCBVTX1 / BBFL7S1 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BYWVTY5 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BF3NP05 / BMDJ397</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / MorphoSys AG / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / CytomX Therapeutics Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mali / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead up 0.11% from 3 week low</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lenacapavir Positive in Treatment Experienced HIV Pts, PrEP Studies Coming</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended March 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Gilead Sciences Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Gilead up 0.77% from 3 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Gilead Sciences, Inc. (GILD) - Performance was due to Veklury sales which is expected to decline in next year</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FDS=US / WISH=US / MRK=US / VECO=US / ALL=US / BK=US / AMD=US / MSFT=US / C=US / CG=US / GL=US / BAC=US / NTRS=US / STT=US / USB=US / WFC=US / GILD=US / GS=US / FRC=US / AXP=US / JPM=US / HBAN=US / MMC=US / MET=US / BRK=US / AIG=US / BEN=US / TROW=US / GSK=US / LNC=US / BLK=US / JNJ=US / PBCT=US / PNC=US / CB=US / AFL=US / UNM=US / PGR=US / HIG=US / CI=US / COF=US / AIZ=US / CME=US / DFS=US / DG=US / AJG=US / MS=US / MCO=US / TRV=US / PFG=US / APO=US / PRU=US / L=US / RE=US / CINF=US / ZION=US / RJF=US / SIVB=US / RF=US / AON=US / NDAQ=US / TFC=US / MRNA=US / ACAD=US / GOOG=US / MKTX=US / OLED=US / INO=US / PERI=US / AMP=US / ICE=US / IVZ=US / WRB=US / SPGI=US / KKR=US / 005930-KR=US / CBOE=US / CFG=US / MSCI=US / SYF=US / WBA=US / CERC=US / WLTW=US / SLNO=US / MWK=US / KRTX=US / FUBO=US / ONDS=US</td><td class="leftalignment">Factset Research Systems Inc / ContextLogic Inc / Merck & Co Inc / Veeco Instruments Inc / Allstate Corp / Bank of New York Mellon Corp / Advanced Micro Devices Inc / Microsoft Corp / Citigroup Inc / Carlyle Group Inc / Globe Life Inc / Bank of America Corp / Northern Trust Corp / State Street Corp / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / Goldman Sachs Group Inc / First Republic Bank / American Express Co / JPMorgan Chase & Co / Huntington Bancshares Inc / Marsh & McLennan Companies Inc / MetLife Inc / Brooks Macdonald Group PLC / American International Group Inc / Franklin Resources Inc / T Rowe Price Group Inc / GlaxoSmithKline PLC / Lincoln National Corp / BlackRock Inc / Johnson & Johnson / People's United Financial Inc / PNC Financial Services Group Inc / Chubb Ltd / Aflac Inc / Unum Group / Progressive Corp / Hartford Financial Services Group Inc / Cigna Corp / Capital One Financial Corp / Assurant Inc / CME Group Inc / Discover Financial Services / Dollar General Corp / Arthur J Gallagher & Co / Morgan Stanley / Moody's Corp / Travelers Companies Inc / Principal Financial Group Inc / Apollo Global Management Inc / Prudential Financial Inc / Loews Corp / Everest Re Group Ltd / Cincinnati Financial Corp / Zions Bancorporation NA / Raymond James Financial Inc / SVB Financial Group / Regions Financial Corp / Aon PLC / Nasdaq Inc / Truist Financial Corp / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Marketaxess Holdings Inc / Universal Display Corp / Inovio Pharmaceuticals Inc / Perion Network Ltd / Ameriprise Financial Inc / Intercontinental Exchange Inc / Invesco Ltd / W R Berkley Corp / S&P Global Inc / KKR & Co Inc / Farfetch Ltd / Cboe Global Markets Inc / Citizens Financial Group Inc / MSCI Inc / Synchrony Financial / Walgreens Boots Alliance Inc / Avalo Therapeutics Inc / Willis Towers Watson PLC / Soleno Therapeutics Inc / Aterian Inc / Karuna Therapeutics Inc / Fubotv Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0231351067 / US0311621009 / US0463531089 / US1101221083 / US2358511028 / US3377381088 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US87612E1064 / US9021041085 / US91307C1027 / US9311421039 / US37940X1028 / US0042251084 / US0491642056 / US31620M1062 / US57636Q1040 / US92826C8394 / US00922R1059 / US58933Y1055 / US69404D1081 / US30303M1027 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US90184L1026 / US0396971071 / US78667J1088 / IE00BTN1Y115 / US81750R1023 / US6323071042 / US70450Y1038 / US8522341036 / US87164F1057 / US03236M2008 / US8760301072 / US05351X1019 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / US68373M1071 / US90184D1000 / US1255231003 / US62921N1054 / US05352A1007 / US92537N1081 / US68902V1070 / US07373B1098 / US56854Q2003 / CA67079A1021 / US74767V1098 / US21077C1071 / US7761531083 / US73739W1045 / US15961R1059</td><td class="leftalignment">Abbott Laboratories / Amazon.com Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Danaher Corp / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / II-VI Inc / United Therapeutics Corp / Walmart Inc / Global Payments Inc / ACADIA Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Fidelity National Information Services Inc / Mastercard Inc / Visa Inc / Air Transport Services Group Inc / Merck & Co Inc / Pacific Biosciences of California Inc / Meta Platforms Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Twitter Inc / Ardelyx Inc / SAGE Therapeutics Inc / Medtronic PLC / Seres Therapeutics Inc / Natera Inc / PayPal Holdings Inc / Block Inc / Syndax Pharmaceuticals Inc / Amyris Inc / Tapestry Inc / Avaya Holdings Corp / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Opera Ltd / Twist Bioscience Corp / Cigna Corp / NGM Biopharmaceuticals Inc / Avantor Inc / Vertiv Holdings Co / Otis Worldwide Corp / Beam Global / Marinus Pharmaceuticals Inc / Nuvei Corp / Quantumscape Corp / ContextLogic Inc / Romeo Power Inc / Poshmark Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / TEVA=US / GILD=US / LOW=US / CHRS=US / LEG=US / CI=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / AMSF=US / DIN=US / BIIB=US / TPX=US / EXP=US / CRD.B=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / RPRX=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / LOCO=US / SHAK=US / WING=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / SFIX=US / GOCO=US / AZEK=US / VTRS=US / DHT.UN=CA</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Lowe's Companies Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Cigna Corp / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Amerisafe Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Crawford & Co / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Royalty Pharma PLC / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Gohealth Inc / Azek Company Inc / Viatris Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2050832 / 2026242 / 2270726 / 2328915 / 2100920 / 2369174 / 2689560 / 2672689 / 2684703 / 2048804 / 2402121 / 2980906 / 7103065 / B1F76F9 / B121557 / 2769796 / B2R3PV1 / BCZS820 / BFZNYB7 / BDHF4K6 / BMQ5T49 / BWFKZT2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BDRW1L7 / BZ4CHH2 / BNG3RZ7 / BMC8SQ7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Pinnacle West Capital Corp / Nuance Communications Inc / Foot Locker Inc / Novartis AG / Western Union Co / Mastercard Inc / Fidelity National Information Services Inc / American Water Works Company Inc / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Zentalis Pharmaceuticals Inc / Cellectis SA / Evergy Inc / Spire Inc / Vistra Corp / AnaptysBio Inc / Soleno Therapeutics Inc / Leslie's Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Initiating on small cap royalty player with a Buy, $15 PT</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">DHT.UN=CA / RPRX.OQ / GILD=US / BIIB=US / RPRX=US / DHT_u.TO</td><td class="leftalignment">Dri Healthcare Trust / Royalty Pharma PLC / Gilead Sciences Inc / Biogen Inc / Royalty Pharma PLC / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Relatively Stable for Large Cap and SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Topical Panel Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">217</td><td class="leftalignment">US0028241000 / US0311621009 / US0463531089 / US1101221083 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US91307C1027 / US58933Y1055 / US69404D1081 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US78667J1088 / IE00BTN1Y115 / US03236M2008 / VGG312491084 / US90184D1000</td><td class="leftalignment">Abbott Laboratories / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Merck & Co Inc / Pacific Biosciences of California Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / SAGE Therapeutics Inc / Medtronic PLC / Amyris Inc / Establishment Labs Holdings Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Health Care Team / Cowen Washington Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Call Takeaways: HIV Therapeutic Landscape</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / GILD=US / GSK=US / JNJ=US / MRNA=US / INO=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Moderna Inc / Inovio Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IVA=FR / PASG=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / PRVL=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / LYS=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Inventiva SA / Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Porvair PLC / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Lysogene SA / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LSI=US / DIS=US / DVN=US / CMA=US / GILD=US / PEB=US / CHTR=US / PB=US / SCOR=US / EWBC=US / TRMK=US / MAR=US / SPOT=US / UMPQ=US / MRO=US / AKR=US / CMCSA=US / WTFC=US / CSTR=US / COLL=US / SAFE=US / PACW=US / VSEC=US / WAL=US / HTH=US / PSA=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / KIM=US / ASB=US / SSB=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / NFLX=US / UCBI=US / BRX=US / MGNI=US / PNFP=US / SBCF=US / BDSI=US / TCBI=US / FNB=US / FHN=US / EXR=US / RNST=US / SCPL=US / CADE=US / NMTR=US / NLSN=US / ZNGA=US / EA=US / FANG=US / IBTX=US / FIVN=US / HTRG=US / CABO=US / LOB=US / ACBI=US / LGF.B=US / PLYA=US / ROKU=US / NCNA=US / MBIN=US / SMAR=US / HWC=US / OZK=US / AMTB=US / OVV=US / 96758W101</td><td class="leftalignment">Life Storage Inc / Walt Disney Co / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Charter Communications Inc / Prosperity Bancshares Inc / Comscore Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Spotify Technology SA / Umpqua Holdings Corp / Marathon Oil Corp / Acadia Realty Trust / Comcast Corp / Wintrust Financial Corp / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / Safehold Inc / PacWest Bancorp / VSE Corp / Western Alliance Bancorp / Hilltop Holdings Inc / Public Storage / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Kimco Realty Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Netflix Inc / United Community Banks Inc / Brixmor Property Group Inc / Magnite Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Extra Space Storage Inc / Renasant Corp / Sciplay Corp / Cadence Bank / 9 Meters Biopharma Inc / Nielsen Holdings PLC / Zynga Inc / Electronic Arts Inc / Diamondback Energy Inc / Independent Bank Group Inc / Five9 Inc / Heritage Insurance Holdings Inc / Cable One Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Roku Inc / NuCana PLC / Merchants Bancorp / Smartsheet Inc / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / Ovintiv Inc / WideOpenWest Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 26, 2021: Focus on Novo GLP-1s</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 booster developments; 4Q20 & FY20 earnings</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.5.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt Color: European Patent Office upholds NCNA’s patent affecting GILD’s Sovaldi</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US / NCNA=US</td><td class="leftalignment">Gilead Sciences Inc / NuCana PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Minh Vong / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AFL.N / AIG.N / AMAT.O / AXAF.PA / BAC.N / BAER.S / BARC.L / BK.N / BMO.TO / BNS.TO / CM.TO / CMS.N / CP.TO / CSGN.S / DGE.L / EOG.N / F.N / FITB.O / HSBA.L / KEY.N / L.TO / LLOY.L / MMC.N / MUVGn.DE / NA.TO / NEM.N / NTRS.O / PB.N / PD.TO / PRU.L / SAN.MC / SOGN.PA / STO.AX / T.TO / TD.TO / TRV.N / USB.N / ZION.O / CMA.N / TRI.N / WY.N / CNQ.TO / GILD.O / FNV.N / POW.TO / TA.TO / RCIb.TO / MET.N / CNR.TO / HBAN.O / ENB.TO / TRP.TO / SU.TO / GS.N / HON.N / MFC.TO / WM.N / UNM.N / AEM.N / MGA.N / BBVA.MC / GIBa.TO / IAG.TO / RDN.N / VLY.N / PACW.O / AMP.N / CINF.O / LNC.N / EQT.N / NLY.N / EPD.N / AWK.N / ARE.N / PLD.N / RSG.N / WSP.TO / MTB.N / OTEX.O / DB1Gn.DE / ARCC.O / FTS.TO / CWB.TO / PFG.N / EMA.TO / CIX.TO / SM.N / AV.L / RF.N / FLS.CO / COP.N / CNP.N / SLF.TO / TSCO.O / CFR.N / WCN.N / DOL.TO / BRO.N / RLI.N / WBS.N / FCF.N / LNG.A / MFA.N / PFS.N / X.TO / EFX.TO / CCLb.TO / FFBC.O / SIGI.O / SIVB.O / WSBC.O / BPOP.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / EQIX.O / STN.TO / ATDb.TO / GOLD.N / TIH.TO / TFC.N / INGA.AS / CSH_u.TO / 878742204 / FHN.N / AINV.O / NTR.N / SCL.TO / MAIN.N / IGM.TO / 416515104 / WAL.N / RDSb.L / BAM.N / MS.N / 025676206 / ISBC.O / CTCa.TO / BLX.TO / MA.N / MWA.N / CSU.TO / PPL.TO / CIM.N / BIP.N / WRB.N / AGNC.O / ARX.TO / CLW.N / HOMB.O / IFC.TO / TCN.TO / NEE.N / TOU.TO / CJT.TO / FRU.TO / BKU.N / FHI.N / TWO.N / GEI.TO / PXT.TO / WTE.TO / XYL.N / SLM.OQ / EFN.TO / ALLY.N / NYCB.N / APAM.N / GRT_u.TO / ORCC.N / PRMW.N / VOYA.N / BEP.N / ONB.OQ / TSLX.N / ARES.N / KXS.TO / NMIH.O / CFG.N / GWB.N / QSR.N / ASB.N / EVA.N / SHOP.N / CIGI.O / TOY.TO / OMF.N / RMR.OQ / UBSG.S / KNSL.OQ / BBU.N / AKERBP.OL / ONEX.TO / AQN.N / CADE.N / WPM.N / KL.N / AQUA.N / AY.O / APTV.N / 05971J102 / VCTR.N / BSIG.N / GSHD.O / MI_U.TO / BHC.N / FOCS.O / FCR_u.TO / GFL.N / LUNE.ST / NVEI.TO / LSEG.L / WFG.N / TIXT.TO / 120681711</td><td class="leftalignment">Aflac Inc / American International Group Inc / Applied Materials Inc / AXA SA / Bank of America Corp / Julius Baer Gruppe AG / Barclays PLC / Bank of New York Mellon Corp / Bank of Montreal / Bank of Nova Scotia / Canadian Imperial Bank of Commerce / CMS Energy Corp / Canadian Pacific Railway Ltd / Credit Suisse Group AG / Diageo PLC / EOG Resources Inc / Ford Motor Co / Fifth Third Bancorp / HSBC Holdings PLC / KeyCorp / Loblaw Companies Ltd / Lloyds Banking Group PLC / Marsh & McLennan Companies Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Newmont Corporation / Northern Trust Corp / Prosperity Bancshares Inc / Precision Drilling Corp / Prudential PLC / Banco Santander SA / Societe Generale SA / Santos Ltd / Telus Corp / Toronto-Dominion Bank / Travelers Companies Inc / US Bancorp / Zions Bancorporation NA / Comerica Inc / Thomson Reuters Corp / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / Power Corporation of Canada / TransAlta Corp / Rogers Communications Inc / MetLife Inc / Canadian National Railway Co / Huntington Bancshares Inc / Enbridge Inc / TC Energy Corp / Suncor Energy Inc / Goldman Sachs Group Inc / Honeywell International Inc / Manulife Financial Corp / Waste Management Inc / Unum Group / Agnico Eagle Mines Ltd / Magna International Inc / Banco Bilbao Vizcaya Argentaria SA / CGI Inc / iA Financial Corporation Inc / Radian Group Inc / Valley National Bancorp / PacWest Bancorp / Ameriprise Financial Inc / Cincinnati Financial Corp / Lincoln National Corp / EQT Corp / Annaly Capital Management Inc / Enterprise Products Partners LP / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / Republic Services Inc / WSP Global Inc / M&T Bank Corp / Open Text Corp / Deutsche Boerse AG / Ares Capital Corp / Fortis Inc / Canadian Western Bank / Principal Financial Group Inc / Emera Inc / CI Financial Corp / SM Energy Co / Aviva PLC / Regions Financial Corp / FLSmidth & Co A/S / Conocophillips / CenterPoint Energy Inc / Sun Life Financial Inc / Tractor Supply Co / Cullen/Frost Bankers Inc / Waste Connections Inc / Dollarama Inc / Brown & Brown Inc / Rli Corp / Webster Financial Corp / First Commonwealth Financial Corp / Cheniere Energy Inc / MFA Financial Inc / Provident Financial Services Inc / TMX Group Ltd / Enerflex Ltd / CCL Industries Inc / First Financial Bancorp / Selective Insurance Group Inc / SVB Financial Group / WesBanco Inc / Popular Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Equinix Inc / Stantec Inc / Alimentation Couche-Tard Inc / Barrick Gold Corp / Toromont Industries Ltd / Truist Financial Corp / ING Groep NV / Chartwell Retirement Residences / Teck Resources Ltd / First Horizon Corp / Apollo Investment Corp / Nutrien Ltd / Shawcor Ltd / Main Street Capital Corp / IGM Financial Inc / Hartford Financial Services Group Inc / Western Alliance Bancorp / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Morgan Stanley / American Equity Investment Life Holding Co / Investors Bancorp Inc / Canadian Tire Corporation Ltd / Boralex Inc / Mastercard Inc / Mueller Water Products Inc / Constellation Software Inc / Pembina Pipeline Corp / Chimera Investment Corp / Brookfield Infrastructure Partners LP / W R Berkley Corp / AGNC Investment Corp / ARC Resources Ltd / Clearwater Paper Corp / Home BancShares Inc / Intact Financial Corp / Tricon Residential Inc / Nextera Energy Inc / Tourmaline Oil Corp / Cargojet Inc / Freehold Royalties Ltd / BankUnited Inc / Federated Hermes Inc / Two Harbors Investment Corp / Gibson Energy Inc / Parex Resources Inc / Westshore Terminals Investment Corp / Xylem Inc / SLM Corp / Element Fleet Management Corp / Ally Financial Inc / New York Community Bancorp Inc / Artisan Partners Asset Management Inc / Granite Real Estate Investment Trust / Owl Rock Capital Corp / Primo Water Corp / Voya Financial Inc / Brookfield Renewable Partners LP / Old National Bancorp / Sixth Street Specialty Lending Inc / Ares Management Corp / Kinaxis Inc / NMI Holdings Inc / Citizens Financial Group Inc / Great Western Bancorp Inc / Restaurant Brands International Inc / Associated Banc-Corp / Enviva Inc / Shopify Inc / Colliers International Group Inc / Spin Master Corp / OneMain Holdings Inc / RMR Group Inc / UBS Group AG / Kinsale Capital Group Inc / Brookfield Business Partners LP / Aker BP ASA / Onex Corp / Algonquin Power & Utilities Corp / Cadence Bank / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Cadence Bank / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Goosehead Insurance Inc / Minto Apartment Real Estate Investment Trust / Bausch Health Companies Inc / Focus Financial Partners Inc / First Capital Real Estate Investment Trust / GFL Environmental Inc / Lundin Energy AB / Nuvei Corp / London Stock Exchange Group PLC / West Fraser Timber Co Ltd / Telus International Cda Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Netherlands / Norway / Puerto Rico / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / PORTFOLIO/ASSET STRATEGIES / Research Digest / Equity</td><td class="leftalignment">Lindsay Brent</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Share of 12% a New High; Teva's Gx Nuvaring Gaining Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">TEVA.TA / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / PD=US / AMZN=US / DVN=US / GILD=US / EOG=US / CRM=US / V=US / SCOR=US / MRO=US / EXPE=US / TNL=US / MANH=US / AIR=US / AVGO=US / ELY=US / MAIN=US / NTST=US / SNAP=US / TRIP=US / VSEC=US / WIX=US / FOUR=US / CVX=US / EPD=US / SNOW=US / PYPL=US / BKNG=US / ADC=US / FB=US / CRTO=US / AUTL=US / VICI=US / PTON=US / FLT=US / LHCG=US / GMS=US / MA=US / GPRE=US / PAG=US / CLR=US / PRPL=US / NOG=US / ATSG=US / AGS=US / CLNY=US / KNSL=US / HGV=US / NXPI=US / ESTE=US / VAC=US / MTDR=US / SPLK=US / PDCE=US / FANG=US / FEYE=US / GOOGL=US / QTWO=US / BABA=US / CMPR=US / WK=US / GDDY=US / ON=US / ARGX=US / ZS=US / WVE=US / CRSP=US / TRVG=US / PLYA=US / OKTA=US / SBOW=US / SFIX=US / FTDR=US / SVMK=US / ALLO=US / ESTC=US / LYFT=US / UBER=US / NXTC=US / OVV=US / ZI=US / BIGC=US / BALY=US / ABNB=US</td><td class="leftalignment">Amgen Inc / PagerDuty Inc / Amazon.com Inc / Devon Energy Corp / Gilead Sciences Inc / EOG Resources Inc / Salesforce.Com Inc / Visa Inc / Comscore Inc / Marathon Oil Corp / Expedia Group Inc / Travel + Leisure Co / Manhattan Associates Inc / AAR Corp / Broadcom Inc / Callaway Golf Co / Main Street Capital Corp / Netstreit Corp / Snap Inc / Tripadvisor Inc / VSE Corp / Wix.Com Ltd / Shift4 Payments Inc / Chevron Corp / Enterprise Products Partners LP / Snowflake Inc. / PayPal Holdings Inc / Booking Holdings Inc / Agree Realty Corp / Meta Platforms Inc / Criteo SA / Autolus Therapeutics PLC / VICI Properties Inc / Peloton Interactive Inc / Fleetcor Technologies Inc / LHC Group Inc / GMS Inc / Mastercard Inc / Green Plains Inc / Penske Automotive Group Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Air Transport Services Group Inc / PlayAGS Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Matador Resources Co / Splunk Inc / PDC Energy Inc / Diamondback Energy Inc / Mandiant Inc / Alphabet Inc / Q2 Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / GoDaddy Inc / ON Semiconductor Corp / argenx SE / Zscaler Inc / WAVE Life Sciences Ltd / CRISPR Therapeutics AG / Trivago NV / Playa Hotels & Resorts NV / Okta Inc / SilverBow Resources Inc / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Elastic NV / Lyft Inc / Uber Technologies Inc / NextCure Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Bally's Corp / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">No Surprises In 4Q20 Earnings. Valuation Is Very Attractive For Entry Into This High Quality Name</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AUTL=US / GILD=US</td><td class="leftalignment">Autolus Therapeutics PLC / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / JNJ.N / LLY.N / MRK.N / AZN.L / SASY.PA / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Cash Conversion Cycle 2010-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Mar. 04, 2021 / 12:10PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MANTA Interim Safety Results OK for Filgo, IBD Still TBD</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD=US / GLPG=US</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GLPG/GILD: MANTA(RAy) of Hope: Filg Clean in Key Safety Study, but Likely Too Late to Salvage Prior Potential</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ / GLPG.AS / GILD.O / GLPG.O</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV / Gilead Sciences Inc / Galapagos NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AAP.N / CAS.TO / CC.N / CCK.N / CE.N / CF.N / DD.N / F.N / GM.N / IP.N / PPG.N / RWEG.DE / UU.L / GILD.O / UHS.N / WLK.N / OLN.N / BLL.N / HCA.N / ARNA.O / AZO.N / ROST.O / SLGN.O / ANF.N / URBN.O / LTC.N / ORLY.O / MOS.N / HUN.N / LHCG.O / BGS.N / EDPR.LS / GLEN.L / SMSS.L / BERY.N / CAPL.N / AXTA.N / WRK.N / UN01.DE / ORSTED.CO / CTVA.N / 260557103 / 77311W101 / BSY.O</td><td class="leftalignment">Advance Auto Parts Inc / Cascades Inc / Chemours Co / Crown Holdings Inc / Celanese Corp / CF Industries Holdings Inc / Dupont De Nemours Inc / Ford Motor Co / General Motors Co / International Paper Co / PPG Industries Inc / Rwe AG / United Utilities Group PLC / Gilead Sciences Inc / Universal Health Services Inc / Westlake Chemical Corp / Olin Corp / Ball Corp / HCA Healthcare Inc / Arena Pharmaceuticals Inc / Autozone Inc / Ross Stores Inc / Silgan Holdings Inc / Abercrombie & Fitch Co / Urban Outfitters Inc / LTC Properties Inc / O'Reilly Automotive Inc / Mosaic Co / Huntsman Corp / LHC Group Inc / B&G Foods Inc / EDP Renovaveis SA / Glencore PLC / Smart Metering Systems PLC / Berry Global Group Inc / Crossamerica Partners LP / Axalta Coating Systems Ltd / Westrock Co / Uniper SE / Orsted A/S / Corteva Inc / Dow Inc / Rocket Companies Inc / Bentley Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Germany / Denmark / Spain / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Cat Got Your Drug? GS-441524 Could Provide GILD Long-Term COVID Optionality</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended January 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Gilead strengthens 4.2% in past quarter; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Gilead Sciences, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CP.TO / EOG.N / NSC.N / SGC.L / STO.AX / BFb.N / PXD.N / CNQ.TO / GILD.O / INCY.O / FER.MC / ETN.N / CNR.TO / CSX.N / SU.TO / UNP.N / MRO.N / DVN.N / RRC.N / EQT.N / ADSK.O / EPD.N / NBIX.O / VTR.N / VRTX.O / SM.N / NET.N / COP.N / CNP.N / CPE.N / BLU.N / SWN.N / LNG.A / EFX.TO / BLUE.O / BCRX.O / ICPT.O / BIIB.O / SCL.TO / ACAD.O / RDSb.L / HICL.L / ATL.MI / PPL.TO / VMW.N / INO.OQ / CLW.N / TOU.TO / FRU.TO / PXT.TO / MTDR.N / AMCX.O / ACHC.O / VCRA.N / SPLK.OQ / SRPT.O / FANG.O / KPT.TO / PRGO.N / ENTA.O / BEP.N / KPTI.O / ITCI.O / QURE.O / VRNS.O / AGRX.O / 78667J108 / EVA.N / CIGI.O / GLPG.O / GBT.OQ / RGNX.O / ADVM.OQ / TWLO.N / AKERBP.OL / OKTA.OQ / CDEV.O / ESTE.N / GRPG.I / ATNX.O / ORSTED.CO / WELL.N / DBX.O / PRVB.O / ESTC.N / GMDA.OQ / ZM.O / KRTX.OQ / CRWD.O / DDOG.O / APA.OQ / JAMF.O / PLTR.N</td><td class="leftalignment">Canadian Pacific Railway Ltd / EOG Resources Inc / Norfolk Southern Corp / Stagecoach Group PLC / Santos Ltd / Brown-Forman Corp / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Incyte Corp / Ferrovial SA / Eaton Corporation PLC / Canadian National Railway Co / CSX Corp / Suncor Energy Inc / Union Pacific Corp / Marathon Oil Corp / Devon Energy Corp / Range Resources Corp / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / Neurocrine Biosciences Inc / Ventas Inc / Vertex Pharmaceuticals Inc / SM Energy Co / Cloudflare Inc / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / BELLUS Health Inc / Southwestern Energy Co / Cheniere Energy Inc / Enerflex Ltd / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Royal Dutch Shell PLC / HICL Infrastructure PLC / Atlantia SpA / Pembina Pipeline Corp / VMware Inc / Inovio Pharmaceuticals Inc / Clearwater Paper Corp / Tourmaline Oil Corp / Freehold Royalties Ltd / Parex Resources Inc / Matador Resources Co / AMC Networks Inc / Acadia Healthcare Company Inc / Vocera Communications Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / KP Tissue Inc / Perrigo Company PLC / Enanta Pharmaceuticals Inc / Brookfield Renewable Partners LP / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Varonis Systems Inc / Agile Therapeutics Inc / SAGE Therapeutics Inc / Enviva Inc / Colliers International Group Inc / Galapagos NV / Global Blood Therapeutics Inc / Regenxbio Inc / Adverum Biotechnologies Inc / Twilio Inc / Aker BP ASA / Okta Inc / Centennial Resource Development Inc / Earthstone Energy Inc / Greencoat Renewables PLC / Athenex Inc / Orsted A/S / Welltower Inc / Dropbox Inc / Provention Bio Inc / Elastic NV / Gamida Cell Ltd / Zoom Video Communications Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Datadog Inc / APA Corp (US) / Jamf Holding Corp / Palantir Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT (BUY) - Lightning Strikes Twice with Immune-Stimulating ADCs; Initiating with a BUY and $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BMDJ397 / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2457864 / 2684703 / 7103065 / 2982924 / BFDV8K0 / BMQ5T49 / BKVDFF7 / BYQHPK7 / BL71K91 / BN2R582 / BG0Q4Y1 / BF3NP05</td><td class="leftalignment">Bolt Biotherapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Zymeworks Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Exicure Inc / Mersana Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: February 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / AAL.OQ / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / BLUE.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / KPTI.O / ITCI.O / 78667J108 / GLPG.O / GBT.OQ / PRVB.O / GMDA.OQ / KRTX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Provention Bio Inc / Gamida Cell Ltd / Karuna Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AWK / C / CNI / CP / DVN / EOG / JNJ / MGY / NSC / OLN / PVH / PXD / RKT / UNP / WLK / ASND.O / GILD.O / AMGN.O / SGMO.O / ARNA.O / ISRG.O / REGN.O / TSCO.O / CALA.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ZIOP.O / ARCT.O / RGLS.O / FANG.O / MEIP.O / RNA.O / FATE.O / QURE.O / AGTC.O / AFMD.O / BLCM.O / TCON.O / ZBH / CYAD.O / GBT.O / VYGR.O / CSX.O / IONS.O / ADAP.O / EDIT.O / AGLE.O / NTLA.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / IOVA.O / CDLX.O / AVRO.O / AUTL.O / KZR.O / STRO.O / CPRI.K / TPTX.O / RTLR.O / MORF.O / BCSF.K / IMV.O / PGEN.O / GHLD.K / GRCL.O / 87975H100</td><td class="leftalignment">American Water Works Company Inc / Citigroup Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Devon Energy Corp / EOG Resources Inc / Johnson & Johnson / Magnolia Oil & Gas Corp / Norfolk Southern Corp / Olin Corp / PVH Corp / Pioneer Natural Resources Co / Rocket Companies Inc / Union Pacific Corp / Westlake Chemical Corp / Ascendis Pharma A/S / Gilead Sciences Inc / Amgen Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / Calithera Biosciences Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Diamondback Energy Inc / MEI Pharma Inc / Avidity Biosciences Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Affimed NV / Bellicum Pharmaceuticals Inc / TRACON Pharmaceuticals Inc / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / CSX Corp / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Cardlytics Inc / AVROBIO Inc / Autolus Therapeutics PLC / Kezar Life Sciences Inc / Sutro Biopharma Inc / Capri Holdings Ltd / Turning Point Therapeutics Inc / Rattler Midstream LP / Morphic Holding Inc / Bain Capital Specialty Finance Inc / IMV Inc / Precigen Inc / Guild Holdings Co / Gracell Biotechnologies Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EDIT=US / MRNA=US / ADAP=US / MRK=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / DRRX=US / ISEE=US / GRTS=US / ICPT=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NK=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / VKTX=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / CWBR=US / NGM=US / KOD=US / AXLA=US / STOK=US / AKRO=US / NBSE=US / ETNB=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Editas Medicine Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / DURECT Corp / Iveric Bio Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Immunitybio Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Kodiak Sciences Inc / Axcella Health Inc / Stoke Therapeutics Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Suspending Coverage: Biotechnology</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BLCM.O / GILD.O / REGN.O / ICPT.O / BIIB.O / IMV.O</td><td class="leftalignment">Amgen Inc / Bellicum Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / IMV Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / ANTO.L / BAC.N / BARC.L / BCE.TO / BK.N / BNPP.PA / C.N / CCI.N / CL.N / CMS.N / COF.N / CSGN.S / DGE.L / EIX.N / EL.N / EOG.N / F.N / FITB.O / GM.N / HSBA.L / JPM.N / KEY.N / KMB.N / KO.N / L.TO / MRK.N / NEM.N / NTRS.O / PFE.N / PNC.N / RIO.L / SO.N / SOGN.PA / T.N / T.TO / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CNQ.TO / GILD.O / FNV.N / ASML.O / CPB.N / TEN.N / CMCSA.O / SJRb.TO / TA.TO / RCIb.TO / AMGN.O / FER.MC / AAL.L / CNR.TO / DUK.N / QBRb.TO / HBAN.O / BWA.N / LEA.N / PNM.N / ENB.TO / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / IMO.TO / GS.N / DBKGn.DE / CLX.N / CAG.N / HON.N / MFC.TO / GIS.N / PCG.N / AEM.N / XOM.N / EPC.N / MGA.N / SBAC.O / AMT.N / BOL.ST / CONE.O / ADI.O / VZ.N / STT.N / EXEL.O / MDRX.O / ALA.TO / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / DSGX.O / FISV.O / SNPS.O / V.N / AXL.N / AWK.N / ARE.N / PLD.N / CHD.N / MTB.N / BC.N / FTS.TO / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / CVX.N / EMA.TO / MU.O / CAGR.PA / NCR.N / NET.N / TEL.N / RF.N / FLS.CO / CNP.N / APF.L / ENDP.O / MEOH.O / CPK.N / DOL.TO / FRC.N / PII.N / ST.N / SWN.N / WES.N / SEM.N / ADS.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / ATDb.TO / TFC.N / INGA.AS / 02209S103 / DLR.N / 427866108 / RDSb.L / BLDR.O / DISCA.O / CDNS.O / MS.N / FIS.N / CCOI.O / HICL.L / CTCa.TO / BLX.TO / MA.N / MWA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / BIP.N / SII.TO / CLW.N / VALE.N / SPB.N / ENV.N / BHPB.L / NEE.N / NXT.AX / CAML.L / MTOR.N / GLEN.L / GEI.TO / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / BEP.N / AGIO.O / VRNS.O / AGRX.O / CFG.N / DEA.N / SHOP.N / PYPL.OQ / SQ.N / RACE.MI / UBSG.S / ADNT.N / FRTA.OQ / GDS.O / PBYI.OQ / AQN.N / VST.N / WOW.N / ATUS.N / GRPG.I / ATNX.O / AQUA.N / AY.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / ESTC.N / NWL.O / 269796108 / ZM.O / CRWD.O / GMAB.O / PING.N / CRNC.OQ / REYN.O / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / 77311W101 / LUMN.N / PTVE.O / BSY.O / MAX.N / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Antofagasta PLC / Bank of America Corp / Barclays PLC / BCE Inc / Bank of New York Mellon Corp / BNP Paribas SA / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Credit Suisse Group AG / Diageo PLC / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / HSBC Holdings PLC / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Merck & Co Inc / Newmont Corporation / Northern Trust Corp / Pfizer Inc / PNC Financial Services Group Inc / Rio Tinto PLC / Southern Co / Societe Generale SA / AT&T Inc / Telus Corp / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / ASML Holding NV / Campbell Soup Co / Tenneco Inc / Comcast Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Amgen Inc / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Enbridge Inc / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Imperial Oil Ltd / Goldman Sachs Group Inc / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Manulife Financial Corp / General Mills Inc / PG&E Corp / Agnico Eagle Mines Ltd / Exxon Mobil Corp / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / American Tower Corp / Boliden AB / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Allscripts Healthcare Solutions Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Descartes Systems Group Inc / Fiserv Inc / Synopsys Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / M&T Bank Corp / Brunswick Corp / Fortis Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Emera Inc / Micron Technology Inc / Credit Agricole SA / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / FLSmidth & Co A/S / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / Methanex Corp / Chesapeake Utilities Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Western Midstream Partners LP / Select Medical Holdings Corp / Alliance Data Systems Corp / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / ING Groep NV / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Royal Dutch Shell PLC / Builders FirstSource Inc / Discovery Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / HICL Infrastructure PLC / Canadian Tire Corporation Ltd / Boralex Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Brookfield Infrastructure Partners LP / Sprott Inc / Clearwater Paper Corp / Vale SA / Spectrum Brands Holdings Inc / Envestnet Inc / BHP Group PLC / Nextera Energy Inc / NEXTDC Ltd / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Gibson Energy Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Agile Therapeutics Inc / Citizens Financial Group Inc / Easterly Government Properties Inc / Shopify Inc / PayPal Holdings Inc / Block Inc / Ferrari NV / UBS Group AG / Adient PLC / Forterra Inc / GDS Holdings Ltd / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Vistra Corp / WideOpenWest Inc / Altice USA Inc / Greencoat Renewables PLC / Athenex Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - March 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">CNR.TO / AMAT.O / BCE.TO / BMO.TO / CL.N / CM.TO / CMS.N / CP.TO / DGE.L / EL.N / EOG.N / F.N / KMB.N / KO.N / L.TO / NA.TO / NEM.N / PD.TO / T.TO / TD.TO / PEP.N / TRI.N / BFb.N / PG.N / WY.N / CNQ.TO / GILD.O / FNV.N / CPB.N / SJRb.TO / TA.TO / RCIb.TO / AGI.N / QBRb.TO / CCA.TO / ENB.TO / TRP.TO / K.N / IMO.TO / SU.TO / CLX.N / CAG.N / HON.N / MFC.TO / GIS.N / AEM.N / EPC.N / MGA.N / GIBa.TO / IAG.TO / ALA.TO / STZ.N / DSGX.O / AWK.N / ARE.N / PLD.N / CHD.N / WSP.TO / OTEX.O / FTS.TO / SAM.N / CWB.TO / EXE.TO / ENR.N / ARE.TO / EMA.TO / CAR_u.TO / FLS.CO / SLF.TO / TSCO.O / MEOH.O / WCN.N / DOL.TO / MNST.O / CCLb.TO / RGLD.O / CASY.O / EQIX.O / STN.TO / ATDb.TO / GOLD.N / TIH.TO / TFC.N / INGA.AS / CSH_u.TO / 02209S103 / 878742204 / NTR.N / 427866108 / RDSb.L / BAM.N / CRR_u.TO / CTCa.TO / BLX.TO / MWA.N / CSU.TO / ET.TO / AUY.N / BGS.N / PPL.TO / INE.TO / BIP.N / SII.TO / CLW.N / AND.TO / IFC.TO / SPB.N / TCN.TO / NEE.N / TOU.TO / JE.TO / CJT.TO / FRU.TO / GEI.TO / WTE.TO / XYL.N / EFN.TO / MDLZ.OQ / GRT_u.TO / KPT.TO / PRMW.N / COTY.N / BEP.N / PLZ_u.TO / BTG.N / KXS.TO / QSR.N / SHOP.N / NXE.TO / OR.N / ONEX.TO / SAND.N / AQN.N / WPM.N / KL.N / AQUA.N / AY.O / APTV.N / MI_U.TO / KDP.N / BHC.N / NWL.O / FCR_u.TO / REYN.O / GFL.N / LUNE.ST / NVEI.TO / WFG.N / 120681711</td><td class="leftalignment">Canadian National Railway Co / Applied Materials Inc / BCE Inc / Bank of Montreal / Colgate-Palmolive Co / Canadian Imperial Bank of Commerce / CMS Energy Corp / Canadian Pacific Railway Ltd / Diageo PLC / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / National Bank of Canada / Newmont Corporation / Precision Drilling Corp / Telus Corp / Toronto-Dominion Bank / PepsiCo Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Alamos Gold Inc / Quebecor Inc / Cogeco Communications Inc / Enbridge Inc / TC Energy Corp / Kellogg Co / Imperial Oil Ltd / Suncor Energy Inc / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Manulife Financial Corp / General Mills Inc / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / Magna International Inc / CGI Inc / iA Financial Corporation Inc / AltaGas Ltd / Constellation Brands Inc / Descartes Systems Group Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / WSP Global Inc / Open Text Corp / Fortis Inc / Boston Beer Company Inc / Canadian Western Bank / Extendicare Inc / Energizer Holdings Inc / Aecon Group Inc / Emera Inc / Canadian Apartment Properties Real Estate Investment Trust / FLSmidth & Co A/S / Sun Life Financial Inc / Tractor Supply Co / Methanex Corp / Waste Connections Inc / Dollarama Inc / Monster Beverage Corp / CCL Industries Inc / Royal Gold Inc / Caseys General Stores Inc / Equinix Inc / Stantec Inc / Alimentation Couche-Tard Inc / Barrick Gold Corp / Toromont Industries Ltd / Truist Financial Corp / ING Groep NV / Chartwell Retirement Residences / Altria Group Inc / Teck Resources Ltd / Nutrien Ltd / Hershey Co / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Crombie Real Estate Investment Trust / Canadian Tire Corporation Ltd / Boralex Inc / Mueller Water Products Inc / Constellation Software Inc / Evertz Technologies Ltd / Yamana Gold Inc / B&G Foods Inc / Pembina Pipeline Corp / Innergex Renewable Energy Inc / Brookfield Infrastructure Partners LP / Sprott Inc / Clearwater Paper Corp / Andlauer Healthcare Group Inc / Intact Financial Corp / Spectrum Brands Holdings Inc / Tricon Residential Inc / Nextera Energy Inc / Tourmaline Oil Corp / Just Energy Group Inc / Cargojet Inc / Freehold Royalties Ltd / Gibson Energy Inc / Westshore Terminals Investment Corp / Xylem Inc / Element Fleet Management Corp / Mondelez International Inc / Granite Real Estate Investment Trust / KP Tissue Inc / Primo Water Corp / Coty Inc / Brookfield Renewable Partners LP / Plaza Retail REIT / B2Gold Corp / Kinaxis Inc / Restaurant Brands International Inc / Shopify Inc / Nexgen Energy Ltd / Osisko Gold Royalties Ltd / Onex Corp / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Minto Apartment Real Estate Investment Trust / Keurig Dr Pepper Inc / Bausch Health Companies Inc / Newell Brands Inc / First Capital Real Estate Investment Trust / Reynolds Consumer Products Inc / GFL Environmental Inc / Lundin Energy AB / Nuvei Corp / West Fraser Timber Co Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: RBC Global Environmental, Social and Governance Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">AMAT.O / CMS.N / DGE.L / EOG.N / F.N / NEM.N / T.TO / WY.N / CNQ.TO / GILD.O / FNV.N / TA.TO / CNR.TO / SU.TO / HON.N / MFC.TO / AEM.N / AWK.N / ARE.N / PLD.N / WSP.TO / EMA.TO / FLS.CO / SLF.TO / TSCO.O / EQIX.O / STN.TO / TFC.N / INGA.AS / 878742204 / RDSb.L / BLX.TO / MWA.N / NEE.N / XYL.N / BEP.N / SHOP.N / AQUA.N / AY.O / APTV.N / LUNE.ST</td><td class="leftalignment">Applied Materials Inc / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Ford Motor Co / Newmont Corporation / Telus Corp / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / TransAlta Corp / Canadian National Railway Co / Suncor Energy Inc / Honeywell International Inc / Manulife Financial Corp / Agnico Eagle Mines Ltd / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / WSP Global Inc / Emera Inc / FLSmidth & Co A/S / Sun Life Financial Inc / Tractor Supply Co / Equinix Inc / Stantec Inc / Truist Financial Corp / ING Groep NV / Teck Resources Ltd / Royal Dutch Shell PLC / Boralex Inc / Mueller Water Products Inc / Nextera Energy Inc / Xylem Inc / Brookfield Renewable Partners LP / Shopify Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Lundin Energy AB</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Automotive / Banks / Beverages & Tobacco / Biotechnology / Building & Building Materials / Conglomerates / Consumer / Energy / Engineering & Construction / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Info. Tech./Software / Insurance / Machinery / Manufacturing / Media / Metals & Minerals / Pharmaceuticals / Railroads / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Sam Crittenden, CFA / Mike Dahl / Mr. Deane Dray, CFA / Mr. James Edwardes Jones / Scott M. Hanold / Herr. Nick Housden / Mr. Sabahat Khan / Robert M. Kwan, CFA / Drew McReynolds, CFA / Darko Mihelic, CFA / Sara Mahaffy / Mr. Nelson Ng, CFA / Greg M. Pardy, CFA / Mr. Paul C. Quinn / Anke Reingen / Mr. Joseph Spak, CFA / Walter N. Spracklin, CFA / Mr. Al J. Stanton / Mr. Mitch T. Steves / Mr. Paul Treiber, CFA / Mr. Shelby Tucker, CFA / Brian Abrahams, MD / Mr. Josh M. Wolfson / Jonathan Atkin / Mr. Biraj Borkhataria / Michael W. Carroll, CFA / Gerard S. Cassidy / Mr. Maurice Choy / Scot Ciccarelli, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 81 US Companies with Undisclosed SEC Probes - March 01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">T.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / FB.OQ / XPO.N / CTG.OQ / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / CVNA.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Meta Platforms Inc / XPO Logistics Inc / Computer Task Group Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Carvana Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Biotechnology / Broadcasting & Cable / Consumer / Education / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine boosters; BEAM acquires GuideTx</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.26.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canada Weekly Portfolio Manager's Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMAT.O / BP.L / CMS.N / CNE.L / DGE.L / ENI.MI / EOG.N / F.N / NA / NVA.TO / PD.TO / REP.MC / STO.AX / TLW.L / TOTF.PA / WPL.AX / TRI.N / PXD.N / CFP.TO / CNQ.TO / GILD.O / TA.TO / IMO.TO / SU.TO / BTE.TO / HON.N / VLO.N / MFC.TO / MRO.N / XOM.N / DVN.N / ORG.AX / RRC.N / EQT.N / ARE.N / WSP.TO / DK.N / POU.TO / ESI.TO / FOG.L / CVX.N / BPT.AX / SM.N / PSI.TO / FLS.CO / COP.N / SLF.TO / CPE.N / TSCO.O / SWN.N / EFX.TO / CCLb.TO / EQIX.O / STN.TO / FAR.AX / COE.AX / CVN.AX / TCW.TO / TFC.N / INGA.AS / CFW.TO / CR.TO / SCL.TO / NESTE.HE / RDSb.L / KOS.N / KAR.AX / SES.TO / ALD.AX / BLX.TO / MWA.N / GALP.LS / BIR.TO / COI.AX / GTE.TO / NOG.A / PBF.N / WGO.AX / CLW.N / CPG.TO / AAV.TO / CEU.TO / ATH.TO / NEE.N / MEG.TO / VET.TO / TOU.TO / JE.TO / ERF.TO / CFX.TO / FRU.TO / PEY.TO / MPC.N / HFC.N / PXT.TO / MTDR.N / XYL.N / TVE.TO / PSX.N / FANG.O / KEL.TO / CJ.TO / PSK.TO / LXE.V / SHOP.N / PARR.N / ATS.AX / AKERBP.OL / CDEV.O / STEP.TO / ESTE.N / AQUA.N / AY.O / APTV.N / ENOG.L / BHC.N / VEN.AX / PIPE.V / LSPD.TO / 2222.SE / OVV.N / GFL.N / LUNE.ST / APA.OQ / TPZ.TO / 120291281</td><td class="leftalignment">Applied Materials Inc / BP PLC / CMS Energy Corp / Capricorn Energy PLC / Diageo PLC / Eni SpA / EOG Resources Inc / Ford Motor Co / National Bank of Canada / Nuvista Energy Ltd / Precision Drilling Corp / Repsol SA / Santos Ltd / Tullow Oil PLC / TotalEnergies SE / Woodside Petroleum Ltd / Thomson Reuters Corp / Pioneer Natural Resources Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / TransAlta Corp / Imperial Oil Ltd / Suncor Energy Inc / Baytex Energy Corp / Honeywell International Inc / Valero Energy Corp / Manulife Financial Corp / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Origin Energy Ltd / Range Resources Corp / EQT Corp / Alexandria Real Estate Equities Inc / WSP Global Inc / Delek US Holdings Inc / Paramount Resources Ltd / Ensign Energy Services Inc / Falcon Oil & Gas Ltd / Chevron Corp / Beach Energy Ltd / SM Energy Co / Pason Systems Inc / FLSmidth & Co A/S / Conocophillips / Sun Life Financial Inc / Callon Petroleum Co / Tractor Supply Co / Southwestern Energy Co / Enerflex Ltd / CCL Industries Inc / Equinix Inc / Stantec Inc / FAR Ltd / Cooper Energy Ltd / Carnarvon Energy Ltd / Trican Well Service Ltd / Truist Financial Corp / ING Groep NV / Calfrac Well Services Ltd / Crew Energy Inc / Shawcor Ltd / Neste Oyj / Royal Dutch Shell PLC / Kosmos Energy Ltd / Karoon Energy Ltd / Secure Energy Services Inc / Ampol Ltd / Boralex Inc / Mueller Water Products Inc / Galp Energia SGPS SA / Birchcliff Energy Ltd / Comet Ridge Ltd / Gran Tierra Energy Inc / Northern Oil and Gas Inc / PBF Energy Inc / Warrego Energy Ltd / Clearwater Paper Corp / Crescent Point Energy Corp / Advantage Energy Ltd / CES Energy Solutions Corp / Athabasca Oil Corp / Nextera Energy Inc / MEG Energy Corp / Vermilion Energy Inc / Tourmaline Oil Corp / Just Energy Group Inc / Enerplus Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Marathon Petroleum Corp / HollyFrontier Corp / Parex Resources Inc / Matador Resources Co / Xylem Inc / Tamarack Valley Energy Ltd / Phillips 66 / Diamondback Energy Inc / Kelt Exploration Ltd / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Leucrotta Exploration Inc / Shopify Inc / Par Pacific Holdings Inc / Australis Oil & Gas Ltd / Aker BP ASA / Centennial Resource Development Inc / Step Energy Services Ltd / Earthstone Energy Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Energean PLC / Bausch Health Companies Inc / Vintage Energy Ltd / Pipestone Energy Corp / Lightspeed Commerce Inc / Saudi Arabian Oil Co / Ovintiv Inc / GFL Environmental Inc / Lundin Energy AB / APA Corp (US) / Topaz Energy Corp / Cenovus Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / Norway / Papua New Guinea / Portugal / Saudi Arabia / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / PORTFOLIO/ASSET STRATEGIES / Research Digest / Equity</td><td class="leftalignment">Lindsay Brent</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the SVB Leerink Global Healthcare Conference - 2.25.21</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ADAP=US / BSX=US / CSII=US / INSP=US / GILD=US / SAN=FR / BAX=US / HOLX=US / IMGN=US / BLUE=US / CNMD=US / EXAS=US / ILMN=US / ICPT=US / TFX=US / SAGE=US / PRVB=US / IMTX=US / MREO=US / CPSI=US / BRKR=US / AMTI=US / ACRS=US / APTX=US / MRNA=US / ALNY=US / MNKD=US / CBAY=US / EQ=US / ITRM=US / FULC=US / ASND=US / CTSO=US / FGEN=US / FATE=US / RDUS=US / VCEL=US / MDGL=US / TRHC=US / RCM=US / KALV=US / SYBX=US / RCKT=US / RUBY=US / IMUX=US / ETNB=US / RVMD=US / NARI=US / MOLN=DE / ABCL=US / LNSR=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Boston Scientific Corp / Cardiovascular Systems Inc / Inspire Medical Systems Inc / Gilead Sciences Inc / Sanofi SA / Baxter International Inc / Hologic Inc / ImmunoGen Inc / bluebird bio Inc / Conmed Corp / Exact Sciences Corp / Illumina Inc / Intercept Pharmaceuticals Inc / Teleflex Inc / SAGE Therapeutics Inc / Provention Bio Inc / Immatics NV / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Bruker Corp / Applied Molecular Transport Inc. / Aclaris Therapeutics Inc / Aptinyx Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cymabay Therapeutics Inc / Equillium Inc / Iterum Therapeutics PLC / Fulcrum Therapeutics Inc / Ascendis Pharma A/S / Cytosorbents Corp / FibroGen Inc / Fate Therapeutics Inc / Radius Health Inc / Vericel Corp / Madrigal Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Kalvista Pharmaceuticals Inc / Synlogic Inc / Rocket Pharmaceuticals Inc / Rubius Therapeutics Inc / Immunic Inc / 89Bio Inc / Revolution Medicines Inc / Inari Medical Inc / Molecular Partners AG / Abcellera Biologics Inc / LENSAR Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GILD - Key Takeaways from the SVB Leerink Global Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">AMAT.O / AXAF.PA / BBY.N / CAS.TO / CC.N / CCK.N / CE.N / CF.N / CM.TO / CMS.N / CRM.N / DD.N / DGE.L / EDP.LS / EOG.N / F.N / IP.N / PPG.N / SRCL.O / TD.TO / DELL.N / GILD.O / TA.TO / UHS.N / FER.MC / WLK.N / SU.TO / HON.N / MFC.TO / OLN.N / BLL.N / RDN.N / RRC.N / ADSK.O / ARE.N / SLGN.O / GIL.N / PFG.N / FLS.CO / SLF.TO / CPE.N / TSCO.O / BLU.N / LNG.A / SEM.N / MNST.O / BCRX.O / AMED.O / ANSS.O / ICPT.O / EQIX.O / STN.TO / TFC.N / INGA.AS / DPZ.N / MOS.N / HUN.N / RDSb.L / LHCG.O / BLX.TO / MWA.N / CQP.A / PPL.TO / VMW.N / ABI.BR / SWI.N / AAV.TO / ADUS.OQ / EGO.N / ENV.N / NEE.N / NXT.AX / PCRX.O / XYL.N / ACHC.O / SRPT.O / BERY.N / WDAY.N / ORCC.N / PRGO.N / PRMW.N / PTCT.O / PRTA.O / DOOR.N / LB.N / ITCI.O / RYAM.N / AXTA.N / EVA.N / SHOP.N / WRK.N / PARR.N / GREG.MC / VNTR.N / OMP.N / AQUA.N / AY.O / SAIL.N / APTV.N / ZS.OQ / KDP.N / PRVB.O / CTVA.N / KRTX.OQ / HCAT.OQ / 260557103 / PNTG.OQ / LUNE.ST / NKLA.OQ / 77311W101 / ALOO.O / 120681711</td><td class="leftalignment">Applied Materials Inc / AXA SA / Best Buy Co Inc / Cascades Inc / Chemours Co / Crown Holdings Inc / Celanese Corp / CF Industries Holdings Inc / Canadian Imperial Bank of Commerce / CMS Energy Corp / Salesforce.Com Inc / Dupont De Nemours Inc / Diageo PLC / EDP Energias de Portugal SA / EOG Resources Inc / Ford Motor Co / International Paper Co / PPG Industries Inc / Stericycle Inc / Toronto-Dominion Bank / Dell Technologies Inc / Gilead Sciences Inc / TransAlta Corp / Universal Health Services Inc / Ferrovial SA / Westlake Chemical Corp / Suncor Energy Inc / Honeywell International Inc / Manulife Financial Corp / Olin Corp / Ball Corp / Radian Group Inc / Range Resources Corp / Autodesk Inc / Alexandria Real Estate Equities Inc / Silgan Holdings Inc / Gildan Activewear Inc / Principal Financial Group Inc / FLSmidth & Co A/S / Sun Life Financial Inc / Callon Petroleum Co / Tractor Supply Co / BELLUS Health Inc / Cheniere Energy Inc / Select Medical Holdings Corp / Monster Beverage Corp / BioCryst Pharmaceuticals Inc / Amedisys Inc / ANSYS Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Stantec Inc / Truist Financial Corp / ING Groep NV / Domino's Pizza Inc / Mosaic Co / Huntsman Corp / Royal Dutch Shell PLC / LHC Group Inc / Boralex Inc / Mueller Water Products Inc / Cheniere Energy Partners LP / Pembina Pipeline Corp / VMware Inc / Anheuser Busch Inbev SA / SolarWinds Corp / Advantage Energy Ltd / Addus Homecare Corp / Eldorado Gold Corp / Envestnet Inc / Nextera Energy Inc / NEXTDC Ltd / Pacira Biosciences Inc / Xylem Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Workday Inc / Owl Rock Capital Corp / Perrigo Company PLC / Primo Water Corp / PTC Therapeutics Inc / Prothena Corporation PLC / Masonite International Corp / Bath & Body Works Inc / Intra-Cellular Therapies Inc / Rayonier Advanced Materials Inc / Axalta Coating Systems Ltd / Enviva Inc / Shopify Inc / Westrock Co / Par Pacific Holdings Inc / Grenergy Renovables SA / Venator Materials PLC / Oasis Midstream Partners LP / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Keurig Dr Pepper Inc / Provention Bio Inc / Corteva Inc / Karuna Therapeutics Inc / Health Catalyst Inc / Dow Inc / Pennant Group Inc / Lundin Energy AB / Nikola Corp / Rocket Companies Inc / Allogene Therapeutics Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Denmark / Spain / France / United Kingdom / Ireland / Luxembourg / Netherlands / Portugal / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AMAT.O / CAS.TO / CM.TO / CMS.N / DGE.L / EOG.N / F.N / L.TO / NVA.TO / TD.TO / CFP.TO / GILD.O / TA.TO / QBRb.TO / SU.TO / TV.TO / BTE.TO / HON.N / MFC.TO / ARE.N / WSP.TO / GIL.N / EXE.TO / PSI.TO / CU.TO / ACOx.TO / FLS.CO / SLF.TO / TSCO.O / EFX.TO / CCLb.TO / EQIX.O / TCLa.TO / STN.TO / MFI.TO / TFC.N / INGA.AS / BEI_u.TO / RDSb.L / SES.TO / BLX.TO / MWA.N / PPL.TO / INE.TO / AND.TO / AAV.TO / EGO.N / TCN.TO / NEE.N / CFX.TO / XYL.N / KEL.TO / PLZ_u.TO / SHOP.N / OR.N / ECN.TO / JWEL.TO / AQUA.N / AY.O / APTV.N / LUNE.ST / ERE_u.TO</td><td class="leftalignment">Applied Materials Inc / Cascades Inc / Canadian Imperial Bank of Commerce / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Ford Motor Co / Loblaw Companies Ltd / Nuvista Energy Ltd / Toronto-Dominion Bank / Canfor Corp / Gilead Sciences Inc / TransAlta Corp / Quebecor Inc / Suncor Energy Inc / Trevali Mining Corp / Baytex Energy Corp / Honeywell International Inc / Manulife Financial Corp / Alexandria Real Estate Equities Inc / WSP Global Inc / Gildan Activewear Inc / Extendicare Inc / Pason Systems Inc / Canadian Utilities Ltd / Atco Ltd / FLSmidth & Co A/S / Sun Life Financial Inc / Tractor Supply Co / Enerflex Ltd / CCL Industries Inc / Equinix Inc / Transcontinental Inc / Stantec Inc / Maple Leaf Foods Inc / Truist Financial Corp / ING Groep NV / Boardwalk Real Estate Investment Trust / Royal Dutch Shell PLC / Secure Energy Services Inc / Boralex Inc / Mueller Water Products Inc / Pembina Pipeline Corp / Innergex Renewable Energy Inc / Andlauer Healthcare Group Inc / Advantage Energy Ltd / Eldorado Gold Corp / Tricon Residential Inc / Nextera Energy Inc / Canfor Pulp Products Inc / Xylem Inc / Kelt Exploration Ltd / Plaza Retail REIT / Shopify Inc / Osisko Gold Royalties Ltd / ECN Capital Corp / Jamieson Wellness Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Lundin Energy AB / European Residential REIT</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: RBC Global Environmental, Social and Governance Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">AMAT.O / CMS.N / DGE.L / EOG.N / F.N / GILD.O / TA.TO / SU.TO / HON.N / MFC.TO / ARE.N / FLS.CO / SLF.TO / TSCO.O / EQIX.O / STN.TO / TFC.N / INGA.AS / RDSb.L / BLX.TO / MWA.N / NEE.N / XYL.N / SHOP.N / AQUA.N / AY.O / APTV.N / LUNE.ST</td><td class="leftalignment">Applied Materials Inc / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Ford Motor Co / Gilead Sciences Inc / TransAlta Corp / Suncor Energy Inc / Honeywell International Inc / Manulife Financial Corp / Alexandria Real Estate Equities Inc / FLSmidth & Co A/S / Sun Life Financial Inc / Tractor Supply Co / Equinix Inc / Stantec Inc / Truist Financial Corp / ING Groep NV / Royal Dutch Shell PLC / Boralex Inc / Mueller Water Products Inc / Nextera Energy Inc / Xylem Inc / Shopify Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Lundin Energy AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Automotive / Banks / Beverages & Tobacco / Biotechnology / Building & Building Materials / Conglomerates / Consumer / Energy / Financial Services / Food / Healthcare / Info. Tech./Computers / Info. Tech./Software / Insurance / Machinery / Manufacturing / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Mike Dahl / Mr. Deane Dray, CFA / Mr. James Edwardes Jones / Scott M. Hanold / Herr. Nick Housden / Mr. Sabahat Khan / Darko Mihelic, CFA / Mr. Nelson Ng, CFA / Greg M. Pardy, CFA / Anke Reingen / Sara Mahaffy / Mr. Joseph Spak, CFA / Mr. Al J. Stanton / Mr. Mitch T. Steves / Mr. Paul Treiber, CFA / Mr. Shelby Tucker, CFA / Brian Abrahams, MD / Jonathan Atkin / Mr. Biraj Borkhataria / Michael W. Carroll, CFA / Gerard S. Cassidy / Mr. Maurice Choy / Scot Ciccarelli, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMAT.O / AXAF.PA / CMS.N / DGE.L / EOG.N / EPED.PA / LOIM.PA / SRP.L / VLOF.PA / GILD.O / HON.N / MFC.TO / ADEN.S / FLS.CO / SLF.TO / STN.TO / TFC.N / INGA.AS / RDSb.L / MWA.N / ABI.BR / ADSGn.DE / XYL.N / GREG.MC / AQUA.N / APTV.N</td><td class="leftalignment">Applied Materials Inc / AXA SA / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Faurecia SE / Klepierre SA / Serco Group PLC / Valeo SE / Gilead Sciences Inc / Honeywell International Inc / Manulife Financial Corp / Adecco Group AG / FLSmidth & Co A/S / Sun Life Financial Inc / Stantec Inc / Truist Financial Corp / ING Groep NV / Royal Dutch Shell PLC / Mueller Water Products Inc / Anheuser Busch Inbev SA / Adidas AG / Xylem Inc / Grenergy Renovables SA / Evoqua Water Technologies Corp / Aptiv PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Gilead's Immunomedics unit – SEC Investigation Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Gavin</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ICAD.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BIIB.OQ / ACAD.OQ / MNKD.OQ / MSB.AX / EBS.N / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / FATE.OQ / AUP.TO / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / TDOC.N / SPNE.OQ / GBT.OQ / ACRS.OQ / DRIO.OQ / TVTY.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / RCUS.N / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / ICAD Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Biogen Inc / ACADIA Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Teladoc Health Inc / SeaSpine Holdings Corp / Global Blood Therapeutics Inc / Aclaris Therapeutics Inc / DarioHealth Corp / Tivity Health Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / Arcus Biosciences Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Feb. 25, 2021 / 1:40PM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">2126335 / 2536763 / 2050832 / 2026242 / 2942605 / 2544960 / 2280220 / 2270726 / 2829515 / 2382892 / 2317087 / 2670519 / 2100920 / 2369174 / 2459202 / 2459020 / 2689560 / 2048804 / 2440637 / 2573083 / 2862532 / 2799351 / 2989301 / B121557 / 2713317 / 2857817 / B2R3PV1 / 2598246 / 2390817 / 2949758 / BCZS820 / B8L2798 / BFH3N85 / BFZCHN7 / B95WG16 / BQPVQZ6 / BYVY8G0 / BS7K7C9 / BP4GNK9 / BXDZ9Z0 / BF5L3T2 / BYNZGK1 / BJXBP41 / BD8DJ71 / BJ1FD74 / BKDS4H5 / BL2HYY7 / BNFWR44 / BJ5FZ74 / BFMXGR0 / BZ8VJQ8 / BFXC911 / BZ05388 / BJVR9Y9 / BYQHPK7 / BF3W461 / BYWVTY5 / BYQRFY1 / BZ0P3Z5 / BYQBFS7 / BKWD3M9 / BD8Q1B8 / BFFVVC1 / BP84RX0</td><td class="leftalignment">Bristol-Myers Squibb Co / Lowe's Companies Inc / Ameren Corp / American Electric Power Company Inc / Avista Corp / Beasley Broadcast Group Inc / DTE Energy Co / Walt Disney Co / Edison International / Audacy Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / IDEXX Laboratories Inc / Intuit Inc / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sangamo Therapeutics Inc / E W Scripps Co / Sinclair Broadcast Group Inc / TJX Companies Inc / Mastercard Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / American Water Works Company Inc / Neogenomics Inc / Gray Television Inc / Nexstar Media Group Inc / Fate Therapeutics Inc / Hemisphere Media Group Inc / Veeva Systems Inc / Wix.Com Ltd / Zoetis Inc / Horizon Therapeutics PLC / Alphabet Inc / Nevro Corp / SAGE Therapeutics Inc / Shopify Inc / Elanco Animal Health Inc / Block Inc / Alcon AG / Snap Inc / Revolve Group Inc / Bill.com Holdings Inc / Casper Sleep Inc / Worldline SA / Adaptive Biotechnologies Corp / Evergy Inc / Vistra Corp / Guardant Health Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Zymeworks Inc / Tandem Diabetes Care Inc / CytomX Therapeutics Inc / Teladoc Health Inc / Tegna Inc / Tabula Rasa HealthCare Inc / Progyny Inc / Tivity Health Inc / Bausch Health Companies Inc / Townsquare Media Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AB680 Accelerating and TIGIT Continues to Progress, Mid-Year Milestones Coming</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">RCUS=US / GILD=US</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">AMAT.O / CMS.N / DGE.L / EOG.N / FLS.N / FOUG.PA / MRK.N / PFE.N / TOL.N / PXD.N / GILD.O / TEN.N / AGI.N / WLK.N / NVDA.O / HON.N / MFC.TO / HD.N / LOW.N / WM.N / JAZZ.O / MTG.N / TJX.N / OKE.N / DK.N / OPTN.O / FLS.CO / SLF.TO / ENDP.O / CHE.N / HCC.N / AMED.O / STN.TO / TCW.TO / TFC.N / INGA.AS / 878742204 / ACAD.O / VIAC.O / RDSb.L / STX.O / BKD.N / TEVA.N / MWA.N / ATL.MI / GETP.PA / PCRX.O / HFC.N / XYL.N / WDC.O / ABBV.N / PRGO.N / CEQP.N / IBP.N / FLXN.O / AGRX.O / RYAM.N / AUPH.O / SUM.N / 78667J108 / TDOC.N / GBT.OQ / SITE.N / IONS.O / TRHC.OQ / NTNX.O / CDEV.O / AQUA.N / APTV.N / AMRX.N / EQH.N / XERS.O / BHC.N / AQST.O / ESTC.N / OSMT.O / 269796108 / FIXX.O / PING.N / PNTG.OQ / TFII.N</td><td class="leftalignment">Applied Materials Inc / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Flowserve Corp / Eiffage SA / Merck & Co Inc / Pfizer Inc / Toll Brothers Inc / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Alamos Gold Inc / Westlake Chemical Corp / NVIDIA Corp / Honeywell International Inc / Manulife Financial Corp / Home Depot Inc / Lowe's Companies Inc / Waste Management Inc / Jazz Pharmaceuticals PLC / MGIC Investment Corp / TJX Companies Inc / ONEOK Inc / Delek US Holdings Inc / OptiNose Inc / FLSmidth & Co A/S / Sun Life Financial Inc / Endo International PLC / Chemed Corp / Warrior Met Coal Inc / Amedisys Inc / Stantec Inc / Trican Well Service Ltd / Truist Financial Corp / ING Groep NV / Teck Resources Ltd / ACADIA Pharmaceuticals Inc / ViacomCBS Inc / Royal Dutch Shell PLC / Seagate Technology Holdings PLC / Brookdale Senior Living Inc / Teva Pharmaceutical Industries Ltd / Mueller Water Products Inc / Atlantia SpA / Getlink SE / Pacira Biosciences Inc / HollyFrontier Corp / Xylem Inc / Western Digital Corp / Abbvie Inc / Perrigo Company PLC / Crestwood Equity Partners LP / Installed Building Products Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Aurinia Pharmaceuticals Inc / Summit Materials Inc / SAGE Therapeutics Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / SiteOne Landscape Supply Inc / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / Nutanix Inc / Centennial Resource Development Inc / Evoqua Water Technologies Corp / Aptiv PLC / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Xeris Biopharma Holdings Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / Elastic NV / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Ping Identity Holding Corp / Pennant Group Inc / TFI International Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / France / United Kingdom / Ireland / Israel / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - February 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMAT.O / CMS.N / DGE.L / EOG.N / NA.TO / CFP.TO / GILD.O / AGI.N / HON.N / MFC.TO / WSP.TO / AIF.TO / CAR_u.TO / FLS.CO / SLF.TO / HCC.N / STN.TO / TCW.TO / HLF.TO / CHE_u.TO / TFC.N / INGA.AS / 878742204 / RDSb.L / CRR_u.TO / MWA.N / CS.TO / H.TO / CPG.TO / WCP.TO / CFX.TO / XYL.N / AUPH.O / AQUA.N / APTV.N / BHC.N / TFII.N / ERE_u.TO</td><td class="leftalignment">Applied Materials Inc / CMS Energy Corp / Diageo PLC / EOG Resources Inc / National Bank of Canada / Canfor Corp / Gilead Sciences Inc / Alamos Gold Inc / Honeywell International Inc / Manulife Financial Corp / WSP Global Inc / Altus Group Ltd / Canadian Apartment Properties Real Estate Investment Trust / FLSmidth & Co A/S / Sun Life Financial Inc / Warrior Met Coal Inc / Stantec Inc / Trican Well Service Ltd / High Liner Foods Inc / Chemtrade Logistics Income Fund / Truist Financial Corp / ING Groep NV / Teck Resources Ltd / Royal Dutch Shell PLC / Crombie Real Estate Investment Trust / Mueller Water Products Inc / Capstone Mining Corp / Hydro One Ltd / Crescent Point Energy Corp / Whitecap Resources Inc / Canfor Pulp Products Inc / Xylem Inc / Aurinia Pharmaceuticals Inc / Evoqua Water Technologies Corp / Aptiv PLC / Bausch Health Companies Inc / TFI International Inc / European Residential REIT</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2Q TIGIT interim will give go-no-go on doublet, and we expect more detailed results in 2H21 at med mtg</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">RCUS.N / GILD.OQ</td><td class="leftalignment">Arcus Biosciences Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Ms. Emma K. Nealon, III / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4502.T / JNJ.N / PFE.N / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Slow Pace of Legal System In Pandemic Means We See No Immediate Risk to HIV or Oncology Franchises</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: RBC Global Environmental, Social and Governance Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AMAT.O / CMS.N / DGE.L / EOG.N / GILD.O / HON.N / MFC.TO / FLS.CO / SLF.TO / STN.TO / TFC.N / INGA.AS / RDSb.L / MWA.N / XYL.N / AQUA.N / APTV.N</td><td class="leftalignment">Applied Materials Inc / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Gilead Sciences Inc / Honeywell International Inc / Manulife Financial Corp / FLSmidth & Co A/S / Sun Life Financial Inc / Stantec Inc / Truist Financial Corp / ING Groep NV / Royal Dutch Shell PLC / Mueller Water Products Inc / Xylem Inc / Evoqua Water Technologies Corp / Aptiv PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment">Advertising / Media / Telecommunications</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">RBCCM Australia Research / Mr. Sabahat Khan / Darko Mihelic, CFA / Anke Reingen / Mr. Joseph Spak, CFA / Mr. Mitch T. Steves / Mr. Shelby Tucker, CFA / Sara Mahaffy / Brian Abrahams, MD / Mr. Biraj Borkhataria / Gerard S. Cassidy / Mr. Deane Dray, CFA / Mr. James Edwardes Jones / Scott M. Hanold / Herr. Nick Housden</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / AERI.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / BDSI.OQ / BIIB.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / NEOS.BO / OMER.OQ / ARDX.OQ / ACRX.OQ / AMRN.NS / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Aerie Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / BioDelivery Sciences International Inc / Biogen Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Neo Corp International Ltd / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / ADF Foods Ltd / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Veru Inc / TherapeuticsMD Inc / Evolus Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GILD - In Conversation with Gilead Sciences: Highlights from the RBC ESG Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Continued stability for Large Cap, Some SMid sequentially lower</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Gilead climbs 10% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 MEDACorp IBD Physician Survey Shows Novel Orals Set to Expand Market</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE=US / BMY=US / GILD=US / ARNA=US / NKTR=US / AMTI=US / ABBV=US / TBPH=US / PTGX=US / GOSS=US</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Arena Pharmaceuticals Inc / Nektar Therapeutics / Applied Molecular Transport Inc. / Abbvie Inc / Theravance Biopharma Inc / Protagonist Therapeutics Inc / Gossamer Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joseph P. Schwartz / Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 12, 2021: Focus on Jan 2021 Rx volumes for branded and generic drugs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CTP2021-ALSEN, MGTX, SIGHT; LentiGlobin BLUEs</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MGTX.OQ / SIGHT.PA / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">MeiraGTx Holdings PLC / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 2.21.21</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ADAP=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / TMO=US / MDT=US / A=US / INCY=US / INSP=US / TEVA=US / GILD=US / MOR=DE / SAN=FR / GSK=GB / SYK=US / BAX=US / AZN=US / WAT=US / JNJ=US / MDRX=US / IMGN=US / NUAN=US / ABMD=US / ALKS=US / ALC=US / AMRN=US / ARNA=US / ATRC=US / BDX=US / BMRN=US / BLUE=US / CSTL=US / CALA=US / CERN=US / CNMD=US / EW=US / ENDP=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / INGN=US / ISRG=US / MYGN=US / NBIX=US / PRGO=US / PRTK=US / RARE=US / HOOK=US / REGN=US / RGEN=US / SENS=US / SIEN=US / SILK=US / TECH=US / TFX=US / VRTX=US / ALGN=US / SGEN=US / SAGE=US / OPT=US / PRVB=US / CGEN=US / ALVR=US / JAZZ=US / PHR=US / STSA=US / RNA=US / IMTX=US / MREO=US / NTRA=US / CPSI=US / NKTR=US / MRNS=US / AMTI=US / BIIB=US / ACRS=US / ARWR=US / APTX=US / NUVA=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / COGT=US / DXCM=US / CYRX=US / CBAY=US / GRAY=US / EQ=US / QTRX=US / AVRO=US / TPTX=US / AMRX=US / FOLD=US / PODD=US / TNDM=US / IFRX=US / ITRM=US / NXGN=US / FULC=US / LUN=US / ASND=US / AVEO=US / NEO=US / RCUS=US / MOLN / CTSO=US / ZGNX=US / PCRX=US / RGNX=US / CLVS=US / PBYI=US / AXGN=US / VCRA=US / CCXI=US / FGEN=US / SRPT=US / GMED=US / ABBV=US / EPZM=US / MRTX=US / AGIO=US / PINC=US / FATE=US / MGNX=US / VEEV=US / VCYT=US / KPTI=US / OM=US / ITCI=US / XNCR=US / HRTX=US / QURE=US / GNCA=US / TBPH=US / ARDX=US / RDUS=US / MASS=US / XENT=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / AFMD=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVRO=US / NVTA=US / RLMD=US / VKTX=US / BPMC=US / HTGM=US / ZBH=US / ABEO=US / TDOC=US / KURA=US / WVE=US / AXSM=US / IONS=US / BGNE=US / NTLA=US / ADVM=US / RETA=US / MDGL=US / PTGX=US / ACIU=US / TRHC=US / MYOV=US / ZYME=US / AVDL=US / OBSV=US / RCM=US / BHVN=US / MRSN=US / KALV=US / ATNX=US / SYBX=US / ZLAB=US / DCPH=US / SCPH=US / SLDB=US / GH=US / RCKT=US / EOLS=US / XERS=US / REPL=US / RUBY=US / CRNX=US / ALLK=US / SBTX=US / TWST=US / AXNX=US / MLND=US / OSMT=US / ORGO=US / HARP=US / GOSS=US / TCRR=US / IMUX=US / AXLA=US / BBIO=US / HCAT=US / BNTX=US / GMAB=US / IPHA=US / ETNB=US / PGNY=US / CNTG=US / IMVT=US / ONEM=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / GDRX=US / SPRB=US / SIOX=US / VTRS=US / ABCM=US / GLTO=US / TVTX=US / ABCL=US / KNTE=US / ELDN=US / PRTC=US / CGEM=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Incyte Corp / Inspire Medical Systems Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / MorphoSys AG / Sanofi SA / GlaxoSmithKline PLC / Stryker Corp / Baxter International Inc / AstraZeneca PLC / Waters Corp / Johnson & Johnson / Allscripts Healthcare Solutions Inc / ImmunoGen Inc / Nuance Communications Inc / ABIOMED Inc / Alkermes Plc / Alcon AG / Amarin Corporation PLC / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / Biomarin Pharmaceutical Inc / bluebird bio Inc / Castle Biosciences Inc / Calithera Biosciences Inc / Cerner Corp / Conmed Corp / Edwards Lifesciences Corp / Endo International PLC / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Inogen Inc / Intuitive Surgical Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Perrigo Company PLC / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Senseonics Holdings Inc / Sientra Inc / Silk Road Medical Inc / Bio-Techne Corp / Teleflex Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Allovir Inc / Jazz Pharmaceuticals PLC / Phreesia Inc / Satsuma Pharmaceuticals Inc / Avidity Biosciences Inc / Immatics NV / Mereo Biopharma Group PLC / Natera Inc / Computer Programs and Systems Inc / Nektar Therapeutics / Marinus Pharmaceuticals Inc / Applied Molecular Transport Inc. / Biogen Inc / Aclaris Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Aptinyx Inc / NuVasive Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cogent Biosciences Inc / Dexcom Inc / Cryoport Inc / Cymabay Therapeutics Inc / Graybug Vision Inc / Equillium Inc / Quanterix Corp / AVROBIO Inc / Turning Point Therapeutics Inc / Amneal Pharmaceuticals Inc / Amicus Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Iterum Therapeutics PLC / NextGen Healthcare Inc / Fulcrum Therapeutics Inc / H Lundbeck A/S / Ascendis Pharma A/S / Aveo Pharmaceuticals Inc / Neogenomics Inc / Arcus Biosciences Inc / Molecular Partners AG / Cytosorbents Corp / Zogenix Inc / Pacira Biosciences Inc / Regenxbio Inc / Clovis Oncology Inc / Puma Biotechnology Inc / AxoGen Inc / Vocera Communications Inc / ChemoCentryx Inc / FibroGen Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Abbvie Inc / Epizyme Inc / Mirati Therapeutics Inc / Agios Pharmaceuticals Inc / Premier Inc / Fate Therapeutics Inc / MacroGenics Inc / Veeva Systems Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Intra-Cellular Therapies Inc / Xencor Inc / Heron Therapeutics Inc / Uniqure NV / Genocea Biosciences Inc / Theravance Biopharma Inc / Ardelyx Inc / Radius Health Inc / 908 Devices Inc. / Intersect Ent Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Affimed NV / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Nevro Corp / Invitae Corp / Relmada Therapeutics Inc / Viking Therapeutics Inc / Blueprint Medicines Corp / HTG Molecular Diagnostics Inc / Zimmer Biomet Holdings Inc / Abeona Therapeutics Inc / Teladoc Health Inc / Kura Oncology Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Reata Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Protagonist Therapeutics Inc / AC Immune SA / Tabula Rasa HealthCare Inc / Myovant Sciences Ltd / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / R1 RCM Inc / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / Kalvista Pharmaceuticals Inc / Athenex Inc / Synlogic Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Guardant Health Inc / Rocket Pharmaceuticals Inc / Evolus Inc / Xeris Biopharma Holdings Inc / Replimune Group Inc / Rubius Therapeutics Inc / Crinetics Pharmaceuticals Inc / Allakos Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Axonics Inc / Tempest Therapeutics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / Gossamer Bio Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / BridgeBio Pharma Inc / Health Catalyst Inc / BioNTech SE / Genmab A/S / Innate Pharma SA / 89Bio Inc / Progyny Inc / Centogene NV / Immunovant Inc / 1Life Healthcare Inc / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Viatris Inc / Abcam PLC / Galecto Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc / PureTech Health PLC / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Gilead strengthens 7.4% in past quarter; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.19.21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Maintains 10% Share; Gx Vascepa Back to 10% Bottle Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">A Virus' Worst Enemy</td><td class="leftalignment">English</td><td class="rightalignment">104</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Mr. Kenneth C. Atkins, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NBIX.OQ / VRTX.OQ / PFE.N / AZN.L / ROG.S / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GLPG.AS: 4Q20 Update: Challenging Set Up for 2021 - No pressure, Toledo; Reducing TP to EUR 69</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GLPG.AS / GILD.OQ</td><td class="leftalignment">Galapagos NV / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">IMUX: In Our View, IMU-838 Remains A Solid Call Option as a COVID Therapeutic</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IMUX.OQ / GILD</td><td class="leftalignment">Immunic Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Lentiglo-"has"-bin? Assessing Reverberations From BLUE's Gene Tx Setback to Our Covered Co's</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / VRTX.O / BLUE.O / SRPT.O / PTCT.O / CRSP.OQ</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / bluebird bio Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALSEN=FR / MGTX=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / REPL=US / KOD=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Sensorion SA / MeiraGTx Holdings PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / Replimune Group Inc / Kodiak Sciences Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2020 Was an Excellent Vintage for Biopharma IPO Returns, No Slowdown Yet in '21</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRK=US / TEVA=US / GILD=US / AZN=US / BMRN=US / OPT=US / ALVR=US / RNA=US / SNY=US / AMTI=US / BIIB=US / GRAY=US / LUN=US / SBTX=US / BNTX=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ITOS=US / SPRB=US / GLTO=US / ABCL=US / KNTE=US</td><td class="leftalignment">Merck & Co Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / AstraZeneca PLC / Biomarin Pharmaceutical Inc / Opthea Ltd / Allovir Inc / Avidity Biosciences Inc / Sanofi SA / Applied Molecular Transport Inc. / Biogen Inc / Graybug Vision Inc / H Lundbeck A/S / Silverback Therapeutics Inc / BioNTech SE / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Spruce Biosciences Inc / Galecto Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Back Above 10% Mkt Share; Viatris' Gx Advair Share Steady</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">VTRS.OQ / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Viatris Inc / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 05, 2021: Focus on Dupixent's resilience</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Ex vivo GT sees positive readouts</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.12.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">CCK.N / EDP.LS / ELE.MC / FMC.N / IBE.MC / IP.N / RWEG.DE / T.TO / PEP.N / PXD.N / CFP.TO / GILD.O / INCY.O / FER.MC / BWA.N / REE.MC / MFC.TO / AEM.N / STZ.N / AMP.N / CINF.O / DVA.N / TJX.N / ROST.O / SAM.N / VRTX.O / NET.N / SLF.TO / ORLY.O / BCRX.O / ICPT.O / BIIB.O / DCP.N / DLR.N / RDSb.L / ALNY.O / BAM.N / 025676206 / MERC.O / AUY.N / IVZ.N / BIP.N / EDPR.LS / ABI.BR / CFX.TO / FHI.N / CTT.N / VCRA.N / RFP.N / FFHu.TO / APAM.N / PTCT.O / BPY.N / BURL.N / KPTI.O / RYAM.N / VNOM.O / QSR.N / BSM.N / GLPG.O / PYPL.OQ / OMF.N / BBU.N / CRSP.OQ / SAND.N / KRP.N / OVID.O / ORSTED.CO / NEXA.TO / VCTR.N / NTGY.MC / BHC.N / FLMN.OQ / NBSE.OQ / MNRL.N / DDOG.O / LUMN.N / AFRM.O</td><td class="leftalignment">Crown Holdings Inc / EDP Energias de Portugal SA / Endesa SA / FMC Corp / Iberdrola SA / International Paper Co / Rwe AG / Telus Corp / PepsiCo Inc / Pioneer Natural Resources Co / Canfor Corp / Gilead Sciences Inc / Incyte Corp / Ferrovial SA / Borgwarner Inc / Red Electrica Corporacion SA / Manulife Financial Corp / Agnico Eagle Mines Ltd / Constellation Brands Inc / Ameriprise Financial Inc / Cincinnati Financial Corp / DaVita Inc / TJX Companies Inc / Ross Stores Inc / Boston Beer Company Inc / Vertex Pharmaceuticals Inc / Cloudflare Inc / Sun Life Financial Inc / O'Reilly Automotive Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / DCP Midstream LP / Digital Realty Trust Inc / Royal Dutch Shell PLC / Alnylam Pharmaceuticals Inc / Brookfield Asset Management Inc / American Equity Investment Life Holding Co / Mercer International Inc / Yamana Gold Inc / Invesco Ltd / Brookfield Infrastructure Partners LP / EDP Renovaveis SA / Anheuser Busch Inbev SA / Canfor Pulp Products Inc / Federated Hermes Inc / CatchMark Timber Trust Inc / Vocera Communications Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Artisan Partners Asset Management Inc / PTC Therapeutics Inc / Brookfield Property Partners LP / Burlington Stores Inc / Karyopharm Therapeutics Inc / Rayonier Advanced Materials Inc / Viper Energy Partners LP / Restaurant Brands International Inc / Black Stone Minerals LP / Galapagos NV / PayPal Holdings Inc / OneMain Holdings Inc / Brookfield Business Partners LP / CRISPR Therapeutics AG / Sandstorm Gold Ltd / Kimbell Royalty Partners LP / Ovid Therapeutics Inc / Orsted A/S / Nexa Resources SA / Victory Capital Holdings Inc / Naturgy Energy Group SA / Bausch Health Companies Inc / Falcon Minerals Corp / NeuBase Therapeutics Inc / Brigham Minerals Inc / Datadog Inc / Lumen Technologies Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Luxembourg / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Patent Patrol – Biotechnology: 4Q20</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / PTCT.O / GLPG.O / CRSP.OQ / OVID.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc / Galapagos NV / CRISPR Therapeutics AG / Ovid Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">2936921 / 2000019 / 2026242 / 2544960 / 2206657 / 2222631 / 2542049 / 2576941 / 2342034 / 2100920 / 2369174 / 2121352 / 2515030 / 2883878 / 2943523 / B1F76F9 / B0PZN11 / 2769796 / 2857817 / B0T7YX2 / B02R1L6 / B2R3PV1 / B3D7K31 / B03PGL4 / B3SWPT2 / B65LWX6 / B7TL820 / B7VD3F2 / BFLR866 / BFZCHN7 / BYY8XK8 / BXDZ9Z0 / BJT1RW7 / BD8DJ71 / BNFWR44 / BJJMGL2 / BKTNTR9 / BK6N347 / BYWMQJ2 / BP3YM85 / BGT3960 / BQXZP64 / BMDCDP2 / BFY7DC4</td><td class="leftalignment">Walmart Inc / Amazon.com Inc / American Electric Power Company Inc / Beasley Broadcast Group Inc / Coca-Cola Co / Cooper Companies Inc / Dominion Energy Inc / Exelixis Inc / Fiserv Inc / FirstEnergy Corp / Gilead Sciences Inc / Group 1 Automotive Inc / Lithia Motors Inc / Teva Pharmaceutical Industries Ltd / Penske Automotive Group Inc / Western Union Co / Under Armour Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / NorthWestern Corp / Ameresco Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Wix.Com Ltd / WEC Energy Group Inc / Shopify Inc / Lyft Inc / Snap Inc / Worldline SA / Fox Corp / ViacomCBS Inc / Uber Technologies Inc / Alteryx Inc / Trupanion Inc / Orchard Therapeutics PLC / Wayfair Inc / Bigcommerce Holdings Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Removing ziritaxestat after IPF failure, PT $72</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BCLI-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BCLI.O / GILD.O / AGEN.O / SGEN.O / BIIB.O / CYTK.O / IDRA.O / BIEI.PK</td><td class="leftalignment">Brainstorm Cell Therapeutics Inc / Gilead Sciences Inc / Agenus Inc / Seagen Inc / Biogen Inc / Cytokinetics Inc / Idera Pharmaceuticals Inc / Premier Biomedical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AIG / AJG / ALL / AON / BKH / CB / CMG / CPT / DD / DRI / FMC / GPS / HIG / LNC / MCD / MET / MMC / MRO / NCR / PAA / PGR / PRU / RE / RNG / RNR / TRV / YUM / TROW.O / GILD.O / WCC / BRO / SBUX.O / AXS / CAKE.O / ACGL.O / DENN.O / QSR / BJRI.O / JACK.O / YELP.K / UIHC.O / BXMT.K / VOYA.K / TWTR.K / WING.O / WLTW.O / TWLO.K / UAA / BHF.O / QGEN.K / EQH / LYFT.O / BRP.O / ROOT.O / 120175706</td><td class="leftalignment">American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Aon PLC / Black Hills Corp / Chubb Ltd / Chipotle Mexican Grill Inc / Camden Property Trust / Dupont De Nemours Inc / Darden Restaurants Inc / FMC Corp / Gap Inc / Hartford Financial Services Group Inc / Lincoln National Corp / McDonald's Corp / MetLife Inc / Marsh & McLennan Companies Inc / Marathon Oil Corp / NCR Corp / Plains All American Pipeline LP / Progressive Corp / Prudential Financial Inc / Everest Re Group Ltd / RingCentral Inc / Renaissancere Holdings Ltd / Travelers Companies Inc / Yum! Brands Inc / T Rowe Price Group Inc / Gilead Sciences Inc / Wesco International Inc / Brown & Brown Inc / Starbucks Corp / AXIS Capital Holdings Ltd / Cheesecake Factory Inc / Arch Capital Group Ltd / Denny's Corp / Restaurant Brands International Inc / BJ's Restaurants Inc / Jack in the Box Inc / Yelp Inc / United Insurance Holdings Corp / Blackstone Mortgage Trust Inc / Voya Financial Inc / Twitter Inc / Wingstop Inc / Willis Towers Watson PLC / Twilio Inc / Under Armour Inc / Brighthouse Financial Inc / Qiagen NV / Equitable Holdings Inc / Lyft Inc / BRP Group Inc / Root Inc / Cisco Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">GILD: ISABELA Halt in IPF Shouldn’t Impact Outlook</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : Isabela isafutile; Ziritaxestat Development Halted To Make for Another Disappointing Collab Setback</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GLPG IPF Ph3 Halted, Rush to Ph3 Violated Good Capital Allocation Principles</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) – Ziritaxestat IPF Program Discontinued; No Material Impact on Our Outlook; Maintain BUY and $78 PT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">So-So Guide; Difficult To Find To Good Reasons To Get More Constructive</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">881624209 / 375558103 / 031162100 / 03168L105</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Amneal Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">GILD and GLPG Discontinue Ziritaxestat's ISABELA Ph. IIIs In IPF</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.OQ / GLPG.AS / US3755581036 / US36315X1019</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV / Gilead Sciences Inc / Galapagos NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Mr. Kenneth C. Atkins, Ph.D. / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">GILD/GLPG: Ziri a Zero, As Stoppage of High-Risk Program Removes IPF Optionality</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / GLPG.O</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALXO: KOL Call Supports Attractive Opportunity in HNSCC; 2021 Data Updates May Further De-Risk ALX148</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALXO.OQ / GILD.OQ</td><td class="leftalignment">ALX Oncology Holdings Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mr. Tiago Fauth / Mark Connolly / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: GILD/GLPG: Mounting concerns on Galapagos' R&D engine as '1690 IPF trial stopped due to risk/benefit concern</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ / GLPG.AS / MRCG.DE</td><td class="leftalignment">Gilead Sciences Inc / Galapagos NV / Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech - 2020 Deal Scorecard for Cell Therapy & Oncology</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY=US / GILD=US / SGMO=US / ABBV=US / ALLO=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Sangamo Therapeutics Inc / Abbvie Inc / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Targeted Oncology ASCO GU Abstracts Overview</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD=US / SGEN=US / CLVS=US</td><td class="leftalignment">Gilead Sciences Inc / Seagen Inc / Clovis Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Dr. Andrew S. Berens, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Some SMid incrementally higher, but stable for Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) - ASCO GU Abstract Takeaways: EV-301 Data Consistent; EV-201 Cohort 2 Extends Padcev's Lead</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2778844 / 2369174</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Road to Reopening: The Evolution of COVID-19 Event Recap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">375558103 / 75886F107 / 452327109 / 74838J101 / 359664109 / 64049K104 / 60770K107 / 729139105 / 02155H200 / 01626L105</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Illumina Inc / Quidel Corp / Fulgent Genetics Inc / Neoleukin Therapeutics Inc / Moderna Inc / Pliant Therapeutics Inc / Altimmune Inc / Aligos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Yasmeen Rahimi, Ph.D. / Steven Mah, Ph.D. / Mr. Tyler M. Van Buren, M.SC / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Gilead Sciences Inc: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR deal termination; big pharma engages GRTS</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GRTS.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Morning Minutes: AEYE, SYTA, BEEM, LCTX, GILD / Corporate Events: see calendar below</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.OQ / AEYE.OQ / BEEM.OQ / LCTX.A / SYTA.OQ / 375558103 / 050734201 / 07373B109 / 53566P109 / 83013Q509</td><td class="leftalignment">Gilead Sciences Inc / AudioEye Inc / Beam Global / Lineage Cell Therapeutics Inc / Siyata Mobile Inc / Gilead Sciences Inc / AudioEye Inc / Beam Global / Lineage Cell Therapeutics Inc / Siyata Mobile Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Maxim Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALXN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIOb / JNJ / GILD.O / REGN.O / VRTX.O / RARE.O / BIIB.O / SRPT.O / AGIO.O / QGEN.K</td><td class="leftalignment">Bio Rad Laboratories Inc / Johnson & Johnson / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Qiagen NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GILD.OQ / NVAX.OQ / NBIX.OQ / ACB.TO / PTCT.OQ / WEED.TO / EYPT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Novavax Inc / Neurocrine Biosciences Inc / Aurora Cannabis Inc / PTC Therapeutics Inc / Canopy Growth Corp / EyePoint Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.5.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gx Vascepa Cracks 11% Mkt Share After Steady Growth in January</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TODAY@11am ET: Virtual KOL Call to Discuss The Competitive Landscape for CD47s in Development</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.OQ / ALXO.OQ</td><td class="leftalignment">Gilead Sciences Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Emma K. Nealon, III / Ms. Li W. Watsek / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Maxim Group</td><td class="leftalignment">Biktarvy Maintains Dominance in HIV but Changing HIV Landscape Makes the Pipeline as Important as Ever; Raising '21 Estimates</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jason McCarthy, Ph.D. / Mr. Michael Okunewitch</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NL0000226223 / DE0006231004 / DE0006969603 / US00738A1060 / US0079031078 / US00971T1016 / US0382221051 / US0718131099 / US0758871091 / US1265011056 / US1270971039 / US1985161066 / US22160K1051 / US2435371073 / US3755581036 / US4433201062 / US4581401001 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5370081045 / US55306N1046 / US5719032022 / US5801351017 / US5950171042 / US5951121038 / US64125C1099 / US6541061031 / US6549022043 / US67066G1040 / US6795801009 / US6821891057 / US7274931085 / US7392761034 / US7475251036 / US7782961038 / US8168501018 / US8305661055 / US8308791024 / US8610121027 / US8725401090 / US87612E1064 / US9182041080 / US9282981086 / US9311421039 / US9581021055 / US9839191015 / US3448491049 / US87157D1090 / US9884981013 / US83088M1027 / US80105N1054 / US21036P1084 / US2533931026 / US6098391054 / US9043111072 / US82706C1080 / US55616P1049 / US5500211090 / US00507V1098 / NL0009538784 / DE000A1EWWW0 / US6200763075 / US3390411052 / US7512121010 / US81762P1021 / US8725901040 / US69366J2006 / US1220171060 / US70438V1061 / US98936J1016 / US64829B1008 / US74736K1016 / US74624M1027 / US34959J1088 / US90138F1021 / US36165L1089 / LGFb / GB00BDSFG982 / LGFa / US83304A1060 / CA1350861060 / US23355L1061 / US05722G1004 / US8760301072 / US53115L1044 / US2575541055 / CA39342L1085 / US90184D1000 / VGG1890L1076 / CA23126M1023 / US70614W1009 / US44891N1090</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Puma SE / ADTRAN Inc / Advanced Micro Devices Inc / Akamai Technologies Inc / Applied Materials Inc / Baxter International Inc / Becton Dickinson and Co / CTS Corp / Coterra Energy Inc / Columbia Sportswear Co / Costco Wholesale Corp / Deckers Outdoor Corp / Gilead Sciences Inc / Hub Group Inc / Intel Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / McDonald's Corp / Microchip Technology Inc / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nokia Oyj / NVIDIA Corp / Old Dominion Freight Line Inc / ON Semiconductor Corp / Plantronics Inc / Power Integrations Inc / Qualcomm Inc / Ross Stores Inc / Semtech Corp / Skechers USA Inc / SkyWest Inc / STMicroelectronics NV / TJX Companies Inc / Target Corp / VF Corp / Vishay Intertechnology Inc / Walmart Inc / Western Digital Corp / Xilinx Inc / Foot Locker Inc / Synaptics Inc / Yum! Brands Inc / Skyworks Solutions Inc / Sanofi SA / Constellation Brands Inc / DICK'S Sporting Goods Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / Macy's Inc / Lululemon Athletica Inc / Activision Blizzard Inc / NXP Semiconductors NV / Adidas AG / Motorola Solutions Inc / Fleetcor Technologies Inc / Ralph Lauren Corp / ServiceNow Inc / T-Mobile US Inc / PTC Therapeutics Inc / Burlington Stores Inc / Paylocity Holding Corp / Zendesk Inc / New Relic Inc / Qorvo Inc / Pure Storage Inc / Fortive Corp / Twilio Inc / GDS Holdings Ltd / Lions Gate Entertainment Corp / TechnipFMC PLC / Lions Gate Entertainment Corp / Snap Inc / Canada Goose Holdings Inc / DXC Technology Co / Baker Hughes Co / Tapestry Inc / Liberty Oilfield Services Inc / Domo Inc / Green Thumb Industries Inc / Twist Bioscience Corp / Capri Holdings Ltd / Curaleaf Holdings Inc / Peloton Interactive Inc / IAC/Interactivecorp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / Finland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FTNT=US / AAPL=US / IBM=US / MRK=US / BMY=US / DIS=US / INTC=US / ADI=US / AMD=US / MSFT=US / MDT=US / AMZN=US / T=US / ORCL=US / VOD=US / TXN=US / U=US / CG=US / GILD=US / AMT=US / DOX=US / GS=US / AKAM=US / YUM=US / MPWR=US / CHTR=US / GE=US / VZ=US / SMTC=US / CCI=US / UPS=US / AZN=US / ZEN=US / EXC=US / XLNX=US / CSL=US / ATVI=US / MGM=US / CMCSA=US / CI=US / DISH=US / NUAN=US / AMSC=US / AME=US / APPS=US / CMI=US / CAJ=US / CTL=US / CRUS=US / CME=US / EGHT=US / EQIX=US / PHG=US / NBIX=US / PCTY=US / QUIK=US / SBAC=US / SNAP=US / TOSYY=US / VG=US / APO=US / SNOW=US / NET=US / CRNT=US / SYNA=US / FB=US / NFLX=US / TWLO=US / GPRO=US / ERIC=US / PTON=US / RNG=US / CEVA=US / GOOG=US / DLR=US / VIAC=US / DISCA=US / ICE=US / CCOI=US / MWA=US / INFI=US / RSI=US / LLNW=US / LUMN=US / TDC=US / IAC=US / KLR=US / AGCO=US / 005930-KR=US / ALPMY=US / MXL=US / NXPI=US / ANGI=US / SRPT=US / TMUS=US / GTT=US / AVYA=US / GOOGL=US / PAYC=US / SIEGY=US / EKTAY=US / NEWR=US / BILL=US / HPE=US / VYGR=US / DZSI=US / YUMC=US / TEUM=US / HLNE=US / SLNO=US / ATUS=US / VREX=US / ZM=US / FSLY=US / CMBM=US / NLOK=US / DKNG=US / ONDS=US</td><td class="leftalignment">Fortinet Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / Amazon.com Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Texas Instruments Inc / Unity Software Inc / Carlyle Group Inc / Gilead Sciences Inc / American Tower Corp / Amdocs Ltd / Goldman Sachs Group Inc / Akamai Technologies Inc / Yum! Brands Inc / Monolithic Power Systems Inc / Charter Communications Inc / General Electric Co / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / Zendesk Inc / Exelon Corp / Xilinx Inc / Carlisle Companies Inc / Activision Blizzard Inc / MGM Resorts International / Comcast Corp / Cigna Corp / DISH Network Corp / Nuance Communications Inc / American Superconductor Corp / AMETEK Inc / Digital Turbine Inc / Cummins Inc / Canon Inc / Lumen Technologies Inc / Cirrus Logic Inc / CME Group Inc / 8x8 Inc / Equinix Inc / Koninklijke Philips NV / Neurocrine Biosciences Inc / Paylocity Holding Corp / QuickLogic Corp / SBA Communications Corp / Snap Inc / Toshiba Corp / Vonage Holdings Corp / Apollo Global Management Inc / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Synaptics Inc / Meta Platforms Inc / Netflix Inc / Twilio Inc / GoPro Inc / Telefonaktiebolaget LM Ericsson / Peloton Interactive Inc / RingCentral Inc / CEVA Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Discovery Inc / Intercontinental Exchange Inc / Cogent Communications Holdings Inc / Mueller Water Products Inc / Infinity Pharmaceuticals Inc / Rush Street Interactive Inc / Limelight Networks Inc / Lumen Technologies Inc / Teradata Corp / IAC/Interactivecorp / Kaleyra Inc / AGCO Corp / Farfetch Ltd / Astellas Pharma Inc / Maxlinear Inc / NXP Semiconductors NV / Angi Inc / Sarepta Therapeutics Inc / T-Mobile US Inc / GTT Communications Inc / Avaya Holdings Corp / Alphabet Inc / Paycom Software Inc / Siemens AG / Elekta AB (publ) / New Relic Inc / Bill.com Holdings Inc / Hewlett Packard Enterprise Co / Voyager Therapeutics Inc / DZS Inc / Yum China Holdings Inc / Pareteum Corp / Hamilton Lane Inc / Soleno Therapeutics Inc / Altice USA Inc / Varex Imaging Corp / Zoom Video Communications Inc / Fastly Inc / Cambium Networks Corp / NortonLifeLock Inc / DraftKings Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Japan / Netherlands / Sweden / United States / Guernsey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Machinery / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / BMY=US / ADI=US / RRC=US / T=US / TXN=US / GILD=US / AMT=US / PEB=US / DGX=US / H=US / CRM=US / V=US / MTN=US / VZ=US / MAR=US / ATVI=US / ESS=US / HLT=US / MANH=US / PENN=US / CI=US / RCL=US / AIR=US / ARCC=US / ARW=US / AVT=US / CCL=US / CHH=US / DRH=US / EXPO=US / MAIN=US / MCHP=US / ORCC=US / PCTY=US / SHOP=US / SNAP=US / VSEC=US / POST=US / LCI=US / AVTR=US / BDN=US / CPT=US / OFC=US / OHI=US / PTON=US / BIIB=US / FLT=US / AINV=US / SHO=US / MPW=US / HST=US / MA=US / EHTH=US / PNNT=US / WH=US / WYND=US / IAC=US / RCUS=US / HGV=US / NXPI=US / RLJ=US / VAC=US / ANGI=US / RHP=US / NCLH=US / TMUS=US / PTCT=US / TSLX=US / 70806A106 / NEWR=US / GSBD=US / ZG=US / WLTW=US / VVV=US / PK=US / LGF.B=US / PLYA=US / RDFN=US / MPWR-US / FSK=US / PLMR=US / BRBR=US / GOCO=US / ONEW=US / FSKR=US / BIGC=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Analog Devices Inc / Range Resources Corp / AT&T Inc / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Quest Diagnostics Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Verizon Communications Inc / Marriott International Inc / Activision Blizzard Inc / Essex Property Trust Inc / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Penn National Gaming Inc / Cigna Corp / Royal Caribbean Cruises Ltd / AAR Corp / Ares Capital Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Exponent Inc / Main Street Capital Corp / Microchip Technology Inc / Owl Rock Capital Corp / Paylocity Holding Corp / Shopify Inc / Snap Inc / VSE Corp / Post Holdings Inc / Lannett Company Inc / Avantor Inc / Brandywine Realty Trust / Camden Property Trust / Corporate Office Properties Trust / Omega Healthcare Investors Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Medical Properties Trust Inc / Host Hotels & Resorts Inc / Mastercard Inc / eHealth Inc / Pennantpark Investment Corp / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / IAC/Interactivecorp / Arcus Biosciences Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Norwegian Cruise Line Holdings Ltd / T-Mobile US Inc / PTC Therapeutics Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / New Relic Inc / Goldman Sachs BDC Inc / Zillow Group Inc / Willis Towers Watson PLC / Valvoline Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Redfin Corp / Monolithic Power Systems Inc / FS KKR Capital Corp / Palomar Holdings Inc / Bellring Brands Inc / Gohealth Inc / OneWater Marine Inc / FS KKR Capital Corp / Bigcommerce Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Liberia / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">116</td><td class="leftalignment">US0091581068 / US0584981064 / US1258961002 / US1270971039 / US1924461023 / US2855121099 / US3755581036 / US4180561072 / US4278661081 / US4433201062 / US4601461035 / US5950171042 / US7010941042 / US7549071030 / US7802871084 / CA8029121057 / CA87971M1032 / CA6837151068 / CA0099051009 / CA7029251088 / CA8959451037 / US87157D1090 / US9884981013 / CA2052491057 / CA2935701078 / CA05534B7604 / CA01626P4033 / CA29258Y1034 / US89785X1019 / CA6252841045 / CA89154B1022 / CA8672241079 / US34959E1091 / CA69946Q1046 / CA0194561027 / BMG162581083 / CA8204391079 / CA6665111002 / CA69338U1012 / CA09202D2077 / CA37252B1022 / CA81373C1023 / CA29269R1055 / US64829B1008 / US70450Y1038 / CA26829L1076 / US23355L1061 / US7045511000 / CA85859H1055 / CA15713J1049 / US8760301072 / US76029N1063 / CA86084H1001 / US1255231003 / CA53227R1064 / US22052L1044 / US70614W1009 / US14316J1088</td><td class="leftalignment">Air Products and Chemicals Inc / Ball Corp / CMS Energy Corp / Coterra Energy Inc / Cognizant Technology Solutions Corp / Electronic Arts Inc / Gilead Sciences Inc / Hasbro Inc / Hershey Co / Hub Group Inc / International Paper Co / Microchip Technology Inc / Parker-Hannifin Corp / Rayonier Inc / Royal Gold Inc / Saputo Inc / Telus Corp / Open Text Corp / AKITA Drilling Ltd / Pason Systems Inc / Trican Well Service Ltd / Synaptics Inc / Yum! Brands Inc / Computer Modelling Group Ltd / Ensign Energy Services Inc / BCE Inc / Alimentation Couche-Tard Inc / Endeavour Silver Corp / TrueBlue Inc / Mullen Group Ltd / Total Energy Services Inc / Suncor Energy Inc / Fortinet Inc / Parex Resources Inc / Allied Properties Real Estate Investment Trust / Brookfield Renewable Partners LP / Shawcor Ltd / Northland Power Inc / PHX Energy Services Corp / Black Diamond Group Ltd / Sagen MI Canada Inc / Secure Energy Services Inc / Enerflex Ltd / New Relic Inc / PayPal Holdings Inc / ECN Capital Corp / DXC Technology Co / Peabody Energy Corp / Step Energy Services Ltd / CES Energy Solutions Corp / Tapestry Inc / Replimune Group Inc / Stingray Group Inc / Cigna Corp / Lightspeed Commerce Inc / Corteva Inc / Peloton Interactive Inc / Carlyle Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Veklury Beat Won't Get Much Credit, High Impact Oncology Catalysts Ahead</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">V / 0989529 / 2126335 / 2000019 / 2496113 / 2778844 / 2973821 / 2219224 / 2229126 / 2270726 / 2542049 / 2328915 / 2369174 / 2121352 / 2515030 / 2623911 / 2630513 / 2632003 / 2048804 / 2825933 / 2503529 / 2181334 / 2795393 / 2212922 / 2857817 / B2R3PV1 / B570P91 / 2390817 / B7TL820 / B4V9661 / B7VD3F2 / B9M2WX3 / BBGVT40 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BYW36M8 / BF09HX3 / BD8DJ71 / BKDS4H5 / BR4T3B3 / BJ2Z0H2 / BFZ1K46 / BFMXGR0 / BYXJQG9 / BKTNTR9 / BZ1LFG7 / BMH0MR7 / BYQCZ35 / BZ4CHH2 / BNG3RZ7 / 021513106</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Kohls Corp / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Columbia Sportswear Co / Walt Disney Co / Dominion Energy Inc / Nextera Energy Inc / Gilead Sciences Inc / Group 1 Automotive Inc / Lithia Motors Inc / Neurocrine Biosciences Inc / New Jersey Resources Corp / New York Times Co / Pinnacle West Capital Corp / South Jersey Industries Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Amerisourcebergen Corp / NRG Energy Inc / Netflix Inc / American Water Works Company Inc / Lear Corp / Gray Television Inc / Meta Platforms Inc / Ralph Lauren Corp / Duke Energy Corp / Bath & Body Works Inc / News Corp / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Tapestry Inc / Snap Inc / Bill.com Holdings Inc / HubSpot Inc / Pinterest Inc / Spotify Technology SA / Evergy Inc / Spire Inc / ViacomCBS Inc / Roku Inc / Zendesk Inc / Madison Square Garden Sports Corp / Soleno Therapeutics Inc / Leslie's Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">AFL.N / AXP.N / BCE.TO / CI.N / COF.N / DD.N / F.N / FLT.N / IBE.MC / NEM.N / PB.N / RL.N / RYN.N / SGEF.PA / SRCL.O / SVT.L / ZION.O / CERN.O / CMA.N / WY.N / GILD.O / FNV.N / CAE.TO / MET.N / AGI.N / HBAN.O / LEA.N / IEX.N / SU.TO / DBKGn.DE / CLX.N / YUM.N / AEM.N / KGC.N / BLL.N / NG.L / VLY.N / SNV.N / MDRX.O / PACW.O / LNC.N / NBIX.O / AME.N / OTEX.O / STL.N / CFR.N / FRC.N / WBS.N / FCF.N / DFS.N / PFS.N / FFBC.O / HCSG.O / PBCT.O / RGLD.O / SIVB.O / WSBC.O / BOKF.O / COLB.O / PCTY.O / WTFC.O / TCBI.O / GOLD.N / FHN.N / IAG.N / 427866108 / WAL.N / RDSb.L / ARWR.O / ISBC.O / MWA.N / AUY.N / SLRS.MC / TDC.N / GETP.PA / ENSG.O / PHR.N / NGD.A / HOMB.O / EGO.N / FTNT.O / SPB.N / MNR.N / PCH.O / BKU.N / CTT.N / XYL.N / SLM.OQ / VCRA.N / RFP.N / ALLY.N / NYCB.N / TMUS.N / PTCT.O / ONB.OQ / BTG.N / SYF.N / CTLT.N / HQY.OQ / GWB.N / ASB.N / TDOC.N / TRHC.OQ / FTV.N / OR.N / LGFB.N / SAND.N / RCM.OQ / GOOS.TO / DXC.N / CADE.N / WPM.N / KL.N / 05971J102 / CTVA.N / HCAT.OQ / NLOK.O / OTRK.OQ / GDRX.O / TLMD.OQ / SHC.OQ</td><td class="leftalignment">Aflac Inc / American Express Co / BCE Inc / Cigna Corp / Capital One Financial Corp / Dupont De Nemours Inc / Ford Motor Co / Fleetcor Technologies Inc / Iberdrola SA / Newmont Corporation / Prosperity Bancshares Inc / Ralph Lauren Corp / Rayonier Inc / Vinci SA / Stericycle Inc / Severn Trent PLC / Zions Bancorporation NA / Cerner Corp / Comerica Inc / Weyerhaeuser Co / Gilead Sciences Inc / Franco-Nevada Corp / CAE Inc / MetLife Inc / Alamos Gold Inc / Huntington Bancshares Inc / Lear Corp / IDEX Corp / Suncor Energy Inc / Deutsche Bank AG / Clorox Co / Yum! Brands Inc / Agnico Eagle Mines Ltd / Kinross Gold Corp / Ball Corp / National Grid PLC / Valley National Bancorp / Synovus Financial Corp / Allscripts Healthcare Solutions Inc / PacWest Bancorp / Lincoln National Corp / Neurocrine Biosciences Inc / AMETEK Inc / Open Text Corp / Sterling Bancorp / Cullen/Frost Bankers Inc / First Republic Bank / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Provident Financial Services Inc / First Financial Bancorp / Healthcare Services Group Inc / People's United Financial Inc / Royal Gold Inc / SVB Financial Group / WesBanco Inc / BOK Financial Corp / Columbia Banking System Inc / Paylocity Holding Corp / Wintrust Financial Corp / Texas Capital Bancshares Inc / Barrick Gold Corp / First Horizon Corp / IAMGOLD Corp / Hershey Co / Western Alliance Bancorp / Royal Dutch Shell PLC / Arrowhead Pharmaceuticals Inc / Investors Bancorp Inc / Mueller Water Products Inc / Yamana Gold Inc / Solaria Energia y Medio Ambiente SA / Teradata Corp / Getlink SE / Ensign Group Inc / Phreesia Inc / New Gold Inc / Home BancShares Inc / Eldorado Gold Corp / Fortinet Inc / Spectrum Brands Holdings Inc / Monmouth Real Estate Investment Corp / Potlatchdeltic Corp / BankUnited Inc / CatchMark Timber Trust Inc / Xylem Inc / SLM Corp / Vocera Communications Inc / Resolute Forest Products Inc / Ally Financial Inc / New York Community Bancorp Inc / T-Mobile US Inc / PTC Therapeutics Inc / Old National Bancorp / B2Gold Corp / Synchrony Financial / Catalent Inc / Healthequity Inc / Great Western Bancorp Inc / Associated Banc-Corp / Teladoc Health Inc / Tabula Rasa HealthCare Inc / Fortive Corp / Osisko Gold Royalties Ltd / Lions Gate Entertainment Corp / Sandstorm Gold Ltd / R1 RCM Inc / Canada Goose Holdings Inc / DXC Technology Co / Cadence Bank / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Cadence Bank / Corteva Inc / Health Catalyst Inc / NortonLifeLock Inc / Ontrak Inc / Goodrx Holdings Inc / Soc Telemed Inc / Sotera Health Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Spain / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AME / APD / AR / ARW / ASH / BAX / BDX / CLR / CLX / CNX / COG / CPB / CPE / DANO.PA / DGX / DVN / EOG / EQT / FLT / FNB / GIS / HSY / IEX / IP / K / KLAC.O / LNC / MCHP.O / MGY / MRO / MTD / NGL / NJR / PXD / RL / RRC / SJM / SKX / SM / SR / SWN / THS / TPR / UPS / WEC / WLL / YUM / JHG / BYND.O / GILD.O / SU.TO / ODFL.O / HUBG.O / WERN.O / LBRT.N / LPI / DXC / HAIN.O / BRKR.O / SBNY.O / AINV.O / TW.O / NOG.A / LPLA.O / ESTE.K / MTDR.K / PDCE.O / MDLZ.O / FANG.O / SMPL.O / BCEI.K / POST.K / DECK.K / HUBS.K / KHC.O / TMUS.O / CDEV.O / OCSL.O / BSIG.K / NOMD.K / BRY.O / CPRI.K / BRBR.K / OAS.O / BILL.K</td><td class="leftalignment">AMETEK Inc / Air Products and Chemicals Inc / Antero Resources Corp / Arrow Electronics Inc / Ashland Global Holdings Inc / Baxter International Inc / Becton Dickinson and Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Coterra Energy Inc / Campbell Soup Co / Callon Petroleum Co / Danone SA / Quest Diagnostics Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Fleetcor Technologies Inc / FNB Corp / General Mills Inc / Hershey Co / IDEX Corp / International Paper Co / Kellogg Co / KLA Corp / Lincoln National Corp / Microchip Technology Inc / Magnolia Oil & Gas Corp / Marathon Oil Corp / Mettler-Toledo International Inc / NGL Energy Partners LP / New Jersey Resources Corp / Pioneer Natural Resources Co / Ralph Lauren Corp / Range Resources Corp / J M Smucker Co / Skechers USA Inc / SM Energy Co / Spire Inc / Southwestern Energy Co / TreeHouse Foods Inc / Tapestry Inc / United Parcel Service Inc / WEC Energy Group Inc / Whiting Petroleum Corp / Yum! Brands Inc / Janus Henderson Group PLC / Beyond Meat Inc / Gilead Sciences Inc / Suncor Energy Inc / Old Dominion Freight Line Inc / Hub Group Inc / Werner Enterprises Inc / Liberty Oilfield Services Inc / Laredo Petroleum Inc / DXC Technology Co / Hain Celestial Group Inc / Bruker Corp / Signature Bank / Apollo Investment Corp / Tradeweb Markets Inc / Northern Oil and Gas Inc / LPL Financial Holdings Inc / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / Civitas Resources Inc / Post Holdings Inc / Deckers Outdoor Corp / HubSpot Inc / Kraft Heinz Co / T-Mobile US Inc / Centennial Resource Development Inc / Oaktree Specialty Lending Corp / Brightsphere Investment Group Inc / Nomad Foods Ltd / Berry Corporation (Bry) / Capri Holdings Ltd / Bellring Brands Inc / Oasis Petroleum Inc / Bill.com Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">4Q take: Lenacapavir opportunity is likely long-term unappreciated HIV growth story for GILD</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GILD: Our Thoughts Post the 4Q20 Call: Gilead's transition to growth? Encouraged, but need to see execution</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">GILD: Outlook Highlights Broadening Pipeline, Higher Risk Profile</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">GILD - GILD 4Q20 Postview: Quiet quarter, in-line guidance; will 2021 be the test case for the "new" GILD?</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : 4Q Snapshot - Remdesivir Drives 2021 Financial Outlook as Core Sales Growth Remains Modest</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / James Scott / Mr. Turner Kufe</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Poised for growth with late-stage assets in view and potential upside to our model; PT $67 from $62</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD=US / RCUS=US</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 Financials Beat; Guidance Implies Flat Y/Y Growth</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Mr. Kenneth C. Atkins, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">key takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">4Q20: Core Business To Grow in '21, Veklury Sales Should Buy Time For Oncology Platform To Mature</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Model Update Post-4Q; Good FY 2021; Guide Above Us and Street With Encouraging Commentary on LT Growth</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2369174</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">4Q20: Veklury Drives Beat, Consistent With Revised Guidance</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Reports Q4: In-Line W/ Pre-Announcement; Several Important Catalysts During 21</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren, M.SC / Tara Bancroft, Ph.D. / James Delorme, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q20 Review: Surprisingly Bullish 2021 Guidance & Material Pipeline Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GILD=US</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Gilead Sciences : First Look at 4Q Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / James Scott / Mr. Turner Kufe</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">UNH.N / GILD.OQ / CHNG.OQ / RCUS.N / IMAB.OQ</td><td class="leftalignment">UnitedHealth Group Inc / Gilead Sciences Inc / Change Healthcare Inc / Arcus Biosciences Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">4Q20 First Take: Core Growth Products Strong, Guidance Reflects Veklury Boost</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Brief of Gilead Sciences Inc conference call, Feb. 04, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">GILD.OQ - Event Transcript of Gilead Sciences Inc conference call, Feb. 04, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Feb 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / APD.N / BAX.N / BDX.N / BMY.N / BP.L / CI.N / CMS.N / F.N / FLT.N / HIG.N / IBM.N / IP.N / MRK.N / PM.N / RL.N / SLB.N / DGX.N / HAL.N / LEA.N / CMI.N / IEX.N / PH.N / DBKGn.DE / CLX.N / YUM.N / UNM.N / WEC.N / XOM.N / HSY.N / AMT.N / MTD.N / BLL.N / SNA.N / ESS.N / ABC.N / PRU.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / SBUX.OQ / ODFL.OQ / MCHP.OQ / GILD.OQ / TPR.N / AMZN.OQ / COLM.OQ / 0700.HK / ARWR.OQ / NOV.N / RDSa.L / ICE.N / 9999.HK / DECK.N / NWSA.OQ / FTNT.OQ / MSI.N / BKR.N / CG.OQ / TMUS.OQ / FTV.N / DXC.N / LYFT.OQ / BYND.OQ / UBER.N / ZM.OQ / NLOK.OQ / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pinterest Inc / Air Products and Chemicals Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / BP PLC / Cigna Corp / CMS Energy Corp / Ford Motor Co / Fleetcor Technologies Inc / Hartford Financial Services Group Inc / International Business Machines Corp / International Paper Co / Merck & Co Inc / Philip Morris International Inc / Ralph Lauren Corp / Schlumberger NV / Quest Diagnostics Inc / Halliburton Co / Lear Corp / Cummins Inc / IDEX Corp / Parker-Hannifin Corp / Deutsche Bank AG / Clorox Co / Yum! Brands Inc / Unum Group / WEC Energy Group Inc / Exxon Mobil Corp / Hershey Co / American Tower Corp / Mettler-Toledo International Inc / Ball Corp / Snap-On Inc / Essex Property Trust Inc / Amerisourcebergen Corp / Prudential Financial Inc / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Starbucks Corp / Old Dominion Freight Line Inc / Microchip Technology Inc / Gilead Sciences Inc / Tapestry Inc / Amazon.com Inc / Columbia Sportswear Co / Tencent Holdings Ltd / Arrowhead Pharmaceuticals Inc / Nov Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / NetEase Inc / Deckers Outdoor Corp / News Corp / Fortinet Inc / Motorola Solutions Inc / Baker Hughes Co / Carlyle Group Inc / T-Mobile US Inc / Fortive Corp / DXC Technology Co / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / NortonLifeLock Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TOMORROW@11am ET: Virtual KOL Call to Discuss The Competitive Landscape for CD47s in Development</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / ALXO.O</td><td class="leftalignment">Gilead Sciences Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Emma K. Nealon, III / Ms. Li W. Watsek / Emily Bodnar</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TOMORROW AM, Virtual KOL Call to Discuss The Competitive Landscape for CD47s in Development</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">IMAB.O / GILD.O / ALXO.O</td><td class="leftalignment">I-Mab / Gilead Sciences Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GILD: Gilead Sciences, Inc - 4Q20 First Take: Getting to growth? 2021 outlook improving, but still more work to be done</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for GILD</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Egypt / Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / HOOK.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / INO.OQ / SRPT.O / ENTA.O / PTCT.O / KPTI.O / XNCR.OQ / ITCI.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / OVID.O / ITRM.O / PRVB.O / GMDA.OQ / NBSE.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Ovid Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / EBAY=US / TXN=US / TEVA=US / GILD=US / PEB=US / CONE=US / LOW=US / FMS=US / HSII=US / DIOD=US / CHRS=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / MAC=US / KFY=US / AMN=US / CBRL=US / CSTR=US / DRI=US / DRH=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGN=US / REGI=US / RHI=US / ROLL=US / SKY=US / THO=US / CCRN=US / MTCH=US / VNO=US / FFIN=US / GBCI=US / DIN=US / PTON=US / RPD=US / TPX=US / EXP=US / BECN=US / SHO=US / DLR=US / PLAY=US / BAH=US / WMG=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / EHC=US / NMTR=US / IAC=US / JACK=US / RCUS=US / TREX=US / NXPI=US / WWD=US / RLJ=US / FBHS=US / ANGI=US / EA=US / RHP=US / TILE=US / IBTX=US / NDLS=US / PINC=US / CNCE=US / MTNB=US / LOCO=US / ANTM=US / WBA=US / SHAK=US / ON=US / WING=US / ARGX=US / 82982L103 / PK=US / GDS=US / JELD=US / SWCH=US / FERGY=US / ARQT=US / AZEK=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / eBay Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Pebblebrook Hotel Trust / CyrusOne Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Heidrick & Struggles International Inc / Diodes Inc / Coherus BioSciences Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Macerich Co / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / RBC Bearings Inc / Skyline Champion Corp / Thor Industries Inc / Cross Country Healthcare Inc / Match Group Inc / Vornado Realty Trust / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Peloton Interactive Inc / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Warner Music Group Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / 9 Meters Biopharma Inc / IAC/Interactivecorp / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Premier Inc / Concert Pharmaceuticals Inc / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Switch Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BDX.N / BMY.N / BSX.N / CI.N / EL.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / HD.N / ITW.N / XOM.N / LIN.N / ARE.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / QCOM.OQ / GILD.OQ / AMZN.OQ / TTWO.OQ / GPN.N / VRTX.OQ / ICE.N / TDG.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Home Depot Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Intercontinental Exchange Inc / TransDigm Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: January 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / ALB.N / AXP.N / BA.N / BAC.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CRM.N / CVS.N / DAL.N / DD.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / GM.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MDT.N / MO.N / MRK.N / OXY.N / SLB.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / CMA.N / PG.N / W.N / RIG.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / MGM.N / RCL.N / SYY.N / HON.N / VLO.N / HD.N / LOW.N / MRO.N / SYK.N / JWN.N / XOM.N / NKE.N / LIN.N / TGT.N / VZ.N / SNV.N / KSS.N / ORCL.N / VFC.N / HP.N / MAC.N / KMI.N / KMX.N / PWR.N / EQT.N / V.N / OKE.N / HWM.N / ACN.N / WSM.N / AIV.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / COHR.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / PII.N / REGN.OQ / ROL.N / SIVB.OQ / THO.N / QDEL.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / CREE.OQ / GILD.OQ / COST.OQ / CPRT.OQ / TRU.N / ACGL.OQ / SSNC.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / MRCY.OQ / EBAY.OQ / NVDA.OQ / MFA.N / CHTR.OQ / NUAN.OQ / ISRG.OQ / ILMN.OQ / ALGN.OQ / GPN.N / PTEN.OQ / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / SBNY.OQ / OSH.N / MOS.N / LVS.N / VIAC.OQ / DISCA.OQ / KOS.N / CDNS.OQ / MS.N / FIS.N / MA.N / SIX.N / SPR.N / CNK.N / IVZ.N / M.N / BGCP.OQ / PBF.N / MRNA.OQ / MSCI.N / CHNG.OQ / AVGO.OQ / FICO.N / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / NEE.N / TSLA.OQ / ADSGN.F / HHC.N / TWO.N / SABR.OQ / MPC.N / HFC.N / HZNP.OQ / AMD.OQ / ENPH.OQ / PSX.N / NOW.N / SRPT.OQ / BERY.N / FANG.OQ / ABBV.N / BFAM.N / COTY.N / FEYE.OQ / MAR.OQ / AAL.OQ / NCLH.N / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / WBA.OQ / SEDG.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / RETA.OQ / TWLO.N / SPG.NZ / TTD.OQ / CDEV.OQ / UAA.N / FTI.PA / CVNA.N / AXON.OQ / ROKU.OQ / PEP.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / FB.PS / CDAY.N / UAL.OQ / STNE.OQ / ETRN.N / NWL.OQ / CPRI.N / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / CRWD.OQ / PTON.OQ / SVC.OQ / SPCE.N / RTX.N / CARR.N / LMND.N / CHK.N^F20 / AMWL.N / LUMN.N / CHX.OQ</td><td class="leftalignment">Abbott Laboratories / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Merck & Co Inc / Occidental Petroleum Corp / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Comerica Inc / Procter & Gamble Co / Wayfair Inc / Transocean Ltd / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Royal Caribbean Cruises Ltd / Sysco Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Stryker Corp / Nordstrom Inc / Exxon Mobil Corp / Nike Inc / Linde PLC / Target Corp / Verizon Communications Inc / Synovus Financial Corp / Kohls Corp / Oracle Corp / VF Corp / Helmerich and Payne Inc / Macerich Co / Kinder Morgan Inc / Carmax Inc / Quanta Services Inc / EQT Corp / Visa Inc / ONEOK Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Coherent Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Thor Industries Inc / Quidel Corp / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Wolfspeed Inc / Gilead Sciences Inc / Costco Wholesale Corp / Copart Inc / TransUnion / Arch Capital Group Ltd / SS&C Technologies Holdings Inc / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Mercury Systems Inc / eBay Inc / NVIDIA Corp / MFA Financial Inc / Charter Communications Inc / Nuance Communications Inc / Intuitive Surgical Inc / Illumina Inc / Align Technology Inc / Global Payments Inc / Patterson-UTI Energy Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Signature Bank / Oak Street Health Inc / Mosaic Co / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Kosmos Energy Ltd / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Six Flags Entertainment Corp / Spirit AeroSystems Holdings Inc / Cinemark Holdings Inc / Invesco Ltd / Macy's Inc / BGC Partners Inc / PBF Energy Inc / Moderna Inc / MSCI Inc / Change Healthcare Inc / Broadcom Inc / Fair Isaac Corp / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Nextera Energy Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / Two Harbors Investment Corp / Sabre Corp / Marathon Petroleum Corp / HollyFrontier Corp / Horizon Therapeutics PLC / Advanced Micro Devices Inc / Enphase Energy Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Diamondback Energy Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Coty Inc / Mandiant Inc / Marriott International Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Reata Pharmaceuticals Inc / Twilio Inc / Stride Property Ltd / Trade Desk Inc / Centennial Resource Development Inc / Under Armour Inc / TechnipFMC PLC / Carvana Co / Axon Enterprise Inc / Roku Inc / PepsiCo Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Ceridian HCM Holding Inc / United Airlines Holdings Inc / StoneCo Ltd / Equitrans Midstream Corp / Newell Brands Inc / Capri Holdings Ltd / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Service Properties Trust / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / Chesapeake Energy Corp / American Well Corp / Lumen Technologies Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Liberia / New Zealand / Panama / Philippines / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / GILD.OQ / AMRN.OQ / BSLN.S / AXSM.OQ / BHVN.N / ARAV.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Amarin Corporation PLC / Basilea Pharmaceutica AG / Axsome Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aravive Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 77 US Companies with Undisclosed SEC Probes - February 01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN.OQ / PG.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / T.N / BEN.N / TRI.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / RMD.N / NKE.N / AMP.N / MTZ.N / ARW.N / TWTR.N / OMI.N / CVX.N / GNTX.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / FB.OQ / XPO.N / CTG.OQ / NTRA.OQ / 100088979 / MFIN.OQ / DXC.N / CVNA.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / LYFT.O / US71742W1036 / 120175706</td><td class="leftalignment">Amgen Inc / Procter & Gamble Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / AT&T Inc / Franklin Resources Inc / Thomson Reuters Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Resmed Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Twitter Inc / Owens & Minor Inc / Chevron Corp / Gentex Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Meta Platforms Inc / XPO Logistics Inc / Computer Task Group Inc / Natera Inc / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Carvana Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Lyft Inc / PhenixFIN Corp / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Spoke to management, color around GILD and TIGIT as a biomarker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.OQ / RCUS=US / GILD=US / RCUS.N</td><td class="leftalignment">Gilead Sciences Inc / Arcus Biosciences Inc / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Monthly Highlights--February 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FISV=US / AAPL=US / VECO=US / WSM=US / NKE=US / CSII=US / FDX=US / CAT=US / INTC=US / MCD=US / CHRW=US / BWA=US / AMZN=US / T=US / ADBE=US / INCY=US / CG=US / D=US / USB=US / WFC=US / GILD=US / NVDA=US / EVER=US / TMX=US / JPM=US / FCEL=US / PLUG=US / BBI=US / NICE=US / SBH=US / CRM=US / GE=US / VZ=US / SYK=US / RMD=US / BAX=US / EMR=US / HON=US / HELE=US / CTAS=US / EXPE=US / TTWO=US / LSTR=US / ATVI=US / HCA=US / HUM=US / LECO=US / DOV=US / RSG=US / ALB=US / AMED=US / APPS=US / ACI=US / ATRC=US / ADSK=US / BOX=US / B=US / BL=US / BLUE=US / CHD=US / KMX=US / CRUS=US / COO=US / CYBR=US / DRI=US / DFS=US / DOCU=US / E=US / ECL=US / EGHT=US / EQIX=US / EXEL=US / HEAR=US / HRL=US / ITT=US / ICPT=US / IDCC=US / ITRI=US / TREE=US / LIFE=US / MNRO=US / TEAM=US / NR=US / NDSN=US / OSIS=US / ORLY=US / PZZA=US / PCTY=US / PHAR=US / REGN=US / ROK=US / SHOP=US / SUNS=US / SCM=US / SNAP=US / TWOU=US / UNFI=US / UTHR=US / URBN=US / Z=US / VRTX=US / VG=US / SAGE=US / PRVB=US / AAP=US / CRNT=US / CCRN=US / PYPL=US / JEF=US / AOS=US / FB=US / SWKS=US / ENSG=US / BE=US / ALPN=US / TWLO=US / CLH=US / MIST=US / WCN=US / DKS=US / MD=US / CASI=US / BIIB=US / ISR=US / SFM=US / ALNY=US / MBRX=US / DPZ=US / GOOG=US / BJRI=US / TXRH=US / ORA=US / FRPT=US / AMRS=US / PERI=US / SNSS=US / ICE=US / AXON=US / TH=US / CMG=US / MWA=US / SIX=US / XPO=US / FSLR=US / AIMC=US / NM=US / QSR=US / TRIT=US / M=US / PODD=US / VMW=US / TNDM=US / WH=US / DAN=US / SPRO=US / WYND=US / KLR=US / SPGI=US / AGCO=US / SLRC=US / CBOE=US / BLRX=US / MSCI=US / NXPI=US / WWD=US / ANGI=US / ZNGA=US / ENPH=US / TCPC=US / RXN=US / PANW=US / GMED=US / AMBA=US / HASI=US / MRTX=US / CNHI=US / ARMK=US / MDWD=US / VBIV=US / LOVE=US / VCEL=US / NVRO=US / NEWR=US / RLMD=US / GKOS=US / WING=US / PSTG=US / SPXC=US / AQMS=US / SQ=US / CERC=US / 113875965 / IONS=US / NTNX=US / 100502968 / WKHS=US / TCMD=US / FLGT=US / IRTC=US / UAA=US / AVDL=US / SRRA=US / OKTA=US / YEXT=US / VREX=US / NCNA=US / RCKT=US / CAAP=US / MOTS=US / SMAR=US / FOCS=US / CWEN=US / FTDR=US / MRKR=US / GMDA=US / CPRI=US / XFOR=US / ZM=US / TMDX=US / IDYA=US / CRWD=US / MWK=US / CMBM=US / FVRR=US / KRTX=US / DDOG=US / FREQ=US / ETNB=US / BXRX=US / MSGS=US / ORIC=US / AYLA=US / NNOX=US / TSHA=US / VLDR=US / ASAN=US / ABNB=US / ONDS=US</td><td class="leftalignment">Fiserv Inc / Apple Inc / Veeco Instruments Inc / Williams-Sonoma Inc / Nike Inc / Cardiovascular Systems Inc / FedEx Corp / Caterpillar Inc / Intel Corp / McDonald's Corp / CH Robinson Worldwide Inc / Borgwarner Inc / Amazon.com Inc / AT&T Inc / Adobe Inc / Incyte Corp / Carlyle Group Inc / Dominion Energy Inc / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / NVIDIA Corp / EverQuote Inc / Terminix Global Holdings Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Brickell Biotech Inc / Nice Ltd / Sally Beauty Holdings Inc / Salesforce.Com Inc / General Electric Co / Verizon Communications Inc / Stryker Corp / Resmed Inc / Baxter International Inc / Emerson Electric Co / Honeywell International Inc / Helen of Troy Ltd / Cintas Corp / Expedia Group Inc / Take-Two Interactive Software Inc / Landstar System Inc / Activision Blizzard Inc / HCA Healthcare Inc / Humana Inc / Lincoln Electric Holdings Inc / Dover Corp / Republic Services Inc / Albemarle Corp / Amedisys Inc / Digital Turbine Inc / Albertsons Companies Inc / AtriCure Inc / Autodesk Inc / Box Inc / Barnes Group Inc / Blackline Inc / bluebird bio Inc / Church & Dwight Co Inc / Carmax Inc / Cirrus Logic Inc / Cooper Companies Inc / Cyberark Software Ltd / Darden Restaurants Inc / Discover Financial Services / DocuSign Inc / Eni SpA / Ecolab Inc / 8x8 Inc / Equinix Inc / Exelixis Inc / Turtle Beach Corp / Hormel Foods Corp / ITT Inc / Intercept Pharmaceuticals Inc / InterDigital Inc / Itron Inc / Lendingtree Inc / aTyr Pharma Inc / Monro Inc / Atlassian Corporation PLC / Newpark Resources Inc / Nordson Corp / OSI Systems Inc / O'Reilly Automotive Inc / Papa John's International Inc / Paylocity Holding Corp / Pharming Group NV / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / Shopify Inc / SLR Senior Investment Corp / Stellus Capital Investment Corp / Snap Inc / 2U Inc / United Natural Foods Inc / United Therapeutics Corp / Urban Outfitters Inc / Zillow Group Inc / Vertex Pharmaceuticals Inc / Vonage Holdings Corp / SAGE Therapeutics Inc / Provention Bio Inc / Advance Auto Parts Inc / Ceragon Networks Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Jefferies Financial Group Inc / A O Smith Corp / Meta Platforms Inc / Skyworks Solutions Inc / Ensign Group Inc / Bloom Energy Corp / Alpine Immune Sciences Inc / Twilio Inc / Clean Harbors Inc / Milestone Pharmaceuticals Inc / Waste Connections Inc / DICK'S Sporting Goods Inc / MEDNAX Inc / CASI Pharmaceuticals Inc / Biogen Inc / IsoRay Inc / Sprouts Farmers Market Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / Domino's Pizza Inc / Alphabet Inc / BJ's Restaurants Inc / Texas Roadhouse Inc / Ormat Technologies Inc / Freshpet Inc / Amyris Inc / Perion Network Ltd / Viracta Therapeutics Inc / Intercontinental Exchange Inc / Axon Enterprise Inc / Target Hospitality Corp / Chipotle Mexican Grill Inc / Mueller Water Products Inc / Six Flags Entertainment Corp / XPO Logistics Inc / First Solar Inc / Altra Industrial Motion Corp / Navios Maritime Holdings Inc / Restaurant Brands International Inc / Triterras Inc / Macy's Inc / Insulet Corp / VMware Inc / Tandem Diabetes Care Inc / Wyndham Hotels & Resorts Inc / Dana Inc / Spero Therapeutics Inc / Travel + Leisure Co / Kaleyra Inc / S&P Global Inc / AGCO Corp / SLR Investment Corp / Cboe Global Markets Inc / BioLine RX Ltd / MSCI Inc / NXP Semiconductors NV / Woodward Inc / Angi Inc / Zynga Inc / Enphase Energy Inc / BlackRock TCP Capital Corp / Zurn Water Solutions Corp / Palo Alto Networks Inc / Globus Medical Inc / Ambarella Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Mirati Therapeutics Inc / CNH Industrial NV / Aramark / Mediwound Ltd / VBI Vaccines Inc / Lovesac Co / Vericel Corp / Nevro Corp / New Relic Inc / Relmada Therapeutics Inc / Glaukos Corp / Wingstop Inc / Pure Storage Inc / SPX Corp / Aqua Metals Inc / Block Inc / Avalo Therapeutics Inc / CNH Industrial NV / Ionis Pharmaceuticals Inc / Nutanix Inc / Precision Drilling Corp / Workhorse Group Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Okta Inc / Yext Inc / Varex Imaging Corp / NuCana PLC / Rocket Pharmaceuticals Inc / Corporacion America Airports SA / Motus GI Holdings Inc / Smartsheet Inc / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Marker Therapeutics Inc / Gamida Cell Ltd / Capri Holdings Ltd / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / CrowdStrike Holdings Inc / Aterian Inc / Cambium Networks Corp / Fiverr International Ltd / Karuna Therapeutics Inc / Datadog Inc / Frequency Therapeutics Inc / 89Bio Inc / Baudax Bio Inc / Madison Square Garden Sports Corp / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Velodyne Lidar Inc / Asana Inc / Airbnb Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / United States / Virgin Islands, British / Marshall Islands</td><td class="leftalignment">Services</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Opportunity Calls for Gilead Sciences Inc Investors</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 4Q20 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccines vs variants; IND cleared for PASG</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PASG.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS FRIDAY, Virtual KOL Call to Discuss The Competitive Landscape for CD47s in Development</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IMAB.O / GILD.O / ALXO.O</td><td class="leftalignment">I-Mab / Gilead Sciences Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 4Q20 Biotech Earnings Consensus Cheat Sheet for VRTX, AMGN, BIIB, GILD, NBIX, and REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / AMGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ABBV.N</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 1.29.21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: EpiPen Mkt Growth Strong; Vascepa Gx at High-Single Digit Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended January 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Zeus Capital</td><td class="leftalignment">Guild Esports (GILD LN) - Building momentum</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GB00BMWVF760</td><td class="leftalignment">Guild Esports PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bob H. Liao</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Preview Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / BAYGN.DE / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Bayer AG / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">LIFE: New Data Highlight Why NRP2 Is a Cancer Target Not to Be Ignored</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LIFE.OQ / GILD</td><td class="leftalignment">aTyr Pharma Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GB0004544929 / US09061G1013 / US0028241000 / US0079031078 / US0231351067 / US0311621009 / US0378331005 / US0382221051 / US0530151036 / US0970231058 / US1271903049 / US2254471012 / US28176E1082 / US30161Q1040 / US30226D1063 / US3696041033 / US3755581036 / US4364401012 / US45253H1014 / US45337C1027 / US4824801009 / US5128071082 / US55306N1046 / US5951121038 / US64125C1099 / US6558441084 / US75886F1075 / US8168501018 / US8636671013 / US8793601050 / US8807701029 / US8832031012 / US91307C1027 / US9138371003 / US9182041080 / US92532F1003 / US9581021055 / US9839191015 / NL0000200384 / US5658491064 / US83088M1027 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / US12541W2098 / US00206R1023 / ACOR.OQ / US42809H1077 / US82706C1080 / US6247581084 / US29089Q1058 / US0043971052 / US03152W1099 / US64110D1046 / US2120151012 / US46333X1081 / US13100M5094 / IE00B58JVZ52 / US88160R1014 / US4361061082 / US56585A1025 / US7185461040 / US30303M1027 / NL0010273215 / US81762P1021 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US69888T2078 / US2681582019 / US31572Q8087 / US22822V1017 / US74736K1016 / US09627Y1091 / US37890U1088 / US74624M1027 / US4622221004 / US07725L1026 / KYG4740B1059 / IL0011407140 / US4990491049 / US8760301072 / US76243J1051 / CH0371153492 / SE0009414576 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Imperial Brands PLC / Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Micro Devices Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Automatic Data Processing Inc / Boeing Co / CACI International Inc / Wolfspeed Inc / Edwards Lifesciences Corp / Exelixis Inc / Extreme Networks Inc / General Electric Co / Gilead Sciences Inc / Hologic Inc / ImmunoGen Inc / Incyte Corp / KLA Corp / Lam Research Corp / MKS Instruments Inc / Micron Technology Inc / Neurocrine Biosciences Inc / Norfolk Southern Corp / Regeneron Pharmaceuticals Inc / Semtech Corp / Stryker Corp / Teledyne Technologies Inc / Teradyne Inc / Textron Inc / United Therapeutics Corp / Universal Stainless & Alloy Products Inc / VF Corp / Vertex Pharmaceuticals Inc / Western Digital Corp / Xilinx Inc / Core Laboratories NV / Marathon Oil Corp / Skyworks Solutions Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Hess Corp / Silicon Motion Technology Corp / Mueller Water Products Inc / Emergent BioSolutions Inc / Accuray Inc / Amicus Therapeutics Inc / NetApp Inc / Continental Resources Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Seagate Technology Holdings PLC / Tesla Inc / HollyFrontier Corp / Marathon Petroleum Corp / Phillips 66 / Meta Platforms Inc / ASML Holding NV / ServiceNow Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Par Pacific Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Qorvo Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Pure Storage Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Urogen Pharma Ltd / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Rhythm Pharmaceuticals Inc / Landis+Gyr Group AG / Oncopeptides AB / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4+2021 Preview: Fundamentals Remain Strong, Should Provide Investment Oppy's</td><td class="leftalignment">English</td><td class="rightalignment">226</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BMY.N / BSX.N / CI.N / LLY.N / MRK.N / PFE.N / PM.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / QCOM.OQ / GILD.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / CMCSA.OQ / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Implications Of New Xeljanz Safety Concerns On Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / INCY.O / GLPG.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Galapagos NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Stable for Large Cap Stocks, SMid incrementally higher</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology 4Q20 Preview: More of the same? Large Cap lethargy, SMid-Cap enthusiasm, against the continuing pandemic backdrop</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">GILD.OQ / AMGN.OQ / BMY.N / LLY.N / PFE.N / REGN.OQ / RARE.OQ / INCY.OQ / NBIX.OQ / ICPT.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / ARNA.OQ / ESPR.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / GLPG.AS / IRWD.OQ / SRPT.OQ / ABBV.N / PTCT.OQ / RNA.OQ / QURE.OQ / FLXN.OQ / ASND.OQ / ANAB.OQ / APLS.OQ / KURA.OQ / NTLA.OQ / ARGX.OQ / IFRX.OQ / SRRK.OQ / CYCN.OQ / ISEE.OQ / STOK.OQ / INBX.OQ / IMVT.OQ / FMTX.OQ / ALXO.OQ / CVAC.OQ / SPRB.OQ / GLTO.OQ / BCAB.OQ / ABCL.OQ</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / Galapagos NV / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Avidity Biosciences Inc / Uniqure NV / Pacira Biosciences Inc / Ascendis Pharma A/S / AnaptysBio Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc / Intellia Therapeutics Inc / argenx SE / InflaRx NV / Scholar Rock Holding Corp / Cyclerion Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Inhibrx Inc / Immunovant Inc / Forma Therapeutics Holdings Inc / ALX Oncology Holdings Inc / CureVac NV / Spruce Biosciences Inc / Galecto Inc / Bioatla Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Denmark / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Dr. Martin Auster, M.D. / Ms. Judah C. Frommer / Mr. Tiago Fauth / Mark Connolly / Jonathan Woo / Yunhee Park / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N / PFE.N / GILD.OQ / AMRN.OQ / EHTH.OQ / OMER.OQ / EVGN.TA / AUP.TO / AKTX.OQ / APLS.OQ / IAN.CD / GTII.CD / MMEN.CD / CURA.CD / TRUL.CD / CL.CD / CCHW.NLB / PHGE.A / SLQT.N / GOCO.OQ / ACRGau.CD / 120346301</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amarin Corporation PLC / eHealth Inc / Omeros Corp / Evogene Ltd / Aurinia Pharmaceuticals Inc / Akari Therapeutics PLC / Apellis Pharmaceuticals Inc / Ianthus Capital Holdings Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Curaleaf Holdings Inc / Trulieve Cannabis Corp / Cresco Labs Inc / Columbia Care Inc / Biomx Inc / SelectQuote Inc / Gohealth Inc / Acreage Holdings Inc / Ayr Wellness Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Access to Medicine Foundation</td><td class="leftalignment">2021 Access to Medicine Index (26 Jan 2021)</td><td class="leftalignment">English</td><td class="rightalignment">237</td><td class="leftalignment">4502.T / 4503.T / 4523.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 4568.T / BAYGn.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Bayer AG / Abbvie Inc</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Team Index</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BSX=US / PFE=US / HD=US / MCD=US / WEN=US / BLD=US / RUN=US / GILD=US / BC=US / LOW=US / IART=US / MUR=US / BRO=US / LEG=US / MANH=US / CBRL=US / ELY=US / FUN=US / KIDS=US / DRI=US / GFF=US / HAS=US / HXL=US / IBP=US / HZO=US / MAS=US / MAT=US / MHK=US / PII=US / REGN=US / SGMO=US / STRA=US / THO=US / WW=US / WGO=US / GOLF=US / OPT=US / BXS=US / FBK=US / NLS=US / DIN=US / MGPI=US / BIIB=US / TPX=US / EXP=US / FHN=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / SIX=US / XPO=US / PGTI=US / SAIA=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / NMTR=US / SEAS=US / CWH=US / IAC=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / FOXF=US / MBUU=US / ARCB=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / WING=US / SPNE=US / TDOC=US / MCFT=US / ACBI=US / 82982L103 / JELD=US / FNKO=US / AXNX=US / KOD=US / FERGY=US / BRBR=US / ONEM=US / ONEW=US / AZEK=US / BALY=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Sunrun Inc / Gilead Sciences Inc / Brunswick Corp / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Murphy Oil Corp / Brown & Brown Inc / Leggett & Platt Inc / Manhattan Associates Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Cedar Fair LP / OrthoPediatrics Corp / Darden Restaurants Inc / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mattel Inc / Mohawk Industries Inc / Polaris Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Thor Industries Inc / WW International Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Opthea Ltd / Cadence Bank / FB Financial Corp / Nautilus Inc / Dine Brands Global Inc / MGP Ingredients Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Six Flags Entertainment Corp / XPO Logistics Inc / PGT Innovations Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Fox Factory Holding Corp / Malibu Boats Inc / ArcBest Corp / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Teladoc Health Inc / Mastercraft Boat Holdings Inc / Atlantic Capital Bancshares Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Funko Inc / Axonics Inc / Kodiak Sciences Inc / Ferguson PLC / Bellring Brands Inc / 1Life Healthcare Inc / OneWater Marine Inc / Azek Company Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - January 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CNR.TO / BB.N / CP.TO / NSC.N / GILD.O / AMGN.O / INCY.O / CSX.N / TV.TO / UNP.N / NBIX.O / VRTX.O / BIIB.O / ALNY.O / 35671D857 / CS.TO / AUY.N / 550372106 / SRPT.O / 505440107 / PTCT.O / CIA.TO / AUPH.O / GLPG.O / GBT.OQ / TFII.TO / NEXA.TO / 900435207</td><td class="leftalignment">Canadian National Railway Co / BlackBerry Ltd / Canadian Pacific Railway Ltd / Norfolk Southern Corp / Gilead Sciences Inc / Amgen Inc / Incyte Corp / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Capstone Mining Corp / Yamana Gold Inc / Lundin Mining Corp / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / Champion Iron Ltd / Aurinia Pharmaceuticals Inc / Galapagos NV / Global Blood Therapeutics Inc / TFI International Inc / Nexa Resources SA / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ANA.MC / BB.N / CP.TO / DFDS.CO / F.N / GM.N / KMB.N / NSC.N / SGC.L / GILD.O / AMGN.O / INCY.O / AAPL.O / CNR.TO / CSX.N / TV.TO / UNP.N / NBIX.O / VRTX.O / BRO.N / BIIB.O / 02209S103 / ALNY.O / 35671D857 / CS.TO / AUY.N / 550372106 / NOG.A / SRPT.O / MDLZ.OQ / 505440107 / PTCT.O / PTC.O / CIA.TO / AUPH.O / GLPG.O / GBT.OQ / CADE.N / NEXA.TO / WMG.OQ / 900435207</td><td class="leftalignment">Acciona SA / BlackBerry Ltd / Canadian Pacific Railway Ltd / DFDS AS / Ford Motor Co / General Motors Co / Kimberly-Clark Corp / Norfolk Southern Corp / Stagecoach Group PLC / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Apple Inc / Canadian National Railway Co / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Brown & Brown Inc / Biogen Inc / Altria Group Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Capstone Mining Corp / Yamana Gold Inc / Lundin Mining Corp / Northern Oil and Gas Inc / Sarepta Therapeutics Inc / Mondelez International Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / PTC Inc / Champion Iron Ltd / Aurinia Pharmaceuticals Inc / Galapagos NV / Global Blood Therapeutics Inc / Cadence Bank / Nexa Resources SA / Warner Music Group Corp / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Denmark / Spain / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: Leading The Way On Innovation And Sustainability – Our Biotech ESG Scorecard</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / VRTX.O / BIIB.O / ALNY.O / SRPT.O / PTCT.O / GLPG.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Lisa Walter / James Hong / Sara Mahaffy / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / David Szeto / Yinglu Zhang / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Microbiome Deep Dive: Key Players, Themes and Events for 2021</td><td class="leftalignment">English</td><td class="rightalignment">87</td><td class="leftalignment">EVGN.O / PHGE.K / MRK / PFE / GILD.O</td><td class="leftalignment">Evogene Ltd / Biomx Inc / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">HCM.L / GILD.OQ / INCY.OQ / AMRN.OQ / BSLN.S / MSB.AX / HALO.OQ / SPRO.OQ / ARDX.OQ / AUP.TO / AERI.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / CDTX.OQ / FBIO.OQ / ZYNE.OQ / BHVN.N / TXMD.OQ / EOLS.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / ALXO.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Gilead Sciences Inc / Incyte Corp / Amarin Corporation PLC / Basilea Pharmaceutica AG / Mesoblast Ltd / Halozyme Therapeutics Inc / Spero Therapeutics Inc / Ardelyx Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / Cidara Therapeutics Inc / Fortress Biotech Inc / Zynerba Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / TherapeuticsMD Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / ALX Oncology Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for GILD.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt color: SGMO is in clinical execution mode; investors should give it another look</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">SGMO=US / GILD=US / BIIB=US</td><td class="leftalignment">Sangamo Therapeutics Inc / Gilead Sciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LJPC=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">La Jolla Pharmaceutical Co / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US0374111054 / US0383361039 / US0584981064 / US0936711052 / US1270971039 / US2441991054 / US25179M1036 / US26875P1012 / US3755581036 / US3976241071 / US4062161017 / US4601461035 / US5463471053 / US6267171022 / US6745991058 / US6935061076 / US6951561090 / US7237871071 / US7310681025 / US75281A1097 / US7549071030 / US75886F1075 / AN8068571086 / US81211K1007 / US8270481091 / US8354951027 / US8454671095 / US92276F1003 / US9621661043 / CA29250N1050 / CA1469001053 / CA9528451052 / US5658491064 / US20825C1045 / US2283681060 / US02043Q1076 / US7588491032 / US3137472060 / US7376301039 / US40637H1095 / CA0010921058 / CA4495861060 / US42809H1077 / CA1375761048 / US5021751020 / US63633D1046 / US9814191048 / US88076W1036 / US3886891015 / US2120151012 / CA1254911003 / US26884L1098 / US78454L1008 / US18538R1032 / CA7063271034 / CA4932711001 / US09739D1000 / US81762P1021 / US09609G1004 / US69327R1014 / US78573L1061 / CA3748252069 / US5764852050 / US08579W1036 / US45845P1084 / US25278X1090 / US31189P1021 / US03674X1063 / US02005N1000 / US03820J1007 / CA45868C1095 / US14174T1079 / US92686J1060 / US1638511089 / US96145D1054 / US95040Q1040 / 100507888 / US5588681057 / US2057683029 / US15136A1025 / US12653C1080 / US03753U1060 / US2997341035 / US87484T1088 / US80706P1030 / US08579X1019 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / CA87807B1076 / US22052L1044 / US26614N1028 / JE00BJ1F3079 / US42250P1030 / US67098H1041 / US69047Q1022 / US80810D1037 / US90278Q1085 / US5168062058 / US13123X5086 / US69526K1051 / US3773201062 / CA00288U1066</td><td class="leftalignment">APA Corp (US) / Aptargroup Inc / Ball Corp / H & R Block Inc / Coterra Energy Inc / Deere & Co / Devon Energy Corp / EOG Resources Inc / Gilead Sciences Inc / Greif Inc / Halliburton Co / International Paper Co / Louisiana-Pacific Corp / Murphy Oil Corp / Occidental Petroleum Corp / PPG Industries Inc / Packaging Corp of America / Pioneer Natural Resources Co / Polaris Inc / Range Resources Corp / Rayonier Inc / Regeneron Pharmaceuticals Inc / Schlumberger NV / Sealed Air Corp / Silgan Holdings Inc / Sonoco Products Co / Southwestern Energy Co / Ventas Inc / Weyerhaeuser Co / Enbridge Inc / Cascades Inc / West Fraser Timber Co Ltd / Marathon Oil Corp / Conocophillips / Crown Holdings Inc / Alnylam Pharmaceuticals Inc / Regency Centers Corp / Federal Realty Investment Trust / Potlatchdeltic Corp / Halozyme Therapeutics Inc / AGF Management Ltd / IGM Financial Inc / Hess Corp / Canfor Corp / LTC Properties Inc / National Health Investors Inc / World Acceptance Corp / Teradata Corp / Graphic Packaging Holding Co / Continental Resources Inc / CI Financial Corp / EQT Corp / SM Energy Co / Clearwater Paper Corp / Pembina Pipeline Corp / Keyera Corp / Boise Cascade Co / ServiceNow Inc / bluebird bio Inc / PDC Energy Inc / Sabra Health Care REIT Inc / Gibson Energy Inc / Matador Resources Co / Berry Global Group Inc / Intercept Pharmaceuticals Inc / Diamondback Energy Inc / Fate Therapeutics Inc / Antero Resources Corp / Ally Financial Inc / Applied Genetic Technologies Corp / Interfor Corp / CareTrust REIT Inc / Viking Therapeutics Inc / Chemours Co / Westrock Co / Welltower Inc / SandRidge Energy Inc / Madrigal Pharmaceuticals Inc / Comstock Resources Inc / Centennial Resource Development Inc / CNX Resources Corp / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Talos Energy Inc / Scholar Rock Holding Corp / Berry Corporation (Bry) / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / TC Energy Corp / Corteva Inc / Dupont De Nemours Inc / Amcor PLC / Healthpeak Properties Inc / O-I Glass Inc / Ovintiv Inc / Schrodinger Inc / Ufp Industries Inc / Laredo Petroleum Inc / Callon Petroleum Co / Pactiv Evergreen Inc / Glatfelter Corp / Abcellera Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 Outlook: Biotech Fundamentals Remain Strong</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">US03753U1060 / US3755581036 / US75886F1075 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US5588681057 / US2997341035 / US80706P1030 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US80810D1037 / CA00288U1066</td><td class="leftalignment">Apellis Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Madrigal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Schrodinger Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Ikechukwu Oji / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine from GRTS; TSHA designations</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GRTS.OQ / TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Virtual KOL Call to Discuss The Competitive Landscape for CD47s in Development</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IMAB.O / GILD.O / ALXO.O</td><td class="leftalignment">I-Mab / Gilead Sciences Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ACB.TO / IBIO.A / ZTS.N / WEED.TO / TLRY.OQ / OGI.TO / XGN.OQ / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Aurora Cannabis Inc / Ibio Inc / Zoetis Inc / Canopy Growth Corp / Tilray Brands Inc / OrganiGram Holdings Inc / Exagen Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: COVID Vaccine Rollout Driving Recent Growth in the EpiPen Market?</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMTK=US / VERU=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / GBT=US / MDT=US / DYN=US / WMT=US / CMS=US / GILD=US / DGX=US / NVS=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CSTL=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / PHG=US / LH=US / REGN=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / CCRN=US / CNC=US / ACA=US / STSA=US / NTRA=US / ENSG=US / MIST=US / MD=US / NKTR=US / SLF=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / TPTX=US / IVA=US / EHC=US / NEO=US / ADUS=US / BEAM=US / ACHC=US / SRPT=US / AGIO=US / FATE=US / VCYT=US / CTRE=US / WBA=US / NVTA=US / VKTX=US / EVH=US / VRAY=US / MDGL=US / IRTC=US / NCNA=US / GH=US / ARVN=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / APLT=US / IDYA=US / BCYC=US / BCEL=US / KRTX=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PNTG=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">DermTech Inc / Veru Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Dyne Therapeutics Inc / Walmart Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Castle Biosciences Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Satsuma Pharmaceuticals Inc / Natera Inc / Ensign Group Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Inventiva SA / Encompass Health Corp / Neogenomics Inc / Addus Homecare Corp / Beam Therapeutics Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Veracyte Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Viking Therapeutics Inc / Evolent Health Inc / ViewRay Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / NuCana PLC / Guardant Health Inc / Arvinas Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Atreca Inc / Karuna Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Pennant Group Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">4Q Large Cap Preview:  We are paying most attention to BIIB and GILD outlooks around 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O / BIIB.O / AMGN.O / INCY.O / REGN.O / VRTX.O</td><td class="leftalignment">Gilead Sciences Inc / Biogen Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Biotech Sector: Pipeline updates and recent license-out deals accentuate LT potential of high-flying biotechs</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">1952.HK / BGNE.OQ / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / MGNX.OQ / TPB.N / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / GTH.OQ</td><td class="leftalignment">Everest Medicines Ltd / Beigene Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / MacroGenics Inc / Turning Point Brands Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Genetron Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Gilead Sciences, Inc.(GILD) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">375558103</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABT.N / BK.N / IBM.N / JNJ.N / KMB.N / SLB.N / T.N / USB.N / PG.N / DHR.N / UNH.N / UNP.N / MCD.N / VZ.N / V.N / RF.N / INTC.OQ / AAPL.OQ / HBAN.OQ / MSFT.OQ / GILD.OQ / ISRG.OQ / TXN.OQ / CMCSA.OQ / MS.N / NEE.N / TSLA.OQ / MDLZ.OQ / FB.PS</td><td class="leftalignment">Abbott Laboratories / Bank of New York Mellon Corp / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Schlumberger NV / AT&T Inc / US Bancorp / Procter & Gamble Co / Danaher Corp / UnitedHealth Group Inc / Union Pacific Corp / McDonald's Corp / Verizon Communications Inc / Visa Inc / Regions Financial Corp / Intel Corp / Apple Inc / Huntington Bancshares Inc / Microsoft Corp / Gilead Sciences Inc / Intuitive Surgical Inc / Texas Instruments Inc / Comcast Corp / Morgan Stanley / Nextera Energy Inc / Tesla Inc / Mondelez International Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Gilead Sciences Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US3755581036</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, GILD</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.OQ</td><td class="leftalignment">Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg / Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">PTON=US / VERU=US / INTC=US / AMD=US / AMZN=US / T=US / DYN=US / BAC=US / GILD=US / NVDA=US / GS=US / NICE=US / CHKP=US / TSM=US / SPOT=US / CYBR=US / MS=US / REGN=US / UTHR=US / VRTX=US / WIX=US / RDWR=US / OPT=US / NET=US / MTCH=US / STSA=US / NFLX=US / VRNT=US / MIST=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / VIAC=US / TPTX=US / IVA=US / SWI=US / FTNT=US / TSLA=US / BEAM=US / XYL=US / PANW=US / SRPT=US / FEYE=US / FATE=US / VRNS=US / GDDY=US / OKTA=US / SAIL=US / IQ=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / TUFN=US / APLT=US / IDYA=US / BCYC=US / CRWD=US / BCEL=US / KRTX=US / PING=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">Peloton Interactive Inc / Veru Inc / Intel Corp / Advanced Micro Devices Inc / Amazon.com Inc / AT&T Inc / Dyne Therapeutics Inc / Bank of America Corp / Gilead Sciences Inc / NVIDIA Corp / Goldman Sachs Group Inc / Nice Ltd / Check Point Software Technologies Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Spotify Technology SA / Cyberark Software Ltd / Morgan Stanley / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Radware Ltd / Opthea Ltd / Cloudflare Inc / Match Group Inc / Satsuma Pharmaceuticals Inc / Netflix Inc / Verint Systems Inc / Milestone Pharmaceuticals Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Inventiva SA / SolarWinds Corp / Fortinet Inc / Tesla Inc / Beam Therapeutics Inc / Xylem Inc / Palo Alto Networks Inc / Sarepta Therapeutics Inc / Mandiant Inc / Fate Therapeutics Inc / Varonis Systems Inc / GoDaddy Inc / Okta Inc / SailPoint Technologies Holdings Inc / iQIYI Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Tufin Software Technologies Ltd / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / CrowdStrike Holdings Inc / Atreca Inc / Karuna Therapeutics Inc / Ping Identity Holding Corp / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Info. Tech./Software / Machinery / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABT.N / BAC.N / BK.N / IBM.N / JNJ.N / KMB.N / SLB.N / T.N / USB.N / PG.N / UNH.N / UNP.N / GS.N / VZ.N / STT.N / RF.N / INTC.OQ / AAPL.OQ / HBAN.OQ / MSFT.OQ / GILD.OQ / ISRG.OQ / NFLX.OQ / TXN.OQ / MS.N / SCHW.N / NEE.N / TSLA.OQ / FB.PS</td><td class="leftalignment">Abbott Laboratories / Bank of America Corp / Bank of New York Mellon Corp / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Schlumberger NV / AT&T Inc / US Bancorp / Procter & Gamble Co / UnitedHealth Group Inc / Union Pacific Corp / Goldman Sachs Group Inc / Verizon Communications Inc / State Street Corp / Regions Financial Corp / Intel Corp / Apple Inc / Huntington Bancshares Inc / Microsoft Corp / Gilead Sciences Inc / Intuitive Surgical Inc / Netflix Inc / Texas Instruments Inc / Morgan Stanley / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Downgrade to Underperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback from Early 2021 Large/Mid-Cap Biotech Presentations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US / REGN=US / UTHR=US / VRTX=US / MRNA=US / SRPT=US</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / GILD.OQ / MSB.AX / ARDX.OQ / ZTS.N / BHVN.N / XELA.OQ / XGN.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Mesoblast Ltd / Ardelyx Inc / Zoetis Inc / Biohaven Pharmaceutical Holding Company Ltd / Exela Technologies Inc / Exagen Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAC / CCO / CMA / CNI / CP / CPB / DANO.PA / EOG / ETM / FMC / GIS / HSY / IPG / K / MRO / NSC / OMC / SHW / SJM / SM / TFX / THS / UNP / BYND.O / GILD.O / AMGN.O / AAPL.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / AXS / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / HAIN.O / BIIB.O / INFI.O / HALO.O / NOG.A / MRNA.O / ARCT.O / MDLZ.O / FANG.O / SMPL.O / POST.K / FATE.O / AFMD.O / BLCM.O / KHC.O / CYAD.O / OMF / CSX.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / NOMD.K / KZR.O / STRO.O / IHRT.O / IMV.O / BRBR.K / RAPT.O</td><td class="leftalignment">Bank of America Corp / Clear Channel Outdoor Holdings Inc / Comerica Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Campbell Soup Co / Danone SA / EOG Resources Inc / Audacy Inc / FMC Corp / General Mills Inc / Hershey Co / Interpublic Group of Companies Inc / Kellogg Co / Marathon Oil Corp / Norfolk Southern Corp / Omnicom Group Inc / Sherwin-Williams Co / J M Smucker Co / SM Energy Co / Teleflex Inc / TreeHouse Foods Inc / Union Pacific Corp / Beyond Meat Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / AXIS Capital Holdings Ltd / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Hain Celestial Group Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Northern Oil and Gas Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / Post Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Kraft Heinz Co / Celyad Oncology SA / OneMain Holdings Inc / CSX Corp / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Nomad Foods Ltd / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Bellring Brands Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / France / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CCO / ETM / IPG / OMC / SHW / TFX / GILD.O / AMGN.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ARCT.O / FATE.O / AFMD.O / BLCM.O / CYAD.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / KZR.O / STRO.O / IHRT.O / IMV.O / RAPT.O</td><td class="leftalignment">Clear Channel Outdoor Holdings Inc / Audacy Inc / Interpublic Group of Companies Inc / Omnicom Group Inc / Sherwin-Williams Co / Teleflex Inc / Gilead Sciences Inc / Amgen Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Celyad Oncology SA / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Anne Bode</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KRYS=US / ADAP=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / LOGC=US / MGEN=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US</td><td class="leftalignment">Krystal Biotech Inc / Adaptimmune Therapeutics PLC / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / LogicBio Therapeutics Inc / Viridian Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BSX=US / PEP=US / CAG=US / KO=US / OXY=US / RRC=US / CL=US / PG=US / MDT=US / T=US / BLD=US / DVN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / PB=US / MGY=US / SWN=US / MUR=US / UMPQ=US / MRO=US / NWL=US / FLO=US / STZ=US / AIZ=US / FUN=US / CENT=US / CHD=US / CNX=US / EPC=US / EQT=US / HAIN=US / IBP=US / MAS=US / MHK=US / SMG=US / HTH=US / CVX=US / POST=US / SNV=US / SIVB=US / ABCB=US / FBK=US / COP=US / ECPG=US / MGPI=US / SBCF=US / PRAA=US / MNST=US / NOMD=US / PRG=US / RNG=US / TPX=US / FRPT=US / THS=US / BLDR=US / SIX=US / ELF=US / OC=US / CADE=US / CLR=US / PRPL=US / SEAS=US / NOG=US / RCUS=US / AAN=US / AR=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / IBTX=US / QTWO=US / FIVN=US / VNOM=US / COUP=US / NVRO=US / WVE=US / EVBG=US / CDEV=US / PVAC=US / JELD=US / SBOW=US / PETQ=US / NCNA=US / DCPH=US / KDP=US / RTLR=US / FERGY=US / BRBR=US / OVV=US / REYN=US / FBRX=US / NCNO=US / BIGC=US / 100087548</td><td class="leftalignment">Boston Scientific Corp / PepsiCo Inc / Conagra Brands Inc / Coca-Cola Co / Occidental Petroleum Corp / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Medtronic PLC / AT&T Inc / TopBuild Corp / Devon Energy Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Umpqua Holdings Corp / Marathon Oil Corp / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / Assurant Inc / Cedar Fair LP / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Scotts Miracle-Gro Co / Hilltop Holdings Inc / Chevron Corp / Post Holdings Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / Conocophillips / Encore Capital Group Inc / MGP Ingredients Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Monster Beverage Corp / Nomad Foods Ltd / PROG Holdings Inc / RingCentral Inc / Tempur Sealy International Inc / Freshpet Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Six Flags Entertainment Corp / elf Beauty Inc / Owens Corning / Cadence Bank / Continental Resources Inc / Purple Innovation Inc / SeaWorld Entertainment Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Aaron's Company Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Independent Bank Group Inc / Q2 Holdings Inc / Five9 Inc / Viper Energy Partners LP / Coupa Software Inc / Nevro Corp / WAVE Life Sciences Ltd / Everbridge Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / PetIQ Inc / NuCana PLC / Deciphera Pharmaceuticals Inc / Keurig Dr Pepper Inc / Rattler Midstream LP / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Reynolds Consumer Products Inc / Forte Biosciences Inc / nCino Inc / Bigcommerce Holdings Inc / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / Luxembourg / Singapore / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Normally Q4 is Solid, but COVID & Currency Cloud Outlook</td><td class="leftalignment">English</td><td class="rightalignment">118</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / REGN=US / VRTX=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : Putting a Wrap on The 2021 Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CVS.N / JNJ.N / MCK.N / PFE.N / GILD.O / AMGN.O / INCY.O / ALKS.O / BMRN.O / REGN.O / VRTX.O / RARE.O / BLUE.O / NVAX.O / SGEN.O / BIIB.O / ACAD.O / MRNA.O / CLVS.O / SAGE.O / GBT.O / NVCR.O / EDIT.O / PBYI.O / JNCE.O / ALLO.O / BNTX.O / LEGN.O / BCAB.O</td><td class="leftalignment">CVS Health Corp / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Alkermes Plc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Novavax Inc / Seagen Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / Editas Medicine Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc / BioNTech SE / Legend Biotech Corp / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BAC.N / BK.N / C.N / IBM.N / JNJ.N / JPM.N / KMB.N / PNC.N / SLB.N / USB.N / WFC.N / PG.N / UNH.N / UNP.N / GS.N / VZ.N / STT.N / RF.N / INTC.OQ / MSFT.OQ / GILD.OQ / ISRG.OQ / NFLX.OQ / TXN.OQ / MS.N / SCHW.N / NEE.N / TER.OQ</td><td class="leftalignment">Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / PNC Financial Services Group Inc / Schlumberger NV / US Bancorp / Wells Fargo & Co / Procter & Gamble Co / UnitedHealth Group Inc / Union Pacific Corp / Goldman Sachs Group Inc / Verizon Communications Inc / State Street Corp / Regions Financial Corp / Intel Corp / Microsoft Corp / Gilead Sciences Inc / Intuitive Surgical Inc / Netflix Inc / Texas Instruments Inc / Morgan Stanley / Charles Schwab Corp / Nextera Energy Inc / Teradyne Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Incremental Observations From Recent Meetings With 30 Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">375558103 / 640268108 / 45337C102 / 09058V103 / 803607100 / 03835T200 / 60468T105 / 462222100 / 52187K101 / G11196105 / 07725L102 / 00773U108 / 00847X104 / 019770106 / 41358P106 / 87808K106 / 68906L105 / 69242L106 / 64049K104 / 10806X102 / 729139105 / 00973J101 / 45790W108 / 38341P102 / 67080M103 / 73730P108 / 01626L105 / 74006W108 / G59665102 / 22663K107</td><td class="leftalignment">Gilead Sciences Inc / Nektar Therapeutics / Incyte Corp / BioCryst Pharmaceuticals Inc / Sarepta Therapeutics Inc / Aptose Biosciences Inc / Mirati Therapeutics Inc / Ionis Pharmaceuticals Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Beigene Ltd / Adverum Biotechnologies Inc / Agios Pharmaceuticals Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Otonomy Inc / Oyster Point Pharma Inc / Neoleukin Therapeutics Inc / BridgeBio Pharma Inc / Pliant Therapeutics Inc / Akouos Inc / Inozyme Pharma Inc / Gossamer Bio Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / MeiraGTx Holdings PLC / Crinetics Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tyler M. Van Buren, M.SC / Alexander Duncan, Ph.D. / Tara Bancroft, Ph.D. / James Delorme, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW SPEAKER ADDED: Virtual KOL Call to Discuss The Competitive Landscape for CD47s in Development</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IMAB.O / GILD.O / ALXO.O</td><td class="leftalignment">I-Mab / Gilead Sciences Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
</tbody></table>
</body>
</html>